PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eldakak, A; Rancati, G; Rubinstein, B; Paul, P; Conaway, V; Li, R				Eldakak, Amr; Rancati, Giulia; Rubinstein, Boris; Paul, Parama; Conaway, Veronica; Li, Rong			Asymmetrically inherited multidrug resistance transporters are recessive determinants in cellular replicative ageing	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; YEAST; LOCALIZATION; SPERMIDINE; AUTOPHAGY; POLARITY; SEPTINS; SIR2	Cellular ageing is known to correlate with the accumulation of many harmful agents', but it is unclear whether ageing can also result from the deterioration of components that are beneficial to the cell, but have a low rate of renewal. Here, we report a group of plasma membrane-associated transporters in yeast, belonging to the multidrug resistance (MDR) protein families, that may represent the latter type of ageing determinants. During the division of a yeast cell, newly synthesized transporter proteins are deposited mostly into the growing bud, whereas previously synthesized MDR proteins remain tightly associated with the mother cortex. Thus, the new and old pools of membrane-bound MDR proteins are spatially segregated during yeast asymmetric cell division, with the older pool stably inherited by the ageing mother. A model based on the observed dynamics of MDR protein inheritance and turnover predicted a decline in MDR activity as the mother cell advances in replicative age. As MDR proteins have crucial roles in cellular metabolism, detoxification and stress response, their collective decline may lead to fitness loss at an advanced age. Supporting this hypothesis, mutants lacking certain MDR genes exhibited a reduced replicative lifespan (RLS), whereas introduction of only one extra copy of these MDR genes extended RLS.	[Eldakak, Amr; Rancati, Giulia; Rubinstein, Boris; Paul, Parama; Conaway, Veronica; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Rancati, Giulia/0000-0003-0835-0139	National Institutes of Health [R01GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Zhou for assistance on RLS experiments; C. Seidel and B. Fleharty for help on RNA purification and quantitative RT-PCR; R. Zhu, K. Wagner and J. Haug for assistamce with cell-sorting experiments and B. Slaughter, N. Pavelka and S. Xia for technical advice and critical comments. This research is supported by the National Institutes of Health, grant R01GM057063 to R.L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burke D., 2000, METHODS YEAST GENETI; BURKE DJ, 1991, MOL CELL BIOL, V11, P3691, DOI 10.1128/MCB.11.7.3691; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; EGILMEZ NK, 1990, J GERONTOL, V45, pB9, DOI 10.1093/geronj/45.1.B9; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Henderson KA, 2008, CURR OPIN CELL BIOL, V20, P723, DOI 10.1016/j.ceb.2008.09.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Kirchman PA, 2007, MECH AGEING DEV, V128, P187, DOI 10.1016/j.mad.2006.10.003; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200	30	37	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					799	U55		10.1038/ncb2085	http://dx.doi.org/10.1038/ncb2085			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20657593	Green Accepted			2022-12-27	WOS:000280561600012
J	Fraley, SI; Feng, YF; Krishnamurthy, R; Kim, DH; Celedon, A; Longmore, GD; Wirtz, D				Fraley, Stephanie I.; Feng, Yunfeng; Krishnamurthy, Ranjini; Kim, Dong-Hwee; Celedon, Alfredo; Longmore, Gregory D.; Wirtz, Denis			A distinctive role for focal adhesion proteins in three-dimensional cell motility	NATURE CELL BIOLOGY			English	Article							FIBRONECTIN FIBRILLOGENESIS; PERICELLULAR PROTEOLYSIS; 3D MATRIX; CANCER; MIGRATION; MECHANISM; SUBSTRATE; KINASE; MECHANOSENSORS; CYTOSKELETAL	Focal adhesions are large multi-protein assemblies that form at the basal surface of cells on planar dishes, and that mediate cell signalling, force transduction and adhesion to the substratum. Although much is known about focal adhesion components in two-dimensional (2D) systems, their role in migrating cells in a more physiological three-dimensional (3D) matrix is largely unknown. Live-cell microscopy shows that for cells fully embedded in a 3D matrix, focal adhesion proteins, including vinculin, paxillin, talin, alpha-actinin, zyxin, VASP, FAK and p130Cas, do not form aggregates but are diffusely distributed throughout the cytoplasm. Despite the absence of detectable focal adhesions, focal adhesion proteins still modulate cell motility, but in a manner distinct from cells on planar substrates. Rather, focal adhesion proteins in matrix-embedded cells regulate cell speed and persistence by affecting protrusion activity and matrix deformation, two processes that have no direct role in controlling 2D cell speed. This study shows that membrane protrusions constitute a critical motility/matrix-traction module that drives cell motility in a 3D matrix.	[Fraley, Stephanie I.; Krishnamurthy, Ranjini; Kim, Dong-Hwee; Celedon, Alfredo; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Fraley, Stephanie I.; Feng, Yunfeng; Kim, Dong-Hwee; Longmore, Gregory D.; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Washington Univ BRIGHT Inst, St Louis, MO 63110 USA; [Celedon, Alfredo] Pontificia Univ Catolica Chile, Dept Mech Engn, Santiago 6904411, Chile	Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pontificia Universidad Catolica de Chile	Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	glongmor@dom.wustl.edu; wirtz@jhu.edu	Wirtz, Denis/A-3257-2010; Fraley, Stephanie I./S-6162-2019; Kim, Dong-Hwee/AAU-4058-2021; Fraley, Stephanie/GSN-9847-2022	Kim, Dong-Hwee/0000-0003-0625-0660; Celedon, Alfredo/0000-0002-3224-8831; Feng, Yunfeng/0000-0001-9150-7795; Fraley, Stephanie/0000-0003-1548-4442	NIH [CA143868, GM084204, GM080673, CA85839]; ARCS; NSF-GRFP; NATIONAL CANCER INSTITUTE [R01CA085839, U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204, R01GM080673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from NIH (CA143868, GM084204, GM080673, and CA85839). S.I.F. was supported by ARCS and NSF-GRFP. We thank Michael McCaffery and Ned Perkins for help with confocal microscopy, members of the Wirtz and Longmore groups for helpful discussions, and John Isaacs of JHMI and his group for generously providing E006AA prostate cancer cells.	Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Hanada M, 2005, CLIN EXP METASTAS, V22, P485, DOI 10.1007/s10585-005-3733-6; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Lee JSH, 2006, J CELL SCI, V119, P1760, DOI 10.1242/jcs.02899; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mao Y, 2006, CELL COMMUN ADHES, V13, P267, DOI 10.1080/15419060601072215; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Munevar S, 2001, MOL BIOL CELL, V12, P3947, DOI 10.1091/mbc.12.12.3947; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Ren XD, 2000, J CELL SCI, V113, P3673; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	31	429	437	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					598	U169		10.1038/ncb2062	http://dx.doi.org/10.1038/ncb2062			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473295	Green Accepted			2022-12-27	WOS:000278213400012
J	Mast, FD; Fagarasanu, A; Rachubinski, R				Mast, Fred D.; Fagarasanu, Andrei; Rachubinski, Richard			The peroxisomal protein importomer: a bunch of transients with expanding waistlines	NATURE CELL BIOLOGY			English	Editorial Material							MEMBRANES	Peroxisomes can import large multimeric protein complexes and even 9-nm gold particles decorated with peroxisome-targeting signals. They achieve these feats of protein passage using a distinctive translocon whose highly dynamic aqueous pore can expand to accommodate the increasing girths of different peroxisome receptor-cargo complexes.	[Mast, Fred D.; Fagarasanu, Andrei; Rachubinski, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Mast, FD (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	rick.rachubinski@ualberta.ca	Mast, Fred/A-6507-2011; Mast, Fred/AAM-2426-2021	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647				Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; LABARCA P, 1986, J MEMBRANE BIOL, V94, P285, DOI 10.1007/BF01869724; McNew JA, 1996, TRENDS BIOCHEM SCI, V21, P54, DOI 10.1016/S0968-0004(96)80181-2; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Tabak HF, 2008, CURR OPIN CELL BIOL, V20, P393, DOI 10.1016/j.ceb.2008.05.008; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675	12	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					203	205		10.1038/ncb0310-203	http://dx.doi.org/10.1038/ncb0310-203			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20190827				2022-12-27	WOS:000275054200003
J	Annicotte, JS; Blanchet, E; Chavey, C; Iankova, I; Costes, S; Assou, S; Teyssier, J; Dalle, S; Sardet, C; Fajas, L				Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Costes, Safia; Assou, Said; Teyssier, Jacques; Dalle, Stephane; Sardet, Claude; Fajas, Lluis			The CDK4-pRB-E2F1 pathway controls insulin secretion	NATURE CELL BIOLOGY			English	Article							PANCREATIC BETA-CELLS; ACTIVATED-RECEPTOR-GAMMA; SENSITIVE K+ CHANNEL; PROMOTES ADIPOGENESIS; TRANSCRIPTION; GROWTH; MICE; MASS; EXPRESSION; PROLIFERATION	CDK4-pRB-E2F1 cell-cycle regulators are robustly expressed in non-proliferating beta cells, suggesting that besides the control of beta-cell number the CDK4-pRB-E2F1 pathway has a role in beta-cell function. We show here that E2F1 directly regulates expression of Kir6.2, which is a key component of the K-ATP channel involved in the regulation of glucose-induced insulin secretion. We demonstrate, through chromatin immunoprecipitation analysis from tissues, that Kir6.2 expression is regulated at the promoter level by the CDK4-pRB-E2F1 pathway. Consistently, inhibition of CDK4, or genetic inactivation of E2F1, results in decreased expression of Kir6.2, impaired insulin secretion and glucose intolerance in mice. Furthermore we show that rescue of Kir6.2 expression restores insulin secretion in E2f1(-/-) beta cells. Finally, we demonstrate that CDK4 is activated by glucose through the insulin pathway, ultimately resulting in E2F1 activation and, consequently, increased expression of Kir6.2. In summary we provide evidence that the CDK4-pRB-E2F1 regulatory pathway is involved in glucose homeostasis, defining a new link between cell proliferation and metabolism.	[Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] INSERM, U834, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] IRCM, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] INSERM, U896, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] Univ Montpellier 1, F-34298 Montpellier, France; [Annicotte, Jean-Sebastien; Blanchet, Emilie; Chavey, Carine; Iankova, Irena; Teyssier, Jacques; Fajas, Lluis] CRLC Val Aurelle Paul Lamarque, F-34298 Montpellier, France; [Costes, Safia; Dalle, Stephane] CNRS, UMR5203, Inst Genom Fonct, F-34094 Montpellier, France; [Costes, Safia; Dalle, Stephane] INSERM, U661, Equipe AVENIR, F-34094 Montpellier, France; [Costes, Safia; Dalle, Stephane] Univ Montpellier 1, F-34094 Montpellier, France; [Assou, Said] Hop St Eloi, Inst Res Biotherapy, Ctr Hosp Univ, F-34295 Montpellier, France; [Sardet, Claude] Inst Genet Mol, F-34293 Montpellier, France; [Sardet, Claude] CNRS, UMR5535, F-34293 Montpellier, France; [Sardet, Claude] Univ Montpellier 2, F-34293 Montpellier, France; [Fajas, Lluis] Ctr Hosp Univ Arnaud de Villeneuve, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Fajas, L (corresponding author), INSERM, U834, F-34298 Montpellier, France.	lluis.fajas@inserm.fr	Annicotte, Jean-Sébastien/H-4641-2018; , Costes/AAC-2820-2020; Coll, Lluis Fajas/C-8567-2014	Annicotte, Jean-Sébastien/0000-0002-2109-4849; , Costes/0000-0001-8323-1207; Chavey, Carine/0000-0002-5267-5638; Fajas, Lluis/0000-0002-1283-9503; assou, said/0000-0001-6448-7995	Agence Nationale pour la Recherche; INSERM-Association Francaise des Diabetiques; Association pour la Recherche contre le Cancer; Fondation pour la Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM-Association Francaise des Diabetiques; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministere de l'Enseignement Superieur et de la Recherche	We thank K. H. Kaestner (pGL3-Kir6.2-Luc), S. Seino and Y. Kurachi (pCDNA3 Kir6.2) for the gift of materials; I. Ait Arssa, M. Brissac, C. Clape, D. Greuet, C. Henriquet and S. Hure for excellent technical help; L. Le Cam. Members of the Fajas lab are acknowledged for support and discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR physio2006), INSERM-Association Francaise des Diabetiques (PNR-Diabete), Association pour la Recherche contre le Cancer, and Fondation pour la Recherche Medicale. E. B. is supported by a grant form the Ministere de l'Enseignement Superieur et de la Recherche, C. C. is supported by a grant from the Agence Nationale pour la Recherche.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; Miki T, 2002, AM J PHYSIOL-ENDOC M, V283, pE1178, DOI 10.1152/ajpendo.00313.2002; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Remedi MS, 2004, DIABETES, V53, P3159, DOI 10.2337/diabetes.53.12.3159; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597	29	102	105	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1017	U247		10.1038/ncb1915	http://dx.doi.org/10.1038/ncb1915			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597485	Green Accepted, Green Submitted			2022-12-27	WOS:000268593200017
J	Vincent, T; Neve, EPA; Johnson, JR; Kukalev, A; Rojo, F; Albanell, J; Pietras, K; Virtanen, I; Philipson, L; Leopold, PL; Crystal, RG; de Herreros, AG; Moustakas, A; Pettersson, RF; Fuxe, J				Vincent, Theresa; Neve, Etienne P. A.; Johnson, Jill R.; Kukalev, Alexander; Rojo, Federico; Albanell, Joan; Pietras, Kristian; Virtanen, Ismo; Philipson, Lennart; Leopold, Philip L.; Crystal, Ronald G.; Garcia de Herreros, Antonio; Moustakas, Aristidis; Pettersson, Ralf F.; Fuxe, Jonas			A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; CADHERIN GENE-EXPRESSION; ADENOVIRUS-RECEPTOR; FACTOR SNAIL; TUMOR-CELLS; CARCINOMA-CELLS; TIGHT JUNCTIONS; BREAST-CANCER; COXSACKIE; METASTASIS	Epithelial-mesenchymal transition (EMT) is essential for organogenesis and is triggered during carcinoma progression to an invasive state(1). Transforming growth factor-beta (TGF-beta) cooperates with signalling pathways, such as Ras and Wnt, to induce EMT2-5, but the molecular mechanisms are not clear. Here, we report that SMAD3 and SMAD4 interact and form a complex with SNAIL1, a transcriptional repressor and promoter of EMT6,7. The SNAIL1-SMAD3/4 complex was targeted to the gene promoters of CAR, a tight-junction protein, and E-cadherin during TGF-beta-driven EMT in breast epithelial cells. SNAIL1 and SMAD3/4 acted as co-repressors of CAR, occludin, claudin-3 and E-cadherin promoters in transfected cells. Conversely, co-silencing of SNAIL1 and SMAD4 by siRNA inhibited repression of CAR and occludin during EMT. Moreover, loss of CAR and E-cadherin correlated with nuclear co-expression of SNAIL1 and SMAD3/4 in a mouse model of breast carcinoma and at the invasive fronts of human breast cancer. We propose that activation of a SNAIL1-SMAD3/4 transcriptional complex represents a mechanism of gene repression during EMT.	[Johnson, Jill R.; Kukalev, Alexander; Philipson, Lennart; Fuxe, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Vincent, Theresa; Neve, Etienne P. A.; Pettersson, Ralf F.] Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden; [Rojo, Federico; Albanell, Joan; Garcia de Herreros, Antonio] IMIM Hosp Mar, Programa Recerca Canc, Dept Oncol, Barcelona 08003, Spain; [Virtanen, Ismo] Univ Helsinki, Inst Biomed Anat, FI-00014 Helsinki, Finland; [Leopold, Philip L.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Crystal, Ronald G.] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA; [Moustakas, Aristidis] Ludwig Inst Canc Res, Uppsala Branch, SE-75124 Uppsala, Sweden; [Vincent, Theresa] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Neve, Etienne P. A.] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, S-17177 Stockholm, Sweden; [Rojo, Federico] Fdn Jimenez Diaz, Serv Anat Patol, E-28040 Madrid, Spain; [Albanell, Joan] Hosp del Mar, Serv Oncol Patol, Barcelona, Spain; [Johnson, Jill R.; Pietras, Kristian; Fuxe, Jonas] Karolinska Inst, Matrix Div, Dept Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Helsinki; Stevens Institute of Technology; Cornell University; Ludwig Institute for Cancer Research; Cornell University; Karolinska Institutet; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Karolinska Institutet	Fuxe, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.fuxe@ki.se	Rojo, Federico/S-6551-2016; Pietras, Kristian/ABG-2097-2021; Fuxe, Jonas/T-4433-2017; Albanell, Joan/R-9470-2019; VIncent, Theresa/HDN-9575-2022; Pietras, Kristian/ABE-8727-2020; de Herreros, A Garcia/H-3104-2014	Pietras, Kristian/0000-0001-6738-4705; Fuxe, Jonas/0000-0003-4576-9377; de Herreros, A Garcia/0000-0001-5270-0808; Rojo, Federico/0000-0001-9989-0290; Johnson, Jill/0000-0002-5149-0084	Swedish Research Council; Swedish Wenner-Gren Foundation; Swedish Childhood Cancer Foundation; International Union Against Cancer (UICC); American Cancer Society International Fellowship; National Institutes of Health (NIH) [PO1 HL59312]; Antonio Garcia de Herreros; Joan Albanell and Federico Rojo [RD06/0020/109, RD06/0020/040]; FIS [PI061513, SAF2006-00339]; Fundacio Privada Cellex; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059312] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Wenner-Gren Foundation; Swedish Childhood Cancer Foundation(European Commission); International Union Against Cancer (UICC); American Cancer Society International Fellowship(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Garcia de Herreros; Joan Albanell and Federico Rojo; FIS(Instituto de Salud Carlos III); Fundacio Privada Cellex(Foundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Carl-Henrik Heldin (Ludwig Institute for Cancer Research, Uppsala Branch) and Ola Hermansson (Department of Neuroscience, Karolinska Institute, Sweden) for fruitful discussions; Clara Franc (IMIM- Hospital del Mar, Barcelona) for the initial immunohistochemical analysis of human tumors; Anita Bergstrom, Silvia Menendez and Marta Garrido for excellent technical assistance and Olov Andersson (Department of Cell and Molecular Biology, Karolinska Institute) for antibodies. Jonas Fuxe was supported by grants from the Swedish Research Council, the Swedish Wenner-Gren Foundation, the Swedish Childhood Cancer Foundation and an International Union Against Cancer (UICC), American Cancer Society International Fellowship for Beginning Investigators. Theresa Vincent was supported by the Swedish Research Council. Philip Leopold and Ronald Crystal were supported by the National Institutes of Health (NIH) by PO1 HL59312 and Antonio Garcia de Herreros, Joan Albanell and Federico Rojo by RD06/0020/109, RD06/0020/040, FIS PI061513, SAF2006-00339 and Fundacio Privada Cellex.	Anders M, 2003, CANCER RES, V63, P2088; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Frey BM, 1998, BLOOD, V91, P2781, DOI 10.1182/blood.V91.8.2781.2781_2781_2792; Hajra KM, 2002, CANCER RES, V62, P1613; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; MAHONEY KH, 1985, J LEUKOCYTE BIOL, V38, P573, DOI 10.1002/jlb.38.5.573; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsumoto K, 2005, UROLOGY, V66, P441, DOI 10.1016/j.urology.2005.02.033; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Philipson L, 2004, CURR TOP MICROBIOL, V273, P87; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wei WZ, 1999, INT J CANCER, V81, P748, DOI 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.0.CO;2-6; Yamashita M, 2007, INT J CANCER, V121, P1690, DOI 10.1002/ijc.22852; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	493	514	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					943	U84		10.1038/ncb1905	http://dx.doi.org/10.1038/ncb1905			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597490	Green Accepted			2022-12-27	WOS:000268593200007
J	Chan, KL; Palmai-Pallag, T; Ying, SM; Hickson, ID				Chan, Kok Lung; Palmai-Pallag, Timea; Ying, Songmin; Hickson, Ian D.			Replication stress induces sister-chromatid bridging at fragile site loci in mitosis	NATURE CELL BIOLOGY			English	Article							FANCONI-ANEMIA; BLOOM-SYNDROME; RECOMBINATION; STABILITY; PATHWAYS; PROTEINS; COMPLEX; CELLS	Several inherited syndromes in humans are associated with cancer predisposition. The gene products defective in two of these disorders, BLM ( a helicase defective in Bloom's syndrome)(1) and FANC A-N ( defective in Fanconi anaemia)(2), associate in a multienzyme complex called BRAFT(3). How these proteins suppress tumorigenesis remains unclear, although both conditions are associated with chromosome instability. Here we show that the Fanconi anaemia proteins FANCD2 and FANCI specifically associate with common fragile site loci irrespective of whether the chromosome is broken. Unexpectedly, these loci are frequently interlinked through BLM-associated ultra-fine DNA bridges(4) (UFBs) even as cells traverse mitosis. Similarly to fragile site expression(5), fragile site bridging is induced after partial inhibition of DNA replication. We propose that, after replication stress, sister chromatids are interlinked by replication intermediates primarily at genetic loci with intrinsic replication difficulties, such as fragile sites. In Bloom's syndrome cells, inefficient resolution of DNA linkages at fragile sites gives rise to increased numbers of anaphase UFBs and micronuclei containing fragile site DNA. Our data have general implications concerning the contribution of fragile site loci to chromosomal instability and tumorigenesis.	[Chan, Kok Lung; Palmai-Pallag, Timea; Ying, Songmin; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Hickson, ID (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	ian.hickson@imm.ox.ac.uk	Hickson, Ian/AAJ-7548-2020	Palmai-Pallag, Timea/0000-0002-7402-2144; chan, kok-lung/0000-0002-8796-8385; Hickson, Ian/0000-0002-0583-566X	Cancer Research UK; Croucher Foundation (Hong Kong)	Cancer Research UK(Cancer Research UK); Croucher Foundation (Hong Kong)	We thank members of the Hickson laboratory for helpful discussions, P. McHugh and L. Wu for helpful comments on the manuscript, and P. White for preparation of the manuscript. B. Lopes, P. Jeggo, F. Esashi, A. D'Andrea, G. Brown, E. Nigg and S. Elledge kindly supplied reagents. This work was supported by Cancer Research UK. K. L. C. was supported by the Croucher Foundation (Hong Kong).	Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; DURKIN SG, 2007, P NATL ACAD SCI USA, V8, P246; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	19	427	435	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					753	U120		10.1038/ncb1882	http://dx.doi.org/10.1038/ncb1882			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465922				2022-12-27	WOS:000266503700021
J	Shukla, A; Malik, M; Cataisson, C; Ho, Y; Friesen, T; Suh, KS; Yuspa, SH				Shukla, Anjali; Malik, Mariam; Cataisson, Christophe; Ho, Yan; Friesen, Travis; Suh, Kwang S.; Yuspa, Stuart H.			TGF-beta signalling is regulated by Schnurri-2-dependent nuclear translocation of CLIC4 and consequent stabilization of phospho-Smad2 and 3	NATURE CELL BIOLOGY			English	Article							CHLORIDE CHANNEL PROTEIN; ION CHANNEL; SMAD PROTEINS; EXPRESSION; GROWTH; KERATINOCYTES; TRANSCRIPTION; MTCLIC/CLIC4; APOPTOSIS; P53	CLIC4 (chloride intracellular channel 4), a multifunctional protein that traffics between the cytoplasm and nucleus, interacts with Schnurri-2, a transcription factor in the bone morphogenetic protein (BMP) signalling pathway. Here we show that transforming growth factor beta (TGF-beta) promotes the expression of CLIC4 and Schnurri-2 as well as their association in the cytoplasm and their translocation to the nucleus. In the absence of CLIC4 or Schnurri-2, TGF-beta signalling is abrogated. Direct nuclear targeting of CLIC4 enhances TGF-beta signalling and removes the requirement for Schnurri-2. Nuclear CLIC4 associates with phospho (p)-Smad2 and p-Smad3, protecting them from dephosphorylation by nuclear phosphatases. An intact TGF-beta signalling pathway is essential for CLIC4-mediated growth-arrest. These results newly identify Schnurri-2 and CLIC4 as modifiers of TGF-beta signalling through their stabilization of p-Smad2 and 3 in the nucleus.	[Shukla, Anjali; Malik, Mariam; Cataisson, Christophe; Ho, Yan; Friesen, Travis; Suh, Kwang S.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov	Shukla, Anjali/G-4046-2014	, Yan/0000-0003-4980-9663	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank L. Wakefield for critically reading the manuscript, M. Anzano for help with genotyping, C. Cheng for help with immunoprecipitation assays and colleagues for providing constructive criticism throughout the study. This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH.	Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shorning BY, 2003, DEV GENES EVOL, V213, P514, DOI 10.1007/s00427-003-0356-2; Suh KS, 2005, CURR PHARM DESIGN, V11, P2753, DOI 10.2174/1381612054546806; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748	25	71	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					777	U154		10.1038/ncb1885	http://dx.doi.org/10.1038/ncb1885			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448624	Green Accepted			2022-12-27	WOS:000266503700024
J	Randow, F; Lehner, PJ				Randow, Felix; Lehner, Paul J.			Viral avoidance and exploitation of the ubiquitin system	NATURE CELL BIOLOGY			English	Review							MHC CLASS-I; HERPES-SIMPLEX-VIRUS; COMPLEX CLASS-I; REGULATORY PROTEIN ICP0; HUMAN CYTOMEGALOVIRUS; MEMBRANE-PROTEIN; E3 LIGASE; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; CELL-SURFACE	The versatility of ubiquitin in regulating protein function and cell behaviour through post-translational protein modification makes it a particularly attractive target for viruses. Here we review how viruses manipulate the ubiquitin system to favour their propagation by redirecting cellular ubiquitin enzymes or encoding their own ubiquitin components to enable replication, egress and immune evasion. These studies not only reveal the many cellular processes requiring ubiquitin but also illustrate how viruses usurp their host cells.	[Randow, Felix] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Lehner, Paul J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Randow, F (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	randow@mrc-lmb.cam.ac.uk; pjl30@cam.ac.uk		Lehner, Paul Joseph/0000-0001-9383-1054	Wellcome Trust; Medical Research Council and Cambridge University Hospitals Biomedical Research Centre; Medical Research Council [G9800943, MC_U105170648] Funding Source: researchfish; MRC [MC_U105170648, G9800943] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council and Cambridge University Hospitals Biomedical Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Jessica Boname, David Komander and members of the Randow and Lehner labs for helpful discussions. We apologize to those authors whose work we have been unable to include because of space constraints. This work was supported by grants from the Wellcome Trust, Medical Research Council and Cambridge University Hospitals Biomedical Research Centre. P. J. L. holds a Lister Institute Research Prize.	Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Becher P, 2002, J VIROL, V76, P13069, DOI 10.1128/JVI.76.24.13069-13076.2002; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; Blanchette P, 2004, MOL CELL BIOL, V24, P9619, DOI 10.1128/MCB.24.21.9619-9629.2004; Blanchette P, 2009, VIROLOGY, V384, P317, DOI 10.1016/j.virol.2008.10.005; Boettcher S, 2008, J VIROL, V82, P6009, DOI 10.1128/JVI.00280-08; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; DAUBEUF S, 2008, BLOOD; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Gilbert MJ, 1996, NATURE, V383, P720, DOI 10.1038/383720a0; GUARINO LA, 1995, CELL, V80, P301, DOI 10.1016/0092-8674(95)90413-1; Haas AL, 1996, BIOCHEMISTRY-US, V35, P5385, DOI 10.1021/bi9524981; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; Hagglund R, 2002, P NATL ACAD SCI USA, V99, P7889, DOI 10.1073/pnas.122246999; Haque M, 2001, J GEN VIROL, V82, P1175, DOI 10.1099/0022-1317-82-5-1175; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HINGAMP PM, 1992, EMBO J, V11, P361, DOI 10.1002/j.1460-2075.1992.tb05058.x; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jarosinski K, 2007, P NATL ACAD SCI USA, V104, P20025, DOI 10.1073/pnas.0706295104; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Masucci MG, 2004, ONCOGENE, V23, P2107, DOI 10.1038/sj.onc.1207372; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; NATHAN JA, 2008, EXP CELL RES, DOI DOI 10.1016/J.YEXCR.2008.10026; Nerenberg BTH, 2005, J VIROL, V79, P597, DOI 10.1128/JVI.79.1.597-601.2005; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Portis T, 2004, TRENDS IMMUNOL, V25, P422, DOI 10.1016/j.it.2004.05.009; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reilly LM, 1996, VIROLOGY, V218, P243, DOI 10.1006/viro.1996.0185; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shackelford J, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S8; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sompallae R, 2008, J VIROL, V82, P10477, DOI 10.1128/JVI.01113-08; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tomazin R, 1999, NAT MED, V5, P1039, DOI 10.1038/12478; Tran K, 2008, J VIROL, V82, P529, DOI 10.1128/JVI.02010-07; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wang JL, 2006, J VIROL, V80, P6003, DOI 10.1128/JVI.00401-06; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Webb JH, 1999, FEBS LETT, V444, P136, DOI 10.1016/S0014-5793(99)00025-3; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004	122	169	179	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					527	U35		10.1038/ncb0509-527	http://dx.doi.org/10.1038/ncb0509-527			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404332				2022-12-27	WOS:000265640000005
J	Geraldo, S; Khanzada, UK; Parsons, M; Chilton, JK; Gordon-Weeks, PR				Geraldo, Sara; Khanzada, Umme K.; Parsons, Maddy; Chilton, John K.; Gordon-Weeks, Phillip R.			Targeting of the F-actin-binding protein drebrin by the microtubule plus-tip protein EB3 is required for neuritogenesis	NATURE CELL BIOLOGY			English	Article							NEURONAL GROWTH CONES; FLUORESCENT PROTEIN; END; FILOPODIA; APC; FILAMENTS; RECRUITMENT; MECHANISMS; DYNAMICS; BUNDLES	Interactions between dynamic microtubules and actin filaments (F-actin) underlie a range of cellular processes including cell polarity and motility. In growth cones, dynamic microtubules are continually extending into selected filopodia, aligning alongside the proximal ends of the F-actin bundles. This interaction is essential for neuritogenesis and growth-cone pathfinding. However, the molecular components mediating the interaction between microtubules and filopodial F-actin have yet to be determined. Here we show that drebrin, an F-actin-associated protein, binds directly to the microtubule-binding protein EB3. In growth cones, this interaction occurs specifically when drebrin is located on F-actin in the proximal region of filopodia and when EB3 is located at the tips of microtubules invading filopodia. When this interaction is disrupted, the formation of growth cones and the extension of neurites are impaired. We conclude that drebrin targets EB3 to coordinate F-actin-microtubule interactions that underlie neuritogenesis.	[Geraldo, Sara; Khanzada, Umme K.; Chilton, John K.; Gordon-Weeks, Phillip R.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; University of London; King's College London	Gordon-Weeks, PR (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, New Hunts House,Guys Campus, London SE1 1UL, England.	phillip.gordon-weeks@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Gordon-Weeks, Phillip R./C-5328-2009	Parsons, Maddy/0000-0002-2021-8379; Gordon-Weeks, Phillip R./0000-0002-4738-4246	Medical Research Council; Royal Society and the Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal; MRC [G9900989, G0100152] Funding Source: UKRI; Medical Research Council [G9900989, G0100152] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society and the Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Britta Eickholt and her laboratory and the P. R. G.-W. laboratory for helpful discussions. We are grateful to Brigitte Keon for the gift of human drebrin E cDNA, Ewan Morrison for EB1 cDNA, Roger Tsien for CherryRFP cDNA, Britta Eickholt for drebrin-RFP, and Niels Galjart for polyclonal antibodies against CLASP 1, CLASP 2 and CLIP-170 and EB3 cDNA, and Matthias Krause for help with kymography and comments on the manuscript. This work was supported by grants from the Medical Research Council, the Royal Society and the Wellcome Trust. Sara Geraldo's PhD studentship is funded by Fundacao para a Ciencia e Tecnologia, Portugal.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Bush MS, 1996, EUR J NEUROSCI, V8, P235, DOI 10.1111/j.1460-9568.1996.tb01208.x; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GORDONWEEKS PR, 1989, J NEUROCYTOL, V18, P451, DOI 10.1007/BF01474542; GORDONWEEKS PR, 1991, NEUROREPORT, V2, P573, DOI 10.1097/00001756-199110000-00005; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mizui T, 2005, MOL CELL NEUROSCI, V30, P630, DOI 10.1016/j.mcn.2005.06.013; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; PHELAN P, 1997, NEUROCHEMISTRY PRACT, P1; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIRAO T, 1992, NEUROREPORT, V3, P109, DOI 10.1097/00001756-199201000-00029; SHIRAO T, 1995, J BIOCHEM-TOKYO, V117, P231, DOI 10.1093/jb/117.2.231; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Stepanova T, 2003, J NEUROSCI, V23, P2655; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	39	182	185	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1181	1189		10.1038/ncb1778	http://dx.doi.org/10.1038/ncb1778			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806788				2022-12-27	WOS:000259682900012
J	Andrews, NL; Lidke, KA; Pfeiffer, JR; Burns, AR; Wilson, BS; Oliver, JM; Lidke, DS				Andrews, Nicholas L.; Lidke, Keith A.; Pfeiffer, Janet R.; Burns, Alan R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.			Actin restricts Fc epsilon RI diffusion and facilitates antigen-induced receptor immobilization	NATURE CELL BIOLOGY			English	Article								The actin cytoskeleton has been implicated in restricting diffusion of plasma membrane components. Here, simultaneous observations of quantum dot-labelled Fc epsilon RI motion and GFP-tagged actin dynamics provide direct evidence that actin filament bundles define micron-sized domains that confine mobile receptors. Dynamic reorganization of actin structures occurs over seconds, making the location and dimensions of actin-defined domains time-dependent. Multiple Fc epsilon RI often maintain extended close proximity without detectable correlated motion, suggesting that they are co-confined within membrane domains. Fc epsilon RI signalling is activated by crosslinking with multivalent antigen. We show that receptors become immobilized within seconds of crosslinking. Disruption of the actin cytoskeleton results in delayed immobilization kinetics and increased diffusion of crosslinked clusters. These results implicate actin in membrane partitioning that not only restricts diffusion of membrane proteins, but also dynamically influences their long-range mobility, sequestration and response to ligand binding.	[Andrews, Nicholas L.; Pfeiffer, Janet R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Andrews, Nicholas L.; Pfeiffer, Janet R.; Wilson, Bridget S.; Oliver, Janet M.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Sandia Natl Labs, Albuquerque, NM 87185 USA	University of New Mexico; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories	Lidke, DS (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	dlidke@salud.unm.edu			NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016918, P20RR011830, S10RR015734, S10RR014668, S10RR022493, S10RR019287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM067594, R01GM049814] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA118100] Funding Source: Medline; NCRR NIH HHS [S10 RR15734, S10 RR019287, S10 RR14668, S10 RR16918, S10 RR022493, P20 RR11830, RR022493, S10 RR19287] Funding Source: Medline; NIAID NIH HHS [R01 AO051575, R01 AI051575] Funding Source: Medline; NIGMS NIH HHS [P20 GM 67594, P20 GM067594-01, R01 GM49814, R01 GM049814, R01 GM049814-07, P20 GM067597, P20 GM067594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDTJOVIN DJ, 2006, P SOC PHOTO-OPT INS, V6096, P1; Barisas BG, 2007, BIOPHYS CHEM, V126, P209, DOI 10.1016/j.bpc.2006.05.026; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DAHL SC, 1994, J CELL BIOL, V125, P1057, DOI 10.1083/jcb.125.5.1057; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Destainville N, 2006, BIOPHYS J, V90, pL17, DOI 10.1529/biophysj.105.075176; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Frankel DJ, 2006, BIOPHYS J, V90, P2404, DOI 10.1529/biophysj.105.073692; Frigeri L, 1999, J IMMUNOL, V162, P2243; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; JACQUIER V, 2006, P NATL ACAD SCI US; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LIU FT, 1980, J IMMUNOL, V124, P2728; MAO SY, 1991, J IMMUNOL, V146, P958; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; MENON AK, 1986, J CELL BIOL, V102, P541, DOI 10.1083/jcb.102.2.541; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; PFEIFFER JR, 1994, J IMMUNOL, V152, P270; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHLESSINGER J, 1976, NATURE, V264, P550, DOI 10.1038/264550a0; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; THOMAS JL, 1992, BIOPHYS J, V61, P1402, DOI 10.1016/S0006-3495(92)81946-X; Thyagarajan R, 2003, J IMMUNOL, V170, P6099, DOI 10.4049/jimmunol.170.12.6099; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	46	227	229	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					955	963		10.1038/ncb1755	http://dx.doi.org/10.1038/ncb1755			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641640	Green Accepted			2022-12-27	WOS:000258147100013
J	Lee, HS; Nishanian, TG; Mood, K; Bong, YS; Daar, IO				Lee, Hyun-Shik; Nishanian, Tagvor G.; Mood, Kathleen; Bong, Yong-Sik; Daar, Ira O.			EphrinB1 controls cell-cell junctions through the Par polarity complex	NATURE CELL BIOLOGY			English	Article							COLORECTAL-CANCER PROGRESSION; RECEPTOR TYROSINE KINASE; EPH RECEPTOR; EPITHELIAL TIGHT; XENOPUS EMBRYOS; PROTEIN PAR6; EYE FIELD; REVERSE; ADHESION; PHOSPHORYLATION	A body of evidence is emerging that shows a requirement for ephrin ligands in the proper migration of cells, and the formation of cell and tissue boundaries. These processes are dependent on the cell-cell adhesion system, which plays a crucial role in normal morphogenetic processes during development, as well as in invasion and metastasis(1-9). Although ephrinB ligands are bi-directional signalling molecules, the precise mechanism by which ephrinB1 signals through its intracellular domain to regulate cell-cell adhesion in epithelial cells remains unclear. Here, we present evidence that ephrinB1 associates with the Par polarity complex protein Par-6 (a scaffold protein required for establishing tight junctions) and can compete with the small GTPase Cdc42 for association with Par-6. This competition causes inactivation of the Par complex, resulting in the loss of tight junctions. Moreover, the interaction between ephrinB1 and Par-6 is disrupted by tyrosine phosphorylation of the intracellular domain of ephrinB1. Thus, we have identified a mechanism by which ephrinB1 signalling regulates cell-cell junctions in epithelial cells, and this may influence how we devise therapeutic interventions regarding these molecules in metastatic disease.	[Lee, Hyun-Shik; Nishanian, Tagvor G.; Mood, Kathleen; Bong, Yong-Sik; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Daar, IO (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov	Lee, Hyun-Shik/G-3555-2011	Daar, Ira/0000-0003-2657-526X	Intramural NIH HHS [Z01 BC010006-12, Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010006, ZIABC010958] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Moody SA, 2000, METH MOL B, V135, P331; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang J, 2006, J PATHOL, V208, P453, DOI 10.1002/path.1937	35	67	67	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					979	986		10.1038/ncb1758	http://dx.doi.org/10.1038/ncb1758			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604196	Green Accepted			2022-12-27	WOS:000258147100016
J	Kinchen, JM; Doukoumetzidis, K; Almendinger, J; Stergiou, L; Tosello-Trampont, A; Sifri, CD; Hengartner, MO; Ravichandran, KS				Kinchen, Jason M.; Doukoumetzidis, Kimon; Almendinger, Johann; Stergiou, Lilli; Tosello-Trampont, Annie; Sifri, Costi D.; Hengartner, Michael O.; Ravichandran, Kodi S.			A pathway for phagosome maturation during engulfment of apoptotic cells	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN COMPLEX; DYNAMIN; DOMAIN; REMOVAL; PHAGOCYTOSIS; DEGRADATION; CLEARANCE; TRANSPORT; DEATH	removal of apoptotic cells is critical for the physiological well-being of the organism(1) and defects in corpse removal have been linked to disease states(2,3).Genes regulating corpse recognition and internalization have been identified(4), but few molecules involved in the processing of internalized corpses are known. through a combination of targeted and unbiased reverse genetic screens in Caenorhabditis elegans, and studies in mammalian cells, we have identified genes required for maturation of apoptotic-cell-containing phagosomes. We have further ordered these candidates, which include the GtPases RAB-5 and RAB-7 and the HOPs complex, into a coherent linear pathway for the maturation of apoptotic cells within phagosomes. In-depth analysis of two additional candidate genes, the phosphatidylinositol 3 kinase ( PI( 3) K) vps -34 and dyn- 1/dynamin, showed an accumulation of internalized, but undegraded, corpses within abnormal rab5-negative phagosomes. We ordered these candidates in our pathway, with DYN-1 functioning upstream of VPs-34 in the recruitment and/or retention of RAB-5 in the phagosome. Finally, we have also identified a previously undescribed biochemical complex containing Vps34, dynamin and Rab5(GDP), thus providing a mechanism for Rab5 recruitment to the nascent phagosome.	[Doukoumetzidis, Kimon; Almendinger, Johann; Stergiou, Lilli; Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Kinchen, Jason M.; Tosello-Trampont, Annie; Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Sifri, Costi D.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA	University of Zurich; University of Virginia; University of Virginia	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.	Michael.Hengartner@molbio.unizh.ch; ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Hengartner, Michael O/E-6235-2011	Sifri, Costi/0000-0001-6033-2515; Hengartner, Michael/0000-0002-7584-596X; Ravichandran, Kodi/0000-0001-9049-1410; Kinchen, Jason/0000-0001-8430-2265	NIGMS NIH HHS [R01 GM064709, R01 GM064709-07, R01 GM069998, R01 GM069998-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, R01GM069998] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Franz Sandra, 2006, Curr Rheumatol Rep, V8, P245, DOI 10.1007/s11926-006-0001-y; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	37	193	288	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					556	566		10.1038/ncb1718	http://dx.doi.org/10.1038/ncb1718			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425118	Green Accepted			2022-12-27	WOS:000255502400012
J	Loer, B; Bauer, R; Bornheim, R; Grell, J; Kremmer, E; Kolanus, W; Hoch, M				Loeer, Birgit; Bauer, Reinhard; Bornheim, Roland; Grell, Jessica; Kremmer, Elisabeth; Kolanus, Waldemar; Hoch, Michael			The NHL-domain protein Wech is crucial for the integrin-cytoskeleton link	NATURE CELL BIOLOGY			English	Article							PS INTEGRINS; RING FINGER; DROSOPHILA; ADHESION; KINASE; MORPHOGENESIS; TALIN; ACTIVATION; MUSCLE; MATRIX	Integrin transmembrane receptors mediate cell adhesion through intracellular linker proteins that connect to the cytoskeleton(1,2). Of the numerous linker proteins identified, only a few, including Talin and Integrin-linked-kinase ( ILK), are essential and evolutionarily conserved. The wech gene encodes a newly discovered and highly conserved regulator of integrin-mediated adhesion in Drosophila melanogaster. Embryos deficient in wech have very similar phenotypes to integrin-null or Talin-null embryos, including muscle detachment from the body wall. The Wech protein contains a B-box zinc-finger and a coiled-coil domain, which is also found in RBCC/ TRIM family(3) members, and an NHL domain(4). In beta-integrin or Talin mutants, Wech is mislocalized, whereas ILK localization depends on Wech. We provide evidence that Wech interacts with the head domain of Talin and the kinase domain of ILK, and propose that Wech is required to connect both core proteins of the linker complex during embryonic muscle attachment. Both the NHL and the B-box/ coiled-coil domains of Wech are required for proper interaction with Talin and ILK. The single murine Wech orthologue is also colocalized with Talin and ILK in muscle tissue. We propose that Wech proteins are crucial and evolutionarily conserved regulators of the integrin-cytoskeleton link.	[Loeer, Birgit; Bauer, Reinhard; Hoch, Michael] Univ Bonn, Lab Mol Dev Biol, Program Unit Dev & Genet, Life & Med Sci Inst, D-53115 Bonn, Germany; [Bornheim, Roland; Grell, Jessica; Kolanus, Waldemar] Univ Bonn, Lab Mol Immunol, LIMES Inst, Program Unit Mol Cell & Immune Biol, D-53115 Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hoch, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, Program Unit Dev & Genet, Life & Med Sci Inst, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de						Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Liu SC, 2000, J CELL SCI, V113, P3563; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Paululat A, 1999, CELL TISSUE RES, V296, P151, DOI 10.1007/s004410051276; ROOTE CE, 1995, DEV BIOL, V169, P322, DOI 10.1006/dbio.1995.1147; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	31	48	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					422	U103		10.1038/ncb1704	http://dx.doi.org/10.1038/ncb1704			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18327251				2022-12-27	WOS:000254561700012
J	Popov, N; Schulein, C; Jaenicke, LA; Eilers, M				Popov, Nikita; Schuelein, Christina; Jaenicke, Laura A.; Eilers, Martin			Ubiquitylation of the amino terminus of Myc by SCF beta-TrCP antagonizes SCFFbw7-mediated turnover	NATURE CELL BIOLOGY			English	Article							KAPPA-B-ALPHA; C-MYC; DNA-REPLICATION; LIGASE COMPLEX; DEPENDENT DEGRADATION; UBIQUITIN CHAINS; CELL-CYCLE; PROTEIN; PROTEOLYSIS; DESTRUCTION	The SCFFbw7 ubiquitin ligase mediates growth-factor-regulated turnover of the Myc oncoprotein. Here we show that SCF beta-TrCP binds to Myc by means of a characteristic phosphodegron and ubiquitylates Myc; this results in enhanced Myc stability. SCFFbw7 and SCF beta-TrCP can exert these differential effects through polyubiquitylation of the amino terminus of Myc. Whereas SCFFbw7 with the Cdc34 ubiquitin-conjugating enzyme specifically requires lysine 48 (K48) of ubiquitin, SCF beta-TrCP uses the UbcH5 ubiquitin-conjugating enzyme to form heterotypic polyubiquitin chains on Myc. Ubiquitylation of Myc by SCF beta-TrCP is required for Myc-dependent acceleration of cell cycle progression after release from an arrest in S phase. Therefore, alternative ubiquitylation events at the N terminus can lead to the ubiquitylation-dependent stabilization of Myc.	[Popov, Nikita; Schuelein, Christina; Jaenicke, Laura A.; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany	University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de		Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft; Wilhelm Sander Stiftung fur Krebsforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Stiftung fur Krebsforschung	We thank Markus Welcker and Bruce Clurman for expression vectors encoding Fbw7 and beta-TrCP2; Victoria Cowling for IMECs; and Axel Behrens for anti-Fbw7 antibody. This study was supported by grants from the Deutsche Forschungsgemeinschaft through the Transregio 17 ('Ras-dependent pathways in human tumours') project and the Wilhelm Sander Stiftung fur Krebsforschung.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chakraborty AA, 2009, EXP CELL RES, V315, P1772, DOI 10.1016/j.yexcr.2009.01.011; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; DiRenzo J, 2002, CANCER RES, V62, P89; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Schorl C, 2003, MOL BIOL CELL, V14, P823, DOI 10.1091/mbc.E02-10-0649; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; ZAAROORREGEV D, 2010, P NATL ACAD SCI US; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	48	111	114	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					973	981		10.1038/ncb2104	http://dx.doi.org/10.1038/ncb2104			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852628				2022-12-27	WOS:000282363500012
J	Marshall, WF				Marshall, Wallace F.			Cilia self-organize in response to planar cell polarity and flow	NATURE CELL BIOLOGY			English	Editorial Material							RIGHT AXIS DETERMINATION; EPITHELIAL-CELLS; NODAL CILIA; POLARIZATION; DYSKINESIA; MECHANISM	Cilia drive fluid flow in development and physiology, but this requires that all cilia in a tissue orient the same way. Earlier studies indicated that both planar cell polarity (PCP) signalling and cilia-generated fluid flows could influence ciliary orientation. We now learn how asymmetric localization of PCP proteins influences the position and orientation of cilia to control the direction of flow.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Marshall, WF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, GH N372F Box 2200,600 16th St, San Francisco, CA 94158 USA.	wallace.marshall@ucsf.edu						Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; FISHER KH, 1991, CAMBRIDGE STUDIES MA, P420; GHEBER L, 1989, BIOPHYS J, V55, P183, DOI 10.1016/S0006-3495(89)82790-0; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Jorissen M, 2004, ACTA OTO-LARYNGOL, V124, P527, DOI 10.1080/00016480410016270; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Rayner CFJ, 1996, AM J RESP CRIT CARE, V153, P1123, DOI 10.1164/ajrccm.153.3.8630555	15	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					314	315		10.1038/ncb0410-314	http://dx.doi.org/10.1038/ncb0410-314			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20360747				2022-12-27	WOS:000276194600004
J	Ewers, H; Romer, W; Smith, AE; Bacia, K; Dmitrieff, S; Chai, WG; Mancini, R; Kartenbeck, J; Chambon, V; Berland, L; Oppenheim, A; Schwarzmann, G; Feizi, T; Schwille, P; Sens, P; Helenius, A; Johannes, L				Ewers, Helge; Roemer, Winfried; Smith, Alicia E.; Bacia, Kirsten; Dmitrieff, Serge; Chai, Wengang; Mancini, Roberta; Kartenbeck, Juergen; Chambon, Valerie; Berland, Ludwig; Oppenheim, Ariella; Schwarzmann, Guenter; Feizi, Ten; Schwille, Petra; Sens, Pierre; Helenius, Ari; Johannes, Ludger			GM1 structure determines SV40-induced membrane invagination and infection	NATURE CELL BIOLOGY			English	Article							SV40 CAPSID PROTEINS; MURINE POLYOMA-VIRUS; CHOLERA-TOXIN; LIPID RAFTS; SHIGA TOXIN; INDEPENDENT ENDOCYTOSIS; GANGLIOSIDE GM1; SIMIAN VIRUS-40; INSECT CELLS; SIMIAN-VIRUS-40	Incoming simian virus 40 (SV40) particles enter tight-fitting plasma membrane invaginations after binding to the carbohydrate moiety of GM1 gangliosides in the host cell plasma membrane through pentameric VP1 capsid proteins. This is followed by activation of cellular signalling pathways, endocytic internalization and transport of the virus via the endoplasmic reticulum to the nucleus. Here we show that the association of SV40 (as well as isolated pentameric VP1) with GM1 is itself sufficient to induce dramatic membrane curvature that leads to the formation of deep invaginations and tubules not only in the plasma membrane of cells, but also in giant unilamellar vesicles (GUVs). Unlike native GM1 molecules with long acyl chains, GM1 molecular species with short hydrocarbon chains failed to support such invagination, and endocytosis and infection did not occur. To conceptualize the experimental data, a physical model was derived based on energetic considerations. Taken together, our analysis indicates that SV40, other polyoma viruses and some bacterial toxins (Shiga and cholera) use glycosphingolipids and a common pentameric protein scaffold to induce plasma membrane curvature, thus directly promoting their endocytic uptake into cells.	[Ewers, Helge; Smith, Alicia E.; Mancini, Roberta; Kartenbeck, Juergen; Helenius, Ari] ETH, Inst Biochem, HPM E, CH-8093 Zurich, Switzerland; [Roemer, Winfried; Chambon, Valerie; Johannes, Ludger] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Roemer, Winfried; Chambon, Valerie; Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Bacia, Kirsten; Schwille, Petra] Tech Univ Dresden, Inst Biophys, BIOTEC, D-01307 Dresden, Germany; [Dmitrieff, Serge; Sens, Pierre] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR Gulliver 7083, F-75231 Paris 05, France; [Chai, Wengang; Feizi, Ten] Imperial Coll London, Glycosci Lab, Harrow HA1 3UJ, Middx, England; [Kartenbeck, Juergen] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Berland, Ludwig] Inst Curie, Ctr Rech, Lab Physicochim, F-75248 Paris 05, France; [Berland, Ludwig] Univ Paris 06, CNRS, UMR168, F-75252 Paris 05, France; [Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91120 Jerusalem, Israel; [Schwarzmann, Guenter] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, Membrane Biol & Lipid Biochem Unit, D-53123 Bonn, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Hebrew University of Jerusalem; University of Bonn	Helenius, A (corresponding author), ETH, Inst Biochem, HPM E, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	sens, pierre/C-3537-2011; Johannes, Ludger/M-9778-2017; Ewers, Helge/I-3455-2012; Ewers, Helge/ABF-3629-2021; Schwille, Petra/A-4983-2010; Johannes, Ludger/W-8593-2019	sens, pierre/0000-0003-4523-3791; Johannes, Ludger/0000-0002-2168-0004; Ewers, Helge/0000-0003-3948-4332; Johannes, Ludger/0000-0002-2168-0004; Feizi, Ten/0000-0001-6495-0329; Dmitrieff, Serge/0000-0002-1362-5670	Swiss SystemsX.ch [LipidX-2008/011]; Human Frontier Science Program; FEBS; CNRS; Israel Science Foundation [604/07]; Delegation Generale pour l'Armement; Wellcome Trust; Deutsche Forschungsgemeinschaft; European Regional Development Fund [4212/04-01]	Swiss SystemsX.ch; Human Frontier Science Program(Human Frontier Science Program); FEBS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Israel Science Foundation(Israel Science Foundation); Delegation Generale pour l'Armement; Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Regional Development Fund(European Commission)	This work was funded by the Swiss SystemsX.ch initiative, grant LipidX-2008/011 (to A.H.), the Human Frontier Science Program (to A.E.S., L.J. and P.S.), a FEBS fellowship (to H.E.), a CNRS fellowship (to W.R.), the Israel Science Foundation (Grant # 604/07 to A.O.), the Delegation Generale pour l'Armement (to L.B.), the Wellcome Trust (to W.C. and T.F.), Deutsche Forschungsgemeinschaft (to G.S.) and the European Regional Development Fund grant # 4212/04-01 (to K.B. and P.S.). H. E. thanks D. Choquet for his patience and support. The authors thank M. Abd-El-Latif for the preparation of VLPs and pentamers.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Campanero-Rhodes MA, 2007, J VIROL, V81, P12846, DOI 10.1128/JVI.01311-07; Chai W, 2006, ANAL CHEM, V78, P1581, DOI 10.1021/ac051606e; Chai WG, 2003, METHOD ENZYMOL, V362, P160; COLE CN, 2001, POLYOMAVIRIDAE VIRUS, P2141; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dangoria NS, 1996, J GEN VIROL, V77, P2173, DOI 10.1099/0022-1317-77-9-2173; Deserno M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031903; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ewers H, 2007, NANO LETT, V7, P2263, DOI 10.1021/nl070766y; FACCI L, 1984, J NEUROCHEM, V42, P299, DOI 10.1111/j.1471-4159.1984.tb02678.x; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Foret L, 2008, P NATL ACAD SCI USA, V105, P14763, DOI 10.1073/pnas.0801173105; Gilbert J, 2005, J VIROL, V79, P615, DOI 10.1128/JVI.79.1.615-618.2005; Gilbert JM, 2000, J VIROL, V74, P8582, DOI 10.1128/JVI.74.18.8582-8588.2000; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HUMMELER K, 1970, J VIROL, V6, P87, DOI 10.1128/JVI.6.1.87-93.1970; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kosukegawa A, 1996, BBA-GEN SUBJECTS, V1290, P37; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LIPOWSKY R, 1992, J PHYS 2, V2; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roitman-Shemer V, 2007, BIOCHEM BIOPH RES CO, V353, P424, DOI 10.1016/j.bbrc.2006.12.038; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SCHWARZMANN G, 1983, BIOCHEMISTRY-US, V22, P5041, DOI 10.1021/bi00290a025; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Turner MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118103; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yan YW, 1996, STRUCTURE, V4, P157, DOI 10.1016/S0969-2126(96)00019-6; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	56	297	303	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					11	U36		10.1038/ncb1999	http://dx.doi.org/10.1038/ncb1999			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20023649				2022-12-27	WOS:000272973800007
J	Hu, HH; Boisson-Dernier, A; Israelsson-Nordstrom, M; Bohmer, M; Xue, SW; Ries, A; Godoski, J; Kuhn, JM; Schroeder, JI				Hu, Honghong; Boisson-Dernier, Aurelien; Israelsson-Nordstroem, Maria; Boehmer, Maik; Xue, Shaowu; Ries, Amber; Godoski, Jan; Kuhn, Josef M.; Schroeder, Julian I.			Carbonic anhydrases are upstream regulators of CO2-controlled stomatal movements in guard cells	NATURE CELL BIOLOGY			English	Article							ABSCISIC-ACID; PHOSPHOENOLPYRUVATE CARBOXYLASE; ANION CHANNELS; BLUE-LIGHT; CO2; CONDUCTANCE; MODULATION; RESPONSES; SIGNALS; TOBACCO	The continuing rise in atmospheric CO2 causes stomatal pores in leaves to close and thus globally affects CO2 influx into plants, water use efficiency and leaf heat stress(1-4). However, the CO2-binding proteins that control this response remain unknown. Moreover, which cell type responds to CO2, mesophyll or guard cells, and whether photosynthesis mediates this response are matters of debate(5-8). We demonstrate that Arabidopsis thaliana double-mutant plants in the beta-carbonic anhydrases beta CA1 and beta CA4 show impaired CO2-regulation of stomatal movements and increased stomatal density, but retain functional abscisic-acid and blue-light responses. beta CA-mediated CO2-triggered stomatal movements are not, in first-order, linked to whole leaf photosynthesis and can function in guard cells. Furthermore, guard cell beta CA-overexpressing plants exhibit instantaneous enhanced water use efficiency. Guard cell expression of mammalian alpha CAII complements the reduced sensitivity of ca1 ca4 plants, showing that carbonic anhydrase-mediated catalysis is an important mechanism for beta CA-mediated CO2 induced stomatal closure and patch clamp analyses indicate that CO2/HCO3-transfers the signal to anion channel regulation. These findings, together with ht1-2 (ref.9) epistasis analysis demonstrate that carbonic anhydrases function early in the CO2 signalling pathway, which controls gas-exchange between plants and the atmosphere.	[Hu, Honghong; Boisson-Dernier, Aurelien; Israelsson-Nordstroem, Maria; Boehmer, Maik; Xue, Shaowu; Ries, Amber; Godoski, Jan; Kuhn, Josef M.; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Xue, Shaowu] Shanxi Univ, Inst Mol Sci, Taiyuan 030006, Peoples R China	University of California System; University of California San Diego; Shanxi University	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Xue, Shaowu/D-5400-2011; Xue, Shaowu/O-8678-2019; Böhmer, Maik/ABE-1146-2021; Nordström, Maria/B-4561-2013; Bohmer, Maik/E-3533-2010	Xue, Shaowu/0000-0002-8838-3362; Xue, Shaowu/0000-0002-8838-3362; Bohmer, Maik/0000-0001-6675-273X; Boisson-Dernier, Aurelien/0000-0002-9790-3710; Schroeder, Julian/0000-0002-3283-5972	NSF [MCB0918220]; NIH [GM060396]; DOE [DE-FG02-03ER15449]; Swedish Research Council Formas; Deutsche Forschungsgemeinschaft; EMBO; King Abdullah University of Science and Technology (KAUST) [KUS-F1-021-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Maktabi, J. Young and C. Engineer for preliminary analyses of aca mutants, R. Xu for assistance, S. Zeeman for suggestions and K. Iba (Kyushu University, Japan) for providing ht1-2 seeds. This research was supported by NSF (MCB0918220), NIH (GM060396) and in part by DOE (DE-FG02-03ER15449) grants (to J. I. S.) and by fellowships from the Swedish Research Council Formas (to M. I. -N.), the Deutsche Forschungsgemeinschaft (to M. B.), EMBO (to J. M. K.) and in part from the King Abdullah University of Science and Technology (KAUST; No. KUS-F1-021-31 to H. H.).	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; [Anonymous], 2008, NATURE, V452, P269, DOI 10.1038/452269a; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Boisson-Dernier A, 2008, CURR BIOL, V18, P63, DOI 10.1016/j.cub.2007.11.067; Brearley J, 1997, PLANTA, V203, P145, DOI 10.1007/s004250050176; Cousins AB, 2007, PLANT PHYSIOL, V145, P1006, DOI 10.1104/pp.107.103390; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Gehlen J, 1996, PLANT MOL BIOL, V32, P831, DOI 10.1007/BF00020481; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holden C, 2009, SCIENCE, V323, P193, DOI 10.1126/science.323.5911.193; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Leymarie J, 1998, PLANT PHYSIOL BIOCH, V36, P539, DOI 10.1016/S0981-9428(98)80180-0; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; Marten H, 2008, PLANT J, V55, P698, DOI 10.1111/j.1365-313X.2008.03542.x; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; NATELSON S, 1978, CLIN CHEM, V24, P1082; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; PIGOTT JD, 1989, ANAL CHEM, V61, P638, DOI 10.1021/ac00181a031; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; RADIN JW, 1994, P NATL ACAD SCI USA, V91, P7217, DOI 10.1073/pnas.91.15.7217; Raschke K, 2003, PLANTA, V217, P639, DOI 10.1007/s00425-003-1033-4; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roelfsema MRG, 2006, PLANT CELL ENVIRON, V29, P1595, DOI 10.1111/j.1365-3040.2006.01536.x; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; von Caemmerer S, 2004, J EXP BOT, V55, P1157, DOI 10.1093/jxb/erh128; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; WILBUR KM, 1948, J BIOL CHEM, V11; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	55	293	322	10	141	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					87	U234		10.1038/ncb2009	http://dx.doi.org/10.1038/ncb2009			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010812	Green Accepted			2022-12-27	WOS:000272973800017
J	Kardash, E; Reichman-Fried, M; Maitre, JL; Boldajipour, B; Papusheva, E; Messerschmidt, EM; Heisenberg, CP; Raz, E				Kardash, Elena; Reichman-Fried, Michal; Maitre, Jean-Leon; Boldajipour, Bijan; Papusheva, Ekaterina; Messerschmidt, Esther-Maria; Heisenberg, Carl-Philipp; Raz, Erez			A role for Rho GTPases and cell-cell adhesion in single-cell motility in vivo	NATURE CELL BIOLOGY			English	Article							E-CADHERIN; SPATIOTEMPORAL DYNAMICS; MIGRATION; ZEBRAFISH; MEMBRANE; BEHAVIOR; ACTIVATION; CATENIN; PROBES; ACTIN	Cell migration is central to embryonic development, homeostasis and disease(1), processes in which cells move as part of a group or individually. Whereas the mechanisms controlling single-cell migration in vitro are relatively well understood(2-4), less is known about the mechanisms promoting the motility of individual cells in vivo. In particular, it is not clear how cells that form blebs in their migration use those protrusions to bring about movement in the context of the three-dimensional cellular environment(5,6). Here we show that the motility of chemokine-guided germ cells within the zebrafish embryo requires the function of the small Rho GTPases Rac1 and RhoA, as well as E-cadherin-mediated cell-cell adhesion. Using fluorescence resonance energy transfer we demonstrate that Rac1 and RhoA are activated in the cell front. At this location, Rac1 is responsible for the formation of actin-rich structures, and RhoA promotes retrograde actin flow. We propose that these actin-rich structures undergoing retrograde flow are essential for the generation of E-cadherin-mediated traction forces between the germ cells and the surrounding tissue and are therefore crucial for cell motility in vivo.	[Kardash, Elena; Reichman-Fried, Michal; Boldajipour, Bijan; Messerschmidt, Esther-Maria; Raz, Erez] Ctr Mol Biol Inflammat, Inst Cell Biol, D-48149 Munster, Germany; [Maitre, Jean-Leon; Papusheva, Ekaterina; Heisenberg, Carl-Philipp] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Raz, E (corresponding author), Ctr Mol Biol Inflammat, Inst Cell Biol, Von Esmarch Str 56, D-48149 Munster, Germany.	erez.raz@uni-muenster.de	Maître, Jean-Léon/C-4372-2017	Maître, Jean-Léon/0000-0002-3688-1474; Boldajipour, Bijan/0000-0003-2065-555X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Kardash, Elena/0000-0002-7425-9862	Deutsche Forschungsgemeinschaft (DFG); Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The FRET biosensors for Rac and RhoA were a gift from M. Matsuda. The yellow variant of GFP, YPet, was generously provided by P. Daugherty. Lifeact fusions were a gift from R. Wedlich-Soldner, and the GFP-CLIP-170 was provided by Franck Perez. We thank Donna Arndt-Jovin and Tom Jovin for their help with the FRET experiments. This work is supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Max Planck Society. E.K. and B.B. are students at the International Max Planck Research School, Gottingen.	Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Koprunner M, 2001, GENE DEV, V15, P2877; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Mich JK, 2009, DEV BIOL, V328, P342, DOI 10.1016/j.ydbio.2009.01.036; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; OYAMA T, 1994, CANCER RES, V54, P6282; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	41	193	199	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					47	U112		10.1038/ncb2003	http://dx.doi.org/10.1038/ncb2003			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010816				2022-12-27	WOS:000272973800011
J	Hayashi-Nishino, M; Fujita, N; Noda, T; Yamaguchi, A; Yoshimori, T; Yamamoto, A				Hayashi-Nishino, Mitsuko; Fujita, Naonobu; Noda, Takeshi; Yamaguchi, Akihito; Yoshimori, Tamotsu; Yamamoto, Akitsugu			A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation	NATURE CELL BIOLOGY			English	Article							RAT HEPATOCYTES; ISOLATION MEMBRANES; PROTEIN; DEGRADATION; TOMOGRAPHY; VACUOLES; CELLS	Autophagy is a bulk degradation process in eukaryotic cells and has fundamental roles in cellular homeostasis. The origin and source of autophagosomal membranes are long-standing questions in the field. Using electron microscopy, we show that, in mammalian culture cells, the endoplasmic reticulum ( ER) associates with early autophagic structures called isolation membranes (IMs). Overexpression of an Atg4B mutant, which causes defects in autophagosome formation, induces the accumulation of ER-IM complexes. Electron tomography revealed that the ER-IM complex appears as a subdomain of the ER that formed a cradle encircling the IM, and showed that both ER and isolation membranes are interconnected.	[Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Hayashi-Nishino, Mitsuko; Yamaguchi, Akihito] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Hayashi-Nishino, Mitsuko; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Shiga 5260829, Japan	Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, 3-1Yamadaoka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp; a_yamamoto@nagahama-i-bio.ac.jp	Yoshimori, Tamotsu/K-9626-2014; Fujita, Naonobu/A-1218-2010; Noda, Takeshi/B-7240-2008	Yoshimori, Tamotsu/0000-0001-9787-3788; Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Nishioka and N. Kajimura for technical assistance with electron tomography, K. Nishino for assistance with setting up a computer and for useful comments on figure presentations, H. Omori for technical assistance with immunoelectron microscopy and K. Matsunaga and N. Taguchi for technical assistance with plasmid construction. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; FURUNO K, 1990, EXP CELL RES, V189, P261, DOI 10.1016/0014-4827(90)90245-6; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kovacs AL, 2007, AUTOPHAGY, V3, P655, DOI 10.4161/auto.4590; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Walker S, 2008, AUTOPHAGY, V4, P1093, DOI 10.4161/auto.7141; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P573, DOI 10.1177/38.4.2319125; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P1571, DOI 10.1177/38.11.2212617; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	22	751	781	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1433	U102		10.1038/ncb1991	http://dx.doi.org/10.1038/ncb1991			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898463				2022-12-27	WOS:000272251300009
J	Sundstrom, JF; Vaculova, A; Smertenko, AP; Savenkov, EI; Golovko, A; Minina, E; Tiwari, BS; Rodriguez-Nieto, S; Zamyatnin, AA; Valineva, T; Saarikettu, J; Frilander, MJ; Suarez, MF; Zavialov, A; Stahl, U; Hussey, PJ; Silvennoinen, O; Sundberg, E; Zhivotovsky, B; Bozhkov, PV				Sundstrom, Jens F.; Vaculova, Alena; Smertenko, Andrei P.; Savenkov, Eugene I.; Golovko, Anna; Minina, Elena; Tiwari, Budhi S.; Rodriguez-Nieto, Salvador; Zamyatnin, Andrey A., Jr.; Valineva, Tuuli; Saarikettu, Juha; Frilander, Mikko J.; Suarez, Maria F.; Zavialov, Anton; Stahl, Ulf; Hussey, Patrick J.; Silvennoinen, Olli; Sundberg, Eva; Zhivotovsky, Boris; Bozhkov, Peter V.			Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome	NATURE CELL BIOLOGY			English	Article							COACTIVATOR PROTEIN P100; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; METACASPASES; APOPTOSIS; RNA; DNA; IDENTIFICATION; INHIBITOR; PROTEASES	Programmed cell death (PCD) is executed by proteases, which cleave diverse proteins thus modulating their biochemical and cellular functions. Proteases of the caspase family and hundreds of caspase substrates constitute a major part of the PCD degradome in animals(1,2). Plants lack close homologues of caspases, but instead possess an ancestral family of cysteine proteases, metacaspases(3,4). Although metacaspases are essential for PCD5-7, their natural substrates remain unknown(4,8). Here we show that metacaspase mcII-Pa cleaves a phylogenetically conserved protein, TSN (Tudor staphylococcal nuclease), during both developmental and stress-induced PCD. TSN knockdown leads to activation of ectopic cell death during reproduction, impairing plant fertility. Surprisingly, human TSN (also known as p100 or SND1), a multifunctional regulator of gene expression(9-15), is cleaved by caspase-3 during apoptosis. This cleavage impairs the ability of TSN to activate mRNA splicing, inhibits its ribonuclease activity and is important for the execution of apoptosis. Our results establish TSN as the first biological substrate of metacaspase and demonstrate that despite the divergence of plants and animals from a common ancestor about one billion years ago and their use of distinct PCD pathways, both have retained a common mechanism to compromise cell viability through the cleavage of the same substrate, TSN.	[Sundstrom, Jens F.; Savenkov, Eugene I.; Golovko, Anna; Minina, Elena; Tiwari, Budhi S.; Zamyatnin, Andrey A., Jr.; Stahl, Ulf; Sundberg, Eva; Bozhkov, Peter V.] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala BioCtr, SE-75007 Uppsala, Sweden; [Vaculova, Alena; Rodriguez-Nieto, Salvador; Zhivotovsky, Boris] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Smertenko, Andrei P.; Hussey, Patrick J.] Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Valineva, Tuuli; Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; [Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Suarez, Maria F.] Univ Malaga, Dept Biol Mol & Bioquim, Fac Ciencias, E-29071 Malaga, Spain; [Zavialov, Anton] Swedish Univ Agr Sci, Dept Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Silvennoinen, Olli] Tampere Univ Hosp, Dept Clin Microbiol, FIN-33520 Tampere, Finland	Swedish University of Agricultural Sciences; Karolinska Institutet; Durham University; Tampere University; University of Helsinki; Universidad de Malaga; Swedish University of Agricultural Sciences; Tampere University; Tampere University Hospital	Bozhkov, PV (corresponding author), Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala BioCtr, Box 7080, SE-75007 Uppsala, Sweden.	andrei.smertenko@durham.ac.uk; peter.bozhkov@vbsg.slu.se	Tiwari, Budhi/AFQ-0101-2022; Vaculová, Alena Hyršlová/H-1931-2014; Minina, Elena/C-9888-2017; Frilander, Mikko J/B-6660-2009; Suárez, María Fernanda Valencia/F-8200-2019; Zamyatnin, Andrey/D-6443-2012; , Budhi S Tiwari/GSD-9696-2022; Zhivotovsky, Boris/A-4346-2014; Zavialov, Anton V./C-7664-2015; Bozhkov, Peter/K-3387-2012	Minina, Elena/0000-0002-2619-1859; Frilander, Mikko J/0000-0002-1732-4808; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Zamyatnin, Andrey/0000-0002-3046-4565; Zhivotovsky, Boris/0000-0002-2238-3482; Zavialov, Anton V./0000-0001-6191-5931; Bozhkov, Peter/0000-0002-8819-3884; Savenkov, Eugene/0000-0002-5802-5089; Smertenko, Andrei/0000-0002-5078-4881; Hyrslova Vaculova, Alena/0000-0002-0445-8807; Hussey, Patrick/0000-0002-7349-8722; Sundstrom, Jens/0000-0003-2848-5284	Swedish Research Council; Swedish Cancer Society; Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning; EC FP6 and FP7 Programs; Carl Tryggers Foundation; Pehrssons Fund; Wenner-Gren Foundation; Royal Swedish Academy of Agriculture and Forestry; Ministerio de Ciencia e Innovacion, Spain	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); EC FP6 and FP7 Programs(European Commission); Carl Tryggers Foundation; Pehrssons Fund; Wenner-Gren Foundation; Royal Swedish Academy of Agriculture and Forestry; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors thank: L. Filonova (Swedish University of Agricultural Sciences) for microsurgery preparations of plant embryos; G. Swardh (Swedish University of Agricultural Sciences) for Arabidopsis transformation and J. Dangl, A. Jones, C. Knorpp and S. Orrenius for comments on the manuscript. This work was supported by the Swedish Research Council (VR), the Swedish Cancer Society, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the EC FP6 and FP7 Programs, the Carl Tryggers Foundation, the Pehrssons Fund, the Wenner-Gren Foundation, the Royal Swedish Academy of Agriculture and Forestry and the Ministerio de Ciencia e Innovacion, Spain. A. V. is a postdoctoral fellow of the Wenner-Gren Foundation.	Bozhkov PV, 2005, CURR TOP DEV BIOL, V67, P135, DOI 10.1016/S0070-2153(05)67004-4; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Filonova LH, 2000, J CELL SCI, V113, P4399; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Howden R, 1998, GENETICS, V149, P621; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlgren Anna, 2009, J Vis Exp, DOI 10.3791/1205; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kuusk S, 2002, DEVELOPMENT, V129, P4707; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Scadden ADJ, 2007, MOL CELL, V28, P491, DOI 10.1016/j.molcel.2007.09.005; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Talanian RV, 1997, J BIOL CHEM, V272, P9677; TONG X, 1995, MOL CELL BIOL, V15, P4735; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Valineva T, 2006, NUCLEIC ACIDS RES, V34, P3938, DOI 10.1093/nar/gkl539; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470	39	161	171	2	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1347	U198		10.1038/ncb1979	http://dx.doi.org/10.1038/ncb1979			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19820703				2022-12-27	WOS:000271425800015
J	Gray, RS; Abitua, PB; Wlodarczyk, BJ; Szabo-Rogers, HL; Blanchard, O; Lee, I; Weiss, GS; Liu, KJ; Marcotte, EM; Wallingford, JB; Finnell, RH				Gray, Ryan S.; Abitua, Philip B.; Wlodarczyk, Bogdan J.; Szabo-Rogers, Heather L.; Blanchard, Otis; Lee, Insuk; Weiss, Greg S.; Liu, Karen J.; Marcotte, Edward M.; Wallingford, John B.; Finnell, Richard H.			The planar cell polarity effector Fuz is essential for targeted membrane trafficking, ciliogenesis and mouse embryonic development	NATURE CELL BIOLOGY			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA-TARDA; INTRAFLAGELLAR TRANSPORT PROTEIN; BARDET-BIEDL-SYNDROME; TRANSMEMBRANE PROTEIN; STRUCTURE PREDICTION; COMPLEX; MODEL; GENE; IDENTIFICATION; DYSFUNCTION	The planar cell polarity (PCP) signalling pathway is essential for embryonic development because it governs diverse cellular behaviours, and 'core PCP' proteins, such as Dishevelled and Frizzled, have been extensively characterized(1-4). By contrast, the 'PCP effector' proteins, such as Intu and Fuz, remain largely unstudied(5,6). These proteins are essential for PCP signalling, but they have never been investigated in mammals and their cell biological activities remain entirely unknown. We report here that Fuz mutant mice show neural tube defects, skeletal dysmorphologies and Hedgehog signalling defects stemming from disrupted ciliogenesis. Using bioinformatics and imaging of an in vivo mucociliary epithelium, we established a central role for Fuz in membrane trafficking, showing that Fuz is essential for trafficking of cargo to basal bodies and to the apical tips of cilia. Fuz is also essential for exocytosis in secretory cells. Finally, we identified a Rab-related small GTPase as a Fuz interaction partner that is also essential for ciliogenesis and secretion. These results are significant because they provide new insights into the mechanisms by which developmental regulatory systems such as PCP signalling interface with fundamental cellular systems such as the vesicle trafficking machinery.	[Wlodarczyk, Bogdan J.; Finnell, Richard H.] Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Gray, Ryan S.; Abitua, Philip B.; Blanchard, Otis; Weiss, Greg S.; Wallingford, John B.] Univ Texas Austin, Dept Mol Cell & Dev Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Finnell, Richard H.] Texas A&M Inst Genom Med, Houston, TX 77030 USA; [Szabo-Rogers, Heather L.; Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Lee, Insuk; Weiss, Greg S.; Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; University of London; King's College London; University of Texas System; University of Texas Austin	Finnell, RH (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA.	rfinnell@ibt.tamhsc.edu	Lee, Insuk/F-7722-2010; Gray, Ryan/G-2187-2010; Gray, Ryan/W-8366-2019; Gray, Ryan/L-3923-2019; Finnell, Richard/D-8174-2018; Liu, Karen/F-2870-2010	Gray, Ryan/0000-0001-9668-6497; Gray, Ryan/0000-0001-9668-6497; Finnell, Richard/0000-0002-5962-8754; Abitua, Philip/0000-0002-8264-0807; Marcotte, Edward/0000-0001-8808-180X; Liu, Karen/0000-0002-2483-2165; Wlodarczyk, Bogdan J./0000-0001-5249-5832	Wellcome Trust; BBSRC; NSF; NIH; Welch Foundation [F-1515]; Texas Institute for Drug and Diagnostic Development; Packard Fellowship; NIH/NIGMS; March of Dimes; Burroughs Wellcome Fund; Sandler Program for Asthma Research; Texas Advanced Research Program; Texas A& M Institute for Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104, R01GM067779] Funding Source: NIH RePORTER; BBSRC [BB/E01335X/1, BB/E013872/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01335X/1, BB/E013872/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Texas Institute for Drug and Diagnostic Development; Packard Fellowship(The David & Lucile Packard Foundation); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sandler Program for Asthma Research; Texas Advanced Research Program; Texas A& M Institute for Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The ES cell clone for making the Fuz mutant mouse was provided by Lexicon Pharmaceuticals. We thank P. Paukstelis for aid with structural modelling, S. Vokes for critical comments on the manuscript, and Wei H. for technical help with histology and immunostaining. Phil Abitua is supported by a Diversity Supplement from the NIH/NIGMS. This work was supported by grants to K. J. L from the Wellcome Trust and the BBSRC; to E. M. M. from the NSF, NIH, Welch Foundation (F-1515), Texas Institute for Drug and Diagnostic Development, and a Packard Fellowship; grants to J. B. W. from the NIH/NIGMS, The March of Dimes, The Burroughs Wellcome Fund, the Sandler Program for Asthma Research, and the Texas Advanced Research Program; and by grants to R. H. F. from the NIH and The Texas A& M Institute for Genomic Medicine.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; BILLETT FS, 1971, J ANAT, V108, P465; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Collier S, 1997, DEVELOPMENT, V124, P4029; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Hagiwara H, 1997, CELL TISSUE RES, V290, P39, DOI 10.1007/s004410050905; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee H, 2002, GENETICS, V160, P1535; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nagata S, 2003, DEV GENES EVOL, V213, P368, DOI 10.1007/s00427-003-0341-9; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; SNELL GD, 1948, ANAT REC, V76, P30; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Wilson J.G., 1965, TERATOLOGY PRINCIPLE, P251; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026	50	155	159	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1225	U153		10.1038/ncb1966	http://dx.doi.org/10.1038/ncb1966			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767740	Green Accepted			2022-12-27	WOS:000270382000012
J	Gibbings, DJ; Ciaudo, C; Erhardt, M; Voinnet, O				Gibbings, Derrick J.; Ciaudo, Constance; Erhardt, Mathieu; Voinnet, Olivier			Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; STRESS GRANULES; PROTEIN; ARGONAUTE; TRANSLATION; MICRORNAS; EXOSOMES; GW182; AUTOANTIBODIES; IDENTIFICATION	In animals, P-bodies or GW-bodies appear to cause the congregation of proteins involved in microRNA (miRNA)-mediated post-transcriptional silencing. The localization of P-bodies does not overlap with that of known organelles and are thus considered independent of lipid bilayers. Nonetheless, an miRNA effector protein, argonaute 2 (AGO2), was initially identified as membrane-associated, and some miRNAs have been found in secreted vesicles (exosomes) that derive from endo-lysosomal compartments called multivesicular bodies (MVBs). Proteins can be sorted in a ubiquitin-dependent manner into MVBs by three heteromeric subcomplexes, collectively termed ESCRT (endosomal sorting complex required for transport), to be further secreted in exosomes and/or degraded by the lysosome. Here we show that GW-bodies containing GW182 and AGO2, two main components of the RNA-induced silencing complex (RISC), are distinct from P-bodies due to their congregation with endosomes and MVBs. Moreover, miRNAs and miRNA-repressible mRNAs are enriched at these cellular membranes, suggesting that endosomes and/or MVBs are sites of miRNA-loaded RISC (miRISC) accumulation and, possibly, action. We further show that purified exosome-like vesicles secreted by MVBs are considerably enriched in GW182, but not P-body components, AGO2 or miRNA-repressible mRNA. Moreover, cells depleted of some ESCRT components show compromised miRNA-mediated gene silencing and over-accumulate GW182, which associates with ubiquitylated proteins. Therefore, GW182, possibly in association with a fraction of miRNA-loaded AGO2, is sorted into MVBs for secretion and/or lysosomal degradation. We propose that this process promotes continuous assembly or disassembly of membrane-associated miRISCs, which is possibly required for miRNA loading or target recognition and subsequent silencing.	[Gibbings, Derrick J.; Ciaudo, Constance; Erhardt, Mathieu; Voinnet, Olivier] Univ Strasbourg, UPR2357, IBMP CNRS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), Univ Strasbourg, UPR2357, IBMP CNRS, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Ciaudo, Constance/A-2014-2012	Ciaudo, Constance/0000-0002-0857-4506; Gibbings, Derrick/0000-0002-9305-8898; Voinnet, Olivier/0000-0001-6982-9544	Schlumberger Foundation for Education and Research; European Research Council [ERC 210890]; La Ligue Contre le Cancer; Fondation pour la Recherche Medicale (FRM)	Schlumberger Foundation for Education and Research(Schlumberger); European Research Council(European Research Council (ERC)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This research was funded by a prize from the Schlumberger Foundation for Education and Research awarded to ON. who is also supported by a starting grant from the European Research Council 'Frontiers of RNAi' ERC 210890. D.G. is supported by a postdoctoral fellowship from La Ligue Contre le Cancer. C. C. was supported by a postdoctoral fellowship from the Fondation pour la Recherche Medicale (FRM). The authors thank S. Amigorena, C. Thery and M. Ostrosowski for providing exosomes from HeLa and dendritic cells and for helpful comments; B. Lorber for help with dynamic light scattering; V. Cognat for bioinformatics analysis; G. Suffert and S. Pfeffer for providing miR206, miRK12-4 and estrogen receptor 3'UTR constructs, and P. Leblanc for independent preparations of density gradients.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Augustin R, 2005, TRAFFIC, V6, P1196, DOI 10.1111/j.1600-0854.2005.00354.x; Bloch DB, 2006, RNA, V12, P707, DOI 10.1261/rna.17406; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Laurino CCFC, 2006, CLIN EXP IMMUNOL, V143, P572, DOI 10.1111/j.1365-2249.2006.03024.x; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li SQ, 2008, J CELL SCI, V121, P4134, DOI 10.1242/jcs.036905; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vidal M, 1997, J CELL SCI, V110, P1867; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	43	747	797	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1143	U223		10.1038/ncb1929	http://dx.doi.org/10.1038/ncb1929			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684575				2022-12-27	WOS:000269482500017
J	Stavreva, DA; Wiench, M; John, S; Conway-Campbell, BL; McKenna, MA; Pooley, JR; Johnson, TA; Voss, TC; Lightman, SL; Hager, GL				Stavreva, Diana A.; Wiench, Malgorzata; John, Sam; Conway-Campbell, Becky L.; McKenna, Mervyn A.; Pooley, John R.; Johnson, Thomas A.; Voss, Ty C.; Lightman, Stafford L.; Hager, Gordon L.			Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription	NATURE CELL BIOLOGY			English	Article							LIGAND-SPECIFIC DYNAMICS; CHROMATIN DYNAMICS; ANDROGEN RECEPTOR; PROMOTER; MECHANISM; EXCHANGE; CELLS; OSCILLATIONS; PULSATILITY; PROTEASOME	Studies on glucocorticoid receptor (GR) action typically assess gene responses by long-term stimulation with synthetic hormones. As corticosteroids are released from adrenal glands in a circadian and high-frequency (ultradian) mode, such treatments may not provide an accurate assessment of physiological hormone action. Here we demonstrate that ultradian hormone stimulation induces cyclic GR-mediated transcriptional regulation, or gene pulsing, both in cultured cells and in animal models. Equilibrium receptor-occupancy of regulatory elements precisely tracks the ligand pulses. Nascent RNA transcripts from GR-regulated genes are released in distinct quanta, demonstrating a profound difference between the transcriptional programs induced by ultradian and constant stimulation. Gene pulsing is driven by rapid GR exchange with response elements and by GR recycling through the chaperone machinery, which promotes GR activation and reactivation in response to the ultradian hormone release, thus coupling promoter activity to the naturally occurring fluctuations in hormone levels. The GR signalling pathway has been optimized for a prompt and timely response to fluctuations in hormone levels, indicating that biologically accurate regulation of gene targets by GR requires an ultradian mode of hormone stimulation.	[Stavreva, Diana A.; Wiench, Malgorzata; John, Sam; Johnson, Thomas A.; Voss, Ty C.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Conway-Campbell, Becky L.; McKenna, Mervyn A.; Pooley, John R.; Lightman, Stafford L.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, 41 Lib Dr, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Stavreva, Diana/AAW-8964-2020	Lightman, Stafford/0000-0002-8546-9646; Wiench, Malgorzata/0000-0002-0202-9881	NIH; National Cancer Institute; Center for Cancer Research; BBSRC [BB/C51297X/1]; Wellcome Trust [074112/Z/04/Z, 075548/Z/04/Z]; NATIONAL CANCER INSTITUTE [Z01BC010308, ZIABC010308] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C51297X/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank T. Karpova and J. McNally for assistance, C. Zeiss Inc. for the opportunity to carry out live cell experiments on a Zeiss Duoscan microscope, D. Shatti for technical assistance with nuclear extract preparation and Y. Kershaw for assistance with the in vivo experiments. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The animal work was supported by a BBSRC grant (BB/C51297X/1) and a Wellcome Trust Programme Grant (074112/Z/04/Z) to S.L. The qPCR was performed on an Applied Biosystems 7500 System funded by a Wellcome Trust Equipment Grant (075548/Z/04/Z).	ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chadwick D., 2000, MECH BIOL SIGNIFICAN; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Conway-Campbell BL, 2007, ENDOCRINOLOGY, V148, P5470, DOI 10.1210/en.2007-0585; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gore A. C, 2002, GNRH MASTER MOL REPR; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Lewis JG, 2005, CLIN CHIM ACTA, V359, P189, DOI 10.1016/j.cccn.2005.03.044; Lightman SL, 2006, BIOCHEM SOC T, V34, P1117, DOI 10.1042/BST0341117; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Liu JM, 1999, MOL ENDOCRINOL, V13, P355, DOI 10.1210/me.13.3.355; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mezo G, 2008, CURR MED CHEM, V15, P2366, DOI 10.2174/092986708785909157; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; QI M, 1990, MOL ENDOCRINOL, V4, P455, DOI 10.1210/mend-4-3-455; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Rothwell P, 2007, EUR J NEUROL, V14, P306; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sugaya K, 2000, J CELL SCI, V113, P2679; Thompson NM, 2003, ENDOCRINOLOGY, V144, P4859, DOI 10.1210/en.2003-0423; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	43	266	271	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1093	U111		10.1038/ncb1922	http://dx.doi.org/10.1038/ncb1922			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684579	Green Accepted			2022-12-27	WOS:000269482500010
J	Ikeda, Y; Men, SZ; Fischer, U; Stepanova, AN; Alonso, JM; Ljung, K; Grebe, M				Ikeda, Yoshihisa; Men, Shuzhen; Fischer, Urs; Stepanova, Anna N.; Alonso, Jose M.; Ljung, Karin; Grebe, Markus			Local auxin biosynthesis modulates gradient-directed planar polarity in Arabidopsis	NATURE CELL BIOLOGY			English	Article							ROOT-HAIR INITIATION; ETHYLENE; TRANSPORT; THALIANA; GNOM; REGULATOR; PATHWAY; GROWTH; TISSUE; CTR1	The coordination of cell polarity within the plane of a single tissue layer (planar polarity) is a crucial task during development of multicellular organisms. Mechanisms underlying establishment of planar polarity, however, differ substantially between plants and animals(1-3). In Arabidopsis thaliana, planar polarity of root-hair positioning along epidermal cells is coordinated towards maximum concentration of an auxin gradient in the root tip(3-5). This gradient has been hypothesized to be sink-driven(6) and computational modelling suggests that auxin efflux carrier activity may be sufficient to generate the gradient in the absence of auxin biosynthesis in the root(7). Here, we demonstrate that the Raf-like kinase constitutive triple response1 (CTR1; refs 8, 9) acts as a concentration-dependent repressor of a biosynthesis-dependent auxin gradient that modulates planar polarity in the root tip. We analysed auxin biosynthesis and concentration gradients in a variety of root-hair-position mutants affected in CTR1 activity, auxin biosynthesis and transport. Our results reveal that planar polarity relies on influx-and efflux-carrier-mediated auxin redistribution from a local biosynthesis maximum. Thus, a local source of auxin biosynthesis contributes to gradient homeostasis during long-range coordination of cellular morphogenesis.	[Ikeda, Yoshihisa; Men, Shuzhen; Grebe, Markus] Umea Univ, Dept Plant Physiol, UPSC, SE-90187 Umea, Sweden; [Ikeda, Yoshihisa; Men, Shuzhen; Fischer, Urs; Ljung, Karin; Grebe, Markus] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden; [Stepanova, Anna N.; Alonso, Jose M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Umea University; Swedish University of Agricultural Sciences; University of North Carolina; North Carolina State University	Grebe, M (corresponding author), Umea Univ, Dept Plant Physiol, UPSC, SE-90187 Umea, Sweden.	markus.grebe@plantphys.umu.se	Ikeda, Yoshihisa/B-4614-2013; Ljung, Karin/AAE-8691-2019; Alonso, Jose M/K-6826-2014; Stepanova, Anna/P-9575-2019	Ljung, Karin/0000-0003-2901-189X; Alonso, Jose M/0000-0001-7087-1571; Stepanova, Anna/0000-0003-1018-4758; Men, Shuzhen/0000-0001-6472-6829; Grebe, Markus/0000-0001-7571-0670; Fischer, Urs/0000-0003-3642-6065	Swedish Research Council (Vetenskapsradet); Swedish Foundation for Strategic Research (SSF); EU; NSF [MCB 0519869, MCB 0315992]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); EU(European Commission); NSF(National Science Foundation (NSF))	We gratefully acknowledge M. Bennett, J. Ecker, M. Estelle, J. Friml, G. Jurgens, K. Palme, B. Scheres, R. Swarup and J. Xu for sharing published research materials used in this study. We are grateful to R. Granbom for tissue preparation and technical assistance with auxin concentration and biosynthesis-rate measurements. We thank L. Bako for valuable advice on protein kinase assays, as well as C. Bellini, R. Bhalerao, Y. Boutte, A. Claes, S. Pietra, M. Rosa and B. Sundberg for helpful comments on the manuscript. This work was supported by grants from the Swedish Research Council (Vetenskapsradet) and the Swedish Foundation for Strategic Research (SSF) to M. G., by an EU Marie-Curie International Incoming Postdoctoral Fellowship to Y. I, and by NSF grants (MCB 0519869, MCB 0315992) to J. M. A.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2004, BIOESSAYS, V26, P719, DOI 10.1002/bies.20065; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; ROMAN G, 1995, GENETICS, V139, P1393; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	38	131	135	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					731	U70		10.1038/ncb1879	http://dx.doi.org/10.1038/ncb1879			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448626				2022-12-27	WOS:000266503700018
J	Brodsky, IE; Medzhitov, R				Brodsky, Igor E.; Medzhitov, Ruslan			Targeting of immune signalling networks by bacterial pathogens	NATURE CELL BIOLOGY			English	Review							NF-KAPPA-B; PHOSPHOTHREONINE LYASE ACTIVITY; DOMAIN-CONTAINING ADAPTERS; ANTHRAX LETHAL FACTOR; YERSINIA-PSEUDOTUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; NEISSERIA-MENINGITIDIS; SALMONELLA EFFECTOR; UBIQUITIN LIGASE; ISOCITRATE LYASE	Host defence against microbial pathogens requires appropriate coordination of multiple signalling pathways. These pathways are triggered by innate immune recognition of conserved microbial molecules, and initiate an inflammatory cascade that involves recruitment of leukocytes to the site of infection, activation of antimicrobial effector mechanisms and induction of an adaptive immune response that promotes clearance of infection and long-term immune memory. Microbial pathogens possess specialized proteins termed virulence factors, which interfere with host defence at several levels. Many virulence factors from diverse pathogens have been identified in recent years and their functions linked to disruption of essential processes of immune defence, from signalling to phagocytosis. Although the diversity of pathogens and virulence factors is immense, common themes have emerged with regard to how microbial pathogens interfere with immune responses. Here we discuss recent advances in our understanding of how virulence factors target innate and adaptive immune responses, focusing on bacterial pathogens. We also propose that pathogens responsible for causing acute infection tend to target central components (hubs) of cellular signalling pathways, causing global disruption of the host response. By contrast, pathogens that cause chronic or persistent infections tend to target more peripheral signalling network components (nodes) to promote pathogen persistence.	[Brodsky, Igor E.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Brodsky, IE (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu						Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Gallos LK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188701; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; MULKS MH, 1978, NEW ENGL J MED, V299, P973, DOI 10.1056/NEJM197811022991802; MULKS MH, 1980, J EXP MED, V152, P1442, DOI 10.1084/jem.152.5.1442; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Seifert HS, 2006, EVOLUTION OF MICROBIAL PATHOGENS, pXI; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vitovski S, 1999, FASEB J, V13, P331, DOI 10.1096/fasebj.13.2.331; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x	73	133	139	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					521	526		10.1038/ncb0509-521	http://dx.doi.org/10.1038/ncb0509-521			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404331				2022-12-27	WOS:000265640000004
J	Lin, HK; Wang, GC; Chen, ZB; Teruya-Feldstein, J; Liu, Y; Chan, CH; Yang, WL; Erdjument-Bromage, H; Nakayama, KI; Nimer, S; Tempst, P; Pandolfi, PP				Lin, Hui-Kuan; Wang, Guocan; Chen, Zhenbang; Teruya-Feldstein, Julie; Liu, Yan; Chan, Chia-Hsin; Yang, Wei-Lei; Erdjument-Bromage, Hediye; Nakayama, Keiichi I.; Nimer, Stephen; Tempst, Paul; Pandolfi, Pier Paolo			Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB	NATURE CELL BIOLOGY			English	Article							CDK INHIBITOR P27; BOX PROTEIN SKP2; TUBEROUS SCLEROSIS; CELL-CYCLE; S-PHASE; 3-KINASE/AKT PATHWAY; TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; TUMOR SUPPRESSION; E3 LIGASE	Skp2 is an F-box protein that forms the SCF complex with Skp1 and Cullin-1 to constitute an E3 ligase for ubiquitylation. Ubiquitylation and degradation of p27 are critical for Skp2-mediated entry to the cell cycle, and overexpression and cytosolic accumulation of Skp2 have been clearly associated with tumorigenesis, although the functional significance of the latter is still unknown. Here we show that Akt/protein kinase B (PKB) interacts with and directly phosphorylates Skp2. We find that Skp2 phosphorylation by Akt triggers SCF complex formation and E3 ligase activity. A phosphorylation-defective Skp2 mutant is drastically impaired in its ability to promote cell proliferation and tumorigenesis. Furthermore, we show that Akt-mediated phosphorylation triggers 14-3- 3 beta-dependent Skp2 relocalization to the cytosol, and we attribute a specific role to cytosolic Skp2 in the positive regulation of cell migration. Finally, we demonstrate that high levels of activation of Akt correlate with the cytosolic accumulation of Skp2 in human cancer specimens. Our results therefore define a novel proto-oncogenic Akt/PKB-dependent signalling pathway.	[Lin, Hui-Kuan; Wang, Guocan; Chen, Zhenbang; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA; [Wang, Guocan; Chen, Zhenbang; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Wang, Guocan; Chen, Zhenbang; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol & Med, Boston, MA 02215 USA; [Lin, Hui-Kuan; Chan, Chia-Hsin; Yang, Wei-Lei] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Yan; Nimer, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Memorial Sloan Kettering Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kyushu University	Lin, HK (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	hklin@mdanderson.org; ppandolf@bidmc.harvard.edu	Wang, Guocan/F-1530-2011; Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; Chan, Chia-Hsin/F-2272-2011	Chan, Chia-Hsin/0000-0001-8506-7500; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NIH [RO1 CA-71692, CA-74031, P30 CA-08748]; Anderson Cancer Center Trust; NATIONAL CANCER INSTITUTE [R01CA074031, P30CA008748, R01CA071692] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Center Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank D. Bohmann, P. Jackson, W. Wei, M. Pagano and M. H. Lee for reagents. We are also grateful to M. Asherov and I. Linkov in the Immunohistochemistry Pathology Core Laboratory, T. Matos for immunohistochemistry technical assistance, P. Bonner for data management, L. Lacomis for help with mass spectrometry, X. H. Zhu for technical advice, and S. Clohessy for flow cytometry analysis. We also thank M. C. Hung and L. Cantley for insightful comments and suggestions, and W. Wei for discussion and for sharing experimental results. Special thanks are extended to B. Carver and L. DiSantis for editing and critical reading of the manuscript, as well as to all the members of the Pandolfi laboratory for comments and discussion. This work was supported by NIH grants RO1 CA-71692 and CA-74031 to P.P.P. and by M.D. Anderson Cancer Center Trust Scholar funds to H.K.L. The Microchemistry & Proteomics Core is supported by NIH grant P30 CA-08748.	Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Bilodeau M, 1999, FEBS LETT, V452, P247, DOI 10.1016/S0014-5793(99)00629-8; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Drobnjak M, 2003, CLIN CANCER RES, V9, P2613; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Li Q, 2004, J CUTAN PATHOL, V31, P633, DOI 10.1111/j.0303-6987.2004.00243.x; Lim MS, 2002, BLOOD, V100, P2950, DOI 10.1182/blood.V100.8.2950; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Shim EH, 2003, CANCER RES, V63, P1583; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	44	184	194	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					420	U144		10.1038/ncb1849	http://dx.doi.org/10.1038/ncb1849			34	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270694	Green Accepted			2022-12-27	WOS:000265264900012
J	Kim, YC; Gerlitz, G; Furusawa, T; Catez, F; Nussenzweig, A; Oh, KS; Kraemer, KH; Shiloh, Y; Bustin, M				Kim, Yong-Chul; Gerlitz, Gabi; Furusawa, Takashi; Catez, Frederic; Nussenzweig, Andre; Oh, Kyu-Seon; Kraemer, Kenneth H.; Shiloh, Yosef; Bustin, Michael			Activation of ATM depends on chromatin interactions occurring before induction of DNA damage	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOMAL-PROTEIN HMGN1; HIGH-MOBILITY; CHECKPOINT; ACETYLATION; REPAIR; MDC1; AUTOPHOSPHORYLATION; PHOSPHORYLATION; MEDIATOR	Efficient and correct responses to double-stranded breaks (DSB) in chromosomal DNA are crucial for maintaining genomic stability and preventing chromosomal alterations that lead to cancer(1,2). The generation of DSB is associated with structural changes in chromatin and the activation of the protein kinase ataxia-telangiectasia mutated (ATM), a key regulator of the signalling network of the cellular response to DSB3,4. The interrelationship between DSB-induced changes in chromatin architecture and the activation of ATM is unclear(4). Here we show that the nucleosome-binding protein HMGN1 modulates the interaction of ATM with chromatin both before and after DSB formation, thereby optimizing its activation. Loss of HMGN1 or ablation of its ability to bind to chromatin reduces the levels of ionizing radiation (IR)-induced ATM autophosphorylation and the activation of several ATM targets. IR treatments lead to a global increase in the acetylation of Lys 14 of histone H3 (H3K14) in an HMGN1-dependent manner and treatment of cells with histone deacetylase inhibitors bypasses the HMGN1 requirement for efficient ATM activation. Thus, by regulating the levels of histone modifications, HMGN1 affects ATM activation. Our studies identify a new mediator of ATM activation and demonstrate a direct link between the steady-state intranuclear organization of ATM and the kinetics of its activation after DNA damage.	[Kim, Yong-Chul; Gerlitz, Gabi; Furusawa, Takashi; Catez, Frederic; Bustin, Michael] NCI, Lab Metab, CCR, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Andre] NCI, Expt Immunol Branch, CCR, NIH, Bethesda, MD 20892 USA; [Oh, Kyu-Seon; Kraemer, Kenneth H.] NCI, Basic Res Lab, CCR, NIH, Bethesda, MD 20892 USA; [Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Bustin, M (corresponding author), NCI, Lab Metab, CCR, NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	CATEZ, Frédéric/AAM-4854-2020; Gabi, Gerlitz/L-9269-2019; Bustin, Michael/G-6155-2015; CATEZ, Frédéric/GQP-7328-2022	CATEZ, Frédéric/0000-0001-8255-9091; Gabi, Gerlitz/0000-0001-6422-8715; Bustin, Michael/0000-0002-5147-7242; Kraemer, Kenneth/0000-0002-2689-3316	NCI; A-T Medical Research Foundation; A-T Children's Project; The Israel Science Foundation; A-T Medical Research Trust; Israel-Germany Joint Program on Cancer Research; A-T Ease Foundation; NATIONAL CANCER INSTITUTE [ZIABC010959, ZIABC011154, ZIABC004496, ZIABC004517] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A-T Medical Research Foundation; A-T Children's Project; The Israel Science Foundation(Israel Science Foundation); A-T Medical Research Trust; Israel-Germany Joint Program on Cancer Research; A-T Ease Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Celeste (NCI) for advice and help, and S. Garfield (Confocal Core Facility of the LEC, NCI), for help with imaging. The research was supported by the intramural program of the NCI. Work in the laboratory of Y. S. is supported by the A-T Medical Research Foundation, the A-T Children's Project, The Israel Science Foundation, the A-T Medical Research Trust, the Israel-Germany Joint Program on Cancer Research, and the A-T Ease Foundation.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Catez F, 2003, BIOCHEM CELL BIOL, V81, P113, DOI 10.1139/o03-040; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Koundrioukoff S, 2004, DNA REPAIR, V3, P969, DOI 10.1016/j.dnarep.2004.03.010; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wurtele H, 2006, CURR OPIN CELL BIOL, V18, P137, DOI 10.1016/j.ceb.2006.02.008; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	32	103	104	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					92	U192		10.1038/ncb1817	http://dx.doi.org/10.1038/ncb1817			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079244	Green Accepted			2022-12-27	WOS:000262157000016
J	Han, XJ; Feng, XL; Rattner, JB; Smith, H; Bose, P; Suzuki, K; Soliman, MA; Scott, MS; Burke, BE; Riabowol, K				Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Scott, Michelle S.; Burke, Brian E.; Riabowol, Karl			Tethering by lamin A stabilizes and targets the ING1 tumour suppressor	NATURE CELL BIOLOGY			English	Article							A-TYPE LAMINS; GILFORD-PROGERIA-SYNDROME; PLANT HOMEODOMAIN FINGER; DEACETYLASE COMPLEX; NUCLEAR LAMINS; PROTEINS; BINDING; ACETYLATION; EXPRESSION; FAMILY	ING proteins interact with core histones through their plant homeodomains (PHDs)(1-4) and with histone acetyltransferase (HAT) and histone deacetylase (HDAC) complexes to alter chromatin structure(5-7). Here we identify a lamin interaction domain (LID) found only in ING proteins, through which they bind to and colocalize with lamin A. Lamin knockout (LMNA(-/-)) cells show reduced levels of ING1 that mislocalize. Ectopic lamin A expression increases ING1 levels and re-targets it to the nucleus to act as an epigenetic regulator(6,8). ING1 lacking the LID does not interact with lamin A or affect apoptosis. In LMNA-/- cells, apoptosis is not affected by ING1. Mutation of lamin A results in several laminopathies, including Hutchinson-Gilford progeria syndrome (HGPS), a severe premature ageing disorder(9). HGPS cells have reduced ING1 levels that mislocalize. Expression of LID peptides to block lamin A-ING1 interaction induces phenotypes reminiscent of laminopathies including HGPS(9,10). These data show that targeting of ING1 to the nucleus by lamin A maintains ING1 levels and biological function. Known roles for ING proteins in regulating apoptosis and chromatin structure indicate that loss of lamin A-ING interaction may be an effector of lamin A loss, contributing to the HGPS phenotype.	[Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Riabowol, Karl] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Han, Xijing; Feng, Xiaolan; Rattner, Jerome B.; Smith, Heather; Bose, Pinaki; Suzuki, Keiko; Soliman, Mohamed A.; Riabowol, Karl] Univ Calgary, Fac Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Rattner, Jerome B.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Soliman, Mohamed A.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo, Egypt; [Burke, Brian E.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32606 USA	University of Calgary; University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Cairo University; State University System of Florida; University of Florida	Riabowol, K (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	karl@ucalgary.ca	Feng, Xiaolan/J-9997-2019; Scott, Michelle/C-7445-2013	Scott, Michelle/0000-0001-6231-7714; Feng, Xiaolan/0000-0002-7333-8198	CIHR; NSERC; NIH; AHFMR; Alberta Cancer Board (ACB); ACB	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHFMR(Alberta Heritage Foundation for Medical Research); Alberta Cancer Board (ACB); ACB	We thank E. White for lamin constructs, J. Quarrie and D. Rancourt for ES cells, the SACRI Microscopy Facility for cell imaging, D. Boland and S. Law of the SAS for ING antibodies, D. Schreimer for LC/MS/MS advice and L. Robertson for help with flow cytometry. This study was supported by grants from the CIHR to K. R., from the NSERC to J. B. R. and to B. B. from the NIH. K. R. is a Scientist of the AHFMR, M. A. S. holds studentships from AHFMR and the Alberta Cancer Board (ACB) and H. S. and P. B. hold an ACB studentship.	Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Garkavtsev I, 1997, MOL CELL BIOL, V17, P2014, DOI 10.1128/MCB.17.4.2014; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helsens K, 2007, PROTEOMICS, V7, P364, DOI 10.1002/pmic.200600682; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nouman GS, 2003, J CLIN PATHOL, V56, P507, DOI 10.1136/jcp.56.7.507; OZAKI T, 1994, ONCOGENE, V9, P2649; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Scott M, 2001, J CELL SCI, V114, P3455; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Vieyra D, 2002, CANCER RES, V62, P4445; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; Walzak AA, 2008, EXP CELL RES, V314, P273, DOI 10.1016/j.yexcr.2007.07.029; Wang J, 2006, CANCER RES, V66, P1906, DOI 10.1158/0008-5472.CAN-05-3444; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	35	76	77	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1333	U181		10.1038/ncb1792	http://dx.doi.org/10.1038/ncb1792			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836436				2022-12-27	WOS:000260586700016
J	Chitalia, VC; Foy, RL; Bachschmid, MM; Zeng, L; Panchenko, MV; Zhou, MI; Bharti, A; Seldin, DC; Lecker, SH; Dominguez, I; Cohen, HT				Chitalia, Vipul C.; Foy, Rebecca L.; Bachschmid, Markus M.; Zeng, Liling; Panchenko, Maria V.; Zhou, Mina I.; Bharti, Ajit; Seldin, David C.; Lecker, Stewart H.; Dominguez, Isabel; Cohen, Herbert T.			Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL	NATURE CELL BIOLOGY			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Nephrology/Annual Renal Week	OCT 31-NOV 05, 2007	San Francisco, CA	Amer Soc Nephrol			F-BOX PROTEIN; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; DEPENDENT PROTEOLYSIS; RENAL-CARCINOMA; TRANSGENIC MICE; XENOPUS EMBRYOS; DEGRADATION; PRODUCT; GENE	The von Hippel-Lindau protein pVHL suppresses renal tumorigenesis in part by promoting the degradation of hypoxia-inducible HIF-alpha transcription factors(1); additional mechanisms have been proposed(2). pVHL also stabilizes the plant homeodomain protein Jade-1, which is a candidate renal tumour suppressor that may correlate with renal cancer risk(3-5). Here we show that Jade-1 binds the oncoprotein beta-catenin in Wnt-responsive fashion. Moreover, Jade-1 destabilizes wildtype beta-catenin but not a cancer-causing form of beta-catenin. Whereas the well-established beta-catenin E3 ubiquitin ligase component beta-TrCP ubiquitylates only phosphorylated beta-catenin(6), Jade-1 ubiquitylates both phosphorylated and non-phosphorylated beta-catenin and therefore regulates canonical Wnt signalling in both Wnt-off and Wnt-on phases. Thus, the different characteristics of beta-TrCP and Jade-1 may ensure optimal Wnt pathway regulation. Furthermore, pVHL downregulates beta-catenin in a Jade-1-dependent manner and inhibits Wnt signalling, supporting a role for Jade-1 and Wnt signalling in renal tumorigenesis. The pVHL tumour suppressor and the Wnt tumorigenesis pathway are therefore directly linked through Jade-1.	[Chitalia, Vipul C.; Foy, Rebecca L.; Zeng, Liling; Panchenko, Maria V.; Zhou, Mina I.; Cohen, Herbert T.] Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA; [Bharti, Ajit] Boston Univ, Sch Med, Mol Stress Response Unit, Boston, MA 02118 USA; [Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Unit, Boston, MA 02118 USA; [Seldin, David C.; Dominguez, Isabel; Cohen, Herbert T.] Boston Univ, Sch Med, Hematol Oncol Sect, Dept Med, Boston, MA 02118 USA; [Lecker, Stewart H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Cohen, HT (corresponding author), Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA.	htcohen@bu.edu		/0000-0001-9617-4141; Chitalia, Vipul/0000-0002-6663-6058; Bharti, Ajit/0000-0001-7972-6688; Seldin, David C/0000-0003-0168-2333; Bachschmid, Markus Michael/0000-0002-0748-5528; Panchenko, Maria/0000-0001-6247-6598; Cohen, Herbert/0000-0003-1900-8718	NATIONAL CANCER INSTITUTE [R01CA079830, R01CA071796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053, R01DK067569] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA79830, R01 CA071796-11, R01 CA079830-08, R01 CA079830, R01 CA071796, R01 CA71796] Funding Source: Medline; NIDDK NIH HHS [R01 DK067569-05, R01 DK67569, T32 DK007053, T32 DK07053, T32 DK007053-32, R01 DK067569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Battagli C, 2003, CANCER RES, V63, P8695; Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Dominguez I, 2004, DEV BIOL, V274, P110, DOI 10.1016/j.ydbio.2004.06.021; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; NIEUWKOOP JM, 1967, NORMAL TABLE XENOPUS; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Panchenko MV, 2004, J BIOL CHEM, V279, P56032, DOI 10.1074/jbc.M410487200; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	32	139	144	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1208	1216		10.1038/ncb1781	http://dx.doi.org/10.1038/ncb1781			9	Cell Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806787	Green Accepted			2022-12-27	WOS:000259682900015
J	Varelas, X; Sakuma, R; Samavarchi-Tehrani, P; Peerani, R; Rao, BM; Dembowy, J; Yaffe, MB; Zandstra, PW; Wrana, JL				Varelas, Xaralabos; Sakuma, Rui; Samavarchi-Tehrani, Payman; Peerani, Raheem; Rao, Balaji M.; Dembowy, Joanna; Yaffe, Michael B.; Zandstra, Peter W.; Wrana, Jeffrey L.			TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; NUCLEAR IMPORT; SIGNAL-TRANSDUCTION; DIFFERENTIATION; TRANSCRIPTION; PHOSPHORYLATION; RECEPTOR; PROTEIN; PLURIPOTENCY	Transforming growth factor-beta (TGF beta) family members regulate many developmental and pathological events through Smad transcriptional modulators. How nuclear accumulation of Smad is coupled to the transcriptional machinery is poorly understood. Here we demonstrate that in response to TGF beta stimulation the transcriptional regulator TAZ binds heteromeric Smad2/3-4 complexes and is recruited to TGF beta response elements. In human embryonic stem cells TAZ is required to maintain self-renewal markers and loss of TAZ leads to inhibition of TGF beta signalling and differentiation into a neuroectoderm lineage. In the absence of TAZ, Smad2/3-4 complexes fail to accumulate in the nucleus and activate transcription. Furthermore, TAZ, which itself engages in shuttling, dominantly controls Smad nucleocytoplasmic localization and can be retained in the nucleus by transcriptional co-factors such as ARC105, a component of the Mediator complex. TAZ thus defines a hierarchical system regulating Smad nuclear accumulation and coupling to the transcriptional machinery.	[Varelas, Xaralabos; Sakuma, Rui; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Dembowy, Joanna; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet & Microbiol, Toronto, ON M5S 1A8, Canada; [Peerani, Raheem; Rao, Balaji M.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Yaffe, Michael B.] Harvard Univ, MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Yaffe, Michael B.] Harvard Univ, MIT, Ctr Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Wrana, Jeffrey/F-8857-2013; Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Rao, Balaji/0000-0001-5695-8953	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; IZZI L, 2007, EMBO J; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	47	474	494	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					837	848		10.1038/ncb1748	http://dx.doi.org/10.1038/ncb1748			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18568018				2022-12-27	WOS:000257268400013
J	Liang, J; Wan, M; Zhang, Y; Gu, PL; Xin, HW; Jung, SY; Qin, J; Wong, JM; Cooney, AJ; Liu, D; Zhou, SY				Liang, Jiancong; Wan, Ma; Zhang, Yi; Gu, Peili; Xin, Huawei; Jung, Sung Yun; Qin, Jun; Wong, Jiemin; Cooney, Austin J.; Liu, Dan; Zhou Songyang			Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells	NATURE CELL BIOLOGY			English	Article							PLURIPOTENCY; NURD; EXPRESSION; INTERACTS; FIBROBLASTS; MAINTENANCE; HOMOLOG; NETWORK; CLONING; GENES	Nanog and Oct4 are essential transcription factors that regulate self-renewal and pluripotency of ES cells. However, the mechanisms by which Nanog and Oct4 modulate ES cell fate remain unknown. Through characterization of endogenous Nanog and Oct4 protein complexes in mouse ES cells, we found that these transcription factors interact with each other and associate with proteins from multiple repression complexes, including the NuRD, Sin3A and PmI complexes. In addition, Nanog, Oct4 and repressor proteins co-occupy Nanog-target genes in mouse ES cells, suggesting that Nanog and Oct4 together may communicate with distinct repression complexes to control gene transcription. To our surprise, of the various core components in the NuRD complex with which Nanog and Oct4 interact, Mta1 was preferred, whereas Mbd3 and Rbbp7 were either absent or present at sub-stoichiometric levels. We named this unique Hdac1/2-and Mta1/2-containing complex NODE (for Nanog and Oct4 associated deacetylase). Interestingly, NODE contained histone deacetylase (HDAC) activity that seemed to be comparable to NuRD, and retained its association with Nanog and Oct4 in Mbd3(-/-)ES cells. In contrast to Mbd3 loss-of-function, knockdown of NODE subunits led to increased expression of developmentally regulated genes and ES-cell differentiation. Our data collectively suggest that Nanog and Oct4 associate with unique repressor complexes on their target genes to control ES cell fate.	[Gu, Peili; Qin, Jun; Wong, Jiemin; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liang, Jiancong; Wan, Ma; Zhang, Yi; Xin, Huawei; Jung, Sung Yun; Qin, Jun; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Cooney, Austin J.; Zhou Songyang] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.edu	Liang, Jiancong/AAC-1321-2022	Liang, Jiancong/0000-0002-7215-4346; Wong, Jiemin/0000-0002-5311-842X; Jung, Sung Yun/0000-0003-1521-7977	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069572, P01GM081627] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK73524] Funding Source: Medline; NIGMS NIH HHS [GM81627, GM69572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	35	336	347	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					731	739		10.1038/ncb1736	http://dx.doi.org/10.1038/ncb1736			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454139				2022-12-27	WOS:000256350100020
J	Kedde, M; van Kouwenhove, M; Zwart, W; Vrielink, JAFO; Elkon, R; Agami, R				Kedde, Martijn; van Kouwenhove, Marieke; Zwart, Wilbert; Vrielink, Joachim A. F. Oude; Elkon, Ran; Agami, Reuven			A Pumilio-induced RNA structure switch in p27-3 ' UTR controls miR-221 and miR-222 accessibility	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; TUMOR-SUPPRESSOR; STRESS GRANULES; LET-7 MICRORNA; P27(KIP1); REVEALS; CANCER; PROLIFERATION; GENE	Key regulators of 3' untranslated regions (3' UTRs) are microRNAs and RNA-binding proteins (RBPs)(1,2). The p27 tumour suppressor is highly expressed in quiescent cells, and its downregulation is required for cell cycle entry after growth factor stimulation(3,4). Intriguingly, p27 accumulates in quiescent cells despite high levels of its inhibitors miR-221 and miR-222 (refs 5, 6). Here we show that miR-221 and miR-222 are underactive towards p27-3' UTR in quiescent cells, as a result of target site hindrance. Pumilio-1 (PUM1) is a ubiquitously expressed RBP that was shown to interact with p27-3' UTR(7,8). In response to growth factor stimulation, PUM1 is upregulated and phosphorylated for optimal induction of its RNA-binding activity towards the p27-3' UTR. PUM1 binding induces a local change in RNA structure that favours association with miR-221 and miR-222, efficient suppression of p27 expression, and rapid entry to the cell cycle. We have therefore uncovered a novel RBP-induced structural switch modulating microRNA-mediated gene expression regulation.	[Kedde, Martijn; van Kouwenhove, Marieke; Vrielink, Joachim A. F. Oude; Elkon, Ran; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Zwart, Wilbert] Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands; [Agami, Reuven] Ctr Biomed Genet UMCU, NL-3584 CG Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022; Kedde, Martijn/F-9716-2016	Agami, Reuven/0000-0002-2848-2473; Zwart, Wilbert/0000-0002-9823-7289	EURYI (European research young investigator award); ERC (European Research Council); Dutch cancer foundation; Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); EMBO	EURYI (European research young investigator award)(European Science Foundation (ESF)); ERC (European Research Council)(European Research Council (ERC)); Dutch cancer foundation(KWF Kankerbestrijding); Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); EMBO(European Molecular Biology Organization (EMBO))	We thank all members of the Agami laboratory for technical help and discussions. We also thank Andre Gerber for constructs, Kees Jalink for advice on fluorescence lifetime imaging microscopy measurements, and R.B. Israel for assistance with statistical analysis. This work was supported by the EURYI (European research young investigator award), ERC (European Research Council), KWF (koningin wilhelmina fonds; Dutch cancer foundation) and Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek; R.A.) and an EMBO long-term fellowship (R.E.).	Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037	25	296	313	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					1014	1020		10.1038/ncb2105	http://dx.doi.org/10.1038/ncb2105			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818387				2022-12-27	WOS:000282363500017
J	Gutierrez, GJ; Tsuji, T; Chen, MF; Jiang, W; Ronai, ZA				Gutierrez, Gustavo J.; Tsuji, Toshiya; Chen, Meifan; Jiang, Wei; Ronai, Ze'ev A.			Interplay between Cdh1 and JNK activity during the cell cycle	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE CHECKPOINT; TERMINAL KINASE JNK; PHOSPHATASE CDC14; UBIQUITIN LIGASE; S-PHASE; DEGRADATION; PHOSPHORYLATION; CDC20; MITOSIS	The ubiquitin ligase APC/C(Cdh1) coordinates degradation of key cell cycle regulators. We report here that a nuclear-localized portion of the stress-activated kinase JNK is degraded by the APC/C(Cdh1) during exit from mitosis and the G1 phase of the cell cycle. Expression of a non-degradable JNK induces prometaphase-like arrest and aberrant mitotic spindle dynamics. Moreover, JNK phosphorylates Cdh1 directly, during G2 and early mitosis, changing its subcellular localization and attenuating its ability to activate the APC/C during G2/M. This regulatory mechanism between JNK and Cdh1 reveals an important function for JNK during the cell cycle.	[Gutierrez, Gustavo J.; Tsuji, Toshiya; Chen, Meifan; Jiang, Wei; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@sanfordburnham.org	Gutierrez, Gustavo/B-6771-2013; Gutierrez, Gustavo/AAO-9957-2021; Holt, Janet E/B-2415-2013	Gutierrez, Gustavo/0000-0003-4133-5002; Gutierrez, Gustavo/0000-0001-8652-972X; Chen, Meifan/0000-0002-4190-4001; Jiang, Wei/0000-0002-2309-9571; RONAI, ZEEV/0000-0002-3859-0400	NCI [CA78419]; Sass foundation; NATIONAL CANCER INSTITUTE [R01CA138143, R01CA078419] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sass foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to R. Agami, M. Brandeis, J. Lukas, J. Bartek, J. Kyriakis, T. Hunter, H. Piwnica-Worms, S. Tsai, J. Hsieh, T. Lorca and O. Coux for essential reagents used in this work. Supports by NCI grant (CA78419) to Z.A.R. and the Sass foundation to G.J.G. are gratefully acknowledged.	ALEXAKI VI, 2008, PIGMENT CELL MELANOM; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	39	44	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					686	U130		10.1038/ncb2071	http://dx.doi.org/10.1038/ncb2071			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20581839	Green Accepted			2022-12-27	WOS:000279374400012
J	Guo, XC; Keyes, WM; Papazoglu, C; Zuber, J; Li, WZ; Lowe, SW; Vogel, H; Mills, AA				Guo, Xuecui; Keyes, William M.; Papazoglu, Cristian; Zuber, Johannes; Li, Wangzhi; Lowe, Scott W.; Vogel, Hannes; Mills, Alea A.			TAp63 induces senescence and suppresses tumorigenesis in vivo	NATURE CELL BIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; P53 HOMOLOG; TUMOR-SUPPRESSOR; ONCOGENIC RAS; P63; APOPTOSIS; CANCER; P73; DELTA-NP63-ALPHA; TRANSCRIPTION	p63 is distinct from its homologue p53 in that its role as a tumour suppressor is controversial, an issue complicated by the existence of two classes of p63 isoforms(1). Here we show that TAp63 isoforms are robust mediators of senescence that inhibit tumorigenesis in vivo. Whereas gain of TAp63 induces senescence, loss of p63 enhances sarcoma development in mice lacking p53. Using a new TAp63-specific conditional mouse model, we demonstrate that TAp63 isoforms are essential for Ras-induced senescence, and that TAp63 deficiency increases proliferation and enhances Ras-mediated oncogenesis in the context of p53 deficiency in vivo. TAp63 induces senescence independently of p53, p19(Arf) and p16(Ink4a), but requires p21(Waf/Cip1) and Rb. TAp63-mediated senescence overrides Ras-driven transformation of p53-deficient cells, preventing tumour initiation, and doxycycline-regulated expression of TAp63 activates p21(Waf/Cip1), induces senescence and inhibits progression of established tumours in vivo. Our findings demonstrate that TAp63 isoforms function as tumour suppressors by regulating senescence through p53-independent pathways. The ability of TAp63 to trigger senescence and halt tumorigenesis irrespective of p53 status identifies TAp63 as a potential target of anti-cancer therapy for human malignancies with compromised p53.	[Lowe, Scott W.; Mills, Alea A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Vogel, Hannes] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University	Mills, AA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mills@cshl.edu	Li, Wangzhi/A-1390-2015; Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835; Vogel, Otto Hannes/0000-0002-0960-3508; Keyes, William M./0000-0002-8917-2268	American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Burgess, A. Bric, R. Dickins, P. Moody and L. Rodgers for suggestions, and L. Bianco and staff for assistance. A. A. M. and X. G. were supported by an American Cancer Society Research Scholar Award.	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bell HS, 2007, J CLIN INVEST, V117, P1008, DOI 10.1172/JCI28920; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Gallegos JR, 2008, J BIOL CHEM, V283, P66, DOI 10.1074/jbc.M704686200; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Liefer KM, 2000, CANCER RES, V60, P4016; MacPartlin M, 2008, J BIOL CHEM, V283, P15754, DOI 10.1074/jbc.M801394200; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; QUELLE DE, 1995, CELL, V83, P993; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sunahara M, 1999, ONCOGENE, V18, P3761, DOI 10.1038/sj.onc.1202972; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2003, CANCER RES, V63, P2351; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	37	197	199	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1451	U150		10.1038/ncb1988	http://dx.doi.org/10.1038/ncb1988			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898465	Green Accepted			2022-12-27	WOS:000272251300012
J	Eisenberg, T; Knauer, H; Schauer, A; Buttner, S; Ruckenstuhl, C; Carmona-Gutierrez, D; Ring, J; Schroeder, S; Magnes, C; Antonacci, L; Fussi, H; Deszcz, L; Hartl, R; Schraml, E; Criollo, A; Megalou, E; Weiskopf, D; Laun, P; Heeren, G; Breitenbach, M; Grubeck-Loebenstein, B; Herker, E; Fahrenkrog, B; Frohlich, KU; Sinner, F; Tavernarakis, N; Minois, N; Kroemer, G; Madeo, F				Eisenberg, Tobias; Knauer, Heide; Schauer, Alexandra; Buettner, Sabrina; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Ring, Julia; Schroeder, Sabrina; Magnes, Christoph; Antonacci, Lucia; Fussi, Heike; Deszcz, Luiza; Hartl, Regina; Schraml, Elisabeth; Criollo, Alfredo; Megalou, Evgenia; Weiskopf, Daniela; Laun, Peter; Heeren, Gino; Breitenbach, Michael; Grubeck-Loebenstein, Beatrix; Herker, Eva; Fahrenkrog, Birthe; Froehlich, Kai-Uwe; Sinner, Frank; Tavernarakis, Nektarios; Minois, Nadege; Kroemer, Guido; Madeo, Frank			Induction of autophagy by spermidine promotes longevity	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN EXTENSION; NECROTIC CELL-DEATH; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; BUDDING YEAST; REGULATES APOPTOSIS; CALORIE RESTRICTION; OXIDATIVE STRESS; GENE-EXPRESSION; MURINE SKIN	Ageing results from complex genetically and epigenetically programmed processes that are elicited in part by noxious or stressful events that cause programmed cell death. Here, we report that administration of spermidine, a natural polyamine whose intracellular concentration declines during human ageing, markedly extended the lifespan of yeast, flies and worms, and human immune cells. In addition, spermidine administration potently inhibited oxidative stress in ageing mice. In ageing yeast, spermidine treatment triggered epigenetic deacetylation of histone H3 through inhibition of histone acetyltransferases (HAT), suppressing oxidative stress and necrosis. Conversely, depletion of endogenous polyamines led to hyperacetylation, generation of reactive oxygen species, early necrotic death and decreased lifespan. The altered acetylation status of the chromatin led to significant upregulation of various autophagy-related transcripts, triggering autophagy in yeast, flies, worms and human cells. Finally, we found that enhanced autophagy is crucial for polyamine-induced suppression of necrosis and enhanced longevity.	[Eisenberg, Tobias; Knauer, Heide; Schauer, Alexandra; Buettner, Sabrina; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Ring, Julia; Schroeder, Sabrina; Antonacci, Lucia; Fussi, Heike; Froehlich, Kai-Uwe; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Magnes, Christoph; Sinner, Frank] Inst Med Technol & Hlth Management, Graz, Austria; [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1010 Vienna, Austria; [Schraml, Elisabeth] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria; [Criollo, Alfredo; Kroemer, Guido] INSERM, U848, Villejuif, France; [Criollo, Alfredo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Criollo, Alfredo; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Megalou, Evgenia; Tavernarakis, Nektarios] Inst Mol Biol & Biotechnol, Fdn Res & Technol Hellas, Iraklion 70013, Crete, Greece; [Weiskopf, Daniela; Grubeck-Loebenstein, Beatrix] Austrian Acad Sci, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria; [Laun, Peter; Heeren, Gino; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, Div Genet, A-5020 Salzburg, Austria; [Herker, Eva] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Fahrenkrog, Birthe] Univ Basel, ME Mueller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland	University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Natural Resources & Life Sciences, Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Foundation for Research & Technology - Hellas (FORTH); Austrian Academy of Sciences; University of Innsbruck; Salzburg University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Basel	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	kroemer@orange.fr; frank.madeo@uni-graz.at	KROEMER, Guido/B-4263-2013; Herker, Eva/B-9699-2014; Eisenberg, Tobias/AAV-7806-2021; Kroemer, Guido/AAY-9859-2020; Fahrenkrog, Birthe/D-5840-2011; Herker, Eva/AAQ-1944-2021; Tavernarakis, Nektarios/B-9684-2013	KROEMER, Guido/0000-0002-9334-4405; Herker, Eva/0000-0001-9644-2484; Tavernarakis, Nektarios/0000-0002-5253-1466; Ruckenstuhl, Christoph/0000-0002-4338-4679; Eisenberg, Tobias/0000-0003-3559-1130; Sinner, Frank Michael/0000-0002-9292-4512; Buttner, Sabrina/0000-0002-2786-8542; Fahrenkrog, Birthe/0000-0003-4080-9413; Weiskopf, Daniela/0000-0003-2968-7371; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Schraml, Elisabeth/0000-0003-0738-9883; Magnes, Christoph/0000-0002-5153-7444; Madeo, Frank/0000-0002-5070-1329; Criollo, Alfredo/0000-0002-2737-7751; Ring, Julia/0000-0003-4991-9328	Austrian Science Fund FWF (Austria) [S-9304-B05, S-9303-B05, S9302-B05, S-9301-B05]; European Commission (Brussels, Europe) [512020]; APOSYS;  [FP6 036894]	Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); European Commission (Brussels, Europe)(European CommissionEuropean Commission Joint Research Centre); APOSYS(European CommissionEuropean Commission Joint Research Centre); 	We thank Ulrike Potocnik, Silvia Dichtinger, Arno Absenger and Elfgard Heintz for assistance. We are grateful to the Austrian Science Fund FWF (Austria) for grant S-9304-B05 (to F. M., S. B. and D. C.-G.), grant S-9303-B05 (to K.-U. F. and H. K.), grant LIPOTOX (to F. M. and S. B.), and grant S-9301-B05 (to B. G.-L.) and to the European Commission for project TransDeath (to K.-U. F. and C. R.), project APOSYS (to F. M., T. E. and G. K.) and project Lifespan (FP6 036894 to B. G.-L.). We are grateful to the Austrian Science Fund FWF (Vienna, Austria) for grants S9302-B05 (to M. B.) and to the European Commission (Brussels, Europe) for project MIMAGE (contract no. 512020; to M. B.).	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BRENNER S, 1974, GENETICS, V77, P71; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; BURHANS WC, 2009, CELL CYCLE, P8; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gianotti V, 2008, J CHROMATOGR A, V1185, P296, DOI 10.1016/j.chroma.2008.02.038; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hobbs CA, 2003, EXP CELL RES, V290, P427, DOI 10.1016/S0014-4827(03)00352-5; Hobbs CA, 2002, CANCER RES, V62, P67; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3; Schraml E, 2007, EXP GERONTOL, V42, P1072, DOI 10.1016/j.exger.2007.08.003; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	76	986	1042	11	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1305	U102		10.1038/ncb1975	http://dx.doi.org/10.1038/ncb1975			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801973	Green Published			2022-12-27	WOS:000271425800010
J	Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E				Giampieri, Silvia; Manning, Cerys; Hooper, Steven; Jones, Louise; Hill, Caroline S.; Sahai, Erik			Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VIVO; CARCINOMA CELLS; LUNG METASTASIS; MAMMARY-TUMORS; INVASION; INTRAVASATION; EXPRESSION; VIMENTIN	Here we use intravital imaging to demonstrate a reversible transition to a motile state as breast cancer cells spread. Imaging primary tumours revealed heterogeneity in cell morphology and motility. Two distinct modes of motility were observed: collective and single-celled. By monitoring the localization of Smad2 and the activity of a TGF beta-dependent reporter gene during breast cancer cell dissemination, we demonstrate that TGF beta signalling is transiently and locally activated in motile single cells. TGF beta 1 switches cells from cohesive to single cell motility through a transcriptional program involving Smad4, EGFR, Nedd9, M-RIP, FARP and RhoC. Blockade of TGF beta signalling prevented cells moving singly in vivo but did not inhibit cells moving collectively. Cells restricted to collective invasion were capable of lymphatic invasion but not blood-borne metastasis. Constitutive TGF beta signalling promoted single cell motility and intravasation but reduced subsequent growth in the lungs. Thus, transient TGF beta signalling is essential for blood-borne metastasis.	[Giampieri, Silvia; Manning, Cerys; Hooper, Steven; Sahai, Erik] CR UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3PX, England; [Jones, Louise] Inst Canc Res, Tumor Biol Ctr, London EC1M 6BQ, England; [Hill, Caroline S.] CR UK London Res Inst, Dev Signalling Lab, London WC2A 3PX, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Queen Mary University London	Sahai, E (corresponding author), CR UK London Res Inst, Tumour Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	erik.sahai@cancer.org.uk		Sahai, Erik/0000-0002-3932-5086; Giampieri, Silvia/0000-0001-5484-3140; Manning, Cerys/0000-0001-8656-5878; Hill, Caroline/0000-0002-8632-0480	Breast Cancer Campaign; CRUK	Breast Cancer Campaign; CRUK(Cancer Research UK)	We thank lab colleagues for advice and comments on this project. We thank members of the LRI FACS laboratory, Clare Watkins and members of the LRI Biological Resources Unit, the Paterson Institute for Cancer Research microarray facility, the LRI Bioinformatics team, Mike Howell of the LRI Developmental Signalling laboratory and Debbie Aubyn of the LRI microscopy laboratory for technical assistance. This work was funded by the Breast Cancer Campaign project grant 12May05 and CRUK.	Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; Fox SB, 1997, J MAMMARY GLAND BIOL, V2, P131, DOI 10.1023/A:1026399613946; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gilles C, 2003, CANCER RES, V63, P2658; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; Wells A, 2000, ADV CANCER RES, V78, P31; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	37	453	459	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1287	U49		10.1038/ncb1973	http://dx.doi.org/10.1038/ncb1973			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838175	Green Accepted			2022-12-27	WOS:000271425800008
J	Makovets, S; Blackburn, EH				Makovets, Svetlana; Blackburn, Elizabeth H.			DNA damage signalling prevents deleterious telomere addition at DNA breaks	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; REPLICATION; PATHWAYS; PHOSPHORYLATION; SUPPRESSION; ELONGATION; HELICASES; PROTEIN; ALPHA	The response to DNA damage involves regulation of several essential processes to maximize the accuracy of DNA damage repair and cell survival(1). Telomerase has the potential to interfere with repair by inappropriately adding telomeres to DNA breaks. It was unknown whether cells modulate telomerase in response to DNA damage to increase the accuracy of repair. Here, we report that telomerase action is regulated as a part of the cellular response to DNA double-strand breaks (DSBs). Using yeast, we show that the main ATR/Mec1 DNA damage signalling pathway regulates telomerase action at DSBs. After DNA damage, MEC1-RAD53-DUN1-dependent phosphorylation of the telomerase inhibitor Pif1 occurs. Using a separation of function PIF1 mutation, we show that this phosphorylation is specifically required for the Pif1-mediated telomerase inhibition that takes place at DNA breaks, but not for that at telomeres. Hence DNA damage signalling down-modulates telomerase action at DNA breaks through Pif1 phosphorylation, thus preventing aberrant healing of broken DNA ends by telomerase. These findings uncover a new regulatory mechanism that coordinates competing DNA end-processing activities and thereby promotes DNA repair accuracy and genome integrity.	[Makovets, Svetlana; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Makovets, Svetlana] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of California System; University of California San Francisco; University of Edinburgh	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu		Makovets, Svetlana/0000-0002-0226-2093	School of Biological Sciences, University of Edinburgh; Wellcome Trust [84637]; NIH [GM26259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026259, R01GM026259] Funding Source: NIH RePORTER	School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Blackburn and Harrington laboratories for encouraging discussions and useful ideas. We also thank C. Anderson for pEHB13045 and H. Interthal and N. E. Murray for critical reading of the manuscript and helpful suggestions. We thank the laboratory of L. A. Harrington for support of S. M. since February 2008 (with funds provided by the School of Biological Sciences, University of Edinburgh, and Wellcome Trust Programme Grant 84637 to L. A. Harrington). This work was supported by NIH grant GM26259 (to E. H. B.).	Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Bosco G, 1998, GENETICS, V150, P1037; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Uchiki T, 2004, J BIOL CHEM, V279, P11293, DOI 10.1074/jbc.M309751200; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	23	82	90	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1383	U288		10.1038/ncb1985	http://dx.doi.org/10.1038/ncb1985			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838171	Green Accepted, Green Submitted			2022-12-27	WOS:000271425800020
J	Tian, C; Xing, GC; Xie, P; Lu, KF; Nie, J; Wang, J; Li, L; Gao, M; Zhang, LQ; He, FC				Tian, Chunyan; Xing, Guichun; Xie, Ping; Lu, Kefeng; Nie, Jing; Wang, Jian; Li, Li; Gao, Mei; Zhang, Lingqiang; He, Fuchu			KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; ATAXIA-TELANGIECTASIA; CELL-SURVIVAL; P53 ACTIVITY; IN-VIVO; ATM; ACTIVATION; FAMILY; GENES; PATHWAY	Only a few p53 regulators have been shown to participate in the selective control of p53-mediated cell cycle arrest or apoptosis. How p53-mediated apoptosis is negatively regulated remains largely unclear. Here we report that Apak (ATM and p53-associated KZNF protein), a Kruppel-associated box (KRAB)-type zinc-finger protein, binds directly to p53 in unstressed cells, specifically downregulates pro-apoptotic genes, and suppresses p53-mediated apoptosis by recruiting KRAB-box-associated protein (KAP)-1 and histone deacetylase 1 (HDAC1) to attenuate the acetylation of p53. Apak inhibits p53 activity by interacting with ATM, a previously identified p53 activator. In response to stress, Apak is phosphorylated by ATM and dissociates from p53, resulting in activation of p53 and induction of apoptosis. These findings revealed Apak to be a negative regulator of p53-mediated apoptosis and showed the dual role of ATM in p53 regulation.	[Tian, Chunyan; Xing, Guichun; Xie, Ping; Lu, Kefeng; Nie, Jing; Wang, Jian; Li, Li; Gao, Mei; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Xie, Ping; Nie, Jing; He, Fuchu] Tsinghua Univ, Dept Biomed Sci & Biotechnol, Beijing 100084, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Academy of Military Medical Sciences - China; Tsinghua University; Fudan University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn		Li, Li/0000-0003-2342-3658; Tian, Chunyan/0000-0003-1589-293X; Lu, Kefeng/0000-0001-8200-9380; Zhang, Lingqiang/0000-0002-9795-2141	Chinese National Basic Research Programs [2007CB914601, 2006CB910802]; Chinese National Natural Science Foundation [30621063, 30600310, 30871373]; Beijing Science and Technology NOVA Program [2007A063]	Chinese National Basic Research Programs(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology NOVA Program	We are grateful to Bert Vogelstein, Michael B. Kastan, Qimin Zhan, Wei Gu, Jiandong Chen, Yue Xiong, Shengcai Lin, Gang Pei and Weiguo Zhu for providing materials; Yi Tie, Heping Pan, Qiao Sun, Juntao Yang, Xiushan Yin, Dahu Li, Bo Dong, Shaofei Zhong, Bin Li and Yanzhi Yuan for technical assistance; and Wei Gu, Yue Xiong, Shengcai Lin, Zigang Dong, Yi Rao and Chengrong Lu for critical reading of the manuscript. This study was supported by Chinese National Basic Research Programs 2007CB914601 (L. Z.) and 2006CB910802 (F. H., L. Z.), Chinese National Natural Science Foundation Projects 30621063 (F. H.) and 30600310, 30871373 (C. T.), and the Beijing Science and Technology NOVA Program 2007A063 (L. Z.).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li J, 2007, BIOCHEM BIOPH RES CO, V363, P895, DOI 10.1016/j.bbrc.2007.08.180; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Liu XJ, 2008, CELL SIGNAL, V20, P230, DOI 10.1016/j.cellsig.2007.10.012; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	50	81	92	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					580	U122		10.1038/ncb1864	http://dx.doi.org/10.1038/ncb1864			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377469				2022-12-27	WOS:000265640000017
J	Kon, N; Hirota, T; Kawamoto, T; Kato, Y; Tsubota, T; Fukada, Y				Kon, Naohiro; Hirota, Tsuyoshi; Kawamoto, Takeshi; Kato, Yukio; Tsubota, Tadashi; Fukada, Yoshitaka			Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; CHRONIC-FATIGUE-SYNDROME; GENE-EXPRESSION; LIGHT; PATHWAYS; SYSTEM; ENTRAINMENT; INHIBITOR; MAMMALS; RHYTHM	The circadian clock is reset by external time cues for synchronization to environmental changes(1). In mammals, the light-input signalling pathway mediated by Per gene induction has been extensively studied(2,3). On the other hand, little is known about resetting mechanisms that are independent of Per induction(4-6). Here we show that activation of activin receptor-like kinase (ALK), triggered by TGF-beta, activin or alkali signals, evoked resetting of the cellular clock independently of Per induction. The resetting was mediated by an immediate-early induction of Dec1, a gene whose physiological role in the function of the circadian clock has been unclear. Acute Dec1 induction was a prerequisite for ALK-mediated resetting and upregulation was dependent on SMAD3, which was phosphorylated for activation in response to the resetting stimuli. Intraperitoneal injection of TGF-beta into wild-type or Dec1-deficient mice demonstrated that Dec1 has an essential role in phase-shift of clock gene expression in the kidney and adrenal gland. These results indicate that ALK-SMAD3-Dec1 signalling provides an input pathway in the mammalian molecular clock.	[Kon, Naohiro; Hirota, Tsuyoshi; Tsubota, Tadashi; Fukada, Yoshitaka] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamoto, Takeshi; Kato, Yukio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan	University of Tokyo; Hiroshima University	Fukada, Y (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Hirota, Tsuyoshi/D-8158-2015; 吉孝, 深田/G-5090-2014; , 河本健/D-7938-2015	Hirota, Tsuyoshi/0000-0003-4876-3608; , 河本健/0000-0003-3337-1775	Japanese Ministry of Education, Culture, Sports, Science and Technology; MEXT, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Okano for valuable discussion; K. Sanada and H. Yoshitane for comments on the manuscripts; M. Akiyama for providing pGL3-Basic-Hyg reporter vector; K. Ui-Tei and Y. Naito for technical advice on RNA interference; M. Takekawa for technical advice for experiment with kinase inhibitors. This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, by the 21st Century COE Program ( Promotion of basic biosciences for the understanding of organisms' uniqueness), and by Global COE Program ( Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan.	Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bennett AL, 1997, J CLIN IMMUNOL, V17, P160, DOI 10.1023/A:1027330616073; Challet E, 2004, NEUROSCI LETT, V355, P131, DOI 10.1016/j.neulet.2003.10.041; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Foster CM, 2005, HUM REPROD, V20, P543, DOI 10.1093/humrep/deh607; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hirano S, 2004, ARCH BIOCHEM BIOPHYS, V422, P81, DOI 10.1016/j.abb.2003.11.011; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue K, 1999, BRAIN RES, V846, P145, DOI 10.1016/S0006-8993(99)01966-6; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakahata Y, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-5; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Tryon WW, 2004, PHYSIOL BEHAV, V82, P849, DOI 10.1016/j.physbeh.2004.07.005; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yannielli P, 2004, PROG NEUROBIOL, V74, P59, DOI 10.1016/j.pneurobio.2004.06.001; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	36	97	99	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1463	U197		10.1038/ncb1806	http://dx.doi.org/10.1038/ncb1806			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19029909				2022-12-27	WOS:000261261800018
J	Satoh, D; Sato, D; Tsuyama, T; Saito, M; Ohkura, H; Rolls, MM; Ishikawa, F; Uemura, T				Satoh, Daisuke; Sato, Daichi; Tsuyama, Taiichi; Saito, Motoki; Ohkura, Hiroyuki; Rolls, Melissa M.; Ishikawa, Fuyuki; Uemura, Tadashi			Spatial control of branching within dendritic arbors by dynein-dependent transport of Rab5-endosomes	NATURE CELL BIOLOGY			English	Article							AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; DROSOPHILA; PROTEINS; RAB5; MORPHOGENESIS; MOTILITY; KINESIN	Dendrites allow neurons to integrate sensory or synaptic inputs, and the spatial disposition and local density of branches within the dendritic arbor limit the number and type of inputs(1,2). Drosophila melanogaster dendritic arborization (da) neurons provide a model system to study the genetic programs underlying such geometry in vivo. Here we report that mutations of motor-protein genes, including a dynein subunit gene (dlic) and kinesin heavy chain (khc), caused not only downsizing of the overall arbor, but also a marked shift of branching activity to the proximal area within the arbor. this phenotype was suppressed when dominant-negative Rab5 was expressed in the mutant neurons, which deposited early endosomes in the cell body. We also showed that 1) in dendritic branches of the wild-type neurons, Rab5-containing early endosomes were dynamically transported and 2) when Rab5 function alone was abrogated, terminal branches were almost totally deleted. these results reveal an important link between microtubule motors and endosomes in dendrite morphogenesis.	[Sato, Daichi; Tsuyama, Taiichi; Uemura, Tadashi] Kyoto Univ, Lab Cell Recognit & Pattern Format, Sakyo Ku, Kyoto 6068507, Japan; [Satoh, Daisuke] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068507, Japan; [Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Lab Cell Cycle Regulat, Sakyo Ku, Kyoto 6068507, Japan; [Ohkura, Hiroyuki] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Rolls, Melissa M.] Univ Oregon, Howard Hughes Med Inst, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA	Kyoto University; Kyoto University; Kyoto University; University of Edinburgh; Howard Hughes Medical Institute; University of Oregon	Uemura, T (corresponding author), Kyoto Univ, Lab Cell Recognit & Pattern Format, Sakyo Ku, S Campus Res Bldg G,Yoshida Konoe Cho, Kyoto 6068507, Japan.	tauemura@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Rolls, Melissa/G-6402-2014	Ishikawa, Fuyuki/0000-0002-5580-2305; Rolls, Melissa/0000-0002-5021-4360; UEMURA, Tadashi/0000-0001-7204-3606; Satoh, Daisuke/0000-0002-4039-1670; Tsuyama, Taiichi/0000-0001-5860-6396; Ohkura, Hiroyuki/0000-0003-4059-431X	Wellcome Trust [081849] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bowman AB, 1999, J CELL BIOL, V146, P165; Brechbiel JL, 2008, CURR BIOL, V18, P745, DOI 10.1016/j.cub.2008.04.033; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	33	143	144	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1164	1171		10.1038/ncb1776	http://dx.doi.org/10.1038/ncb1776			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758452				2022-12-27	WOS:000259682900010
J	Cuomo, ME; Knebel, A; Morrice, N; Paterson, H; Cohen, P; Mittnacht, S				Cuomo, Maria Emanuela; Knebel, Axel; Morrice, Nick; Paterson, Hugh; Cohen, Philip; Mittnacht, Sibylle			p53-driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation	NATURE CELL BIOLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CYCLIN; DUPLICATION; PROTEIN; P53; CANCER; KINASE; HUMAN-HERPESVIRUS-8; NUCLEOPHOSMIN; INHIBITION	Chromosome loss or gain is associated with a large number of solid cancers, providing genomic plasticity and thus adaptability to cancer cells(1,2). Numerical centrosome abnormalities arising from centrosome over-duplication or failed cytokinesis are a recognized cause of aneuploidy(3,4). In higher eukaryotic cells, the centrosome duplicates only once per cell cycle to ensure the formation of a bipolar mitotic spindle that orchestrates the balanced distribution of the sister chromatids to the respective daughter cells(5). Here we delineate the events that allow abnormal centrosome duplication, resulting in mitotic errors and incorrect chromosome segregation in cells with sustained cyclin-dependent kinase (CDK) activity. We have identified NPM1 as a substrate for CDK6 activated by the Kaposi's sarcoma herpesvirus (KSHV) D-type cyclin and shown that p53-driven apoptosis occurs downstream of NPM1 phosphorylation as a checkpoint mechanism that prevents accumulation of cells with supernumerary centrosomes. Our findings provide evidence that abnormal chromosome segregation in KSHV-infected cells is a direct consequence of NPM1 phosphorylation and predict that genomic instability is an inevitable consequence of latent KSHV infection.	[Cuomo, Maria Emanuela; Paterson, Hugh; Mittnacht, Sibylle] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, London SW3 6JB, England; [Knebel, Axel] Kinasource, Unit S Dudhope Mill 9, Dundee DD1 5AN, Scotland; [Knebel, Axel; Morrice, Nick; Cohen, Philip] Univ Dundee, James Black Ctr, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Dundee	Cuomo, ME (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England.	emanuela@icr.ac.uk		Knebel, Axel/0000-0002-9197-6054	Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U127084348] Funding Source: Medline; MRC [MC_U127084348] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Cuomo ME, 2005, J BIOL CHEM, V280, P35844, DOI 10.1074/jbc.M503877200; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Ojala PM, 1999, CANCER RES, V59, P4984; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002	28	38	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					723	730		10.1038/ncb1735	http://dx.doi.org/10.1038/ncb1735			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454140				2022-12-27	WOS:000256350100019
J	Kohler, A; Schneider, M; Cabal, GG; Nehrbass, U; Hurt, E				Koehler, Alwin; Schneider, Maren; Cabal, Ghislain G.; Nehrbass, Ulf; Hurt, Ed			Yeast Ataxin-7 links histone deubiquitination with gene gating and mRNA export	NATURE CELL BIOLOGY			English	Article							CEREVISIAE SAGA COMPLEX; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; H2B UBIQUITYLATION; POLYMERASE-II; ACETYLTRANSFERASE ACTIVITY; NUCLEAR-ENVELOPE; ASSOCIATION; UBP8; RECRUITMENT	Targeting of a gene to the nuclear pore complexes (NPCs), known as gene gating, can affect its transcriptional state1-9. However, the mechanism underlying gene gating is poorly understood. Here, we have identified SAGA-associated Sgf73 (ref. 10), the yeast orthologue of human Ataxin-7 (ref. 11), as a regulator of histone H2B ubiquitin levels, a modification linked to both transcription initiation and elongation(12,13). Sgf73 is a key component of a minimal histone-deubiquitinating complex. Activation of the H2B deubiquitinating protease, Ubp8, is cooperative and requires complex formation with the amino-terminal zinc-finger-containing domain of Sgf73 and Sgf11-Sus1. Through a separate domain, Sgf73 mediates recruitment of the TREX-2 mRNA export factors Sac3 and Thp1 to SAGA and their stable interaction with Sus1-Cdc31. This latter step is crucial to target TREX-2 to the NPC. Loss of Sgf73 from SAGA abrogates gene gating of GAL1 and causes a GAL1 mRNA export defect. Thus, Sgf73 provides a molecular scaffold to integrate the regulation of H2B ubiquitin levels, tethering of a gene to the NPC and export of mRNA.	[Koehler, Alwin; Schneider, Maren; Hurt, Ed] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; [Koehler, Alwin] Univ Kinderklin Heidelberg, D-69120 Heidelberg, Germany; [Cabal, Ghislain G.; Nehrbass, Ulf] Inst Pasteur, Unite Biol Cellulaire Noyau, F-75724 Paris 15, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Nehrbass, Ulf/0000-0002-7028-8076; Cabal, Ghislain/0000-0002-9728-506X				Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; KOHLER A, 2006, CELL, V17, P4428; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2006, NUCLEIC ACIDS RES, V34, P6225, DOI 10.1093/nar/gkl844; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	35	155	163	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					707	715		10.1038/ncb1733	http://dx.doi.org/10.1038/ncb1733			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488019				2022-12-27	WOS:000256350100017
J	Young, AP; Schlisio, S; Minamishima, YA; Zhang, Q; Li, LJ; Grisanzio, C; Signoretti, S; Kaelin, WG				Young, Arthur P.; Schlisio, Susanne; Minamishima, Yoji Andrew; Zhang, Qing; Li, Lianjie; Grisanzio, Chiara; Signoretti, Sabina; Kaelin, William G., Jr.			VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; E1A; INACTIVATION; P53; SUPPRESSION; ACTIVATION; INDUCTION; PROTEINS; COMPLEX; LESIONS	Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans(1). Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions(1). Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.	[Young, Arthur P.; Schlisio, Susanne; Minamishima, Yoji Andrew; Zhang, Qing; Li, Lianjie; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Grisanzio, Chiara; Signoretti, Sabina] Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; [Grisanzio, Chiara; Signoretti, Sabina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Li, Lianjie; Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Minamishima, Yoji Andrew/E-5380-2010; ZHANG, QING/AGY-7972-2022	Minamishima, Yoji Andrew/0000-0001-7995-9318; ZHANG, QING/0000-0002-6595-8995; Schlisio, Susanne/0000-0002-2605-3771				Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; KAELIN WG, ANN REV PATHOL, V2, P145; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; LI L, MOL CELL BIOL, V27, P5381; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; WALTHER MM, 1995, J UROLOGY, V154, P2010, DOI 10.1016/S0022-5347(01)66674-6; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0	32	185	190	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					361	U115		10.1038/ncb1699	http://dx.doi.org/10.1038/ncb1699			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297059				2022-12-27	WOS:000253778300019
J	Tiklova, K; Senti, KA; Wang, SQ; Graslund, A; Samakovlis, C				Tiklova, Katarina; Senti, Kirsten-Andre; Wang, Shenqiu; Graslund, Astrid; Samakovlis, Christos			Epithelial septate junction assembly relies on melanotransferrin iron binding and endocytosis in Drosophila	NATURE CELL BIOLOGY			English	Article								Iron is an essential element in many biological processes. In vertebrates, serum transferrin is the major supplier of iron to tissues, but the function of additional transferrin-like proteins remains poorly understood. Melanotransferrin (MTf) is a phylogenetically conserved, iron-binding epithelial protein. Elevated MTf levels have been implicated in melanoma pathogenesis. Here, we present a functional analysis of MTf in Drosophila melanogaster. Similarly to its human homologue, Drosophila MTf is a lipid-modified, iron-binding protein attached to epithelial cell membranes, and is a component of the septate junctions that form the paracellular permeability barrier in epithelial tissues. We demonstrate that septate junction assembly during epithelial maturation relies on endocytosis and apicolateral recycling of iron-bound MTf. Mouse MTf complements the defects of Drosophila MTf mutants. Drosophila provides the first genetic model for the functional dissection of MTf in epithelial junction assembly and morphogenesis.	[Tiklova, Katarina; Senti, Kirsten-Andre; Wang, Shenqiu; Samakovlis, Christos] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Senti, Kirsten-Andre/AAB-3036-2020	Senti, Kirsten-Andre/0000-0002-7208-7593	EMBO; G. Gustafsson Foundation; Vetenskapsradet; Cancerfonden	EMBO(European Molecular Biology Organization (EMBO)); G. Gustafsson Foundation; Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society)	We are indebted to S. Baumgartner, M. Gonzalez-Gaitan, R. Fehon, G. Beitel, M. Bhat, F. Missirlis, H. Bellen, M. Hortsch, D. Ready, V. Auld, the Bloomington Drosophila Stock Center, the Drosophila Genomics Resource Center (DGRC; Indiana), and the Developmental Studies Hybridoma Bank (DSHB; Iowa) for Drosophila strains, clones and antibodies. We thank M. Sahlin for initial help with iron detection, T. Astlind for the EPR measurements and M. Bjork and I. Granell for expert technical assistance. We are grateful to members of the Samakovlis lab for suggestions. K.S. was supported by an EMBO postdoctoral fellowship. The work was supported by grants from the G. Gustafsson Foundation, Vetenskapsradet and Cancerfonden to C.S.	ALEMANY R, 1993, J CELL SCI, V104, P1155; BAUMGARTNER S, 1996, CELL, V1059, P87; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Laval M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-38; Rahmanto YS, 2009, BBA-MOL CELL RES, V1793, P1210, DOI 10.1016/j.bbamcr.2009.02.003; SURYO R, 2007, ONCOGENE, V26, P6113; TOMANCAK P, 2002, GENOME BIOL, V14, P88	8	61	62	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1071	U57		10.1038/ncb2111	http://dx.doi.org/10.1038/ncb2111			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935638				2022-12-27	WOS:000283711500010
J	Roukens, MG; Alloul-Ramdhani, M; Baan, B; Kobayashi, K; Peterson-Maduro, J; van Dam, H; Schulte-Merker, S; Baker, DA				Roukens, M. Guy; Alloul-Ramdhani, Mariam; Baan, Bart; Kobayashi, Kazuki; Peterson-Maduro, Josi; van Dam, Hans; Schulte-Merker, Stefan; Baker, David A.			Control of endothelial sprouting by a Tel-CtBP complex	NATURE CELL BIOLOGY			English	Article							INHIBITS TUMOR-GROWTH; EMBRYONIC LETHALITY; NOTCH; VEGF; DLL4; MORPHOGENESIS; MODULATION; ARTERIAL; LACKING; KINASE	We show that the transcriptional repressor Tel plays an evolutionarily conserved role in angiogenesis: it is indispensable for the sprouting of human endothelial cells and for normal development of the Danio rerio blood circulatory system. Tel orchestrates endothelial sprouting by binding to the generic co-repressor, CtBP. The Tel-CtBP complex temporally restricts a VEGF (vascular endothelial growth factor)-mediated pulse of dll4 expression and thereby directly links VEGF receptor intracellular signalling and intercellular Notch-Dll4 signalling. It further controls branching by regulating expression of other factors that constrain angiogenesis such as sprouty family members and ve-cadherin. Thus, the Tel-CtBP complex conditions endothelial cells for angiogenesis by controlling the balance between stimulatory and antagonistic sprouting cues. Tel control of branching seems to be a refinement of invertebrate tracheae morphogenesis that requires Yan, the invertebrate orthologue of Tel. This work highlights Tel and its associated networks as potential targets for the development of therapeutic strategies to inhibit pathological angiogenesis.	[Roukens, M. Guy; Alloul-Ramdhani, Mariam; Baker, David A.] LUMC, Sect Growth Control & Transcript, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Baan, Bart; Kobayashi, Kazuki; van Dam, Hans] LUMC, Sect Signal Transduct, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Baker, DA (corresponding author), LUMC, Sect Growth Control & Transcript, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.	d.baker@lumc.nl		van Dam, Hans/0000-0002-8307-4325; Roukens, Guy/0000-0002-4270-8678				Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Krebs LT, 2000, GENE DEV, V14, P1343; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	48	37	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					933	942		10.1038/ncb2096	http://dx.doi.org/10.1038/ncb2096			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20835243				2022-12-27	WOS:000282363500008
J	[Anonymous]				[Anonymous]			Focusing on Autophagy	NATURE CELL BIOLOGY			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					813	813						1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811352	Bronze			2022-12-27	WOS:000281561900001
J	Smutny, M; Cox, HL; Leerberg, JM; Kovacs, EM; Conti, MA; Ferguson, C; Hamilton, NA; Parton, RG; Adelstein, RS; Yap, AS				Smutny, Michael; Cox, Hayley L.; Leerberg, Joanne M.; Kovacs, Eva M.; Conti, Mary Anne; Ferguson, Charles; Hamilton, Nicholas A.; Parton, Robert G.; Adelstein, Robert S.; Yap, Alpha S.			Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens	NATURE CELL BIOLOGY			English	Article							CELL-CELL CONTACTS; CADHERIN-ADHESIVE CONTACTS; PHOSPHATIDYLINOSITOL 3-KINASE; ACTIN; JUNCTIONS; MORPHOGENESIS; ORGANIZATION; ORCHESTRATE; MATURATION; MUTATIONS	Classic cadherin receptors cooperate with regulators of the actin cytoskeleton to control tissue organization in health and disease. At the apical junctions of epithelial cells, the cadherin ring of the zonula adherens (ZA) couples with a contiguous ring of actin filaments(1-3) to support morphogenetic processes such as tissue integration and cellular morphology(4,5). However, the molecular mechanisms that coordinate adhesion and cytoskeleton at these junctions are poorly understood. Previously we identified nonmuscle myosin II as a target of Rho signalling that supports cadherin junctions in mammalian epithelial cells(6). Myosin II has various cellular functions, which are increasingly attributable to the specific biophysical properties and regulation of its different isoforms(7). Here we report that myosin II isoforms have distinct and necessary roles at cadherin junctions. Although two of the three mammalian myosin II isoforms are found at the ZA, their localization is regulated by different upstream signalling pathways. Junctional localization of myosin IIA required E-cadherin adhesion, Rho/ROCK and myosin light-chain kinase, whereas junctional myosin IIB depended on Rap1. Further, these myosin II isoforms support E-cadherin junction integrity by different mechanisms. Myosin IIA RNA-mediated interference (RNAi) selectively perturbed the accumulation of E-cadherin in the apical ZA, decreased cadherin homophilic adhesion and disrupted cadherin clustering. In contrast, myosin IIB RNAi decreased filament content, altered dynamics, and increased the lateral movement of the perijunctional actin ring. Myosin IIA and IIB therefore identify two distinct functional modules, with different upstream signals that control junctional localization, and distinct functional effects. We propose that these two isoform-based modules cooperate to coordinate adhesion receptor and F-actin organization to form apical cadherin junctions.	[Smutny, Michael; Cox, Hayley L.; Leerberg, Joanne M.; Kovacs, Eva M.; Ferguson, Charles; Hamilton, Nicholas A.; Parton, Robert G.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia; [Conti, Mary Anne; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	University of Queensland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Yap, Alpha S./J-1554-2014; Hamilton, Nicholas A/A-6033-2010; Parton, Robert G/C-5673-2009; Kovacs, Eva/U-3526-2019	Yap, Alpha S./0000-0002-1038-8956; Hamilton, Nicholas A/0000-0003-0331-3427; Parton, Robert G/0000-0002-7494-5248; Kovacs, Eva/0000-0002-7228-4028; Adelstein, Robert/0000-0002-8683-2144; Smutny, Michael/0000-0002-5920-9090	National Health and Medical Research Council (NHMRC) of Australia; National Institutes of Health (NIH); ACRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004218] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank our colleagues who provided reagents, especially Jim Bear for the pLL5.0 lentiviral construct, Rachel Murphy and Nigel McMillan for training us in lentiviral work, Regine Hartmann for her assistance with cloning, Suzie Verma and Carmen Buttery for assistance with tissue culture, and our colleagues in the laboratory for their untiring support and encouragement. The work in Australia was funded by the National Health and Medical Research Council (NHMRC) of Australia; that in the USA was supported by the National Institutes of Health (NIH). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF) Cancer Biology Imaging Centre at the Institute for Molecular Bioscience, established with the generous support of the ACRF. We gratefully acknowledge the help and advice of Guanghui Wang and the NIH National Heart, Lung and Blood	Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dube N, 2008, CELL SIGNAL, V20, P1608, DOI 10.1016/j.cellsig.2008.05.006; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kolega J, 1998, J CELL SCI, V111, P2085; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; YONEMURA S, 1995, J CELL SCI, V108, P127	37	226	230	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					696	U147		10.1038/ncb2072	http://dx.doi.org/10.1038/ncb2072			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20543839	Green Accepted			2022-12-27	WOS:000279374400013
J	Meinecke, M; Cizmowski, C; Schliebs, W; Kruger, V; Beck, S; Wagner, R; Erdmann, R				Meinecke, Michael; Cizmowski, Christian; Schliebs, Wolfgang; Krueger, Vivien; Beck, Sabrina; Wagner, Richard; Erdmann, Ralf			The peroxisomal importomer constitutes a large and highly dynamic pore	NATURE CELL BIOLOGY			English	Article							MITOCHONDRIAL INNER MEMBRANE; RECEPTOR PEX5P; PROTEIN IMPORT; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; CHANNEL; COMPLEX; TRANSLOCATION; PREPROTEINS; INSERTION	The peroxisomal protein import machinery differs fundamentally from known translocons (endoplasmic reticulum, mitochondria, chloroplasts, bacteria) as it allows membrane passage of folded, even oligomerized proteins(1). However, the mechanistic principles of protein translocation across the peroxisomal membrane remain unknown. There are various models that consider membrane invagination events, vesicle fusion or the existence of large import pores. Current data show that a proteinaceous peroxisomal importomer enables docking of the cytosolic cargo-loaded receptors, cargo translocation and receptor recycling(2). Remarkably, the cycling import receptor Pex5p changes its topology from a soluble cytosolic form to an integral membrane-bound form. According to the transient pore hypothesis, the membrane-bound receptor is proposed to form the core component of the peroxisomal import pore(3). Here, we demonstrate that the membrane-associated import receptor Pex5p together with its docking partner Pex14p forms a gated ion-conducting channel which can be opened to a diameter of about 9 nm by the cytosolic receptor-cargo complex. The newly identified pore shows striking dynamics, as expected for an import machinery translocating proteins of variable sizes.	[Cizmowski, Christian; Schliebs, Wolfgang; Beck, Sabrina; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Bochum, Germany; [Meinecke, Michael; Krueger, Vivien; Wagner, Richard] Univ Osnabruck, FB Biol Chem, D-4500 Osnabruck, Germany	Ruhr University Bochum; University Osnabruck	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Bochum, Germany.	ralf.erdmann@rub.de	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [SFB431, SFB642, DFGSchl 584/1-2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB431 (M. M. and R. W.), SFB642 (R. E.), DFGSchl 584/1-2 (WS) and the Fonds der Chemischen Industrie. We thank Wolf Kunau for helpful comments and discussion.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; ELGERSMA Y, 1996, J BIOL CHEM, V9, P185; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; LABARCA P, 1986, J MEMBRANE BIOL, V94, P285, DOI 10.1007/BF01869724; LEMMENS M, 1989, BIOCHIM BIOPHYS ACTA, V984, P351, DOI 10.1016/0005-2736(89)90302-7; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Titorenko VI, 2002, J CELL BIOL, V156, P481, DOI 10.1083/jcb.200111075; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1	32	198	200	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					273	U68		10.1038/ncb2027	http://dx.doi.org/10.1038/ncb2027			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154681				2022-12-27	WOS:000275054200013
J	Smyth, JT; Petranka, JG; Boyles, RR; DeHaven, WI; Fukushima, M; Johnson, KL; Williams, JG; Putney, JW				Smyth, Jeremy T.; Petranka, John G.; Boyles, Rebecca R.; DeHaven, Wayne I.; Fukushima, Miwako; Johnson, Katina L.; Williams, Jason G.; Putney, James W., Jr.			Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis	NATURE CELL BIOLOGY			English	Article							ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ INFLUX; MAST-CELLS; DEPLETION; KINASE; ORAI1; IDENTIFICATION; MICRODOMAINS; HOMEOSTASIS	Store-operated Ca2+ entry (SOCE) and Ca2+ release-activated Ca2+ currents (I-crac) are strongly suppressed during mitosis, the only known physiological situation in which Ca2+ store depletion is uncoupled from the activation of Ca2+ influx. We found that the endoplasmic reticulum (ER) Ca2+ sensor STIM1 failed to rearrange into near-plasma membrane puncta in mitotic cells, a critical step in the SOCE-activation pathway. We also found that STIM1 from mitotic cells is recognized by the phospho-specific MPM-2 antibody, suggesting that STIM1 is phosphorylated during mitosis. Removal of ten MPM-2 recognition sites by truncation at amino acid 482 abolished MPM-2 recognition of mitotic STIM1, and significantly rescued STIM1 rearrangement and SOCE response in mitosis. We identified Ser 486 and Ser 668 as mitosis-specific phosphorylation sites, and STIM1 containing mutations of these sites to alanine also significantly rescued mitotic SOCE. Therefore, phosphorylation of STIM1 at Ser 486 and Ser 668, and possibly other sites, underlies suppression of SOCE during mitosis.	[Smyth, Jeremy T.; Petranka, John G.; Boyles, Rebecca R.; DeHaven, Wayne I.; Fukushima, Miwako; Putney, James W., Jr.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Johnson, Katina L.; Williams, Jason G.] NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789; Boyles, Rebecca/0000-0003-0073-6854; Matsuki-Fukushima, Miwako/0000-0002-0397-0673	Intramural Program; National Institute of Environmental Health Sciences; National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087] Funding Source: NIH RePORTER	Intramural Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Tucker and H. Rutledge for assistance with confocal microscopy and C. Bortner and M. Sifre for help with flow cytometry. C. Williams and D. Miller reviewed the manuscript and offered helpful suggestions. This work was supported by the Intramural Program, National Institute of Environmental Health Sciences, National Institutes of Health.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Che SL, 1997, FEBS LETT, V413, P417, DOI 10.1016/S0014-5793(97)00948-4; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Ding M, 1997, EXP CELL RES, V231, P3, DOI 10.1006/excr.1996.3439; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; HEPLER PK, 1994, CELL CALCIUM, V16, P322, DOI 10.1016/0143-4160(94)90096-5; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; KAWASAKI T, 2009, BIOCH BIOPHYS RES CO; KREK W, 1995, METHOD ENZYMOL, V254, P114; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Preston GA, 1997, CANCER RES, V57, P537; PRESTON SF, 1991, CELL REGUL, V2, P915, DOI 10.1091/mbc.2.11.915; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Russa AD, 2008, ARCH HISTOL CYTOL, V71, P249, DOI 10.1679/aohc.71.249; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitaker M, 2001, SEMIN CELL DEV BIOL, V12, P53, DOI 10.1006/scdb.2000.0217; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; YUAN JP, 2009, NATURE CELL BIOL; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	39	127	129	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1465	U190		10.1038/ncb1995	http://dx.doi.org/10.1038/ncb1995			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19881501	Green Accepted			2022-12-27	WOS:000272251300014
J	von Kriegsheim, A; Baiocchi, D; Birtwistle, M; Sumpton, D; Bienvenut, W; Morrice, N; Yamada, K; Lamond, A; Kalna, G; Orton, R; Gilbert, D; Kolch, W				von Kriegsheim, Alex; Baiocchi, Daniela; Birtwistle, Marc; Sumpton, David; Bienvenut, Willy; Morrice, Nicholas; Yamada, Kayo; Lamond, Angus; Kalna, Gabriella; Orton, Richard; Gilbert, David; Kolch, Walter			Cell fate decisions are specified by the dynamic ERK interactome	NATURE CELL BIOLOGY			English	Article							SIGNAL-REGULATED KINASE; FACIO-CUTANEOUS SYNDROME; NERVE GROWTH-FACTOR; MAP KINASE; PROTEIN-KINASE; ACTIVATION; TRANSCRIPTION; MUTATIONS; PEA-15; TRPS1	Extracellular signal-regulated kinase (ERK) controls fundamental cellular functions, including cell fate decisions(1,2). In PC12, cells shifting ERK activation from transient to sustained induces neuronal differentiation(3). As ERK associates with both regulators and effectors(4), we hypothesized that the mechanisms underlying the switch could be revealed by assessing the dynamic changes in ERK-interacting proteins that specifically occur under differentiation conditions. Using quantitative proteomics, we identified 284 ERK-interacting proteins. Upon induction of differentiation, 60 proteins changed their binding to ERK, including many proteins that were not known to participate in differentiation. We functionally characterized a subset, showing that they regulate the pathway at several levels and by different mechanisms, including signal duration, ERK localization, feedback, crosstalk with the Akt pathway and differential interaction and phosphorylation of transcription factors. Integrating these data with a mathematical model confirmed that ERK dynamics and differentiation are regulated by distributed control mechanisms rather than by a single master switch.	[von Kriegsheim, Alex; Baiocchi, Daniela; Birtwistle, Marc; Sumpton, David; Bienvenut, Willy; Kalna, Gabriella; Kolch, Walter] Beatson Inst Canc Res, Signalling & Prote Lab, Glasgow G61 1BD, Lanark, Scotland; [Morrice, Nicholas] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Yamada, Kayo; Lamond, Angus] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Gilbert, David] Univ Glasgow, Dept Comp Sci, Bioinformat Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Orton, Richard; Kolch, Walter] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	Beatson Institute; University of Dundee; University of Dundee; University of Glasgow; University of Glasgow	Kolch, W (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	walter.kolch@ucd.ie	von Kriegsheim, Alex/C-2371-2016; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Gilbert, David/G-1432-2011; RASOR, Scotland/A-3274-2011	von Kriegsheim, Alex/0000-0002-4952-8573; Lamond, Angus/0000-0001-6204-6045; Sumpton, David/0000-0002-9004-4079; Birtwistle, Marc/0000-0003-0415-6523; Birtwistle, Marc/0000-0002-0341-0705; Kolch, Walter/0000-0001-5777-5016; Bienvenut, Willy/0000-0003-4192-3920	European Union [LSHG-CT-2003-505520]; RASOR; BBSRC; EPSRC; Cancer Research UK; MRC [G0301131, G0801738] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C511613/1, BB/C511572/1] Funding Source: researchfish; Medical Research Council [G0301131, G0801738] Funding Source: researchfish	European Union(European Commission); RASOR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Mortensen for help with MSQuant, A. Pitt and C. Ward for help with MS, O. Rath for the design of primers and G. Cesareni and A. Chatraryamontri for help with submission of the interaction data to the IMEx consortium through MINT. The work was supported by the European Union Interaction Proteome project (LSHG-CT-2003-505520), the RASOR project (BBSRC and EPSRC) and Cancer Research UK.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Brewer Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000093; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; George AJT, 2005, TRENDS IMMUNOL, V26, P653, DOI 10.1016/j.it.2005.09.011; Harrisingh MC, 2004, CELL CYCLE, V3, P1255, DOI 10.4161/cc.3.10.1182; Kaiser FJ, 2004, EUR J HUM GENET, V12, P121, DOI 10.1038/sj.ejhg.5201094; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kobayashi H, 2002, AM J MED GENET, V107, P26, DOI 10.1002/ajmg.10081; Krueger J, 2005, MOL BIOL CELL, V16, P3552, DOI 10.1091/mbc.E04-11-1007; Le Gallic L, 2004, MOL CELL BIOL, V24, P1206, DOI 10.1128/MCB.24.3.1206-1218.2004; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Volmat V, 2001, J CELL SCI, V114, P3433; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	32	212	214	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1458	U172		10.1038/ncb1994	http://dx.doi.org/10.1038/ncb1994			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935650	Green Accepted			2022-12-27	WOS:000272251300013
J	Wakabayashi, T; Craessaerts, K; Bammens, L; Bentahir, M; Borgions, F; Herdewijn, P; Staes, A; Timmerman, E; Vandekerckhove, J; Rubinstein, E; Boucheix, C; Gevaert, K; De Strooper, B				Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; Borgions, Filip; Herdewijn, Piet; Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Rubinstein, Eric; Boucheix, Claude; Gevaert, Kris; De Strooper, Bart			Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains	NATURE CELL BIOLOGY			English	Article							TNF-ALPHA; PRESENILIN; COMPLEX; PROTEIN; NICASTRIN; IDENTIFICATION; APH-1; ORGANIZATION; COMPONENT; FAMILY	gamma-Secretase, an aspartyl protease that belongs to the iCLiPs (intramembrane cleaving proteases) family, is a multiprotein complex that consists of presenilin (PS), nicastrin (NCT), Aph-1 and Pen-2 (ref. 1). It is responsible for generation of the beta-amyloid peptide (A beta), the primary component of senile plaques in the brains of patients with Alzheimer's disease. Although the four components are necessary and sufficient for gamma-secretase activity(2-4), additional proteins are possibly involved in its regulation. Consequently, we purified proteins associated with the active gamma-secretase complex from reconstituted PS deficient fibroblasts, using tandem affinity purification (TAP)(5) and identified a series of proteins that transiently interact with the gamma-secretase complex and are probably involved in complex maturation, membrane trafficking and, importantly, the tetraspanin web. Tetraspanins form detergent-resistant microdomains in the cell membrane and regulate cell adhesion, cell signalling and proteolysis(6,7). Association of the gamma-secretase complex with tetraspanin-enriched microdomains provides an explanation for the previously documented localization of gamma-secretase to raft-like domains(8). Thus, these studies suggest that maintenance of the integrity of tetraspanin microdomains contributes to the refinement of proteolytic activity of the gamma-secretase complex.	[Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Wakabayashi, Tomoko; Craessaerts, Katleen; Bammens, Leen; Bentahir, Mostafa; De Strooper, Bart] Flanders Inst Biotechnol, VIB, Dept Mol & Dev Genet, Leuven, Belgium; [Borgions, Filip; Herdewijn, Piet] Katholieke Univ Leuven, Med Chem Lab, B-3000 Leuven, Belgium; [Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Gevaert, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Staes, An; Timmerman, Evy; Vandekerckhove, Joel; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Rubinstein, Eric; Boucheix, Claude] INSERM, U602, Villejuif, France; [Rubinstein, Eric; Boucheix, Claude] Univ Paris 11, Inst Andre Lwoff, Villejuif, France	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium.	bart.destrooper@med.kuleuven.be	Gevaert, Kris/AAE-4212-2019; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Wakabayashi, Tomoko/GSD-1544-2022; Gevaert, Kris/H-3637-2013; Gevaert, Kris/D-6489-2017; Rubinstein, Eric/B-4650-2019	Gevaert, Kris/0000-0002-4237-0283; De Strooper, Bart/0000-0001-5455-5819; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Rubinstein, Eric/0000-0001-7623-9665; Boucheix, Claude/0000-0003-4184-7008; Staes, An/0000-0001-8767-8508; Herdewijn, Piet/0000-0003-3589-8503	Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA); Federal Office for Scientific Affairs, Flemisch government [P6/58]; Fund for Scientific Research-Flanders (Belgium), Ghent University [IUAP06]; Inter University Attraction Poles [IUAP06]; European Union Interaction Proteome (6th Framework Program); FWO (Fonds voor Wetenschappelijk Onderzoek); Canon Foundation in Europe; EC	Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA)(KU Leuven); Federal Office for Scientific Affairs, Flemisch government; Fund for Scientific Research-Flanders (Belgium), Ghent University(Ghent UniversityFWO); Inter University Attraction Poles(Belgian Federal Science Policy Office); European Union Interaction Proteome (6th Framework Program)(European Commission); FWO (Fonds voor Wetenschappelijk Onderzoek)(FWO); Canon Foundation in Europe(Canon Foundation); EC(European CommissionEuropean Commission Joint Research Centre)	We thank T. E. Golde (Mayo Clinic, FL, US) for SPPL3 cDNA, S. Aerts (VIB), E. Karran and the bioinformatics team of Elli-Lilly for helpful discussion and A. Thathiah for critical reading of the manuscript. This work was supported by a Pioneer award from the Alzheimer's Association, the Fund for Scientific Research, Flanders; Katholieke Universiteit Leuven (GOA); Federal Office for Scientific Affairs (IUAP P6/58) and a Methusalem grant from the Flemisch government. The laboratory in Ghent is supported by research grants from the Fund for Scientific Research-Flanders (Belgium), the Concerted Research Actions (GOA) from the Ghent University, the Inter University Attraction Poles (IUAP06) and the European Union Interaction Proteome (6th Framework Program). L. B. is fellow of the FWO (Fonds voor Wetenschappelijk Onderzoek) and T. W. was fellow of the Canon Foundation in Europe and Marie Curie program of the EC.	Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; HARDER T, 1994, BBA-MOL CELL RES, V1223, P375, DOI 10.1016/0167-4889(94)90098-1; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	36	102	104	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1340	U181		10.1038/ncb1978	http://dx.doi.org/10.1038/ncb1978			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838174				2022-12-27	WOS:000271425800014
J	Bourne, HR				Bourne, Henry R.			Ambition, surprise and delight: necessary lessons	NATURE CELL BIOLOGY			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Bourne, HR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94158 USA.	bourne@cmp.ucsf.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1046	1046		10.1038/ncb0909-1046	http://dx.doi.org/10.1038/ncb0909-1046			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19724256				2022-12-27	WOS:000269482500002
J	Mori, D; Yamada, M; Mimori-Kiyosue, Y; Shirai, Y; Suzuki, A; Ohno, S; Saya, H; Wynshaw-Boris, A; Hirotsune, S				Mori, Daisuke; Yamada, Masami; Mimori-Kiyosue, Yuko; Shirai, Yasuhito; Suzuki, Atsushi; Ohno, Shigeo; saya, Hideaki; Wynshaw-Boris, Anthony; Hirotsune, Shinji			An essential role of the aPKC-Aurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; HIPPOCAMPAL NEURONAL POLARITY; A KINASE; CYTOPLASMIC DYNEIN; ACTIN-FILAMENTS; NERVOUS-SYSTEM; SELF-RENEWAL; ACTIVATION; SPINDLE; COMPLEX	Orchestrated remodelling of the cytoskeketon is prominent during neurite extension. In contrast with the extensive characterization of actin filament regulation, little is known about the dynamics of microtubules during neurite extension. Here we identify an atypical protein kinase C (aPKC)-Aurora A-NDEL1 pathway that is crucial for the regulation of microtubule organization during neurite extension. aPKC phosphorylates Aurora A at Thr 287 (T287), which augments interaction with TPX2 and facilitates activation of Aurora A at the neurite hillock, followed by phosphorylation of NDEL1 at S251 and recruitment. Suppression of aPKC, Aurora A or TPX2, or disruption of Well, results in severe impairment of neurite extension. Analysis of microtubule dynamics with a microtubule plus-end marker revealed that suppression of the aPKC-Aurora A-NDEL1 pathway resulted in a significant decrease in the frequency of microtubule emanation from the microtubule organizing centre (MTOC), suggesting that Aurora A acts downstream of aPKC. These findings demonstrate a surprising role of aPKC-Aurora A-NDEL1 pathway in microtubule remodelling during neurite extension.	[Mori, Daisuke; Yamada, Masami; Hirotsune, Shinji] Osaka City Univ, Dept Genet Dis Res, Grad Sch Med, Osaka 5458585, Japan; [Mimori-Kiyosue, Yuko] KAN Res Inst Inc 3F, Res Grp Cytoskeleton & Cell Motil, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shirai, Yasuhito] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Suzuki, Atsushi; Ohno, Shigeo] Yokohama City Univ, Dept Mol Biol, Grad Sch Med Sci, Kanazawa Ku, Kanagawa 2360004, Japan; [saya, Hideaki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res, Tokyo, Japan; [Wynshaw-Boris, Anthony] UCSF Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] UCSF Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Osaka Metropolitan University; Kobe University; Yokohama City University; Keio University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hirotsune, S (corresponding author), Osaka City Univ, Dept Genet Dis Res, Grad Sch Med, Asahi Machi 1-4-3 Abeno, Osaka 5458585, Japan.	shinjih@med.osaka-cu.ac.jp	Ohno, Shigeo/B-1768-2010; Mimori-Kiyosue, Yuko/K-9158-2015; Shirai, Yasuhito/O-3255-2018; Saya, Hideyuki/J-4325-2013; Mori, Daisuke/M-4952-2014	Ohno, Shigeo/0000-0002-1294-5269; Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Mori, Daisuke/0000-0002-9072-2546; Saya, Hideyuki/0000-0001-6610-1902	Osaka Community Foundation; Ministry of Education, Science, Sports and Culture of Japan; Japan Spina Bifida and Hydrocephalus Research Foundation; Takeda Science Foundation; Hoh-ansha Foundation; National Institutes of Health [NS41030, HD47380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041030] Funding Source: NIH RePORTER	Osaka Community Foundation; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Spina Bifida and Hydrocephalus Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hoh-ansha Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yukimi Kira, Yoriko Yabunaka, Gaku Kuwabara, Toshiyuki Kawashima and Takako Takitho for technical support, and Hiromichi Nishimura and Keiko Fujimoto for mouse breeding. This work was also supported by the Osaka Community Foundation to D.M. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to S.H. This work was also supported by the Cell Science Research Foundation, the Japan Spina Bifida and Hydrocephalus Research Foundation, the Takeda Science Foundation and the Hoh-ansha Foundation to S.H, and National Institutes of Health grants NS41030 and HD47380 to A.W.-B.	Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOBYNS WB, 1989, NEUROL CLIN, V7, P89, DOI 10.1016/S0733-8619(18)30830-2; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	51	94	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1057	U47		10.1038/ncb1919	http://dx.doi.org/10.1038/ncb1919			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19668197				2022-12-27	WOS:000269482500007
J	Hengst, U; Deglincerti, A; Kim, HJ; Jeon, NL; Jaffrey, SR				Hengst, Ulrich; Deglincerti, Alessia; Kim, Hyung Joon; Jeon, Noo Li; Jaffrey, Samie R.			Axonal elongation triggered by stimulus-induced local translation of a polarity complex protein	NATURE CELL BIOLOGY			English	Article							MICROFLUIDIC CULTURE PLATFORM; NERVE GROWTH CONES; CELL POLARITY; MESSENGER-RNA; SONIC HEDGEHOG; NETRIN-1; GUIDANCE; NEURONS; MIDLINE; VISUALIZATION	During development, axon growth rates are precisely regulated to provide temporal control over pathfinding(1,2). The precise temporal regulation of axonal growth is a key step in the formation of functional synapses and the proper patterning of the nervous system. The rate of axonal elongation is increased by factors such as netrin-1 and nerve growth factor (NGF), which stimulate axon outgrowth using incompletely defined pathways. To clarify the mechanism of netrin-1- and NGF-stimulated axon growth, we explored the role of local protein translation. We found that intra-axonal protein translation is required for stimulated, but not basal, axon outgrowth. To identify the mechanism of translation-dependent outgrowth, we examined the PAR complex, a cytoskeleton regulator(3). We found that the PAR complex, like local translation, is required for stimulated, but not basal, outgrowth. Par3 mRNA is localized to developing axons, and NGF and netrin-1 trigger its local translation. Selective ablation of Par3 mRNA from axons abolishes the outgrowth-promoting effect of NGF. These results identify a new role for local translation and the PAR complex in axonal outgrowth.	[Hengst, Ulrich; Deglincerti, Alessia; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, Ithaca, NY 10065 USA; [Kim, Hyung Joon] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul 151742, South Korea	Cornell University; University of California System; University of California Irvine; Seoul National University (SNU)	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, Ithaca, NY 10065 USA.	srj2003@med.cornell.edu	Hengst, Ulrich/L-1413-2014	Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958	National Institute of Neurological Diseases and Stroke; Klingenstein Fellowship in the Neurosciences; Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award; New York State Spinal Cord Injury Research Board; Boehringer Ingelheim Fonds; Paralysis Project of America; National Institute of Mental Health [K99]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH081058, K99MH081058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klingenstein Fellowship in the Neurosciences(Klingenstein Philanthropies); Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award; New York State Spinal Cord Injury Research Board; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Paralysis Project of America; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Pawson (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Canada) for the PAR6 antibody, S. Schlesinger and A. Jeromin for Sindbis plasmids, J. Harris (University of California Irvine, USA), for preparing masters for casting microfluidic chambers and members of the Jaffrey laboratory for helpful discussions. This research was supported by the National Institute of Neurological Diseases and Stroke, a Klingenstein Fellowship in the Neurosciences, Irma T. Hirschl and Monique Weill-Caulier Trusts Career Scientist Award, the New York State Spinal Cord Injury Research Board (S. R. J.), a predoctoral fellowship from Boehringer Ingelheim Fonds (A. D.), a fellowship from the Paralysis Project of America and a Pathway to Independence Award (K99) from the National Institute of Mental Health (U. H.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Eng H, 1999, J NEUROSCI, V19, P1; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Femino AM, 2003, METHOD ENZYMOL, V361, P245; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gore BB, 2008, NEURON, V57, P501, DOI 10.1016/j.neuron.2008.01.006; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; KENNEDY TE, 1994, CELL, V78, P435; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SUGANUMA M, 1990, CANCER RES, V50, P3521; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	39	137	140	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1024	U263		10.1038/ncb1916	http://dx.doi.org/10.1038/ncb1916			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620967	Green Accepted			2022-12-27	WOS:000268593200018
J	Gutierrez, R; Lindeboom, JJ; Paredez, AR; Emons, AMC; Ehrhardt, DW				Gutierrez, Ryan; Lindeboom, Jelmer J.; Paredez, Alex R.; Emons, Anne Mie C.; Ehrhardt, David W.			Arabidopsis cortical microtubules position cellulose synthase delivery to the plasma membrane and interact with cellulose synthase trafficking compartments	NATURE CELL BIOLOGY			English	Article							PRIMARY-CELL-WALL; PLANT-CELLS; GOLGI NETWORK; ARRAYS; COMPLEXES; DIFFERENTIATION; MORPHOGENESIS; ORGANIZATION; INHIBITOR; PROTEINS	Plant cell morphogenesis relies on the organization and function of two polymer arrays separated by the plasma membrane: the cortical microtubule cytoskeleton and cellulose microfibrils in the cell wall. Studies using in vivo markers confirmed that one function of the cortical microtubule array is to drive organization of cellulose microfibrils by guiding the trajectories of active cellulose synthase (CESA) complexes in the plasma membrane, thus orienting nascent microfibrils. Here we provide evidence that cortical microtubules also position the delivery of CESA complexes to the plasma membrane and interact with small CESA-containing compartments by a mechanism that permits motility driven by microtubule depolymerization. The association of CESA compartments with cortical microtubules was greatly enhanced during osmotic stress and other treatments that limit cellulose synthesis. On recovery from osmotic stress, delivery of CESA complexes to the plasma membrane was observed in association with microtubule-tethered compartments. These results reveal multiple functions for the microtubule cortical array in organizing CESA in the cell cortex.	[Gutierrez, Ryan; Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Gutierrez, Ryan; Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lindeboom, Jelmer J.; Emons, Anne Mie C.] Wageningen Univ, Lab Plant Cell Biol, NL-6708 PB Wageningen, Netherlands; [Paredez, Alex R.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Emons, Anne Mie C.] FOM, Inst Atom & Mol Phys, Dept Biomol Syst, NL-1098 SJ Amsterdam, Netherlands	Carnegie Institution for Science; Stanford University; Wageningen University & Research; University of California System; University of California Berkeley; AMOLF	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Paredez, Alexander/E-7171-2014; Paredez, Alexander R/B-9799-2009	Paredez, Alexander/0000-0002-9298-3264; Paredez, Alexander R/0000-0002-9298-3264; Lindeboom, Jelmer J/0000-0003-4294-4838	National Science Foundation [0524334]; EU Commission [FP6-2004-NEST-C1-028974]	National Science Foundation(National Science Foundation (NSF)); EU Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the National Science Foundation (0524334) and the EU Commission (FP6-2004-NEST-C1-028974).	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Barton DA, 2008, PLANT CELL, V20, P982, DOI 10.1105/tpc.108.058503; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; EMONS AM, 1985, PLANTA, V163, P350, DOI 10.1007/BF00395143; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; HANDA S, 1983, PLANT PHYSIOL, V73, P834, DOI 10.1104/pp.73.3.834; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; HEPLER PK, 1964, J CELL BIOL, V20, P529, DOI 10.1083/jcb.20.3.529; HERTH W, 1983, PLANTA, V159, P347, DOI 10.1007/BF00393174; IRAKI NM, 1989, PLANT PHYSIOL, V91, P39, DOI 10.1104/pp.91.1.39; Kiedaisch BM, 2003, PLANTA, V217, P922, DOI 10.1007/s00425-003-1071-y; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; McFarlane HE, 2008, PLANTA, V227, P1363, DOI 10.1007/s00425-008-0708-2; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Oda Y, 2005, PLANT PHYSIOL, V137, P1027, DOI 10.1104/pp.104.052613; Paradez A, 2006, CURR OPIN PLANT BIOL, V9, P571, DOI 10.1016/j.pbi.2006.09.005; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Rasband W, IMAGEJ; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STAEHELIN LA, 1982, DEV ORDER ITS ORIGIN, P133; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zheng HY, 2002, PLANT PHYSIOL, V129, P530, DOI 10.1104/pp.003970	48	476	488	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					797	U43		10.1038/ncb1886	http://dx.doi.org/10.1038/ncb1886			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525940				2022-12-27	WOS:000267603100007
J	Schmidt, MHH; Bicker, F; Nikolic, I; Meister, J; Babuke, T; Picuric, S; Muller-Esterl, W; Plate, KH; Dikic, I				Schmidt, Mirko H. H.; Bicker, Frank; Nikolic, Iva; Meister, Jeannette; Babuke, Tanja; Picuric, Srdjan; Mueller-Esterl, Werner; Plate, Karl H.; Dikic, Ivan			Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal	NATURE CELL BIOLOGY			English	Article							NUCLEAR ANTIGEN-2; MAMMALIAN NOTCH; IN-VIVO; DROSOPHILA; RECEPTOR; DELTA; GENE; ACTIVATION; SERRATE; PATHWAY	Epidermal growth factor-like domain 7 (EGFL7) is a secreted factor implicated in cellular responses such as cell migration and blood vessel formation; however the molecular mechanisms underlying the effects of EGFL7 are largely unknown. Here we have identified transmembrane receptors of the Notch family as EGFL7-binding molecules. Secreted EGFL7 binds to a region in Notch involved in ligand-mediated receptor activation, thus acting as an antagonist of Notch signalling. Expression of EGFL7 in neural stem cells (NSCs) in vitro decreased Notch-specific signalling and consequently, reduced proliferation and self-renewal of NSCs. Such altered Notch signalling caused a shift in the differentiation pattern of cultured NSCs towards an excess of neurons and oligodendrocytes. We identified neurons as a source of EGFL7 in the brain, suggesting that brain-derived EGFL7 acts as an endogenous antagonist of Notch signalling that regulates proliferation and differentiation of subventricular zone-derived adult NSCs.	[Schmidt, Mirko H. H.; Babuke, Tanja; Picuric, Srdjan; Mueller-Esterl, Werner; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Schmidt, Mirko H. H.; Bicker, Frank; Nikolic, Iva; Meister, Jeannette; Plate, Karl H.] Goethe Univ Frankfurt, Sch Med, Inst Neurol, D-60528 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Mirko.Schmidt@kgu.de; Ivan.Dikic@biochem2.de	Dikic, Ivan/O-4650-2015; Schmidt, Mirko H. H./ABI-6650-2020	Dikic, Ivan/0000-0001-8156-9511; Schmidt, Mirko H. H./0000-0001-7411-8835; Nikolic, Iva/0000-0002-0141-5975	DFG; EMBO	DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO))	We thank all our colleagues who provided constructs. Thanks to Julio Granados, Yonathan Lissanu Deribe and Koraljka Husnjak for initial help with the yeast two- hybrid system. Thanks to Verdon Taylor for helpful suggestions, Ruth von Laer for help with FACS analysis and Stefan Momma and David G. McEwan for comments on the manuscript. This work was financially supported by the DFG within the SFB Transregio 23, subproject A4 and the Excellence Cluster Cardiopulmonary System, by the Adolf Messer Foundation, by the Paul and Ursula Klein Foundation, and an EMBO long- term fellowship granted to M. H.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; DE SB, 1999, NATURE, V398, P518; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Ge CH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-48; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Ohuchi T, 2002, J NEUROSCI METH, V118, P1, DOI 10.1016/S0165-0270(02)00116-4; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakai T, 1998, J VIROL, V72, P6034, DOI 10.1128/JVI.72.7.6034-6039.1998; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	47	107	118	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					873	U245		10.1038/ncb1896	http://dx.doi.org/10.1038/ncb1896			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503073				2022-12-27	WOS:000267603100017
J	Zeng, SC; Xiang, T; Pandita, TK; Gonzalez-Suarez, I; Gonzalo, S; Harris, CC; Yang, Q				Zeng, Sicong; Xiang, Tao; Pandita, Tej K.; Gonzalez-Suarez, Ignacio; Gonzalo, Susana; Harris, Curtis C.; Yang, Qin			Telomere recombination requires the MUS81 endonuclease	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; HUMAN-CELLS; MAINTENANCE; RESOLUTION; SHELTERIN; BODIES; PHASE; TRF2; ALT	Telomerase-negative cancer cells maintain their telomeres through the alternative lengthening of telomeres (ALT) pathway(1-3). Although a growing body of evidence demonstrates that the ALT mechanism is a post-replicative telomere recombination process, molecular details of this pathway are largely unknown. Here we demonstrate that MUS81, a DNA structure specific recombination endonuclease, has a key role in the maintenance of telomeres in human ALT cells. We find that MUS81 specifically localizes to ALT-associated promyelocytic leukaemia (PML) nuclear bodies (APBs) and associates with telomeric DNA in ALT cells, which is enriched during the G2 phase of the cell cycle. Depletion of MUS81 results in the reduction of ALT-specific telomere recombination and leads to proliferation arrest of ALT cells. In addition, the endonuclease activity of MUS81 is required for recombination-based ALT cell survival, and the interaction of MUS81 with the telomeric repeat-binding factor TRF2 regulates this enzymatic activity, thereby maintaining telomere recombination. Thus, our results suggest that MUS81 is involved in the maintenance of ALT cell survival at least in part by homologous recombination of telomeres.	[Zeng, Sicong; Xiang, Tao; Pandita, Tej K.; Gonzalez-Suarez, Ignacio; Gonzalo, Susana; Yang, Qin] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Gonzalez-Suarez, Ignacio; Gonzalo, Susana] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, Q (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, 4511 Forest Pk, St Louis, MO 63108 USA.	qyang@wustl.edu	Pandita, Tej K/AAM-9188-2020; Gonzalo, Susana/T-8275-2019	Gonzalo, Susana/0000-0001-9631-1206	Concern Foundation; NIH [CA10445/CA123232]; Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA129537, ZIABC005795, R01CA123232, P01CA104457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034746] Funding Source: NIH RePORTER	Concern Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. R. Reddel for ALT cells, and C. H. McGowan for wild-type and mutant MUS81 constructs, the MUS81 antibody and Mus81<SUP>+/+</SUP> and Mus81<SUP>-/-</SUP> MEFs. We thank I. Hickson and J. Roti Roti for proof-reading. This work is supported in part by grants from Concern Foundation to Q. Y. and NIH CA10445/CA123232 to T. K. P. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Blais V, 2004, MOL BIOL CELL, V15, P552, DOI 10.1091/mbc.E03-08-0580; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Gao H, 2003, MOL BIOL CELL, V14, P4826, DOI 10.1091/mbc.E03-05-0276; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grobelny JV, 2000, J CELL SCI, V113, P4577; Heyer WD, 2004, CURR BIOL, V14, pR56, DOI 10.1016/j.cub.2003.12.043; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Stansel RM, 2001, EMBO J, V20, P5532; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang R, 2005, CANCER RES, V65, P2526, DOI 10.1158/0008-5472.CAN-04-2421; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	77	79	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					616	U387		10.1038/ncb1867	http://dx.doi.org/10.1038/ncb1867			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363487	Green Accepted			2022-12-27	WOS:000265640000020
J	Nishiyama, M; Oshikawa, K; Tsukada, Y; Nakagawa, T; Iemura, S; Natsume, T; Fan, Y; Kikuchi, A; Skoultchi, AI; Nakayama, KI				Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Iemura, Shun-ichiro; Natsume, Tohru; Fan, Yuhong; Kikuchi, Akira; Skoultchi, Arthur I.; Nakayama, Keiichi I.			CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis	NATURE CELL BIOLOGY			English	Article							LINKER HISTONES; SACCHAROMYCES-CEREVISIAE; GENE-REGULATION; MICE LACKING; P53 PATHWAY; DNA-DAMAGE; IN-VITRO; CHROMATIN; TRANSCRIPTION; PROTEIN	The chromodomain helicase DNA-binding (CHD) family of enzymes is thought to regulate gene expression, but their role in the regulation of specific genes has been unclear. Here we show that CHD8 is expressed at a high level during early embryogenesis and prevents apoptosis mediated by the tumour suppressor protein p53. CHD8 was found to bind to p53 and to suppress its transactivation activity. CHD8 promoted the association of p53 and histone H1, forming a trimeric complex on chromatin that was required for inhibition of p53-dependent transactivation and apoptosis. Depletion of CHD8 or histone H1 resulted in p53 activation and apoptosis. Furthermore, Chd8(-/-) mice died early during embryogenesis, manifesting widespread apoptosis, whereas deletion of p53 ameliorated this developmental arrest. These observations reveal a mode of p53 regulation mediated by CHD8, which may set a threshold for induction of apoptosis during early embryogenesis by counteracting p53 function through recruitment of histone H1.	[Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Nishiyama, Masaaki; Oshikawa, Kiyotaka; Tsukada, Yu-ichi; Nakagawa, Tadashi; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr JBIRC, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Fan, Yuhong; Skoultchi, Arthur I.] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fan, Yuhong] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kikuchi, Akira] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan	Kyushu University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Yeshiva University; Albert Einstein College of Medicine; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Hiroshima University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Nishiyama, Masaaki/GWU-5575-2022; Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Takeda Science Foundation; NIH [CA79057]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA079057, R56CA079057] Funding Source: NIH RePORTER	Takeda Science Foundation(Takeda Science Foundation (TSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Kitamura for pMX-puro; J.M. Cunningham and K. Hanada for the mCAT-1 plasmid; S. Miyake for the PG13-, p21-, and p21 mutant-Luc plasmids; T. Takemori for the NF-kappa B Luc plasmid; F. Ishikawa and R. Funayama for the N-fusion and C-fusion plasmids; M. Kitagawa for HCT116 and SaOS2 cells; M. Sato, Y. Yamada, T. Moroishi, Y. Katayama, N. Nishimura and K. Oyamada for technical assistance; M. Kimura and A. Ohta for help with preparation of the manuscript; and T. Ushijima, K. Hayashi and members of the authors' laboratories for discussion. K.I.N. was supported by Takeda Science Foundation. Y.F. and A.I.S. were supported by NIH grant CA79057. Y.F. is a GCC Cancer Scholar supported by Georgia Cancer Coalition.	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Becker PB, 2005, NAT STRUCT MOL BIOL, V12, P732, DOI 10.1038/nsmb0905-732; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Rupp RAW, 2005, CELL, V123, P1178, DOI 10.1016/j.cell.2005.12.004; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS H, 1999, ENTREP REGION DEV, V11, P317; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823; Zhang L, 2005, EMBO J, V24, P2379, DOI 10.1038/sj.emboj.7600711; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	45	135	138	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					172	U139		10.1038/ncb1831	http://dx.doi.org/10.1038/ncb1831			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151705	Green Accepted			2022-12-27	WOS:000263285500015
J	Weinberg, RA				Weinberg, Robert A.			Twisted epithelial-mesenchymal transition blocks senescence	NATURE CELL BIOLOGY			English	Editorial Material							CELLS; ACCUMULATION; PROGRESSION; RESISTANCE; EMBRYO	The epithelial-mesenchymal transition (EMT) is a cellular transdifferentiation program that enables epithelial cancer cells to acquire traits of high-grade malignancy, notably invasive and metastatic powers. A new study indicates that it may also function early in tumour progression by preventing oncogene-induced senescence.	MIT, Whitehead Inst Biomed Res, Ludwig Ctr Mol Oncol, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Ludwig Ctr Mol Oncol, Dept Biol, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu						Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104	13	64	71	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1021	1023		10.1038/ncb0908-1021	http://dx.doi.org/10.1038/ncb0908-1021			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	18758491				2022-12-27	WOS:000258910400006
J	Pulvirenti, T; Giannotta, M; Capestrano, M; Capitani, M; Pisanu, A; Polishchuk, RS; Pietro, ES; Beznoussenko, GV; Mironov, AA; Turacchio, G; Hsu, VW; Sallese, M; Luini, A				Pulvirenti, Teodoro; Giannotta, Monica; Capestrano, Mariagrazia; Capitani, Mirco; Pisanu, Antonio; Polishchuk, Roman S.; Pietro, Enrica San; Beznoussenko, Galina V.; Mironov, Alexander A.; Turacchio, Gabriele; Hsu, Victor W.; Sallese, Michele; Luini, Alberto			A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway	NATURE CELL BIOLOGY			English	Article							LUMINAL ER PROTEINS; HUMAN KDEL RECEPTOR; SRC FAMILY KINASES; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; TYROSINE KINASE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; COMPLEX; ENDOCYTOSIS	As with other complex cellular functions, intracellular membrane transport involves the coordinated engagement of a series of organelles and machineries; however, the molecular basis of this coordination is unknown. Here we describe a Golgi-based signalling system that is activated by traffic and is involved in monitoring and balancing trafficking rates into and out of the Golgi complex. We provide evidence that the traffic signal is due to protein chaperones that leave the endoplasmic reticulum and reach the Golgi complex where they bind to the KDEL receptor. This initiates a signalling reaction that includes the activation of a Golgi pool of Src kinases and a phosphorylation cascade that in turn activates intra-Golgi trafficking, thereby maintaining the dynamic equilibrium of the Golgi complex. The concepts emerging from this study should help to understand the control circuits that coordinate high-order cellular functions.	[Pulvirenti, Teodoro; Giannotta, Monica; Capestrano, Mariagrazia; Capitani, Mirco; Pisanu, Antonio; Polishchuk, Roman S.; Pietro, Enrica San; Beznoussenko, Galina V.; Mironov, Alexander A.; Turacchio, Gabriele; Sallese, Michele; Luini, Alberto] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Lab Membrane Traff, I-66030 Chieti, Italy; [Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luini, A (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Lab Membrane Traff, I-66030 Chieti, Italy.	sallese@negrisud.it; luini@negrisud.it	Pulvirenti, Teodoro/AAJ-7661-2020; Luini, Alberto/L-1372-2013; Sallese, Michele/J-5347-2016	Pulvirenti, Teodoro/0000-0001-9342-6614; Luini, Alberto/0000-0002-8729-2549; Sallese, Michele/0000-0002-2555-3571; Polishchuk, Roman/0000-0002-7698-1955	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP04235] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Austin CD, 1996, J CELL BIOL, V135, P1471, DOI 10.1083/jcb.135.6.1471; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Cetkovic H, 2004, GENE, V342, P251, DOI 10.1016/j.gene.2004.07.044; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; GREEN H, 1965, P NATL ACAD SCI USA, V53, P1360, DOI 10.1073/pnas.53.6.1360; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Hiyoshi M, 2008, BLOOD, V111, P243, DOI 10.1182/blood-2007-04-086017; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; KEUSCH GT, 1995, INFECT IMMUN, V63, P1138, DOI 10.1128/IAI.63.3.1138-1141.1995; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; Li M, 2008, MOL CELL BIOL, V28, P630, DOI 10.1128/MCB.00150-07; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; McGarrigle D., 2007, SCI STKE, V392, pp, DOI [10.1126/stke.3922007pe35, DOI 10.1126/STKE.3922007PE35]; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Mironov A, 1997, J CELL BIOL, V139, P1109, DOI 10.1083/jcb.139.5.1109; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sallese M, 2006, EMBO J, V25, P2663, DOI 10.1038/sj.emboj.7601172; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; SORKIN A, 2005, SCI STKE, pE1; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Webb RJ, 2005, AM J PHYSIOL-CELL PH, V289, pC748, DOI 10.1152/ajpcell.00019.2005; XIA ZP, 2005, SCI STKE, pE7; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200	60	145	146	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					912	922		10.1038/ncb1751	http://dx.doi.org/10.1038/ncb1751			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641641				2022-12-27	WOS:000258147100009
J	Shi, S; Larson, K; Guo, DD; Lim, SJ; Dutta, P; Yan, SJ; Li, WX				Shi, Song; Larson, Kimberly; Guo, Dongdong; Lim, Su Jun; Dutta, Pranabananda; Yan, Shian-Jang; Li, Willis X.			Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability	NATURE CELL BIOLOGY			English	Article							DNA-BINDING; CELL-CYCLE; JAK-STAT; MELANOGASTER; ACTIVATION; PROTEINS; PATTERNS; DEFECTS	STAT ( Signal transducer and activator of transcription) is a potent transcription factor and its aberrant activation by phosphorylation is associated with human cancers(1-4). We have shown previously that overactivation of JAK, which phosphorylates STAT(5,6), disrupts heterochromatin formation globally in Drosophila melanogaster(7). However, it remains unclear how this effect is mediated and whether STAT is involved. Here, we demonstrate that Drosophila STAT ( STAT92E) is involved in controlling heterochromatin protein 1 ( HP1) distribution and heterochromatin stability. We found, unexpectedly, that loss of STAT92E, had the same effects as overactivation of JAK in disrupting heterochromatin formation and heterochromatic gene silencing, whereas overexpression of STAT92E had the opposite effects. We have further shown that the unphosphorylated or 'transcriptionally inactive' form of STAT92E is localized on heterochromatin in association with HP1, and is required for stabilizing HP1 localization and histone H3 Lys 9 methylation ( H3mK9). However, activation by phosphorylation reduces heterochromatin-associated STAT92E, causing HP1 displacement and heterochromatin destabilization. Thus, reducing levels of unphosphorylated STAT92E, either by loss of STAT92E or increased phosphorylation, causes heterochromatin instability. These results suggest that activation of STAT by phosphorylation controls both access to chromatin and activity of the transcription machinery.	[Shi, Song; Larson, Kimberly; Guo, Dongdong; Lim, Su Jun; Dutta, Pranabananda; Yan, Shian-Jang; Li, Willis X.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis X/AAL-7212-2020; Li, Willis/ABC-5695-2020	Li, Willis X/0000-0001-9041-7341; Li, Willis/0000-0001-9041-7341	NATIONAL CANCER INSTITUTE [R01CA131326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077046, R01GM065774] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131326-01A2, R01 CA131326] Funding Source: Medline; NIGMS NIH HHS [R01 GM077046, R01GM65774, R01 GM065774, R01 GM077046-04, R01GM077046] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Betz A, 2006, NAT GENET, V38, P977, DOI 10.1038/ng0906-977; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KAMINKER JS, 2002, GENOME BIOL, V0003; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; KELLUM R, 1995, J CELL SCI, V108, P1407; Li JH, 2003, MECH DEVELOP, V120, P1455, DOI 10.1016/j.mod.2003.09.004; Li WX, 2002, DEVELOPMENT, V129, P4241; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Ronsseray S, 2001, GENETICS, V159, P1631; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; SWEITZER SM, 1995, J BIOL CHEM, V270, P16510, DOI 10.1074/jbc.270.28.16510; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	27	85	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					491	U279		10.1038/ncb1713	http://dx.doi.org/10.1038/ncb1713			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344984	Green Accepted			2022-12-27	WOS:000254561700021
J	Schmitz, MHA; Held, M; Janssens, V; Hutchins, JRA; Hudecz, O; Ivanova, E; Goris, J; Trinkle-Mulcahy, L; Lamond, AI; Poser, I; Hyman, AA; Mechtler, K; Peters, JM; Gerlich, DW				Schmitz, Michael H. A.; Held, Michael; Janssens, Veerle; Hutchins, James R. A.; Hudecz, Otto; Ivanova, Elitsa; Goris, Jozef; Trinkle-Mulcahy, Laura; Lamond, Angus I.; Poser, Ina; Hyman, Anthony A.; Mechtler, Karl; Peters, Jan-Michael; Gerlich, Daniel W.			Live-cell imaging RNAi screen identifies PP2A-B55 alpha and importin-beta 1 as key mitotic exit regulators in human cells	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE-2A; VERTEBRATE CELLS; LIVING CELLS; MITOSIS; DROSOPHILA; SUBUNIT; DEPHOSPHORYLATION; CALCINEURIN	When vertebrate cells exit mitosis various cellular structures are re-organized to build functional interphase cells(1). This depends on Cdk1 (cyclin dependent kinase 1) inactivation and subsequent dephosphorylation of its substrates(2-4). Members of the protein phosphatase 1 and 2A (PP1 and PP2A) families can dephosphorylate Cdk1 substrates in biochemical extracts during mitotic exit(5,6), but how this relates to postmitotic reassembly of interphase structures in intact cells is not known. Here, we use a live-cell imaging assay and RNAi knockdown to screen a genome-wide library of protein phosphatases for mitotic exit functions in human cells. We identify a trimeric PP2A-B55 alpha complex as a key factor in mitotic spindle breakdown and postmitotic reassembly of the nuclear envelope, Golgi apparatus and decondensed chromatin. Using a chemically induced mitotic exit assay, we find that PP2A-B55 alpha functions downstream of Cdk1 inactivation. PP2A-B55 alpha isolated from mitotic cells had reduced phosphatase activity towards the Cdk1 substrate, histone H1, and was hyper-phosphorylated on all subunits. Mitotic PP2A complexes co-purified with the nuclear transport factor importin-beta 1, and RNAi depletion of importin-beta 1 delayed mitotic exit synergistically with PP2A-B55 alpha. This demonstrates that PP2A-B55 alpha and importin-beta 1 cooperate in the regulation of postmitotic assembly mechanisms in human cells.	[Schmitz, Michael H. A.; Held, Michael; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland; [Schmitz, Michael H. A.; Held, Michael; Gerlich, Daniel W.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Janssens, Veerle; Ivanova, Elitsa; Goris, Jozef] Katholieke Univ Leuven, Gasthuisberg O&N1, Lab Prot Phosphorylat & Prote, Dept Mol Cell Biol,Fac Med, B-3000 Louvain, Belgium; [Hutchins, James R. A.; Mechtler, Karl; Peters, Jan-Michael] Inst Mol Pathol, A-1030 Vienna, Austria; [Hudecz, Otto; Mechtler, Karl] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Trinkle-Mulcahy, Laura] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Lamond, Angus I.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Marine Biological Laboratory - Woods Hole; KU Leuven; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Ottawa; University of Ottawa; University of Dundee; Max Planck Society	Gerlich, DW (corresponding author), Univ Zurich, Div Psychiat Res, August Forel Str 1, CH-8008 Zurich, Switzerland.	daniel.gerlich@bc.biol.ethz.ch	Gerlich, Daniel Wolfram W/A-6991-2016; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Mechtler, Karl/AAF-2717-2019; Trinkle-Mulcahy, Laura/E-2197-2013; Janssens, Veerle/I-7059-2016	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Hyman, Anthony A/0000-0003-3664-154X; Mechtler, Karl/0000-0002-3392-9946; Janssens, Veerle/0000-0002-6772-8448	Swiss National Science Foundation (SNF) [3100A0-114120, PDFMP3_124904]; European Science Foundation; Evelyn and Melvin Spiegel Fund; Roche; Molecular Life Sciences Ph.D. programme Zurich; 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy [P6/28]; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'; Max Planck Society; MitoCheck (EU); BMBF (Bundesministerium fur Bildung and Forschung); DiGtoP [01GS0859]; Boehringer Ingelheim; Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III); European Commission; Austrian Science Foundation (FWF); Medical Research Council [G0801738, G0301131] Funding Source: researchfish; MRC [G0801738, G0301131] Funding Source: UKRI	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Science Foundation(European Science Foundation (ESF)European Commission); Evelyn and Melvin Spiegel Fund; Roche(Roche Holding); Molecular Life Sciences Ph.D. programme Zurich; 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'(FWO); Max Planck Society(Max Planck SocietyFoundation CELLEX); MitoCheck (EU)(European Commission); BMBF (Bundesministerium fur Bildung and Forschung)(Federal Ministry of Education & Research (BMBF)); DiGtoP; Boehringer Ingelheim(Boehringer Ingelheim); Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank F. Uhlmann and B. Novak for critical comments on the manuscript. We thank S. Maar, the ETHZ Light Microscopy Centre (LMC), the ETHZ RNAi Screening Centre (RISC), M. Augsburg (The Max Planck Institute of Molecular Cell Biology and Genetics; MPI-CBG), M. Leuschner (MPI-CBG) and A. Ssykor (MPI-CBG) for technical assistance. We thank U. Kutay (ETHZ) for anti-importin-beta 1 and anti-nucleolin antibodies,). Rohrer (University of Zurich) for providing GalT-eGFP plasmid, J. Ellenberg (EMBL, Heidelberg) for IBB-eGFP plasmid, M.C. Cardoso (Technical University, Darmstadt) for eGFP-PCNA plasmid and Sanofi Aventis and the National Cancer Institute for providing flavopiridol. This work was supported by Swiss National Science Foundation (SNF) research grant 3100A0-114120, SNF ProDoc grant PDFMP3_124904, a European Young Investigator (EURYI) award of the European Science Foundation to D.W.G., a MBL Summer Research Fellowship by the Evelyn and Melvin Spiegel Fund to D.W.G., a Roche Ph.D. fellowship to M.H.A.S. and a Mueller fellowship of the Molecular Life Sciences Ph.D. programme Zurich to M.H. M.H. and M.H.A.S. are fellows of the Zurich Ph.D. programme in Molecular Life Sciences. V.J. and J.G. were supported by grants of the 'Geconcerteerde OnderzoeksActies' of the Flemish government, the 'Interuniversitary Attraction Poles of the Belgian Science Policy P6/28 and the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' A.I.L. is a Wellcome Trust Principal Research Fellow. A.A.H. acknowledges funding by the Max Planck Society, MitoCheck (the EU-FP6 integrated project), and a BMBF (Bundesministerium fur Bildung and Forschung) grant, DiGtoP (01GS0859). Work in the groups of K.M. and J.M.P. was supported by MitoCheck (the EU-FP6 integrated project), Boehringer Ingelheim, the GEN-AU programme of the Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III), MeioSys within the Seventh Framework Programme of the European Commission and by Chromosome Dynamics, which is funded by the Austrian Science Foundation (FWF).	AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Berdougo E, 2008, CELL CYCLE, V7, P1184, DOI 10.4161/cc.7.9.5792; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; LEE TH, 1994, MOL BIOL CELL, V5, P323, DOI 10.1091/mbc.5.3.323; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006	34	250	252	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					886	893		10.1038/ncb2092	http://dx.doi.org/10.1038/ncb2092			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20711181	Green Submitted, Green Accepted			2022-12-27	WOS:000281561900012
J	Connelly, JT; Gautrot, JE; Trappmann, B; Tan, DWM; Donati, G; Huck, WTS; Watt, FM				Connelly, John T.; Gautrot, Julien E.; Trappmann, Britta; Tan, David Wei-Min; Donati, Giacomo; Huck, Wilhelm T. S.; Watt, Fiona M.			Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions	NATURE CELL BIOLOGY			English	Article							TRANSIT-AMPLIFYING CELLS; TERMINAL DIFFERENTIATION; POLYMER BRUSHES; SKIN-DISEASE; EXPRESSION; DYNAMICS; FOS; SRF; KERATINOCYTES; TRANSCRIPTION	Epidermal homeostasis depends on a balance between stem cell renewal and differentiation and is regulated by extrinsic signals from the extracellular matrix (ECM)(1,2). A powerful approach to analysing the pathways involved is to engineer single-cell microenvironments in which individual variables are precisely and quantitatively controlled(3-5). Here, we employ micropatterned surfaces to identify the signalling pathways by which restricted ECM contact triggers human epidermal stem cells to initiate terminal differentiation. On small (20 mu m diameter) circular islands, keratinocytes remained rounded, and differentiated at higher frequency than cells that could spread on large (50 mu m diameter) islands. Differentiation did not depend on ECM composition or density. Rather, the actin cytoskeleton mediated shape-induced differentiation by regulating serum response factor (SRF) transcriptional activity. Knockdown of SRF or its co-factor MAL inhibited differentiation, whereas overexpression of MAL stimulated SRF activity and involucrin expression. SRF target genes FOS and JUNB were also required for differentiation: c-Fos mediated serum responsiveness, whereas JunB was regulated by actin and MAL. Our findings demonstrate how biophysical cues are transduced into transcriptional responses that determine epidermal cell fate.	[Connelly, John T.; Tan, David Wei-Min; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Gautrot, Julien E.; Trappmann, Britta; Huck, Wilhelm T. S.] Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Cambridge CB2 1EW, England; [Donati, Giacomo; Watt, Fiona M.] CRUK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Huck, Wilhelm T. S.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	University of Cambridge; University of Cambridge; CRUK Cambridge Institute; Radboud University Nijmegen	Watt, FM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	Fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022; Huck, Wilhelm T.S./B-1471-2012; Trappmann, Britta/AAQ-8712-2020; Gautrot, Julien/S-7920-2016	Watt, Fiona/0000-0001-9151-5154; Gautrot, Julien/0000-0002-1614-2578; Trappmann, Britta/0000-0002-6260-4075; DONATI, Giacomo/0000-0002-0370-8288; Connelly, John/0000-0002-5955-8848	Wellcome Trust; Medical Research Council (MRC); Cancer research UK (CRUK); TUMIC European Union FP7 network; NIH (National Institutes of Health)	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer research UK (CRUK)(Cancer Research UK); TUMIC European Union FP7 network; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Wellcome Trust, the Medical Research Council (MRC), Cancer research UK (CRUK) and the TUMIC European Union FP7 network. J.T.C. is the recipient of an NIH (National Institutes of Health) postdoctoral fellowship. We thank R. Treisman and G. Posern for providing reagents and the core facilities of the Wellcome Trust Centre for Stem Cell Research for technical assistance.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; DOVER R, 1987, J INVEST DERMATOL, V89, P349, DOI 10.1111/1523-1747.ep12471751; GANDARILLAS A, 1995, ONCOGENE, V11, P1403; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Honma M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/mbc.E05-12-1173; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Masutani H, 1997, ONCOGENE, V15, P1661, DOI 10.1038/sj.onc.1201328; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Watt FM, 2010, PHILOS T R SOC B, V365, P155, DOI 10.1098/rstb.2009.0149; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhou F, 2006, J AM CHEM SOC, V128, P16253, DOI 10.1021/ja0654377; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	39	335	342	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					711	U177		10.1038/ncb2074	http://dx.doi.org/10.1038/ncb2074			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20581838	Green Published, Green Submitted			2022-12-27	WOS:000279374400015
J	Jun, JI; Lau, LF				Jun, Joon-Il; Lau, Lester F.			The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing	NATURE CELL BIOLOGY			English	Article							HUMAN SKIN FIBROBLASTS; BENIGN PROSTATIC HYPERPLASIA; ONCOGENE-INDUCED SENESCENCE; IMMEDIATE-EARLY GENE; CELLULAR SENESCENCE; IN-VIVO; INTEGRIN ALPHA(6)BETA(1); REGULATES SENESCENCE; MOLECULAR-MECHANISMS; GROWTH ARREST	Cellular senescence is a recognized mechanism of tumour suppression; however, its contribution to other pathologies is not well understood. We show that the matricellular protein CCN1 (also known as CYR61; cysteine-rich protein 61), which is dynamically expressed at sites of wound repair, can induce fibroblast senescence by binding to integrin a(6)beta(1) and the heparan sulphate proteoglycans (receptors involved in cell adhesion). CCN1 induces DNA damage response pathways and activates p53 and the RAC1-NOX1 complex, which generates reactive oxygen species (ROS). This results in the ROS-dependent activation of the p16(INK4a)/pRb pathway, leading to senescence and concomitant expression of antifibrotic genes. Senescent fibroblasts accumulate in granulation tissues of healing cutaneous wounds and express antifibrotic genes in wild-type mice. These processes are lost in knockin mice that express a senescence-defective Ccn1 mutant, resulting in exacerbated fibrosis. Topical application of CCN1 protein to wounds reverses these defects. Thus, fibroblast senescence is a CCN1-dependent wound healing response in cutaneous injury that functions to curb fibrosis during tissue repair.	[Jun, Joon-Il; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA.	LFLau@uic.edu		Lau, Lester/0000-0002-4364-2914	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. DiPietro for advice, J. Campisi and S. Lowe for reagents, S. W. Shin for assistance, and members of the laboratory for discussion. This work was supported by grants from the National Institutes of Health to L.F.L.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chiarugi Paola, 2003, Ital J Biochem, V52, P28; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mori A, 2007, CANCER INVEST, V25, P738, DOI 10.1080/02770900701512597; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Schomber T, 2004, BLOOD, V103, P4511, DOI 10.1182/blood-2003-07-2397; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wilson L, 2002, BIOTECHNIQUES, V32, P548, DOI 10.2144/02323st07; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	69	579	599	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					676	U106		10.1038/ncb2070	http://dx.doi.org/10.1038/ncb2070			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526329	Green Accepted			2022-12-27	WOS:000279374400011
J	Srikanth, S; Jung, HJ; Kim, KD; Souda, P; Whitelegge, J; Gwack, Y				Srikanth, Sonal; Jung, Hea-Jin; Kim, Kyun-Do; Souda, Puneet; Whitelegge, Julian; Gwack, Yousang			A novel EF-hand protein, CRACR2A, is a cytosolic Ca2+ sensor that stabilizes CRAC channels in T cells	NATURE CELL BIOLOGY			English	Article							STORE; STIM1; ORAI1; MEMBRANE; ACTIVATION; ENTRY; BINDING; DOMAIN; OLIGOMERIZATION; TRANSCRIPTION	Orai1 and STIM1 are critical components of Ca2+ release-activated Ca2+ (CRAC) channels that mediate store-operated Ca2+ entry (SOCE) in immune cells. Although it is known that Orai1 and STIM1 co-cluster and physically interact to mediate SOCE, the cytoplasmic machinery modulating these functions remains poorly understood. We sought to find modulators of Orai1 and STIM1 using affinity protein purification and identified a novel EF-hand protein, CRACR2A (also called CRAC regulator 2A, EFCAB4B or FLJ33805). We show that CRACR2A interacts directly with Orai1 and STIM1, forming a ternary complex that dissociates at elevated Ca2+ concentrations. Studies using knockdown mediated by small interfering RNA (siRNA) and mutagenesis show that CRACR2A is important for clustering of Orai1 and STIM1 upon store depletion. Expression of an EF-hand mutant of CRACR2A enhanced STIM1 clustering, elevated cytoplasmic Ca2+ and induced cell death, suggesting its active interaction with CRAC channels. These observations implicate CRACR2A, a novel Ca2+ binding protein that is highly expressed in T cells and conserved in vertebrates, as a key regulator of CRAC channel-mediated SOCE.	[Srikanth, Sonal; Jung, Hea-Jin; Kim, Kyun-Do; Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Souda, Puneet; Whitelegge, Julian] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gwack, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	ygwack@mednet.ucla.edu			National Institute of Health [AI-083432]; Stein Oppenheimer Endowment Award; Cancer Research Coordinating Committee; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stein Oppenheimer Endowment Award; Cancer Research Coordinating Committee; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Kenneth Philipson for critical reading of this manuscript and kind suggestions on Ca<SUP>2+</SUP> overlay experiments. We thank Bernard Ribalet for help with patch clamp experiments, Baljit Khakh for sharing equipments and Earl Homsher for helpful discussions. This work was supported by National Institute of Health grant AI-083432, Stein Oppenheimer Endowment Award, Cancer Research Coordinating Committee Award (Y.G.) and a fellowship from the American Heart Association (S.S.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bauer MC, 2008, BIOCHEMISTRY-US, V47, P6089, DOI 10.1021/bi800496a; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	48	177	184	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					436	U63		10.1038/ncb2045	http://dx.doi.org/10.1038/ncb2045			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418871	Green Accepted			2022-12-27	WOS:000277283700009
J	Eden, ER; White, IJ; Tsapara, A; Futter, CE				Eden, Emily R.; White, Ian J.; Tsapara, Anna; Futter, Clare E.			Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction	NATURE CELL BIOLOGY			English	Article							TYROSINE-PHOSPHATASE 1B; ENDOPLASMIC-RETICULUM; MULTIVESICULAR ENDOSOMES; INWARD VESICULATION; VESICLE FORMATION; PROTEIN; HRS; CELLS; PTP1B; VAP	The epidermal growth factor receptor (EGFR) is a critical determinator of cell fate. Signalling from this receptor tyrosine kinase is spatially regulated by progression through the endocytic pathway, governing receptor half-life and accessibility to signalling proteins and phosphatases. Endocytosis of EGFR is required for interaction with the protein tyrosine phosphatase PTP1B (ref. 1), which localizes to the cytoplasmic face of the endoplasmic reticulum (ER)(2), raising the question of how PTP1B comes into contact with endosomal EGFR. We show that EGFR-PTP1B interaction occurs by means of direct membrane contacts between the perimeter membrane of multivesicular bodies (MVBs) and the ER. The population of EGFR interacting with PTP1B is the same population that undergo ESCRT (endosomal sorting complex required for transport)-mediated sorting within MVBs, and PTP1B activity promotes the sequestration of EGFR on to MVB internal vesicles. Membrane contacts between endosomes and the ER form in both the presence and absence of stimulation by EGF. Thus membrane contacts between endosomes and the ER may represent a global mechanism for direct interaction between proteins on these two organelles.	[Eden, Emily R.; White, Ian J.; Tsapara, Anna; Futter, Clare E.] UCL, Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London	Futter, CE (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	c.futter@ucl.ac.uk	TSAPARA, ANNA/AAT-8478-2020	Eden, Emily/0000-0001-9352-5532; Futter, Clare/0000-0001-5559-9389	Wellcome Trust [078304]; Cancer Research UK [C20675]; MRC [G0801878] Funding Source: UKRI; Medical Research Council [G0801878] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Lorna Bailey, Tim Levine, Steve Moss, Minoo Razi and the Futter laboratory and Institute of Ophthalmology EM unit members for technical help and advice. This work was funded by the Wellcome Trust (078304) and Cancer Research UK (C20675).	Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966	35	234	237	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					267	U64		10.1038/ncb2026	http://dx.doi.org/10.1038/ncb2026			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118922				2022-12-27	WOS:000275054200012
J	Ashida, H; Kim, M; Schmidt-Supprian, M; Ma, A; Ogawa, M; Sasakawa, C				Ashida, Hiroshi; Kim, Minsoo; Schmidt-Supprian, Marc; Ma, Averil; Ogawa, Michinaga; Sasakawa, Chihiro			A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKK gamma to dampen the host NF-kappa B-mediated inflammatory response	NATURE CELL BIOLOGY			English	Article							DEPENDENT GENE-EXPRESSION; IMMUNE-RESPONSES; POLYUBIQUITIN CHAINS; PROTEIN; ACTIVATION; SYSTEM; BINDS; DISCRIMINATION; RECOGNITION; EFFECTORS	NF-kappa B (nuclear factor kappa B) has a pivotal role in many cellular processes, including the inflammatory and immune responses and, therefore, its activation is tightly regulated by the IKK (I kappa B kinase) complex and by I kappa B alpha degradation. When Shigella bacteria multiply within epithelial cells they release peptidoglycans, which are recognized by Nod1 and stimulate the NF-kappa B pathway, thus leading to a severe inflammatory response. Here, we show that IpaH9.8, a Shigella effector possessing E3 ligase activity, dampens the NF-kappa B-mediated inflammatory response to the bacterial infection in a unique way. IpaH9.8 interacts with NEMO/IKK gamma and ABIN-1, a ubiquitin-binding adaptor protein, promoting ABIN-1-dependent polyubiquitylation of NEMO. Consequently, polyubiquitylated NEMO undergoes proteasome-dependent degradation, which perturbs NF-kappa B activation. As NEMO is essential for NF-kappa B activation, we propose that the polyubiquitylation and degradation of NEMO during Shigella infection is a new bacterial strategy to modulate host inflammatory responses.	[Ashida, Hiroshi; Ogawa, Michinaga; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, Tokyo 1088639, Japan; [Ashida, Hiroshi; Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Tokyo; University of Tokyo; Max Planck Society; University of California System; University of California San Francisco	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Kim, Minsoo/0000-0001-8536-8653	The Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST);  [20229006];  [20659067];  [18073003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	The Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Sasakawa laboratory for their advice. This work was supported by Grand-in-Aid for Scientific Research (S) (20229006); a Grand-in-Aid for Exploratory Research (20659067); a Grant-in-Aid for Scientific Research on Priority Areas (18073003); the Strategic Cooperation to Control Emerging and Reemerging Infections Funded by The Special Coordination Funds for Promoting Science and Technology; and a Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; WAGNER S, 2008, ONCOGENE, V21, P1; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	34	192	201	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					66	U164		10.1038/ncb2006	http://dx.doi.org/10.1038/ncb2006			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010814	Green Accepted			2022-12-27	WOS:000272973800014
J	Natarajan, P; Liu, K; Patil, DV; Sciorra, VA; Jackson, CL; Graham, TR				Natarajan, Paramasivam; Liu, Ke; Patil, Dustin V.; Sciorra, Vicki A.; Jackson, Catherine L.; Graham, Todd R.			Regulation of a Golgi flippase by phosphoinositides and an ArfGEF	NATURE CELL BIOLOGY			English	Article							P-TYPE ATPASE; BINDING-PROTEIN HOMOLOG; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; AMINOPHOSPHOLIPID TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; MEMBRANE DYNAMICS; IN-VIVO; TRAFFICKING; SECRETION; COMPLEX	The essential role for phosphatidylinositol-4-phosphate (PtdIns(4)P) in vesicle-mediated protein transport from the trans-Golgi network (TGN) was first described in the budding yeast Saccharomyces cerevisiae(1-3). However, the identity of downstream effectors of PtdIns( 4) P in this system has been elusive. Here, we show that Drs2p, a type IV P-type ATPase required for phospholipid translocase ( flippase) activity and transport vesicle budding from the TGN(4-8), is an effector of PtdIns(4) P. Drs2p-dependent flip of a fluorescent phosphatidylserine analogue across purified TGN membranes requires synthesis of PtdIns(4) P by the phosphatidylinositol-4-kinase (PI(4)K) Pik1p. PtdIns(4) P binds to a regulatory domain in the C-terminal tail of Drs2p that has homology to a split PH domain and is required for Drs2p activity. In addition, basic residues required for phosphoinositide binding overlap a previously mapped binding site for the ArfGEF Gea2p(9). ArfGEF binding to this C-terminal domain also stimulates flippase activity in TGN membrane preparations. These interactions suggest the presence of a coincidence detection system used to activate phospholipid translocation at sites of vesicle formation.	[Natarajan, Paramasivam; Liu, Ke; Patil, Dustin V.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sciorra, Vicki A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jackson, Catherine L.] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Vanderbilt University; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Jackson, Catherine/A-3421-2013; Jackson, Catherine/T-5688-2019	Jackson, Catherine/0000-0002-0843-145X; Patil, Dustin/0000-0003-0587-0139	NIH [GM62367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ACKNOWLEDGEMENTS We thank Scott D. Emr and Anjon Audhya for yeast strains, John York for providing the GST-Inp53-Sac1 plasmid, Jonathan Goldberg for the His-Gea2p-Sec7 plasmid and our lab colleagues for comments on this manuscript. These studies were supported by NIH Grant GM62367 ( to T. R. G.)	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2006, METHODS, V39, P163, DOI 10.1016/j.ymeth.2006.05.009; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2	32	89	92	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1421	U73		10.1038/ncb1989	http://dx.doi.org/10.1038/ncb1989			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898464	Green Accepted			2022-12-27	WOS:000272251300007
J	Lee, YS; Pressman, S; Andress, AP; Kim, K; White, JL; Cassidy, JJ; Li, X; Lubell, K; Lim, DH; Cho, IS; Nakahara, K; Preall, JB; Bellare, P; Sontheimer, EJ; Carthew, RW				Lee, Young Sik; Pressman, Sigal; Andress, Arlise P.; Kim, Kevin; White, Jamie L.; Cassidy, Justin J.; Li, Xin; Lubell, Kim; Lim, Do Hwan; Cho, Ik Sang; Nakahara, Kenji; Preall, Jonathan B.; Bellare, Priya; Sontheimer, Erik J.; Carthew, Richard W.			Silencing by small RNAs is linked to endosomal trafficking	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNAS; DROSOPHILA; BIOGENESIS; MICRORNAS; COMPLEXES; PROTEIN; MECHANISMS; ORGANELLES; DEFICIENT; UBIQUITIN	Small RNAs direct RNA-induced silencing complexes (RISCs) to regulate stability and translation of mRNAs(1,2). RISCs associated with target mRNAs often accumulate in discrete cytoplasmic foci known as GW-bodies(3). However, RISC proteins can associate with membrane compartments such as the Golgi and endoplasmic reticuium(4). Here, we show that GW-bodies are associated with late endosomes (multivesicular bodies, MVBs). Blocking the maturation of MVBs into lysosomes by loss of the tethering factor HPS4 (ref. 5) enhances short interfering RNA (siRNA)- and micro RNA (miRNA)-mediated silencing in Drosophila melanogaster and humans. It also triggers over-accumulation of GW-bodies. Blocking MVB formation by ESCRT (endosomal sorting complex required for transport)6 depletion results in impaired miRNA silencing and loss of GW-bodies. These results indicate that active RISCs are physically and functionally coupled to MVBs. We further show that MVBs promote the competence of RISCs in loading small RNAs. We suggest that the recycling of RISCs is promoted by MVBs, resulting in RISCs more effectively engaging with small RNA effectors and possibly target RNAs. It may provide a means to enhance the dynamics of RNA silencing in the cytoplasm.	[Lee, Young Sik; Pressman, Sigal; Andress, Arlise P.; Kim, Kevin; White, Jamie L.; Cassidy, Justin J.; Li, Xin; Lubell, Kim; Nakahara, Kenji; Preall, Jonathan B.; Bellare, Priya; Sontheimer, Erik J.; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60201 USA; [Lee, Young Sik; Lim, Do Hwan; Cho, Ik Sang] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136713, South Korea; [Li, Xin] NYU, Dept Biol, New York, NY 10003 USA; [Bellare, Priya] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Northwestern University; Korea University; New York University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lee, YS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60201 USA.	ys-lee@korea.ac.kr; r-carthew@northwestern.edu	Lim, Dohwan/ABA-2685-2020; Li, Xin/D-3421-2013; Nakahara, Kenji/F-5780-2012	Li, Xin/0000-0002-3428-3569; Nakahara, Kenji/0000-0002-9541-3208; Lim, Do-Hwan/0000-0002-2054-1416; Sontheimer, Erik/0000-0002-0881-0310	FRAXA; CMBD; National Institutes of Health [GM072830, GM77581, GM68743]; Korean BioGreen 21 Program [2007030103403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743, R01GM072830, R01GM077581] Funding Source: NIH RePORTER	FRAXA; CMBD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Cagan, H. Folsch, P. Sharp, G. J. Hannon, Q. Liu, X. Wang, C. Horvath, G. Goshima, V. Helfand, M. Lowe, I. Hariharan, D. Bilder, J. Treisman, M. Siomi and J. Pham for reagents; H. Folsch, I. Fields, A. Komuro, and D. Harris for help with some of the experiments; H. Jiang for help with statistics and the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly strains and antibodies. Y.S.L. was supported by a FRAXA postdoctoral Fellowship; J.J.C. was supported by the CMBD Training Grant and J.B.P. was supported by a Presidential Fellowship. This work was also supported by grants from the National Institutes of Health to E.J.S. (GM072830) and R.W.C. (GM77581, GM68743), and from a grant from the Korean BioGreen 21 Program to Y.S.L. (20070301034036).	Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fielenbach N, 2007, DEV CELL, V12, P443, DOI 10.1016/j.devcel.2007.01.018; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Lin MD, 2008, DEV BIOL, V322, P276, DOI 10.1016/j.ydbio.2008.07.033; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Nguyen T, 2007, J INVEST DERMATOL, V127, P421, DOI 10.1038/sj.jid.5700566; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	262	277	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1150	U243		10.1038/ncb1930	http://dx.doi.org/10.1038/ncb1930			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684574	Green Accepted			2022-12-27	WOS:000269482500018
J	Wignall, SM; Villeneuve, AM				Wignall, Sarah M.; Villeneuve, Anne M.			Lateral microtubule bundles promote chromosome alignment during acentrosomal oocyte meiosis	NATURE CELL BIOLOGY			English	Article							MEIOTIC SPINDLE FORMATION; CAENORHABDITIS-ELEGANS; KINASE AIR-2; FUNCTIONAL-ANALYSIS; MITOTIC SPINDLE; KINETOCHORE; KINESIN; SEGREGATION; MECHANISMS; ATTACHMENT	Although centrosomes serve to organize microtubules in most cell types, oocyte spindles form and mediate meiotic chromosome segregation in their absence. Here, we used high-resolution imaging of both bipolar and experimentally generated monopolar spindles in Caenorhabditis elegans to reveal a surprising organization of microtubules and chromosomes within acentrosomal structures. We found that homologous chromosome pairs (bivalents) are surrounded by microtubule bundles running along their sides, whereas microtubule density is extremely low at chromosome ends despite a high concentration of kinetochore proteins at those regions. Furthermore, we found that the chromokinesin KLP-19 (kinesin-like protein 19) is targeted to a ring around the centre of each bivalent and provides a polar ejection force that is required for congression. Together, these observations create a new picture of chromosome-microtubule association in acentrosomal spindles and reveal a mechanism by which metaphase alignment can be achieved using this organization. Specifically, we propose that ensheathment by lateral microtubule bundles places spatial constraints on the chromosomes, thereby promoting biorientation, and that localized motors mediate movement along these bundles, thereby promoting alignment.	[Wignall, Sarah M.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wignall, Sarah M.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Wignall, SM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	swignall@stanford.edu; villen@cmgm.stanford.edu	Wignall, Sadie/AHD-0715-2022	Wignall, Sadie/0000-0001-9828-9356	NIGMS NIH HHS [R01 GM053804-11, R01 GM053804-10, R01 GM053804-13, R01 GM053804, R01 GM053804-14, R01 GM53804, R01 GM053804-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Jang JK, 2007, GENETICS, V177, P267, DOI 10.1534/genetics.107.076091; Jang JK, 2005, MOL BIOL CELL, V16, P4684, DOI 10.1091/mbc.E04-11-0964; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; MAINS PE, 1990, GENETICS, V126, P593; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Srayko M, 2000, GENE DEV, V14, P1072; Stiernagle Theresa, 2006, WormBook, P1; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643	45	102	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					839	U135		10.1038/ncb1891	http://dx.doi.org/10.1038/ncb1891			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525937	Green Accepted			2022-12-27	WOS:000267603100012
J	Brandt, DT; Baarlink, C; Kitzing, TM; Kremmer, E; Ivaska, J; Nollau, P; Grosse, R				Brandt, Dominique T.; Baarlink, Christian; Kitzing, Thomas M.; Kremmer, Elisabeth; Ivaska, Johanna; Nollau, Peter; Grosse, Robert			SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta(1)-integrin	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; SRF ACTIVITY; MIGRATION; INTEGRIN; DYNAMICS; DIA1; BETA-1-INTEGRIN; COACTIVATOR; METASTASIS; MECHANISMS	Gene expression reprogramming governs cellular processes such as proliferation, differentiation and cell migration through the complex and tightly regulated control of transcriptional cofactors that exist in multiprotein complexes. Here we describe SCAI (suppressor of cancer cell invasion), a novel and highly conserved protein that regulates invasive cell migration through three-dimensional matrices. SCAI acts on the RhoA-Dia1 signal transduction pathway and localizes in the nucleus, where it binds and inhibits the myocardin-related transcription factor MAL by forming a ternary complex with serum response factor (SRF). Genomewide expression analysis surprisingly reveals that one of the strongest upregulated genes after suppression of SCAI is beta(1)-integrin. Decreased levels of SCAI are tightly correlated with increased invasive cell migration, and SCAI is downregulated in several human tumours. Functional analysis of the beta(1)-integrin gene strongly argues that SCAI is a novel transcriptional cofactor that controls gene expression downstream of Dia1 to dictate changes in cell invasive behaviour.	[Brandt, Dominique T.; Baarlink, Christian; Kitzing, Thomas M.; Grosse, Robert] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Ivaska, Johanna] VTT Tech Res Ctr Finland, FIN-20520 Turku, Finland; [Ivaska, Johanna] Univ Turku, FIN-20520 Turku, Finland; [Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Ctr Clin Pathol, Dept Clin Chem, D-20246 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; VTT Technical Research Center Finland; University of Turku; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grosse, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	robert.grosse@pharma.uni-heidelberg.de		Ivaska, Johanna/0000-0002-6295-6556; Grosse, Robert/0000-0002-3380-5273	Emmy Noether Program of the Deutsche Forschungsgemeinschaft [GR 2111/1-3]; Wilhelm Sander-Stiftung [2008.020.1]; CHS Foundation; EMBO Young Investigator Program; Academy of Finland; European Research Council	Emmy Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; CHS Foundation; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	We thank B. Di Ventura and W. Birchmeier for critical reading, and R. Treisman and T. Worzfeld for stimulating discussions. We are grateful to A. Ripperger, K. Reeck and G. Streichert for technical assistance, and U. Engel at the Nikon Imaging Center for imaging advice. This work was funded by the Emmy Noether Program of the Deutsche Forschungsgemeinschaft (GR 2111/1-3) and the Wilhelm Sander-Stiftung (2008.020.1) to R. G. R. G. is a member of the excellence cluster Cellular Networks and supported by the CHS Foundation. J. I. is supported by the EMBO Young Investigator Program, Academy of Finland, and the European Research Council.	Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05	32	99	108	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					557	U83		10.1038/ncb1862	http://dx.doi.org/10.1038/ncb1862			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19350017				2022-12-27	WOS:000265640000015
J	Matsunaga, K; Saitoh, T; Tabata, K; Omori, H; Satoh, T; Kurotori, N; Maejima, I; Shirahama-Noda, K; Ichimura, T; Isobe, T; Akira, S; Noda, T; Yoshimori, T				Matsunaga, Kohichi; Saitoh, Tatsuya; Tabata, Keisuke; Omori, Hiroko; Satoh, Takashi; Kurotori, Naoki; Maejima, Ikuko; Shirahama-Noda, Kanae; Ichimura, Tohru; Isobe, Toshiaki; Akira, Shizuo; Noda, Takeshi; Yoshimori, Tamotsu			Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; SACCHAROMYCES-CEREVISIAE; TUMOR-SUPPRESSOR; CELL-DEATH; RETROGRADE TRANSPORT; NERVOUS-SYSTEM; MEMBRANE; YEAST; UVRAG; TUMORIGENESIS	Beclin 1, a protein essential for autophagy, binds to hVps34/Class III phosphatidylinositol-3-kinase and UVRAG. Here, we have identified two Beclin 1 associated proteins, Atg14L and Rubicon. Atg14L and UVRAG bind to Beclin 1 in a mutually exclusive manner, whereas Rubicon binds only to a subpopulation of UVRAG complexes; thus, three different Beclin 1 complexes exist. GFP- Atg14L localized to the isolation membrane and autophagosome, as well as to the ER and unknown puncta. Knockout of Atg14L in mouse ES cells caused a defect in autophagosome formation. GFP-Rubicon was localized at the endosome/lysosome. Knockdown of Rubicon caused enhancement of autophagy, especially at the maturation step, as well as enhancement of endocytic trafficking. These data suggest that the Beclin 1-hVps34 complex functions in two different steps of autophagy by altering the subunit composition.	[Matsunaga, Kohichi; Tabata, Keisuke; Omori, Hiroko; Kurotori, Naoki; Maejima, Ikuko; Shirahama-Noda, Kanae; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Matsunaga, Kohichi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4558540, Japan; [Saitoh, Tatsuya; Satoh, Takashi; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Ichimura, Tohru; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan; [Yoshimori, Tamotsu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Graduate University for Advanced Studies - Japan; Osaka University; Osaka University; Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Yoshimori, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tamyoshi@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Isobe, Toshiaki/Q-9279-2017; Yoshimori, Tamotsu/K-9626-2014; Noda, Takeshi/B-7240-2008	Yoshimori, Tamotsu/0000-0001-9787-3788; Noda, Takeshi/0000-0003-3581-7961; Tabata, Keisuke/0000-0001-6776-1689; MAEJIMA, Ikuko/0000-0002-0396-5890	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Beth Levine for Beclin 1 cDNA, Noboru Mizushima for anti-Atg16L antibody and Atg5 knockout mouse ES cells, Sumio Sugano and Yutaka Suzuki for UVRAG cDNA, Toshio Kitamura for PLAT-E cells and pMX-puro vector, Roger Y. Tesien for the plasmid encoding mStrawberry protein, Ryuichi Masaki for pEGFP-msALDH(35) vector, Yusuke Yamada for Beclin 1 deletion mutants cDNA construction, Asaya Nishi and Kunihiro Kawanishi for technical assistance. The work described in this report was supported in part by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gniadek TJ, 2007, TRAFFIC, V8, P339, DOI 10.1111/j.1600-0854.2007.00538.x; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; James P, 1996, GENETICS, V144, P1425; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kikuno R, 2002, NUCLEIC ACIDS RES, V30, P166, DOI 10.1093/nar/30.1.166; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Masaki R, 2003, J BIOCHEM, V134, P415, DOI 10.1093/jb/mvg159; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	55	838	901	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					385	U69		10.1038/ncb1846	http://dx.doi.org/10.1038/ncb1846			39	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270696				2022-12-27	WOS:000265264900009
J	Kobayashi, K; Luo, M; Zhang, Y; Wilkes, DC; Ge, GX; Grieskamp, T; Yamada, C; Liu, TC; Huang, G; Basson, CT; Kispert, A; Greenspan, DS; Sato, TN				Kobayashi, Koichi; Luo, Min; Zhang, Yue; Wilkes, David C.; Ge, Gaoxiang; Grieskamp, Thomas; Yamada, Chikaomi; Liu, Ting-Chun; Huang, Guorui; Basson, Craig T.; Kispert, Andreas; Greenspan, Daniel S.; Sato, Thomas N.			Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-1; XENOPUS EMBRYOS; WNT ANTAGONIST; TISSUE; GROWTH; CELLS; MICE; METALLOPROTEINASES; INHIBITORS; EXPRESSION	Secreted Frizzled-related proteins (sFRPs) have emerged as key regulators of a wide range of developmental and disease processes. Most of the known functions of mammalian sFRPs have been attributed to their ability to antagonize Wnt signalling. Recently however, Xenopus laevis and zebrafish sFRP, Sizzled, was shown to function as an antagonist of Chordin processing by Tolloid-like metalloproteinases. This has led to the proposal that sFRPs may function as evolutionarily conserved antagonists of chordinase activities of this class of proteinases. In contrast to this proposal, we show here that the mammalian sFRP, sFRP2, does not affect Chordin processing, but instead, can serve as a direct enhancer of procollagen C proteinase activity of Tolloid-like metalloproteinases. We also show that the level of fibrosis, in which procollagen processing by Tolloid-like proteinases has a rate-limiting role, is markedly reduced in Sfrp2-null mice subjected to myocardial infarction. Importantly, this reduced level of fibrosis is accompanied by significantly improved cardiac function. This study thus uncovers a function for sFRP2 and a potential therapeutic application for sFRP2 antagonism in controlling fibrosis in the infarcted heart.	[Zhang, Yue; Greenspan, Daniel S.] Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; [Ge, Gaoxiang; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Ge, Gaoxiang; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Kobayashi, Koichi; Luo, Min; Wilkes, David C.; Yamada, Chikaomi; Liu, Ting-Chun; Basson, Craig T.; Sato, Thomas N.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Wilkes, David C.; Basson, Craig T.] Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY USA; [Wilkes, David C.; Basson, Craig T.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; [Grieskamp, Thomas; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Cornell University; Cornell University; Cornell University; Hannover Medical School	Greenspan, DS (corresponding author), Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA.	dsgreens@wisc.edu; island1005@aol.com	Huang, Guorui/M-9641-2013; Kobayashi, Koichi/M-4911-2014	Greenspan, Daniel/0000-0001-8096-7446	German Research Foundation (DFG); European Union FP6 [LSHM-CT-2005-018630]; Snart Cardiovascular Fund; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union FP6(European Commission); Snart Cardiovascular Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Kuangfu Hsiao, Patricia Cobo and Guy Hoffman for technical assistance, and Tony Brown (Cornell) for providing information regarding qPCR primers for Wnt genes. K. K. and M. L. would like to acknowledge Rosemary Kraemer's teaching of technical procedures for the mouse myocardial infarction model. Work in the laboratory of A. K. is supported by funding from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (from Regenerative Biology of Reconstructive Therapy), and by the European Union FP6 contract 'Heart Repair' (LSHM-CT-2005-018630). C. T. B. is an Established Investigator of the American Heart Association and is supported by the Snart Cardiovascular Fund. This work was supported in part by grants from the NIH (C.T.B,D.S.G,T.N.S).	Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; BERG RA, 1982, METHOD ENZYMOL, V82, P372; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dufourcq P, 2002, CIRCULATION, V106, P3097, DOI 10.1161/01.CIR.0000039342.85015.5C; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Garrigue-Antar L, 2004, J BIOL CHEM, V279, P49835, DOI 10.1074/jbc.M408134200; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Lee CS, 2000, DEVELOPMENT, V127, P109; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Mayr T, 1997, MECH DEVELOP, V63, P109, DOI 10.1016/S0925-4773(97)00035-X; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Salic AN, 1997, DEVELOPMENT, V124, P4739; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	53	179	187	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					46	U90		10.1038/ncb1811	http://dx.doi.org/10.1038/ncb1811			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079247	Green Accepted			2022-12-27	WOS:000262157000010
J	Hansen, KH; Bracken, AP; Pasini, D; Dietrich, N; Gehani, SS; Monrad, A; Rappsilber, J; Lerdrup, M; Helin, K				Hansen, Klaus H.; Bracken, Adrian P.; Pasini, Diego; Dietrich, Nikolaj; Gehani, Simmi S.; Monrad, Astrid; Rappsilber, Juri; Lerdrup, Mads; Helin, Kristian			A model for transmission of the H3K27me3 epigenetic mark	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; CELL FATE; LYSINE 9; POLYCOMB; H3; PROTEINS; JMJD3; SUZ12; EZH2	Organization of chromatin by epigenetic mechanisms is essential for establishing and maintaining cellular identity in developing and adult organisms. A key question that remains unresolved about this process is how epigenetic marks are transmitted to the next cell generation during cell division. Here we provide a model to explain how trimethylated Lys 27 of histone 3 (H3K27me3), which is catalysed by the EZH2-containing Polycomb Repressive Complex 2 (PRC2), is maintained in proliferating cells. We show that the PRC2 complex binds to the H3K27me3 mark and colocalizes with this mark in G1 phase and with sites of ongoing DNA replication. Efficient binding requires an intact trimeric PRC2 complex containing EZH2, EED and SUZ12, but is independent of the catalytic SET domain of EZH2. Using a heterologous reporter system, we show that transient recruitment of the PRC2 complex to chromatin, upstream of the transcriptional start site, is sufficient to maintain repression through endogenous PRC2 during subsequent cell divisions. Thus, we suggest that once the H3K27me3 is established, it recruits the PRC2 complex to maintain the mark at sites of DNA replication, leading to methylation of H3K27 on the daughter strands during incorporation of newly synthesized histones. This mechanism ensures maintenance of the H3K27me3 epigenetic mark in proliferating cells, not only during DNA replication when histones synthesized de novo are incorporated, but also outside S phase, thereby preserving chromatin structure and transcriptional programs.	[Hansen, Klaus H.; Bracken, Adrian P.; Pasini, Diego; Dietrich, Nikolaj; Gehani, Simmi S.; Monrad, Astrid; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Rappsilber, Juri] Univ Edinburgh, Welcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lerdrup, Mads] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Edinburgh; University of Copenhagen	Hansen, KH (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	klaus.hansen@bric.dk; kristian.helin@bric.dk	Rappsilber, Juri/ABF-3328-2020; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Pasini, Diego/J-9674-2012; Rappsilber, Juri/B-7265-2015	Helin, Kristian/0000-0003-1975-6097; Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Lerdrup, Mads/0000-0002-7730-8973; Hansen, Klaus/0000-0001-9657-8816; Bracken, Adrian/0000-0002-1547-9443	Novo Nordisk Foundation; Association for International Cancer Research; Danish Cancer Society; Danish Medical Research Council; Danish Natural Science Research Council; Danish National Research Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Association for International Cancer Research; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank Danny Reinberg for providing the 5xGal4TKLucNeo reporter plasmid. We thank members of the Helin laboratory for technical advice and fruitful discussion. This work was supported by grants from the Novo Nordisk Foundation, Association for International Cancer Research, the Danish Cancer Society, the Danish Medical Research Council, the Danish Natural Science Research Council and the Danish National Research Foundation.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; DIETRICH N, 2007, EMBO J; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572	44	540	544	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1291	U89		10.1038/ncb1787	http://dx.doi.org/10.1038/ncb1787			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931660				2022-12-27	WOS:000260586700011
J	Ng, RK; Dean, W; Dawson, C; Lucifero, D; Madeja, Z; Reik, W; Hemberger, M				Ng, Ray Kit; Dean, Wendy; Dawson, Claire; Lucifero, Diana; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam			Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTOR; MOUSE EMBRYO; TROPHECTODERM; DIFFERENTIATION; EXPRESSION; MASS; UNDERMETHYLATION; EOMESODERMIN	Mouse ES cells can differentiate into all three germ layers of the embryo but are generally excluded from the trophoblast lineage. Here we show that ES cells deficient in DNA methylation can differentiate efficiently into trophoblast derivatives. In a genome-wide screen we identified the transcription factor Elf5 as methylated and repressed in ES cells, and hypomethylated and expressed in TS and methylation-deficient ES cells. Elf5 creates a positive-feedback loop with the TS cell determinants Cdx2 and Eomes that is restricted to the trophoblast lineage by epigenetic regulation of Elf5. Importantly, the late-acting function of Elf5 allows initial plasticity and regulation in the early blastocyst. Thus, Elf5 functions as a gatekeeper, downstream of initial lineage determination, to reinforce commitment to the trophoblast lineage or to abort this pathway in epiblast cells. This epigenetic restriction of cell lineage fate provides a molecular mechanism for Waddington's concept of canalization of developmental pathways.	[Ng, Ray Kit; Dean, Wendy; Dawson, Claire; Lucifero, Diana; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Ng, Ray Kit; Madeja, Zofia; Reik, Wolf; Hemberger, Myriam] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Hemberger, M (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	myriam.hemberger@bbsrc.ac.uk	Dean, Wendy/GSE-3948-2022; Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Hemberger, Myriam/0000-0003-3332-6958; Dean, Wendy/0000-0001-9441-5044; Madeja, Zofia Eliza/0000-0001-9649-2422	MRC Career Development Award; Croucher Foundation; BBSRC; MRC; EU NoE The Epigenome; CellCentric; DIUS; BBSRC [BBS/E/B/0000C225] Funding Source: UKRI; MRC [G0300723, G0400154, G0700098, G120/824] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C225, BBS/E/B/0000M100] Funding Source: researchfish; Medical Research Council [G120/824, G0700098, G0400154, G0300723] Funding Source: researchfish	MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Croucher Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; CellCentric; DIUS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Fatima Santos and Annabelle Lewis for expert help with confocal microscopy and qPCR design, respectively. We also thank En Li for Dnmt1<SUP>-</SUP> mice and ES cells, and Haruhiko Koseki, Nick Gilbert and David Skalnik for ES cell lines. This work was supported by an MRC Career Development Award to M. H., by the Croucher Foundation Fellowship to R. K. N., and by BBSRC, MRC, EU NoE The Epigenome, CellCentric, and DIUS.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Choi YS, 2006, BIOCHEM J, V398, P497, DOI 10.1042/BJ20060375; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DYCE J, 1987, DEVELOPMENT, V100, P685; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; GARDNER RL, 1985, PHILOS T R SOC B, V312, P163, DOI 10.1098/rstb.1985.0186; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Lei H, 1996, DEVELOPMENT, V122, P3195; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Metzger DE, 2007, DEV DYNAM, V236, P1175, DOI 10.1002/dvdy.21133; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; ROSSANT J, 1980, DEV BIOL, V76, P475, DOI 10.1016/0012-1606(80)90395-4; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sambrook J., 2001, MOL CLONING LAB MANU; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Uy GD, 2002, DEVELOPMENT, V129, P3913; Waddington C.H., 1940, ORG GENES; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	46	251	256	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1280	U68		10.1038/ncb1786	http://dx.doi.org/10.1038/ncb1786			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836439	Green Accepted			2022-12-27	WOS:000260586700010
J	Winter, M; Sombroek, D; Dauth, I; Moehlenbrink, J; Scheuermann, K; Crone, J; Hofmann, TG				Winter, Melanie; Sombroek, Dirk; Dauth, Ilka; Moehlenbrink, Jutta; Scheuermann, Karin; Crone, Johanna; Hofmann, Thomas G.			Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR	NATURE CELL BIOLOGY			English	Article							HOMEODOMAIN-INTERACTING PROTEIN-KINASE-2; CELL-CYCLE CHECKPOINTS; PROTEIN KINASE-2; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; P53 PHOSPHORYLATION; IONIZING-RADIATION; NUCLEAR-BODIES; TRANSCRIPTION; DEGRADATION	The tumour suppressor HIPK2 is an important regulator of cell death induced by DNA damage, but how its activity is regulated remains largely unclear. Here we demonstrate that HIPK2 is an unstable protein that colocalizes and interacts with the E3 ubiquitin ligase Siah-1 in unstressed cells. Siah-1 knockdown increases HIPK2 stability and steady-state levels, whereas Siah-1 expression facilitates HIPK2 polyubiquitination, degradation and thereby inactivation. During recovery from sublethal DNA damage, HIPK2, which is stabilized on DNA damage, is degraded through a Siah-1-dependent, p53-controlled pathway. Downregulation of Siah-1 inhibits HIPK2 degradation and recovery from damage, driving the cells into apoptosis. We have also demonstrated that DNA damage triggers disruption of the HIPK2-Siah-1 complex, resulting in HIPK2 stabilization and activation. Disruption of the HIPK2-Siah-1 complex is mediated by the ATM/ATR pathway and involves ATM/ATR-dependent phosphorylation of Siah-1 at Ser 19. Our results provide a molecular framework for HIPK2 regulation in unstressed and damaged cells.	[Winter, Melanie; Sombroek, Dirk; Dauth, Ilka; Moehlenbrink, Jutta; Scheuermann, Karin; Crone, Johanna; Hofmann, Thomas G.] German Canc Res Ctr, Cellular Senescence Grp, DKFZ, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hofmann, TG (corresponding author), German Canc Res Ctr, Cellular Senescence Grp, DKFZ, Im Neuenheimer Feld 242, D-69120 Heidelberg, Germany.	t.hofmann@dkfz.de						Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hofmann TG, 2005, J BIOL CHEM, V280, P29224, DOI 10.1074/jbc.M503921200; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hofmann TG, 2000, ONCOGENE, V19, P1153, DOI 10.1038/sj.onc.1203406; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; LUNA RMD, 1995, NATURE, V378, P203; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Moller A, 2003, CANCER RES, V63, P4310; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	50	156	159	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					812	824		10.1038/ncb1743	http://dx.doi.org/10.1038/ncb1743			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18536714				2022-12-27	WOS:000257268400011
J	Fukuhara, S; Sako, K; Minami, T; Noda, K; Kim, HZ; Kodama, T; Shibuya, M; Takakura, N; Koh, GY; Mochizuki, N				Fukuhara, Shigetomo; Sako, Keisuke; Minami, Takashi; Noda, Kazuomi; Kim, Hak Zoo; Kodama, Tatsuhiko; Shibuya, Masabumi; Takakura, Nobuyuki; Koh, Gou Young; Mochizuki, Naoki			Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1	NATURE CELL BIOLOGY			English	Article							VASCULAR ENDOTHELIAL CADHERIN; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; ADULT VASCULATURE; PLASMA LEAKAGE; GROWTH-FACTORS; IN-VIVO; ANGIOGENESIS; ACTIVATION; PROTEIN	Tie2 belongs to the receptor tyrosine kinase family and functions as a receptor for Angiopoietin-1 (Ang1). Gene-targeting analyses of either Ang1 or Tie2 in mice reveal a critical role of Ang1-Tie2 signalling in developmental vascular formation. It remains elusive how the Tie2 signalling pathway plays distinct roles in both vascular quiescence and angiogenesis. We demonstrate here that Ang1 bridges Tie2 at cell-cell contacts, resulting in trans-association of Tie2 in the presence of cell-cell contacts. In clear contrast, in isolated cells, extracellular matrix-bound Ang1 locates Tie2 at cell-substratum contacts. Furthermore, Tie2 activated at cell-cell or cell-substratum contacts leads to preferential activation of Akt and Erk, respectively. Microarray analyses and real-time PCR validation clearly show the differential gene expression profile in vascular endothelial cells upon Ang1 stimulation in the presence or absence of cell-cell contacts, implying downstream signalling is dependent upon the spatial localization of Tie2.	[Fukuhara, Shigetomo; Sako, Keisuke; Noda, Kazuomi; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Minami, Takashi; Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kim, Hak Zoo; Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Kim, Hak Zoo; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Res Inst Microbial Dis, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; University of Tokyo; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of Tokyo; Osaka University	Fukuhara, S (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Koh, Gou Young/C-1615-2011	sako, keisuke/0000-0002-6453-8075				Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Aplin AE, 1999, J BIOL CHEM, V274, P31223, DOI 10.1074/jbc.274.44.31223; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Lin PN, 1998, P NATL ACAD SCI USA, V95, P8829, DOI 10.1073/pnas.95.15.8829; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoon M, 2003, BIOCHEM BIOPH RES CO, V308, P101, DOI 10.1016/S0006-291X(03)01341-X; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zanetti A, 2002, ARTERIOSCL THROM VAS, V22, P617, DOI 10.1161/01.ATV.0000012268.84961.AD	47	275	290	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					513	526		10.1038/ncb1714	http://dx.doi.org/10.1038/ncb1714			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425120				2022-12-27	WOS:000255502400008
J	Omori, Y; Zhao, CT; Saras, A; Mukhopadhyay, S; Kim, W; Furukawa, T; Sengupta, P; Veraksa, A; Malicki, J				Omori, Yoshihiro; Zhao, Chengtian; Saras, Arunesh; Mukhopadhyay, Saikat; Kim, Woong; Furukawa, Takahisa; Sengupta, Piali; Veraksa, Alexey; Malicki, Jarema			elipsa is an early determinant of ciliogenesis that links the IFT particle to membrane-associated small GTPase Rab8	NATURE CELL BIOLOGY			English	Article							MUTATIONS AFFECTING DEVELOPMENT; INTRAFLAGELLAR TRANSPORT; CAENORHABDITIS-ELEGANS; SENSORY CILIA; ZEBRAFISH RETINA; PROTEIN; NEURONS; GENES; COMPLEX; FUSION	The formation and function of cilia involves the movement of intraflagellar transport ( IFT) particles underneath the ciliary membrane, along axonemal microtubules(1,2). Although this process has been studied extensively, its molecular basis remains incompletely understood. For example, it is unknown how the IFT particle interacts with transmembrane proteins. To study the IFT particle further, we examined elipsa, a locus characterized by mutations that cause particularly early ciliogenesis defects in zebrafish. We show here that elipsa encodes a coiled-coil polypeptide that localizes to cilia. Elipsa protein binds to ift20, a component of IFT particles, and Elipsa homologue in Caenorhabditis elegans, DYF-11, translocates in sensory cilia, similarly to the IFT particle. This indicates that Elipsa is an IFT particle polypeptide. In the context of zebrafish embryogenesis, Elipsa interacts genetically with Rabaptin5, a well-studied regulator of endocytosis, which in turn interacts with Rab8, a small GTPase, known to localize to cilia. We show that Rabaptin5 binds to both Elipsa and Rab8, suggesting that these proteins provide a bridging mechanism between the IFT particle and protein complexes that assemble at the ciliary membrane.	[Omori, Yoshihiro; Zhao, Chengtian; Saras, Arunesh; Malicki, Jarema] Harvard Univ, Sch Med, Dept Ophthalmol, MEEI, Boston, MA 02114 USA; [Mukhopadhyay, Saikat; Kim, Woong; Sengupta, Piali] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Mukhopadhyay, Saikat; Kim, Woong; Sengupta, Piali] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Veraksa, Alexey] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Brandeis University; Brandeis University; University of Massachusetts System; University of Massachusetts Boston	Malicki, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, MEEI, R513,243 Charles St, Boston, MA 02114 USA.	jarema_malicki@meei.harvard.ed	malicki, jarema/G-8611-2014	malicki, jarema/0000-0002-5947-8805; Mukhopadhyay, Saikat/0000-0003-4790-3090; Veraksa, Alexey/0000-0003-2920-080X	NEI NIH HHS [P30EY14104, R01 EY11882, R01 EY016859] Funding Source: Medline; NIDCD NIH HHS [R01 DC005103] Funding Source: Medline; NINDS NIH HHS [P30 NS44232] Funding Source: Medline; PHS HHS [R01 56223] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011882, R01EY016859, P30EY014104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005103] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Brand M, 1996, DEVELOPMENT, V123, P129; Colbert HA, 1997, J NEUROSCI, V17, P8259; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kunitomo H, 2008, GENES CELLS, V13, P13, DOI 10.1111/j.1365-2443.2007.01147.x; Ling L, 2000, J BIOL CHEM, V275, P23852, DOI 10.1074/jbc.M001095200; Malicki J, 1996, DEVELOPMENT, V123, P263; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941	34	168	175	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					437	U140		10.1038/ncb1706	http://dx.doi.org/10.1038/ncb1706			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364699				2022-12-27	WOS:000254561700014
J	Ptacin, JL; Lee, SF; Garner, EC; Toro, E; Eckart, M; Comolli, LR; Moerner, W; Shapiro, L				Ptacin, Jerod L.; Lee, Steven F.; Garner, Ethan C.; Toro, Esteban; Eckart, Michael; Comolli, Luis R.; Moerner, We.; Shapiro, Lucy			A spindle-like apparatus guides bacterial chromosome segregation	NATURE CELL BIOLOGY			English	Article							DNA SEGREGATION; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; PARTITIONING PROTEIN; PLASMID SEGREGATION; F-PLASMID; BINDING; CELL; SOPA; PARB	Until recently, a dedicated mitotic apparatus that segregates newly replicated chromosomes into daughter cells was believed to be unique to eukaryotic cells. Here we demonstrate that the bacterium Caulobacter crescentus segregates its chromosome using a partitioning (Par) apparatus that has surprising similarities to eukaryotic spindles. We show that the C. crescentus ATPase ParA forms linear polymers in vitro and assembles into a narrow linear structure in vivo. The centromere-binding protein ParB binds to and destabilizes ParA structures in vitro. We propose that this ParB-stimulated ParA depolymerization activity moves the centromere to the opposite cell pole through a burnt bridge Brownian ratchet mechanism. Finally, we identify the pole-specific TipN protein(1,2) as a new component of the Par system that is required to maintain the directionality of DNA transfer towards the new cell pole. Our results elucidate a bacterial chromosome segregation mechanism that features basic operating principles similar to eukaryotic mitotic machines, including a multivalent protein complex at the centromere that stimulates the dynamic disassembly of polymers to move chromosomes into daughter compartments.	[Ptacin, Jerod L.; Toro, Esteban; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Lee, Steven F.; Moerner, We.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Garner, Ethan C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Eckart, Michael] Stanford Univ, Stanford Prot & Nucle Acid Facil, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Garner, Ethan/J-4025-2014; Moerner, William E/C-3260-2008; Comolli, Luis Raul/C-5907-2017	Garner, Ethan/0000-0003-0141-3555; Moerner, William E/0000-0002-2830-209X; Comolli, Luis Raul/0000-0002-9313-6550	National Institutes of Health [R01 GM51426 R24, GM073011-04d]; NIH/NIGMS [F32GM088966-1, R01GM086196-2]; Smith Stanford Graduate Fellowship; Helen Hay Whitney postdoctoral fellowship; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM073011, F32GM088966, R01GM051426, R01GM086196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Smith Stanford Graduate Fellowship; Helen Hay Whitney postdoctoral fellowship; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jimmy Blair for assistance with modelling of ParA mutants, and critical reading of the manuscript; and Grant Bowman, Erin Goley and Julie Biteen for technical advice. We thank Jian Zhu and Thomas Earnest for providing purified 6His-ParB. This work is supported by National Institutes of Health grants R01 GM51426 R24 and GM073011-04d to L.S., NIH/NIGMS fellowship F32GM088966-1 to LP., NIH/NIGMS award R01GM086196-2 to W.E.M., the Smith Stanford Graduate Fellowship to E.T., and a Helen Hay Whitney postdoctoral fellowship to E.G. This work was also supported by the Director, Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; BITEEN JS, 2008, NATURE METHODS; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; BOWMAN GR, MOL MICROBIOL, V76, P173; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; Ebersbach G, 2004, MOL MICROBIOL, V52, P385, DOI 10.1111/j.1365-2958.2004.04002.x; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Fiebig A, 2006, MOL MICROBIOL, V60, P1164, DOI 10.1111/j.1365-2958.2006.05175.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101	41	249	253	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					791	U46		10.1038/ncb2083	http://dx.doi.org/10.1038/ncb2083			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20657594	Green Accepted			2022-12-27	WOS:000280561600011
J	Stolz, A; Ertych, N; Kienitz, A; Vogel, C; Schneider, V; Fritz, B; Jacob, R; Dittmar, G; Weichert, W; Petersen, I; Bastians, H				Stolz, Ailine; Ertych, Norman; Kienitz, Anne; Vogel, Celia; Schneider, Verena; Fritz, Barbara; Jacob, Ralf; Dittmar, Gunnar; Weichert, Wilko; Petersen, Iver; Bastians, Holger			The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells	NATURE CELL BIOLOGY			English	Article							CHK2 PROTEIN-KINASE; HUMAN CANCER-CELLS; LUNG-CANCER; INSTABILITY; ANEUPLOIDY; PHOSPHORYLATION; CHECKPOINT; P53; SUSCEPTIBILITY; TUMORIGENESIS	Chromosomal instability (CIN) is a major hallmark of human cancer and might contribute to tumorigenesis(1). Genes required for the normal progression of mitosis represent potential CIN genes and, as such, are important tumour suppressors. The Chk2 kinase and its downstream targets p53 and Brca1 are tumour suppressors that have been functionally linked to the DNA damage response pathway(2). Here, we report a function of Chk2, independent of p53 and DNA damage, that is required for proper progression of mitosis, and for the maintenance of chromosomal stability in human somatic cells. Depletion of Chk2 or abrogation of its kinase activity causes abnormal mitotic spindle assembly associated with a delay in mitosis, which promotes the generation of lagging chromosomes, chromosome missegregation and CIN, while still allowing survival and growth. Furthermore, we have identified Brca1 as a mitotic target of the Chk2 kinase in the absence of DNA damage. Accordingly, loss of BRCA1 or its Chk2-mediated phosphorylation leads to spindle formation defects and CIN. Thus, the CHK2-BRCA1 tumour suppressor pathway is required for chromosomal stability, which might contribute to their tumour suppressor function.	[Stolz, Ailine; Ertych, Norman; Kienitz, Anne; Vogel, Celia; Schneider, Verena; Bastians, Holger] Univ Marburg, Inst Mol Biol & Tumour Res IMT, D-35037 Marburg, Germany; [Fritz, Barbara] Univ Marburg, Inst Human Genet, D-35033 Marburg, Germany; [Jacob, Ralf] Univ Marburg, Inst Cell Biol & Cell Pathol, D-35032 Marburg, Germany; [Dittmar, Gunnar] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Weichert, Wilko] Charite, Inst Pathol, D-10117 Berlin, Germany; [Petersen, Iver] Univ Jena, Inst Pathol, D-07740 Jena, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Bastians, H (corresponding author), Univ Marburg, Inst Mol Biol & Tumour Res IMT, Emil Mannkopf Str 2, D-35037 Marburg, Germany.	bastians@imt.uni-marburg.de	Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019; Jacob, Ralf/B-8163-2011	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; 	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Robert Benezra, Loren Michel, Prasad Jallepalli, Bert Vogelstein, Jiri Lukas, Stephen Taylor, Reuven Agami, Fen Xia, Junjie Chen, Sylvie Mazoyer, Jay Chung, Michael Brandeis, Linda Wordeman and Duane Compton for providing cell lines, antibodies and plasmids. We thank Robert J. Schultz (Developmental Therapeutics Program of the National Cancer Institute, USA) for the gift of UCN-01, and Rolf Muller and Alexandra Elli for support. We are grateful to Heike Krebber and Matthias Dobbelstein for comments on the manuscript. This work was supported by a grant and a Heisenberg fellowship to H. B. from the Deutsche Forschungsgemeinschaft.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bunz F, 2002, CANCER RES, V62, P1129; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Fritz B, 1998, HUM GENET, V103, P441, DOI 10.1007/s004390050848; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KISHIMOTO Y, 1992, CANCER RES, V52, P4799; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stolz A, 2009, CANCER RES, V69, P3874, DOI 10.1158/0008-5472.CAN-08-3597; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	36	108	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					492	U179		10.1038/ncb2051	http://dx.doi.org/10.1038/ncb2051			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20364141				2022-12-27	WOS:000277283700015
J	Montagnac, G; Chavrier, P				Montagnac, Guillaume; Chavrier, Philippe			Abscission accomplished by PtdIns(3)P	NATURE CELL BIOLOGY			English	Editorial Material							CENTRAL SPINDLE; PLASMA-MEMBRANE; CYTOKINESIS; ESCRT; COMPLEX; KIF13A; AP-1	Cytokinesis - the final step of mitosis in which the two daughter cells separate - requires accumulation of specific proteins and lipids at the connecting bridge to ensure cleavage by abscission. Phosphatidylinositol-3-phosphate (PtdIns(3)P), an endosomal phosphoinositide, and FYVE-CENT, a PtdIns3P-binding protein, are found in the bridge, where they contribute to the mechanism of abscission.	[Montagnac, Guillaume] Inst Curie, Ctr Rech, F-75248 Paris 05, France; CNRS, UMR144, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Montagnac, G (corresponding author), Inst Curie, Ctr Rech, 26 Rue Ulm, F-75248 Paris 05, France.	guillaume.montagnac@curie.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X				Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HORNICK JE, 2010, SEMIN CELL DEV BIOL; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x	19	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					308	310		10.1038/ncb0410-308	http://dx.doi.org/10.1038/ncb0410-308			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20360746				2022-12-27	WOS:000276194600002
J	Sagona, AP; Nezis, IP; Pedersen, NM; Liestol, K; Poulton, J; Rusten, TE; Skotheim, RI; Raiborg, C; Stenmark, H				Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Liestol, Knut; Poulton, John; Rusten, Tor Erik; Skotheim, Rolf I.; Raiborg, Camilla; Stenmark, Harald			PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody	NATURE CELL BIOLOGY			English	Article							ESCRT-III; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PROTEIN INTERACTIONS; MEDIATED ABSCISSION; STRUCTURAL BASIS; EARLY ENDOSOMES; COILED-COIL; AUTOPHAGY; MEMBRANE; TUMORIGENESIS	Several subunits of the class III phosphatidylinositol-3-OH kinase (PI(3)K-III) complex are known as tumour suppressors. Here we uncover a function for this complex and its catalytic product phosphatidylinositol-3-phosphate (PtdIns( 3) P) in cytokinesis. We show that PtdIns(3) P localizes to the midbody during cytokinesis and recruits a centrosomal protein, FYVE-CENT (ZFYVE26), and its binding partner TTC19, which in turn interacts with CHMP4B, an endosomal sorting complex required for transport (ESCRT)-III subunit implicated in the abscission step of cytokinesis. Translocation of FYVE-CENT and TTC19 from the centrosome to the midbody requires another FYVE-CENT-interacting protein, the microtubule motor KIF13A. Depletion of the VPS34 or Beclin 1 subunits of PI(3)K-III causes cytokinesis arrest and an increased number of binucleate and multinucleate cells, in a similar manner to the depletion of FYVE-CENT, KIF13A or TTC19. These results provide a mechanism for the translocation and docking of a cytokinesis regulatory machinery at the midbody.	[Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Liestol, Knut; Poulton, John; Rusten, Tor Erik; Skotheim, Rolf I.; Raiborg, Camilla; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway; [Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Poulton, John; Rusten, Tor Erik; Raiborg, Camilla; Stenmark, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; [Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0310 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Stenmark, H (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway.	stenmark@ulrik.uio.no	Nezis, Ioannis/AAE-8625-2020; Stenmark, Harald/B-8868-2008; Nezis, Ioannis P/I-4910-2014; Skotheim, Rolf I./H-6192-2017; Nezis, Ioannis/Q-6124-2019	Nezis, Ioannis P/0000-0003-0233-7574; Skotheim, Rolf I./0000-0002-5609-4048; Nezis, Ioannis/0000-0003-0233-7574; Rusten, Tor Erik/0000-0002-9150-2676	Research Council of Norway; South-Eastern Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	We thank Nobutaka Hirokawa for providing the expression construct for Myc-KIF13A, Aviva Tolkovsky for the gift of HeLa GFP-LC3 cells, Wes Sundquist for providing CHMP4A constructs, and Thomas P. Neufeld for the vps34 mutant flies. A.P.S. is a PhD student of the ENDOCYTE Research Training Network of the European Union. I.P.N. is a postdoctoral fellow of the Stem Cell Research Programme of the Research Council of Norway. N.M.P. is a postdoctoral fellow of the South-Eastern Norway Regional Health Authority. C.R. is a postdoctoral fellow, and T.E.R. and R.I.S. are senior research fellows, of the Norwegian Cancer Society.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Montagnac G, 2008, BIOCHEM SOC T, V36, P442, DOI 10.1042/BST0360442; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Raiborg C, 2001, J CELL SCI, V114, P2255; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stenmark H, 2001, SEMIN CELL DEV BIOL, V12, P193, DOI 10.1006/scdb.2000.0236; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	42	162	177	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					362	U140		10.1038/ncb2036	http://dx.doi.org/10.1038/ncb2036			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20208530	Green Published			2022-12-27	WOS:000276194600009
J	Simons, K				Simons, Kai			New beginnings: getting the kick I needed	NATURE CELL BIOLOGY			English	Editorial Material									Max Planck Inst Mol Cell Biol & Genet, D-0130 Dresden, Germany	Max Planck Society	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-0130 Dresden, Germany.	simons@mpi-cbg.de		Simons, Kai/0000-0002-9231-9996					0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					202	202		10.1038/ncb0310-202	http://dx.doi.org/10.1038/ncb0310-202			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20190826	Bronze			2022-12-27	WOS:000275054200002
J	Noon, AT; Shibata, A; Rief, N; Lobrich, M; Stewart, GS; Jeggo, PA; Goodarzi, AA				Noon, Angela T.; Shibata, Atsushi; Rief, Nicole; Loebrich, Markus; Stewart, Grant S.; Jeggo, Penelope A.; Goodarzi, Aaron A.			53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair	NATURE CELL BIOLOGY			English	Article							ZINC-FINGER PROTEINS; ATAXIA-TELANGIECTASIA; MRN COMPLEX; CHROMATIN; DAMAGE; ATM; 53BP1; MDC1; ACTIVATION; PATHWAY	DNA double-strand breaks (DSBs) trigger ATM (ataxia telangiectasia mutated) signalling and elicit genomic rearrangements and chromosomal fragmentation if misrepaired or unrepaired. Although most DSB repair is ATM-independent, similar to 15% of ionizing radiation (IR)-induced breaks persist in the absence of ATM-signalling(1). 53BP1 (p53-binding protein 1) facilitates ATM-dependent DSB repair but is largely dispensable for ATM activation or checkpoint arrest. ATM promotes DSB repair within heterochromatin by phosphorylating KAP-1 (KRAB-associated protein 1, also known as TIF1 beta, TRIM28 or KRIP-1; ref. 2). Here, we show that the ATM signalling mediator proteins MDC1, RNF8, RNF168 and 53BP1 are also required for heterochromatic DSB repair. Although KAP-1 phosphorylation is critical for 53BP1-mediated repair, overall phosphorylated KAP-1 (pKAP-1) levels are only modestly affected by 53BP1 loss. pKAP-1 is transiently pan-nuclear but also forms foci overlapping with gamma H2AX in heterochromatin. Cells that do not form 53BP1 foci, including human RIDDLE (radiosensitivity, immunodeficiency, dysmorphic features and learning difficulties) syndrome cells, fail to form pKAP-1 foci. 53BP1 amplifies Mre11-NBS1 accumulation at late-repairing DSBs, concentrating active ATM and leading to robust, localized pKAP-1. We propose that ionizing-radiation induced foci (IRIF) spatially concentrate ATM activity to promote localized alterations in regions of chromatin otherwise inhibitory to repair.	[Noon, Angela T.; Shibata, Atsushi; Jeggo, Penelope A.; Goodarzi, Aaron A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Stewart, Grant S.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Rief, Nicole; Loebrich, Markus] Tech Univ Darmstadt, Radiat Biol & DNA Repair, D-64287 Darmstadt, Germany	University of Sussex; Cancer Research UK; University of Birmingham; Technical University of Darmstadt	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; a.goodarzi@sussex.ac.uk	Shibata, Atsushi/AAX-1283-2021	Shibata, Atsushi/0000-0001-8912-6977; Stewart, Grant/0000-0002-0960-3241	Alberta Heritage Foundation for Medical Research; Association for International Cancer Research (AICR); MRC; AICR; Wellcome Research Fund; Department of Health (UK); EU [LSHG-CT-2005-512113, FI6R-CT-2003-508842]; Medical Research Council [G0500897, G0801130B] Funding Source: researchfish; MRC [G0500897] Funding Source: UKRI	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Association for International Cancer Research (AICR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; Wellcome Research Fund; Department of Health (UK); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Paull for discussions of unpublished data, A. Vindigni for mass spectrometry analysis, K. Iwabuchi for 53BP1 expression constructs and Y. Shiloh and Y. Ziv for providing KAP-1 expression constructs. A. A. G. was supported by grants from the Alberta Heritage Foundation for Medical Research and the Association for International Cancer Research (AICR). The P. A. J. laboratory is funded by the MRC, AICR, the Wellcome Research Fund, the Department of Health (UK) and the EU integrated projects on DNA-Repair (LSHG-CT-2005-512113) and Risc-Rad (FI6R-CT-2003-508842).	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; YUAN J, 2009, J BIOL CHEM; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	40	254	259	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					177	U191		10.1038/ncb2017	http://dx.doi.org/10.1038/ncb2017			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081839				2022-12-27	WOS:000274139400012
J	Monier, B; Pelissier-Monier, A; Brand, AH; Sanson, B				Monier, Bruno; Pelissier-Monier, Anne; Brand, Andrea H.; Sanson, Benedicte			An actomyosin-based barrier inhibits cell mixing at compartmental boundaries in Drosophila embryos	NATURE CELL BIOLOGY			English	Article							ASSISTED LASER INACTIVATION; LINEAGE RESTRICTION BOUNDARY; NONMUSCLE MYOSIN-II; CRANIOFRONTONASAL SYNDROME; GENE-EXPRESSION; DORSAL CLOSURE; EPH RECEPTORS; GROWTH CONE; HEDGEHOG; ADHESION	Partitioning tissues into compartments that do not intermix is essential for the correct morphogenesis of animal embryos and organs(1-3). Several hypotheses have been proposed to explain compartmental cell sorting, mainly differential adhesion(1-9), but also regulation of the cytoskeleton(10,11) or of cell proliferation(10,12). Nevertheless, the molecular and cellular mechanisms that keep cells apart at boundaries remain unclear. Here we demonstrate, in early Drosophila melanogaster embryos, that actomyosin-based barriers stop cells from invading neighbouring compartments. Our analysis shows that cells can transiently invade neighbouring compartments, especially when they divide, but are then pushed back into their compartment of origin. Actomyosin cytoskeletal components are enriched at compartmental boundaries, forming cable-like structures when the epidermis is mitotically active. When MyoII (non-muscle myosin II) function is inhibited, including locally at the cable by chromophore-assisted laser inactivation (CALI)(13,14), in live embryos, dividing cells are no longer pushed back, leading to compartmental cell mixing. We propose that local regulation of actomyosin contractibility, rather than differential adhesion, is the primary mechanism sorting cells at compartmental boundaries.	[Monier, Bruno; Pelissier-Monier, Anne; Brand, Andrea H.; Sanson, Benedicte] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Pelissier-Monier, Anne; Brand, Andrea H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Monier, B (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	bm343@cam.ac.uk; bs251@cam.ac.uk	Brand, Andrea H/F-8220-2014	Brand, Andrea H/0000-0002-2089-6954; Sanson, Benedicte/0000-0002-2782-4195; Monier, Bruno/0000-0002-3553-6396	HFSP; Wellcome Trust; EMBO; ARC (Association pour la Recherche contre le Cancer); Herchel Smith; Medical Research Council [G0300072] Funding Source: researchfish; MRC [G0300072] Funding Source: UKRI	HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Herchel Smith; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Lawrence for the initial observation of the segmental pattern of MyoII cables and for Supplementary Information, Movie 1; B. Bordbar for help in screening chromosomal deficiencies; D. Kiehart, R. Karess, G. Davis, J. Pradel, R. Holmgren, the UK Protein Trap Insertion Consortium, the Bloomington Stock Centre and the Developmental Studies Hybridoma Bank for reagents and B. Harris, R. Keynes, L. Perrin, M. Semeriva and D. St Johnston for critical reading of the manuscript. This work was funded by HFSP and Wellcome Trust grants to B. S; a Wellcome Trust Program Grant to A. H. B; an EMBO fellowship to A. P-M and ARC (Association pour la Recherche contre le Cancer) and Herchel Smith fellowships to B. M.	BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blair SS, 1997, DEVELOPMENT, V124, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P287; Chandraratna D, 2007, J CELL SCI, V120, P2594, DOI 10.1242/jcs.03472; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Clyne PJ, 2003, GENETICS, V165, P1433; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Horstkotte E, 2005, PHOTOCHEM PHOTOBIOL, V81, P358, DOI 10.1562/2004-07-22-RA-240.1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Inoue T, 2001, DEVELOPMENT, V128, P561; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Laplante C, 2006, DEVELOPMENT, V133, P3255, DOI 10.1242/dev.02492; Larsen C, 2008, DEV BIOL, V321, P310, DOI 10.1016/j.ydbio.2008.04.026; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; MARTINEZARIAS A, DEV DROSPHILLA MELAN; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Vegh M, 2003, GENETICS, V163, P1427; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yan P, 2006, BIOCHEMISTRY-US, V45, P4736, DOI 10.1021/bi052395a; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	60	174	175	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					60	U147		10.1038/ncb2005	http://dx.doi.org/10.1038/ncb2005			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966783	Green Accepted			2022-12-27	WOS:000272973800013
J	Tuduri, S; Crabbe, L; Conti, C; Tourriere, H; Holtgreve-Grez, H; Jauch, A; Pantesco, V; De Vos, J; Thomas, A; Theillet, C; Pommier, Y; Tazi, J; Coquelle, A; Pasero, P				Tuduri, Sandie; Crabbe, Laure; Conti, Chiara; Tourriere, Helene; Holtgreve-Grez, Heidi; Jauch, Anna; Pantesco, Veronique; De Vos, John; Thomas, Aubin; Theillet, Charles; Pommier, Yves; Tazi, Jamal; Coquelle, Arnaud; Pasero, Philippe			Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription	NATURE CELL BIOLOGY			English	Article							SPLICING FACTOR ASF/SF2; DNA-REPLICATION; FORK PROGRESSION; SR PROTEINS; HUMAN-CELLS; ORIGIN CHOICE; FRAGILE SITES; PHOSPHORYLATION; DAMAGE; RECRUITMENT	Topoisomerase I (Top1) is a key enzyme in functioning at the interface between DNA replication, transcription and mRNA maturation. Here, we show that Top1 suppresses genomic instability in mammalian cells by preventing a conflict between transcription and DNA replication. Using DNA combing and ChIP (chromatin immunoprecipitation)-on-chip, we found that Top1-deficient cells accumulate stalled replication forks and chromosome breaks in S phase, and that breaks occur preferentially at gene-rich regions of the genome. Notably, these phenotypes were suppressed by preventing the formation of RNA-DNA hybrids (R-loops) during transcription. Moreover, these defects could be mimicked by depletion of the splicing factor ASF/SF2 (alternative splicing factor/splicing factor 2), which interacts functionally with Top1. Taken together, these data indicate that Top1 prevents replication fork collapse by suppressing the formation of R-loops in an ASF/SF2-dependent manner. We propose that interference between replication and transcription represents a major source of spontaneous replication stress, which could drive genomic instability during the early stages of tumorigenesis.	[Tuduri, Sandie; Theillet, Charles; Coquelle, Arnaud] Univ Montpellier I, IRCM, INSERM, CRLC Val Aurelle Paul Lamarque,U896, F-34298 Montpellier, France; [Tuduri, Sandie; Crabbe, Laure; Tourriere, Helene; Thomas, Aubin; Pasero, Philippe] CNRS, Inst Human Genet, UPR1142, F-34396 Montpellier, France; [Conti, Chiara; Pommier, Yves] NIH, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Holtgreve-Grez, Heidi; Jauch, Anna] Univ Heidelberg Hosp, Inst Human Genet, D-69120 Heidelberg, Germany; [Pantesco, Veronique; De Vos, John] INSERM, U847, F-34000 Montpellier, France; [Pantesco, Veronique; De Vos, John] CHU Montpellier, Inst Rech Biotherapie, Hop St Eloi, F-34000 Montpellier, France; [Pantesco, Veronique; De Vos, John] Univ Montpellier I, F-34000 Montpellier, France; [Tazi, Jamal] CNRS, Inst Mol Genet, UMR5535, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Institutes of Health (NIH) - USA; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Coquelle, A (corresponding author), Univ Montpellier I, IRCM, INSERM, CRLC Val Aurelle Paul Lamarque,U896, F-34298 Montpellier, France.	arnaud.coquelle@inserm.fr; philippe.pasero@igh.cnrs.fr	De Vos, John/A-5703-2010; Coquelle, Arnaud/AAE-5425-2020; Theillet, Charles/O-7634-2018; Pasero, Philippe/O-2340-2018; Crabbé, Laure/P-8955-2014	De Vos, John/0000-0003-1880-4130; Pasero, Philippe/0000-0001-5891-0822; Crabbé, Laure/0000-0001-7764-3600; Tazi, Jamal/0000-0002-1949-8748; Theillet, Charles/0000-0001-5555-2759	FRM (Equipe FRM); ANR; INCa; EMBO Young Investigator Programme; Ligue contre le cancer (Comite de l'Herault); ARC (Association pour la Recherche contre le Cancer); EMBO; CNRS; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	FRM (Equipe FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); INCa(Institut National du Cancer (INCA) France); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); Ligue contre le cancer (Comite de l'Herault); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); EMBO(European Molecular Biology Organization (EMBO)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Debatisse and M. Mechali for discussions and critical comments on the manuscript, D. Durocher for communicating data before publication, J. Piette for his initial contribution to this project and E. Schwob and the DNA combing facility of Montpellier for providing silanized coverslips. Work in the P. P. laboratory is supported by FRM (Equipe FRM), ANR, INCa and the EMBO Young Investigator Programme. Work in the J. T. laboratory is supported by ANR. A. C. is supported by the Ligue contre le cancer (Comite de l'Herault), ARC (Association pour la Recherche contre le Cancer) and INCa. S. T., L. C. and H. T. were recipients of fellowships from ARC, EMBO and CNRS, respectively.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gilbert DM, 2007, CHROMOSOMA, V116, P341, DOI 10.1007/s00412-007-0105-9; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hann C, 1998, J BIOL CHEM, V273, P8425, DOI 10.1074/jbc.273.14.8425; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Holmes WF, 2005, J BIOL CHEM, V280, P37400, DOI 10.1074/jbc.M506995200; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Malanga M, 2008, J BIOL CHEM, V283, P19991, DOI 10.1074/jbc.M709495200; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; NICKOLOFF JA, 1990, MOL CELL BIOL, V10, P4837, DOI 10.1128/MCB.10.9.4837; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Soret J, 2003, CANCER RES, V63, P8203; Tazi J, 2005, MOL PHARMACOL, V67, P1186, DOI 10.1124/mol.104.007633; THRASH C, 1985, P NATL ACAD SCI USA, V82, P4374, DOI 10.1073/pnas.82.13.4374; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Wei XY, 1998, SCIENCE, V281, P1502, DOI 10.1126/science.281.5382.1502; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Zhang CX, 2000, DEV BIOL, V222, P27, DOI 10.1006/dbio.2000.9704	54	348	355	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1315	U125		10.1038/ncb1984	http://dx.doi.org/10.1038/ncb1984			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838172	Green Submitted, Green Accepted			2022-12-27	WOS:000271425800011
J	Herrero-Mendez, A; Almeida, A; Fernandez, E; Maestre, C; Moncada, S; Bolanos, JP				Herrero-Mendez, Angel; Almeida, Angeles; Fernandez, Emilio; Maestre, Carolina; Moncada, Salvador; Bolanos, Juan P.			The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1	NATURE CELL BIOLOGY			English	Article							NITRIC-OXIDE; QUANTITATIVE-DETERMINATION; FRUCTOSE 2,6-BISPHOSPHATE; GLUCOSE-METABOLISM; RNA INTERFERENCE; PROTEIN-KINASE; RAT-BRAIN; PATHWAY; TISSUES; CELLS	Neurons are known to have a lower glycolytic rate than astrocytes and when stressed they are unable to upregulate glycolysis(1) because of low Pfkfb3 (6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3) activity(2). This enzyme generates fructose-2,6- bisphosphate (F2,6P(2))(3), the most potent activator of 6-phosphofructo-1-kinase (Pfk1; ref. 4), a master regulator of glycolysis(5). Here, we show that Pfkfb3 is absent from neurons in the brain cortex and that Pfkfb3 in neurons is constantly subject to proteasomal degradation by the action of the E3 ubiquitin ligase(6), anaphase-promoting complex/cyclosome (APC/C)-Cdh1. By contrast, astrocytes have low APC/C-Cdh1 activity and therefore Pfkfb3 is present in these cells. Upregulation of Pfkfb3 by either inhibition of Cdh1 or overexpression of Pfkfb3 in neurons resulted in the activation of glycolysis. This, however, was accompanied by a marked decrease in the oxidation of glucose through the pentose phosphate pathway (a metabolic route involved in the regeneration of reduced glutathione(7))resulting in oxidative stress and apoptotic death. Thus, by actively downregulating glycolysis by APC/C-Cdh1, neurons use glucose to maintain their antioxidant status at the expense of its utilization for bioenergetic purposes.	[Herrero-Mendez, Angel; Almeida, Angeles; Fernandez, Emilio; Maestre, Carolina; Bolanos, Juan P.] Univ Salamanca, Dept Bioquim & Biol Mol, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain; [Almeida, Angeles; Maestre, Carolina] Hosp Univ Salamanca, Unidad Invest, Inst Estudios Ciencias Salud Castilla & Leon, Salamanca 37007, Spain; [Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Salamanca; University of Salamanca; University of London; University College London	Bolanos, JP (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain.	s.moncada@ucl.ac.uk; jbolanos@usal.es	ALMEIDA, ANGELES/B-4727-2017; Maestre, Carolina/A-9662-2014; Bolaños, Juan Pedro/M-9518-2019; 2009, Secribsal/A-1266-2012	ALMEIDA, ANGELES/0000-0003-0485-8904; Maestre, Carolina/0000-0003-2480-8082; Bolaños, Juan Pedro/0000-0002-3949-6862; 	Ministerio de Ciencia e Innovacion [SAF2007-61492, CSD2007-00020]; Instituto de Salud Carlos-III [FIS06/0794]; Junta de Castilla y Leon [SA066A07]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos-III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Ministerio de Ciencia e Innovacion (SAF2007-61492 and Consolider-Ingenio CSD2007-00020, Spain), Instituto de Salud Carlos-III (FIS06/0794 and Renevas), and Junta de Castilla y Leon (SA066A07 and Red de Terapia Celular y Medicina Regenerativa). We would like to thank H. Yamano for valuable help with the APC/C-Cdh1 activity assays, Carmela Gomez-Rodriguez for immunohistochemistry experiments, M. Resch for technical assistance and A. Higgs for critical evaluation of this paper.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; COHEN SS, 1950, BIOL BULL, V99, P369; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; HAMMERSTEDT RH, 1973, ANAL BIOCHEM, V56, P292, DOI 10.1016/0003-2697(73)90192-9; HOTHERSALL JS, 1979, ARCH BIOCHEM BIOPHYS, V198, P478, DOI 10.1016/0003-9861(79)90522-8; HUANG M, 1982, J BIOL CHEM, V257, P1358; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; KATZ J, 1965, J BIOL CHEM, V240; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; LARRABEE MG, 1990, BIOCHEM J, V272, P127, DOI 10.1042/bj2720127; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHAL G, 1985, METHOD ENZYMAT AN, P191; NOGALES PG, 2003, J BIOL CHEM, V278, P864; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pfleger CM, 2000, GENE DEV, V14, P655; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Riera L, 2003, FEBS LETT, V550, P23, DOI 10.1016/S0014-5793(03)00808-1; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; THAUER RK, 1970, ANAL BIOCHEM, V38, P461, DOI 10.1016/0003-2697(70)90471-9; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe F, 1997, J NEUROCHEM, V69, P1	35	532	536	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					747	U105		10.1038/ncb1881	http://dx.doi.org/10.1038/ncb1881			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448625				2022-12-27	WOS:000266503700020
J	Maddika, S; Chen, JJ				Maddika, Subbareddy; Chen, Junjie			Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase	NATURE CELL BIOLOGY			English	Article							MICROTUBULE-SEVERING ACTIVITY; CUL4-DDB1 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; C-ELEGANS; HYPERPLASTIC-DISCS; GLYCOGEN-SYNTHASE; FAMILY PROTEIN; S-PHASE; PHOSPHORYLATION	Protein kinases have central functions in various cellular signal transduction pathways through their substrate phosphorylation. Here we show that a protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex. DYRK2 associates with an E3 ligase complex containing EDD, DDB1 and VPRBP proteins (EDVP complex). Strikingly, DYRK2 serves as a scaffold for the EDVP complex, because small-interfering-RNA-mediated depletion of DYRK2 disrupts the formation of the EDD DDB1-VPRBP complex. Although the kinase activity of DYRK2 is dispensable for its ability to mediate EDVP complex formation, it is required for the phosphorylation and subsequent degradation of its downstream substrate, katanin p60. Collectively, our results reveal a new type of E3-ubiquitin ligase complex in humans that depends on a protein kinase for complex formation as well as for the subsequent phosphorylation, ubiquitylation and degradation of their substrates.	[Maddika, Subbareddy; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	junjie.chen@yale.edu			National Institutes of Health; Department of Defense; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jamie Wood for critical reading of the manuscript and for providing valuable suggestions. We thank Amanda Russell for providing EDD expression vectors. This work was supported in part by grants from the National Institutes of Health (to J.C.). J.C. is a recipient of an Era of Hope Scholars award from the Department of Defense and is a member of Mayo Clinic Breast SPORE programme.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kinstrie R, 2006, BIOCHEM J, V398, P45, DOI 10.1042/BJ20060159; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Miller CT, 2003, CANCER RES, V63, P4136; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985	33	132	138	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					409	U110		10.1038/ncb1848	http://dx.doi.org/10.1038/ncb1848			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19287380	Green Accepted			2022-12-27	WOS:000265264900011
J	Gousset, K; Schiff, E; Langevin, C; Marijanovic, Z; Caputo, A; Browman, DT; Chenouard, N; de Chaumont, F; Martino, A; Enninga, J; Olivo-Marin, JC; Mannel, D; Zurzolo, C				Gousset, Karine; Schiff, Edwin; Langevin, Christelle; Marijanovic, Zrinka; Caputo, Anna; Browman, Duncan T.; Chenouard, Nicolas; de Chaumont, Fabrice; Martino, Angelo; Enninga, Jost; Olivo-Marin, Jean-Christophe; Maennel, Daniela; Zurzolo, Chiara			Prions hijack tunnelling nanotubes for intercellular spread	NATURE CELL BIOLOGY			English	Article							FOLLICULAR DENDRITIC CELLS; MEMBRANE NANOTUBES; IMMUNE CELLS; PEYERS-PATCHES; NEURONAL CELLS; IMAGINAL DISCS; CUTTING EDGE; T-CELLS; IN-VIVO; SCRAPIE	In variant Creutzfeldt-Jakob disease, prions (PrPSc) enter the body with contaminated foodstuffs and can spread from the intestinal entry site to the central nervous system (CNS) by intercellular transfer from the lymphoid system to the peripheral nervous system (PNS)(1). Although several means(2-4) and different cell types(5-7) have been proposed to have a role, the mechanism of cell-to-cell spreading remains elusive. Tunnelling nanotubes (TNTs) have been identified between cells(8-12), both in vitro and in vivo(10,11,13), and may represent a conserved means of cell-to-cell communication(14-16). Here we show that TNTs allow transfer of exogenous and endogenous PrPSc between infected and naive neuronal CAD cells(17). Significantly, transfer of endogenous PrPSc aggregates was detected exclusively when cells chronically infected with the 139A mouse prion strain were connected to mouse CAD cells by means of TNTs, identifying TNTs as an efficient route for PrPSc spreading in neuronal cells. In addition, we detected the transfer of labelled PrPSc from bone marrow-derived dendritic cells to primary neurons connected through TNTs. Because dendritic cells can interact with peripheral neurons in lymphoid organs, TNT-mediated intercellular transfer would allow neurons to transport prions retrogradely to the CNS1. We therefore propose that TNTs are involved in the spreading of PrPSc within neurons in the CNS and from the peripheral site of entry to the PNS by neuroimmune interactions with dendritic cells.	[Gousset, Karine; Schiff, Edwin; Langevin, Christelle; Marijanovic, Zrinka; Caputo, Anna; Browman, Duncan T.; Zurzolo, Chiara] Inst Pasteur, Unite Traf Membranaire & Pathogenese, F-75724 Paris 15, France; [Schiff, Edwin; Maennel, Daniela] Univ Regensburg, Dept Immunol, D-93042 Regensburg, Germany; [Caputo, Anna; Zurzolo, Chiara] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Chenouard, Nicolas; de Chaumont, Fabrice; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Images Quantitat, F-75724 Paris 15, France; [Martino, Angelo] Inst Pasteur, Unite Rech Genet Mycobacterienne, F-75724 Paris 15, France; [Enninga, Jost] Inst Pasteur, Grp Dynam Interact Hote Pathogene, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Regensburg; University of Naples Federico II; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zurzolo, C (corresponding author), Inst Pasteur, Unite Traf Membranaire & Pathogenese, 25 Rue Dr Roux, F-75724 Paris 15, France.	zurzolo@unina.it	Olivo-Marin, Jean-Christophe/K-4428-2015; Zurzolo, Chiara/AAH-5225-2019; Gousset, Karine/ADS-3249-2022	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Gousset, Karine/0000-0002-0988-2332; Langevin, Christelle/0000-0002-6013-4460; de Chaumont, Fabrice/0000-0001-7613-7204; ZURZOLO, Chiara/0000-0001-6048-6602	Pasteur Foundation Fellowship Program; Bavarian Research Foundation; Fondation Canadienne Louis Pasteur; Ile-de-France; European Union [023183]; Telethon [GGP0414]	Pasteur Foundation Fellowship Program; Bavarian Research Foundation; Fondation Canadienne Louis Pasteur; Ile-de-France; European Union(European Commission); Telethon(Fondazione Telethon)	We thank P. Lazarow, G. Guizzunti and C. Bowler for critical reading of the manuscript. We thank S. Blanchard and D. Bohl- Delfaud for their help in preparing the GFP - PrPwt- retroviral vector, and P. Casanova and J. Vinatier for technical help. We thank H. Laude, A. F. Hill, P. Cossart and M. Way for their gifts ( cells, constructs and reagents). We are grateful for assistance with microscopes and image processing received from the Plate-Forme Imagerie Dynamique at the Pasteur Institut. K. G. is supported by the Pasteur Foundation Fellowship Program, E. S. received a fellowship (2004-07) from the Bavarian Research Foundation (BFS), D. B. received funding from the Fondation Canadienne Louis Pasteur, and Z. M. received funding from Ile-de-France. This work was supported by grants to C. Z. from the European Union ( Strainbarrier (FP6 Contract No 023183 ( Food)) and from Telethon GGP0414.	Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Brejot T, 2006, EXP NEUROL, V198, P167, DOI 10.1016/j.expneurol.2005.11.026; CHENOUARD N, 2008, IAPR INT C PATT REC, P8; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Defaweux V, 2005, MICROSC RES TECHNIQ, V66, P1, DOI 10.1002/jemt.20135; Demontis F, 2007, DEV DYNAM, V236, P3408, DOI 10.1002/dvdy.21324; Dorban G, 2007, HISTOCHEM CELL BIOL, V128, P243, DOI 10.1007/s00418-007-0303-9; DUFOUR A, 2008, P 42 AS C S IN PRESS; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Lambrecht BN, 2001, RESP RES, V2, P133, DOI 10.1186/rr49; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marim MD, 2008, I S BIOMED IMAGING, P1003, DOI 10.1109/ISBI.2008.4541168; McBride PA, 1999, NEUROSCI LETT, V265, P135, DOI 10.1016/S0304-3940(99)00223-2; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Qi YP, 1997, J NEUROSCI, V17, P1217; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819	44	451	459	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					328	U232		10.1038/ncb1841	http://dx.doi.org/10.1038/ncb1841			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198598				2022-12-27	WOS:000263777900017
J	Medjkane, S; Perez-Sanchez, C; Gaggioli, C; Sahai, E; Treisman, R				Medjkane, Souhila; Perez-Sanchez, Cristina; Gaggioli, Cedric; Sahai, Erik; Treisman, Richard			Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; GROWTH-FACTOR-RECEPTOR; NONMUSCLE MYOSIN-II; IN-VIVO; STROMAL FIBROBLASTS; ACTIN CYTOSKELETON; CARCINOMA-CELLS; MIGRATION; INVASION	Rho GTPases control cytoskeletal dynamics through cytoplasmic effectors and regulate transcriptional activation through myocardin-related transcription factors (MRTFs), which are co-activators for serum response factor (SRF). We used RNA interference to investigate the contribution of the MRTF-SRF pathway to cytoskeletal dynamics in MDA-MB-231 breast carcinoma and B16F2 melanoma cells, in which basal MRTF-SRF activity is Rho- dependent. Depletion of MRTFs or SRF reduced cell adhesion, spreading, invasion and motility in culture, without affecting proliferation or inducing apoptosis. MRTF-depleted tumour cell xenografts showed reduced cell motility but proliferated normally. Tumour cells depleted of MRTF or SRF failed to colonize the lung from the bloodstream, being unable to persist after their arrival in the lung. Only a few genes show MRTF-dependent expression in both cell lines. Two of these, MYH9 (NMHCIIa) and MYL9 (MLC2), are also required for invasion and lung colonization. Conversely, expression of activated MAL/MRTF-A increases lung colonization by poorly metastatic B16F0 cells. Actin-based cell behaviour and experimental metastasis thus require Rho-dependent nuclear signalling through the MRTF-SRF network.	[Medjkane, Souhila; Perez-Sanchez, Cristina; Treisman, Richard] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Transcript Lab, London WC2A 3PX, England; [Gaggioli, Cedric; Sahai, Erik] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Tumor Biol Lab, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Treisman, R (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Transcript Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Richard.Treisman@cancer.org.uk	Gaggioli, Cedric/F-3658-2011; gaggioli, cedric/L-5363-2019; Gaggioli, Cedric/Q-2642-2019	Gaggioli, Cedric/0000-0002-4710-1605; Gaggioli, Cedric/0000-0002-4710-1605; Medjkane, Souhila/0000-0001-7973-7707; Treisman, Richard/0000-0002-9658-0067; Sahai, Erik/0000-0002-3932-5086	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Caceres M, 2005, EXP CELL RES, V309, P229, DOI 10.1016/j.yexcr.2005.05.020; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dua P, 2008, EUR J CANCER, V44, P1587, DOI 10.1016/j.ejca.2008.04.009; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; GUETTLER S, 2007, MOL CELL BIOL; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kusama T, 2006, INT J ONCOL, V29, P217; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakajima M, 2003, CANCER CHEMOTH PHARM, V52, P319, DOI 10.1007/s00280-003-0641-9; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100	50	315	324	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					257	U85		10.1038/ncb1833	http://dx.doi.org/10.1038/ncb1833			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198601	Green Accepted			2022-12-27	WOS:000263777900009
J	Yuan, JP; Zeng, WZ; Dorwart, MR; Choi, YJ; Worley, PF; Muallem, S				Yuan, Joseph P.; Zeng, Weizhong; Dorwart, Michael R.; Choi, Young-Jin; Worley, Paul F.; Muallem, Shmuel			SOAR and the polybasic STIM1 domains gate and regulate Orai channels	NATURE CELL BIOLOGY			English	Article							STORE-OPERATED CHANNELS; TRPC CHANNELS; CIRCULAR-DICHROISM; PLASMA-MEMBRANE; CA2+ INFLUX; CRAC; PROTEINS; STOICHIOMETRY; CONFORMATION; ACTIVATION	Influx of Ca2+ through store-operated Ca2+ channels (SOCs) is a central component of receptor-evoked Ca2+ signals(1). Orai channels are SOCs2-4 that are gated by STIM1, a Ca2+ sensor located in the ER5,6 but how it gates and regulates the Orai channels is unknown. Here, we report the molecular basis for gating of Orais by STIM1. All Orai channels are fully activated by the conserved STIM1 amino acid fragment 344-442, which we termed SOAR ( the STIM1 Orai activating region). SOAR acts in combination with STIM1 (450-485) to regulate the strength of interaction with Orai1. Activation of Orai1 by SOAR recapitulates all the kinetic properties of Orai1 activation by STIM1. However, mutations of STIM1 within SOAR prevent activation of Orai1 but not co-clustering of STIM1 and Orai1 in response to Ca2+ store depletion, indicating that STIM1-Orai1 co-clustering is not sufficient for Orai1 activation. An intact carboxy terminus alpha-helicial region of Orai is required for activation by SOAR. Deleting most of the Orai1 amino terminus impaired Orai1 activation by STIM1, but Orai(Delta 1-73) interacted with and was fully activated by SOAR. Accordingly, the characteristic inward rectification of Orai is mediated by an interaction between the polybasic STIM1 (672-685) and a Pro-rich region in the N terminus of Orai1. Hence, the essential properties of Orai1 function can be rationalized by interactions with discrete regions of STIM1.	[Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA; [Yuan, Joseph P.; Zeng, Weizhong; Dorwart, Michael R.; Choi, Young-Jin; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu			National Institutes of Health [DE12309, DK38938]; Ruth S. Harrell Professorship in Medical Research; National Institute on Drug Abuse [DA00266, DA10309]; National Institute of Mental Health [MH068830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013902, R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, P50DA000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth S. Harrell Professorship in Medical Research; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a grant from the National Institutes of Health Grants DE12309 and DK38938 and the Ruth S. Harrell Professorship in Medical Research ( S. M.), and by the National Institute on Drug Abuse (NIDA; DA00266, DA10309) and the National Institute of Mental Health (NIMH; MH068830; P. F. W.).	CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	27	508	518	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					337	U246		10.1038/ncb1842	http://dx.doi.org/10.1038/ncb1842			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182790	Green Accepted			2022-12-27	WOS:000263777900018
J	Miller, AL; Bement, WM				Miller, Ann L.; Bement, William M.			Regulation of cytokinesis by Rho GTPase flux	NATURE CELL BIOLOGY			English	Article							ACTIVATING-PROTEIN; CONTRACTILE RING; MITOTIC SPINDLE; AURORA-B; ACTIN-FILAMENTS; MGCRACGAP; COMPLEX; CDC42; PHOSPHORYLATION; MICROTUBULES	In animal cells, cytokinesis is powered by a contractile ring of actin filaments (F-actin) and myosin-2. Formation of the contractile ring is dependent on the small GTPase RhoA(1,2), which is activated in a precise zone at the cell equator(3). It has long been assumed that cytokinesis and other Rho-dependent processes are controlled in a sequential manner, whereby Rho activation by guanine nucleotide exchange factors (GEFs) initiates a particular event, and Rho inactivation by GTPase activating proteins (GAPs) terminates that event. MgcRacGAP is a conserved cytokinesis regulator thought to be required only at the end of cytokinesis(4,5). Here we show that GAP activity of MgcRacGAP is necessary early during cytokinesis for the formation and maintenance of the Rho activity zone. Disruption of GAP activity by point mutation results in poorly focused Rho activity zones, whereas complete removal of the GAP domain results in unfocused zones that show lateral instability and/or rapid side-to-side oscillations. We propose that the GAP domain of MgcRacGAP has two unexpected roles throughout cytokinesis: first, it transiently anchors active Rho, and second, it promotes local Rho inactivation, resulting in the constant flux of Rho through the GTPase cycle.	[Miller, Ann L.; Bement, William M.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Bement, William M.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miller, AL (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	almiller1@wisc.edu	Bement, William/AAA-5444-2021	Miller, Ann/0000-0002-7293-764X	American Cancer Society; Helen Hay Whitney Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052932] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank George von Dassow and Julie Canman for helpful discussions; Chloe Bulinski for the EMTB-3xGFP construct; Todd Stukenberg, Johne Liu and Aaron Straight for providing antibodies; John Wallingford and Esther Kieserman for advice on the midzone staining procedure; and members of the Bement Lab for advice and critical reading of the manuscript. A. L. M. is supported by postdoctoral fellowships from the American Cancer Society and the Helen Hay Whitney Foundation. W. M. B. is supported by an NIH grant.	Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; Danilchik MV, 2008, DEV DYNAM, V237, P565, DOI 10.1002/dvdy.21442; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Faire K, 1999, J CELL SCI, V112, P4243; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kieserman EK, 2008, CURR BIOL, V18, P116, DOI 10.1016/j.cub.2007.12.028; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Lee JS, 2004, EXP CELL RES, V293, P275, DOI 10.1016/j.yexcr.2003.10.015; Leonard DA, 1998, J BIOL CHEM, V273, P16210, DOI 10.1074/jbc.273.26.16210; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toure A, 2008, FEBS LETT, V582, P1182, DOI 10.1016/j.febslet.2007.12.036; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	33	182	183	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					71	U137		10.1038/ncb1814	http://dx.doi.org/10.1038/ncb1814			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060892	Green Accepted			2022-12-27	WOS:000262157000013
J	Ohn, T; Kedersha, N; Hickman, T; Tisdale, S; Anderson, P				Ohn, Takbum; Kedersha, Nancy; Hickman, Tyler; Tisdale, Sarah; Anderson, Paul			A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; P-BODIES; GLUCOSE DEPRIVATION; SITES; DECAY; DEGRADATION; CARDIOPROTECTION; ACCUMULATION; TRANSLATION; RECRUITMENT	Stress granules (SGs) and processing bodies (PBs) are microscopically visible ribonucleoprotein granules that cooperatively regulate the translation and decay of messenger RNA(1-3). Using an RNA-mediated interference-based screen, we identify 101 human genes required for SG assembly, 39 genes required for PB assembly, and 31 genes required for coordinate SG and PB assembly. Although 51 genes encode proteins involved in mRNA translation, splicing and transcription, most are not obviously associated with RNA metabolism. We find that several components of the hexosamine biosynthetic pathway, which reversibly modifies proteins with O-linked N-acetylglucosamine (O-GlcNAc) in response to stress, are required for SG and PB assembly. O-GlcNAc-modified proteins are prominent components of SGs but not PBs, and include RACK1 (receptor for activated C kinase 1), prohibitin-2, glyceraldehyde-3-phosphate dehydrogenase and numerous ribosomal proteins. Our results suggest that O-GlcNAc modification of the translational machinery is required for aggregation of untranslated messenger ribonucleoproteins into SGs. The lack of enzymes of the hexosamine biosynthetic pathway in budding yeast may contribute to differences between mammalian SGs and related yeast EGP (eIF4E, 4G and Pab1 containing) bodies.	[Ohn, Takbum; Kedersha, Nancy; Hickman, Tyler; Tisdale, Sarah; Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Anderson, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 1 Jimmy Fund Way, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu		Hickman, Tyler/0000-0003-2623-3251	NIH [AI065858, AI033600, AR0514732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI033600, R01AI033600, P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank C. Shamu and colleagues in the ICCB-L RNAi screening facilities at Harvard Medical School for their assistance. We also thank N. Ramadan at the Drosophila RNAi Screening Centre at Harvard Medical School for assistance with the automated microscope. We thank Jens Lykke-Andersen for the DCP1a antibody, and Carlos Morales for the Myc-tagged sortilin plasmid. We thank Keith Blackwell, Pavel Ivanov and Dan Schoenberg for critical review of the manuscript. This work was supported by NIH grants AI065858, AI033600 and AR0514732.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEDERSHA N, METHODS ENZ IN PRESS; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Zachara NE, 2007, AM J PHYSIOL-HEART C, V293, pH1324, DOI 10.1152/ajpheart.00697.2007; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	36	281	292	5	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1224	1231		10.1038/ncb1783	http://dx.doi.org/10.1038/ncb1783			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18794846	Green Accepted			2022-12-27	WOS:000259682900017
J	Yang, Z; Loncarek, J; Khodjakov, A; Rieder, CL				Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.			Extra centrosomes and/or chromosomes prolong mitosis in human cells	NATURE CELL BIOLOGY			English	Article							CYCLE PROGRESSION; ANAPHASE ONSET; SOMATIC-CELLS; CHECKPOINT; SPINDLE; TUMORS	Using laser microsurgery and cell fusion we have explored how additional centrosomes and/or chromosomes influence the duration of mitosis in human cells. We found that doubling the chromosome number added approximately 10 min to a 20 min division, whereas doubling the number of centrosomes added approximately 30 min more. extra centrosomes and/or chromosomes prolong mitosis by delaying satisfaction of the spindle assembly checkpoint. thus mitosis can be prolonged by non-genetic means and extra chromosomes and centrosomes probably contribute to the elevated mitotic index seen in many tumours.	[Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.] New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Albany, NY 12201 USA; [Khodjakov, Alexey; Rieder, Conly L.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Khodjakov, Alexey; Rieder, Conly L.] Marine Biol Lab, Woods Hole, MA 02543 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Marine Biological Laboratory - Woods Hole	Rieder, CL (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Empire State Plaza, Albany, NY 12201 USA.	rieder@wadsworth.org	Yang, Zhenye/G-9641-2018; yang, zhenye/D-3519-2009	Loncarek, Jadranka/0000-0003-1879-5473; Yang, Zhenye/0000-0001-7797-5891	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040198, R37GM040198, R01GM059363] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59363, R01 GM059363, R01 GM059363-10, R37 GM040198, R37 GM040198-24, GM40198] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; SISKEN JE, 1985, CELL TISSUE KINET, V18, P137, DOI 10.1111/j.1365-2184.1985.tb00642.x; SISKEN JE, 1982, J CELL PHYSIOL, V113, P219, DOI 10.1002/jcp.1041130206; Sluder G, 1997, J CELL SCI, V110, P421; Therman Eeva, 1989, Critical Reviews in Oncogenesis, V1, P293; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716	15	101	103	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					748	751		10.1038/ncb1738	http://dx.doi.org/10.1038/ncb1738			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469805	Green Accepted, Green Submitted			2022-12-27	WOS:000256350100022
J	Nygren, JM; Liuba, K; Breitbach, M; Stott, S; Thoren, L; Roell, W; Geisen, C; Sasse, P; Kirik, D; Bjorklund, A; Nerlov, C; Fleischmann, BK; Jovinge, S; Jacobsen, SEW				Nygren, Jens M.; Liuba, Karina; Breitbach, Martin; Stott, Simon; Thoren, Lina; Roell, Wilhelm; Geisen, Caroline; Sasse, Philipp; Kirik, Deniz; Bjorklund, Anders; Nerlov, Claus; Fleischmann, Bernd K.; Jovinge, Stefan; Jacobsen, Sten Eirik W.			Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SKELETAL-MUSCLE; PURKINJE NEURONS; MYELOMONOCYTIC CELLS; VASCULAR ENDOTHELIUM; IN-VIVO; MICE; CARDIOMYOCYTES; HEPATOCYTES	Recent studies have suggested that regeneration of non-haematopoietic cell lineages can occur through heterotypic cell fusion(1-3) with haematopoietic cells of the myeloid lineage(2 - 6). Here we show that lymphocytes also form heterotypic-fusion hybrids with cardiomyocytes, skeletal muscle, hepatocytes and Purkinje neurons. However, through lineage fate-mapping we demonstrate that such in vivo fusion of lymphoid and myeloid blood cells does not occur to an appreciable extent in steady-state adult tissues or during normal development. Rather, fusion of blood cells with different non-haematopoietic cell types is induced by organ-specific injuries or whole-body irradiation(1-10), which has been used in previous studies to condition recipients of bone marrow transplants. Our findings demonstrate that blood cells of the lymphoid and myeloid lineages contribute to various non-haematopoietic tissues by forming rare fusion hybrids, but almost exclusively in response to injuries or inflammation.	[Nygren, Jens M.; Liuba, Karina; Thoren, Lina; Jovinge, Stefan; Jacobsen, Sten Eirik W.] Lund Univ, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden; [Nygren, Jens M.; Liuba, Karina; Stott, Simon; Thoren, Lina; Kirik, Deniz; Bjorklund, Anders; Nerlov, Claus; Jovinge, Stefan; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden; [Nygren, Jens M.] Lund Univ, Div Immunol, Dept Expt Med Sci, S-22184 Lund, Sweden; [Breitbach, Martin; Geisen, Caroline; Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; [Stott, Simon; Kirik, Deniz; Bjorklund, Anders] Lund Univ, Wallenberg Neurosci Ctr, Div Neurobiol, S-22362 Lund, Sweden; [Roell, Wilhelm] Univ Bonn, Dept Cardiac Surg, D-53105 Bonn, Germany; [Nerlov, Claus] EMBL Monterotondo, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Jovinge, Stefan] Lund Univ, Univ Lund Hosp, Dept Cardiol, Coronary Program,Heart & Lung Div, S-22185 Lund, Sweden; [Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Headington OX3 9DS, England	Lund University; Lund University; Lund University; University of Bonn; Lund University; University of Bonn; European Molecular Biology Laboratory (EMBL); Lund University; Skane University Hospital; University of Oxford	Jacobsen, SEW (corresponding author), Lund Univ, Hematopoiet Stem Cell Lab, BMC B10, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Kirik, Deniz/E-5156-2011; Sasse, Philipp/G-9866-2013; Björklund, Anders/ABA-1326-2020; Jacobsen, Sten Eirik W/D-3974-2018	Sasse, Philipp/0000-0002-8502-9472; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Roell, Wilhelm/0000-0002-2213-5024; Stott, Simon/0000-0002-5741-4664; Nygren, Jens M/0000-0002-3576-2393	Medical Research Council [G0700711B] Funding Source: researchfish; MRC [G0501838] Funding Source: UKRI; Medical Research Council [G0501838] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Hallahan D, 1996, CANCER RES, V56, P5150; Irintchev A, 2002, CELL TISSUE RES, V308, P143, DOI 10.1007/s00441-002-0519-x; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; OGLE BM, 2005, NATURE REV MOL CELL; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; STADTFELD M, 2007, DEV BIOL; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	30	120	127	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					584	592		10.1038/ncb1721	http://dx.doi.org/10.1038/ncb1721			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425115				2022-12-27	WOS:000255502400015
J	Smalley, MJ; Reis-Filho, JS; Ashworth, A				Smalley, Matthew J.; Reis-Filho, Jorge S.; Ashworth, Alan			BRCa1 and stem cells: tumour typecasting	NATURE CELL BIOLOGY			English	Editorial Material							BREAST-CANCER	Phenotypic variation between tumour types is likely to reflect the nature of the cell of origin and the genes involved in pathogenesis. Compared with most sporadic breast cancers, those arising in carriers of BRCA1 mutations usually have distinctive pathological characteristics. a new study suggests that a role for BRCA1 in the determination of stem-cell fate may explain this phenomenon.	[Smalley, Matthew J.; Reis-Filho, Jorge S.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Smalley, MJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	Matthew.Smalley@icr.ac.uk; Jorge.Reis-Filho@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Smalley, Matthew J/M-7000-2015	Smalley, Matthew J/0000-0001-9540-1146				Ashworth A, 2005, CANCER CELL, V8, P95, DOI 10.1016/j.ccr.2005.07.011; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; Novelli M, 2003, P NATL ACAD SCI USA, V100, P3311, DOI 10.1073/pnas.0437825100; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876	16	15	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					377	379		10.1038/ncb0408-377	http://dx.doi.org/10.1038/ncb0408-377			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379596				2022-12-27	WOS:000254561700004
J	Christianson, JC; Shaler, TA; Tyler, RE; Kopito, RR				Christianson, John C.; Shaler, Thomas A.; Tyler, Ryan E.; Kopito, Ron R.			OS-9 and GRP94 deliver mutant alpha 1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD	NATURE CELL BIOLOGY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; PROTEIN DISLOCATION; IDENTIFIES YOS9P; GENE; EXPRESSION; CHAPERONE; RECEPTOR	Terminally misfolded or unassembled proteins in the early secretory pathway are degraded by a ubiquitin- and proteasome-dependent process known as ER-associated degradation (ERAD). How substrates of this pathway are recognized within the ER and delivered to the cytoplasmic ubiquitin- conjugating machinery is unknown. We report here that OS-9 and XTP3-B/Erlectin are ER-resident glycoproteins that bind to ERAD substrates and, through the SEL1L adaptor, to the ER-membrane-embedded ubiquitin ligase Hrd1. Both proteins contain conserved mannose 6-phosphate receptor homology (MRH) domains, which are required for interaction with SEL1L, but not with substrate. OS-9 associates with the ER chaperone GRP94 which, together with Hrd1 and SEL1L, is required for the degradation of an ERAD substrate, mutant alpha(1)-antitrypsin. These data suggest that XTP3-B and OS-9 are components of distinct, partially redundant, quality control surveillance pathways that coordinate protein folding with membrane dislocation and ubiquitin conjugation in mammalian cells.	[Christianson, John C.; Tyler, Ryan E.; Kopito, Ron R.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Christianson, John C.; Tyler, Ryan E.; Kopito, Ron R.] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Shaler, Thomas A.] PPD, Menlo Pk, CA 94025 USA	Stanford University; Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Lorry Lokey Bldg,337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu	Christianson, John C/Y-4567-2019	Christianson, John/0000-0002-0474-1207	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074874-04, R01 GM074874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Cruciat CM, 2006, J BIOL CHEM, V281, P12986, DOI 10.1074/jbc.M511872200; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Grant B, 1996, GENETICS, V143, P237; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; WARD CL, 1994, J BIOL CHEM, V269, P25710; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	50	380	389	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					272	U13		10.1038/ncb1689	http://dx.doi.org/10.1038/ncb1689			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264092	Green Accepted			2022-12-27	WOS:000253778300009
J	Yang, MH; Wu, MZ; Chiou, SH; Chen, PM; Chang, SY; Liu, CJ; Teng, SC; Wu, KJ				Yang, Muh-Hwa; Wu, Min-Zu; Chiou, Shih-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Liu, Chung-Ji; Teng, Shu-Chun; Wu, Kou-Juey			Direct regulation of TWIST by HIF-1 alpha promotes metastasis	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; HYPOXIA-INDUCIBLE FACTOR-1; TRANSCRIPTION FACTOR SNAIL; CADHERIN GENE-EXPRESSION; RENAL-CELL CARCINOMA; TUMOR PROGRESSION; NECK-CANCER; FACTOR 1-ALPHA; C-MYC; HEAD	Stabilization of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) transcription complex, caused by intratumoural hypoxia, promotes tumour progression and metastasis, leading to treatment failure and mortality in different types of human cancers. The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis. Notably, HIF-1 alpha- and TWIST-null mice show similarities in their phenotypes. Here, we have shown that hypoxia or overexpression of HIF-1 alpha promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes. We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter. However, siRNA-mediated repression of TWIST in HIF-1 alpha-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes. Co-expression of HIF-1 alpha, TWIST and Snail in primary tumours of patients with head and neck cancers correlated with metastasis and the worst prognosis. These results provide evidence of a key signalling pathway involving HIF-1 alpha and TWIST that promotes metastasis in response to intratumoural hypoxia.	[Yang, Muh-Hwa; Wu, Min-Zu; Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chiou, Shih-Hwa; Wu, Kou-Juey] Natl Yang Ming Univ, Dept Clin Med, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chen, Po-Min] Taipei Vet Gen Hosp, Div Hematol Oncol, Dept Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Chang, Shyue-Yih] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Wu, Kou-Juey] Taipei Vet Gen Hosp, Genom Res Ctr, Taipei 112, Taiwan; [Liu, Chung-Ji] Taipei Mackay Mem Hosp, Dept Dent, Taipei 104, Taiwan; [Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Mackay Memorial Hospital; National Taiwan University	Wu, KJ (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sec 2,Li Niong St, Taipei 112, Taiwan.	kjwu2@ym.edu.tw	Wu, Kou-Juey/P-4654-2015; Yang, Muh-Hwa/AAE-4691-2020	TENG, SHU-CHUN/0000-0002-6492-2560				Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Corsi AK, 2000, DEVELOPMENT, V127, P2041; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Pugh CW, 2001, BREAST CANCER RES, V3, P313, DOI 10.1186/bcr313; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sawair FA, 2003, J ORAL PATHOL MED, V32, P1, DOI 10.1034/j.1600-0714.2003.00060.x; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tickoo SK, 2007, J UROLOGY, V177, P1258, DOI 10.1016/j.juro.2006.11.100; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929	39	984	1022	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					295	305		10.1038/ncb1691	http://dx.doi.org/10.1038/ncb1691			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297062				2022-12-27	WOS:000253778300011
J	Boehlke, C; Kotsis, F; Patel, V; Braeg, S; Voelker, H; Bredt, S; Beyer, T; Janusch, H; Hamann, C; Godel, M; Muller, K; Herbst, M; Hornung, M; Doerken, M; Kottgen, M; Nitschke, R; Igarashi, P; Walz, G; Kuehn, EW				Boehlke, Christopher; Kotsis, Fruzsina; Patel, Vishal; Braeg, Simone; Voelker, Henriette; Bredt, Saskia; Beyer, Theresa; Janusch, Heike; Hamann, Christoph; Goedel, Markus; Mueller, Klaus; Herbst, Martin; Hornung, Miriam; Doerken, Mara; Koettgen, Michael; Nitschke, Roland; Igarashi, Peter; Walz, Gerd; Kuehn, E. Wolfgang			Primary cilia regulate mTORC1 activity and cell size through Lkb1	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; CYST FORMATION; MECHANISMS; POLARITY; COMPLEX; GROWTH; PHOSPHORYLATION; TARGET; RAPTOR; GENE	The mTOR pathway is the central regulator of cell size(1). External signals from growth factors and nutrients converge on the mTORC1 multi-protein complex to modulate downstream targets, but how the different inputs are integrated and translated into specific cellular responses is incompletely understood(2-4). Deregulation of the mTOR pathway occurs in polycystic kidney disease (PKD)(5-7), where cilia (filiform sensory organelles) fail to sense urine flow because of inherited mutations in ciliary proteins(8). We therefore investigated if cilia have a role in mTOR regulation. Here, we show that ablation of cilia in transgenic mice results in enlarged cells when compared with control animals. In vitro analysis demonstrated that bending of the cilia by flow is required for mTOR downregulation and cell-size control. Surprisingly, regulation of cell size by cilia is independent of flow-induced calcium transients, or Akt. However, the tumour-suppressor protein Lkb1 localises in the cilium, and flow results in increased AMPK phosphorylation at the basal body. Conversely, knockdown of Lkb1 prevents normal cell-size regulation under flow conditions. Our results demonstrate that the cilium regulates mTOR signalling and cell size, and identify the cilium-basal body compartment as a spatially restricted activation site for Lkb1 signalling.	[Boehlke, Christopher; Kotsis, Fruzsina; Braeg, Simone; Voelker, Henriette; Bredt, Saskia; Beyer, Theresa; Janusch, Heike; Hamann, Christoph; Goedel, Markus; Mueller, Klaus; Herbst, Martin; Hornung, Miriam; Doerken, Mara; Koettgen, Michael; Walz, Gerd; Kuehn, E. Wolfgang] Univ Freiburg, Renal Unit, Dept Med, Univ Med Ctr, D-79106 Freiburg, Germany; [Patel, Vishal; Igarashi, Peter] Univ Texas Dallas, SW Med Ctr, Div Nephrol, Dallas, TX 75390 USA; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr, Ctr Biol Syst Anal, D-79104 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79108 Freiburg, Germany	University of Freiburg; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Freiburg; University of Freiburg	Kuehn, EW (corresponding author), Univ Freiburg, Renal Unit, Dept Med, Univ Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolfgang.kuehn@uniklinik-freiburg.de	Patel, Vishal/GMW-7076-2022; Nitschke, Roland/F-9525-2010; Boehlke, Christopher/AAZ-6627-2021	Patel, Vishal/0000-0003-2875-4659; Nitschke, Roland/0000-0002-9397-8475; Boehlke, Christopher/0000-0002-6985-0201; Kottgen, Michael/0000-0003-2406-5039; Igarashi, Peter/0000-0001-8698-1185	DFG [KFO 201, WA597, SFB 592, SFB 592 Z2]; Excellence Initiative of the German Federal and State Governments [EXC 294]; NIH [P30DK79328, R01DK67565, T32DK07257]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067565, T32DK007257, P30DK079328] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DFG KFO 201 (to E.W.K.), WA597 and SFB 592 (to G.W.), SFB 592 Z2 and by the Excellence Initiative of the German Federal and State Governments (EXC 294 to R.N.), and NIH grants P30DK79328, R01DK67565 and T32DK07257 (to P.I.). We thank B. Yoder for anti-sera, R. Lamb, H. Clevers, Y. Mimori-Kiyosue, M. Sebbagh and A. Miyawaki for constructs, S. Arnold, M. Simons, D. Bennet and M. Bloech for critical appraisal of the manuscript and S. Lienkamp, F. Grahammer and members of the Walz lab for helpful discussions.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kotsis F, 2008, PFLUG ARCH EUR J PHY, V456, P1025, DOI 10.1007/s00424-008-0475-8; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maekawa F, 2000, ENDOCRINOLOGY, V141, P375, DOI 10.1210/en.141.1.375; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Sebbagh M, 2009, CURR BIOL, V19, P37, DOI 10.1016/j.cub.2008.11.033; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; VAN L, 2006, J BIOL CHEM */* RHEB, V281, P19793; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Zhang QH, 2005, LAB INVEST, V85, P45, DOI 10.1038/labinvest.3700207	44	248	255	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1115	U126		10.1038/ncb2117	http://dx.doi.org/10.1038/ncb2117			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972424	Green Accepted			2022-12-27	WOS:000283711500016
J	Chuikov, S; Levi, BP; Smith, ML; Morrison, SJ				Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.			Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; SELF-RENEWAL; MICE; HOMEOSTASIS; PATHWAYS; FAMILY; GENES; FOXOS; LGR5	To better understand the mechanisms that regulate stem cell identity and function, we sought to identify genes that are preferentially expressed by stem cells and critical for their function in multiple tissues. Prdm16 is a transcription factor that regulates leukaemogenesis(1), palatogenesis(2) and brown-fat development(3-5), but which was not known to be required for stem cell function. We demonstrate that Prdm16 is preferentially expressed by stem cells throughout the nervous and haematopoietic systems and is required for their maintenance. In the haematopoietic and nervous systems, Prdm16 deficiency led to changes in the levels of reactive oxygen species (ROS), depletion of stem cells, increased cell death and altered cell-cycle distribution. In neural stem/progenitor cells, Prdm16 binds to the Hgf promoter, and Hgf expression declined in the absence of Prdm16. Addition of recombinant HGF to Prdm16-deficient neural stem cells in cell culture reduced the depletion of these cells and partially rescued the increase in ROS levels. Administration of the anti-oxidant, N-acetyl-cysteine, to Prdm16-deficient mice partially rescued defects in neural stem/progenitor cell function and neural development. Prdm16 therefore promotes stem cell maintenance in multiple tissues, partly by modulating oxidative stress.	[Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; National Institutes of Neurological Disease and Stroke [NS40750]; Leukemia and Lymphoma Society; American Heart Association [0725726Z]; Irvington Institute-Cancer Research Institute; UM-Comprehensive Cancer, NIH [CA46592]; Rheumatic Core Disease Center [P30 AR48310]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Neurological Disease and Stroke; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); Irvington Institute-Cancer Research Institute; UM-Comprehensive Cancer, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatic Core Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute and by the National Institutes of Neurological Disease and Stroke (NS40750). S. C. was supported by a career development award from the Leukemia and Lymphoma Society. B.P.L. was supported by an American Heart Association Postdoctoral Fellowship (0725726Z) and an Irvington Institute-Cancer Research Institute/Edmond J. Safra Memorial Fellowship. Flow-cytometry work was partially supported by the UM-Comprehensive Cancer, NIH CA46592. We thank M. White and D. Adams for flow-cytometry assistance, G. Wendt for technical assistance, and E. Smith (Hybridoma Core Facility) for antibody production, partially supported through the Rheumatic Core Disease Center (P30 AR48310).	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Ren T, 2007, J NEUROSCI, V27, P10345, DOI 10.1523/JNEUROSCI.2787-07.2007; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	29	148	151	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					999	1006		10.1038/ncb2101	http://dx.doi.org/10.1038/ncb2101			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20835244	Green Accepted			2022-12-27	WOS:000282363500015
J	Kraft, C; Peter, M; Hofmann, K				Kraft, Claudine; Peter, Matthias; Hofmann, Kay			Selective autophagy: ubiquitin-mediated recognition and beyond	NATURE CELL BIOLOGY			English	Article							PROTEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; TARGETING PATHWAY; DEGRADATION; PARKIN; P62/SQSTM1; RECEPTOR; P62; CYTOPLASM; HDAC6	Eukaryotic cells use autophagy and the ubiquitin-proteasome system as their major protein degradation pathways. Whereas the ubiquitin-proteasome system is involved in the rapid degradation of proteins, autophagy pathways can selectively remove protein aggregates and damaged or excess organelles. Proteasome-mediated degradation requires previous ubiquitylation of the cargo, which is then recognized by ubiquitin receptors directing it to 26S proteasomes. Although autophagy has long been viewed as a random cytoplasmic degradation system, the involvement of ubiquitin as a specificity factor for selective autophagy is rapidly emerging. Recent evidence also suggests active crosstalk between proteasome-mediated degradation and selective autophagy. Here, we discuss the molecular mechanisms that link autophagy and the proteasome system, as well as the emerging roles of ubiquitin and ubiquitin-binding proteins in selective autophagy. On the basis of the evolutionary history of autophagic ubiquitin receptors, we propose a common origin for metazoan ubiquitin-dependent autophagy and the cytoplasm-to-vacuole targeting pathway of yeast.	[Kraft, Claudine; Peter, Matthias] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Miltenyi Biotec	Kraft, C (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	matthias.peter@bc.biol.ethz.ch; kay.hofmann@miltenyibiotec.de	Hofmann, Kay/D-6714-2011	Hofmann, Kay/0000-0002-2289-9083; Peter, Matthias/0000-0002-2160-6824	Swiss National Science Foundation (SNF); SystemsX.ch; Eidgenossische Technische Hochschule Zurich; Deutsche Forschungsgemeinschaft [SPP1365]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SystemsX.ch; Eidgenossische Technische Hochschule Zurich(ETH Zurich); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Reinhard Dechant and Jason Mercer for critical reading of the manuscript. C.K. is supported by a Marie-Heim Vogtlin fellowship from the Swiss National Science Foundation (SNF). M.P. is a member of the Competence Center for Systems Physiology and Metabolic Diseases (SPMD), and supported by grants from the SNF, SystemsX.ch and the Eidgenossische Technische Hochschule Zurich. K.H. is supported by the Deutsche Forschungsgemeinschaft priority programme SPP1365.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	45	479	491	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					836	841		10.1038/ncb0910-836	http://dx.doi.org/10.1038/ncb0910-836			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811356				2022-12-27	WOS:000281561900005
J	Li, XX; Dawe, RK				Li, Xuexian; Dawe, R. Kelly			Fused sister kinetochores initiate the reductional division in meiosis I	NATURE CELL BIOLOGY			English	Article							CHROMOSOME SEGREGATION; MONOPOLAR ATTACHMENT; FUNCTIONAL GENOMICS; DROSOPHILA MEI-S332; CHROMATID COHESION; HOMOLOG; CENTROMERE; SHUGOSHIN; DIFFERENTIATION; ORIENTATION	During meiosis I the genome is reduced to the haploid content by a coordinated reductional division event. Homologous chromosomes align, recombine and segregate while the sister chromatids co-orient and move to the same pole(1,2). Several data suggest that sister kinetochores co-orient early in metaphase I and that sister chromatid cohesion (which requires Rec8 and Shugoshin) supports monopolar orientation. Nevertheless, it is unclear how the sister kinetochores function as single unit during this period. A gene (monopolin)(3) with a co-orienting role was identified in Saccharomyces cerevisiae; however, it does not have the same function in fission yeast(4) and no similar genes have been found in other species. Here we pursue this issue using knockdown mutants of the core kinetochore protein MIS12 (minichromosome instability 12). MIS12 binds to base of the NDC80 complex, which in turn binds directly to microtubuies(5-7). In maize plants with systemically reduced levels of MIS12, a visible MIS12-NDC80 bridge between sister kinetochores at meiosis I is broken. Kinetochores separate and orient randomly in metaphase 1, causing chromosomes to stall in anaphase due to normal cohesion, marked by Shugoshin, between the chromatids. The data establish that sister kinetochores in meiosis I are fused by a shared microtubule-binding face and that this direct linkage is required for reductional division.	[Li, Xuexian; Dawe, R. Kelly] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Dawe, R. Kelly] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dawe, RK (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	kelly@plantbio.uga.edu			National Science Foundation [0421671]	National Science Foundation(National Science Foundation (NSF))	We thank X. Zhang for her support and help with RT-PCR and image analysis, H. Tang for help with statistics, R. Wang for providing Shugoshin antibodies, A. Luce for technical support and C. Topp and L. Kanizay for helpful comments. This study was supported by a grant from the National Science Foundation to R.K.D. (0421671).	Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; COUNCE SJ, 1973, CHROMOSOMA, V44, P231, DOI 10.1007/BF00329119; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Dawe RK, 1998, ANNU REV PLANT PHYS, V49, P371, DOI 10.1146/annurev.arplant.49.1.371; Du Y, 2007, CHROMOSOME RES, V15, P767, DOI 10.1007/s10577-007-1160-z; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Golubovskaya IN, 2006, J CELL SCI, V119, P3306, DOI 10.1242/jcs.03054; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; KERREBROCK AW, 1992, GENETICS, V130, P827; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; McGinnis K, 2007, PLANT PHYSIOL, V143, P1441, DOI 10.1104/pp.106.094334; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sato H, 2005, CHROMOSOME RES, V13, P827, DOI 10.1007/s10577-005-1016-3; Stoop-Myer C, 1999, NAT CELL BIOL, V1, pE125, DOI 10.1038/12956; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zhang XL, 2005, PLANT CELL, V17, P572, DOI 10.1105/tpc.104.028522; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	32	67	71	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1103	U122		10.1038/ncb1923	http://dx.doi.org/10.1038/ncb1923			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684578				2022-12-27	WOS:000269482500011
J	Jang, ACC; Chang, YC; Bai, JW; Montell, D				Jang, Anna C. -C.; Chang, Yu-Chiuan; Bai, Jianwu; Montell, Denise			Border-cell migration requires integration of spatial and temporal signals by the BTB protein Abrupt	NATURE CELL BIOLOGY			English	Article							DROSOPHILA ECDYSONE-RECEPTOR; GENE-FUNCTION; P450 ENZYME; MELANOGASTER; METAMORPHOSIS; ECR; OOGENESIS; MICRORNA; BEHAVIOR; PATHWAY	During development, elaborate patterns of cell differentiation and movement must occur in the correct locations and at the proper times. Developmental timing has been studied less than spatial pattern formation, and the mechanisms integrating the two are poorly understood. Border-cell migration in the Drosophila ovary occurs specifically at stage 9. Timing of the migration is regulated by the steroid hormone ecdysone, whereas spatial patterning of the migratory population requires localized activity of the JAK-STAT pathway. Ecdysone signalling is patterned spatially as well as temporally, although the mechanisms are not well understood. In stage 9 egg chambers, ecdysone signalling is highest in anterior follicle cells including the border cells. We identify the gene abrupt as a repressor of ecdysone signalling and border-cell migration. Abrupt protein is normally lost from border-cell nuclei during stage 9, in response to JAK-STAT activity. This contributes to the spatial pattern of the ecdysone response. Abrupt attenuates ecdysone signalling by means of a direct interaction with the basic helix-loop-helix (bHLH) domain of the P160 ecdysone receptor coactivator Taiman (Tai). Taken together, these findings provide a molecular mechanism by which spatial and temporal cues are integrated.	[Jang, Anna C. -C.; Chang, Yu-Chiuan; Montell, Denise] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Bai, Jianwu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02175 USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School	Montell, D (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R01GM073164] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM46425, R01 GM046425, R01 GM073164, R01 GM73164, R01 GM073164-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Banerjee I, 2007, J NEUROENDOCRINOL, V19, P831, DOI 10.1111/j.1365-2826.2007.01598.x; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carney GE, 2000, GENETICS, V154, P1203; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Doe CQ, 2006, CELL, V127, P254, DOI 10.1016/j.cell.2006.10.008; Frasch M, 2008, GENE DEV, V22, P1572, DOI 10.1101/gad.1690608; Freeman MR, 1999, DEVELOPMENT, V126, P4591; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Riddiford Lynn M., 1993, P899; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; RUBENSTEIN EC, 1982, J EXP ZOOL, V223, P305, DOI 10.1002/jez.1402230313; Schubiger M, 2003, MECH DEVELOP, V120, P909, DOI 10.1016/S0925-4773(03)00134-5; SCHWARTZ MB, 1989, INSECT BIOCHEM, V19, P243, DOI 10.1016/0020-1790(89)90068-1; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yao JG, 2005, EMBO J, V24, P2602, DOI 10.1038/sj.emboj.7600725; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	55	76	77	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					569	U100		10.1038/ncb1863	http://dx.doi.org/10.1038/ncb1863			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19350016	Green Accepted			2022-12-27	WOS:000265640000016
J	Kirino, Y; Kim, N; de Planell-Saguer, M; Khandros, E; Chiorean, S; Klein, PS; Rigoutsos, I; Jongens, TA; Mourelatos, Z				Kirino, Yohei; Kim, Namwoo; de Planell-Saguer, Mariangels; Khandros, Eugene; Chiorean, Stephanie; Klein, Peter S.; Rigoutsos, Isidore; Jongens, Thomas A.; Mourelatos, Zissimos			Arginine methylation of Piwi proteins catalysed by dPRMT5 is required for Ago3 and Aub stability	NATURE CELL BIOLOGY			English	Article							SPLICEOSOMAL SM PROTEINS; SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; INTERACTING RNAS; METHYLTRANSFERASE CAPSULEEN; TRANSPOSON CONTROL; CELL-FORMATION; TUDOR DOMAINS; 3' TERMINI; GERMLINE	Piwi family proteins are essential for germline development and bind piwi-interacting RNAs (piRNAs)(1-3). The grandchildless gene aub of Drosophila melanogaster encodes the piRNA-binding protein Aubergine (Aub), which is essential for formation of primordial germ cells (PGCs)(4). Here we report that Piwi family proteins of mouse, Xenopus laevis and Drosophila contain symmetrical dimethylarginines (sDMAs). We found that Piwi proteins are expressed in Xenopus oocytes and we identified numerous Xenopus piRNAs. We report that the Drosophila homologue of protein methyltransferase 5 (dPRMT5, csul/ dart5), which is also the product of a grandchildless gene(5,6), is required for arginine methylation of Drosophila Piwi, Ago3 and Aub proteins in vivo. Loss of dPRMT5 activity led to a reduction in the levels of piRNAs, Ago3 and Aub proteins, and accumulation of retrotransposons in the Drosophila ovary. Our studies explain the relationship between aub and dPRMT5 (csul/ dart5) genes by demonstrating that dPRMT5 is the enzyme that methylates Aub. Our findings underscore the significance of sDMA modification of Piwi proteins in the germline and suggest an interacting pathway of genes that are required for piRNA function and PGC specification.	[Kirino, Yohei; Kim, Namwoo; de Planell-Saguer, Mariangels; Khandros, Eugene; Mourelatos, Zissimos] Univ Penn, Dept Pathol & Lab Med, Div Neuropathol, Sch Med, Philadelphia, PA 19104 USA; [Chiorean, Stephanie; Jongens, Thomas A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; International Business Machines (IBM)	Mourelatos, Z (corresponding author), Univ Penn, Dept Pathol & Lab Med, Div Neuropathol, Sch Med, Philadelphia, PA 19104 USA.	mourelaz@uphs.upenn.edu	Rigoutsos, Isidore/C-5381-2012	Kirino, Yohei/0000-0001-5232-4742; Kim, Namwoo/0000-0002-1684-5417; Rigoutsos, Isidore/0000-0003-1529-8631; Mourelatos, Zissimos/0000-0002-9852-1845	Human Frontier Science Program [GM76621, GM0720777, NS056070, UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056070, R01NS046573] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. C. Siomi, H. Siomi, K. Saito, G. Dreyfuss for antibodies; to J. Anne for csul flies; to S. Kuramochi-Miyagawa and T. Nakano for Miwi and Mili cDNA constructs; to Rebecca Beerman for help with fly methodology; to Y. Kawamura for immunofluorescence protocols and to members of the Mourelatos lab for discussions. Mass spectrometry was performed at the Proteomics Core Facility (University of Pennsylvania) and at the Proteomics Resource of the Keck Foundation (Yale University). Illumina sequencing was performed at the Functional Genomics Core of the University of Pennsylvania. Protein production was at the Protein Expression Core of the Wistar Institute. We apologize to colleagues whose studies were not cited because of space limitations. This work was supported by a Human Frontier Science Program Long Term Fellowship to Y. K., and NIH grants to T. A. J. (NS046573), P. S. K. (GM76621) and Z. M.(GM0720777, NS056070, UL1RR024134). Z. M. also received ITMAT-PENN and URF-PENN.	Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Bossi Elena, 2007, V375, P107; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kiriakidou M, 2005, METH MOL B, V309, P295; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	52	175	194	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					652	U478		10.1038/ncb1872	http://dx.doi.org/10.1038/ncb1872			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377467	Green Accepted			2022-12-27	WOS:000265640000025
J	Liu, QH; Busby, JC; Molkentin, JD				Liu, Qinghang; Busby, Jennifer Caldwell; Molkentin, Jeffery D.			Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point	NATURE CELL BIOLOGY			English	Article							TAK1 MAPKKK; CALCINEURIN; PROTEIN; PHOSPHORYLATION; KINASE; FAMILY; IDENTIFICATION; PHOSPHATASE-1; ACTIVATOR; RECEPTOR	The calcium-activated protein phosphatase calcineurin is controlled by regulator of calcineurin (RCAN) in organisms ranging from yeast to mammals. Here we performed a yeast two-hybrid screen with RCAN1 as bait, identifying TAK1 binding protein 2 (TAB2) as an interacting partner. TAB2 interacted directly with RCAN1 in vitro and in vivo, recruiting TAK1, TAB1 and calcineurin, forming a macromolecular signalling complex. Overexpression of TAK1 and TAB1, or active TAK1(Delta N), promoted direct phosphorylation of RCAN1 in vitro and in vivo. TAK1 phosphorylated RCAN1 at Ser 94 and Ser 136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signalling, and enhancing NFATc1 nuclear translocation, NFAT transcriptional activation and the hypertrophic growth of cultured cardiomyocytes. The TAK1-TAB1-TAB2 and the calcineurin-NFAT signalling modules did not interact in Rcan1/2-or Tab2-deficient mouse embryonic fibroblast (MEF) cultures. Calcineurin activation also dephosphorylated and inhibited TAK1 and TAB1, an effect that was absent in Rcan1/2 deficient MEFs. Functionally, TAK1 was indispensable for the cardiomyocyte growth response induced by pro-hypertrophic stimuli through calcineurin. These results describe a signalling relationship between two central regulatory pathways in which TAK1-TAB1-TAB2 selectively induces calcineurin-NFAT signalling through direct phosphorylation of RCAN1, while calcineurin activation diminishes TAK1 signalling by dephosphorylation of TAK1 and TAB1.	[Liu, Qinghang; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Liu, Qinghang; Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati, OH 45229 USA; [Busby, Jennifer Caldwell] Scripps Res Inst, Jupiter, FL 33458 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Scripps Research Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Liu, Qinghang/0000-0003-0638-6509; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health; Fondation Leducq; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060562, R01HL081104, R01HL060562, P50HL077101, P01HL069779, R01HL062927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are very grateful to Yang Xia for the generous gift of the S108/112A mutant RCAN1 plasmid, and Jun Tsuji for providing the Tak1<SUP>-/-</SUP> MEFs originated from Akira's laboratory. This work was supported by grants from the National Institutes of Health (J.D.M), the Fondation Leducq (Heart failure network grant to J.D.M), and the Howard Hughes Medical Institute.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Cohen PTW, 2002, J CELL SCI, V115, P241; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Godeny MD, 2007, CELL SIGNAL, V19, P600, DOI 10.1016/j.cellsig.2006.08.010; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	30	98	102	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					154	U93		10.1038/ncb1823	http://dx.doi.org/10.1038/ncb1823			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136967	Green Accepted			2022-12-27	WOS:000263285500013
J	Dogan, T; Harms, GS; Hekman, M; Karreman, C; Oberoi, TK; Alnemri, ES; Rapp, UR; Rajalingam, K				Dogan, Taner; Harms, Gregory S.; Hekman, Mirko; Karreman, Christiaan; Oberoi, Tripat Kaur; Alnemri, Emad S.; Rapp, Ulf R.; Rajalingam, Krishnaraj			X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility	NATURE CELL BIOLOGY			English	Article							APOPTOSIS PROTEINS; SIGNALING PATHWAYS; XIAP; INHIBITOR; CHAPERONE; DESTABILIZATION	Inhibitor of apoptosis proteins (IAP) are evolutionarily conserved anti-apoptotic regulators(1,2). C-RAF protein kinase is a direct RAS effector protein, which initiates the classical mitogen-activated protein kinase ( MAPK) cascade. This signalling cascade mediates diverse biological functions, such as cell growth, proliferation, migration, differentiation and survival(3,4). Here we demonstrate that XIAP and c-IAPs bind directly to C-RAF kinase and that siRNA-mediated silencing of XIAP and c-IAPs leads to stabilization of C-RAF in human cells. XIAP binds strongly to C-RAF and promotes the ubiquitylation of C-RAF in vivo through the Hsp90-mediated quality control system, independently of its E3 ligase activity. In addition, XIAP or c-IAP-1/2 knockdown cells showed enhanced cell migration in a C-RAF-dependent manner. XIAP promotes binding of CHIP ( carboxy terminal Hsc70-interacting protein), a chaperone-associated ubiquitin ligase, to the C-RAF-Hsp90 complex in vivo. Interfering with CHIP expression resulted in stabilization of C-RAF and enhanced cell migration, as observed in XIAP knockdown cells. Our data show an unexpected role of XIAP and c-IAPs in the turnover of C-RAF protein, thereby modulating the MAPK signalling pathway and cell migration.	[Dogan, Taner; Oberoi, Tripat Kaur; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Emmy Noether Grp, DFG, Med Sch,Inst Biochem 2, Frankfurt, Germany; [Hekman, Mirko; Karreman, Christiaan; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum, MZS, D-97070 Wurzburg, Germany; [Harms, Gregory S.] Univ Wurzburg, Dept Mol Microscopy, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Ctr Apoptosis Res, Kimmel Canc Inst, Philadelphia, PA 19107 USA	German Research Foundation (DFG); Goethe University Frankfurt; University of Wurzburg; University of Wurzburg; Jefferson University	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Emmy Noether Grp, DFG, Med Sch,Inst Biochem 2, Frankfurt, Germany.	krishna@biochem2.de	Rajalingam, krishnaraj/D-3081-2011; Alnemri, Emad S/B-4526-2010	Oberoi, Tripat Kaur/0000-0001-9299-9496	DFG [RA1739/1-1, SFB487, SFB581]; NIH [GMO76167]	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Pascal Meier, Richard Marais, Len Neckers, Yuri Lazebnik and H. Wayant for valuable reagents; Brigitte Ruester and Reinhard Henschler for assistance with cell sorting; Renate Metz for help with the purification of proteins; Andreas Fischer for Biacore analysis; Juliane Mooz and Barbara Bauer for technical assistance. This work is supported by an Emmy Noether programme grant (RA1739/1-1) to K. R. from the DFG and various grants to U. R. R. from DFG, including Immunomodulation and German-French Graduate Schools, SFB487, SFB581, and grants from the Scheel Stiftung. E. S. A. is supported by grants from the NIH (GMO76167). We thank Antoine Galmiche for sharing unpublished observations, Ralf Schreck and Ritva Tikkanen for critically reading the manuscript.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2004, BBA-MOL CELL RES, V1644, P149, DOI 10.1016/j.bbamcr.2003.10.015; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tian S, 2006, INT J ONCOL, V29, P861; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vucic D, 2008, CURR CANCER DRUG TAR, V8, P110, DOI 10.2174/156800908783769373; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	31	82	82	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1447	1455		10.1038/ncb1804	http://dx.doi.org/10.1038/ncb1804			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011619				2022-12-27	WOS:000261261800015
J	Sorrentino, A; Thakur, N; Grimsby, S; Marcusson, A; von Bulow, V; Schuster, N; Zhang, S; Heldin, CH; Landstrom, M				Sorrentino, Alessandro; Thakur, Noopur; Grimsby, Susanne; Marcusson, Anders; von Bulow, Verena; Schuster, Norbert; Zhang, Shouting; Heldin, Carl-Henrik; Landstroem, Marene			The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CELL-MEMBRANE; PATHWAY; BINDING; UBIQUITINATION; IDENTIFICATION; SUFFICIENT; MECHANISMS; APOPTOSIS; REQUIRES	Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that regulates embryonic development and tissue homeostasis; however, aberrations of its activity occur in cancer(1,2). TGF-beta signals through its Type II and Type I receptors (T beta RII and T beta RI) causing phosphorylation of Smad proteins(3,4). TGF-beta-associated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, was originally identified as an effector of TGF-beta-induced p38 activation(5). However, the molecular mechanisms for its activation are unknown. Here we report that the ubiquitin ligase (E3) TRAF6 interacts with a consensus motif present in T beta RI. The T beta RI-TRAF6 interaction is required for TGF-beta-induced autoubiquitylation of TRAF6 and subsequent activation of the TAK1-p38/JNK pathway, which leads to apoptosis. T beta RI kinase activity is required for activation of the canonical Smad pathway, whereas E3 activity of TRAF6 regulates the activation of TAK1 in a receptor kinase-independent manner. Intriguingly, TGF-beta-induced TRAF6-mediated Lys 63-linked polyubiquitylation of TAK1 Lys 34 correlates with TAK1 activation. Our data show that TGF-beta specifically activates TAK1 through interaction of T beta RI with TRAF6, whereas activation of Smad2 is not dependent on TRAF6.	[Sorrentino, Alessandro; Thakur, Noopur; Grimsby, Susanne; Marcusson, Anders; von Bulow, Verena; Schuster, Norbert; Zhang, Shouting; Heldin, Carl-Henrik; Landstroem, Marene] Uppsala Univ, Rudbeck Lab, Ludwig Inst Canc Res, SE-75185 Uppsala, Sweden; [Thakur, Noopur; Marcusson, Anders; Landstroem, Marene] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Landstrom, M (corresponding author), Uppsala Univ, Rudbeck Lab, Ludwig Inst Canc Res, SE-75185 Uppsala, Sweden.	Marene.Landstrom@genpat.uu.se	高, 雨莉/HGU-8187-2022; Thakur, Noopur/AAD-5145-2019	Landstrom, Marene/0000-0001-6737-7230; Thakur, Noopur/0000-0002-5531-7182				Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Takatsu Y, 2000, MOL CELL BIOL, V20, P3015, DOI 10.1128/MCB.20.9.3015-3026.2000; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523	27	412	429	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1199	1207		10.1038/ncb1780	http://dx.doi.org/10.1038/ncb1780			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758450				2022-12-27	WOS:000259682900014
J	Shaye, DD; Casanova, J; Llimargas, M				Shaye, Daniel D.; Casanova, Jordi; Llimargas, Marta			Modulation of intracellular trafficking regulates cell intercalation in the Drosophila trachea	NATURE CELL BIOLOGY			English	Article							MORPHOGENESIS; PROTEIN; RAB11; ENDOCYTOSIS; MOVEMENTS; MIGRATION; TRANSPORT; HOMOLOG; SYSTEM	Through intercalation, a fundamental mechanism underlying elongation during morphogenesis, epithelial cells exchange places in a spatially oriented manner(1). epithelial cells are tightly coupled through distinct intercellular junctions, including adherens junctions. Whether trafficking-mediated regulation of adhesion through adherens junctions modulates intercalation in vivo remains controversial(1,2). In Drosophila melanogaster, cells in most branches intercalate during tracheal development. However, Wingless (Wg)-promoted expression of the transcription factor spalt (sal) in the dorsal trunk inhibits intercalation(3) by an unknown mechanism. Here we have examined the role of trafficking in tracheal intercalation and show that it requires endocytosis, whereas it is opposed by Rab11-mediated recycling in the dorsal trunk. subapical Rab11 accumulation is enhanced by sal and elevated Rab11-mediated recycling occurs in the dorsal trunk, suggesting that upregulation of Rab11 is one way in which sal inhibits intercalation. We found that dRip11, which regulates Rab11 localization and function(4), is regulated by sal and can modulate intercalation. Finally, we provide evidence that levels of E-cadherin (DE-cad), an adherens junction component(5) and Rab11-compartment cargo(6-8), are dynamically regulated by trafficking during tracheal development, and that such regulation modulates intercalation. Our work suggests a mechanism by which trafficking of adhesion molecules regulates intercalation, and shows how this mechanism can be modulated in vivo to influence cell behaviour.	[Shaye, Daniel D.; Casanova, Jordi; Llimargas, Marta] CSIC, Inst Mol Biol, E-08028 Barcelona, Spain; [Shaye, Daniel D.; Casanova, Jordi] Inst Recerca Biomed Barcelona, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Llimargas, M (corresponding author), CSIC, Inst Mol Biol, C Baldiri Reixac 10, E-08028 Barcelona, Spain.	jcrbmc@cid.csic.es; mlcbmc@cid.csic.es	Casanova, Jordi/L-5181-2014; Shaye, Daniel/AAY-5351-2020	Casanova, Jordi/0000-0001-6121-8589; Shaye, Daniel/0000-0002-3962-6903				Beloussov LV, 2000, DEV GENES EVOL, V210, P92, DOI 10.1007/s004270050015; Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482; Chen CK, 1998, DEVELOPMENT, V125, P4959; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dollar G, 2002, DEVELOPMENT, V129, P517; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Jarrett O, 2002, INT J DEV BIOL, V46, P467; Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048; Kleeff J, 2002, DIS ESOPHAGUS, V15, P10, DOI 10.1046/j.1442-2050.2002.00211.x; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Moline MM, 1999, DEVELOPMENT, V126, P4375; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Rodman JS, 2000, J CELL SCI, V113, P183; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0	30	89	90	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					964	970		10.1038/ncb1756	http://dx.doi.org/10.1038/ncb1756			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641639				2022-12-27	WOS:000258147100014
J	Rowlinson, SW; Yoshizato, H; Barclay, JL; Brooks, AJ; Behncken, SN; Kerr, LM; Millard, K; Palethorpe, K; Nielsen, K; Clyde-Smith, J; Hancock, JF; Waters, MJ				Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.			An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway	NATURE CELL BIOLOGY			English	Article							KINASE-ACTIVITY; FACTOR-I; DIMERIZATION; ACTIVATION; COMPLEX; ANTAGONIST; DOMAIN; IDENTIFICATION; PREADIPOCYTES; TRANSDUCTION	The growth and metabolic actions of growth hormone (GH) are believed to be mediated through the GH receptor (GHR) by JAK2 activation. The GHR exists as a constitutive homdimer, with signal transduction by ligand- induced realignment of receptor subunits(1). Based on the crystal structures(2,3), we identify a conformational change in the F'G' loop of the lower cytokine module, which results from binding of hGH but not G120R hGH antagonist. Mutations disabling this conformational change cause impairment of ERK but not JAK2 and STAT5 activation by the GHR in FDC-P1 cells. This results from the use of two associated tyrosine kinases by the GHR, with JAK2 activating STAT5, and Lyn activating ERK1/2. We provide evidence that Lyn signals through phospholipase C gamma, leading to activation of Ras. Accordingly, mice with mutations in the JAK2 association motif respond to GH with activation of hepatic Src and ERK1/2, but not JAK2/STAT5. We suggest that F'G' loop movement alters the signalling choice between JAK2 and a Src family kinase by regulating TMD realignment. Our findings could explain debilitated ERK but not STAT5 signalling in some GH- resistant dwarfs and suggest pathway- specific cytokine agonists.	[Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Rowlinson, Scott W.; Yoshizato, Hideo; Barclay, Johanna L.; Brooks, Andrew J.; Behncken, Stuart N.; Kerr, Linda M.; Millard, Kirstin; Palethorpe, Kathryn; Nielsen, Katherine; Clyde-Smith, Jodie; Hancock, John F.; Waters, Michael J.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Waters, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.waters@imb.uq.edu.au	Brooks, Andrew/A-9969-2011; Barclay, Johanna/G-6293-2012; waters, michael j/C-9582-2014; Clyde-Smith, Jodi/R-8910-2016	Brooks, Andrew/0000-0002-2691-1668; Barclay, Johanna/0000-0001-5737-1775; Clyde-Smith, Jodi/0000-0001-9798-9924; Hancock, John/0000-0003-0542-4710				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Behncken SN, 1997, J BIOL CHEM, V272, P27077, DOI 10.1074/jbc.272.43.27077; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; CLARKSON RWE, 1995, MOL ENDOCRINOL, V9, P108, DOI 10.1210/me.9.1.108; Clayton PE, 1999, ACTA PAEDIATR, V88, P174, DOI 10.1111/j.1651-2227.1999.tb14382.x; COLOSI P, 1993, J BIOL CHEM, V268, P12617; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Daniel N, 1996, MOL CELL ENDOCRINOL, V118, P25, DOI 10.1016/0303-7207(95)03763-2; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Gent J, 2003, MOL ENDOCRINOL, V17, P967, DOI 10.1210/me.2002-0261; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Lewis MD, 2004, J CLIN ENDOCR METAB, V89, P1068, DOI 10.1210/jc.2003-030652; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Rowlinson SW, 1998, J BIOL CHEM, V273, P5307, DOI 10.1074/jbc.273.9.5307; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SMIT LS, 1999, HDB PHYSL, P445; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Walker JL, 1998, J CLIN ENDOCR METAB, V83, P2554, DOI 10.1210/jc.83.7.2554; Wan Y, 2003, MOL ENDOCRINOL, V17, P2240, DOI 10.1210/me.2003-0162; Zhu T, 2002, J BIOL CHEM, V277, P45592, DOI 10.1074/jbc.M201385200	32	75	78	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					740	747		10.1038/ncb1737	http://dx.doi.org/10.1038/ncb1737			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488018				2022-12-27	WOS:000256350100021
J	Monzen, K; Ito, Y; Naito, AT; Kasai, H; Hiroi, Y; Hayashi, D; Shiojima, I; Yamazaki, T; Miyazono, K; Asashima, M; Nagai, R; Komuro, I				Monzen, Koshiro; Ito, Yuzuru; Naito, Atsuhiko T.; Kasai, Hiroki; Hiroi, Yukio; Hayashi, Doubun; Shiojima, Ichiro; Yamazaki, Tsutomu; Miyazono, Kohei; Asashima, Makoto; Nagai, Ryozo; Komuro, Issei			A crucial role of a high mobility group protein HMGA2 in cardiogenesis	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEINS; CONGENITAL HEART-DISEASE; CARDIOMYOCYTE DIFFERENTIATION; XENOPUS EMBRYOS; GENE; INDUCTION; NKX2-5; TRANSCRIPTION; PROMOTES; ELEMENTS	The high mobility group ( HMG) of nuclear proteins regulates expression of many genes through architectural remodelling of the chromatin structure, and formation of multiprotein complexes on promoter/enhancer regions. This leads to the active transcription of their target genes(1-3). Here we show that HMGA2, a member of the HMGA sub-family of HMG proteins, has a critical function in cardiogenesis. Overexpression of HMGA2 enhanced, whereas siRNA-mediated knockdown of HMGA2 blocked, cardiomyocyte differentiation of the embryonal carcinoma cell line P19CL6. Moreover, overexpression of a dominant-negative HMGA2 or morpholino-mediated knockdown of HMGA2 expression blocked normal heart formation in Xenopus laevis embryos, suggesting that HMGA2 has an important role in cardiogenesis both in vitro and in vivo. Mechanistically, HMGA2 associated with Smad1/4 and showed synergistic trans-activation of the gene for a cardiac transcription factor Nkx2.5; a conserved HMGA2 binding site was required for the promoter activity of Nkx2.5 gene, both in P19CL6 cells and in transgenic Xenopus embryos. Thus, HMGA2 is a positive regulator of Nkx2.5 gene expression and is essential for normal cardiac development.	[Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan; [Monzen, Koshiro; Kasai, Hiroki; Hiroi, Yukio; Hayashi, Doubun; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Yuzuru; Asashima, Makoto] Japan Sci & Technol Agcy, ICORP Organ Regenerat Project, Meguro Ku, Tokyo, Japan; [Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; [Naito, Atsuhiko T.; Shiojima, Ichiro; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Chiba University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Asashima, Makoto/O-8389-2018	Asashima, Makoto/0000-0002-0012-026X				Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; Battista S, 1999, CANCER RES, V59, P4793; Breckenridge RA, 2001, DEV BIOL, V232, P191, DOI 10.1006/dbio.2001.0164; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Foley A, 2004, TRENDS CARDIOVAS MED, V14, P121, DOI 10.1016/j.tcm.2004.01.003; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hosoda T, 2001, J BIOL CHEM, V276, P35978, DOI 10.1074/jbc.M100485200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sparrow DB, 2000, DEV BIOL, V227, P65, DOI 10.1006/dbio.2000.9891; Srivastava D, 2001, ANNU REV PHYSIOL, V63, P451, DOI 10.1146/annurev.physiol.63.1.451; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	31	62	65	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					567	574		10.1038/ncb1719	http://dx.doi.org/10.1038/ncb1719			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425117				2022-12-27	WOS:000255502400013
J	Marangos, P; Carroll, J				Marangos, Petros; Carroll, John			Securin regulates entry into M-phase by modulating the stability of cyclin B	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MOUSE OOCYTES; CHROMATID SEPARATION; AURORA-B; DESTRUCTION; DEGRADATION; PROTEOLYSIS; INHIBITOR; FERTILIZATION; COMPETITION	Timely progression into mitosis is necessary for normal cell division. This transition is sensitive to the levels of cyclin B, the regulatory subunit of the master mitotic kinase, Cdk1. Cyclin B accumulates during G2 and prophase when its rate of destruction by the anaphase promoting complex ( APC) is low(1). Securin is also an APC substrate and is known for its role in inactivating the cohesin-cleaving enzyme, separase, until the metaphase to anaphase transition. Here we show that securin has an additional role in cell-cycle regulation, that of modulating the timing of entry into M-phase. In mouse oocytes, excess securin caused stabilization of cyclin B and precocious entry into M-phase. Depletion of securin increased cyclin B degradation, resulting in delayed progression into M-phase. This effect required APC activity and was reversed by expression of wild-type securin. These data reveal a role for securin at the G2-M transition and suggest a more general mechanism whereby physiological levels of co-competing APC substrates function in modulating the timing of cell-cycle transitions.	[Marangos, Petros; Carroll, John] UCL, Dept Cell & Dev Biol, Div Biosci, London WC1E 6BT, England	University of London; University College London	Marangos, P (corresponding author), UCL, Dept Cell & Dev Biol, Div Biosci, Gower St, London WC1E 6BT, England.	p.marangos@ucl.ac.uk; j.carroll@ucl.ac.uk	Holt, Janet E/B-2415-2013	Marangos, Petros/0000-0001-5121-8235; Carroll, John/0000-0001-9644-5861	Medical Research Council [G0400530] Funding Source: Medline; MRC [G0400530] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; DI FB, 2007, J CELL BIOL, V177, P425; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Marangos P, 2004, DEV BIOL, V272, P26, DOI 10.1016/j.ydbio.2004.04.012; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Salazar C, 2006, ANN NY ACAD SCI, V1091, P517, DOI 10.1196/annals.1378.093; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	31	66	70	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					445	U151		10.1038/ncb1707	http://dx.doi.org/10.1038/ncb1707			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364698				2022-12-27	WOS:000254561700015
J	Mazumdar, J; O'Brien, WT; Johnson, RS; LaManna, JC; Chavez, JC; Klein, PS; Simon, MC				Mazumdar, Jolly; O'Brien, W. Timothy; Johnson, Randall S.; LaManna, Joseph C.; Chavez, Juan C.; Klein, Peter S.; Simon, M. Celeste			O-2 regulates stem cells through Wnt/beta-catenin signalling	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; HEMATOPOIETIC STEM; VASCULAR NICHE; HYPOXIA; TRANSCRIPTION; HIF-2-ALPHA; HIF-1-ALPHA; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS	Stem cells reside in specialized microenvironments or 'niches' that regulate their function. In vitro studies using hypoxic culture conditions (< 5% O-2) have revealed strong regulatory links between O-2 availability and functions of stem and precursor cells(1-6). Although some stem cells are perivascular, others may occupy hypoxic niches and be regulated by O-2 gradients. However, the underlying mechanisms remain unclear. Here, we show that hypoxia inducible factor-1 alpha (HIF-1 alpha), a principal mediator of hypoxic adaptations, modulates Wnt/beta-catenin signalling in hypoxic embryonic stem (ES) cells by enhancing beta-catenin activation and expression of the downstream effectors LEF-1 and TCF-1. This regulation extends to primary cells, including isolated neural stem cells (NSCs), and is not observed in differentiated cells. In vivo, Wnt/beta-catenin activity is closely associated with low O-2 regions in the subgranular zone of the hippocampus, a key NSC niche(7). Hif-1 alpha deletion impairs hippocampal Wnt-dependent processes, including NSC proliferation, differentiation and neuronal maturation. This decline correlates with reduced Wnt/beta-catenin signalling in the subgranular zone. O-2 availability, therefore, may have a direct role in stem cell regulation through HIF-1 alpha modulation of Wnt/beta-catenin signalling.	[Mazumdar, Jolly; Simon, M. Celeste] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [O'Brien, W. Timothy; Klein, Peter S.] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [LaManna, Joseph C.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chavez, Juan C.] Wyeth Res, Translat Med, Collegeville, PA 19426 USA; [Mazumdar, Jolly; Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of California System; University of California San Diego; Case Western Reserve University; Pfizer; Howard Hughes Medical Institute; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	LaManna, Joseph C/C-3347-2012; Johnson, Randall/AAM-1189-2021; LaManna, Joseph/D-3860-2013; Simon, Celeste/AAG-3941-2021	LaManna, Joseph C/0000-0002-0159-4512; Johnson, Randall/0000-0002-4084-6639; LaManna, Joseph/0000-0002-0159-4512; 	Howard Hughes Medical Institute (HHMI); Abramson Family Cancer Research Institute; National Institutes of Health [MH58324]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038632] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Abramson Family Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Kinzler and B. Vogelstein for the Wnt (TOP/FOP) reporter constructs; P. Carmeliet for Hif-1 alpha<SUP>-/-</SUP>ES cells; and E. Brown for Ubc-Cre-ER<SUP>T2</SUP> mice. We thank X. Sun, Case Western Reserve University, and H. Yu, University of Pennsylvania for technical assistance with tissue harvesting and sectioning. We thank B. Keith and the Simon lab for discussion and critical review of the manuscript. This work was supported by funds from the Howard Hughes Medical Institute (HHMI), the Abramson Family Cancer Research Institute, and the National Institutes of Health (Grant No. MH58324 to P.S.K). M.C.S. is an investigator of the HHMI.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Maltepe E, 2000, BIOCHEM BIOPH RES CO, V273, P231, DOI 10.1006/bbrc.2000.2928; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Raleigh JA, 1998, CANCER RES, V58, P3765; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Studer L, 2000, J NEUROSCI, V20, P7377; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	34	352	370	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					1007	1013		10.1038/ncb2102	http://dx.doi.org/10.1038/ncb2102			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852629	Green Accepted			2022-12-27	WOS:000282363500016
J	Ku, NO; Toivola, DM; Strnad, P; Omary, MB				Ku, Nam-On; Toivola, Diana M.; Strnad, Pavel; Omary, M. Bishr			Cytoskeletal keratin glycosylation protects epithelial tissue from injury	NATURE CELL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; O-GLCNAC MODIFICATION; INTERMEDIATE-FILAMENTS; TRANSGENIC MICE; SIGNALING PATHWAYS; LIVER-DISEASE; NUCLEOCYTOPLASMIC PROTEINS; MITOTIC ARREST; KINASE-B; CELLS	Keratins 8 and 18 (K8 and K18) are heteropolymeric intermediate filament phosphoglycoproteins of simple-type epithelia. Mutations in K8 and K18 predispose the affected individual to liver disease as they protect hepatocytes from apoptosis. K18 undergoes dynamic O-linked N-acetylglucosamine glycosylation at Ser 30, 31 and 49. We investigated the function of K18 glycosylation by generating mice that overexpress human K18 S30/31/49A substitution mutants that cannot be glycosylated (K18-Gly(-)), and compared the susceptibility of these mice to injury with wild-type and other keratin-mutant mice. K18-Gly(-) mice are more susceptible to liver and pancreatic injury and apoptosis induced by streptozotocin or to liver injury by combined N-acetyl-D-glucosaminidase inhibition and Fas administration. The enhanced apoptosis in the livers of mice that express K18-Gly(-) involves the inactivation of Akt1 and protein kinase C theta as a result of their site-specific hypophosphorylation. Akt1 binds to K8, which probably contributes to the reciprocal hyperglycosylation and hypophosphorylation of Akt1 that occurs on K18 hypoglycosylation, and leads to decreased Akt1 kinase activity. Therefore, K18 glycosylation provides a unique protective role in epithelial injury by promoting the phosphorylation and activation of cell-survival kinases.	[Ku, Nam-On; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ku, Nam-On] Yonsei Univ, Dept Biomed Sci, Grad Sch, Seoul 120749, South Korea; [Ku, Nam-On; Toivola, Diana M.] Abo Akad Univ, Dept Biosci, FI-20521 Turku, Finland; [Strnad, Pavel] Univ Med Ctr Ulm, Dept Internal Med 1, D-89081 Ulm, Germany	University of Michigan System; University of Michigan; Yonsei University; Abo Akademi University; Ulm University	Ku, NO (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	namonku@yonsei.ac.kr; mbishr@umich.edu		Omary, Bishr/0000-0002-8624-2347; Toivola, Diana M./0000-0001-7165-9839	NIH [DK47918]; Department of Veterans Affairs; NIH Digestive Disease Center [DK56339]; NIH Michigan Gastrointestinal Peptide Research Center [DK34933]; Korean Ministry of Education, Science and Technology [R31-2008-000-10086-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918, P30DK056339, P30DK034933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH Digestive Disease Center; NIH Michigan Gastrointestinal Peptide Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. shim (The Sanford-Burnham Medical Research Institute) and T. Magin (University of Leipzig) for making the mice that express wild-type K18 and the K18-null available to us, Y. Chen-Tsai and the Stanford University Transgenic Facility for helping generate the transgenic mice, E. Resurreccion for assistance with immune staining and P. Chu for assistance with hematoxylin and eosin staining. This work was supported by NIH grant DK47918 and the Department of Veterans Affairs (M.B.O.), NIH Digestive Disease Center grant DK56339 to Stanford University, NIH Michigan Gastrointestinal Peptide Research Center grant DK34933 and WCU project (R31-2008-000-10086-0) from the Korean Ministry of Education, Science and Technology to N.-O.K.	ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU CF, 1994, J CELL SCI, V107, P1833; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; KU NO, 1995, J BIOL CHEM, V270, P11820, DOI 10.1074/jbc.270.20.11820; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nadeau SI, 2007, ADV EXP MED BIOL, V594, P100; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Paramio JM, 2001, MOL CELL BIOL, V21, P7449, DOI 10.1128/MCB.21.21.7449-7459.2001; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	50	90	92	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					876	885		10.1038/ncb2091	http://dx.doi.org/10.1038/ncb2091			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729838	Green Accepted			2022-12-27	WOS:000281561900011
J	Madeo, F; Tavernarakis, N; Kroemer, G				Madeo, Frank; Tavernarakis, Nektarios; Kroemer, Guido			Can autophagy promote longevity?	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN EXTENSION; CELL-SURVIVAL; CALORIC RESTRICTION; RESVERATROL; APOPTOSIS; GENES; SIRT1; YEAST; ACTIVATORS; DROSOPHILA	Organismal lifespan can be extended by genetic manipulation of cellular processes such as histone acetylation, the insulin/IGF-1 (insulin-like growth factor 1) pathway or the p53 system. Longevity-promoting regimens, including caloric restriction and inhibition of TOR with rapamycin, resveratrol or the natural polyamine spermidine, have been associated with autophagy (a cytoprotective self-digestive process) and in some cases were reported to require autophagy for their effects. We summarize recent developments that outline these links and hypothesize that clearing cellular damage by autophagy is a common denominator of many lifespan-extending manipulations.	[Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Tavernarakis, Nektarios/B-9684-2013; KROEMER, Guido/B-4263-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; KROEMER, Guido/0000-0002-9334-4405; Madeo, Frank/0000-0002-5070-1329	Ligue Nationale contre le Cancer (equipe labellisee); Fondation pour la Recherche Medicate; European Union; Canceropole Ile-de-France; Institut National du Cancer; Agence Nationale pour la Recherche; Austrian Science Fund [S-9304-B05]; European Commission (APOSYS); European Research Council (ERC); European Commission; European Molecular Biology Organization (EMBO)	Ligue Nationale contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Austrian Science Fund(Austrian Science Fund (FWF)); European Commission (APOSYS)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	G.K. is supported by grants from the Ligue Nationale contre le Cancer (equipe labellisee), Fondation pour la Recherche Medicate, the European Union, Canceropole Ile-de-France, Institut National du Cancer and Agence Nationale pour la Recherche. F.M. is supported by grants from the Austrian Science Fund (S-9304-B05, LIPOTOX) and European Commission (APOSYS). N.T. is supported by grants from the European Research Council (ERC), the European Commission 6<SUP>th</SUP> and 7<SUP>th</SUP> Framework programs and the European Molecular Biology Organization (EMBO).	Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; DORMAN JB, 1995, GENETICS, V141, P1399; Edinger AL, 2003, CANCER CELL, V4, P422, DOI 10.1016/S1535-6108(03)00306-4; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Kaeberlein M, 2008, CELL METAB, V8, P4, DOI 10.1016/j.cmet.2008.06.004; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LI Y, 1989, CANCER RES, V68, P6889; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rockenfeller P, 2010, BBA-MOL CELL RES, V1803, P499, DOI 10.1016/j.bbamcr.2010.01.001; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; SUN JY, 1994, J BIOL CHEM, V269, P18638; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vigne P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005422; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang ZF, 2007, AUTOPHAGY, V3, P149, DOI 10.4161/auto.3631; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	72	335	347	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					842	846		10.1038/ncb0910-842	http://dx.doi.org/10.1038/ncb0910-842			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811357				2022-12-27	WOS:000281561900006
J	Wang, XB; He, L; Wu, YI; Hahn, KM; Montell, DJ				Wang, Xiaobo; He, Li; Wu, Yi I.; Hahn, Klaus M.; Montell, Denise J.			Light-mediated activation reveals a key role for Rac in collective guidance of cell movement in vivo	NATURE CELL BIOLOGY			English	Article							BORDER CELLS; MIGRATION; GTPASES; MORPHOGENESIS; BEHAVIOR	The small GTPase Rac induces actin polymerization, membrane ruffling and focal contact formation in cultured single cells(1) but can either repress or stimulate motility in epithelial cells depending on the conditions(2, 3). The role of Rac in collective epithelial cell movements in vivo, which are important for both morphogenesis and metastasis(4-7), is therefore difficult to predict. Recently, photoactivatable analogues of Rac (PA-Rac) have been developed, allowing rapid and reversible activation or inactivation of Rac using light(8). In cultured single cells, light-activated Rac leads to focal membrane ruffling, protrusion and migration. Here we show that focal activation of Rac is also sufficient to polarize an entire group of cells in vivo, specifically the border cells of the Drosophila ovary. Moreover, activation or inactivation of Rac in one cell of the cluster caused a dramatic response in the other cells, suggesting that the cells sense direction as a group according to relative levels of Rac activity. Communication between cells of the cluster required Jun amino-terminal kinase (JNK) but not guidance receptor signalling. These studies further show that photoactivatable proteins are effective tools in vivo.	[Wang, Xiaobo; He, Li; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Wu, Yi I.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, 855 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu	Wang, Xiaobo/A-8604-2011	Wang, Xiaobo/0000-0002-3311-1378; Hahn, Klaus/0000-0002-1970-7562; HE, LI/0000-0003-2155-606X	Cell Migration Consortium;  [GM046425];  [GM057464]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R29GM046425, R01GM057464, R01GM046425, R55GM057464] Funding Source: NIH RePORTER	Cell Migration Consortium; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM046425 to D.J.M. and GM057464 to K.M.H. and by the Cell Migration Consortium.	Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Llense F, 2008, CURR BIOL, V18, P538, DOI 10.1016/j.cub.2008.03.029; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; McDonald Jocelyn A., 2004, V294, P175; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sander EE, 1999, EUR J CANCER, V35, P1302, DOI 10.1016/S0959-8049(99)00145-8; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Wang XJ, 2007, DEV BIOL, V301, P532, DOI 10.1016/j.ydbio.2006.08.031; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241	31	229	231	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					591	U154		10.1038/ncb2061	http://dx.doi.org/10.1038/ncb2061			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473296	Green Submitted, Green Accepted			2022-12-27	WOS:000278213400011
J	Vermeulen, L; Melo, FDSE; van der Heijden, M; Cameron, K; de Jong, JH; Borovski, T; Tuynman, JB; Todaro, M; Merz, C; Rodermond, H; Sprick, MR; Kemper, K; Richel, DJ; Stassi, G; Medema, JP				Vermeulen, Louis; Melo, Felipe De Sousa E.; van der Heijden, Maartje; Cameron, Kate; de Jong, Joan H.; Borovski, Tijana; Tuynman, Jurriaan B.; Todaro, Matilde; Merz, Christian; Rodermond, Hans; Sprick, Martin R.; Kemper, Kristel; Richel, Dick J.; Stassi, Giorgio; Medema, Jan Paul			Wnt activity defines colon cancer stem cells and is regulated by the microenvironment	NATURE CELL BIOLOGY			English	Article							HEPATOCYTE GROWTH-FACTOR; COLORECTAL-CANCER; BETA-CATENIN; TUMOR PROGRESSION; SMALL-INTESTINE; MET ONCOGENE; EXPRESSION; RECEPTOR; NICHE; GENE	Despite the presence of mutations in APC or beta-catenin, which are believed to activate the Wnt signalling cascade constitutively, most colorectal cancers show cellular heterogeneity when beta-catenin localization is analysed, indicating a more complex regulation of Wnt signalling. We explored this heterogeneity with a Wnt reporter construct and observed that high Wnt activity functionally designates the colon cancer stem cell (CSC) population. In adenocarcinomas, high activity of the Wnt pathway is observed preferentially in tumour cells located close to stromal myofibroblasts, indicating that Wnt activity and cancer stemness may be regulated by extrinsic cues. In agreement with this notion, myofibroblast-secreted factors, specifically hepatocyte growth factor, activate beta-catenin-dependent transcription and subsequently CSC clonogenicity. More significantly, myofibroblast-secreted factors also restore the CSC phenotype in more differentiated tumour cells both in vitro and in vivo. We therefore propose that stemness of colon cancer cells is in part orchestrated by the microenvironment and is a much more dynamic quality than previously expected that can be defined by high Wnt activity.	[Vermeulen, Louis; Melo, Felipe De Sousa E.; van der Heijden, Maartje; Cameron, Kate; de Jong, Joan H.; Borovski, Tijana; Tuynman, Jurriaan B.; Rodermond, Hans; Sprick, Martin R.; Kemper, Kristel; Richel, Dick J.; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, CEMM, LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Cellular & Mol Pathophysiol Lab, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [Merz, Christian] APOGENIX GmbH, D-69120 Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Palermo	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, CEMM, LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	J.P.Medema@amc.uva.nl	todaro, matilde/AAC-1003-2022; Pillay, Nischalan/F-9536-2012; Stassi, Giorgio/AAC-1175-2022; De Sousa E Melo, Felipe/F-9498-2010; Tuynman, JB/AAS-7745-2020; Tuynman, J/X-2465-2019; Sprick, Martin R./A-8611-2008; Vermeulen, Louis/B-7488-2008; Sprick, Martin R./I-7995-2019	todaro, matilde/0000-0001-8686-8043; Tuynman, JB/0000-0001-5952-8000; Sprick, Martin R./0000-0001-9691-7574; Vermeulen, Louis/0000-0002-6066-789X; Sprick, Martin R./0000-0001-9691-7574; Medema, Jan Paul/0000-0003-3045-2924	Netherlands Organisation for Scientific Research; Dutch Cancer Society (KWF Kankerbestrijding) [2009-4416]; Academisch Medisch Centrum (AMC); AMC Graduate School; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding); Academisch Medisch Centrum (AMC); AMC Graduate School; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The authors are indebted to the work performed by Willem Bemelman and Thomas van Gulik, surgeons at the AMC without whom the studies described here would not have been possible. In addition, we thank Riccardo Fodde for constructive discussions on CSCs and Wnt, and the animal care takers for their work for this project. Finally, we thank Berend Hooibrink and Toni van Capel for assistance with fluorescence-activated cell sorting experiments. This work was supported by a VICI grant from the Netherlands Organisation for Scientific Research and a Dutch Cancer Society (KWF Kankerbestrijding) grant (2009-4416) (to J.P.M.), an Academisch Medisch Centrum (AMC) fellowship (to L. V. and F.d.S.M.), the AMC Graduate School (to K. K.) and by the Associazione Italiana per la Ricerca sul Cancro (AIRC) (to G. S. and M. T.).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boon EMJ, 2002, CANCER RES, V62, P5126; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; GRODEN J, 1995, CANCER RES, V55, P1531; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; STOKER M, 1985, J CELL SCI, V77, P209; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	48	1314	1375	2	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					468	U121		10.1038/ncb2048	http://dx.doi.org/10.1038/ncb2048			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418870				2022-12-27	WOS:000277283700012
J	Ostrowski, M; Carmo, NB; Krumeich, S; Fanget, I; Raposo, G; Savina, A; Moita, CF; Schauer, K; Hume, AN; Freitas, RP; Goud, B; Benaroch, P; Hacohen, N; Fukuda, M; Desnos, C; Seabra, MC; Darchen, F; Amigorena, S; Moita, LF; Thery, C				Ostrowski, Matias; Carmo, Nuno B.; Krumeich, Sophie; Fanget, Isabelle; Raposo, Graca; Savina, Ariel; Moita, Catarina F.; Schauer, Kristine; Hume, Alistair N.; Freitas, Rui P.; Goud, Bruno; Benaroch, Philippe; Hacohen, Nir; Fukuda, Mitsunori; Desnos, Claire; Seabra, Miguel C.; Darchen, Francois; Amigorena, Sebastian; Moita, Luis F.; Thery, Clotilde			Rab27a and Rab27b control different steps of the exosome secretion pathway	NATURE CELL BIOLOGY			English	Article							CELL-DERIVED EXOSOMES; MULTIVESICULAR ENDOSOMES; PLASMA-MEMBRANE; B-LYMPHOCYTES; VESICLES; PROTEINS; GRANULES; RELEASE; GTPASES; ASSOCIATION	Exosomes are secreted membrane vesicles that share structural and biochemical characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes could be involved in intercellular communication and in the pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome biogenesis and secretion are, however, poorly understood. Using an RNA interference (RNAi) screen, we identified five Rab GTPases that promote exosome secretion in HeLa cells. Among these, Rab27a and Rab27b were found to function in MVE docking at the plasma membrane. The size of MVEs was strongly increased by Rab27a silencing, whereas MVEs were redistributed towards the perinuclear region upon Rab27b silencing. Thus, the two Rab27 isoforms have different roles in the exosomal pathway. In addition, silencing two known Rab27 effectors, Slp4 (also known as SYTL4, synaptotagmin-like 4) and Slac2b (also known as EXPH5, exophilin 5), inhibited exosome secretion and phenocopied silencing of Rab27a and Rab27b, respectively. Our results therefore strengthen the link between MVEs and exosomes, and introduce ways of manipulating exosome secretion in vivo.	[Carmo, Nuno B.; Moita, Catarina F.; Freitas, Rui P.; Moita, Luis F.] Inst Mol Med, Cell Biol Immune Syst Unit, P-1649028 Lisbon, Portugal; [Ostrowski, Matias; Krumeich, Sophie; Savina, Ariel; Benaroch, Philippe; Amigorena, Sebastian; Thery, Clotilde] INSERM, U932, F-75005 Paris, France; [Ostrowski, Matias; Krumeich, Sophie; Raposo, Graca; Savina, Ariel; Schauer, Kristine; Goud, Bruno; Benaroch, Philippe; Amigorena, Sebastian; Thery, Clotilde] Inst Curie, F-75005 Paris, France; [Raposo, Graca; Schauer, Kristine; Goud, Bruno] CNRS, UMR144, F-75005 Paris, France; [Hume, Alistair N.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1169056 Lisbon, Portugal; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02142 USA; [Hacohen, Nir] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Fanget, Isabelle; Desnos, Claire; Darchen, Francois] CNRS, Inst Biol Physicochim, FRE 3146, F-75005 Paris, France; [Fukuda, Mitsunori] Tohoku Univ, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9809578, Japan	Universidade de Lisboa; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Imperial College London; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); Tohoku University	Moita, LF (corresponding author), Inst Mol Med, Cell Biol Immune Syst Unit, Sala P3-B-40,Edificio Egas Moniz,Ave Prof Egas Mo, P-1649028 Lisbon, Portugal.	lmoita@fm.ul.pt; clotilde.thery@curie.fr	thery, clotilde/F-6373-2013; Carmo, Nuno/AAP-7327-2021; Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Moita, Luis/HCI-2793-2022; Carmo, Nuno/L-9869-2017; Moita, Luis F./L-1296-2013; Goud, Bruno/GWC-4807-2022; Fukuda, MItsunori/I-1511-2015	thery, clotilde/0000-0001-8294-6884; Seabra, Miguel C/0000-0002-6404-4892; Moita, Luis/0000-0003-0707-315X; Carmo, Nuno/0000-0001-6570-7400; Moita, Luis F./0000-0003-0707-315X; Fukuda, MItsunori/0000-0002-8620-5853; Ferreira Moita, Catarina/0000-0002-9910-2343; Raposo, graca/0000-0001-9590-1298; Schauer, Kristine/0000-0002-6102-8790; Benaroch, Philippe/0000-0002-2655-0129; Amigorena, Sebastian/0000-0001-8583-8416; Hume, Alistair/0000-0001-9443-1087; Ostrowski, Matias/0000-0002-3982-1338	Institut National du Cancer; Institut Curie; Association pour la Recherche sur le Cancer and Fondation de France; Agence Nationale de la Recherche [ANR-06-BLAN-0211-02]; Fundacao Luso-Americana para o Desenvolvimento; Funda ao para a Ciencia e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Institut National du Cancer(Institut National du Cancer (INCA) France); Institut Curie; Association pour la Recherche sur le Cancer and Fondation de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao Luso-Americana para o Desenvolvimento; Funda ao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by post-doctoral salaries from Institut National du Cancer and Institut Curie to M. O., grants from Association pour la Recherche sur le Cancer and Fondation de France to C. T., and from the Agence Nationale de la Recherche to F. D. (ANR-06-BLAN-0211-02). L. F. M. is a Young Investigator from the Human Frontier Science Program and receives support from Fundacao Luso-Americana para o Desenvolvimento and Funda ao para a Ciencia e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). We thank PICT IbiSA Imaging Facility at Curie Institute, V. Racine and J.-B. Sibarita for providing a copy of their multidimensional image analysis program, I. Hurbain for help in electron microscopy quantification, P. Simoes and M. H. Raquel for some of the lentiviral preparations, T. Tolmachova for bones of Rab27-knockout mice, J. Mordoh for providing an anti-CD63 FC-5.01 antibody and R. Allan for critical reading of the manuscript.	Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Beraud-Dufour S, 2002, J CELL SCI, V115, P1779; Blott EJ, 2001, J CELL SCI, V114, P2405; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fukuda M, 2002, J BIOL CHEM, V277, P39673, DOI 10.1074/jbc.M205349200; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ramalho JS, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-2; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Savina A, 2002, J CELL SCI, V115, P2505; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	49	1549	1612	16	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					19	U61		10.1038/ncb2000	http://dx.doi.org/10.1038/ncb2000			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966785	Green Submitted			2022-12-27	WOS:000272973800008
J	Fan, ZP; Yamaza, T; Lee, JS; Yu, JH; Wang, SL; Fan, GP; Shi, ST; Wang, CY				Fan, Zhipeng; Yamaza, Takayoshi; Lee, Janice S.; Yu, Jinhua; Wang, Songlin; Fan, Guoping; Shi, Songtao; Wang, Cun-Yu			BCOR regulates mesenchymal stem cell function by epigenetic mechanisms	NATURE CELL BIOLOGY			English	Article							DOMAIN-CONTAINING PROTEINS; CARDIO-DENTAL SYNDROME; HISTONE DEMETHYLATION; TRANSCRIPTION FACTOR; COREPRESSOR; DIFFERENTIATION; EXPRESSION; DEFECTS; COMPLEX; REGENERATION	The BCL-6 co-repressor (BCOR) represses gene transcription by interacting with BCL-6 (refs 1, 2). BCOR mutation is responsible for oculo-facio-cardio-dental (OFCD) syndrome, which is characterized by canine teeth with extremely long roots, congenital cataracts, craniofacial defects and congenital heart disease(3-5). Here we show that BCOR mutation increased the osteo-dentinogenic potential of mesenchymal stem cells (MSCs) isolated from a patient with OFCD, providing a molecular explanation for abnormal root growth. AP-2 alpha was identified as a repressive target of BCOR, and BCOR mutation resulted in abnormal activation of AP-2 alpha. Gain- and loss-of-function assays suggest that AP-2 alpha is a key factor that mediates the increased osteo-dentinogenic capacity of MSCs. Moreover, we found that BCOR maintained tissue homeostasis and gene silencing through epigenetic mechanisms. BCOR mutation increased histone H3K4 and H3K36 methylation in MSCs, thereby reactivating transcription of silenced target genes. By studying a rare human genetic disease, we have unravelled an epigenetic mechanism for control of human adult stem cell function.	[Fan, Zhipeng; Yu, Jinhua; Wang, Cun-Yu] Univ Calif Los Angeles, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA; [Yamaza, Takayoshi; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Lee, Janice S.] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA; [Wang, Songlin] Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Southern California; University of California System; University of California San Francisco; Capital Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, CY (corresponding author), Univ Calif Los Angeles, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu		Yamaza, Takayoshi/0000-0001-7055-3370; Yu, Jinhua/0000-0003-4874-9910; Fan, Zhipeng/0000-0003-0629-3476; Fan, Guoping/0000-0001-5235-6410	National Institute of Dental and Craniofacial Research [R01DE1016513, R01DE017684, R21DE017632]; Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, R01DE019412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017684, R21DE017632] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research Grants (R01DE1016513 and R01DE017684) to C. Y. W. (R21DE017632) and S. S., and the Shapiro Family Charitable Foundation. We thank Vivian Bardwell for reagents.	ARTHUR A, 2008, STEM CELLS; Brewer S, 2004, DEV BIOL, V267, P135, DOI 10.1016/j.ydbio.2003.10.039; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hedera P, 2003, AM J MED GENET A, V123A, P261, DOI 10.1002/ajmg.a.20444; Horn D, 2005, EUR J HUM GENET, V13, P563, DOI 10.1038/sj.ejhg.5201391; Huynh KD, 2000, GENE DEV, V14, P1810; Jahagirdar BN, 2005, STEM CELL REV, V1, P53, DOI 10.1385/SCR:1:1:053; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Oberoi S, 2005, AM J MED GENET A, V136A, P275, DOI 10.1002/ajmg.a.30811; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Scheller EL, 2008, J DENT RES, V87, P126, DOI 10.1177/154405910808700206; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schulze BRB, 1999, AM J MED GENET, V82, P429, DOI 10.1002/(SICI)1096-8628(19990219)82:5<429::AID-AJMG13>3.0.CO;2-S; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi Songtao, 2004, Biotechnol Genet Eng Rev, V21, P133; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; West-Mays JA, 2002, DEV BIOL, V245, P13, DOI 10.1006/dbio.2002.0624; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596	35	185	196	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1002	U215		10.1038/ncb1913	http://dx.doi.org/10.1038/ncb1913			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578371	Green Accepted			2022-12-27	WOS:000268593200015
J	Wu, JQ; Guo, JY; Tang, W; Yang, CS; Freel, CD; Chen, C; Nairn, AC; Kornbluth, S				Wu, Judy Qiju; Guo, Jessie Yanxiang; Tang, Wanli; Yang, Chih-Sheng; Freel, Christopher D.; Chen, Chen; Nairn, Angus C.; Kornbluth, Sally			PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE INHIBITOR-1; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; M-PHASE; MITOSIS; CDC14; CALCINEURIN; EXTRACTS; KINASE; ACTIVATION	Loss of cell division cycle 2 (Cdc2, also known as Cdk1) activity after cyclin B degradation is necessary, but not sufficient, for mitotic exit. Proteins phosphorylated by Cdc2 and downstream mitotic kinases must be dephosphorylated. We report here that protein phosphatase-1 (PP1) is the main catalyst of mitotic phosphoprotein dephosphorylation. Suppression of PP1 during early mitosis is maintained through dual inhibition by Cdc2 phosphorylation and the binding of inhibitor-1. Protein kinase A (PKA) phosphorylates inhibitor-1, mediating binding to PP1. As Cdc2 levels drop after cyclin B degradation, auto-dephosphorylation of PP1 at its Cdc2 phosphorylation site (Thr 320) allows partial PP1 activation. This promotes PP1-regulated dephosphorylation at the activating site of inhibitor-1 (Thr 35) followed by dissociation of the inhibitor-1-PP1 complex and then full PP1 activation to promote mitotic exit. Thus, Cdc2 both phosphorylates multiple mitotic substrates and inhibits their PP1-mediated dephosphorylation.	[Wu, Judy Qiju; Guo, Jessie Yanxiang; Tang, Wanli; Yang, Chih-Sheng; Freel, Christopher D.; Chen, Chen; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Duke University; Yale University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu		Nairn, Angus/0000-0002-7075-0195	NIH [RO1 GM67225, DA10044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants to S. K. (RO1 GM67225) and A. C. N. (DA10044).	Amon A, 2008, FEBS J, V275, P5774, DOI 10.1111/j.1742-4658.2008.06693.x; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bianchi M, 2001, BIOCHEM BIOPH RES CO, V280, P1, DOI 10.1006/bbrc.2000.4067; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Casaletto JB, 2005, J CELL BIOL, V169, P61, DOI 10.1083/jcb.200411056; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Che SL, 1998, FEBS LETT, V424, P225, DOI 10.1016/S0014-5793(98)00158-6; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; El-Armouche A, 2006, BIOCHEM BIOPH RES CO, V346, P700, DOI 10.1016/j.bbrc.2006.05.182; GUSTAFSON EL, 1991, J COMP NEUROL, V310, P170, DOI 10.1002/cne.903100204; Higuchi E, 2000, EUR J PHARMACOL, V408, P107, DOI 10.1016/S0014-2999(00)00767-6; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Trautmann S, 2002, CURR BIOL, V12, pR733, DOI 10.1016/S0960-9822(02)01250-2; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045	30	178	178	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					644	U451		10.1038/ncb1871	http://dx.doi.org/10.1038/ncb1871			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19396163	Green Accepted			2022-12-27	WOS:000265640000024
J	Lefkimmiatis, K; Srikanthan, M; Maiellaro, I; Moyer, MP; Curci, S; Hofer, AM				Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Moyer, Mary Pat; Curci, Silvana; Hofer, Aldebaran M.			Store-operated cyclic AMP signalling mediated by STIM1	NATURE CELL BIOLOGY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CA2+ STORE; FLUORESCENT PROTEIN; INTRACELLULAR CA2+; CAPACITATIVE CA2+; CRAC CHANNEL; I-CRAC; CAMP; CALCIUM	Depletion of Ca2+ from the endoplasmic reticulum ( ER) results in activation of plasma membrane Ca2+ entry channels. This 'store-operated' process requires translocation of a transmembrane ER Ca2+ sensor protein, stromal interaction molecule 1 (STIM1), to sites closely apposed to Ca2+ channels at the cell surface. However, it is not known whether a reduction in Ca2+ stores is coupled to other signalling pathways by this mechanism. We found that lowering the concentration of free Ca2+ in the ER, independently of the cytosolic Ca2+ concentration, also led to recruitment of adenylyl cyclases. This resulted in enhanced cAMP accumulation and PKA activation, measured using FRET-based cAMP indicators. Translocation of STIM1 was required for efficient coupling of ER Ca2+ depletion to adenylyl cyclase activity. We propose the existence of a pathway (store-operated cAMP signalling or SOcAMPS) in which the content of internal Ca2+ stores is directly connected to cAMP signalling through a process that involves STIM1.	[Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Brigham & Womens Hosp, VA Boston Healthcare Syst, W Roxbury, MA 02132 USA; [Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Brigham & Womens Hosp, Dept Surg, W Roxbury, MA 02132 USA; [Lefkimmiatis, Konstantinos; Srikanthan, Meera; Maiellaro, Isabella; Curci, Silvana; Hofer, Aldebaran M.] Harvard Univ, Sch Med, W Roxbury, MA 02132 USA; [Moyer, Mary Pat] INCELL Corp LLC, San Antonio, TX 78249 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University	Hofer, AM (corresponding author), Brigham & Womens Hosp, VA Boston Healthcare Syst, 1400 VFW Pkwy, W Roxbury, MA 02132 USA.	ahofer@rics.bwh.harvard.edu	Lefkimmiatis, Konstantinos/AAL-1647-2021; Lefkimmiatis, Konstantinos/I-1239-2016	Lefkimmiatis, Konstantinos/0000-0001-7137-7866; Lefkimmiatis, Konstantinos/0000-0001-7137-7866; Maiellaro, Isabella/0000-0001-5595-8011	Department of Veteran's Affairs; Harvard Digestive Diseases Center; American Heart Association	Department of Veteran's Affairs(US Department of Veterans Affairs); Harvard Digestive Diseases Center; American Heart Association(American Heart Association)	We are grateful to the following individuals for their kind gifts of plasmids: Kees Jalink for the Epac sensor, Roger Tsien for mCherry, Jin Zhang for AKAR3, Marie Dziadek and Lorna Johnstone for STIM1 and STIM2, Masaru Okabe for pCX-EGFP, and Tobias Meyer for YFP-STIM1, YFP-STIM1D76A, and YFP-STIM2 constructs. We thank Jessica Roy for technical assistance and Drs. Dheeraj Pelluru, Eberhard Fromter and Raj K. Goyal for helpful comments. This study was supported by a Merit Review award from the Department of Veteran's Affairs (A.M.H.) and by an NIH Center grant from the Harvard Digestive Diseases Center (to A.M. H.). K.L. is the recipient of an American Heart Association Postdoctoral Fellowship award..	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Baragli A, 2008, CELL SIGNAL, V20, P480, DOI 10.1016/j.cellsig.2007.10.033; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; CHENG KT, 2008, J BIOL CHEM; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Maloney JA, 1999, AM J PHYSIOL-CELL PH, V276, pC221, DOI 10.1152/ajpcell.1999.276.1.C221; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PEINELT C, 2008, J PHYSL; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SARGEANT P, 1994, EXP PHYSIOL, V79, P269, DOI 10.1113/expphysiol.1994.sp003762; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Strayer DS, 1999, BIOCHEM J, V344, P39, DOI 10.1042/0264-6021:3440039; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Urushidani T, 1997, J MEMBRANE BIOL, V159, P99, DOI 10.1007/s002329900274; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	53	119	122	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					433	U164		10.1038/ncb1850	http://dx.doi.org/10.1038/ncb1850			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19287379				2022-12-27	WOS:000265264900013
J	Goldfarb, DS				Goldfarb, David S.			How to grow a bud: an importin acts in asymmetric division	NATURE CELL BIOLOGY			English	Editorial Material							MESSENGER-RNA EXPORT; BOX PROTEIN DBP5; GLE1; LOCALIZATION; TRANSLATION	The growth of daughter cells in budding yeast is a classic model for investigating mechanisms involved in asymmetric cell division. an unexpected collaboration between the dead-box protein Dbp5 and the nuclear transport receptor Kap104 controls localized protein synthesis at the bud tip during mitosis.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Goldfarb, DS (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dasg@mail.rochester.edu						Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Kutay U, 2008, CELL, V134, P564, DOI 10.1016/j.cell.2008.08.009; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Singhvi A, 2009, TRENDS CELL BIOL, V19, P1, DOI 10.1016/j.tcb.2008.10.004; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	14	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					243	245		10.1038/ncb0309-243	http://dx.doi.org/10.1038/ncb0309-243			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255571				2022-12-27	WOS:000263777900007
J	Cai, CX; Masumiya, H; Weisleder, N; Matsuda, N; Nishi, M; Hwang, M; Ko, JK; Lin, PH; Thornton, A; Zhao, XL; Pan, Z; Komazaki, S; Brotto, M; Takeshima, H; Ma, JJ				Cai, Chuanxi; Masumiya, Haruko; Weisleder, Noah; Matsuda, Noriyuki; Nishi, Miyuki; Hwang, Moonsun; Ko, Jae-Kyun; Lin, Peihui; Thornton, Angela; Zhao, Xiaoli; Pan, Zui; Komazaki, Shinji; Brotto, Marco; Takeshima, Hiroshi; Ma, Jianjie			MG53 nucleates assembly of cell membrane repair machinery	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; PLASMA-MEMBRANE; CA2+ RELEASE; DYSFERLIN; DISRUPTIONS; MECHANISM; CHANNELS; SARCOLEMMA; CALCIUM	Dynamic membrane repair and remodelling is an elemental process that maintains cell integrity and mediates efficient cellular function. Here we report that MG53, a muscle-specific tripartite motif family protein (TRIM72), is a component of the sarcolemmal membrane-repair machinery. MG53 interacts with phosphatidylserine to associate with intracellular vesicles that traffic to and fuse with sarcolemmal membranes. Mice null for MG53 show progressive myopathy and reduced exercise capability, associated with defective membrane-repair capacity. Injury of the sarcolemmal membrane leads to entry of the extracellular oxidative environment and MG53 oligomerization, resulting in recruitment of MG53-containing vesicles to the injury site. After vesicle translocation, entry of extracellular Ca2+ facilitates vesicle fusion to reseal the membrane. Our data indicate that intracellular vesicle translocation and Ca2+-dependent membrane fusion are distinct steps involved in the repair of membrane damage and that MG53 may initiate the assembly of the membrane repair machinery in an oxidation-dependent manner.	[Masumiya, Haruko; Nishi, Miyuki; Takeshima, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 980, Japan; [Cai, Chuanxi; Weisleder, Noah; Hwang, Moonsun; Ko, Jae-Kyun; Lin, Peihui; Thornton, Angela; Zhao, Xiaoli; Pan, Zui; Brotto, Marco; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ctr Lab Frontier Sci, Tokyo, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama 3500495, Japan	Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Metropolitan Institute of Medical Science; Kyoto University; Saitama Medical University	Takeshima, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 980, Japan.	takeshim@pharm.kyoto-u.ac.jp; maj2@umdnj.edu	Lin, Pei-Hui/I-3011-2015; Weisleder, Noah L/A-7098-2013; Matsuda, Noriyuki/AAI-3156-2020; Cai, Chuanxi/AAW-1488-2020	Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah L/0000-0002-2619-8022; Matsuda, Noriyuki/0000-0001-8199-952X; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X; Takeshima, Hiroshi/0000-0003-4525-3725	NIH; Ministry of Education, Science, Sports and Culture of Japan; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Michael Reid, Jerome Parness, and Heping Cheng for helpful suggestions to this work. Yi Chu provided assistance in data processing and graphic conversions. We also thank the Cancer Institute of New Jersey Tissue Analytic Services Shared Resource and the UMDNJ-Cell Imaging Core facility, which is supported by NCRR from NIH, for providing assistance with imaging. This work was supported by grants from NIH (J.M.), Ministry of Education, Science, Sports and Culture of Japan ( H. T.) and the American Heart Association (C.C.,N.W.,M.B.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saito A, 2002, ACTA NEUROPATHOL, V104, P615, DOI 10.1007/s00401-002-0593-x; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928	37	314	339	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					56	U108		10.1038/ncb1812	http://dx.doi.org/10.1038/ncb1812			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043407	Green Accepted			2022-12-27	WOS:000262157000011
J	Calzado, MA; de la Vega, L; Moller, A; Bowtell, DDL; Schmitz, ML				Calzado, Marco A.; de la Vega, Laureano; Moeller, Andreas; Bowtell, David D. L.; Schmitz, M. Lienhard			An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN KINASE-2; P53; PHOSPHORYLATION; DEGRADATION; APOPTOSIS; STABILITY	Oxygen deprivation (hypoxia) results in reprogrammed gene expression patterns that induce multifaceted cellular responses. Here we identify a regulated interaction between the serine/threonine kinase HIPK2 and the ubiquitin E3 ligase Siah2 as a mechanism controlling the hypoxic response. Under normoxic conditions, several mechanisms ensure HIPK2 stability: only a fraction of HIPK2 is found in association with Siah2, whereas HIPK2-mediated phosphorylation of this E3 ligase at positions 26, 28 and 68 weakens mutual binding and destabilizes its phosphorylated interaction partner. Hypoxic conditions allow a markedly increased HIPK2/Siah2 interaction and result in efficient polyubiquitylation and proteasomal degradation of the kinase. Accordingly, hypoxia-induced HIPK2 elimination is markedly reduced in Siah2-deficient cells. As HIPK2 has an important role as a negative regulator of gene expression, its elimination from promoter-associated repressor complexes allows the induction of a substantial fraction of hypoxia-induced genes.	[Calzado, Marco A.; de la Vega, Laureano; Schmitz, M. Lienhard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Moeller, Andreas; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Dept Res, Canc Genom & Biochem Lab, Melbourne, Vic 3002, Australia; [Moeller, Andreas; Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	Justus Liebig University Giessen; Peter Maccallum Cancer Center; University of Melbourne	Schmitz, ML (corresponding author), Univ Giessen, Fac Med, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	lienhard.schmitz@biochemie.med.uni-giessen.de	Calzado, Marco A./S-2295-2019; Schmitz, M. Lienhard/D-9328-2017; Calzado, Marco/E-9046-2016; de la Vega, Laureano/AAE-5456-2020; Möller, Andreas/O-1063-2015; Bowtell, David/H-1007-2016	Calzado, Marco A./0000-0002-5338-535X; Schmitz, M. Lienhard/0000-0002-6984-7192; Calzado, Marco/0000-0002-5338-535X; de la Vega, Laureano/0000-0003-2707-7414; Möller, Andreas/0000-0002-8618-6998; Bowtell, David/0000-0001-9089-7525	Deutsche Forschungsgemeinschaft [SCHM 1417/4-1, SCHM 1417/5-1, SFB 547]; ECCPS-Excellence Cluster Cardio-Pulmonary System; ISCIII-RETIC [RD06/006]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ECCPS-Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); ISCIII-RETIC(Instituto de Salud Carlos III)	We are grateful to Stephanie Wack for excellent technical assistance, Michael Kracht for inspiring discussions and Elena Puccetti (Frankfurt) for help with microarrays. Our work is supported by grants from the Deutsche Forschungsgemeinschaft projects SCHM 1417/4-1, SCHM 1417/5-1, SFB 547 and the ECCPS-Excellence Cluster Cardio-Pulmonary System. M. A. C has been partially co-funded by the ISCIII-RETIC RD06/006 (RIS).	Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; KANEIISHII C, 2008, J BIOL CHEM; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; MOLLER A, 2008, ONCOGENE; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; QI J, 2008, P NATL ACAD SCI US; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; SHIMA Y, 2008, MOL CELL BIOL; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743	25	105	107	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					85	U180		10.1038/ncb1816	http://dx.doi.org/10.1038/ncb1816			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043406				2022-12-27	WOS:000262157000015
J	Caldwell, JH; Howell, KE				Caldwell, John H.; Howell, Kathryn E.			Pores galore for the Golgi	NATURE CELL BIOLOGY			English	Editorial Material							SECRETORY PATHWAY; ANION CHANNEL; COMPLEX; PH; DETERMINANTS	Strict control of cisternal pH in the Golgi is required for posttranslational modification and trafficking of proteins and lipids. a chloride channel to neutralize the charge of the proton pump and to keep the Golgi membrane potential near zero has finally been discovered.	[Caldwell, John H.; Howell, Kathryn E.] Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Caldwell, JH (corresponding author), Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA.	kathryn.howell@uchsc.edu						Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nordeen MH, 2000, BIOPHYS J, V78, P2918, DOI 10.1016/S0006-3495(00)76832-9; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Thompson RJ, 2006, AM J PHYSIOL-CELL PH, V290, pC499, DOI 10.1152/ajpcell.00585.2004; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200	16	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1125	1127		10.1038/ncb1008-1125	http://dx.doi.org/10.1038/ncb1008-1125			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18830217				2022-12-27	WOS:000259682900003
J	Diks, SH; da Silva, MAS; Hillebrands, JL; Bink, RJ; Versteeg, HH; van Rooijen, C; Brouwers, A; Chitnis, AB; Peppelenbosch, MP; Zivkovic, D				Diks, Sander H.; da Silva, Maria A. Sartori; Hillebrands, Jan-Luuk; Bink, Robert J.; Versteeg, Henri H.; van Rooijen, Carina; Brouwers, Anke; Chitnis, Ajay B.; Peppelenbosch, Maikel P.; Zivkovic, Danica			d-Asb11 is an essential mediator of canonical Delta-Notch signalling	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; CELL FATE; MIND BOMB; ZEBRAFISH; DROSOPHILA; ENDOCYTOSIS; PATHWAY; PROTEIN; GENE; NRARP	In canonical Delta-Notch signalling, expression of Delta activates Notch in neighbouring cells, leading to of Delta in these cells(1). This process of lateral inhibition results in selection of either Delta-signalling cells or Notch-signalling cells. Here we show that d-Asb11 is an important mediator of this lateral inhibition. In zebrafish embryos, morpholino oligonucleotide (MO)-mediated knockdown of d-Asb11 caused repression of specific Delta-Notch elements and their transcriptional targets, whereas these were induced when d-Asb11 was misexpressed. d-Asb11 also activated legitimate Notch reporters cell-non-autonomously in vitro and in vivo when co-expressed with a Notch reporter. However, it repressed Notch reporters when expressed in Delta-expressing cells. Consistent with these results, d-Asb11 was able to specifically ubiquitylate and degrade DeltaA both in vitro and in vivo. We conclude that d-Asb11 is a component in the regulation of Delta-Notch signalling, important in fine-tuning the lateral inhibition gradients between DeltaA and Notch through a cell non-autonomous mechanism.	[Diks, Sander H.; da Silva, Maria A. Sartori; Hillebrands, Jan-Luuk; Versteeg, Henri H.; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [da Silva, Maria A. Sartori; Bink, Robert J.; van Rooijen, Carina; Brouwers, Anke; Zivkovic, Danica] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Chitnis, Ajay B.] NICHD, Sect Neural Dev Dynam, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Peppelenbosch, MP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	M.P.Peppelenbosch@med.umcg.nl	Versteeg, Henri/G-1783-2018; Sartori, Maria A/R-9317-2016	Versteeg, Henri/0000-0003-4294-175X; Sartori, Maria A/0000-0002-6474-280X; Peppelenbosch, Maikel/0000-0001-9112-6028; Hillebrands, Jan-Luuk/0000-0003-3135-3274				Appel B, 1998, DEVELOPMENT, V125, P371; Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Crowe R, 1998, DEVELOPMENT, V125, P767; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Diks SH, 2006, J CELL BIOL, V174, P581, DOI 10.1083/jcb.200601081; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Holley SA, 2002, DEVELOPMENT, V129, P1175; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JOORE J, 1994, MECH DEVELOP, V46, P137, DOI 10.1016/0925-4773(94)90082-5; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Latimer AJ, 2002, DEVELOPMENT, V129, P2555; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Westerfield M, 1994, ZEBRAFISH BOOK; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	34	19	19	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1190	1198		10.1038/ncb1779	http://dx.doi.org/10.1038/ncb1779			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776899				2022-12-27	WOS:000259682900013
J	Gregory, PA; Bert, AG; Paterson, EL; Barry, SC; Tsykin, A; Farshid, G; Vadas, MA; Khew-Goodall, Y; Goodall, GJ				Gregory, Philip A.; Bert, Andrew G.; Paterson, Emily L.; Barry, Simon C.; Tsykin, Anna; Farshid, Gelareh; Vadas, Mathew A.; Khew-Goodall, Yeesim; Goodall, Gregory J.			The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1	NATURE CELL BIOLOGY			English	Article							CANCER CELL-LINES; BREAST-CANCER; E-CADHERIN; MICRORNA EXPRESSION; TRANSCRIPTIONAL REPRESSOR; GENES; METASTASIS; MORPHOGENESIS; PROGRESSION; DELTA-EF1	Epithelial to mesenchymal transition (EMT) facilitates tissue remodelling during embryonic development and is viewed as an essential early step in tumour metastasis. We found that all five members of the microRNA-200 family (miR- 200a, miR- 200b, miR- 200c, miR- 141 and miR- 429) and miR- 205 were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-beta or to ectopic expression of the protein tyrosine phosphatase Pez. Enforced expression of the miR- 200 family alone was sufficient to prevent TGF-beta-induced EMT. Together, these microRNAs cooperatively regulate expression of the E-cadherin transcriptional repressors ZEB1 ( also known as delta EF1) and SIP1 ( also known as ZEB2), factors previously implicated in EMT and tumour metastasis. Inhibition of the microRNAs was sufficient to induce EMT in a process requiring upregulation of ZEB1 and/or SIP1. Conversely, ectopic expression of these microRNAs in mesenchymal cells initiated mesenchymal to epithelial transition ( MET). Consistent with their role in regulating EMT, expression of these microRNAs was found to be lost in invasive breast cancer cell lines with mesenchymal phenotype. Expression of the miR- 200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. These data suggest that downregulation of the microRNAs may be an important step in tumour progression.	[Gregory, Philip A.; Bert, Andrew G.; Paterson, Emily L.; Tsykin, Anna; Vadas, Mathew A.; Khew-Goodall, Yeesim; Goodall, Gregory J.] Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA 5000, Australia; [Barry, Simon C.] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Barry, Simon C.] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Farshid, Gelareh] Inst Med & Vet Sci, Div Tissue Pathol, Adelaide, SA 5000, Australia; [Khew-Goodall, Yeesim] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Gregory, Philip A.; Vadas, Mathew A.; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; Womens & Childrens Hospital Australia; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA 5000, Australia.	greg.goodall@imvs.sa.gov.au	Vadas, Mathew/R-1378-2019; Gregory, Philip/F-4089-2013	Gregory, Philip/0000-0002-0999-0632; Goodall, Gregory/0000-0003-1294-0692; Barry, Simon/0000-0002-0597-7609; Tsykin, Anna/0000-0001-5965-6803; Bert, Andrew/0000-0003-3876-1537				Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; PARK SM, 2008, GENES DEV; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	35	2968	3132	2	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					593	601		10.1038/ncb1722	http://dx.doi.org/10.1038/ncb1722			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18376396				2022-12-27	WOS:000255502400016
J	Rocca, DL; Martin, S; Jenkins, EL; Hanley, JG				Rocca, Daniel L.; Martin, Stephane; Jenkins, Emma L.; Hanley, Jonathan G.			Inhibition of Arp2/3-mediated actin polymerization by PICK1 regulates neuronal morphology and AMPA receptor endocytosis	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; LONG-TERM DEPRESSION; DENDRITIC SPINES; ARP2/3 COMPLEX; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; PROTEIN PICK1; IMAGING ACTIN; N-WASP	The dynamic regulation of actin polymerization plays crucial roles in cell morphology and endocytosis. The mechanistic details of these processes and the proteins involved are not fully understood, especially in neurons. PICK1 is a PDZ-BAR-domain protein involved in regulated AMPA receptor (AMPAR) endocytosis in neurons. Here, we demonstrate that PICK1 binds filamentous (F)-actin and the actin-nucleating Arp2/3 complex, and potently inhibits Arp2/3-mediated actin polymerization. RNA interference (RNAi) knockdown of PICK1 in neurons induces a reorganization of the actin cytoskeleton resulting in aberrant cell morphology. Wild-type PICK1 rescues this phenotype, but a mutant PICK1, PICK1(W413A), that does not bind or inhibit Arp2/3 has no effect. Furthermore, this mutant also blocks NMDA-induced AMPAR internalization. This study identifies PICK1 as a negative regulator of Arp2/3-mediated actin polymerization that is critical for a specific form of vesicle trafficking, and also for the development of neuronal architecture.	[Rocca, Daniel L.; Martin, Stephane; Jenkins, Emma L.; Hanley, Jonathan G.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Univ Walk, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk	Martin, Stéphane/G-5954-2012	Martin, Stéphane/0000-0001-6771-7645; Hanley, Jonathan/0000-0003-1704-4707	Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [G0601841B] Funding Source: researchfish; Medical Research Council [G0501455, G0501455(76848)] Funding Source: Medline; Wellcome Trust [072005] Funding Source: Medline; MRC [G0501455] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	41	161	168	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					259	U7		10.1038/ncb1688	http://dx.doi.org/10.1038/ncb1688			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297063	Green Accepted			2022-12-27	WOS:000253778300008
J	Jakobsson, L; Franco, CA; Bentley, K; Collins, RT; Ponsioen, B; Aspalter, IM; Rosewell, I; Busse, M; Thurston, G; Medvinsky, A; Schulte-Merker, S; Gerhardt, H				Jakobsson, Lars; Franco, Claudio A.; Bentley, Katie; Collins, Russell T.; Ponsioen, Bas; Aspalter, Irene M.; Rosewell, Ian; Busse, Marta; Thurston, Gavin; Medvinsky, Alexander; Schulte-Merker, Stefan; Gerhardt, Holger			Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting	NATURE CELL BIOLOGY			English	Article						m	TYROSINE KINASE; GROWTH-FACTOR; IN-VIVO; NOTCH; VEGF; FLT-1; EMBRYOS; BINDING; DLL4; VASCULOGENESIS	Sprouting angiogenesis requires the coordinated behaviour of endothelial cells, regulated by Notch and vascular endothelial growth factor receptor (VEGFR) signalling. Here, we use computational modelling and genetic mosaic sprouting assays in vitro and in vivo to investigate the regulation and dynamics of endothelial cells during tip cell selection. We find that endothelial cells compete for the tip cell position through relative levels of Vegfr1 and Vegfr2, demonstrating a biological role for differential Vegfr regulation in individual endothelial cells. Differential Vegfr levels affect tip selection only in the presence of a functional Notch system by modulating the expression of the ligand Dll4. Time-lapse microscopy imaging of mosaic sprouts identifies dynamic position shuffling of tip and stalk cells in vitro and in vivo, indicating that the VEGFR-Dll4-Notch signalling circuit is constantly re-evaluated as cells meet new neighbours. The regular exchange of the leading tip cell raises novel implications for the concept of guided angiogenic sprouting.	[Jakobsson, Lars; Franco, Claudio A.; Bentley, Katie; Collins, Russell T.; Aspalter, Irene M.; Busse, Marta; Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London WC2A 3PX, England; [Ponsioen, Bas; Schulte-Merker, Stefan] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Rosewell, Ian] Canc Res UK, Clare Hall Labs, London Res Inst, Transgen Serv, Potters Bar EN6 3LD, Herts, England; [Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Medvinsky, Alexander] MRC, Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Gerhardt, Holger] Vesalius Res Ctr, Vasc Patterning Lab, O&N1, B-3000 Louvain, Belgium	Cancer Research UK; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Cancer Research UK; Regeneron	Gerhardt, H (corresponding author), Canc Res UK, London Res Inst, Vasc Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	holger.gerhardt@cancer.org.uk	Franco, Claudio A/D-8117-2015; Gerhardt, Holger/G-4610-2011; Franco, Claudio A/B-1060-2013; Jakobsson, Lars/B-4200-2011; Gerhardt, Holger/G-4610-2011	Franco, Claudio A/0000-0002-2861-3883; Gerhardt, Holger/0000-0002-3030-0384; Franco, Claudio A/0000-0002-2861-3883; Jakobsson, Lars/0000-0001-7956-587X; Bentley, Katie/0000-0002-9391-659X; Thurston, Gavin/0000-0002-4105-5919; Gerhardt, Holger/0000-0001-9228-7472; Aspalter, Irene Maria/0000-0002-6155-9006; Collins, Russell T/0000-0002-1847-4517	CRUK; Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO); Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Leukaemia Research Fund; Dutch Organization of Scientific Research [175.010.2007.007]; Nederlandse Akademie van Wetenschappen (KNAW); Medical Research Council [G0700711B] Funding Source: researchfish	CRUK(Cancer Research UK); Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Leukaemia Research Fund; Dutch Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Nederlandse Akademie van Wetenschappen (KNAW); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the Cancer Research UK (CRUK) Light Microscopy facility, P. Jordan, the Protein Purification lab, S. Kjaer, J. Yang and J. Ure. We thank D. Barr and I. Moal for simulation and analysis work performed in the Biomolecular Modelling Laboratory CRUK, D. Sauvaget and J. Babbage for technical assistance and B. Thompson for comments on the manuscript. The authors are supported by CRUK, the Lister Institute of Preventive Medicine, the European Molecular Biology Organization (EMBO) Young Investigator Programme, the Fondation Leducq Transatlantic Network of Excellence ARTEMIS (H.G.), the Leukaemia Research Fund (to A.M.) and an EMBO long-term post-doctoral fellowship (to L.J.). We thank J. van Rheenen for discussions and assistance on the SP5 microscope (Leica Microsystems; equipment grant from the Dutch Organization of Scientific Research; NOW, 175.010.2007.007). We also thank A. de Graaff (M.Sc.) and the Hubrecht Imaging Centre (HIC) for imaging support. B.P. and S.S.-M. were supported by the Nederlandse Akademie van Wetenschappen (KNAW).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1994, J BIOL CHEM, V269, P25646; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, NOVART FDN SYMP, V283, P238; SUCHTING S, 2007, NOVART FDN SYMP, V80, P77; SUCHTING S, 2007, NOVART FDN SYMP, V283, P238; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	49	629	641	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					943	953		10.1038/ncb2103	http://dx.doi.org/10.1038/ncb2103			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20871601				2022-12-27	WOS:000282363500009
J	Khodjakov, A; Pines, J				Khodjakov, Alexey; Pines, Jonathon			Centromere tension: a divisive issue	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; AURORA B KINASE; CHROMOSOMAL INSTABILITY; MICROTUBULE ATTACHMENT; ANAPHASE ONSET; BUDDING YEAST; KINETOCHORE; CELLS; SEGREGATION; ORIENTATION	It has been proposed that the spindle assembly checkpoint detects both unattached kinetochores and lack of tension between sister kinetochores when sister chromatids are not attached to opposite spindle poles. However, here we argue that there is only one signal - whether kinetochores are attached to microtubules or not - and this has implications for our understanding of both chromosome segregation and the control of genomic stability.	[Khodjakov, Alexey] Wadsworth Ctr, Albany, NY 12201 USA; [Khodjakov, Alexey] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Pines, Jonathon] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Pines, Jonathon] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Wadsworth Center; Rensselaer Polytechnic Institute; University of Cambridge; University of Cambridge	Khodjakov, A (corresponding author), Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org; jp103@cam.ac.uk	Holt, Janet E/B-2415-2013	Pines, Jonathon/0000-0002-5227-6004	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; NIGMS NIH HHS [R01 GM059363-12, R01 GM059363] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; BAKHOUM SF, 2009, CURR BIOL, V19, pR1032; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, BIOCHEM SOC T, V37, P976, DOI 10.1042/BST0370976; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 2001, J CELL SCI, V114, P4173; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150; ZIRKLE RE, 1970, RADIAT RES, V41, P516, DOI 10.2307/3572841	32	69	69	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					919	923		10.1038/ncb1010-919	http://dx.doi.org/10.1038/ncb1010-919			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20885417	Green Accepted			2022-12-27	WOS:000282363500003
J	Siekhaus, D; Haesemeyer, M; Moffitt, O; Lehmann, R				Siekhaus, Daria; Haesemeyer, Martin; Moffitt, Olivia; Lehmann, Ruth			RhoL controls invasion and Rap1 localization during immune cell transmigration in Drosophila	NATURE CELL BIOLOGY			English	Article							SMALL GTPASES; BLOOD-CELLS; MIGRATION; ADHESION; MECHANISMS; INTEGRIN; MELANOGASTER; LEUKOCYTE; RECEPTOR; TISSUE	Human immune cells have to penetrate an endothelial barrier during their beneficial pursuit of infection and their destructive infiltration of tissues in autoimmune diseases. This transmigration requires Rap1 GTPase to activate integrin affinity(1). We define a new model system for this process by demonstrating, with live imaging and genetics, that during embryonic development Drosophila melanogaster immune cells penetrate an epithelial, Drosophila E-cadherin (DE-cadherin)-based tissue barrier. A mutant in RhoL, a GTPase homologue that is specifically expressed in haemocytes, blocks this invasive step but not other aspects of guided migration. RhoL mediates integrin adhesion caused by Drosophila Rap1 overexpression and moves Rap1 away from a concentration in the cytoplasm to the leading edge during invasive migration. These findings indicate that a programmed migratory step during Drosophila development bears striking molecular similarities to vertebrate immune cell transmigration during inflammation, and identify RhoL as a new regulator of invasion, adhesion and Rap1 localization. Our work establishes the utility of Drosophila for identifying novel components of immune cell transmigration and for understanding the in vivo interplay of immune cells with the barriers they penetrate.	[Lehmann, Ruth] NYU, Sch Med, HHMI, New York, NY 10016 USA; NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, HHMI, New York, NY 10016 USA.	Ruth.Lehmann@med.nyu.edu	Haesemeyer, Martin/Q-2123-2017; Siekhaus, Daria/AAN-1779-2020	Haesemeyer, Martin/0000-0003-2704-3601; Siekhaus, Daria/0000-0001-8323-8353; Moffitt, Olivia/0000-0001-5107-1413; Lehmann, Ruth/0000-0002-8454-5651	NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Jukam, P. Kunwar, A-M. Sudarov, and S. Wang for help during the GAL4 enhancer screen, and D. Demy for input. We thank all the people who shared their reagents: U. Heberlein, K. Brueckner, N. Perrimon, D. Montell, R. Reuter and A. Page-McCaw for stocks and T. Uemura, D. Branton, R, Dubreuil, H. Bellen, N. Lowe, D. Ryoo and J. Treisman for antibodies. We thank the Developmental Studies Hybridoma Bank developed with NICHD support and maintained by the University of Iowa for antibodies and the Bloomington Stock Center for flies. We are grateful for conversations with P. Rangan, P. Kunwar and many other members of the laboratory. We thank M. Dustin, S. Schwab and laboratory members for comments on the manuscript. We thank NICHD for supporting part of this work. R.L. is an investigator of the HHMI.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi EY, 2009, FRONT BIOSCI-LANDMRK, V14, P1596, DOI 10.2741/3327; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; de Velasco B, 2006, DEV GENES EVOL, V216, P39, DOI 10.1007/s00427-005-0029-4; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Menasche G, 2007, IMMUNOL REV, V218, P82, DOI 10.1111/j.1600-065X.2007.00543.x; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	35	49	50	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					605	U181		10.1038/ncb2063	http://dx.doi.org/10.1038/ncb2063			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20495554	Green Accepted			2022-12-27	WOS:000278213400013
J	Novoa, I; Gallego, J; Ferreira, PG; Mendez, R				Novoa, Isabel; Gallego, Javier; Ferreira, Pedro G.; Mendez, Raul			Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; POLY(A) TAIL; DEADENYLATION; EXPRESSION; GENES; PHOSPHORYLATION; FRACTIONATION; DEGRADATION; SPECIFICITY	Meiotic and early-embryonic cell divisions in vertebrates take place in the absence of transcription and rely on the translational regulation of stored maternal messenger RNAs. Most of these mRNAs are regulated by the cytoplasmic-polyadenylation-element-binding protein (CPEB), which mediates translational activation and repression through cytoplasmic changes in their poly(A) tail length. It was unknown whether translational regulation by cytoplasmic polyadenylation and CPEB can also regulate mRNAs at specific points of mitotic cell-cycle divisions. Here we show that CPEB-mediated post-transcriptional regulation by phase-specific changes in poly(A) tail length is required for cell proliferation and specifically for entry into M phase in mitotically dividing cells. This translational control is mediated by two members of the CPEB family of proteins, CPEB1 and CPEB4. We conclude that regulation of poly(A) tail length is not only required to compensate for the lack of transcription in specialized cell divisions but also acts as a general mechanism to control mitosis.	[Novoa, Isabel; Gallego, Javier; Ferreira, Pedro G.; Mendez, Raul] Ctr Genom Regulat, Gene Regulat Program, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendez, R (corresponding author), Ctr Genom Regulat, Gene Regulat Program, C Dr Aiguader 88, Barcelona 08003, Spain.	inovoa@ir.vhebron.net; raul.mendez@crg.es	Ferreira, Pedro G/J-6379-2013; Ferreira, Pedro/HDO-1346-2022; Gallego, Javier/GQI-2928-2022	Ferreira, Pedro G/0000-0003-3838-8664; Gallego, Javier/0000-0001-5635-5001; Mendez, Raul/0000-0002-1952-6905; Novoa, Isabel/0000-0003-1821-1685	Spanish Ministry of Science and Innovation; Fundacio 'Marato de TV3'; FIS and Marie Curie Reintegration grants; MEC	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio 'Marato de TV3'; FIS and Marie Curie Reintegration grants; MEC(European Commission)	Anti-MS2 antibodies were provided by Mike Kiledjian (Rutgers University), anti-CPSF100 antibodies by James Manley (Columbia University), and anti-CPEB1 antibodies by Dominique Weil (Institut Andre Lwoff). We thank Oscar Fornas (Flow Cytometry Facility at UPF) and Lauro Sumoy (Microarray Facility) for technical advice, and members of the Mendez and Fatima Gebauer laboratory, Mercedes Fernandez, Juan Valcarcel, Josep Vilardell, Roderic Guigo and other colleagues from the Gene Expression Program, for helpful advice and critically reading the manuscript. This work was supported by grants from the Spanish Ministry of Science and Innovation, Fundacio 'Marato de TV3' to R. M., and FIS and Marie Curie Reintegration grants to I.N. R.M. is a recipient of a contract from the I3 contract (MEC), and I.N. from the 'Programa Ramon y Cajal' (MEC).	Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cao QP, 2006, NAT STRUCT MOL BIOL, V13, P1128, DOI 10.1038/nsmb1169; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Pique Maria, 2006, V322, P183; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Walker J, 1998, METH MOL B, V77, P365; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	44	119	124	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					447	U82		10.1038/ncb2046	http://dx.doi.org/10.1038/ncb2046			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20364142				2022-12-27	WOS:000277283700010
J	van Diepen, MT; Parsons, M; Downes, CP; Leslie, NR; Hindges, R; Eickholt, BJ				van Diepen, Michiel T.; Parsons, Maddy; Downes, C. Peter; Leslie, Nicholas R.; Hindges, Robert; Eickholt, Britta J.			MyosinV controls PTEN function and neuronal cell size	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PTEN; UNCONVENTIONAL MYOSIN; EPITHELIAL-CELLS; IN-VIVO; BRAIN; PHOSPHORYLATION; MEMBRANE; MORPHOGENESIS; STABILITY; DISEASE	The tumour suppressor PTEN can inhibit cell proliferation and migration as well as control cell growth, in different cell types(1). PTEN functions predominately as a lipid phosphatase, converting PtdIns(3,4,5)P-3 to PtdIns(4,5)P-2, thereby antagonizing PI(3) K (phosphoinositide 3-kinase) and its established downstream effector pathways(2). However, much is unclear concerning the mechanisms that regulate PTEN movement to the cell membrane, which is necessary for its activity towards PtdIns(3,4,5)P-3 (refs 3-5). Here we show a requirement for functional motor proteins in the control of PI3K signalling, involving a previously unknown association between PTEN and myosinV. FRET (Forster resonance energy transfer) measurements revealed that PTEN interacts directly with myosinV, which is dependent on PTEN phosphorylation mediated by CK2 and/or GSK3. Inactivation of myosinV transport function in neurons increased cell size, which, in line with known attributes of PTEN-loss(6,7), required PI(3) K and mTor. Our data demonstrate a myosin-based transport mechanism that regulates PTEN function, providing new insights into the signalling networks regulating cell growth.	[van Diepen, Michiel T.; Hindges, Robert; Eickholt, Britta J.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Downes, C. Peter; Leslie, Nicholas R.] Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of London; King's College London; University of London; King's College London; University of Dundee	Eickholt, BJ (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, New Hunts House, London SE1 1UL, England.	britta.J.eickholt@kcl.ac.uk	Parsons, Maddy/B-2203-2013; Leslie, Nicholas/D-2699-2009; Eickholt, Britta/C-5337-2009; Hindges, Robert/C-5344-2009	Parsons, Maddy/0000-0002-2021-8379; Hindges, Robert/0000-0003-0095-7913; LESLIE, Nicholas/0000-0001-5131-0541; van Diepen, Michiel/0000-0001-8156-4294; Eickholt, Britta/0000-0001-7873-8687	Biotechnology and Biological Science Research Council [BB/C514307/1]; MRC [G9403619]; MRC [G0801865] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C514307/1] Funding Source: researchfish; Medical Research Council [G9403619, G0801865] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Science Research Council to B. J. E. (BB/C514307/1), an MRC program grant to C. P. D. (G9403619). M. P. is a Royal Society University Research Fellow. We thank J. Hammer III for providing the myosinVa cDNA, C. Sutherland for the GSK3 inhibitor CT99021, E. Blanc for help with statistical analyses and F. Gertler for comments on the manuscript.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Brown JR, 2002, BIOL BULL, V203, P210, DOI 10.2307/1543401; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rodriguez OC, 2002, J CELL SCI, V115, P991; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	29	71	71	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1191	U55		10.1038/ncb1961	http://dx.doi.org/10.1038/ncb1961			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767745	Green Accepted			2022-12-27	WOS:000270382000007
J	Khadaroo, B; Teixeira, MT; Luciano, P; Eckert-Boulet, N; Germann, SM; Simon, MN; Gallina, I; Abdallah, P; Gilson, E; Geli, V; Lisby, M				Khadaroo, Basheer; Teixeira, M. Teresa; Luciano, Pierre; Eckert-Boulet, Nadine; Germann, Susanne M.; Simon, Marie Noelle; Gallina, Irene; Abdallah, Pauline; Gilson, Eric; Geli, Vincent; Lisby, Michael			The DNA damage response at eroded telomeres and tethering to the nuclear pore complex	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; YEAST TELOMERES; BINDING PROTEIN; KU HETERODIMER; S-PHASE; G-TAILS; REPAIR; COLOCALIZATION	The ends of linear eukaryotic chromosomes are protected by telomeres, which serve to ensure proper chromosome replication and to prevent spurious recombination at chromosome ends. In this study, we show by single cell analysis that in the absence of telomerase, a single short telomere is sufficient to induce the recruitment of checkpoint and recombination proteins. Notably, a DNA damage response at eroded telomeres starts many generations before senescence and is characterized by the recruitment of Cdc13 (cell division cycle 13), replication protein A, DNA damage checkpoint proteins and the DNA repair protein Rad52 into a single focus. Moreover, we show that eroded telomeres, although remaining at the nuclear periphery, move to the nuclear pore complex. Our results link the DNA damage response at eroded telomeres to changes in subnuclear localization and suggest the existence of collapsed replication forks at eroded telomeres.	[Khadaroo, Basheer; Luciano, Pierre; Simon, Marie Noelle; Geli, Vincent] Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France; [Teixeira, M. Teresa; Abdallah, Pauline] Univ Lyon 1, Ecole Normale Super, CNRS, UMR 5239,Lab Biol Mol Cellule, F-69364 Lyon 07, France; [Eckert-Boulet, Nadine; Germann, Susanne M.; Gallina, Irene; Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Copenhagen	Geli, V (corresponding author), Univ Aix Marseille 2, CNRS, Unite Propre Rech 3081, F-13402 Marseille 20, France.	geli@ibsm.cnrs-mrs.fr	Germann, Susanne Manuela/K-9062-2014; Lisby, Michael/K-9814-2014; Teixeira, Maria Teresa/A-2100-2011	Germann, Susanne Manuela/0000-0002-4737-8452; Lisby, Michael/0000-0002-4830-5247; Teixeira, Maria Teresa/0000-0002-9466-7951; Gallina, Irene/0000-0002-3741-9038	The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; Deutscher Akademischer Austausch Dienst; Lundbeck Foundation; LNNC; Lebanese National council for Scientific Research; Association pour la Recherche sur le Cancer	The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Lundbeck Foundation(Lundbeckfonden); LNNC; Lebanese National council for Scientific Research; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank members of the Geli, Gilson and Lisby laboratories for helpful discussions concerning this work, A. Nicolas, X. Zhao, R. Rothstein, B. Palancade, V. Lundblad and R. Wellinger for sharing reagents and for fruitful discussions, S. Larose and R. Wellinger, who engineered the pTet-off-TLC1 construct, and S. Brill for the anti-RPA antibody. This work was supported by The Danish Agency for Science, Technology and Innovation (M. L.), the Villum Kann Rasmussen Foundation (M. L.), the Deutscher Akademischer Austausch Dienst (S. M. G.) and the Lundbeck Foundation (N. E. B.). The Agence Nationale de la Recherche (ANR programme blanc) and the Ligue Nationale Contre le Cancer (LNCC, equipes labelisees) supported V. G. and E. G. laboratories; B. K. is a recipient of a fellowship from the LNNC and P. A. is supported by the Lebanese National council for Scientific Research (CNRSL) and the Association pour la Recherche sur le Cancer (ARC).	Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bhattacharyya MK, 2006, TRENDS BIOCHEM SCI, V31, P114, DOI 10.1016/j.tibs.2005.12.001; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Le S, 1999, GENETICS, V152, P143; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Sherman F., 1986, METHODS YEAST GENETI; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V	31	143	145	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					980	U161		10.1038/ncb1910	http://dx.doi.org/10.1038/ncb1910			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597487				2022-12-27	WOS:000268593200012
J	Clavaguera, F; Bolmont, T; Crowther, RA; Abramowski, D; Frank, S; Probst, A; Fraser, G; Stalder, AK; Beibel, M; Staufenbiel, M; Jucker, M; Goedert, M; Tolnay, M				Clavaguera, Florence; Bolmont, Tristan; Crowther, R. Anthony; Abramowski, Dorothee; Frank, Stephan; Probst, Alphonse; Fraser, Graham; Stalder, Anna K.; Beibel, Martin; Staufenbiel, Matthias; Jucker, Mathias; Goedert, Michel; Tolnay, Markus			Transmission and spreading of tauopathy in transgenic mouse brain	NATURE CELL BIOLOGY			English	Article							PAIRED HELICAL FILAMENTS; TAU-PROTEIN; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; INTRACEREBRAL INFUSION; PARKINSONS-DISEASE; MICE; PATHOLOGY; DEMENTIA; PHOSPHORYLATION	Hyperphosphorylated tau makes up the filamentous intracellular inclusions of several neurodegenerative diseases, including Alzheimer's disease(1). In the disease process, neuronal tau inclusions first appear in the transentorhinal cortex from where they seem to spread to the hippocampal formation and neocortex(2). Cognitive impairment becomes manifest when inclusions reach the hippocampus, with abundant neocortical tau inclusions and extracellular beta-amyloid deposits being the defining pathological hallmarks of Alzheimer's disease. An abundance of tau inclusions, in the absence of beta-amyloid deposits, defines Pick's disease, progressive supranuclear palsy, corticobasal degeneration and other diseases(1). Tau mutations cause familial forms of frontotemporal dementia, establishing that tau protein dysfunction is sufficient to cause neurodegeneration and dementia(3-5). Thus, transgenic mice expressing mutant (for example, P301S) human tau in nerve cells show the essential features of tauopathies, including neurodegeneration and abundant filaments made of hyperphosphorylated tau protein(6,8). By contrast, mouse lines expressing single isoforms of wild-type human tau do not produce tau filaments or show neurodegeneration(7,8). Here we have used tau-expressing lines to investigate whether experimental tauopathy can be transmitted. We show that injection of brain extract from mutant P301S tau-expressing mice into the brain of transgenic wild-type tau-expressing animals induces assembly of wild-type human tau into filaments and spreading of pathology from the site of injection to neighbouring brain regions.	[Clavaguera, Florence; Frank, Stephan; Probst, Alphonse; Tolnay, Markus] Univ Basel, Inst Pathol, Dept Neuropathol, Basel, Switzerland; [Bolmont, Tristan; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Crowther, R. Anthony; Fraser, Graham; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Abramowski, Dorothee; Beibel, Martin; Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland; [Stalder, Anna K.] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; MRC Laboratory Molecular Biology; Novartis; University of Basel	Tolnay, M (corresponding author), Univ Basel, Inst Pathol, Dept Neuropathol, Basel, Switzerland.	mg@mrc-lmb.cam.ac.uk; mtolnay@uhbs.ch			MRC [MC_U105184319, MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5] Funding Source: researchfish; Medical Research Council [MC_U105184291, MC_U105184319, U.1051.02.002(78792)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; MERCKEN M, 1992, J NEUROCHEM, V58, P548, DOI 10.1111/j.1471-4159.1992.tb09754.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x	35	1198	1241	1	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					909	U325		10.1038/ncb1901	http://dx.doi.org/10.1038/ncb1901			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503072	Green Accepted			2022-12-27	WOS:000267603100022
J	Huang, J; Huen, MSY; Kim, H; Leung, CCY; Glover, JNM; Yu, XC; Chen, JJ				Huang, Jun; Huen, Michael S. Y.; Kim, Hongtae; Leung, Charles Chung Yun; Glover, J. N. Mark; Yu, Xiaochun; Chen, Junjie			RAD18 transmits DNA damage signalling to elicit homologous recombination repair	NATURE CELL BIOLOGY			English	Article							DEFECTIVE POSTREPLICATION REPAIR; DOUBLE-STRAND BREAKS; ONCOGENIC TRANSLOCATIONS; UBIQUITIN STRUCTURES; GENOMIC INSTABILITY; RAD51L2 RAD51C; PROTEIN; BRCA1; CHECKPOINT; CELLS	To maintain genome stability, cells respond to DNA damage by activating signalling pathways that govern cell-cycle checkpoints and initiate DNA repair. Cell-cycle checkpoint controls should connect with DNA repair processes, however, exactly how such coordination occurs in vivo is largely unknown. Here we describe a new role for the E3 ligase RAD18 as the integral component in translating the damage response signal to orchestrate homologous recombination repair (HRR). We show that RAD18 promotes homologous recombination in a manner strictly dependent on its ability to be recruited to sites of DNA breaks and that this recruitment relies on a well-defined DNA damage signalling pathway mediated by another E3 ligase, RNF8. We further demonstrate that RAD18 functions as an adaptor to facilitate homologous recombination through direct interaction with the recombinase RAD51C. Together, our data uncovers RAD18 as a key factor that orchestrates HRR through surveillance of the DNA damage signal.	[Huang, Jun; Huen, Michael S. Y.; Kim, Hongtae; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Leung, Charles Chung Yun; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Yale University; University of Alberta	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010		National Institutes of Health; Anna Fuller Fund Fellowship; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA130899, R01CA132755, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund Fellowship; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Shiomi for HCT116 RAD18<SUP>-/-</SUP> cells, M. Yamaizumi for RAD18<SUP>-/-</SUP> MEFs, S. Akira for UBC13-deficient cells, H. Nagasawa for IRS3 and V79 cells, M. Jasin for U2OS cells with DR-GFP integration and pCBASce plasmids, B. P. Chen for NU7441 and J. Groenendyk for helping with the BIAcore system. J. C would like to thank all colleagues for discussions and technical assistance, and J. Wood for proofreading. This work was supported by grants from the National Institutes of Health to J. C., M. S. Y. H. is supported by the Anna Fuller Fund Fellowship and J. C. is a recipient of an Era of Hope Scholar award from the Department of Defense ( a member of the Mayo Clinic Breast SPORE program).	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hinz JM, 2003, CARCINOGENESIS, V24, P249, DOI 10.1093/carcin/24.2.249; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Petrini JHJ, 2007, SCIENCE, V316, P1138, DOI 10.1126/science.1143700; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Reynolds J, 2004, NAT CELL BIOL, V6, P184, DOI 10.1038/ncb0304-184a; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yoshimura A, 2006, DNA REPAIR, V5, P1307, DOI 10.1016/j.dnarep.2006.05.045; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	53	217	227	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					592	U155		10.1038/ncb1865	http://dx.doi.org/10.1038/ncb1865			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19396164	Green Accepted			2022-12-27	WOS:000265640000018
J	Shapiro, PJ; Hsu, HH; Jung, H; Robbins, ES; Ryoo, HD				Shapiro, Peter J.; Hsu, Hans H.; Jung, Heekyung; Robbins, Edith S.; Ryoo, Hyung Don			Regulation of the Drosophila apoptosome through feedback inhibition	NATURE CELL BIOLOGY			English	Article							DEVELOPMENTAL CELL-DEATH; CASPASE DRONC; DIAP1; GENE; PROTEIN; REAPER; APAF-1; HOMOLOG; SYSTEM; FORM	Apoptosis is induced by caspases, which are members of the cysteine protease family(1). Caspases are synthesized as inactive zymogens and initiator caspases first gain activity by associating with an oligomeric complex of their adaptor proteins, such as the apoptosome(2,3). Activated initiator caspases subsequently cleave and activate effector caspases. Although such a proteolytic cascade would predict that a small number of active caspases could irreversibly amplify caspase activity and trigger apoptosis, many cells can maintain moderate levels of caspase activity to perform non-apoptotic roles in cellular differentiation, shape change and migration(4). Here we show that the Drosophila melanogaster apoptosome engages in a feedback inhibitory loop, which moderates its activation level in vivo. Specifically, the adaptor protein Apaf-1 lowers the level of its associated initiator caspase Dronc, without triggering apoptosis. Conversely, Dronc lowers Apaf-1 protein levels. This mutual suppression depends on the catalytic site of Dronc and a caspase cleavage site within Apaf-1. Moreover, the Drosophila inhibitor of apoptosis protein 1 (Diap1) is required for this process. We speculate that this feedback inhibition allows cells to regulate the degree of caspase activation for apoptotic and non-apoptotic purposes.	[Shapiro, Peter J.; Hsu, Hans H.; Jung, Heekyung; Robbins, Edith S.; Ryoo, Hyung Don] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Ryoo, HD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	hyungdon.ryoo@nyumc.org		Robbins, Edith S/0000-0003-1035-0621	NIH [5T32GM007239-32, 1RO1GM079425]; Leukemia-Lymphoma Society; Dimes Foundation; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia-Lymphoma Society(Leukemia and Lymphoma Society); Dimes Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John Abrams, Andreas Bergmann, George Jackson, Pascal Meier for fly stocks; David Sabatini for making available the scanning electron microscope; Milton Adesnik, Ramanuj Dasgupta, Zehra Ordulu, David Sabatini, Greg Suh and Jessica Treisman for advice and comments on the manuscript. P. J. S. is supported by an NIH predoctoral training grant 5T32GM007239-32. H. D. R. is a Special Fellow of the Leukemia-Lymphoma Society, a Basil O'Conner Scholar of the March of Dimes Foundation and an Ellison Medical Foundation New Scholar. This work was supported by a grant to H. D. R. from the National Institutes of Health (1RO1GM079425)	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Herman-Bachinsky Y, 2007, CELL DEATH DIFFER, V14, P861, DOI 10.1038/sj.cdd.4402079; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	35	47	48	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1440	U134		10.1038/ncb1803	http://dx.doi.org/10.1038/ncb1803			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011620	Green Accepted			2022-12-27	WOS:000261261800014
J	Skog, J; Wurdinger, T; van Rijn, S; Meijer, DH; Gainche, L; Sena-Esteves, M; Curry, WT; Carter, BS; Krichevsky, AM; Breakefield, XO				Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Curry, William T., Jr.; Carter, Bob S.; Krichevsky, Anna M.; Breakefield, Xandra O.			Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; CELLS; EXOSOMES; CANCER; ANGIOGENESIS; RECEPTOR; MEMBRANE; DETERMINANTS; SUPPRESSION	Glioblastoma tumour cells release microvesicles (exosomes) containing mRNA, miRNA and angiogenic proteins. These microvesicles are taken up by normal host cells, such as brain microvascular endothelial cells. By incorporating an mRNA for a reporter protein into these microvesicles, we demonstrate that messages delivered by microvesicles are translated by recipient cells. These microvesicles are also enriched in angiogenic proteins and stimulate tubule formation by endothelial cells. Tumour-derived microvesicles therefore serve as a means of delivering genetic information and proteins to recipient cells in the tumour environment. Glioblastoma microvesicles also stimulated proliferation of a human glioma cell line, indicating a self-promoting aspect. Messenger RNA mutant/variants and miRNAs characteristic of gliomas could be detected in serum microvesicles of glioblastoma patients. The tumour-specific EGFRvIII was detected in serum microvesicles from 7 out of 25 glioblastoma patients. Thus, tumour-derived microvesicles may provide diagnostic information and aid in therapeutic decisions for cancer patients through a blood test.	[Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Charlestown, MA 02129 USA; [Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Charlestown, MA 02129 USA; [Skog, Johan; Wuerdinger, Tom; van Rijn, Sjoerd; Meijer, Dimphna H.; Gainche, Laura; Sena-Esteves, Miguel; Breakefield, Xandra O.] Harvard Univ, Sch Med, Neurosci Program, Charlestown, MA 02129 USA; [Wuerdinger, Tom] VU Med Ctr, Dept Neurosurg, Neurooncol Res Grp, Canc Ctr Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Curry, William T., Jr.; Carter, Bob S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA; [Krichevsky, Anna M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Breakefield, XO (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 149 13th St, Charlestown, MA 02129 USA.	breakefield@hms.harvard.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324; Skog, Johan/0000-0002-0926-1691; Krichevsky, Anna/0000-0002-5080-5507	Wenner-Gren Foundation [NCI CA86355, NCI CA69246]; Goldhirs Foundation; Brain Tumor Society; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P01CA069246, P50CA086355] Funding Source: NIH RePORTER	Wenner-Gren Foundation; Goldhirs Foundation; Brain Tumor Society; American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to express our gratitude to B. Tannous for supplying the Gluc lentivirus construct, C. Maguire, M. Broekman, K. Miranda, L. Russo and O. Saydam for fruitful discussions. We also would like to thank Applied Biosystems for supplying the miRNA qRT-PCR primers and S. Idema (Neuro-oncology Research Group, Cancer Center Amsterdam) for supplying some of the serum/biopsy samples. This work was supported by the Wenner-Gren Foundation (J.S.) Stiftelsen Olle Engkvist Byggmastare (J.S.), NCI CA86355 (X. O. B. and M. S. E.), NCI CA69246 (X. O. B., M. S. E. and B. S. C.), The Goldhirs Foundation (B. S. C.) the Brain Tumor Society (A. M. K.) and the American Brain Tumor Association (T. W.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chaput N, 2005, EXPERT OPIN BIOL TH, V5, P737, DOI 10.1517/14712598.5.6.737; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Delves GH, 2007, SEMIN THROMB HEMOST, V33, P75, DOI 10.1055/s-2006-958465; Eberle K, 2000, ANTICANCER RES, V20, P1679; Gabrilovich DI, 2007, CURR CANCER DRUG TAR, V7, P1, DOI 10.2174/156800907780006850; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rolhion C, 2001, J NEUROSURG, V94, P97, DOI 10.3171/jns.2001.94.1.0097; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Sonabend Adam M, 2007, Expert Rev Anticancer Ther, V7, pS45, DOI 10.1586/14737140.7.12s.S45; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x	37	3454	3670	22	600	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1470	U209		10.1038/ncb1800	http://dx.doi.org/10.1038/ncb1800			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011622	Green Accepted			2022-12-27	WOS:000261261800019
J	Zheng, Y; Wildonger, J; Ye, B; Zhang, Y; Kita, A; Younger, SH; Zimmerman, S; Jan, LY; Jan, YN				Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung			Dynein is required for polarized dendritic transport and uniform microtubule orientation in axons	NATURE CELL BIOLOGY			English	Article							RECYCLING ENDOSOMES; SECRETORY PATHWAY; DROSOPHILA; NEURONS; PROTEIN; GOLGI; MORPHOGENESIS; TRAFFICKING; PLASTICITY; COMPLEX	Axons and dendrites differ in both microtubule organization and in the organelles and proteins they contain. Here we show that the microtubule motor dynein has a crucial role in polarized transport and in controlling the orientation of axonal microtubules in Drosophila melanogaster dendritic arborization (da) neurons. Changes in organelle distribution within the dendritic arbors of dynein mutant neurons correlate with a proximal shift in dendritic branch position. Dynein is also necessary for the dendrite-specific localization of Golgi outposts and the ion channel Pickpocket. Axonal microtubules are normally oriented uniformly plus-end-distal; however, without dynein, axons contain both plus-and minus-end distal microtubules. These data suggest that dynein is required for the distinguishing properties of the axon and dendrites: without dynein, dendritic organelles and proteins enter the axon and the axonal microtubules are no longer uniform in polarity.	[Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Zheng, Yi; Wildonger, Jill; Ye, Bing; Zhang, Ye; Kita, Angela; Younger, Susan H.; Zimmerman, Sabina; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	Ye, Bing/V-1306-2018; Zhang, Ye/D-1664-2010	Ye, Bing/0000-0002-8828-4065; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Kirschstein NRSA [F32-MH75223, F32-HD53199]; NIH Pathway to Independence [K99MH080599]; Sandler Family Supporting Foundation; NIH [R01NS40929, R01NS47200]; Investigators of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH080599, F32MH075223, R01MH084234, K99MH080599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, R37NS040929, R01NS047200] Funding Source: NIH RePORTER	Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigators of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank T. Uemura, F. B. Gao, L. Luo, R. Warrior, T. Hays and the Bloomington Stock Center for fly stocks; W. Song, C. Han, S. Zhu, P. Soba, J. Parrish, J. Kardon and S. Reck-Peterson for helpful suggestions and comments on the manuscript, and members of the Jan Lab for stimulating discussions. We thank T. Uemura for communicating results before publication. This work was supported by Kirschstein NRSA fellowships F32-MH75223 (Y. Zheng.), F32-HD53199 (J. W.), an NIH Pathway to Independence Award K99MH080599 (B. Y.), a graduate fellowship from Genentech and the Sandler Family Supporting Foundation (Y. Zhang) and NIH grants R01NS40929 and R01NS47200 (Y.N.J.). Y.N.J. and L. Y. J. are Investigators of the Howard Hughes Medical Institute.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Clark IE, 1997, DEVELOPMENT, V124, P461; Cui W, 2005, MOL BIOL CELL, V16, P5400, DOI 10.1091/mbc.E05-06-0582; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000	30	212	215	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1172	1180		10.1038/ncb1777	http://dx.doi.org/10.1038/ncb1777			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18758451	Green Accepted			2022-12-27	WOS:000259682900011
J	Nojima, H; Adachi, M; Matsui, T; Okawa, K; Tsukita, S; Tsukita, S				Nojima, Hisashi; Adachi, Makoto; Matsui, Takeshi; Okawa, Katsuya; Tsukita, Shoichiro; Tsukita, Sachiko			IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade	NATURE CELL BIOLOGY			English	Article							CYCLE PROGRESSION; MAP KINASE; PROTEIN; CDC42; EFFECTOR; RAC1; RAS; CALMODULIN; GROWTH; IDENTIFICATION	Proliferation of epithelial cells must be spatiotemporally regulated to maintain the organization of epithelial sheets. Here we show that the IQGAP family, comprising IQGAP1, 2 and 3, underlies lateral cell-cell contacts of epithelial cells. Of the three proteins, IQGAP3 is unique in that its expression is specifically confined to proliferating cells. Knockdown of IQGAP3 in cultured epithelial cells caused inhibition of proliferation and ERK activity. When exogenously expressed in quiescent cells, IQGAP3 was capable of inducing cell-cycle re-entry, which was completely inhibited by the MEK inhibitor U0126. Thus, IQGAP3 is necessary and sufficient for driving cell proliferation and ERK acts downstream of IQGAP3. Furthermore, IQGAP3 specifically interacted with the active, GTP-bound form of Ras, and in IQGAP3 knockdown cells, the activity of Ras, but not of other small GTPases, was inhibited. Thus, IQGAP3 regulates the promotion of cell proliferation through Ras-dependent ERK activation.	[Nojima, Hisashi; Matsui, Takeshi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Grad Sch Frontier Biosci, Biol Sci Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Adachi, Makoto; Tsukita, Shoichiro] Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Fac Med, Frontier Technol Ctr, Sakyo Ku, Kyoto 6068501, Japan	Osaka University; Kyoto University; Kyoto University	Tsukita, S (corresponding author), Osaka Univ, Grad Sch Med, Grad Sch Frontier Biosci, Biol Sci Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	atsukita@biosci.med.osaka-u.ac.jp	Matsui, Takeshi/C-4730-2017					Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GERDES J, 1984, J IMMUNOL, V133, P1710; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; TSUKITA S, 1993, J CELL BIOL, V123, P1049, DOI 10.1083/jcb.123.5.1049; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517	35	70	75	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					971	978		10.1038/ncb1757	http://dx.doi.org/10.1038/ncb1757			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604197				2022-12-27	WOS:000258147100015
J	Saurin, AT; Durgan, J; Cameron, AJ; Faisal, A; Marber, MS; Parker, PJ				Saurin, Adrian T.; Durgan, Joanne; Cameron, Angus J.; Faisal, Amir; Marber, Michael S.; Parker, Peter J.			The regulated assembly of a PKC epsilon complex controls the completion of cytokinesis	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CONTRACTILE RING; STRUCTURAL BASIS; CLEAVAGE FURROW; PHOSPHORYLATION; CELLS; IDENTIFICATION; SPECIFICITY; BINDING; TUMORIGENESIS	The cell cycle is exquisitely controlled by multiple sequential regulatory inputs to ensure fidelity. Here we demonstrate that the final step in division, the physical separation of daughter cells, is controlled by a member of the PKC gene superfamily. Specifically, we have identified three phosphorylation sites within PKC epsilon that control its association with 14-3-3. These phosphorylations are executed by p38 MAP kinase (Ser 350), GSK3 (Ser 346) and PKC itself (Ser 368). Integration of these signals is essential during mitosis because mutations that prevent phosphorylation of PKC epsilon and/or PKC epsilon binding to 14-3-3 also cause defects in the completion of cytokinesis. Using chemical genetic and dominant-negative approaches it is shown that selective inhibition of PKCe halts cells at the final stages of separation. This arrest is associated with persistent RhoA activation at the midbody and a delay in actomyosin ring dissociation. This study therefore identifies a new regulatory mechanism that controls exit from cytokinesis, which has implications for carcinogenesis.	[Saurin, Adrian T.; Durgan, Joanne; Cameron, Angus J.; Faisal, Amir; Parker, Peter J.] Imperial Canc Res Fund, Prot Phosphorylat Lab, London Res Inst, Canc Res UK, London WC2A 3PX, England; [Marber, Michael S.] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, New Hunts House, London SE1 1UL, England	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Parker, PJ (corresponding author), Imperial Canc Res Fund, Prot Phosphorylat Lab, London Res Inst, Canc Res UK, London WC2A 3PX, England.	peter.parker@cancer.org.uk	Faisal, Amir/AAE-8992-2020; Parker, Peter j/D-5192-2013; marber, michael/AAW-7916-2021	Cameron, Angus/0000-0003-3906-2789; Marber, Michael/0000-0002-3463-7128; Saurin, Adrian/0000-0001-9317-2255; parker, peter/0000-0002-6218-2933; Faisal, Amir/0000-0002-7376-8286	British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)		Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Dai JG, 2003, J NEUROCHEM, V84, P23, DOI 10.1046/j.1471-4159.2003.01254.x; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; FAISAL A, J BIOL CHEM; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Han DC, 2001, ONCOGENE, V20, P346, DOI 10.1038/sj.onc.1204068; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Nguyen TA, 2004, J BIOL CHEM, V279, P52714, DOI 10.1074/jbc.M403040200; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Saurin AT, 2002, CARDIOVASC RES, V55, P672, DOI 10.1016/S0008-6363(02)00325-5; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	37	94	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					891	901		10.1038/ncb1749	http://dx.doi.org/10.1038/ncb1749			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604201				2022-12-27	WOS:000258147100007
J	Eliscovich, C; Peset, I; Vernos, I; Mendez, R				Eliscovich, Carolina; Peset, Isabel; Vernos, Isabelle; Mendez, Raul			Spindle-localized CPE-mediated translation controls meiotic chromosome segregation	NATURE CELL BIOLOGY			English	Article							MOS MESSENGER-RNA; MITOTIC APPARATUS; XENOPUS-OOCYTES; MEIOSIS-I; MASKIN; PHOSPHORYLATION; CHROMOKINESIN; TRANSITION; TPX2; XKID	Meiotic progression requires the translational activation of stored maternal mRNAs, such as those encoding cyclin B1 or mos. The translation of these mRNAs is regulated by the cytoplasmic polyadenylation element (CPE) present in their 3'UTRs, which recruits the CPE-binding protein CPEB1. This RNA-binding protein not only dictates the timing and extent of translational activation by cytoplasmic polyadenylation(2,3) but also participates, together with the translational repressor Maskin, in the transport and localization, in a quiescent state, of its targets to subcellular locations where their translation will take place(4). During the early development of Xenopus laevis, CPEB localizes at the animal pole of oocytes and later on at embryonic spindles and centrosomes(5). Disruption of embryonic CPEB-mediated translational regulation results in abnormalities in the mitotic apparatus and inhibits embryonic mitosis(5). Here we show that spindle-localized translational activation of CPE-regulated mRNAs, encoding for proteins with a known function in spindle assembly and chromosome segregation, is essential for completion of the first meiotic division and for chromosome segregation in Xenopus oocytes.	[Eliscovich, Carolina; Peset, Isabel; Vernos, Isabelle; Mendez, Raul] CRG, Barcelona 08003, Spain; [Vernos, Isabelle] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), CRG, C Dr Aiguader 88, Barcelona 08003, Spain.	raul.mendez@crg.es	Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214; Mendez, Raul/0000-0002-1952-6905	ICREA Funding Source: Custom	ICREA(ICREA)		Alliegro MC, 2006, P NATL ACAD SCI USA, V103, P9034, DOI 10.1073/pnas.0602859103; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Becker Bret E., 2006, V322, P69; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Perez LH, 2002, NAT CELL BIOL, V4, P737, DOI 10.1038/ncb850; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; WORMINGTON M, 1991, METHOD CELL BIOL, V36, P167; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	26	68	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					858	865		10.1038/ncb1746	http://dx.doi.org/10.1038/ncb1746			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18536713				2022-12-27	WOS:000257268400015
J	Castillo-Lluva, S; Tatham, MH; Jones, RC; Jaffray, EG; Edmondson, RD; Hay, RT; Malliri, A				Castillo-Lluva, Sonia; Tatham, Michael H.; Jones, Richard C.; Jaffray, Ellis G.; Edmondson, Ricky D.; Hay, Ronald T.; Malliri, Angeliki			SUMOylation of the GTPase Rac1 is required for optimal cell migration	NATURE CELL BIOLOGY			English	Article							RHO-FAMILY GTPASES; GROWTH-FACTOR; IN-VIVO; NUCLEAR-LOCALIZATION; POLYBASIC REGION; PIAS PROTEINS; KINASE; SUMO; UBIQUITIN; IDENTIFICATION	The Rho-like GTPase, Rac1, induces cytoskeletal rearrangements required for cell migration. Rac activation is regulated through a number of mechanisms, including control of nucleotide exchange and hydrolysis, regulation of subcellular localization or modulation of protein-expression levels(1-3). Here, we demonstrate that (the small ubiquitin-like modifier) SUMO E3-ligase, PIAS3, interacts with Rac1 and is required for increased Rac activation and optimal cell migration in response to hepatocyte growth factor (HGF) signalling. Rac1 can be conjugated to SUMO-1 in response to hepatocyte growth factor treatment and SUMOylation is enhanced by PIAS3. Furthermore, we identify non-consensus sites within the polybasic region of Rac1 as the main location for SUMO conjugation. PIAS3-mediated SUMOylation of Rac1 controls the levels of Rac1-GTP and the ability of Rac1 to stimulate lamellipodia, cell migration and invasion. The finding that a Ras superfamily member can be SUMOylated provides insights into the regulation of these critical mediators of cell behaviour. Our data reveal a role for SUMO in the regulation of cell migration and invasion.	[Castillo-Lluva, Sonia; Malliri, Angeliki] Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Tatham, Michael H.; Jaffray, Ellis G.; Hay, Ronald T.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Sir James Black Ctr Coll Life Sci, Dundee DD1 5EH, Scotland; [Jones, Richard C.; Edmondson, Ricky D.] US FDA, NCTR, Jefferson, AR 72079 USA	Cancer Research UK; University of Manchester; University of Dundee; US Food & Drug Administration (FDA)	Malliri, A (corresponding author), Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England.	amalliri@picr.man.ac.uk	Hay, Ronald/S-3233-2019; CASTILLO-LLUVA, SONIA/AAA-1776-2020; Hay, Ronald T/F-9338-2011; Tatham, Michael H/E-9622-2010	Hay, Ronald/0000-0001-7113-9024; Hay, Ronald T/0000-0001-7113-9024; Tatham, Michael H/0000-0001-6986-1691; Castillo-LLuva, Sonia/0000-0001-5357-7178; Malliri, Angeliki/0000-0001-6848-090X	CRUK [C147/A6058]; EMBO; Cancer Research UK [12937] Funding Source: researchfish	CRUK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	This study was supported by CRUK grant C147/A6058 and an EMBO Long-Term fellowship to S.C.L. M.H.T. and E.G.J. were supported by CRUK. We thank N. Maurice (Glasgow, UK) for mass spectrometry analysis, I. Matic (Dundee, UK) for help with SUMO-Rac1 branched-peptide data interpretation, H. Yokosawa, L. Trusolino and L. Vidali for reagents, N. Mack for help with the calcium-switch experiments, I. Arozarena and C. Wellbrock for help with invasion assays, and members of the Cell Signalling Group, A. Hurlstone, N. Divecha, J. Perez-Martin and C. Wilkinson, for critical reading of the manuscript and helpful discussions.	Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hays JL, 2003, J BIOL CHEM, V278, P27456, DOI 10.1074/jbc.M210648200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Martin SF, 2007, ANAL BIOCHEM, V363, P83, DOI 10.1016/j.ab.2006.12.018; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Yamashina K, 2006, J BIOCHEM, V139, P305, DOI 10.1093/jb/mvj033; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	38	111	116	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1078	U70		10.1038/ncb2112	http://dx.doi.org/10.1038/ncb2112			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935639	Green Accepted			2022-12-27	WOS:000283711500011
J	Gao, C; Cao, WP; Bao, L; Zuo, W; Xie, GM; Cai, TT; Fu, W; Zhang, J; Wu, W; Zhang, X; Chen, YG				Gao, Chan; Cao, Weipeng; Bao, Lan; Zuo, Wei; Xie, Guoming; Cai, Tiantian; Fu, Wei; Zhang, Jian; Wu, Wei; Zhang, Xu; Chen, Ye-Guang			Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PROTEIN; REQUIRES DIRECT BINDING; CATENIN PATHWAY; BETA-CATENIN; UBIQUITINATION; GENE; TUMORIGENESIS; LIGASE; INHIBITION; ACTIVATION	In eukaryotic cells, autophagy is a highly conserved self-digestion process to promote cell survival in response to nutrient starvation and other metabolic stresses. Autophagy is regulated by cell signalling such as the mTOR (mammalian target of rapamycin) pathway. However, the significance of autophagy in modulation of signal transduction is unclear. Here we show that autophagy negatively regulates Wnt signalling by promoting Dishevelled (Dvl) degradation. Von Hippel-Lindau protein-mediated ubiquitylation is critical for the binding of Dvl2 to p62, which in turn facilitates the aggregation and the LC3-mediated autophagosome recruitment of Dvl2 under starvation; the ubiquitylated Dvl2 aggregates are ultimately degraded through the autophagy-lysosome pathway. Moreover, a reverse correlation between Dvl expression and autophagy is observed in late stages of colon cancer development, indicating that autophagy may contribute to the aberrant activation of Wnt signalling in tumour formation.	[Gao, Chan; Cao, Weipeng; Zuo, Wei; Xie, Guoming; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Gao, Chan; Cao, Weipeng; Zuo, Wei; Xie, Guoming; Cai, Tiantian; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Bao, Lan; Zhang, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Wei] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100191, Peoples R China; [Zhang, Jian] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	高, 雨莉/HGU-8187-2022; Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401, 2010CB833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	We thank Terje Johansen for p62 constructs, Long Yu for human LC3 construct, Noboru Mizushima for Atg5<SUP>-/-</SUP> MEFs, Masaaki Komatsu for Atg7<SUP>-/-</SUP> MEFs, and Li Yu, Rod Nusse, Daniel J. Klionsky, Juan Liang and Zhao Chen for suggestions. This work was supported by grants from the National Natural Science Foundation of China (30930050 and 30921004) and the 973 Program (2006CB943401 and 2010CB833706) to Y.-G.C.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	57	292	305	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					781	+		10.1038/ncb2082	http://dx.doi.org/10.1038/ncb2082			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639871				2022-12-27	WOS:000280561600010
J	Balestrini, A; Cosentino, C; Errico, A; Garner, E; Costanzo, V				Balestrini, Alessia; Cosentino, Claudia; Errico, Alessia; Garner, Elizabeth; Costanzo, Vincenzo			GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication	NATURE CELL BIOLOGY			English	Article							POLYMERASE-ALPHA; XENOPUS; INITIATION; CHROMATIN; PHOSPHORYLATION; ORIGINS; GEMININ; BINDING; CDC45; SLD3	Many of the factors required for chromosomal DNA replication have been identified in unicellular eukaryotes. However, DNA replication is poorly understood in multicellular organisms. Here, we report the identification of GEMC1 (geminin coiled-coil containing protein 1), a novel vertebrate protein required for chromosomal DNA replication. GEMC1 is highly conserved in vertebrates and is preferentially expressed in proliferating cells. Using Xenopus laevis egg extract we show that Xenopus GEMC1 (xGEMC1) binds to the checkpoint and replication factor TopBP1, which promotes binding of xGEMC1 to chromatin during pre-replication complex (pre-RC) formation. We demonstrate that xGEMC1 interacts directly with replication factors such as Cdc45 and the kinase Cdk2-CyclinE, through which it is heavily phosphorylated. Phosphorylated xGEMC1 stimulates initiation of DNA replication, whereas depletion of xGEMC1 prevents the onset of DNA replication owing to the impairment of Cdc45 loading onto chromatin. Similarly, downregulation of GEMC1 expression prevents DNA replication in embryonic and somatic vertebrate cells. These data suggest that GEMC1 promotes initiation of chromosomal DNA replication in multicellular organisms by mediating TopBP1- and Cdk2-dependent recruitment of Cdc45 onto replication origins.	[Errico, Alessia; Costanzo, Vincenzo] London Res Inst, Cell Cycle Labs, S Mimms EN6 3LD, Herts, England		Costanzo, V (corresponding author), London Res Inst, Cell Cycle Labs, S Mimms EN6 3LD, Herts, England.	vincenzo.costanzo@cancer.org.uk	Cosentino, Claudia/AAF-1100-2019	Costanzo, Vincenzo/0000-0002-2920-9508	Cancer Research UK; Lister Institute of Preventive Medicine; European Research Council (ERC) [N. 206281]; EMBO	Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO))	We thank T. Hunt, members of Clare Hall Laboratories and members of the Genome Stability Unit for their comments, H. Mahbubani and J. Kirk for technical support with X. laevis, J. Gannon for technical assistance in antibody production and M. Wu for embryo injection. This work was supported by grants from Cancer Research UK. V. C. is also supported by the Lister Institute of Preventive Medicine, the European Research Council (ERC) start-up grant (N. 206281) and the EMBO Young Investigator Program (YIP).	BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Costanzo V, 2004, METH MOL B, V241, P255; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SLACK J, 1984, NATURE, V311, P107, DOI 10.1038/311107a0; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	78	80	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					484	U156		10.1038/ncb2050	http://dx.doi.org/10.1038/ncb2050			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383140	Green Accepted			2022-12-27	WOS:000277283700014
J	Canettieri, G; Di Marcotullio, L; Greco, A; Coni, S; Antonucci, L; Infante, P; Pietrosanti, L; De Smaele, E; Ferretti, E; Miele, E; Pelloni, M; De Simone, G; Pedone, EM; Gallinari, P; Giorgi, A; Steinkuhler, C; Vitagliano, L; Pedone, C; Schinina, ME; Screpanti, I; Gulino, A				Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; De Simone, Giuseppina; Pedone, Emilia Maria; Gallinari, Paola; Giorgi, Alessandra; Steinkuehler, Christian; Vitagliano, Luigi; Pedone, Carlo; Schinina, M. Eugenia; Screpanti, Isabella; Gulino, Alberto			Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; MEDULLOBLASTOMA; PROLIFERATION; ACTIVATION; TRANSCRIPTION; SUPPRESSOR; NEUROGENESIS; DEGRADATION; RENKCTD11; NEURONS	Hedgehog signalling is crucial for development and is deregulated in several tumours, including medulloblastoma. Regulation of the transcriptional activity of Gli (glioma-associated oncogene) proteins, effectors of the Hedgehog pathway, is poorly understood. We show here that Gli1 and Gli2 are acetylated proteins and that their HDAC-mediated deacetylation promotes transcriptional activation and sustains a positive autoregulatory loop through Hedgehog-induced upregulation of HDAC1. This mechanism is turned off by HDAC1 degradation through an E3 ubiquitin ligase complex formed by Cullin3 and REN, a Gli antagonist lost in human medulloblastoma. Whereas high HDAC1 and low REN expression in neural progenitors and medulloblastomas correlates with active Hedgehog signalling, loss of HDAC activity suppresses Hedgehog-dependent growth of neural progenitors and tumour cells. Consistent with this, abrogation of Gli1 acetylation enhances cellular proliferation and transformation. These data identify an integrated HDAC-and ubiquitin-mediated circuitry, where acetylation of Gli proteins functions as an unexpected key transcriptional checkpoint of Hedgehog signalling.	[Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; Screpanti, Isabella; Gulino, Alberto] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Giorgi, Alessandra; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00161 Rome, Italy; [Gallinari, Paola; Steinkuehler, Christian] IRBM, Merck Res Labs Rome, I-00040 Pomezia, Italy; [Gulino, Alberto] Neuromed Inst, I-86077 Pozzilli, Italy; [De Simone, Giuseppina; Pedone, Emilia Maria; Vitagliano, Luigi; Pedone, Carlo] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy	Sapienza University Rome; Sapienza University Rome; Merck & Company; IRCCS Neuromed; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, 324 Viale Regina Elena, I-00161 Rome, Italy.	alberto.gulino@uniroma1.it	De Simone, Giuseppina/AAJ-4964-2021; Infante, Paola/G-9094-2018; Miele, Evelina/M-4611-2013; Gallinari, Paola/ABE-8238-2021; Miele, Evelina/ABB-7545-2021; Pedone, Emilia Maria/K-2229-2015; Miele, Evelina/AAK-1963-2021; De Smaele, Enrico/C-1124-2013; Pedone, Emilia/HDN-2342-2022; Ferretti, Elisabetta/G-5413-2013	Miele, Evelina/0000-0002-4747-1032; Miele, Evelina/0000-0002-4747-1032; Pedone, Emilia Maria/0000-0003-0203-8611; De Smaele, Enrico/0000-0003-4524-4423; Pedone, Emilia/0000-0003-0203-8611; Ferretti, Elisabetta/0000-0001-7265-6429; CANETTIERI, Gianluca/0000-0001-6694-2613; Antonucci, Laura/0000-0001-8965-2432; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; Infante, Paola/0000-0003-0682-3916; De Simone, Giuseppina/0000-0001-9783-5431	Associazione Italiana per la Ricerca sul Cancro, Telethon [GGP07118]; Ministry of University and Research (FIRB and PRIN); Ministry of Health; Fondazione Roma Foundation; Mariani Foundation; Cenci-Bolognetti Foundation; Rome Oncogenomic Center	Associazione Italiana per la Ricerca sul Cancro, Telethon(Fondazione AIRC per la ricerca sul cancroFondazione Telethon); Ministry of University and Research (FIRB and PRIN)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministry of Health; Fondazione Roma Foundation(Fondazione Roma); Mariani Foundation; Cenci-Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Rome Oncogenomic Center	We thank M. P. Scott for the gift of Ptch1<SUP>-/-</SUP> cells, G. Giannini and M. Levrero, for helpful suggestions, L. Di Magno, M. Della Guardia, C. Fragomeli and D. Mazza for experimental support. This work was supported by the Associazione Italiana per la Ricerca sul Cancro, Telethon Grant GGP07118, the Ministry of University and Research (FIRB and PRIN), the Ministry of Health, the Fondazione Roma Foundation, the Mariani Foundation, the Cenci-Bolognetti Foundation and the Rome Oncogenomic Center.	ALTABA ARI, 2006, HEDGEHOG GLI SIGNALI, P48349; Argenti B, 2005, J NEUROSCI, V25, P8338, DOI 10.1523/JNEUROSCI.2438-05.2005; Bar EE, 2007, AM J PATHOL, V170, P347, DOI 10.2353/ajpath.2007.060066; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shaked M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002668; Spiller SE, 2006, J NEURO-ONCOL, V79, P259, DOI 10.1007/s11060-006-9142-0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	42	256	269	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					132	U91		10.1038/ncb2013	http://dx.doi.org/10.1038/ncb2013			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081843				2022-12-27	WOS:000274139400007
J	Wilcox, AJ; Laney, JD				Wilcox, Alexander J.; Laney, Jeffrey D.			A ubiquitin-selective AAA-ATPase mediates transcriptional switching by remodelling a repressor-promoter DNA complex	NATURE CELL BIOLOGY			English	Article							YEAST MAT-ALPHA-2 REPRESSOR; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MCM1 PROTEIN; LIVING CELLS; DEGRADATION; ALPHA-2; REGULATOR; HOMEODOMAIN; PROTEASOME	Switches between different phenotypes and their underlying states of gene transcription occur as cells respond to intrinsic developmental cues or adapt to changing environmental conditions. Post-translational modification of the master regulatory transcription factors that define the initial phenotype is a common strategy to direct such transitions. Emerging evidence indicates that the modification of key transcription factors by the small polypeptide ubiquitin has a central role in many of these transitions(1,2). However, the molecular mechanisms by which ubiquitylation regulates the switching of promoters between active and inactive states are largely unknown. Ubiquitylation of the yeast transcriptional repressor alpha(2) is necessary to evoke the transition between mating-types(3), and here we dissect the impact of this modification on alpha(2) dynamics at its target promoters. Ubiquitylation of alpha(2) does not alter DNA occupancy by depleting the existing pool of the transcription factor, despite its well-characterized function in directing repressor turnover. Rather, alpha(2) ubiquitylation has a direct role in the rapid removal of the repressor from its DNA targets. This disassembly of alpha(2) from DNA depends on the ubiquitin-selective AAA-ATPase Cdc48. Our findings expand the functional targets of Cdc48 to include active transcriptional regulatory complexes in the nucleus. These data reveal an ubiquitin-dependent extraction pathway for dismantling transcription factor-DNA complexes and provide an archetype for the regulation of transcriptional switching events by ubiquitylation.	[Wilcox, Alexander J.; Laney, Jeffrey D.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Laney, JD (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-L2, Providence, RI 02912 USA.	jeffrey_laney@brown.edu		Wilcox, Allen/0000-0002-3376-1311	National Institutes of Health [GM71764]; March of Dimes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Y. Xie and M. Hochstrasser for sharing data and reagents in advance of publication, for providing strains and plasmids and for many discussions. We thank R. Hampton and S. Jentsch for providing strains, R. Whitaker and R. Reenan for the sequencing of cdc48 alleles, J. Mead and D. Vershon for the His-tagged alpha 2 construct, S. Gregory and A. Dahlberg for their help with the footprinting experiments, and T. Serio for numerous discussions. Our ideas were also shaped by discussions with K. Wilkinson and R. Deshaies. The manuscript was improved by comments from T. Serio, J. Bender, Y. Xie, M. Hochstrasser, R. Reenan and A. DeSimone. This work was supported by a grant from the National Institutes of Health (GM71764 to J. D. L.) and by a Basil O'Connor Starter Scholar Research Award from the March of Dimes.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; DESHAIES R, 1995, CURR OPIN CELL BIOL, V7, P781, DOI 10.1016/0955-0674(95)80061-1; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GANTER B, 1993, J MOL BIOL, V234, P975, DOI 10.1006/jmbi.1993.1652; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gregory PD, 1998, METHODS, V15, P295, DOI 10.1006/meth.1998.0633; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Laney JD, 2003, GENE DEV, V17, P2259, DOI 10.1101/gad.1115703; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mead J, 1996, MOL CELL BIOL, V16, P2135; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; RICHTERRUOFF B, 1994, FEBS LETT, V354, P50, DOI 10.1016/0014-5793(94)01085-4; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhong HL, 1997, J BIOL CHEM, V272, P8402, DOI 10.1074/jbc.272.13.8402	41	51	52	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1481	U218		10.1038/ncb1997	http://dx.doi.org/10.1038/ncb1997			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915556	Green Accepted			2022-12-27	WOS:000272251300016
J	Saito, A; Hino, SI; Murakami, T; Kanemoto, S; Kondo, S; Saitoh, M; Nishimura, R; Yoneda, T; Furuichi, T; Ikegawa, S; Ikawa, M; Okabe, M; Imaizumi, K				Saito, Atsushi; Hino, Shin-ichiro; Murakami, Tomohiko; Kanemoto, Soshi; Kondo, Shinichi; Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki; Furuichi, Tatsuya; Ikegawa, Shiro; Ikawa, Masahito; Okabe, Masaru; Imaizumi, Kazunori			Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; CREB/ATF-FAMILY; MATRIX PROTEIN; ER STRESS; CLEAVAGE; MEMBER; OASIS	Many tissues have a specific signal transduction system for endoplasmic reticulum (ER) dysfunction; however, the mechanisms underlying the ER stress response in cartilage remain unclear. BBF2H7 (BBF2 human homologue on chromosome 7), an ER-resident basic leucine zipper transcription factor, is activated in response to ER stress(1) and is highly expressed in chondrocytes. In this study, we generated Bbf2h7(-/-) ice to assess the in vivo function of BBF2H7. The mice showed severe chondrodysplasia and died by suffocation shortly after birth because of an immature chest cavity. The cartilage showed a lack of typical columnar structure in the proliferating zone and a decrease in the size of the hypertrophic zone, resulting in a significant reduction of extracellular matrix proteins. Interestingly, proliferating chondrocytes showed abnormally expanded ER, containing aggregated type II collagen (Col2) and cartilage oligomeric matrix protein (COMP). We identified Sec23a, which encodes a coat protein complex II component responsible for protein transport from the ER to the Golgi(2,3), as a target of BBF2H7, which directly bound to a CRE-like sequence in the promoter region of Sec23a to activate its transcription. When Sec23a was introduced to Bbf2h7(-/-) chondrocytes, the impaired transport and secretion of cartilage matrix proteins was totally restored, indicating that by activating protein secretion the BBF2H7-Sec23a pathway has a crucial role in chondrogenesis. Our findings provide a new link by which ER stress is converted to signalling for the activation of ER-to-Golgi trafficking.	[Saito, Atsushi; Hino, Shin-ichiro; Murakami, Tomohiko; Kanemoto, Soshi; Kondo, Shinichi; Imaizumi, Kazunori] Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, Miyazaki 8891692, Japan; [Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Minato Ku, Tokyo 1088639, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	University of Miyazaki; Osaka University; RIKEN; Osaka University; Osaka University	Imaizumi, K (corresponding author), Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	imaizumi@med.miyazaki-u.ac.jp	ikawa, masahito/A-5315-2009; Ikegawa, Shiro/N-6895-2015; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ikegawa, Shiro/0000-0003-0316-2147; Okabe, Masaru/0000-0002-0803-9044; Nishimura, Riko/0000-0001-7279-8363				Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Cremer MA, 1998, J MOL MED, V76, P275, DOI 10.1007/s001090050217; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; HEATHER P, 2001, MOL CELL, V7, P1153; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Woods A, 2007, ENDOCRINOLOGY, V148, P5030, DOI 10.1210/en.2007-0695; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	26	154	162	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1197	U73		10.1038/ncb1962	http://dx.doi.org/10.1038/ncb1962			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767744				2022-12-27	WOS:000270382000008
J	Yoshikawa, Y; Ogawa, M; Hain, T; Yoshida, M; Fukumatsu, M; Kim, M; Mimuro, H; Nakagawa, I; Yanagawa, T; Ishii, T; Kakizuka, A; Sztul, E; Chakraborty, T; Sasakawa, C				Yoshikawa, Yuko; Ogawa, Michinaga; Hain, Torsten; Yoshida, Mitsutaka; Fukumatsu, Makoto; Kim, Minsoo; Mimuro, Hitomi; Nakagawa, Ichiro; Yanagawa, Toru; Ishii, Tetsuro; Kakizuka, Akira; Sztul, Elizabeth; Chakraborty, Trinad; Sasakawa, Chihiro			Listeria monocytogenes ActA-mediated escape from autophagic recognition	NATURE CELL BIOLOGY			English	Article							DEFENSE-MECHANISM; CELL-DEATH; PROTEIN; P62; REPLICATION; DEGRADATION; VACUOLES; COMPLEX; SURFACE	Autophagy degrades unnecessary organelles and misfolded protein aggregates(1), as well as cytoplasm-invading bacteria(2). Nevertheless, the bacteria Listeria monocytogenes efficiently escapes autophagy(3,4). We show here that recruitment of the Arp2/3 complex and Ena/VASP, via the bacterial ActA protein, to the bacterial surface disguises the bacteria from autophagic recognition, an activity that is independent of the ability to mediate bacterial motility. L. monocytogenes expressing ActA mutants that lack the ability to recruit the host proteins initially underwent ubiquitylation, followed by recruitment of p62 (also known as SQSTM1) and LC3, before finally undergoing autophagy. The ability of ActA to mediate protection from ubiquitylation was further demonstrated by generating aggregate-prone GFP-ActA-Q79C and GFP ActA-170* chimaeras, consisting of GFP (green fluorescent protein), the ActA protein and segments of polyQ(5) or Golgi membrane protein GCP170 (ref. 6). GFP-ActA-Q79C and GFP-ActA-170* formed aggregates in the host cell cytoplasm, however, these ActA-containing aggregates were not targeted for association with ubiquitin and p62. Our findings indicate that ActA-mediated host protein recruitment is a unique bacterial disguise tactic to escape from autophagy.	[Yoshikawa, Yuko; Ogawa, Michinaga; Fukumatsu, Makoto; Mimuro, Hitomi; Sasakawa, Chihiro] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Hain, Torsten; Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Yoshida, Mitsutaka] Juntendo Univ, Div Ultrastruct Res, Biomed Res Ctr, Grad Sch Med,Bunkyo Ku, Tokyo 1138421, Japan; [Kim, Minsoo; Nakagawa, Ichiro; Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Yanagawa, Toru; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto 6068501, Japan; [Sztul, Elizabeth] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Sasakawa, Chihiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Justus Liebig University Giessen; Juntendo University; University of Tokyo; University of Tsukuba; Kyoto University; University of Alabama System; University of Alabama Birmingham; Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Yanagawa, Toru/GYU-6448-2022	Yanagawa, Toru/0000-0003-0868-2563; Kim, Minsoo/0000-0001-8536-8653	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; German Ministry of Education and Research; EU	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	We thank all members of the Sasakawa laboratory for discussions and technical advice and A. Amend and N. Schlarenko for help with the generation of several ActA mutants. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. O. and C. S, the Special Coordination Funds for Promoting Science from the Japan Science and Technology Agency to C. S, and the ERA-NET Pathogenomics Network funded by the German Ministry of Education and Research and the EU to T. H. and T. C.	Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pistor S, 2000, J CELL SCI, V113, P3277; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Van Troys M, 2008, BIOCHEM BIOPH RES CO, V375, P194, DOI 10.1016/j.bbrc.2008.07.152; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	31	325	336	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1233	U175		10.1038/ncb1967	http://dx.doi.org/10.1038/ncb1967			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749745				2022-12-27	WOS:000270382000013
J	Kiermaier, E; Woehrer, S; Peng, YT; Mechtler, K; Westermann, S				Kiermaier, Eva; Woehrer, Sophie; Peng, Yutian; Mechtler, Karl; Westermann, Stefan			A Dam1-based artificial kinetochore is sufficient to promote chromosome segregation in budding yeast	NATURE CELL BIOLOGY			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; RING COMPLEX; MICROTUBULE ATTACHMENT; MITOTIC SPINDLE; CENTROMERE; ARCHITECTURE; MECHANISMS; INTERFACE; TENSION	Kinetochores are large multiprotein complexes that mediate chromosome segregation in all eukaryotes by dynamically connecting specialized chromosome regions, termed centromeres, to the plus-ends of spindle microtubules(1,2). Even the relatively simple kinetochores of the budding yeast Saccharomyces cerevisiae consist of more than 80 proteins, making analysis of their respective roles a daunting task(3). Here, we have developed a system that allows us to artificially recruit proteins to DNA sequences and determine whether they can provide any aspect of kinetochore function in vivo. We show that artificial recruitment of the microtubule-binding Dam 1 complex to a plasmid lacking any centromere DNA is sufficient to confer mitotic stabilization. The Dam1-based artificial kinetochores are able to attach, bi-orient and segregate mini-chromosomes on the mitotic spindle, and they bypass the requirement for essential DNA-binding components of natural kinetochores. Thus, we have built a simplified chromosome segregation system by directly recruiting a microtubule force-transducing component to DNA.	[Kiermaier, Eva; Woehrer, Sophie; Mechtler, Karl; Westermann, Stefan] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Peng, Yutian] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of California System; University of California Berkeley	Westermann, S (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	westermann@imp.ac.at	Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Kiermaier, Eva/0000-0001-6165-5738; Westermann, Stefan/0000-0001-6921-9113	European Research Council [FP7/2007-2013]; ERC [203499]; Austrian Science Fund EWE [SFB F34-B03]	European Research Council(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Austrian Science Fund EWE(Austrian Science Fund (FWF))	The authors wish to thank all members of the Westermann lab for discussions, and Jan-Michael Peters and Barry Dickson for critical reading of the manuscript. We thank Som Lacefield and Andrew Murray for communicating results before publication, and the Nasmyth and Drubin/Barnes labs for strains and plasmids. Research in the laboratory of S.W. was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC starting grant agreement no. [203499], and by the Austrian Science Fund EWE (SFB F34-B03).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Megee PC, 1999, SCIENCE, V285, P254, DOI 10.1126/science.285.5425.254; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Wang HW, 2007, NAT STRUCT MOL BIOL, V14, P721, DOI 10.1038/nsmb1274; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	28	42	42	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1109	U137		10.1038/ncb1924	http://dx.doi.org/10.1038/ncb1924			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684577				2022-12-27	WOS:000269482500012
J	Aghamohammadzadeh, S; Ayscough, KR				Aghamohammadzadeh, Soheil; Ayscough, Kathryn R.			Differential requirements for actin during yeast and mammalian endocytosis	NATURE CELL BIOLOGY			English	Article							PPZ PROTEIN PHOSPHATASES; CELL POLARITY; CYTOSKELETON; INVAGINATION; RECRUITMENT; PATHWAY	Key features of clathrin-mediated endocytosis have been conserved across evolution. However, endocytosis in Saccharomyces cerevisiae is completely dependent on a functional actin cytoskeleton, whereas actin appears to be less critical in mammalian cell endocytosis. We reveal that the fundamental requirement for actin in the early stages of yeast endocytosis is to provide a strong framework to support the force generation needed to direct the invaginating plasma membrane into the cell against turgor pressure. By providing osmotic support, pressure differences across the plasma membrane were removed and this reduced the requirement for actin-bundling proteins in normal endocytosis. Conversely, increased turgor pressure in specific yeast mutants correlated with a decreased rate of endocytic patch invagination.	[Aghamohammadzadeh, Soheil; Ayscough, Kathryn R.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	ayscough@sheffield.ac.uk			BBSRC; MRC [G0601600]; Wellcome Trust [GR077544AIA]; Medical Research Council [G0601600] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Allan, E. Smythe and S. Winder for discussions and critical reading of the manuscript, L. Yenush (Universidad Politecnica de Valencia, Spain) for yeast strains. K. R. A. is a senior non-clinical MRC Fellow (G0601600). S. A. is supported by a BBSRC studentship. The light microscopy-imaging centre at the University of Sheffield was funded by a grant from the Wellcome Trust (GR077544AIA).	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; Kaiser C., 1994, METHODS YEAST GENETI; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Whitacre JL, 2001, GENETICS, V157, P533; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	14	150	153	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1039	U283		10.1038/ncb1918	http://dx.doi.org/10.1038/ncb1918			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597484	Green Accepted			2022-12-27	WOS:000268593200020
J	Silvera, D; Arju, R; Darvishian, F; Levine, PH; Zolfaghari, L; Goldberg, J; Hochman, T; Formenti, SC; Schneider, RJ				Silvera, Deborah; Arju, Rezina; Darvishian, Farbod; Levine, Paul H.; Zolfaghari, Ladan; Goldberg, Judith; Hochman, Tsivia; Formenti, Silvia C.; Schneider, Robert J.			Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer	NATURE CELL BIOLOGY			English	Article							MAMMARY EPITHELIAL-CELLS; INITIATION-FACTOR EIF-4E; E-CADHERIN EXPRESSION; TRANSLATION INITIATION; RHOC-GTPASE; PROLIFERATION; P120-CATENIN; PROTEIN; EMBOLI; MODEL	Inflammatory breast cancer (IBC) is the most lethal form of primary breast cancer(1). IBC lethality derives from generation of tumour emboli, which are non-adherent cell clusters that rapidly spread by a form of continuous invasion known as passive metastasis(2-5). In most cancers, expression of E-cadherin, an epithelial marker, is indicative of low metastatic potential(6,7). In IBC, E-cadherin is overexpressed(8) and supports formation of tumour emboli by promoting tumour cell interactions rather than adherence to stroma(2,3,9). E-cadherin, a surface component of adherens junctions, is anchored by interaction with p120 catenin (p120). We show that the unique pathogenic properties of IBC result in part from overexpression of the translation initiation factor eIF4GI in most IBCs. eIF4GI reprograms the protein synthetic machinery for increased translation of mRNAs with internal ribosome entry sites (IRESs) that promote IBC tumour cell survival and formation of tumour emboli. Overexpression of eIF4GI promotes formation of IBC tumour emboli by enhancing translation of IRES-containing p120 mRNAs. These findings provide a new understanding of translational control in the development of advanced breast cancer.	[Silvera, Deborah; Arju, Rezina; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Darvishian, Farbod] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Levine, Paul H.; Zolfaghari, Ladan] George Washington Univ, Sch Publ Hlth, Washington, DC 20037 USA; [Goldberg, Judith; Hochman, Tsivia] NYU, Dept Environm Med, Sch Med, Div Biostat, New York, NY 10016 USA; [Formenti, Silvia C.] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10016 USA; [Formenti, Silvia C.; Schneider, Robert J.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA	New York University; New York University; George Washington University; New York University; New York University; New York University	Schneider, RJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Robert.schneider@nyumc.org		Schneider, Robert/0000-0001-5807-5564; Goldberg, Judith D./0000-0003-3758-6976	US Department of Defence [W81XWH-06-1-0629]; Breast Cancer Research Foundation [15-C6000-33141]; NY State Breast Cancer Research Fund; Breast Cancer Discovery Fund	US Department of Defence(United States Department of Defense); Breast Cancer Research Foundation; NY State Breast Cancer Research Fund; Breast Cancer Discovery Fund	We thank I. Mohr and members of the Schneider lab for their comments on the manuscript. This study was supported by the US Department of Defence Breast Cancer Center of Excellence Research Program (W81XWH-06-1-0629), the Breast Cancer Research Foundation (15-C6000-33141; R. J. S. and S. C. F.), Shifrin and Myers, the NY State Breast Cancer Research Fund (D. S.) and the Breast Cancer Discovery Fund.	Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brooks PC, 1999, METH MOL B, V129, P257; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Comtesse N, 2007, INT J CANCER, V120, P2538, DOI 10.1002/ijc.22585; Cuesta R, 2000, GENE DEV, V14, P1460; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gong Y, 2008, SEMIN ONCOL, V35, P33, DOI 10.1053/j.seminoncol.2007.11.014; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lerebours F, 2005, BREAST CANCER RES, V7, P52, DOI 10.1186/bcr997; LIOTTA LA, 1976, CANCER RES, V36, P889; McClusky DR, 2005, ANN SURG, V242, P584, DOI 10.1097/01.sla.0000184224.55949.90; MIYAGI Y, 1995, CANCER LETT, V91, P247, DOI 10.1016/0304-3835(95)03737-H; MOORE DH, 1992, GYNECOL ONCOL, V47, P44, DOI 10.1016/0090-8258(92)90073-R; Parker C, 2001, BRIT J CANCER, V85, P1958, DOI 10.1054/bjoc.2001.2178; Portera CC, 2006, BREAST CANCER RES TR, V100, pS177; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tomlinson JS, 2001, CANCER RES, V61, P5231; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Wheelock MJ, 2001, J MAMMARY GLAND BIOL, V6, P275, DOI 10.1023/A:1011319507155; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	34	171	175	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					903	U312		10.1038/ncb1900	http://dx.doi.org/10.1038/ncb1900			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525934				2022-12-27	WOS:000267603100021
J	Naim, V; Rosselli, F				Naim, Valeria; Rosselli, Filippo			The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE RESPONSE; HISTONE H2AX; COMMON PATHWAY; BLOOM-SYNDROME; FRAGILE SITES; ANEMIA; INSTABILITY; CELLS; MONOUBIQUITINATION; CHECKPOINT	Loss-of-function of caretaker genes characterizes a group of cancer predisposition diseases that feature cellular hypersensitivity to DNA damage and chromosome fragility; this group includes Fanconi anaemia and Bloom syndrome(1-3). The products of the 13 FANC genes(4) (mutated in Fanconi anaemia), which constitute the 'FANC' pathway, and BLM (the RecQ helicase mutated in Bloom syndrome) are thought to collaborate during the S phase of the cell cycle, preventing chromosome instability. Recently, BLM has been implicated in the completion of sister chromatid separation during mitosis, a complex process in which precise regulation and execution is crucial to preserve genomic stability. Here we show for the first time a role for the FANC pathway in chromosome segregation during mitotic cell division. FANCD2, a key component of the pathway, localizes to discrete spots on mitotic chromosomes. FANCD2 chromosomal localization is responsive to replicative stress and specifically targets aphidicolin (APH)-induced chromatid gaps and breaks. Our data indicate that the FANC pathway is involved in rescuing abnormal anaphase and telophase (ana-telophase) cells, limiting aneuploidy and reducing chromosome instability in daughter cells. We further address a cooperative role for the FANC pathway and BLM in preventing micronucleation, through FANC-dependent targeting of BLM to non-centromeric abnormal structures induced by replicative stress. We reveal new crosstalk between FANC and BLM proteins, extending their interaction beyond the S-phase rescue of damaged DNA(5-6) to the safeguarding of chromosome stability during mitosis.	[Naim, Valeria; Rosselli, Filippo] Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy,CEA LRC43V, F-94805 Villejuif, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Rosselli, F (corresponding author), Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy,CEA LRC43V, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	rosselli@igr.fr	Naim, Valeria/ABD-1533-2021; Filippo, Rosselli/AAO-6393-2020	Filippo, Rosselli/0000-0003-1080-5745; Naim, Valeria/0000-0002-2149-8712	La Ligue Contre le Cancer; Electricite de France (EDF); Institut Nationale pour le Cancer (INCa); INCa-Lilly	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Electricite de France (EDF)(Electricite de France (EDF)); Institut Nationale pour le Cancer (INCa)(Institut National du Cancer (INCA) France); INCa-Lilly	~We thank all the past and present members of F. Rosselli's team for technical support and helpful discussions, J. Soulier and D. Briot for the FA-C complemented cell lines, E. Nigg for the anti-PICH antibody, Y. Lecluse for FACS analysis, A. Jalil for help with confocal microscopy and P. Kannouche for providing materials and technical advice. This work was supported by grants from La Ligue Contre le Cancer (Equipe Labellisee 2006 and 2009), Electricite de France (EDF) and Institut Nationale pour le Cancer (INCa) to F. R., and a fellowship from INCa-Lilly to V. N.	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; FUNDIA A, 1994, HEREDITAS, V120, P47, DOI 10.1111/j.1601-5223.1994.00047.x; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kinzler KW, 1997, NATURE, V386, P763; Maluf SW, 2001, CANCER GENET CYTOGEN, V124, P71, DOI 10.1016/S0165-4608(00)00322-8; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2004, CELL CYCLE, V3, P179; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; PORFIRIO B, 1991, HUM GENET, V86, P256; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651	31	241	245	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					761	U127		10.1038/ncb1883	http://dx.doi.org/10.1038/ncb1883			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465921				2022-12-27	WOS:000266503700022
J	Wang, SP; Wang, WL; Chang, YL; Wu, CT; Chao, YC; Kao, SH; Yuan, A; Lin, CW; Yang, SC; Chan, WK; Li, KC; Hong, TM; Yang, PC				Wang, Shu-Ping; Wang, Wen-Lung; Chang, Yih-Leong; Wu, Chen-Tu; Chao, Yu-Chih; Kao, Shih-Han; Yuan, Ang; Lin, Chung-Wu; Yang, Shuenn-Chen; Chan, Wing-Kai; Li, Ker-Chau; Hong, Tse-Ming; Yang, Pan-Chyr			p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTORS SNAIL; E-CADHERIN EXPRESSION; REPRESSES E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; BREAST-CANCER; MOUSE MODEL; CARCINOMA; METASTASIS; MUTATION; ADHESION	The tumour suppressor p53 is known to prevent cancer progression by inhibiting proliferation and inducing apoptosis of tumour cells. Slug, an invasion promoter, exerts its effects by repressing E-cadherin transcription. Here we show that wild-type p53 (wtp53) suppresses cancer invasion by inducing Slug degradation, whereas mutant p53 may stabilize Slug protein. In non-small-cell lung cancer (NSCLC), mutation of p53 correlates with low MDM2, high Slug and low E-cadherin expression. This expression profile is associated with poor overall survival and short metastasis-free survival in patients with NSCLC. wtp53 upregulates MDM2 and forms a wtp53-MDM2-Slug complex that facilitates MDM2-mediated Slug degradation. Downregulation of Slug by wtp53 or MDM2 enhances E-cadherin expression and represses cancer cell invasiveness. In contrast, mutant p53 inactivates Slug degradation and leads to Slug accumulation and increased cancer cell invasiveness. Our findings indicate that wtp53 and p53 mutants may differentially control cancer invasion and metastasis through the p53-MDM2-Slug pathway.	[Yuan, Ang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10043, Taiwan; [Wang, Shu-Ping; Wang, Wen-Lung; Chao, Yu-Chih] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Kao, Shih-Han] Natl Taiwan Univ, Coll Med, Grad Inst Mol Biol, Taipei 10043, Taiwan; [Lin, Chung-Wu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10043, Taiwan; [Yang, Shuenn-Chen; Yang, Pan-Chyr] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chan, Wing-Kai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10043, Taiwan; [Li, Ker-Chau] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Hong, Tse-Ming] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10043, Taiwan	National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University	Yang, PC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10043, Taiwan.	pcyang@ntu.edu.tw	Yang, Pan-Chyr/B-8808-2009; Wang, Shu-Ping/S-4379-2018; Li, Ker-Chau/AAQ-4886-2021	Wang, Shu-Ping/0000-0002-5895-1269; WU, CHEN-TU/0000-0001-8458-4119; LIN, CHUNG-WU/0000-0001-5042-0503; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048; Chan, Wing-Kai/0000-0002-5328-548X; YUAN, ANG/0000-0002-5664-1339	National Science Council; Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine [DOH94-TD-G-111-020, DOH95-TD-G-111-010, DOH96-TD-G-111-009, DOH97-TD-G-111-018, DOH98-TD-G-111-007, NSC97-3112-B-002-033, NSC97-2314-B-002-146-MY3]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine	We thank H. K. Sytwu (Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan) for providing the plasmids for the lentivirus infection system, Pei-Fang Hung and Lu-Kai Wang for technical assistance, and Pei-Ying Lin for English language editing. This work was supported by the National Science Council and Department of Health, Executive Yuan of the Republic of China, through the National Research Program for Genomic Medicine Grants (DOH94-TD-G-111-020, DOH95-TD-G-111-010, DOH96-TD-G-111-009, DOH97-TD-G-111-018, DOH98-TD-G-111-007, NSC97-3112-B-002-033 and NSC97-2314-B-002-146-MY3). shRNA constructs were obtained from the National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taipei, Taiwan.	Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bermejo-Rodriguez C, 2006, GENOMICS, V87, P113, DOI 10.1016/j.ygeno.2005.09.014; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bukholm IK, 1997, VIRCHOWS ARCH, V431, P317, DOI 10.1007/s004280050105; Cano A, 1996, INT J CANCER, V65, P254; Chang YL, 2007, CLIN CANCER RES, V13, P52, DOI 10.1158/1078-0432.CCR-06-1743; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; HENNIG G, 1995, ONCOGENE, V11, P475; HSIAO M, 1994, AM J PATHOL, V145, P702; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levrero M, 2000, J CELL SCI, V113, P1661; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ravi R, 2000, GENE DEV, V14, P34; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Travis WD., 2004, TRAVIS WB WHO CLASSI; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900	50	369	379	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					694	U22		10.1038/ncb1875	http://dx.doi.org/10.1038/ncb1875			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19448627				2022-12-27	WOS:000266503700014
J	Tuite, MF; Cox, BS				Tuite, Mick F.; Cox, Brian S.			Prions remodel gene expression in yeast	NATURE CELL BIOLOGY			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; PROTEIN; MECHANISM; DOMAIN; URE3	Epigenetic mechanisms participate in the regulation of gene transcription in eukaryotes. Two studies in yeast have revealed an additional mechanism for controlling global gene transcription that is based on an inherited self-perpetuating change in the conformation of two different components of key transcriptional regulatory complexes.	[Tuite, Mick F.; Cox, Brian S.] Univ Kent, Dept Biosci, Kent Fungal Grp, Canterbury CT2 7NJ, Kent, England	University of Kent	Tuite, MF (corresponding author), Univ Kent, Dept Biosci, Kent Fungal Grp, Canterbury CT2 7NJ, Kent, England.	m.f.tuite@kent.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X	Biotechnology and Biological Sciences Research Council [BB/D018242/1] Funding Source: Medline; BBSRC [BB/D018242/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	16	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					241	243		10.1038/ncb0309-241	http://dx.doi.org/10.1038/ncb0309-241			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255570				2022-12-27	WOS:000263777900006
J	Bell, RD; Deane, R; Chow, NW; Long, XC; Sagare, A; Singh, I; Streb, JW; Guo, H; Rubio, A; Van Nostrand, W; Miano, JM; Zlokovic, BV				Bell, Robert D.; Deane, Rashid; Chow, Nienwen; Long, Xiaochun; Sagare, Abhay; Singh, Itender; Streb, Jeffrey W.; Guo, Huang; Rubio, Anna; Van Nostrand, William; Miano, Joseph M.; Zlokovic, Berislav V.			SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; ELEMENT-BINDING PROTEIN-2; ALZHEIMER-DISEASE; NEUROVASCULAR DYSFUNCTION; APOLIPOPROTEIN-E; IN-VITRO; PEPTIDE; SMOOTH; GENE; EXPRESSION	Amyloid beta-peptide (A beta) deposition in cerebral vessels contributes to cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD). Here, we report that in AD patients and two mouse models of AD, overexpression of serum response factor (SRF) and myocardin (MYOCD) in cerebral vascular smooth muscle cells (VSMCs) generates an A beta non-clearing VSMC phenotype through transactivation of sterol regulatory element binding protein-2, which downregulates low density lipoprotein receptor-related protein-1, a key A beta clearance receptor. Hypoxia stimulated SRF/MYOCD expression in human cerebral VSMCs and in animal models of AD. We suggest that SRF and MYOCD function as a transcriptional switch, controlling A beta cerebrovascular clearance and progression of AD.	[Bell, Robert D.; Deane, Rashid; Sagare, Abhay; Singh, Itender; Guo, Huang; Zlokovic, Berislav V.] Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Chow, Nienwen; Guo, Huang; Rubio, Anna] Univ Rochester, Sch Med & Dent, Socratech Res Labs, Rochester, NY 14642 USA; [Long, Xiaochun; Streb, Jeffrey W.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Van Nostrand, William] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	University of Rochester; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zlokovic, BV (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Arthur Kornberg Med Res Bldg,601 Elmwood Ave, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Sagare, Abhay/Y-3273-2019; Miano, Joseph/L-5634-2018	Sagare, Abhay/0000-0002-8178-3785; Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	Socratech LLC;  [R37AG023084];  [R37NS34467];  [1R43 AG02400];  [HL62572];  [R42AG026950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, R42AG026950] Funding Source: NIH RePORTER	Socratech LLC; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ms. Theresa Barrett for assisting with some immunostaining studies. This study was supported by R37AG023084, R37NS34467 and Socratech LLC to BVZ, 1R43 AG02400 to NC and HL62572 and R42AG026950 to JMM. JMM and BVZ are co-senior authors.	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Davis J, 2003, J BIOL CHEM, V278, P19054, DOI 10.1074/jbc.M301398200; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Herring A, 2008, BRAIN PATHOL, V18, P32, DOI 10.1111/j.1750-3639.2007.00094.x; Herz J, 2003, CELL, V112, P289, DOI 10.1016/S0092-8674(03)00073-4; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 2007, ALZHEIMERS DIS ADV G, P179; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Pettersen JA, 2008, ARCH NEUROL-CHICAGO, V65, P790, DOI 10.1001/archneur.65.6.790; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Ribault S, 2001, CIRC RES, V88, P468, DOI 10.1161/01.RES.88.5.468; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; SATO R, 1994, J BIOL CHEM, V269, P17267; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Urmoneit B, 1997, LAB INVEST, V77, P157; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhu PC, 2006, INT J EXP PATHOL, V87, P463, DOI 10.1111/j.1365-2613.2006.00503.x; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	61	205	208	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					143	U83		10.1038/ncb1819	http://dx.doi.org/10.1038/ncb1819			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098903	Green Accepted			2022-12-27	WOS:000263285500012
J	Jansson, M; Durant, ST; Cho, EC; Sheahan, S; Edelmann, M; Kessler, B; La Thangue, NB				Jansson, Martin; Durant, Stephen T.; Cho, Er-Chieh; Sheahan, Sharon; Edelmann, Mariola; Kessler, Benedikt; La Thangue, Nicholas B.			Arginine methylation regulates the p53 response	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; GENE-EXPRESSION; LI-FRAUMENI; COFACTOR; PATHWAY; TETRAMERIZATION; MUTATIONS; APOPTOSIS; MEDIATOR; TARGETS	Activation of the p53 tumour suppressor protein in response to DNA damage leads to apoptosis or cell-cycle arrest. Enzymatic modifications are widely believed to affect and regulate p53 activity. We describe here a level of post-translational control that has an important functional consequence on the p53 response. We show that the protein arginine methyltransferase (PRMT) 5, as a co-factor in a DNA damage responsive co-activator complex that interacts with p53, is responsible for methylating p53. Arginine methylation is regulated during the p53 response and affects the target gene specificity of p53. Furthermore, PRMT5 depletion triggers p53-dependent apoptosis. Thus, methylation on arginine residues is an underlying mechanism of control during the p53 response.	[Jansson, Martin; Durant, Stephen T.; Cho, Er-Chieh; Sheahan, Sharon; La Thangue, Nicholas B.] Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Oxford OX3 7DQ, England; [Edelmann, Mariola; Kessler, Benedikt] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford	La Thangue, NB (corresponding author), Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Old Rd Campus Res Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7DQ, England.	nick.lathangue@ndcls.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Jansson, Martin/0000-0002-6946-145X; Edelmann, Mariola/0000-0003-0459-7716	MRC; Cancer Research UK; EU; LRF; AICR; MRC [G0501068, G9400953, G0500905] Funding Source: UKRI; Medical Research Council [G9400953, G0500905, G0501068] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EU(European Commission); LRF; AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the MRC, Cancer Research UK, EU, LRF and AICR for supporting this work, and Rosemary Williams for assistance in preparing the manuscript.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; NISHI K, 1994, J BIOL CHEM, V269, P6320; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Zhao RB, 2000, GENE DEV, V14, P981	30	327	355	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1431	U122		10.1038/ncb1802	http://dx.doi.org/10.1038/ncb1802			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011621				2022-12-27	WOS:000261261800013
J	Vaughn, AE; Deshmukh, M				Vaughn, Allyson E.; Deshmukh, Mohanish			Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c	NATURE CELL BIOLOGY			English	Article							CASPASE ACTIVATION; DEATH; STATE; OXYGEN; SYSTEM; GLUTATHIONE; MECHANISM; RELEASE	Neurons and cancer cells use glucose extensively, yet the precise advantage of this adaptation remains unclear. These two seemingly disparate cell types also show an increased regulation of the apoptotic pathway, which allows for their long-term survival(1). Here we show that both neurons and cancer cells strictly inhibit cytochrome c-mediated apoptosis by a mechanism dependent on glucose metabolism. We report that the pro-apoptotic activity of cytochrome c is influenced by its redox state and that increases in reactive oxygen species (ROS) following an apoptotic insult lead to the oxidation and activation of cytochrome c. In healthy neurons and cancer cells, however, cytochrome c is reduced and held inactive by intracellular glutathione (GSH), generated as a result of glucose metabolism by the pentose phosphate pathway. These results uncover a striking similarity in apoptosis regulation between neurons and cancer cells and provide insight into an adaptive advantage offered by the Warburg effect for cancer cell evasion of apoptosis and for long-term neuronal survival.	[Vaughn, Allyson E.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Deshmukh, Mohanish] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Deshmukh, M (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Box 7250,115 Mason Farm Rd, Chapel Hill, NC 27599 USA.	mohanish@med.unc.edu			NIH [NS42197, GM078366, NS055486]; UNC Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042197, F31NS055486] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jeffery Rathmell, Gary Pielak, Eugene Johnson and members of the Deshmukh Lab for helpful discussions and critical review of this manuscript. This work was supported by NIH grants NS42197 and GM078366 ( to M. D.), NS055486 ( to A. E. V.) and by the UNC Cancer Research Fund.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Borutaite V, 2007, J BIOL CHEM, V282, P31124, DOI 10.1074/jbc.M700322200; Cai JY, 1999, J BIOENERG BIOMEMBR, V31, P327, DOI 10.1023/A:1005423818280; CARNEY JM, 1994, ANN NY ACAD SCI, V738, P44; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Doyle DF, 1996, BIOCHEMISTRY-US, V35, P7403, DOI 10.1021/bi960409u; Esposti MD, 2002, APOPTOSIS, V7, P433, DOI 10.1023/A:1020035124855; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Hampton MB, 1998, BIOCHEM J, V329, P95; Hancock JT, 2001, FREE RADICAL BIO MED, V31, P697, DOI 10.1016/S0891-5849(01)00646-3; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kuo WY, 2000, INT J CANCER, V85, P857, DOI 10.1002/(SICI)1097-0215(20000315)85:6<857::AID-IJC20>3.3.CO;2-L; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pan ZH, 1999, CELL DEATH DIFFER, V6, P683, DOI 10.1038/sj.cdd.4400544; Patel CN, 2001, PROTEIN EXPRES PURIF, V22, P220, DOI 10.1006/prep.2001.1438; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Wang XD, 2001, GENE DEV, V15, P2922; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; YANG J, 1997, SCIENCE, V275, P1132; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	33	286	292	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1477	U228		10.1038/ncb1807	http://dx.doi.org/10.1038/ncb1807			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19029908	Green Submitted, Green Accepted			2022-12-27	WOS:000261261800020
J	Li, HB; Guo, FL; Rubinstein, B; Li, R				Li, Hongbin; Guo, Fengli; Rubinstein, Boris; Li, Rong			Actin-driven chromosomal motility leads to symmetry breaking in mammalian meiotic oocytes	NATURE CELL BIOLOGY			English	Article							MOUSE OOCYTES; MECHANISM; SPINDLE; CYTOSKELETON; NETWORK; CELL; MICROTUBULES; MATURATION; FORMIN-2; COMPLEX	Movement of meiosis I (MI) chromosomes from the oocyte centre to a subcortical location is the first step in the establishment of cortical polarity. this is required for two consecutive rounds of asymmetric meiotic cell divisions, which generate a mature egg and two polar bodies(1). Here we use live-cell imaging and genetic and pharmacological manipulations to determine the force-generating mechanism underlying this chromosome movement. Chromosomes were observed to move toward the cortex in a pulsatile manner along a meandering path. this movement is not propelled by myosin-II-driven cortical flow but is associated with a cloud of dynamic actin filaments trailing behind the chromosomes/spindle. Formation of these filaments depends on the actin nucleation activity of Fmn2, a formin-family protein that concentrates around chromosomes through its amino-terminal region. symmetry breaking of the actin cloud relative to chromosomes, and net chromosome translocation toward the cortex require actin turnover.	[Li, Hongbin; Guo, Fengli; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers-institute.org			Stowers Institute for Medical Research	Stowers Institute for Medical Research	We thank Roland Wedlich-Soldner (Max Plank Institute, Munich) for providing F-Lifeact peptide; Philip Leder (Harvard Medical School, Boston)) for Fmn2<SUP>-/-</SUP> mice and full-length Fmn2 cDNA; Marie-Helene Verlhac (Universite Paris VI, Paris) for pBluescript RN3 vector; Eric Jessen (Stowers Institute, Kansa City, applying to all persons mentioned hereafter) for help in site-directed mutagenesis; Rhonda Allen for electron microscopy; Xiaoxue Fan for help with actin preparation; Praveen Suraneni and Manqi Deng for help with the mouse work; Heather Marshall and Michael Durnin for training in oocyte dissection and microinjection; and Stowers Imaging Center for assistance with live imaging; Stacie Hughes for comments on the manuscript. This work was supported by funds to R. L. from the Stowers Institute for Medical Research.	Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Boggio EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000604; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; CAPCO DG, 1993, CELL MOTIL CYTOSKEL, V24, P85, DOI 10.1002/cm.970240202; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Fehrenbacher KL, 2003, TRENDS CELL BIOL, V13, P472, DOI 10.1016/S0962-8924(03)00174-0; Gobert GN, 2000, J ELECTRON MICROSC, V49, P539, DOI 10.1093/oxfordjournals.jmicro.a023841; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; LONGO E, 1985, J THEOR BIOL, V112, P783, DOI 10.1016/S0022-5193(85)80061-8; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Miyazaki A, 2005, DEV BIOL, V280, P237, DOI 10.1016/j.ydbio.2005.01.026; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Verlhac MH, 2008, MOL CELL ENDOCRINOL, V282, P12, DOI 10.1016/j.mce.2007.11.018; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Yang HY, 2005, J CELL BIOL, V169, P447, DOI 10.1083/jcb.200411132	30	119	121	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1301	U101		10.1038/ncb1788	http://dx.doi.org/10.1038/ncb1788			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836438				2022-12-27	WOS:000260586700012
J	Kim, E; Goraksha-Hicks, P; Li, L; Neufeld, TP; Guan, KL				Kim, Eunjung; Goraksha-Hicks, Pankuri; Li, Li; Neufeld, Thomas P.; Guan, Kun-Liang			Regulation of TORC1 by Rag GTPases in nutrient response	NATURE CELL BIOLOGY			English	Article							AMINO-ACID SUFFICIENCY; GTP-BINDING PROTEINS; P70 S6 KINASE; CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; TUBEROUS SCLEROSIS; SIGNALING PATHWAY; MAMMALIAN TARGET; FAT-BODY	TORC1 (target of rapamycin complex 1) has a crucial role in the regulation of cell growth and size. A wide range of signals, including amino acids, is known to activate TORC1. Here, we report the identification of Rag GTPases as activators of TORC1 in response to amino acid signals. Knockdown of Rag gene expression suppressed the stimulatory effect of amino acids on TORC1 in Drosophila melanogaster S2 cells. Expression of constitutively active (GTP-bound) Rag in mammalian cells activated TORC1 in the absence of amino acids, whereas expression of dominant-negative Rag blocked the stimulatory effects of amino acids on TORC1. Genetic studies in Drosophila also show that Rag GTPases regulate cell growth, autophagy and animal viability during starvation. Our studies establish a function of Rag GTPases in TORC1 activation in response to amino acid signals.	[Kim, Eunjung; Li, Li; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Eunjung; Li, Li; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Goraksha-Hicks, Pankuri; Neufeld, Thomas P.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	neufe003@umn.edu; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Neufeld, Thomas/0000-0001-5659-4811	NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509, R01GM062694] Funding Source: NIH RePORTER; NCI NIH HHS [CA108941, R01 CA108941-05, R01 CA108941] Funding Source: Medline; NIGMS NIH HHS [R01 GM062694-09, R01 GM062509-08, R01 GM062694, GM62694, R01 GM062509, GM62509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BUN YM, 1992, MOL CELL BIOL, V12, P2958; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hirose E, 1998, J CELL SCI, V111, P11; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kwiatkowski DJ, 2003, CANCER BIOL THER, V2, P471, DOI 10.4161/cbt.2.5.446; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nakashima N, 1999, GENETICS, V152, P853; Nakashima N, 1996, J CELL SCI, V109, P2311; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	48	929	967	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					935	945		10.1038/ncb1753	http://dx.doi.org/10.1038/ncb1753			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604198	Green Accepted			2022-12-27	WOS:000258147100011
J	Swarup, K; Benkova, E; Swarup, R; Casimiro, I; Peret, B; Yang, Y; Parry, G; Nielsen, E; De Smet, I; Vanneste, S; Levesque, MP; Carrier, D; James, N; Calvo, V; Ljung, K; Kramer, E; Roberts, R; Graham, N; Marillonnet, S; Patel, K; Jones, JDG; Taylor, CG; Schachtman, DP; May, S; Sandberg, G; Benfey, P; Friml, J; Kerr, I; Beeckman, T; Laplaze, L; Bennett, MJ				Swarup, Kamal; Benkova, Eva; Swarup, Ranjan; Casimiro, Ilda; Peret, Benjamin; Yang, Yaodong; Parry, Geraint; Nielsen, Erik; De Smet, Ive; Vanneste, Steffen; Levesque, Mitch P.; Carrier, David; James, Nicholas; Calvo, Vanessa; Ljung, Karin; Kramer, Eric; Roberts, Rebecca; Graham, Neil; Marillonnet, Sylvestre; Patel, Kanu; Jones, Jonathan D. G.; Taylor, Christopher G.; Schachtman, Daniel P.; May, Sean; Sandberg, Goran; Benfey, Philip; Friml, Jiri; Kerr, Ian; Beeckman, Tom; Laplaze, Laurent; Bennett, Malcolm J.			The auxin influx carrier LAX3 promotes lateral root emergence	NATURE CELL BIOLOGY			English	Article							CULTURED TOBACCO CELLS; ARABIDOPSIS-THALIANA; GENE; TRANSPORT; INITIATION; ORGANIZATION; EXPRESSION; MUTATIONS	Lateral roots originate deep within the parental root from a small number of founder cells at the periphery of vascular tissues and must emerge through intervening layers of tissues. We describe how the hormone auxin, which originates from the developing lateral root, acts as a local inductive signal which re-programmes adjacent cells. Auxin induces the expression of a previously uncharacterized auxin influx carrier LAX3 in cortical and epidermal cells directly overlaying new primordia. Increased LAX3 activity reinforces the auxin-dependent induction of a selection of cell-wall-remodelling enzymes, which are likely to promote cell separation in advance of developing lateral root primordia.	[Swarup, Kamal; Swarup, Ranjan; Parry, Geraint; Carrier, David; James, Nicholas; Roberts, Rebecca; Graham, Neil; May, Sean; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Benkova, Eva; Friml, Jiri] Univ Tubingen, ZMBP, D-72074 Tubingen, Germany; [Casimiro, Ilda; Calvo, Vanessa] Univ Extremadura, Fac Ciencias, Badajoz, Spain; [Peret, Benjamin; Laplaze, Laurent] INRA, IRD, UMR DiA PC, Agro M,UM2, F-34394 Montpellier 5, France; [Yang, Yaodong; Nielsen, Erik; Taylor, Christopher G.; Schachtman, Daniel P.] Donald Danforth Plant Sci Ctr, St Louis, MO 63122 USA; [Benkova, Eva; De Smet, Ive; Vanneste, Steffen; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Levesque, Mitch P.; Benfey, Philip] Duke Univ, Dept Biol, Durham, NC USA; [Levesque, Mitch P.; Benfey, Philip] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Carrier, David; Kerr, Ian] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England; [Ljung, Karin] SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Kramer, Eric] Simons Rock Coll, Dept Phys, Great Barrington, MA 01201 USA; [Marillonnet, Sylvestre; Patel, Kanu; Jones, Jonathan D. G.] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England; [Sandberg, Goran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Parry, Geraint] Indiana Univ, Dept Biol, Bloomington, IN USA; [De Smet, Ive] Univ Tubingen, ZMBP Entwicklungsgenet, D-72074 Tubingen, Germany; [Levesque, Mitch P.] Max Planck Inst Dev Biol, Tubingen, Germany	University of Nottingham; Eberhard Karls University of Tubingen; Universidad de Extremadura; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Donald Danforth Plant Science Center; Flanders Institute for Biotechnology (VIB); Ghent University; Duke University; Duke University; University of Nottingham; Swedish University of Agricultural Sciences; Umea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Umea University; Indiana University System; Indiana University Bloomington; Eberhard Karls University of Tubingen; Max Planck Society	Bennett, MJ (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	malcolm.bennett@nottingham.ac.uk	Laplaze, Laurent/I-5435-2016; Casimiro, Ilda/R-3506-2019; Beeckman, Tom/ABA-1164-2020; Jones, Jonathan DG/J-5129-2012; De Smet, Ive/A-6583-2011; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABI-1703-2020; may, sean t/B-6838-2012; Benkova, Eva/E-2910-2012; Friml, Jiri/D-9511-2012; Kerr, Ian D/B-3803-2015; Nielsen, Erik/G-5843-2013; Ljung, Karin/AAE-8691-2019; De Smet, Ive/E-6086-2011; Graham, Neil/C-5489-2008; Yang, Yaodong/L-8445-2019; Taylor, Christopher/E-4508-2012; Kramer, Eric M/B-9752-2008; Bennett, Malcolm/G-4004-2010	Laplaze, Laurent/0000-0002-6568-6504; Jones, Jonathan DG/0000-0002-4953-261X; De Smet, Ive/0000-0003-4607-8893; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; may, sean t/0000-0001-5282-3250; Friml, Jiri/0000-0002-8302-7596; Kerr, Ian D/0000-0002-7544-8454; Ljung, Karin/0000-0003-2901-189X; De Smet, Ive/0000-0003-4607-8893; Graham, Neil/0000-0001-9080-8967; Yang, Yaodong/0000-0002-6599-5665; Bennett, Malcolm/0000-0003-0475-390X; Schachtman, Daniel/0000-0003-1807-4369; PERET, Benjamin/0000-0003-1336-0796; Kramer, Eric/0000-0002-1424-2356; swarup, Ranjan/0000-0002-6438-9188	Biotechnology and Biological Sciences Research Council [G18881, G17764, BB/E022758/1, REI20541, BB/D019613/1, BB/C514958/1, BBS/B/1356X, BB/E01772X/1] Funding Source: Medline; BBSRC [BB/E01772X/1, BB/E022758/1, BB/D019613/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beeckman T., 1994, Plant Molecular Biology Reporter, V12, P37, DOI 10.1007/BF02668662; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dharmasiri S, 2006, SCIENCE, V312, P1218, DOI 10.1126/science.1122847; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dubrovsky J.G., 2003, ENCY APPL PLANT SCI, P1101; Dubrovsky JG, 2001, PLANTA, V214, P30, DOI 10.1007/s004250100598; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Imhoff V, 2000, PLANTA, V210, P580, DOI 10.1007/s004250050047; Ivanchenko MG, 2006, PLANT J, V46, P436, DOI 10.1111/j.1365-313X.2006.02702.x; KARLINNEUMANN GA, 1991, PLANT CELL, V3, P573, DOI 10.1105/tpc.3.6.573; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; LLORET PG, 2002, LATERAL ROOT INITIAT; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tian Q, 1999, DEVELOPMENT, V126, P711; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Wen F, 2006, ANN PLANT REV, V25, P91; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029	40	542	566	5	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					946	954		10.1038/ncb1754	http://dx.doi.org/10.1038/ncb1754			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18622388				2022-12-27	WOS:000258147100012
J	Yan, D; Lin, XH				Yan, Dong; Lin, Xinhua			Opposing roles for glypicans in Hedgehog signalling	NATURE CELL BIOLOGY			English	Editorial Material							DALLY-LIKE; DROSOPHILA; BINDING; PATHWAY; ENDOCYTOSIS; RECEPTOR		[Yan, Dong; Lin, Xinhua] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yan, D (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	xinhua.lin@cchmc.org						Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Callejo A, 2008, P NATL ACAD SCI USA, V105, P912, DOI 10.1073/pnas.0705603105; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	16	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					761	763		10.1038/ncb0708-761	http://dx.doi.org/10.1038/ncb0708-761			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18591969				2022-12-27	WOS:000257268400006
J	Zhao, XD; Heng, JIT; Guardavaccaro, D; Jiang, R; Pagano, M; Guillemot, F; Iavarone, A; Lasorella, A				Zhao, Xudong; Heng, Julian Ik-Tsen; Guardavaccaro, Daniele; Jiang, Richeng; Pagano, Michele; Guillemot, Francois; Iavarone, Antonio; Lasorella, Anna			The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; C-MYC; NEURONAL DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; NEUROBLASTOMA-CELLS; DEGRADATION; PROTEIN; TARGET; PROTEASOME	Development of the nervous system requires that timely withdrawal from the cell cycle be coupled with initiation of differentiation. Ubiquitin-mediated degradation of the N-Myc oncoprotein in neural stem/ progenitor cells is thought to trigger the arrest of proliferation and begin differentiation. Here we report that the HECT-domain ubiquitin ligase Huwe1 ubiquitinates the N-Myc oncoprotein through Lys 48-mediated linkages and targets it for destruction by the proteasome. This process is physiologically implemented by embryonic stem (ES) cells differentiating along the neuronal lineage and in the mouse brain during development. Genetic and RNA interference-mediated inactivation of the Huwe1 gene impedes N-Myc degradation, prevents exit from the cell cycle by opposing the expression of Cdk inhibitors and blocks differentiation through persistent inhibition of early and late markers of neuronal differentiation. Silencing of N-myc in cells lacking Huwe1 restores neural differentiation of ES cells and rescues cell-cycle exit and differentiation of the mouse cortex, demonstrating that Huwe1 restrains proliferation and enables neuronal differentiation by mediating the degradation of N-Myc. These findings indicate that Huwe1 links destruction of N-Myc to the quiescent state that complements differentiation in the neural tissue.	[Zhao, Xudong; Jiang, Richeng; Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Heng, Julian Ik-Tsen; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Guardavaccaro, Daniele; Pagano, Michele] NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Zhao, Xudong] Shanghai Res Ctr Model Organisms, Shanghai 201203, Peoples R China	Columbia University; Columbia University; Columbia University; Columbia University; MRC National Institute for Medical Research; New York University	Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu; al2179@columbia.edu	Guillemot, Francois/AAV-1482-2021	pagano, michele/0000-0003-3210-2442; Heng, Julian Ik-Tsen/0000-0002-0378-7078; Iavarone, Antonio/0000-0002-0683-4634; Guardavaccaro, Daniele/0000-0002-4517-1765; zhao, zhao xu dong/0000-0001-9126-7365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; MRC [MC_U117570528] Funding Source: UKRI; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U117570528] Funding Source: Medline; NIGMS NIH HHS [R01 GM057587-11, R01 GM057587] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; BERNARD O, 1992, NEURON, V9, P1217, DOI 10.1016/0896-6273(92)90079-S; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOGENMANN E, 1995, ONCOGENE, V10, P1915; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CIECHANOVER A, 1991, PROG CLIN BIOL RES, V366, P37; Cotta Claudiu V, 2008, Cancer, V112, P552, DOI 10.1002/cncr.23196; Deb-Basu D, 2006, CELL CYCLE, V5, P1348, DOI 10.4161/cc.5.12.2860; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fortunel NO, 2003, SCIENCE, V302, P393; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Galvin KE, 2007, DEV BIOL, V308, P331, DOI 10.1016/j.ydbio.2007.05.031; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; Peverali FA, 1996, ONCOGENE, V12, P457; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Seeger R C, 1988, Prog Clin Biol Res, V271, P41; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; STANTON BR, 1992, BRAIN PATHOL, V2, P71; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	48	203	214	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					643	653		10.1038/ncb1727	http://dx.doi.org/10.1038/ncb1727			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488021	Green Accepted			2022-12-27	WOS:000256350100011
J	Kawauchi, K; Araki, K; Tobiume, K; Tanaka, N				Kawauchi, Keiko; Araki, Keigo; Tobiume, Kei; Tanaka, Nobuyuki			P53 regulates glucose metabolism through an IKK-NF-kappa B pathway and inhibits cell transformation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; CANCER-CELLS; ALPHA; PHOSPHORYLATION; APOPTOSIS; TRANSPORTERS; GLYCOLYSIS	Cancer cells use aerobic glycolysis preferentially for energy provision(1,2) and this metabolic change is important for tumour growth(3,4). Here, we have found a link between the tumour suppressor p53, the transcription factor NF-kappa B and glycolysis. In p53-deficient primary cultured cells, kinase activities of IKK alpha and IKK beta and subsequent NF-kappa B activity were enhanced. Activation of NF-kappa B, by loss of p53, caused an increase in the rate of aerobic glycolysis and upregulation of Glut3. Oncogenic Ras-induced cell transformation and acceleration of aerobic glycolysis in p53-deficient cells were suppressed in the absence of p65/ NF-kappa B expression, and were restored by GLUT3 expression. It was also shown that a glycolytic inhibitor diminished the enhanced IKK activity in p53-deficient cells. Moreover, in Ras-expressing p53-deficient cells, IKK activity was suppressed by p65 deficiency and restored by GLUT3 expression. Taken together, these data indicate that p53 restricts activation of the IKK - NF-kappa B pathway through suppression of glycolysis. These results suggest that a positivefeedback loop exists, whereby glycolysis drives IKK - NF-kappa B activation, and that hyperactivation of this loop by loss of p53 is important in oncogene- induced cell transformation.	[Kawauchi, Keiko; Araki, Keigo; Tobiume, Kei; Tanaka, Nobuyuki] Nippon Med Coll, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Nippon Medical School	Tanaka, N (corresponding author), Nippon Med Coll, Dept Mol Oncol, Inst Gerontol, Nakahara Ku, Kosugi Cho 1-396, Kawasaki, Kanagawa 2118533, Japan.	nobuta@nms.ac.jp	Kawauchi, Keiko/G-4198-2010	Tanaka, Nobuyuki/0000-0002-6373-2220				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2005, CANCER RES, V65, P177; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Meller J, 2007, J NUCL MED, V48, P35; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WARBURG O, 1956, SCIENCE, V124, P269; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	30	458	473	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					611	618		10.1038/ncb1724	http://dx.doi.org/10.1038/ncb1724			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18391940				2022-12-27	WOS:000255502400018
J	Chen, SA; Bohrer, LR; Rai, AN; Pan, YQ; Gan, L; Zhou, XZ; Bagchi, A; Simon, JA; Huang, HJ				Chen, Shuai; Bohrer, Laura R.; Rai, Aswathy N.; Pan, Yunqian; Gan, Lu; Zhou, Xianzheng; Bagchi, Anindya; Simon, Jeffrey A.; Huang, Haojie			Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; DEVELOPMENTAL REGULATORS; POLYCOMB; EXPRESSION; CANCER; COMPLEXES; DIFFERENTIATION; PROLIFERATION; MECHANISMS	The Polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing(1-4). This function of EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression(5-10). Here, we demonstrate that under physiological conditions, cyclin-dependent kinase 1 (CDK1) and cyclin-dependent kinase 2 (CDK2) phosphorylate EZH2 at Thr 350 in an evolutionarily conserved motif. Phosphorylation of Thr 350 is important for recruitment of EZH2 and maintenance of H3K27me3 levels at EZH2-target loci. Blockage of Thr 350 phosphorylation not only diminishes the global effect of EZH2 on gene silencing, it also mitigates EZH2-mediated cell proliferation and migration. These results demonstrate that CDK-mediated phosphorylation is a key mechanism governing EZH2 function and that there is a link between the cell-cycle machinery and epigenetic gene silencing.	[Chen, Shuai; Bohrer, Laura R.; Rai, Aswathy N.; Pan, Yunqian; Gan, Lu; Zhou, Xianzheng; Bagchi, Anindya; Simon, Jeffrey A.; Huang, Haojie] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Chen, Shuai; Bohrer, Laura R.; Pan, Yunqian; Gan, Lu; Huang, Haojie] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Rai, Aswathy N.; Simon, Jeffrey A.] Univ Minnesota, Biochem Mol Biol & Biophys Grad Program, Minneapolis, MN 55455 USA; [Zhou, Xianzheng] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Bagchi, Anindya; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Huang, HJ (corresponding author), Univ Minnesota, Masonic Canc Ctr, 420 Delaware St SE, Minneapolis, MN 55455 USA.	haojie.huang@stonybrook.edu		Chen, Shuai/0000-0003-1280-018X	National Institutes of Health [CA134514, CA130908, GM49850]; Department of Defense [W81XWH-07-1-0137, W81XWH-09-1-622, W81XWH-07-1-0373]; University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA134514, R01CA130908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. -C. Hung, Y. Zhang, H. Piwnica-Worms and L. Naldini for plasmids, R. A. Weinberg for BJ cells, K. Zhang for helping in the analysis of mass spectrometry data, and Z. Zhang for critical comments and suggestions. This work was supported in part by grants from the National Institutes of Health (CA134514 and CA130908 to H.H. and GM49850 to J.S.), the Department of Defense (W81XWH-07-1-0137 and W81XWH-09-1-622 to H.H. and W81XWH-07-1-0373 to J.S.), and a Brainstorm Award from University of Minnesota Masonic Cancer Center (to H.H.).	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Huang HJ, 2004, ONCOGENE, V23, P2161, DOI 10.1038/sj.onc.1207326; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	38	188	199	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1108	U118		10.1038/ncb2116	http://dx.doi.org/10.1038/ncb2116			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935635	Green Accepted			2022-12-27	WOS:000283711500015
J	Ramachandran, R; Fausett, BV; Goldman, D				Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel			Ascl1a regulates Muller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway	NATURE CELL BIOLOGY			English	Article							NEURONAL PROGENITORS; NEURAL REGENERATION; PHOTORECEPTOR; EXPRESSION; IDENTIFICATION; PROLIFERATION; INHIBITION	Unlike mammals, teleost fish mount a robust regenerative response to retinal injury that culminates in restoration of visual function(1,2). This regenerative response relies on dedifferentiation of Muller glia into a cycling population of progenitor cells. However, the mechanism underlying this dedifferentiation is unknown. Here, we report that genes encoding pluripotency factors are induced following retinal injury. Interestingly, the proneural transcription factor, Ascl1a, and the pluripotency factor, Lin-28, are induced in Muller glia within 6 h following retinal injury and are necessary for Muller glia dedifferentiation. We demonstrate that Ascl1a is necessary for lin-28 expression and that Lin-28 suppresses let-7 microRNA (miRNA) expression. Furthermore, we demonstrate that let-7 represses expression of regeneration-associated genes such as, ascl1a, hspd1, lin-28, oct4, pax6b and c-myc. hspd1, oct4 and c-myc(a) exhibit basal expression in the uninjured retina and let-7 may inhibit this expression to prevent premature Muller glia dedifferentiation. The opposing actions of Lin-28 and let-7 miRNAs on Muller glia differentiation and dedifferentiation are similar to that of embryonic stem cells(3) and suggest novel targets for stimulating Muller glia dedifferentiation and retinal regeneration in mammals.	[Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldman, D (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	neuroman@umich.edu		Ramachandran, Rajesh/0000-0002-9888-4750	NIH NEI [RO1 EY018132]; NIH NICHD [T32HD007507]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007507] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018132] Funding Source: NIH RePORTER	NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Hyde for sharing gfap:gfp transgenic fish, R. Thompson, D. Turner and M. Uhler for sharing expression vectors and reagents, J. Beals for help with confocal microscopy, the UM Flow Cytometry Core for help purifying GFP-labelled Muller glia, V. Kapuria for help with western blots; B. R. Wilfred and D. Turner for advice on miRNAs, P. Macpherson for help with statistics, T. Melendez for expert care of fish and D. Turner, J. Parent and members of the Goldman lab for their support and comments on this work. This work was supported by funds from the NIH NEI RO1 EY018132 (to DG.) and NIH NICHD T32HD007507 (to R.R.).	Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jadhav AP, 2009, PROG RETIN EYE RES, V28, P249, DOI 10.1016/j.preteyeres.2009.05.002; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li J, 2006, BIOCHEM BIOPH RES CO, V350, P648, DOI 10.1016/j.bbrc.2006.09.114; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mensinger AF, 1999, VISUAL NEUROSCI, V16, P241, DOI 10.1017/S0952523899162059; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ooto Sotaro, 2006, Nippon Ganka Gakkai Zasshi, V110, P864; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2010, EXP EYE RES, V90, P572, DOI 10.1016/j.exer.2010.02.001; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wan J, 2008, VISION RES, V48, P223, DOI 10.1016/j.visres.2007.11.002; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205	40	245	257	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1101	U106		10.1038/ncb2115	http://dx.doi.org/10.1038/ncb2115			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935637	Green Accepted			2022-12-27	WOS:000283711500014
J	Wang, XC; Li, WD; Zhao, DF; Liu, B; Shi, Y; Chen, BH; Yang, HW; Guo, PF; Geng, X; Shang, ZH; Peden, E; Kage-Nakadai, E; Mitani, S; Xue, D				Wang, Xiaochen; Li, Weida; Zhao, Dongfeng; Liu, Bin; Shi, Yong; Chen, Baohui; Yang, Hengwen; Guo, Pengfei; Geng, Xin; Shang, Zhihong; Peden, Erin; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			Caenorhabditis elegans transthyretin-like protein TTR-52 mediates recognition of apoptotic cells by the CED-1 phagocyte receptor	NATURE CELL BIOLOGY			English	Article							CORPSE ENGULFMENT; CRKII/DOCK180/RAC PATHWAY; PHOSPHATIDYLSERINE; DEATH; CLEARANCE; MIGRATION; SURFACE; DRAPER; GENE; CALRETICULIN	During apoptosis, dying cells are swiftly removed by phagocytes. It is not fully understood how apoptotic cells are recognized by phagocytes. Here we report the identification and characterization of the Caenorhabditis elegans ttr-52 gene, which encodes a transthyretin-like protein and is required for efficient cell corpse engulfment. The TTR-52 protein is expressed in, and secreted from, C. elegans endoderm and clusters around apoptotic cells. Genetic analysis indicates that TTR-52 acts in the cell corpse engulfment pathway mediated by CED-1, CED-6 and CED-7 and affects clustering of the phagocyte receptor CED-1 around apoptotic cells. TTR-52 recognizes surface-exposed phosphatidylserine (PtdSer) in vivo and binds to both PtdSer and the extracellular domain of CED-1 in vitro. TTR-52 is therefore the first bridging molecule identified in C. elegans that mediates recognition of apoptotic cells by crosslinking the PtdSer 'eat me' signal with the phagocyte receptor CED-1.	[Wang, Xiaochen; Shi, Yong; Yang, Hengwen; Geng, Xin; Shang, Zhihong; Peden, Erin; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Xiaochen; Li, Weida; Zhao, Dongfeng; Liu, Bin; Chen, Baohui; Guo, Pengfei] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] JST, CREST, Shinjuku Ku, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; National Institute of Biological Sciences, Beijing; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	wangxiaochen@nibs.ac.cn; ding.xue@colorado.edu	Yang, Hengwen/G-8091-2012; Guo, Peng/GWC-0572-2022; Li, Weida/M-4700-2013; guo, peng/AAG-4052-2019; Geng, Xin/C-7634-2012; liu, Bin/V-3391-2019; yang, hengwen/GQH-7922-2022	liu, Bin/0000-0001-7489-9125; XUE, DING/0000-0002-8429-8136; Chen, Baohui/0000-0002-8999-6531; Li, Weida/0000-0001-6578-6321; Guo, Pengfei/0000-0002-4618-6803; yang, hengwen/0000-0002-6418-1985	NIGMS NIH HHS [R01 GM79097, R01 GM59083, T32 GM142607, R01 GM079097-04, R01 GM079097, R01 GM088241, T32 GM008759, R01 GM059083-11, R01 GM059083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088241, R01GM059083, R01GM079097, T32GM008759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; BRENNER S, 1974, GENETICS, V77, P71; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Eneqvist T, 2003, EUR J BIOCHEM, V270, P518, DOI 10.1046/j.1432-1033.2003.03408.x; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geng X, 2008, NAT STRUCT MOL BIOL, V15, P1094, DOI 10.1038/nsmb.1488; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lee Y, 2006, MOL CELLS, V22, P141; Lundberg E, 2006, J STRUCT BIOL, V155, P445, DOI 10.1016/j.jsb.2006.04.002; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Riddle DL, 1997, C ELEGANS; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Saverwyns H, 2008, INT J PARASITOL, V38, P1545, DOI 10.1016/j.ijpara.2008.04.004; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Schreiber G, 2002, J ENDOCRINOL, V175, P61, DOI 10.1677/joe.0.1750061; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Sonnhammer ELL, 1997, GENOMICS, V46, P200, DOI 10.1006/geno.1997.4989; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	54	85	94	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					655	U69		10.1038/ncb2068	http://dx.doi.org/10.1038/ncb2068			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526330	Green Accepted			2022-12-27	WOS:000279374400009
J	Drost, J; Mantovani, F; Tocco, F; Elkon, R; Comel, A; Holstege, H; Kerkhoven, R; Jonkers, J; Voorhoeve, PM; Agami, R; Del Sal, G				Drost, Jarno; Mantovani, Fiamma; Tocco, Francesca; Elkon, Ran; Comel, Anna; Holstege, Henne; Kerkhoven, Ron; Jonkers, Jos; Voorhoeve, P. Mathijs; Agami, Reuven; Del Sal, Giannino			BRD7 is a candidate tumour suppressor gene required for p53 function	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; TRANSCRIPTIONAL REGULATION; EXPRESSION SIGNATURE; S-PHASE; ACETYLATION; BREAST; SENESCENCE; CELLS; BROMODOMAIN; HISTONE	Oncogene-induced senescence is a p53-dependent defence mechanism against uncontrolled proliferation. Consequently, many human tumours harbour p53 mutations and others show a dysfunctional p53 pathway, frequently by unknown mechanisms. Here we identify BRD7 (bromodomain-containing 7) as a protein whose inhibition allows full neoplastic transformation in the presence of wild-type p53. In human breast tumours harbouring wild-type, but not mutant, p53 the BRD7 gene locus was frequently deleted and low BRD7 expression was found in a subgroup of tumours. Functionally, BRD7 is required for efficient p53-mediated transcription of a subset of target genes. BRD7 interacts with p53 and p300 and is recruited to target gene promoters, affecting histone acetylation, p53 acetylation and promoter activity. Thus, BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence.	[Drost, Jarno; Elkon, Ran; Voorhoeve, P. Mathijs; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Mantovani, Fiamma; Tocco, Francesca; Comel, Anna; Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk, I-34012 Trieste, Italy; [Mantovani, Fiamma; Tocco, Francesca; Comel, Anna; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34100 Trieste, Italy; [Holstege, Henne; Jonkers, Jos] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Kerkhoven, Ron] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; University of Trieste; Netherlands Cancer Institute; Netherlands Cancer Institute	Voorhoeve, PM (corresponding author), Duke NUS Grad Med Sch, Div Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	mathijs.voorhoeve@duke-nus.edu.sg; r.agami@nki.nl; delsal@lncib.it	Drost, Jarno/J-9758-2012; Jonkers, Jos/AAG-3246-2019; agami, reuven/GOG-8289-2022; Drost, Jarno/M-6964-2017	Drost, Jarno/0000-0002-2941-6179; Jonkers, Jos/0000-0002-9264-9792; Drost, Jarno/0000-0002-2941-6179; Holstege, Henne/0000-0002-7688-3087; DEL SAL, GIANNINO/0000-0003-2185-6003; Agami, Reuven/0000-0002-2848-2473	Dutch Cancer Society; European Young Investigator (EURYI); Centre for Biomedical Genetics (CBG); European Research Council (ERC); Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca; EC [503576, 502963]	Dutch Cancer Society(KWF Kankerbestrijding); European Young Investigator (EURYI)(European Science Foundation (ESF)); Centre for Biomedical Genetics (CBG); European Research Council (ERC)(European Research Council (ERC)European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank Licio Collavin for discussion; Mauro Giacca, Marina Lusic and Lucia Pattarini for access to ICGEB facilities; Thomas Dobner for providing BRD7 expression constructs; Bruno Amati for p300 expression plasmid; Roderick Bijersbergen for assistance in the RNA-mediated interference array experiment; and Joachim Oude-Vrielink and Mariette Schrier for technical assistance. This work was supported by grants from the Dutch Cancer Society (KWF) to J.D., P. M. V and R. A., a European Young Investigator (EURYI) award to R.A. and by the Centre for Biomedical Genetics (CBG) (R.A.), the European Research Council (ERC) (R.A.), the Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Universita e della Ricerca (G.D.S.) and by EC FP6 (contracts 503576 and 502963).	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Argos M, 2008, CANCER GENET CYTOGEN, V182, P69, DOI 10.1016/j.cancergencyto.2008.01.001; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; GEVRY N, GENES DEV, V21, P1869; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kzhyshkowska J, 2003, BIOCHEM J, V371, P385, DOI 10.1042/BJ20021281; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; ROEPMAN P, CLIN CANC RES, V15, P7003; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; SPRUCK CH, 1992, CANCER RES, V52, P4787; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yu Y, 2000, ACTA BIOCH BIOPH SIN, V32, P327; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013	49	148	155	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					380	U189		10.1038/ncb2038	http://dx.doi.org/10.1038/ncb2038			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228809				2022-12-27	WOS:000276194600011
J	Hiratsuka, S; Watanabe, A; Sakurai, Y; Akashi-Takamura, S; Ishibashi, S; Miyake, K; Shibuya, M; Akira, S; Aburatani, H; Maru, Y				Hiratsuka, Sachie; Watanabe, Akira; Sakurai, Yoshiko; Akashi-Takamura, Sachiko; Ishibashi, Sachie; Miyake, Kensuke; Shibuya, Masabumi; Akira, Shizuo; Aburatani, Hiroyuki; Maru, Yoshiro			The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase	NATURE CELL BIOLOGY			English	Article							TOLL-LIKE RECEPTORS; CELL ACTIVATION; LUNG; A3; LIPOPOLYSACCHARIDE; INFLAMMATION; INDUCTION; SECRETION; MOLECULE; AFFINITY	A large number of macrophages and haematopoietic progenitor cells accumulate in pre-metastatic lungs(1,2) in which chemoattractants, such as S100A8 and S100A9, are produced by distant primary tumours serving as metastatic soil(3). The exact mechanism by which these chemoattractants elicit cell accumulation is not known. Here, we show that serum amyloid A (SAA) 3, which is induced in pre-metastatic lungs by S100A8 and S100A9, has a role in the accumulation of myeloid cells and acts as a positive-feedback regulator for chemoattractant secretion. We also show that in lung endothelial cells and macrophages, Toll-like receptor (TLR) 4 acts as a functional receptor for SAA3 in the pre-metastatic phase. In our study, SAA3 stimulated NF-kappa B signalling in a TLR4-dependent manner and facilitated metastasis. This inflammation-like state accelerated the migration of primary tumour cells to lung tissues, but this was suppressed by the inhibition of either TLR4 or SAA3. Thus, blocking SAA3-TLR4 function in the pre-metastatic phase could prove to be an effective strategy for the prevention of pulmonary metastasis.	[Hiratsuka, Sachie; Sakurai, Yoshiko; Ishibashi, Sachie; Maru, Yoshiro] Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan; [Watanabe, Akira; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Infect Genet,Minato Ku, Tokyo 1088639, Japan; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka 5651871, Japan	Tokyo Women's Medical University; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp	Eckhardt, Erik/G-1567-2010; Akira, Shizuo/C-3134-2009		Ministry of Education, Culture, Sports, Science and Technology [12147210, 16101006]; NIBIO program; New Energy and Industrial Technology Development Organization; Uehara foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIBIO program(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Uehara foundation(Uehara Memorial Foundation)	We thank P. E. Scherer for providing the anti-mouse SAA3 antibody and pGEX-SAA3 vector, and T. Noda for preparation of the VEGFR1TK<SUP>-/-</SUP> mouse. We are grateful to B. Panda for checking the manuscript and also O. N. Witte for critical reading of manuscript and providing comments. This study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, 12147210 (Y.M.) and 16101006 (H. A.) the NIBIO program and NFAT project of New Energy and Industrial Technology Development Organization (H. A.) and Uehara foundation (S. H.)	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; MEEK RL, 1989, P NATL ACAD SCI USA, V86, P1890, DOI 10.1073/pnas.86.6.1890; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; PAGET S, 1989, CANCER METAST REV, V8, P98; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; VERGHESE MW, 1982, J IMMUNOL, V128, P608; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang H, 2001, AMYLOID, V8, P250, DOI 10.3109/13506120108993821	30	485	500	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1349	U229		10.1038/ncb1794	http://dx.doi.org/10.1038/ncb1794			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18820689				2022-12-27	WOS:000260586700018
J	Niwa, S; Tanaka, Y; Hirokawa, N				Niwa, Shinsuke; Tanaka, Yosuke; Hirokawa, Nobutaka			KIF1B beta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD	NATURE CELL BIOLOGY			English	Article							GDP/GTP EXCHANGE PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; SYNAPTIC VESICLE; PLASMA-MEMBRANE; DEATH DOMAIN; MYOSIN-VA; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; KINESIN MOTOR; C-ELEGANS	Synaptic proteins are synthesized in the cell body and transported down the axon by microtubule-dependent motors. We previously reported that KIF1B beta and KIF1A motors are essential for transporting synaptic vesicle precursors; however the mechanisms that regulate transport, as well as cargo recognition and control of cargo loading and unloading remain largely unknown. Here, we show that DENN/MADD (Rab3-GEP) is an essential part of the regulation mechanism through direct interaction with the stalk domain of KIF1B beta and KIF1A. We also show that DENN/MADD binds preferentially to GTP-Rab3 and acts as a Rab3 effector. These molecular interactions are fundamental as sequential genetic perturbations revealed that KIF1B beta and KIF1A are essential for the transport of DENN/MADD and Rab3, whereas DENN/ MADD is essential for the transport of Rab3. GTP-Rab3 was more effectively transported than GDP-Rab3, suggesting that the nucleotide state of Rab3 regulates axonal transport of Rab3-carrying vesicles through preferential interaction with DENN/ MADD.	[Niwa, Shinsuke; Tanaka, Yosuke; Hirokawa, Nobutaka] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp		NIWA, SHINSUKE/0000-0002-8367-9228; Tanaka, Yosuke/0000-0001-5376-5726	Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank H. Fukuda, H. Sato, T. Aizawa and others from the Hirokawa laboratory for discussions and technical assistance. We are also grateful to the Kazusa DNA Institute (Chiba, Japan) for providing KIAA clones. This study was supported by a Grant-in-Aid for Specially Promoted Research to N. H. and Global COE programme to University of Tokyo from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; FISCHER V, 1991, NATURE, V349, P79; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Iwasaki K, 2000, EMBO J, V19, P4806, DOI 10.1093/emboj/19.17.4806; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kommers GD, 2002, VET PATHOL, V39, P353, DOI 10.1354/vp.39-3-353; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; LI JY, 1995, EUR J CELL BIOL, V67, P297; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NGSEE JK, 1993, MOL BIOL CELL, V7, P747; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Roa M, 1997, J IMMUNOL, V159, P2815; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; STETTLER O, 1994, NEUROSCIENCE, V62, P587, DOI 10.1016/0306-4522(94)90391-3; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	50	129	135	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1269	U52		10.1038/ncb1785	http://dx.doi.org/10.1038/ncb1785			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849981				2022-12-27	WOS:000260586700009
J	Lu, KF; Yin, XS; Weng, TJ; Xi, SL; Li, L; Xing, GC; Cheng, X; Yang, X; Zhang, LQ; He, FC				Lu, Kefeng; Yin, Xiushan; Weng, Tujun; Xi, Shenli; Li, Li; Xing, Guichun; Cheng, Xuan; Yang, Xiao; Zhang, Lingqiang; He, Fuchu			Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1	NATURE CELL BIOLOGY			English	Article							CONTAINING PROTEIN CKIP-1; FUNCTIONAL DIVERSITY; BONE HOMEOSTASIS; NEDD4 FAMILY; DEGRADATION; OSTEOBLAST; POLARITY; RHOA	E3 ubiquitin ligases are final effectors of the enzyme cascade controlling ubiquitylation(1). A central issue in understanding their regulation is to decipher mechanisms of their assembly and activity(2). In contrast with RING-type E3s, fewer mechanisms are known for regulation of HECT-type E3s(2-4). Smad ubiquitylation regulatory factor 1 (Smurf1), a C2-WW-HECT-domain E3, is crucial for bone homeostasis, in which it suppresses osteoblast activity(5,6). However, whether and how its activity is regulated remains unclear. Here we show that Smurf1, but not Smurf2, interacts with casein kinase-2 interacting protein-1 (CKIP-1), resulting in an increase in its E3 ligase activity. Surprisingly, CKIP-1 targets specifically the linker region between the WW domains of Smurf1, thereby augmenting its affinity for and promoting ubiquitylation of the substrate. Moreover, CKIP-1-deficient mice undergo an age-dependent increase in bone mass as a result of accelerated osteogenesis and decreased Smurf1 activity. These findings provide evidence that the WW domains linker is important in complex assembly and in regulating activity of HECT-type E3s and that CKIP-1 functions as the first auxiliary factor to enhance the activation of Smurf1.	[Lu, Kefeng; Yin, Xiushan; Xi, Shenli; Li, Li; Xing, Guichun; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Weng, Tujun; Cheng, Xuan; Yang, Xiao] Beijing Inst Biotechnol, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Academy of Military Medical Sciences - China; Fudan University	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Prote Res Ctr, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn	sitong, bao/GXH-5258-2022; yin, xiushan/G-9679-2016; XIAO, YANG/GPW-5529-2022	Yang, Xiao/0000-0002-0298-9831; Lu, Kefeng/0000-0001-8200-9380; Li, Li/0000-0003-2342-3658; Zhang, Lingqiang/0000-0002-9795-2141				Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	30	140	151	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					994	1002		10.1038/ncb1760	http://dx.doi.org/10.1038/ncb1760			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641638				2022-12-27	WOS:000258147100018
J	Johansson, CB; Youssef, S; Koleckar, K; Holbrook, C; Doyonnas, R; Corbel, SY; Steinman, L; Rossi, FMV; Blau, HM				Johansson, Clas B.; Youssef, Sawsan; Koleckar, Kassie; Holbrook, Colin; Doyonnas, Regis; Corbel, Stephane Y.; Steinman, Lawrence; Rossi, Fabio M. V.; Blau, Helen M.			Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation	NATURE CELL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BLOOD-BRAIN-BARRIER; BONE-MARROW; SKELETAL-MUSCLE; STEM-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MYELOMONOCYTIC PRECURSORS; MULTIPLE-SCLEROSIS; REGENERATION	Transplanted bone marrow-derived cells (BMDCs) have been reported to fuse with cells of diverse tissues(1-13), but the extremely low frequency of fusion has led to the view that such events are biologically insignificant. Nonetheless, in mice with a lethal recessive liver disease ( tyrosinaemia), transplantation of wildtype BMDCs restored liver function by cell fusion and prevented death(3,9), indicating that cell fusion can have beneficial effects. Here we report that chronic inflammation resulting from severe dermatitis or autoimmune encephalitis leads to robust fusion of BMDCs with Purkinje neurons and formation of hundreds of binucleate heterokaryons per cerebellum, a 10-100- fold higher frequency than previously reported(8,10,11,14). Single haematopoietic stem-cell transplants showed that the fusogenic cell is from the haematopoietic lineage and parabiosis experiments revealed that fusion can occur without irradiation. Transplantation of rat bone marrow into mice led to activation of dormant rat Purkinje neuron-specific genes in BMDC nuclei after fusion with mouse Purkinje neurons, consistent with nuclear reprogramming. The precise neurological role of these heterokaryons awaits elucidation, but their frequency in brain after inflammation is clearly much higher than previously appreciated.	[Youssef, Sawsan; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Corbel, Stephane Y.; Rossi, Fabio M. V.] UBC, Biomed Res Ctr, Vancouver, BC V6T 1C7, Canada; [Johansson, Clas B.; Koleckar, Kassie; Doyonnas, Regis; Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University; University of British Columbia; Stanford University	Johansson, CB (corresponding author), Karolinska Inst, CMM, SE-17176 Stockholm, Sweden.	clas.johansson@ki.se; hblau2@stanford.edu	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620; Doyonnas, Regis/0000-0002-3818-0807; Steinman, Lawrence/0000-0002-2437-2250	NIA NIH HHS [R37 AG009521, R01 AG009521, AG024987, AG020961, R01 AG024987, AG009521, R01 AG020961] Funding Source: Medline; NICHD NIH HHS [R01 HD018179, HD018179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG024987, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Fendrick SE, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-9; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hall KU, 1999, J BIOL CHEM, V274, P3485, DOI 10.1074/jbc.274.6.3485; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ikarashi K, 2005, KIDNEY INT, V67, P1925, DOI 10.1111/j.1523-1755.2005.00291.x; ILDSTAD ST, 1991, J EXP MED, V174, P467, DOI 10.1084/jem.174.2.467; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pachter JS, 2003, J NEUROPATH EXP NEUR, V62, P593, DOI 10.1093/jnen/62.6.593; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Sacco T, 2006, MOL CELL NEUROSCI, V33, P170, DOI 10.1016/j.mcn.2006.07.006; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; Vassilopoulos G, 2003, NATURE; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yuan H, 2006, INT J RADIAT ONCOL, V66, P860, DOI 10.1016/j.ijrobp.2006.06.043	40	171	179	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					575	583		10.1038/ncb1720	http://dx.doi.org/10.1038/ncb1720			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425116	Green Accepted			2022-12-27	WOS:000255502400014
J	Libert, S; Cohen, D; Guarente, L				Libert, Sergiy; Cohen, Dena; Guarente, Leonard			Neurogenesis directed by Sirt1	NATURE CELL BIOLOGY			English	Editorial Material							RESTRICTION; ACTIVATION; DISEASE	differentiation of neuronal stem cells into astrocytes or neurons is important in maintaining brain function. Oxidative stress and inflammation are now shown to bias differentiation toward astrocytes by modulating activity of the anti-ageing gene Sirt1. These findings link a longevity gene to the activity of neuronal stem cells and their response to stress.	[Libert, Sergiy; Cohen, Dena; Guarente, Leonard] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Libert, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	Libert, Sergiy/D-8136-2016	Libert, Sergiy/0000-0003-2497-5390	NIA NIH HHS [R01 AG015339-05, R01 AG015339, R01 AG015339-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015339] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; PROZOROVSKI, 2008, NATURE CELL BIOL, V10, P385; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200	9	32	34	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					373	374		10.1038/ncb0408-373	http://dx.doi.org/10.1038/ncb0408-373			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379594	Green Accepted			2022-12-27	WOS:000254561700002
J	Lagos, D; Pollara, G; Henderson, S; Gratrix, F; Fabani, M; Milne, RSB; Gotch, F; Boshoff, C				Lagos, Dimitrios; Pollara, Gabriel; Henderson, Stephen; Gratrix, Fiona; Fabani, Martin; Milne, Richard S. B.; Gotch, Frances; Boshoff, Chris			miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; KAPOSI-SARCOMA; TARGET RECOGNITION; INDUCED MICRORNA; HERPESVIRUS; CREB; CELLS; PHOSPHORYLATION; ACTIVATION; RESPONSES	MicroRNAs are small, non-coding RNAs that negatively regulate gene expression(1). It has been proposed that microRNAs could function in the regulation of innate immunity(2,3), but this has not been demonstrated for viral infection. Here we test this hypothesis using the human pathogenic virus Kaposi's sarcoma-associated herpesvirus (KSHV) and one of its putative natural cellular targets, primary lymphatic endothelial cells(4) (LECs). We show that an early antiviral microRNA response (6 h post-infection) includes expression of microRNAs that enhance viral gene expression. In particular, the CREB-induced miR-132 microRNA is highly upregulated after infection and has a negative effect on the expression of interferon-stimulated genes, facilitating viral replication. We show a similar function for miR-132 during infection of monocytes with herpes simplex virus-1 (HSV-1) and human cytomegalovirus (HCMV). miR-132 regulates innate antiviral immunity by inhibiting expression of the p300 transcriptional co-activator. p300 is downregulated early after KSHV infection, and inhibition of miR-132 induction restores p300 expression. Furthermore, p300 regulates miR-132 levels, revealing a dynamic equilibrium between miR-132 and p300. By targeting p300, rather than a transcription factor or signalling protein, miR-132 has a broad role in the regulation of antiviral immunity.	[Lagos, Dimitrios; Pollara, Gabriel; Henderson, Stephen; Gratrix, Fiona; Boshoff, Chris] UCL, UCL Canc Inst, Canc Res UK Viral Oncol Grp, London WC1E 6BT, England; [Fabani, Martin] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Milne, Richard S. B.] UCL, Royal Free Hosp, UCL Ctr Virol, London NW3 2PF, England; [Gotch, Frances] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England	Cancer Research UK; University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London	Lagos, D (corresponding author), UCL, UCL Canc Inst, Canc Res UK Viral Oncol Grp, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.	d.lagos@ucl.ac.uk; c.boshoff@ucl.ac.uk		Henderson, Stephen/0000-0002-9032-3828; Lagos, Dimitris/0000-0003-0637-281X	U.K. Medical Research Council; Cancer Research U.K; MRC [G0800168, MC_U105178803, G0501957] Funding Source: UKRI; Medical Research Council [G0800168, G0501957, MC_U105178803] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research U.K(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the U.K. Medical Research Council and Cancer Research U.K. We thank G. Wilkinson and R. Stanton for providing HCMV and C. Atkinson for help with HCMV qPCR. We are grateful to members of the Cancer Research UK Viral Oncology Group, in particular J. Funes and V. Emuss for advice and discussions.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fabani MM, 2008, RNA, V14, P336, DOI 10.1261/rna.844108; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	40	261	281	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					513	U232		10.1038/ncb2054	http://dx.doi.org/10.1038/ncb2054			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418869				2022-12-27	WOS:000277283700018
J	Zhang, WK; Wang, D; Duan, YY; Loy, MMT; Chan, HC; Huang, PB				Zhang, Wei Kevin; Wang, Dong; Duan, Yuanyuan; Loy, Michael M. T.; Chan, Hsiao Chang; Huang, Pingbo			Mechanosensitive gating of CFTR	NATURE CELL BIOLOGY			English	Article							REGULATORY VOLUME DECREASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; POTASSIUM CHANNELS; PRIMARY CULTURES; APICAL MEMBRANE; CATION CHANNEL; MOUSE NEPHRON; MODEL	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion and intracellular ligand-gated channel associated with cystic fibrosis, a lethal genetic disorder common among Caucasians(1). Here we show that CFTR is robustly activated by membrane stretch induced by negative pressures as small as 5 mmHg at the single-channel, cellular and tissue levels. Stretch increased the product of the number of channels present and probability of being open (NPo), and also increased the unitary conductance of CFTR in cell-attached membrane patches. CFTR stretch-mediated activation appears to be an intrinsic property independent of cytosolic factors and kinase signalling. CFTR stretch-mediated activation resulted in chloride transport in Calu-3 human airway epithelial cells and mouse intestinal tissues. Our study has revealed an unexpected function of CFTR in mechanosensing, in addition to its roles as a ligand-gated anion channel(1) and a regulator of other membrane transporters(2), demonstrating for the first time a mechanosensitive anion channel with a clearly defined molecular identity. Given that CFTR is often found in mechanically dynamic environments, its mechanosensitivity has important physiological implications in epithelial ion transport and cell volume regulation in vivo.	[Zhang, Wei Kevin; Loy, Michael M. T.; Huang, Pingbo] Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Wei Kevin; Wang, Dong; Duan, Yuanyuan; Huang, Pingbo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Loy, Michael M. T.] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med, Minist Educ China,Sch Biomed Sci,Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong; Ministry of Education, China	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Hong Kong, Hong Kong, Peoples R China.	bohuangp@ust.hk	Huang, Pingbo/I-1127-2019; Zhang, Wei/M-4241-2019; Chan, Hsiao Chang/E-1507-2016	Huang, Pingbo/0000-0002-4560-8760; Zhang, Wei/0000-0003-4960-6137; 	Hong Kong Research Grants Council [GRF661009]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	We thank R. Madhavan for stimulating discussion, J.M. Stutts for critical reading of the manuscript and Changyan Xie for assistance in manuscript preparation. This work was supported by the Hong Kong Research Grants Council grant GRF661009 (to P.H.).	Azizi F, 1997, EXP LUNG RES, V23, P257, DOI 10.3109/01902149709087371; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Barriere H, 2003, AM J PHYSIOL-RENAL, V284, pF796, DOI 10.1152/ajprenal.00237.2002; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; CHANG WH, 1992, J EXP BIOL, V169, P87; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1996, AM J PHYSIOL, V270, P259; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fischer H, 1998, PFLUG ARCH EUR J PHY, V436, P175, DOI 10.1007/s004240050620; FISCHER H, 1994, J GEN PHYSIOL, V104, P541, DOI 10.1085/jgp.104.3.541; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; HALE T, 2004, EXERCISE PHYSL THEMA; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; HAWS C, 1992, AM J PHYSIOL, V263, P692; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; KONDO M, 1992, AM J PHYSIOL, V262, P176; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; Muhm JM, 2007, NEW ENGL J MED, V357, P18, DOI 10.1056/NEJMoa062770; Sardini A, 2003, BBA-BIOMEMBRANES, V1618, P153, DOI 10.1016/j.bbamem.2003.10.008; Schultz B. D., 1999, Physiological Reviews, V79, pS109; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; Valverde MA, 2000, CELL PHYSIOL BIOCHEM, V10, P321, DOI 10.1159/000016365; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Yao XQ, 2001, BBA-BIOMEMBRANES, V1511, P381, DOI 10.1016/S0005-2736(01)00300-5	40	57	59	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					507	U214		10.1038/ncb2053	http://dx.doi.org/10.1038/ncb2053			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20400957				2022-12-27	WOS:000277283700017
J	De Smet, I; Voss, U; Jurgens, G; Beeckman, T				De Smet, Ive; Voss, Ute; Juergens, Gerd; Beeckman, Tom			Receptor-like kinases shape the plant	NATURE CELL BIOLOGY			English	Review							ASYMMETRIC CELL-DIVISION; SIGNAL-TRANSDUCTION; SERINE-PROTEASE; ROOT-MERISTEM; SECRETORY PEPTIDE; EPIDERMAL SURFACE; ORGAN DEVELOPMENT; CLE PEPTIDES; ARABIDOPSIS; PATTERN	To generate the various tissues and organs that build up the adult body, plants and animals require organized formative cell divisions and correct cell specification. In plants, these processes are controlled mainly by phytohormones and transcriptional networks. Recently, ligand-receptor-like kinase signalling pathways have been revealed as additional potentially crucial regulators of cell specification in plants. We review here the importance of such signalling cascades for plant growth and development, and we discuss, where possible, similarities to well-investigated cascades in animals.	[De Smet, Ive; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [De Smet, Ive; Juergens, Gerd] Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany; [Voss, Ute] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Flanders Institute for Biotechnology (VIB); Ghent University	De Smet, I (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	ive.desmet@tuebingen.mpg.de	Beeckman, Tom/ABA-1164-2020; Voss, Ute/X-3755-2019; De Smet, Ive/A-6583-2011; De Smet, Ive/E-6086-2011; Beeckman, Tom/ABI-1703-2020	Voss, Ute/0000-0003-2124-9334; De Smet, Ive/0000-0003-4607-8893; De Smet, Ive/0000-0003-4607-8893; Beeckman, Tom/0000-0001-8656-2060	European Molecular Biology organization [EMBO-ALTF 108-2006]; Marie Curie Intra-European Fellowship scheme [FP6 MEIF-CT-2007-041375]; Deutsche Forschungsgemeinschaft [Ju 179/12-1, AFGN 179/15-1]; Interuniversity Poles of Attraction Program -Belgian Science Policy	European Molecular Biology organization(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship scheme(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interuniversity Poles of Attraction Program -Belgian Science Policy	We thank G. V. Isterdael for assistance in producing the figures and S. Lau, A. Renault, A. Maier and two anonymous referees for critical comments. We wish to apologize to those whose contributions we could not include because of space limitations. This work was supported by the European Molecular Biology organization (postdoctoral fellowship EMBO-ALTF 108-2006 to I. D. S.), Marie Curie Intra-European Fellowship scheme (postdoctoral fellowship FP6 MEIF-CT-2007-041375 to I. D. S.), the Deutsche Forschungsgemeinschaft (Ju 179/12-1 and AFGN 179/15-1 to G. J.), and by grants from the Interuniversity Poles of Attraction Program -Belgian Science Policy (Barn contract) to T. B.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; BELKHADIR Y, 2006, SCI STKE, pCM4; Berger D, 2000, GENE DEV, V14, P1119; Berger F, 1998, CURR BIOL, V8, P421, DOI 10.1016/S0960-9822(98)70176-9; Bhalerao RP, 2003, NAT CELL BIOL, V5, P939, DOI 10.1038/ncb1103-939; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Cartwright HN, 2009, SCIENCE, V323, P649, DOI 10.1126/science.1161686; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Casson S, 2008, NEW PHYTOL, V178, P9, DOI 10.1111/j.1469-8137.2007.02351.x; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2007, CURR OPIN GENET DEV, V17, P337, DOI 10.1016/j.gde.2007.04.012; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; DOLAN L, 1995, PHILOS T R SOC B, V350, P95, DOI 10.1098/rstb.1995.0143; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fiers M, 2004, GENE, V327, P37, DOI 10.1016/j.gene.2003.11.014; Fiers M, 2007, CURR OPIN PLANT BIOL, V10, P39, DOI 10.1016/j.pbi.2006.11.003; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Gifford ML, 2005, PLANT CELL, V17, P1154, DOI 10.1105/tpc.104.029975; Gregan J, 2007, NAT PROTOC, V2, P2996, DOI 10.1038/nprot.2007.447; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Jia GX, 2008, P NATL ACAD SCI USA, V105, P2220, DOI 10.1073/pnas.0708795105; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mitchum MG, 2008, CURR OPIN PLANT BIOL, V11, P75, DOI 10.1016/j.pbi.2007.10.010; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nodine MD, 2008, DEV BIOL, V314, P161, DOI 10.1016/j.ydbio.2007.11.021; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Scheres B, 2007, NAT REV MOL CELL BIO, V8, P345, DOI 10.1038/nrm2164; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Smith JC, 2008, PHILOS T R SOC B, V363, P1387, DOI 10.1098/rstb.2007.2256; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Stahl Y, 2009, CURR BIOL, V19, P909, DOI 10.1016/j.cub.2009.03.060; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Stokes KD, 2008, ARCH BIOCHEM BIOPHYS, V477, P219, DOI 10.1016/j.abb.2008.05.010; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Tanaka H, 2001, DEVELOPMENT, V128, P4681; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Tsuwamoto R, 2008, PLANT J, V54, P30, DOI 10.1111/j.1365-313X.2007.03395.x; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Watanabe M, 2004, PLANT J, V39, P298, DOI 10.1111/j.1365-313X.2004.02132.x; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Yadav RK, 2008, DEV BIOL, V323, P261, DOI 10.1016/j.ydbio.2008.08.010; Yang SL, 2005, PLANT PHYSIOL, V139, P186, DOI 10.1104/pp.105.063529; Yang SL, 2003, PLANT CELL, V15, P2792, DOI 10.1105/tpc.016618; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhao XA, 2008, PLANT J, V54, P375, DOI 10.1111/j.1365-313X.2008.03426.x	104	199	203	2	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1166	1173		10.1038/ncb1009-1166	http://dx.doi.org/10.1038/ncb1009-1166			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19794500				2022-12-27	WOS:000270382000002
J	Rajan, A; Tien, AC; Haueter, CM; Schulze, KL; Bellen, HJ				Rajan, Akhila; Tien, An-Chi; Haueter, Claire M.; Schulze, Karen L.; Bellen, Hugo J.			The Arp2/3 complex and WASp are required for apical trafficking of Delta into microvilli during cell fate specification of sensory organ precursors	NATURE CELL BIOLOGY			English	Article							ALDRICH-SYNDROME PROTEIN; DROSOPHILA-MELANOGASTER; ENDOCYTIC PATHWAY; NOTCH ACTIVATION; FOLLICLE CELLS; NUMB PROTEIN; ACTIN; DIVISION; LINEAGE; GENE	Cell fate decisions mediated by the Notch signalling pathway require direct cell-cell contact between adjacent cells. In Drosophila melanogaster, an external sensory organ (ESO) develops from a single sensory organ precursor (SOP) and its fate specification is governed by differential Notch activation. Here we show that mutations in actin-related protein-3 (Arp3) compromise Notch signalling, leading to a fate transformation of the ESO. Our data reveal that during ESO fate specification, most endocytosed vesicles containing the ligand Delta traffic to a prominent apical actin-rich structure (ARS) formed in the SOP daughter cells. Using immunohistochemistry and transmission electron microscopy (TEM) analyses, we show that the ARS contains numerous microvilli on the apical surface of SOP progeny. In Arp2/3 and WASp mutants, the surface area of the ARS is substantially reduced and there are significantly fewer microvilli. More importantly, trafficking of Delta-positive vesicles from the basal area to the apical portion of the ARS is severely compromised. Our data indicate that WASp-dependent Arp2/3 actin polymerization is crucial for apical presentation of Delta, providing a mechanistic link between actin polymerization and Notch signalling.	[Rajan, Akhila; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tien, An-Chi; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Haueter, Claire M.; Schulze, Karen L.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064-21S1, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Dollar G, 2002, DEVELOPMENT, V129, P517; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HEINTZELMAN MB, 1992, CURR TOP DEV BIOL, V26, P93, DOI 10.1016/S0070-2153(08)60442-1; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Imai K, 2003, CURR OPIN ALLERGY CL, V3, P427, DOI 10.1097/01.all.0000104452.09202.9c; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Manning L, 1999, DEVELOPMENT, V126, P2063; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Parks AL, 2000, DEVELOPMENT, V127, P1373; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tal T, 2002, DEV BIOL, V243, P260, DOI 10.1006/dbio.2002.0571; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yip MLR, 1997, DEVELOPMENT, V124, P2129; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	75	78	78	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					815	U82		10.1038/ncb1888	http://dx.doi.org/10.1038/ncb1888			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543274	Green Accepted			2022-12-27	WOS:000267603100009
J	Wang, SQ; Tsarouhas, V; Xylourgidis, N; Sabri, N; Tiklova, K; Nautiyal, N; Gallio, M; Samakovlis, C				Wang, Shenqiu; Tsarouhas, Vasilios; Xylourgidis, Nikos; Sabri, Nafiseh; Tiklova, Katarina; Nautiyal, Naumi; Gallio, Marco; Samakovlis, Christos			The tyrosine kinase Stitcher activates Grainy head and epidermal wound healing in Drosophila	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; CELL-MIGRATION; GROWTH; TISSUE; BINDING; REPAIR; GFP; TRANSFORMATION; MORPHOGENESIS; PROTEINS	Epidermal injury initiates a cascade of inflammation, epithelial remodelling and integument repair at wound sites. The regeneration of the extracellular barrier and damaged tissue repair rely on the precise orchestration of epithelial responses triggered by the injury(1,2). Grainy head (Grh) transcription factors induce gene expression to crosslink the extracellular barrier in wounded flies and mice(3,4). However, the activation mechanisms and functions of Grh factors in re-epithelialization remain unknown. Here we identify stitcher (stit), a new Grh target in Drosophila melanogaster. stit encodes a Ret-family receptor tyrosine kinase required for efficient epidermal wound healing. Live imaging analysis reveals that Stit promotes actin cable assembly during wound re-epithelialization. Stit activation also induces extracellular signal-regulated kinase (ERK) phosphorylation along with the Grh-dependent expression of stit and barrier repair genes at the wound sites. The transcriptional stimulation of stit on injury triggers a positive feedback loop increasing the magnitude of epithelial responses. Thus, Stit activation upon wounding coordinates cytoskeletal rearrangements and the level of Grh-mediated transcriptional wound responses.	[Wang, Shenqiu; Tsarouhas, Vasilios; Xylourgidis, Nikos; Sabri, Nafiseh; Tiklova, Katarina; Nautiyal, Naumi; Gallio, Marco; Samakovlis, Christos] Stockholm Univ, Wenner Gren Inst, Dept Dev Biol, S-10691 Stockholm, Sweden	Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Dev Biol, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Tsarouhas, Vasilios/AAG-8226-2020	Tsarouhas, Vasilios/0000-0002-2933-1351; Gallio, Marco/0000-0003-2132-0639				Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Gabay L, 1997, DEVELOPMENT, V124, P3535; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harden N, 2005, SCIENCE, V308, P364, DOI 10.1126/science.1112050; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Ostrowski S, 2002, GENETICS, V161, P171; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; WENCZAK BA, 1992, J CLIN INVEST, V90, P2392, DOI 10.1172/JCI116130; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	43	55	55	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					890	U282		10.1038/ncb1898	http://dx.doi.org/10.1038/ncb1898			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525935				2022-12-27	WOS:000267603100019
J	Fichelson, P; Moch, C; Ivanovitch, K; Martin, C; Sidor, CM; Lepesant, JA; Bellaiche, Y; Huynh, JR				Fichelson, Pierre; Moch, Clara; Ivanovitch, Kenzo; Martin, Charlotte; Sidor, Clara M.; Lepesant, Jean-Antoine; Bellaiche, Yohanns; Huynh, Jean-Rene			Live-imaging of single stem cells within their niche reveals that a U3snoRNP component segregates asymmetrically and is required for self-renewal in Drosophila	NATURE CELL BIOLOGY			English	Article							OOCYTE SPECIFICATION; GERMLINE CYST; GENE; OVARY; DIVISION; TRANSCRIPTION; PROTEIN; PROLIFERATION; MELANOGASTER; MECHANISMS	Stem cells generate self-renewing and differentiating progeny over many rounds of asymmetric divisions. How stem cell growth rate and size are maintained over time remains unknown. We isolated mutations in a Drosophila melanogaster gene, wicked (wcd), which induce premature differentiation of germline stem cells (GSCs). Wcd is a member of the U3 snoRNP complex required for pre-ribosomal RNA maturation. This general function of Wcd contrasts with its specific requirement for GSC self-renewal. However, live imaging of GSCs within their niche revealed a pool of Wcd-forming particles that segregate asymmetrically into the GSCs on mitosis, independently of the Dpp signal sent by the niche. A fraction of Wcd also segregated asymmetrically in dividing larval neural stem cells (NSCs). In the absence of Wcd, NSCs became smaller and produced fewer neurons. Our results show that regulation of ribosome synthesis is a crucial parameter for stem cell maintenance and function.	[Fichelson, Pierre; Moch, Clara; Ivanovitch, Kenzo; Sidor, Clara M.; Lepesant, Jean-Antoine; Huynh, Jean-Rene] Univ Paris 07, CNRS, Inst Jacques Monod, F-75251 Paris 05, France; [Fichelson, Pierre; Ivanovitch, Kenzo; Sidor, Clara M.; Lepesant, Jean-Antoine] Univ Paris 06, CNRS, Inst Jacques Monod, F-75251 Paris 05, France; [Moch, Clara; Martin, Charlotte; Bellaiche, Yohanns; Huynh, Jean-Rene] Inst Curie, UMR 144, F-75248 Paris 05, France; [Fichelson, Pierre; Ivanovitch, Kenzo] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Fichelson, Pierre; Ivanovitch, Kenzo] UCL, Dept Anat & Dev Biol, Cell Biol Unit, London WC1E 6BT, England; [Sidor, Clara M.] London Res Inst, Canc Res UK, London WC2A 3PX, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of London; University College London; University of London; University College London; Cancer Research UK	Huynh, JR (corresponding author), Inst Curie, Dept Genet & Dev Biol, U934, UMR3215, 26 Rue Ulm, F-75248 Paris 05, France.	jean-rene.huynh@curie.fr	ivanovitch, kenzo/K-2343-2013; ivanovitch, kenzo/AAE-3214-2022	ivanovitch, kenzo/0000-0003-4706-7686; ivanovitch, kenzo/0000-0003-4706-7686; Sidor, Clara/0000-0002-2125-8858; Moch, Clara/0000-0002-8674-3440; HUYNH, Jean-Rene/0000-0002-4078-399X	Arthritis Research UK [3802] Funding Source: Medline; Medical Research Council Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bolivar J, 2006, DEV DYNAM, V235, P2969, DOI 10.1002/dvdy.20967; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gho M, 1999, DEVELOPMENT, V126, P3573; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Godfrey AC, 2006, RNA, V12, P396, DOI 10.1261/rna.2270406; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Hong A, 2003, DEVELOPMENT, V130, P1235, DOI 10.1242/dev.00352; Huynh J.-R., 2006, FUSOME CELL CELL COM; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; KAI T, 2005, DEV BIOL; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lanzotti DJ, 2004, MOL BIOL CELL, V15, P1112, DOI 10.1091/mbc.E03-09-0649; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; MaalOe O, 1966, CONTROL MACROMOLECUL; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NEUMULLER RA, 2008, NATURE; Page SL, 2000, GENETICS, V155, P1757; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	53	61	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					685	U11		10.1038/ncb1874	http://dx.doi.org/10.1038/ncb1874			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430468				2022-12-27	WOS:000266503700013
J	Chew, J; Biswas, S; Shreeram, S; Humaidi, M; Wong, ET; Dhillion, MK; Teo, H; Hazra, A; Fang, CC; Lopez-Collazo, E; Bulavin, DV; Tergaonkar, V				Chew, Joanne; Biswas, Subhra; Shreeram, Sathyavageeswaran; Humaidi, Mahathir; Wong, Ee Tsin; Dhillion, Manprit Kaur; Teo, Hsiangling; Hazra, Amit; Fang, Cheok Chit; Lopez-Collazo, Eduardo; Bulavin, Dmitry V.; Tergaonkar, Vinay			WIP1 phosphatase is a negative regulator of NF-kappa B signalling	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; P65 SUBUNIT; ACTIVATION; KINASE; PHOSPHORYLATION; PATHWAY; P38; IKK; P53; DEGRADATION	Post-translational modifications of NF-kappa B through phosphorylations enhance its transactivation potential. Much is known about the kinases that phosphorylate NF-kappa B, but little is known about the phosphatases that dephosphorylate it. By using a genome-scale siRNA screen, we identified the WIP1 phosphatase as a negative regulator of NF-kappa B signalling. WIP1-mediated regulation of NF-kappa B occurs in both a p38-dependent and independent manner. Overexpression of WIP1 resulted in decreased NF-kappa B activation in a dose-dependent manner, whereas WIP1 knockdown resulted in increased NF-kappa B function. We show that WIP1 is a direct phosphatase of Ser 536 of the p65 subunit of NF-kappa B. Phosphorylation of Ser 536 is known to be essential for the transactivation function of p65, as it is required for recruitment of the transcriptional co-activator p300. WIP1-mediated regulation of p65 regulated binding of NF-kappa B to p300 and hence chromatin remodelling. Consistent with our results, mice lacking WIP1 showed enhanced inflammation. These results provide the first genetic proof that a phosphatase directly regulates NF-kappa B signalling in vivo.	[Chew, Joanne; Humaidi, Mahathir; Wong, Ee Tsin; Teo, Hsiangling; Hazra, Amit; Tergaonkar, Vinay] Inst Mol & Cell Biol, Lab NF B signalling, Singapore 138673, Singapore; [Shreeram, Sathyavageeswaran; Bulavin, Dmitry V.] Inst Mol & Cell Biol, Cell Cycle Control & Tumorigenesis Grp, Singapore 138673, Singapore; [Fang, Cheok Chit] Inst Mol & Cell Biol, Lab Cell Cycle Control, Singapore 138673, Singapore; [Biswas, Subhra; Dhillion, Manprit Kaur] ASTAR, Biomed Sci Inst, Singapore Immunol Network, Singapore 138648, Singapore; [Tergaonkar, Vinay] Hosp Univ La Paz, Unidad Invest, Madrid 28046, Spain; [Tergaonkar, Vinay] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Hospital Universitario La Paz; National University of Singapore	Tergaonkar, V (corresponding author), Inst Mol & Cell Biol, Lab NF B signalling, 61 Biopolis Dr, Singapore 138673, Singapore.	vinayt@imcb.a-star.edu.sg	; Lopez-Collazo, Eduardo/U-6634-2018	Sathyavageeswaran, Shreeram/0000-0002-6111-1818; Teo, Hsiang Ling/0000-0002-3849-809X; Lopez-Collazo, Eduardo/0000-0003-1957-877X				Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Schito ML, 2006, J IMMUNOL, V176, P4818, DOI 10.4049/jimmunol.176.8.4818; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; SINGH S, 1995, J BIOL CHEM, V270, P10631, DOI 10.1074/jbc.270.18.10631; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	40	130	140	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					659	U493		10.1038/ncb1873	http://dx.doi.org/10.1038/ncb1873			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377466				2022-12-27	WOS:000265640000026
J	Shakya, A; Cooksey, R; Cox, JE; Wang, V; McClain, DA; Tantin, D				Shakya, Arvind; Cooksey, Robert; Cox, James E.; Wang, Victoria; McClain, Donald A.; Tantin, Dean			Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity	NATURE CELL BIOLOGY			English	Article							HISTONE H2B; POU DOMAIN; TRANSCRIPTION; IMMUNOGLOBULIN; PROMOTER; CANCER; BINDING; ENHANCER; ACTIVATION; EXPRESSION	Cancer cells frequently undergo a shift from oxidative to glycolytic metabolism(1). Although there is interest in targeting metabolism as a form of cancer therapy, this area still remains in its infancy. Using cells, embryos and adult animals, we show here that loss of the widely expressed transcription factor Oct1 induces a coordinated metabolic shift: mitochondrial activity and amino acid oxidation are increased, while glucose metabolism is reduced. Altered expression of direct Oct1 targets encoding metabolic regulators provides a mechanistic underpinning to these results. We show that these metabolic changes directly oppose tumorigenicity. Collectively, our findings show that Oct1, the genes it regulates and the pathways these genes affect could be used as targets for new modes of cancer therapy.	[Shakya, Arvind; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Cooksey, Robert; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA; [Cox, James E.] Univ Utah, Sch Med, Hlth Sci Ctr, Core Res Facil, Salt Lake City, UT 84112 USA; [Wang, Victoria] Harvard Radiat Oncol Program, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School	Tantin, D (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	dean.tantin@path.utah.edu		McClain, Don/0000-0002-3310-2359; Shakya, Arvind/0000-0001-7993-6159	Centers of Excellence Grant in Molecular Haematology; National Institutes of Health; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043526] Funding Source: NIH RePORTER	Centers of Excellence Grant in Molecular Haematology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to J. Kaplan for helpful suggestions during the formative stages of this work. We thank D. Ayer and J. Rutter for critical reading of the manuscript. C. Cheng provided the H - RasV12 retroviral construct and T. Jacks provided p53 -/ - mice. We thank D. Abel and J. Soto for use of laboratory equipment and N. Chandler and the EM core facility for TEM. We thank P. Sharp and members of his laboratory for invaluable assistance. We also thank D. Stillman, J. Rutter, S. Lessnick and J. Shaw for helpful advice and reagents. This work was supported by a Centers of Excellence Grant in Molecular Haematology from the National Institutes of Health and a grant from the American Cancer Society to D. T.	Almeida R, 2005, J PATHOL, V207, P396, DOI 10.1002/path.1861; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Glahn F, 2008, ARCH TOXICOL, V82, P513, DOI 10.1007/s00204-008-0331-9; GUNDERSON SI, 1988, J BIOL CHEM, V263, P17603; Hafstad AD, 2006, AM J PHYSIOL-HEART C, V290, pH1763, DOI 10.1152/ajpheart.01063.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HICKS GG, 1991, MOL CELL BIOL, V11, P1344, DOI 10.1128/MCB.11.3.1344; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; Melgar S, 2007, AM J PHYSIOL-GASTR L, V292, pG165, DOI 10.1152/ajpgi.00152.2006; QIN XF, 1994, EMBO J, V13, P5967, DOI 10.1002/j.1460-2075.1994.tb06942.x; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SAKAI K, 1988, BIOCHIM BIOPHYS ACTA, V952, P297, DOI 10.1016/0167-4838(88)90130-6; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; Stryer L., 2006, BIOCHEMISTRY; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	36	77	79	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					320	U204		10.1038/ncb1840	http://dx.doi.org/10.1038/ncb1840			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219035				2022-12-27	WOS:000263777900016
J	Bakhoum, SF; Thompson, SL; Manning, AL; Compton, DA				Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.			Genome stability is ensured by temporal control of kinetochore-microtubule dynamics	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MAMMALIAN TISSUE-CELLS; AURORA-B; CHROMOSOME INSTABILITY; COLORECTAL CANCERS; MITOTIC CENTROMERE; CLONAL EVOLUTION; ERROR-CORRECTION; REGULATES MCAK; MITOSIS	Most solid tumours are aneuploid and many frequently mis-segregate chromosomes. This chromosomal instability is commonly caused by persistent mal-oriented attachment of chromosomes to spindle microtubules. Chromosome segregation requires stable microtubule attachment at kinetochores, yet those attachments must be sufficiently dynamic to permit correction of mal-orientations. How this balance is achieved is unknown, and the permissible boundaries of attachment stability versus dynamics essential for genome stability remain poorly understood. Here we show that two microtubule-depolymerizing kinesins, Kif2b and MCAK, stimulate kinetochore-microtubule dynamics during distinct phases of mitosis to correct mal-orientations. Few-fold reductions in kinetochore-microtubule turnover, particularly in early mitosis, induce severe chromosome segregation defects. In addition, we show that stimulation of microtubule dynamics at kinetochores restores stability to chromosomally unstable tumour cell lines, establishing a causal relationship between deregulation of kinetochore-microtubule dynamics and chromosomal instability. Thus, temporal control of microtubule attachment to chromosomes during mitosis is central to genome stability in human cells.	[Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Bakhoum, Samuel F.; Thompson, Sarah L.; Manning, Amity L.; Compton, Duane A.] Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Norris Cotton Cancer Center	Compton, DA (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	duane.a.compton@dartmouth.edu	Manning, Amity/AAC-8205-2019	Manning, Amity/0000-0003-1332-9086; Compton, Duane/0000-0002-4445-9118; Bakhoum, Samuel/0000-0002-4779-8422	National Institutes of Health [GM51542, GM008704]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051542, T32GM008704, R01GM051542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Linda Wordeman (University of Washington) for providing plasmids encoding GFP-tagged proteins, Tarun Kapoor for providing Hesperadin, and Kevin Sullivan for providing the CenpB-GFP U2OS cells. This work was supported by National Institutes of Health grants GM51542 to D. A. C. and GM008704 to S. L. T.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 1999, MUTAGENESIS, V14, P563, DOI 10.1093/mutage/14.6.563; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HOULSTON R, 2008, GUT, DOI DOI 10.1136/GUT.2007.135004; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RAJAGOPALAN H, 2001, NATURE, V409, P355; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	39	310	316	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					27	U51		10.1038/ncb1809	http://dx.doi.org/10.1038/ncb1809			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060894	Green Accepted			2022-12-27	WOS:000262157000008
J	Berger, SL				Berger, Shelley L.			Out of the jaws of death: PRMT5 steers p53	NATURE CELL BIOLOGY			English	Editorial Material							TRANSCRIPTION; PROTEIN; METHYLATION; ACETYLATION; ARGININE	The tumour suppressor p53 triggers either cell-cycle arrest or apoptosis. Now, arginine methylation joins a panoply of other post-translational modifications that regulate p53. PRMT5 mediates p53 methylation, which disposes the cell to arrest rather than death.	Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	The Wistar Institute	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St,Room 201, Philadelphia, PA 19104 USA.	berger@wistar.org		Berger, Shelley/0000-0001-5398-4400	NCI NIH HHS [R01 CA078831] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078831] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BURLEY SK, 1994, STRUCTURE, V2, P789, DOI 10.1016/S0969-2126(94)00079-4; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; HUANG J, 2008, CURR OPIN GENE DEV, V449, P105; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012	15	12	21	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1389	1390		10.1038/ncb1208-1389	http://dx.doi.org/10.1038/ncb1208-1389			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043433	Green Accepted			2022-12-27	WOS:000261261800008
J	Nilius, B; Voets, T				Nilius, Bernd; Voets, Thomas			A TRP channel-steroid marriage	NATURE CELL BIOLOGY			English	Editorial Material							PREGNENOLONE SULFATE; NEUROACTIVE STEROIDS; DEHYDROEPIANDROSTERONE; INHIBITION; MEMORY	A surprising functional association between TRPM3, a mysterious member of the family of transient receptor potential (TRP) cation channels, and the sulphated version of pregnenolone, 'mother' of all steroid hormones, has been identified.	[Nilius, Bernd; Voets, Thomas] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium	KU Leuven	Nilius, B (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, Campus Gasthuisberg,Herestr 49,Bus 802, B-3000 Louvain, Belgium.	bernd.nilius@med.kuleuven.be	Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821				Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bicikova M, 2002, STEROIDS, V67, P399, DOI 10.1016/S0039-128X(01)00196-9; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; DEPERETTI E, 1986, ACTA ENDOCRINOL-COP, V113, P259; Eisenman LN, 2003, J PHYSIOL-LONDON, V550, P679, DOI 10.1113/jphysiol.2003.043810; FLOOD JF, 1995, P NATL ACAD SCI USA, V92, P10806, DOI 10.1073/pnas.92.23.10806; Horak M, 2004, J NEUROSCI, V24, P10318, DOI 10.1523/JNEUROSCI.2099-04.2004; Kudo K, 2002, EUR J PHARMACOL, V456, P19, DOI 10.1016/S0014-2999(02)02623-7; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oberwinkler J., 2007, V179, P253; Shen WX, 2000, J NEUROSCI, V20, P3571, DOI 10.1523/JNEUROSCI.20-10-03571.2000; Tagawa N, 2000, CLIN CHEM, V46, P523; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vallee M, 2004, EXP GERONTOL, V39, P1695, DOI 10.1016/j.exger.2004.07.012; WAGNER, 2008, NATURE, V10, P1421	16	22	23	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1383	1384		10.1038/ncb1208-1383	http://dx.doi.org/10.1038/ncb1208-1383			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043430	Green Published			2022-12-27	WOS:000261261800005
J	Garinis, GA; van der Horst, GTJ; Vijg, J; Hoeijmakers, JHJ				Garinis, George A.; van der Horst, Gijsbertus T. J.; Vijg, Jan; Hoeijmakers, Jan H. J.			DNA damage and ageing: new-age ideas for an age-old problem	NATURE CELL BIOLOGY			English	Review							NUCLEOTIDE EXCISION-REPAIR; LIFE-SPAN; CALORIC RESTRICTION; GENOME MAINTENANCE; GENE-EXPRESSION; PRIMROSE PATH; MOUSE MODEL; GROWTH; MICE; MUTATIONS	Loss of genome maintenance may causally contribute to ageing, as exemplified by the premature appearance of multiple symptoms of ageing in a growing family of human syndromes and in mice with genetic defects in genome maintenance pathways. Recent evidence revealed a similarity between such prematurely ageing mutants and long-lived mice harbouring mutations in growth signalling pathways. At first sight this seems paradoxical as they represent both extremes of ageing yet show a similar 'survival' response that is capable of delaying age-related pathology and extending lifespan. Understanding the mechanistic basis of this response and its connection with genome maintenance would open exciting possibilities for counteracting cancer or age-related diseases, and for promoting longevity.	[Garinis, George A.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, NL-3000 CA Rotterdam, Netherlands; [Vijg, Jan] Buck Inst Aging Res, Novato, CA 94945 USA	Erasmus University Rotterdam; Erasmus MC; Buck Institute for Research on Aging	Garinis, GA (corresponding author), FORTH, Inst Mol Biol & Biotechnol, POB 1385, GR-71110 Iraklion, Crete, Greece.	j.hoeijmakers@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Garinis, George A./B-2943-2012; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Garinis, George A./0000-0002-3200-5004; 	Netherlands Organization for Scientific Research (NWO); Research Institute Diseases of the Elderly; SenterNovem IOP-Genomics [IGE03009]; NIH [1PO1 AG17242-02]; NIEHS [1UO1 ES011044]; EC [QRTL-1999-02002]; Dutch Cancer Society [EUR 99-2004]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute Diseases of the Elderly; SenterNovem IOP-Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EC(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Netherlands Organization for Scientific Research (NWO) through the foundation of the Research Institute Diseases of the Elderly, as well as grants from SenterNovem IOP-Genomics (IGE03009), NIH (1PO1 AG17242-02), NIEHS (1UO1 ES011044), EC (QRTL-1999-02002), and the Dutch Cancer Society (EUR 99-2004).	Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Andressoo JO, 2006, CANCER CELL, V10, P121, DOI 10.1016/j.ccr.2006.05.027; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bartke A, 1999, P SOC EXP BIOL MED, V222, P113, DOI 10.1046/j.1525-1373.1999.d01-121.x; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Beeharry N, 2005, CURR MOL MED, V5, P187, DOI 10.2174/1566524053586554; BOHR DWV, 2008, DNA REPAIR AGING; Bootsma D., 2001, METABOLIC MOL BASES, V1, P677; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; de Boer J, 1999, CANCER RES, V59, P3489; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Grillari J, 2007, NUCLEIC ACIDS RES, V35, P7566, DOI 10.1093/nar/gkm1065; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hasty P, 2004, AGING CELL, V3, P67, DOI 10.1111/j.1474-9728.2004.00087.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x; MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59; MCCAY CM, 1989, NUTRITION, V5, P155; Miller RA, 2004, AGING CELL, V3, P47, DOI 10.1111/j.1474-9728.2004.00081.x; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Sander M, 2005, TOXICOL APPL PHARM, V208, P1, DOI 10.1016/j.taap.2004.12.012; Schaerer OD, 2008, CHEMBIOCHEM, V9, P21, DOI 10.1002/cbic.200700619; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Yang HY, 2007, AGING CELL, V6, P35, DOI 10.1111/j.1474-9726.2006.00259.x; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	63	256	266	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1241	1247		10.1038/ncb1108-1241	http://dx.doi.org/10.1038/ncb1108-1241			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18978832	Green Accepted			2022-12-27	WOS:000260586700004
J	Carninci, P				Carninci, Piero			Non-coding RnA transcription: turning on neighbours	NATURE CELL BIOLOGY			English	Editorial Material							MAMMALIAN TRANSCRIPTOME; GENOME; IDENTIFICATION; ELEMENTS; MAPS	Even though less than 2% of the mammalian genome encodes proteins, a significant fraction can be transcribed into non-coding RNAs. An elegant study identifies a function for non-coding RNA transcription in activating neighbouring genes.	RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan	RIKEN	Carninci, P (corresponding author), RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Carninci, Piero/K-1568-2014	Carninci, Piero/0000-0001-7202-7243				Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707	11	26	28	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1023	1024		10.1038/ncb0908-1023	http://dx.doi.org/10.1038/ncb0908-1023			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	18758492				2022-12-27	WOS:000258910400007
J	Chernoff, YO				Chernoff, Yury O.			Prion: disease or relief?	NATURE CELL BIOLOGY			English	Editorial Material							GENETIC-VARIATION; EFFICIENCY	The self-perpetuating amyloid isoform, or prion, of the yeast translation termination factor eRF3 modulates programmed translational frameshifting that controls a regulatory circuit determining the polyamine levels in a yeast cell. But it is still unclear whether this effect is adaptive or pathological.	[Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Chernoff, Yury O.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Chernoff, YO (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu	Chernoff, Yury O/J-2833-2014	Chernoff, Yury/0000-0002-8934-9051				BALASUNDARAM D, 1994, P NATL ACAD SCI USA, V91, P172, DOI 10.1073/pnas.91.1.172; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Burck CL, 1999, RNA, V5, P1451, DOI 10.1017/S1355838299990490; Chernoff YO, 2001, MUTAT RES-REV MUTAT, V488, P39, DOI 10.1016/S1383-5742(00)00060-0; DINMAN JD, 1995, GENETICS, V141, P95; Inge-Vechtomov SG, 2007, PRION, V1, P228, DOI 10.4161/pri.1.4.5059; Kulikov V. N., 2001, Genetika, V37, P602; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708	15	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1019	1021		10.1038/ncb0908-1019	http://dx.doi.org/10.1038/ncb0908-1019			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	18758490				2022-12-27	WOS:000258910400005
J	Ji, P; Jayapal, SR; Lodish, HF				Ji, Peng; Jayapal, Senthil Raja; Lodish, Harvey F.			Enucleation of cultured mouse fetal erythroblasts requires Rac GTPases and mDia2	NATURE CELL BIOLOGY			English	Article							MATURATION; CELLS; ERYTHROPOIETIN; DIFFERENTIATION; MECHANISM; FORMINS; DESIGN; RED	Mammalian erythroid cells undergo enucleation, an asymmetric cell division involving extrusion of a pycnotic nucleus enveloped by the plasma membrane(1-3). The mechanisms that power and regulate the enucleation process have remained obscure. Here, we show that deregulation of Rac GTPase during a late stage of erythropoiesis completely blocks enucleation of cultured mouse fetal erythroblasts without affecting their proliferation or differentiation. Formation of the contractile actin ring (CAR) on the plasma membrane of enucleating erythroblasts was disrupted by inhibition of Rac GTPases. Furthermore, we demonstrate that mDia2, a downstream effector of Rho GTPases and a formin protein required for nucleation of unbranched actin filaments(4-6), is also required for enucleation of mouse fetal erythroblasts. We show that Rac1 and Rac2 bind to mDia2 in a GTP-dependent manner and that downregulation of mDia2, but not mDia1, by small interfering RNA ( siRNA) during the late stages of erythropoiesis blocked both CAR formation and erythroblast enucleation. Additionally, overexpression of a constitutively active mutant of mDia2 rescued the enucleation defects induced by the inhibition of Rac GTPases. These results reveal important roles for Rac GTPases and their effector mDia2 in enucleation of mammalian erythroblasts.	[Ji, Peng; Jayapal, Senthil Raja; Lodish, Harvey F.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lodish, HF (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, 9 Cambridge Ctr,Floor 6, Cambridge, MA 02142 USA.	lodish@wi.mit.edu		Jayapal, Senthil Raja/0000-0002-0670-7766	NHLBI NIH HHS [P01 HL 32262] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; KOURY MJ, 1988, J CELL PHYSIOL, V137, P65, DOI 10.1002/jcp.1041370108; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Repasky E A, 1981, Prog Clin Biol Res, V55, P679; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	26	150	151	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					314	U39		10.1038/ncb1693	http://dx.doi.org/10.1038/ncb1693			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264091				2022-12-27	WOS:000253778300013
J	Tooze, SA; Yoshimori, T				Tooze, Sharon A.; Yoshimori, Tamotsu			The origin of the autophagosomal membrane	NATURE CELL BIOLOGY			English	Article							FREEZE-FRACTURE; INDUCED AUTOPHAGOCYTOSIS; MOUSE-LIVER; GOLGI; PHAGOPHORE; STARVATION; LYSOSOMES; PROTEINS; VACUOLES; BECLIN-1	Macroautophagy is initiated by the formation of the phagophore (also called the isolation membrane). This membrane can both selectively and non-selectively engulf cytosolic components, grow and close around the sequestered components and then deliver them to a degradative organelle, the lysosome. Where this membrane comes from and how it grows is not well understood. Since the discovery of autophagy in the 1950s the source of the membrane has been investigated, debated and re-investigated, with the consensus view oscillating between a de novo assembly mechanism or formation from the membranes of the endoplasmic reticulum (ER) or the Golgi. In recent months, new information has emerged that both the ER and mitochondria may provide a membrane source, enlightening some older findings and revealing how complex the initiation of autophagy may be in mammalian cells.	[Tooze, Sharon A.] London Res Inst Canc Res UK, Secretory Pathways Lab, London WC2A 3PX, England; [Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Osaka 5650871, Japan	University of London; Institute of Cancer Research - UK; Osaka University	Tooze, SA (corresponding author), London Res Inst Canc Res UK, Secretory Pathways Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	sharon.tooze@cancer.org.uk	Yoshimori, Tamotsu/K-9626-2014	Yoshimori, Tamotsu/0000-0001-9787-3788; Tooze, Sharon/0000-0002-2182-3116	Cancer Research U.K.; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Takeda Science Foundation	Cancer Research U.K.(Cancer Research UK); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	S.A.T. would like to thank Cancer Research U.K. for funding. T.Y. was supported by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by the Takeda Science Foundation.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2010, FEBS LETT, V584, P1296, DOI 10.1016/j.febslet.2010.02.061; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HIRSIMAKI Y, 1982, EUR J CELL BIOL, V27, P298; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; MARI M, 2010, J CELL BIOL, DOI DOI 10.1080/JCB200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; NOVIKOFF PM, 1971, J CELL BIOL, V50, P859, DOI 10.1083/jcb.50.3.859; Orsi A, 2010, CURR OPIN CELL BIOL, V22, P150, DOI 10.1016/j.ceb.2009.11.013; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; PUNNONEN EL, 1989, CELL TISSUE RES, V258, P269; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reggiori F, 2009, DEV CELL, V17, P747, DOI 10.1016/j.devcel.2009.12.004; REUNANEN H, 1985, HISTOCHEMISTRY, V83, P513, DOI 10.1007/BF00492453; REZ G, 1980, LAB INVEST, V43, P269; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	36	412	431	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					831	835		10.1038/ncb0910-831	http://dx.doi.org/10.1038/ncb0910-831			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811355				2022-12-27	WOS:000281561900004
J	Cramer, LP				Cramer, Louise P.			Forming the cell rear first: breaking cell symmetry to trigger directed cell migration	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENT BUNDLES; FIBROBLAST POLARIZATION; MYOSIN IIB; RHO-KINASE; POLARITY; DYNAMICS; MOTILITY; PROTRUSION; LOCOMOTION; MECHANISM	Directed cell migration requires the breaking of cell symmetry to generate a cell front and a cell rear along an axis approximately aligned with the direction of locomotion. In most cell types, regulated actin polymerization promotes initial cell front formation and its subsequent persistent protrusion, whereas myosin II-based forces are required to initially create and then maintain the cell rear. Molecular models for cell migration have focused extensively on cell protrusion, and the breaking of cell symmetry is almost universally portrayed with the cell front forming first. Although data supports this model for cells moving towards chemo-attractants, in the absence of any guidance cue, cell symmetry is broken by the cells constitutively forming the cell rear first. This allows an alternative model for triggering cell migration starting with retraction at the back of the cell. In this model, actomyosin II activity within the cell body and prospective cell rear occurs before a spatial bias in actin polymerization at the cell front. Creating the cell rear first may be a useful tool employed by a wide-range of migrating cell types, particularly when moving away from repellent cues.	[Cramer, Louise P.] UCL, MRC Lab, London WC1E 6BT, England; [Cramer, Louise P.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Cramer, LP (corresponding author), UCL, MRC Lab, Gower St, London WC1E 6BT, England.	l.cramer@ucl.ac.uk			Biotechnology and Biological Sciences Research Council [C18722] Funding Source: Medline; Medical Research Council [MC_CF12266] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		ALLEN RD, 1975, MOL CELL MOVEMENT, P239; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; CHEN WT, 1981, J CELL SCI, V49, P1; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DUNN GA, 1995, J CELL SCI, V108, P1239; Dunn GA, 1980, CELL ADHESION MOTILI, P409; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Koehl G, 2002, CELL BIOL INT, V26, P287, DOI 10.1006/cbir.2001.0855; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Mast SO, 1926, J MORPHOL PHYSIOL, V41, P347, DOI 10.1002/jmor.1050410205; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mseka T, 2007, J CELL SCI, V120, P4332, DOI 10.1242/jcs.017640; Mseka T, 2009, CELL MOTIL CYTOSKEL, V66, P743, DOI 10.1002/cm.20403; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Peckham M, 2001, J CELL SCI, V114, P1367; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shutova MS, 2008, CELL MOTIL CYTOSKEL, V65, P734, DOI 10.1002/cm.20295; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Swailes NT, 2004, J ANAT, V205, P381, DOI 10.1111/j.0021-8782.2004.00341.x; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026; ZIGMOND SH, 1979, J CELL BIOL, V82, P517, DOI 10.1083/jcb.82.2.517	40	79	80	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					628	632		10.1038/ncb0710-628	http://dx.doi.org/10.1038/ncb0710-628			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20596043				2022-12-27	WOS:000279374400002
J	Mor, A; Suliman, S; Ben-Yishay, R; Yunger, S; Brody, Y; Shav-Tal, Y				Mor, Amir; Suliman, Shimrit; Ben-Yishay, Rakefet; Yunger, Sharon; Brody, Yehuda; Shav-Tal, Yaron			Dynamics of single mRNP nucleocytoplasmic transport and export through the nuclear pore in living cells	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA TRANSPORT; KINETIC-ANALYSIS; MAMMALIAN-CELLS; COMPLEX; TRANSLOCATION; PROTEIN; PARTICLE; TRANSCRIPTION; LOCALIZATION; DYSTROPHIN	The flow of genetic information in eukaryotic cells occurs through the nucleocytoplasmic translocation of mRNAs. Knowledge of in vivo messenger RNA export kinetics remains poor in comparison with that of protein transport. We have established a mammalian system that allowed the real-time visualization and quantification of large single mRNA-protein complexes (mRNPs) during export. The in vivo dynamics of bulk mRNP transport and export, from transcription to the nuclear pore complex (NPC), occurred within a 5-40 minute time frame, with no NPC pile-up. mRNP export was rapid (about 0.5 s) and kinetically faster than nucleoplasmic diffusion. Export inhibition demonstrated that mRNA-NPC interactions were independent of ongoing export. Nucleoplasmic transport dynamics of intron-containing and intronless mRNAs were similar, yet an intron did increase export efficiency. Here we provide visualization and analysis at the single mRNP level of the various steps in nuclear gene expression and the inter-chromatin tracks through which mRNPs diffuse, and demonstrate the kinetics of mRNP-NPC interactions and translocation.	[Shav-Tal, Yaron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Inst Nanotechnol, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Shav-Tal, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	shavtaly@mail.biu.ac.il		Shav-Tal, Yaron/0000-0002-8017-948X	Israel Science Foundation [250/06]; Israel Ministries of Health and Science	Israel Science Foundation(Israel Science Foundation); Israel Ministries of Health and Science	We thank J. Tremblay (Laval University, Canada) for GFP-Dys and GFP-mini-Dys, J. Ellenberg (EMBL Heidelberg, Germany) for the POM121-mCherry plasmid, and R. Drummer (Bar-Ilan University (BIU), Israel) for statistical analysis. This work was supported by grants to Y.S.T. from the Israel Science Foundation (grant 250/06) and the Israel Ministries of Health and Science. Y.S.T. thanks the Israel Science Foundation for the fluorescence live-cell imaging microscope. Y.B. is an Azrielli fellow. Y.S.T. is the Jane Stern Lebell Family Fellow in Life Sciences at BIU.	Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; BASTOS RN, 1977, CELL, V11, P641, DOI 10.1016/0092-8674(77)90081-2; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Braga J, 2004, PROG MOL SUBCELL BIO, V35, P119; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chapdelaine P, 2000, PROTEIN ENG, V13, P611, DOI 10.1093/protein/13.9.611; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; DARGEMONT C, 1992, J CELL BIOL, V118, P1, DOI 10.1083/jcb.118.1.1; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fakan S, 2004, HISTOCHEM CELL BIOL, V122, P83, DOI 10.1007/s00418-004-0681-1; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FRANKE WW, 1974, CELL NUCLEUS, V1, P219; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Iborra FJ, 2000, J CELL SCI, V113, P291; Iborra FJ, 1998, J CELL SCI, V111, P2269; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; JELINEK W, 1973, J MOL BIOL, V75, P515, DOI 10.1016/0022-2836(73)90458-0; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MARIMAN E, 1982, NUCLEIC ACIDS RES, V10, P6131, DOI 10.1093/nar/10.19.6131; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; MICHAEL WM, 1995, CELL, V83, P415; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Pante N, 1997, RNA, V3, P498; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RIEDEL N, 1987, P NATL ACAD SCI USA, V84, P3540, DOI 10.1073/pnas.84.11.3540; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHRODER HC, 1988, BIOCHEM J, V252, P777, DOI 10.1042/bj2520777; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; Siebrasse JP, 2002, EMBO REP, V3, P887, DOI 10.1093/embo-reports/kvf171; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Visser AE, 2000, J CELL SCI, V113, P2585; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	57	189	190	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					543	U61		10.1038/ncb2056	http://dx.doi.org/10.1038/ncb2056			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453848				2022-12-27	WOS:000278213400006
J	Atfi, A; Baron, R				Atfi, Azeddine; Baron, Roland			PTH battles TGF-beta in bone	NATURE CELL BIOLOGY			English	Editorial Material							PARATHYROID-HORMONE; RECEPTOR	Bone remodelling in vertebrates is coordinately regulated by the opposing effects of parathyroid hormone (PTH) and transforming growth factor-beta (TGF-beta). PTH couples the processes of bone resorption and formation by enforcing simultaneous internalization of TGF-beta type II receptor (T beta RII) and PTH type 1 receptor (PTH1R), which attenuates both TGF-beta and PTH signalling in vivo.	[Atfi, Azeddine] Hop St Antoine, NSERM, UMRS 938, F-75571 Paris, France; [Atfi, Azeddine; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital	Atfi, A (corresponding author), Hop St Antoine, NSERM, UMRS 938, 184 Rue Faubourg St Antoine, F-75571 Paris, France.	azeddine.atfi@inserm.fr						Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Alliston Tamara N., 2000, P233; Atfi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.126pe33; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Kousteni Stavroula, 2008, Curr Osteoporos Rep, V6, P72, DOI 10.1007/s11914-008-0013-9; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	15	16	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					205	207		10.1038/ncb0310-205	http://dx.doi.org/10.1038/ncb0310-205			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20190828				2022-12-27	WOS:000275054200004
J	Tang, CJC; Fu, RH; Wu, KS; Hsu, WB; Tang, TK				Tang, Chieh-Ju C.; Fu, Ru-Huei; Wu, Kuo-Sheng; Hsu, Wen-Bin; Tang, K. Tang			CPAP is a cell-cycle regulated protein that controls centriole length	NATURE CELL BIOLOGY			English	Article							COILED-COIL PROTEIN; CENTROSOME DUPLICATION; C-ELEGANS; CAENORHABDITIS-ELEGANS; KEN BOX; PROCENTRIOLE; RECRUITMENT; BIOGENESIS; MECHANISMS; INTERACTS	Centriole duplication involves the growing of a procentriole (progeny centriole) next to the proximal end of each preexisting centriole (parental centriole). The molecular mechanisms that regulate procentriole elongation remain obscure. We show here that expression of the centriolar protein CPAP (centrosomal P4.1-associated protein) is carefully regulated during the cell cycle, with the protein being degraded in late mitosis. Depletion of CPAP inhibited centrosome duplication, whereas excess CPAP induced the formation of elongated procentriole-like structures (PLSs), which contain stable microtubules and several centriolar proteins. Ultrastructural analysis revealed that these structures are similar to procentrioles with elongated microtubules. Overexpression of a CPAP mutant (CPAP-377EE) that does not bind to tubulin dimers significantly inhibited the formation of CPAP-induced PLSs. Together, these results suggest that CPAP is a new regulator of centriole length and its intrinsic tubulin-dimer binding activity is required for procentriole elongation.	[Tang, Chieh-Ju C.; Fu, Ru-Huei; Wu, Kuo-Sheng; Hsu, Wen-Bin; Tang, K. Tang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Wu, Kuo-Sheng] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Tang, TK (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	tktang@ibms.sinica.edu.tw	Tang, Tang K./S-7012-2018	Tang, Tang K./0000-0002-3660-0695; Fu, Ru-Huei/0000-0001-9367-1759				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Chen CY, 2006, BIOCHEM BIOPH RES CO, V342, P1203, DOI 10.1016/j.bbrc.2006.02.089; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KOHLMAIER G, 2004, CURR BIOL IN PRESS; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Paoletti A, 1996, J CELL SCI, V109, P3089; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; SCHMIDT TI, CURR BIOL IN PRESS; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	35	201	203	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					825	U103		10.1038/ncb1889	http://dx.doi.org/10.1038/ncb1889			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503075				2022-12-27	WOS:000267603100010
J	Fink, G; Hajdo, L; Skowronek, KJ; Reuther, C; Kasprzak, AA; Diez, S				Fink, Gero; Hajdo, Lukasz; Skowronek, Krzysztof J.; Reuther, Cordula; Kasprzak, Andrzej A.; Diez, Stefan			The mitotic kinesin-14 Ncd drives directional microtubule-microtubule sliding	NATURE CELL BIOLOGY			English	Article							CROSS-LINKS MICROTUBULES; MOTOR PROTEIN; DROSOPHILA; EG5; IDENTIFICATION; MOVEMENT; SPINDLES; MEIOSIS; MUTANTS	During mitosis and meiosis, the bipolar spindle facilitates chromosome segregation through microtubule sliding as well as microtubule growth and shrinkage(1). Kinesin-14, one of the motors involved, causes spindle collapse in the absence of kinesin-5 (refs 2, 3), participates in spindle assembly(4) and modulates spindle length(5). However, the molecular mechanisms underlying these activities are not known. Here, we report that Drosophila melanogaster kinesin-14 (Ncd) alone causes sliding of anti-parallel microtubules but locks together (that is, statically crosslinks) those that are parallel. Using single molecule imaging we show that Ncd diffuses along microtubules in a tail-dependent manner and switches its orientation between sliding microtubules. Our results show that kinesin-14 causes sliding and expansion of an anti-parallel microtubule array by dynamic interactions through the motor domain on the one side and the tail domain on the other. This mechanism accounts for the roles of kinesin-14 in spindle organization.	[Fink, Gero; Reuther, Cordula; Diez, Stefan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Hajdo, Lukasz; Skowronek, Krzysztof J.; Kasprzak, Andrzej A.] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Hajdo, Lukasz] Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland; [Skowronek, Krzysztof J.] Int Inst Mol & Cell Biol, PL-02093 Warsaw, Poland	Max Planck Society; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Lodz; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Diez, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	diez@mpi-cbg.de	Skowronek, Krzysztof/G-2855-2010; Diez, Stefan/E-8172-2010; Kasprzak, Andrzej A. A/R-4476-2016	Skowronek, Krzysztof/0000-0001-9973-7085; Diez, Stefan/0000-0002-0750-8515; Kasprzak, Andrzej A. A/0000-0002-3602-5379; Reuther, Cordula/0000-0002-3787-4022	German Federal Ministry of Education and Research [03 N 8712]; Polish Network for Mechanisms of Cell Motility [2 P04C 131 29]; Max-Planck-Society; Boehringer Ingelheim Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Polish Network for Mechanisms of Cell Motility; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	We acknowledge the members of the Kasprzak and the Diez labs for comments on the manuscript as well as C. Brauer and D. Naumburger for technical support. We thank C. Leduc, B. Nitzsche, C. Gell and J. Howard for fruitful discussion, F. Ruhnow for help with the microtubule tracking, as well as S. Bajer and E. Kocik for help with FPLC experiments. This work was supported by the German Federal Ministry of Education and Research (Grant 03 N 8712), the Polish Network for Mechanisms of Cell Motility, the Grant 2 P04C 131 29 and the Max-Planck-Society. G. Fink was supported by a fellowship from the Boehringer Ingelheim Foundation	Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; CHANDRA R, 1993, J BIOL CHEM, V268, P9005; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; ENDOW SA, 1994, J CELL SCI, V107, P859; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; HATSUMI M, 1992, J CELL SCI, V101, P547; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1993, GENETICS, V135, P35; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN AA, 1991, J CELL SCI, P125; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; KIMBLE M, 1983, J CELL SCI, V62, P301; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3	35	152	153	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					717	U47		10.1038/ncb1877	http://dx.doi.org/10.1038/ncb1877			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430467				2022-12-27	WOS:000266503700016
J	Shen, JH; Yu, WM; Brotto, M; Scherman, JA; Guo, CY; Stoddard, C; Nosek, TM; Valdivia, HH; Qu, CK				Shen, Jinhua; Yu, Wen-Mei; Brotto, Marco; Scherman, Joseph A.; Guo, Caiying; Stoddard, Christopher; Nosek, Thomas M.; Valdivia, Hector H.; Qu, Cheng-Kui			Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca2+ homeostasis	NATURE CELL BIOLOGY			English	Article							OPERATED CALCIUM-CHANNEL; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; MICE LACKING; ACTIVATION; INHIBITOR; MOUSE; THAPSIGARGIN; DYSFUNCTION; FATIGUE	The intracellular Ca2+ concentration ([Ca2+](i)) in skeletal muscles must be rapidly regulated during the excitation-contraction-relaxation process(1). However, the signalling components involved in such rapid Ca2+ movement are not fully understood. Here we report that mice deficient in the newly identified PtdInsP (phosphatidylinositol phosphate) phosphatase MIP/MTMR14 (muscle-specific inositol phosphatase) show muscle weakness and fatigue. Muscles isolated from MIP/MTMR14(-/-) mice produced less contractile force, had markedly prolonged relaxation and showed exacerbated fatigue relative to normal muscles. Further analyses revealed that MIP/MTMR14 deficiency resulted in spontaneous Ca2+ leakage from the internal store - the sarcoplasmic reticulum. This was attributed to decreased metabolism (dephosphorylation) and the subsequent accumulation of MIP/MTMR14 substrates, especially PtdIns(3,5)P-2 and PtdIns (3,4)P-2. Furthermore, we found that PtdIns(3,5)P-2 and PtdIns(3,4)P-2 bound to, and directly activated, the Ca2+ release channel (ryanodine receptor 1, RyR1) of the sarcoplasmic reticulum. These studies provide the first evidence that finely controlled PtdInsP levels in muscle cells are essential for maintaining Ca2+ homeostasis and muscle performance.	[Shen, Jinhua; Yu, Wen-Mei; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Brotto, Marco] Univ Missouri, Sch Nursing & Med, Kansas City, MO 64108 USA; [Scherman, Joseph A.; Valdivia, Hector H.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Guo, Caiying; Stoddard, Christopher] Univ Connecticut, Ctr Hlth, Gene Targeting & Transgen Facil, Farmington, CT 06030 USA; [Nosek, Thomas M.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; University of Missouri System; University of Missouri Kansas City; University of Wisconsin System; University of Wisconsin Madison; University of Connecticut; Case Western Reserve University	Qu, CK (corresponding author), Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	cxq6@case.edu		Nosek, Thomas/0000-0001-6466-9035	NIH [HL068212, HL082670, HL55438]; American Heart Association [0535555N]; Case Center for Transdisciplinary Research on Energetics and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL082670, R01HL055438, R01HL068212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Case Center for Transdisciplinary Research on Energetics and Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to D. Chess, M. Chandler, T. Stefan, J. Jacobberger, L. Brotto, N. Wiesleder and J. Ma for technical assistance and helpful discussions. Motor function tests were performed by the Case Western Reserve University Rodent Behavior Core. This work was supported by NIH grants (HL068212 and HL082670) to C. K. Q. and (HL55438) H. H. V., an American Heart Association grant (0535555N) to M. B. and a pilot grant from the Case Center for Transdisciplinary Research on Energetics and Cancer to T. M. N., C. K. Q. and M. B.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Amran MS, 2003, CARDIOVASC DRUG REV, V21, P255; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Benkusky NA, 2004, BIOCHEM BIOPH RES CO, V322, P1280, DOI 10.1016/j.bbrc.2004.08.033; Bhogal MS, 1998, ANN NY ACAD SCI, V853, P260, DOI 10.1111/j.1749-6632.1998.tb08274.x; BOGO V, 1981, NEUROTOXICOLOGY, V2, P765; Brotto MAD, 2002, EXP PHYSIOL, V87, P77, DOI 10.1113/eph8702224; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; DEAN RL, 1981, EXP AGING RES, V7, P427, DOI 10.1080/03610738108259823; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; ISHII T, 1994, P NATL ACAD SCI USA, V91, P6103, DOI 10.1073/pnas.91.13.6103; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Nagaraj RY, 2000, PHYSIOL GENOMICS, V4, P43, DOI 10.1152/physiolgenomics.2000.4.1.43; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Nosek TM, 2000, PHYSIOL GENOMICS, V4, P25, DOI 10.1152/physiolgenomics.2000.4.1.25; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; Zhu XS, 2004, J BIOL CHEM, V279, P26588, DOI 10.1074/jbc.M403284200; Zhu XS, 2004, CELL CALCIUM, V35, P165, DOI 10.1016/j.ceca.2003.09.002	37	72	73	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					769	U141		10.1038/ncb1884	http://dx.doi.org/10.1038/ncb1884			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465920	Green Accepted			2022-12-27	WOS:000266503700023
J	Mercer, J; Helenius, A				Mercer, Jason; Helenius, Ari			Virus entry by macropinocytosis	NATURE CELL BIOLOGY			English	Review							CLATHRIN-INDEPENDENT ENDOCYTOSIS; FLUID-PHASE PINOCYTOSIS; STIMULATED A431 CELLS; EPITHELIAL TIGHT JUNCTIONS; RECEPTOR TYROSINE KINASES; VACCINIA VIRUS; P21-ACTIVATED-KINASE-1 PAK1; PHOSPHOINOSITIDE 3-KINASE; MEMBRANE RUFFLES; APOPTOTIC CELLS	As obligatory intracellular parasites, viruses rely on host-cell functions for most aspects of their replication cycle. This is born out during entry, when most viruses that infect vertebrate and insect cells exploit the endocytic activities of the host cell to move into the cytoplasm. Viruses belonging to vaccinia, adeno, picorna and other virus families have been reported to take advantage of macropinocytosis, an endocytic mechanism normally involved in fluid uptake. The virus particles first activate signalling pathways that trigger actin-mediated membrane ruffling and blebbing. Usually, this is followed by the formation of large vacuoles (macropinosomes) at the plasma membrane, internalization of virus particles and penetration by the viruses or their capsids into the cytosol through the limiting membrane of the macropinosomes. We review the molecular machinery involved in macropinocytosis and describe what is known about its role in virus entry.	[Mercer, Jason; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH, Inst Biochem, Schafmattsrasse 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch		Mercer, Jason/0000-0003-1466-9541	ETH Zurich; EMBO	ETH Zurich(ETH Zurich); EMBO(European Molecular Biology Organization (EMBO))	We apologize to those individuals whose work we were unable to discuss due to space limitations. We thank members of the Helenius laboratory for thoughtful discussion. Funding was obtained from ETH Zurich and EMBO.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2000, J CELL SCI, V113, P3329; Araki N, 2006, CELL STRUCT FUNCT, V31, P145, DOI 10.1247/csf.06029; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; BARSAGI D, 1987, J CELL PHYSIOL, P69; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Bretscher A, 1997, J CELL SCI, V110, P3011; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Fabbri A, 2002, INT J MED MICROBIOL, V291, P551; Fontenot DR, 2007, BIOCHEM BIOPH RES CO, V363, P901, DOI 10.1016/j.bbrc.2007.09.046; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Garner JA, 2003, ADV DRUG DELIVER REV, V55, P1497, DOI 10.1016/j.addr.2003.07.006; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; Grimmer S, 2002, J CELL SCI, V115, P2953; Grogan A, 1997, J CELL SCI, V110, P3071; Hamasaki M, 2004, ANAT REC PART A, V277A, P298, DOI 10.1002/ar.a.20027; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Hayashi S, 2007, CURR OPIN PHARMACOL, V7, P237, DOI 10.1016/j.coph.2006.11.014; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; ICHIHASHI Y, 1983, VIROLOGY, V130, P306, DOI 10.1016/0042-6822(83)90085-5; Imelli N, 2004, J VIROL, V78, P3089, DOI 10.1128/JVI.78.6.3089-3098.2004; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kee SH, 2004, MICROBIOL IMMUNOL, V48, P823, DOI 10.1111/j.1348-0421.2004.tb03614.x; KELLER HU, 1990, J CELL PHYSIOL, V145, P465, DOI 10.1002/jcp.1041450311; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497; Lucas M., 2008, IMAGING MICROSC, V10, P30; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Machesky LM, 1997, BIOCHEM J, V328, P105; Maniak M, 2001, BBA-GEN SUBJECTS, V1525, P197, DOI 10.1016/S0304-4165(01)00105-2; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meier O, 2003, J GENE MED, V5, P451, DOI 10.1002/jgm.409; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; MIYATA Y, 1989, J BIOL CHEM, V264, P15565; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Petruzziello R, 1996, J GEN VIROL, V77, P303, DOI 10.1099/0022-1317-77-2-303; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roberts RL, 2000, J LEUKOCYTE BIOL, V68, P627; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331; SWANSON JA, 1989, J CELL SCI, V94, P135; Swanson JA, 1999, J CELL SCI, V112, P307; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Wang JH, 2008, VIROLOGY, V381, P143, DOI 10.1016/j.virol.2008.08.028; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; WATTS C, 1992, J CELL SCI, V103, P1; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; YOUNG VB, 1992, J CELL BIOL, V116, P197, DOI 10.1083/jcb.116.1.197	127	575	589	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					510	520		10.1038/ncb0509-510	http://dx.doi.org/10.1038/ncb0509-510			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404330				2022-12-27	WOS:000265640000003
J	Lawrence, PA; Struhl, G; Casal, J				Lawrence, Peter A.; Struhl, Gary; Casal, Jose			Do the protocadherins Fat and Dachsous link up to determine both planar cell polarity and the dimensions of organs?	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR GENE; WING GROWTH; DROSOPHILA; PROLIFERATION; INSIGHTS; GRADIENT; HEDGEHOG; SIZE; ACTS	Most, perhaps all cells in epithelial sheets are polarized in the plane of the sheet. This type of polarity, referred to as planar cell polarity (PCP), can be expressed in the orientation of cilia and stereocilia, in oriented outgrowths such as hairs, in the plane of cell division, in directed cell movement and possibly in the orientation of axon extension(1,2). Another popular area in current research is growth: there is an attempt to find systems that fix the shape and size of organs. Although both polarity and growth are subject to overall control by morphogen gradients(3), the mechanisms of this control are almost completely unknown. Here we discuss recent evidence for a 'steepness hypothesis' that links these two apparently disconnected features of animal development.	[Lawrence, Peter A.; Casal, Jose] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lawrence, Peter A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Struhl, Gary] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	University of Cambridge; MRC Laboratory Molecular Biology; Columbia University; Howard Hughes Medical Institute	Lawrence, PA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	pal@mrc-lmb.cam.ac.uk		Lawrence, Peter/0000-0002-9554-8268; Casal, Jose/0000-0002-5149-1335	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U105184283] Funding Source: Medline; Wellcome Trust [078889] Funding Source: Medline; MRC [MC_U105184283] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Day SJ, 2000, DEVELOPMENT, V127, P2977; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Huxley J., 1932, PROBLEMS RELATIVE GR; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lawrence P. A., 1970, Adv. Insect Physiol., V7, P197, DOI 10.1016/S0065-2806(08)60242-8; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; Lawrence PA, 2004, NATURE, V429, P247, DOI 10.1038/429247a; LAWRENCE PA, 1972, J CELL SCI, V11, P815; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; MA D, 2003, NATURE; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; MATAKATSU H, 2006, DEVELOPMENT; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Struhl G, 1997, DEVELOPMENT, V124, P2155; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Thompson D.W, 1917, GROWTH FORM; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zecca M, 2007, DEVELOPMENT, V134, P3011, DOI 10.1242/dev.006445; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	37	53	53	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1379	1382		10.1038/ncb1208-1379	http://dx.doi.org/10.1038/ncb1208-1379			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043429	Green Accepted, Green Submitted			2022-12-27	WOS:000261261800004
J	Mujtaba, S; Manzur, KL; Gurnon, JR; Kang, M; Van Etten, JL; Zhou, MM				Mujtaba, Shiraz; Manzur, Karishma L.; Gurnon, James R.; Kang, Ming; Van Etten, James L.; Zhou, Ming-Ming			Epigenetic transcriptional repression of cellular genes by a viral SET protein	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; POLYCOMB GROUP PROTEINS; EMBRYONIC STEM-CELLS; CHROMATIN-STRUCTURE; H3K27 DEMETHYLASES; CHLORELLA VIRUSES; PCAF BROMODOMAIN; STRUCTURAL BASIS; BREAST-CANCER	Viruses recruit host proteins to secure viral genome maintenance and replication. However, whether they modify host histones directly to interfere with chromatin-based transcription is unknown. Here we report that Paramecium bursaria chlorella virus 1 (PBCV-1) encodes a functional SET domain histone Lys methyltransferase (HKMTase) termed vSET, which is linked to rapid inhibition of host transcription after viral infection. We show that vSET is packaged in the PBCV-1 virion, and that it contains a nuclear localization signal and probably represses host transcription by methylating histone H3 at Lys 27 (H3K27), a modification known to trigger gene silencing in eukaryotes. We also show that vSET induces cell accumulation at the G2/M phase by recruiting the Polycomb repressive complex CBX8 to the methylated H3K27 site in a heterologous system. vSET-like proteins that have H3K27 methylation activity are conserved in chlorella viruses. Our findings suggest a viral mechanism to repress gene transcription by direct modification of chromatin by PBCV-1 vSET.	[Gurnon, James R.; Kang, Ming; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Gurnon, James R.; Kang, Ming; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Mujtaba, Shiraz; Manzur, Karishma L.; Zhou, Ming-Ming] NYU, Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Icahn School of Medicine at Mount Sinai; New York University	Van Etten, JL (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	jvanetten@unlnotes.unl.edu; ming-ming.zhou@mssm.edu			NIH-NCI; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. W. Enquist for the Us9-GFP construct, M. Ptashne for the Gal4-DBD construct, P. Traber for the firefly luciferase construct, R. Slany for the HOX7A luciferase construct, I. V. Agarkova for the results used in Fig. 1a, and M. Walsh for helpful discussions. Fluorescence microscopy imaging was performed at the Mount Sinai Microscopy Shared Resource Facility supported in part with funding from NIH-NCI shared resources grant. This work was supported by grants from the National Institutes of Health (M.-M.Z. and J.L.V.E.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alvarez-Venegas R, 2007, MOL BIOL EVOL, V24, P482, DOI 10.1093/molbev/msl184; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Kang M, 2004, VIROLOGY, V326, P150, DOI 10.1016/j.virol.2004.05.023; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Manzur KL, 2005, FEBS LETT, V579, P3859, DOI 10.1016/j.febslet.2005.05.026; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SCHUSTER AM, 1986, VIROLOGY, V150, P170, DOI 10.1016/0042-6822(86)90276-X; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Svingen T, 2003, CANCER BIOL THER, V2, P518, DOI 10.4161/cbt.2.5.441; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2006, RES PRO CEL, V41, P1, DOI 10.1007/010; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	35	48	49	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1114	1122		10.1038/ncb1772	http://dx.doi.org/10.1038/ncb1772			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160493	Green Accepted, Green Published			2022-12-27	WOS:000258910400018
J	Stiber, J; Hawkins, A; Zhang, ZS; Wang, S; Burch, J; Graham, V; Ward, CC; Seth, M; Finch, E; Malouf, N; Williams, RS; Eu, JP; Rosenberg, P				Stiber, Jonathan; Hawkins, April; Zhang, Zhu-Shan; Wang, Sunny; Burch, Jarrett; Graham, Victoria; Ward, Cary C.; Seth, Malini; Finch, Elizabeth; Malouf, Nadia; Williams, R. Sanders; Eu, Jerry P.; Rosenberg, Paul			STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle	NATURE CELL BIOLOGY			English	Article							CA2+ ENTRY; CRAC CHANNELS; PORE SUBUNIT; C-ELEGANS; DEPLETION; ORAI1; RELEASE; SENSOR; ACTIVATION; CURRENTS	It is now well established that stromal interaction molecule 1 (STIM1) is the calcium sensor of endoplasmic reticulum stores required to activate store-operated calcium entry (SOC) channels at the surface of non-excitable cells. However, little is known about STIM1 in excitable cells, such as striated muscle, where the complement of calcium regulatory molecules is rather disparate from that of non-excitable cells. Here, we show that STIM1 is expressed in both myotubes and adult skeletal muscle. Myotubes lacking functional STIM1 fail to show SOC and fatigue rapidly. Moreover, mice lacking functional STIM1 die perinatally from a skeletal myopathy. In addition, STIM1 haploinsufficiency confers a contractile defect only under conditions where rapid refilling of stores would be needed. These findings provide insight into the role of STIM1 in skeletal muscle and suggest that STIM1 has a universal role as an ER/SR calcium sensor in both excitable and non-excitable cells.	[Stiber, Jonathan; Hawkins, April; Zhang, Zhu-Shan; Wang, Sunny; Burch, Jarrett; Graham, Victoria; Ward, Cary C.; Seth, Malini; Finch, Elizabeth; Williams, R. Sanders; Eu, Jerry P.; Rosenberg, Paul] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Malouf, Nadia] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill	Rosenberg, P (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.	rosen029@mc.duke.edu	Tuluc, Petronel/C-2527-2011	Rosenberg, Paul/0000-0002-5659-160X	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [K08-HL077520, K08 HL077520-02, K08 HL071841-04, K08 HL077520, K08 HL071841, K08 HL071841-03, K08-HL-071841-04, K08 HL077520-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077520, K08HL071841] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Lorenzon P, 2000, J PHYSIOL-LONDON, V525, P499, DOI 10.1111/j.1469-7793.2000.00499.x; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Lorin-Nebel C, 2007, J PHYSIOL-LONDON, V580, P67, DOI 10.1113/jphysiol.2006.124883; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Maclennan DH, 2004, J MUSCLE RES CELL M, V25, P600; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; SCUHYNA TM, 2007, J PHYSL, V581, P369; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Whitehead NP, 2006, NEUROMUSCULAR DISORD, V16, P845, DOI 10.1016/j.nmd.2006.07.024; Williams RS, 2002, COLD SPRING HARB SYM, V67, P339, DOI 10.1101/sqb.2002.67.339; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	50	278	284	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					688	697		10.1038/ncb1731	http://dx.doi.org/10.1038/ncb1731			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18488020	Green Accepted, Green Submitted			2022-12-27	WOS:000256350100015
J	Taddei, I; Deugnier, MA; Faraldo, MM; Petit, V; Bouvard, D; Medina, D; Fassler, R; Thiery, JP; Glukhova, MA				Taddei, Ilaria; Deugnier, Marie-Ange; Faraldo, Marisa M.; Petit, Valerie; Bouvard, Daniel; Medina, Daniel; Faessler, Reinhard; Thiery, Jean Paul; Glukhova, Marina A.			beta 1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; GLAND; DIFFERENTIATION; INTEGRIN; LINE; MORPHOGENESIS; EXPRESSION; REGULATOR; REVEALS; GATA-3	The mammary gland epithelium comprises two major cell types: basal and luminal. Basal cells interact directly with the extracellular matrix (ECM) and express higher levels of the ECM receptors, integrins, than luminal cells. We show that deletion of beta 1 integrin from basal cells abolishes the regenerative potential of the mammary epithelium and affects mammary gland development. The mutant epithelium was characterized by an abnormal ductal branching pattern and aberrant morphogenesis in pregnancy, although at the end of gestation, the secretory alveoli developed from beta 1 integrin-positive progenitors. Lack of beta 1 integrin altered the orientation of the basal-cell division axis and in mutant epithelium, in contrast to control tissue, the progeny of beta 1 integrin-null basal cells, identified by a genetic marker, was found in the luminal compartment. These results reveal, for the first time, the essential role of the basal mammary epithelial cell-ECM interactions mediated by beta 1 integrins in the maintenance of a functional stem cell population, mammary morphogenesis and segregation of the two major mammary cell lineages.	[Taddei, Ilaria; Deugnier, Marie-Ange; Faraldo, Marisa M.; Petit, Valerie; Thiery, Jean Paul; Glukhova, Marina A.] Inst Curie, CNRS, Ctr Rech, UMR144, F-75248 Paris 05, France; [Thiery, Jean Paul] ASTAR, IMCB, Singapore 138673, Singapore; [Medina, Daniel] Baylor Coll Med, Houston, TX 77030 USA; [Bouvard, Daniel; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Baylor College of Medicine; Max Planck Society	Glukhova, MA (corresponding author), Inst Curie, CNRS, Ctr Rech, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	Marina.Glukhova@curie.fr	Bouvard, Daniel/B-1260-2017; Deugnier, Marie-Ange/M-7556-2018; Bouvard, Daniel/M-2727-2013; Martin-Faraldo, Maria-Luisa/M-5811-2018; Deugnier, Marie-Ange/AAF-5877-2021; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Bouvard, Daniel/0000-0002-0845-6681; Deugnier, Marie-Ange/0000-0002-2199-1099; Thiery, Jean Paul/0000-0003-0478-5020; Faraldo, Marisa/0000-0001-9497-1171; PETIT, Valerie/0000-0003-1645-9396				Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; DEOME KB, 1959, CANCER RES, V19, P515; Deugnier MA, 2002, J CELL BIOL, V159, P453, DOI 10.1083/jcb.200207138; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Faraldo MM, 1998, EMBO J, V17, P2139, DOI 10.1093/emboj/17.8.2139; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Wagner KU, 2002, DEVELOPMENT, V129, P1377; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025	29	187	194	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					716	722		10.1038/ncb1734	http://dx.doi.org/10.1038/ncb1734			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469806	Green Submitted, Green Accepted			2022-12-27	WOS:000256350100018
J	Tasdemir, E; Maiuri, MC; Galluzzi, L; Vitale, I; Djavaheri-Mergny, M; D'Amelio, M; Criollo, A; Morselli, E; Zhu, CL; Harper, F; Nannmark, U; Samara, C; Pinton, P; Vicencio, JM; Carnuccio, R; Moll, UM; Madeo, F; Paterlini-Brechot, P; Rizzuto, R; Szabadkai, G; Pierron, G; Blomgren, K; Tavernarakis, N; Codogno, P; Cecconi, F; Kroemer, G				Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Djavaheri-Mergny, Mojgan; D'Amelio, Marcello; Criollo, Alfredo; Morselli, Eugenia; Zhu, Changlian; Harper, Francis; Nannmark, Ulf; Samara, Chrysanthi; Pinton, Paolo; Vicencio, Jose Miguel; Carnuccio, Rosa; Moll, Ute M.; Madeo, Frank; Paterlini-Brechot, Patrizia; Rizzuto, Rosario; Szabadkai, Gyorgy; Pierron, Gerard; Blomgren, Klas; Tavernarakis, Nektarios; Codogno, Patrice; Cecconi, Francesco; Kroemer, Guido			Regulation of autophagy by cytoplasmic p53	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-SURVIVAL; APOPTOSIS; STRESS; INHIBITION; PATHWAY; RESTORATION; DISRUPTION; CLEARANCE; INDUCTION	Multiple cellular stressors, including activation of the tumour suppressor p53, can stimulate autophagy. Here we show that knockout, knockdown or pharmacological inhibition of p53 can induce autophagy in human, mouse and nematode cells. Enhanced autophagy improved the survival of p53-deficient cancer cells under conditions of hypoxia and nutrient depletion, allowing them to maintain high ATP levels. Inhibition of p53 led to autophagy in enucleated cells, and cytoplasmic, not nuclear, p53 was able to repress the enhanced autophagy of p53(-/-)cells. Many different inducers of autophagy (for example, starvation, rapamycin and toxins affecting the endoplasmic reticulum) stimulated proteasome-mediated degradation of p53 through a pathway relying on the E3 ubiquitin ligase HDM2. Inhibition of p53 degradation prevented the activation of autophagy in several cell lines, in response to several distinct stimuli. These results provide evidence of a key signalling pathway that links autophagy to the cancer-associated dysregulation of p53.	[Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Tasdemir, Ezgi; Maiuri, M. Chiara; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Tasdemir, Ezgi; Galluzzi, Lorenzo; Vitale, Ilio; Criollo, Alfredo; Morselli, Eugenia; Vicencio, Jose Miguel; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Maiuri, M. Chiara; Carnuccio, Rosa] Univ Naples Federico II, Sch Biotechnol Sci, I-80131 Naples, Italy; [Maiuri, M. Chiara; Carnuccio, Rosa] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy; [Djavaheri-Mergny, Mojgan; Codogno, Patrice] Univ Paris 11, Fac Pharm, INSERM, U756, F-92290 Chatenay Malabry, France; [Szabadkai, Gyorgy] UCL, Dept Physiol, London WC1E 6BT, England; [Paterlini-Brechot, Patrizia; Szabadkai, Gyorgy] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, INSERM U807, F-75015 Paris, France; [D'Amelio, Marcello; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy; [D'Amelio, Marcello; Cecconi, Francesco] IRCCS, Fondaz Santa Lucia, I-00133 Rome, Italy; [Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Pinton, Paolo; Rizzuto, Rosario] Univ Ferrara, ICSI, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Samara, Chrysanthi; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Nannmark, Ulf] Gothenburg Univ, Inst Biomed, Dept Med Biochem & Cell Biol, S-41124 Gothenburg, Sweden; [Harper, Francis; Pierron, Gerard] Inst Andre Lwoff, CNRS, FRE 2937, F-94801 Villejuif, France; [Zhu, Changlian; Blomgren, Klas] Gothenburg Univ, Queen Silvia Childrens Hosp, Dept Pediat Oncol, Inst Neurosci & Physiol,Ctr Brain Repair & Rehabi, Gothenburg, Sweden	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Naples Federico II; University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Rome Tor Vergata; IRCCS Santa Lucia; University of Graz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Ferrara; Foundation for Research & Technology - Hellas (FORTH); University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); Queen Silvia Children's Hospital; University of Gothenburg	Kroemer, G (corresponding author), INSERM, U848, F-94805 Villejuif, France.	kroemer@igr.fr	Tavernarakis, Nektarios/B-9684-2013; Vitale, Ilio/M-3960-2017; Djavaheri-Mergny, Mojgan/N-6315-2017; Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAH-3286-2021; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAG-6294-2019; Djavaheri-Mergny, Mojgan/L-3890-2019; Pinton, Paolo/J-8025-2012; KROEMER, Guido/B-4263-2013; Codogno, Patrice/G-1384-2013; Cecconi, Francesco/K-3969-2016; Zhu, Changlian/AAN-6205-2020	Tavernarakis, Nektarios/0000-0002-5253-1466; Vitale, Ilio/0000-0002-5918-1841; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Galluzzi, Lorenzo/0000-0003-2257-8500; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Pinton, Paolo/0000-0001-7108-6508; KROEMER, Guido/0000-0002-9334-4405; Codogno, Patrice/0000-0002-5492-3180; Cecconi, Francesco/0000-0002-5614-4359; Blomgren, Klas/0000-0002-0476-7271; Paterlini- Brechot, Patrizia/0000-0001-7981-6325; Szabadkai, Gyorgy/0000-0002-3006-3577; D'Amelio, Marcello/0000-0001-6526-1832; Zhu, Changlian/0000-0002-5029-6730; Madeo, Frank/0000-0002-5070-1329; Rizzuto, Rosario/0000-0001-7044-5097; Criollo, Alfredo/0000-0002-2737-7751	NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG025532-01A10002, P01 AG025532-020002] Funding Source: Medline; Telethon [TCP99038] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vater CA, 1996, ONCOGENE, V13, P739; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	50	857	921	7	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					676	687		10.1038/ncb1730	http://dx.doi.org/10.1038/ncb1730			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18454141	Green Accepted			2022-12-27	WOS:000256350100014
J	Prozorovski, T; Schulze-Topphoff, U; Glumm, R; Baumgart, J; Schroter, F; Ninnemann, O; Siegert, E; Bendix, I; Brustle, O; Nitsch, R; Zipp, F; Aktas, O				Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Baumgart, Jan; Schroeter, Friederike; Ninnemann, Olaf; Siegert, Elise; Bendix, Ivo; Bruestle, Oliver; Nitsch, Robert; Zipp, Frauke; Aktas, Orhan			Sirt1 contributes critically to the redox-dependent fate of neural progenitors	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; CENTRAL-NERVOUS-SYSTEM; LIFE-SPAN; MULTIPLE-SCLEROSIS; BHLH REPRESSORS; STEM-CELL; KAPPA-B; EGF; PROTEIN; BRAIN	Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a failure to replenish neurons and by astrogliosis. The underlying molecular pathways, however, are poorly understood. Here, we show that subtle alterations of the redox state, found in different brain pathologies, regulate the fate of mouse neural progenitor cells ( NPCs) through the histone deacetylase ( HDAC) Sirt1. Mild oxidation or direct activation of Sirt1 suppressed proliferation of NPCs and directed their differentiation towards the astroglial lineage at the expense of the neuronal lineage, whereas reducing conditions had the opposite effect. Under oxidative conditions in vitro and in vivo, Sirt1 was upregulated in NPCs, bound to the transcription factor Hes1 and subsequently inhibited pro-neuronal Mash1. In utero shRNA-mediated knockdown of Sirt1 in NPCs prevented oxidation-mediated suppression of neurogenesis and caused upregulation of Mash1 in vivo. Our results provide evidence for an as yet unknown metabolic master switch that determines the fate of neural progenitors.	[Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany; [Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Max Delbruck Ctr Mol Med, D-10117 Berlin, Germany; [Baumgart, Jan; Ninnemann, Olaf; Nitsch, Robert] Charite Univ Med Berlin, Inst Cell & Neurobiol, D-10117 Berlin, Germany; [Bruestle, Oliver] Univ Bonn, Med Ctr, Inst Reconstruct Neurobiol, D-53105 Bonn, Germany; [Bruestle, Oliver] Hertie Fdn, D-53105 Bonn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn	Zipp, F (corresponding author), Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany.	frauke.zipp@charite.de	Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015; Nitsch, Robert/AAI-9129-2021	Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Bendix, Ivo/0000-0002-9751-3640; Baumgart, Jan/0000-0003-1996-4267; Siegert, Elise/0000-0002-9594-0446				Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Merad-Saidoune M, 1999, EXP NEUROL, V158, P428, DOI 10.1006/exnr.1999.7108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wernig M, 2002, J NEUROPATH EXP NEUR, V61, P101, DOI 10.1093/jnen/61.2.101; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	362	372	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					385	U35		10.1038/ncb1700	http://dx.doi.org/10.1038/ncb1700			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344989				2022-12-27	WOS:000254561700008
J	Tsai, WB; Chung, YM; Takahashi, Y; Xu, ZH; Hu, MCT				Tsai, Wen-Bin; Chung, Young Min; Takahashi, Yoko; Xu, Zhaohui; Hu, Mickey C. -T.			Functional interaction between FOXO3a and ATM regulates DNA damage response	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR FOXO3A; ATAXIA-TELANGIECTASIA; G(2)-M CHECKPOINT; MICE LACKING; CELL-CYCLE; ACTIVATION; KINASE; PROTEIN; REPAIR; GENE	The maintenance of genomic stability in cells is relentlessly challenged by environmental stresses that induce DNA breaks, which activate the DNA-damage pathway mediated by ataxia-telangiectasia mutated ( ATM) and its downstream mediators to control damage-induced cell-cycle checkpoints and DNA repair(1-3). Here, we show that FOXO3a interacts with ATM to promote phosphorylation of ATM at Ser 1981 and prompting its downstream mediators to form nuclear foci in response to DNA damage. Silencing FOXO3a in cells abrogates the formation of ATM-pS1981 and phospho-histone H2AX foci after DNA damage. Increasing FOXO3a in cells promotes ATM-regulated signalling, the intra-S-phase or G2-M cell-cycle checkpoints, and the repair of damaged DNA, whereas cells lacking FOXO3a did not trigger the DNA-repair mechanism after DNA damage. The carboxy-terminal domain of FOXO3a binds to the FAT domain of ATM, thereby contributing to the activation of ATM. These results suggest that ATM may be regulated directly by FOXO3a in the DNA-damage response.	[Tsai, Wen-Bin; Chung, Young Min; Takahashi, Yoko; Xu, Zhaohui; Hu, Mickey C. -T.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hu, Mickey C. -T.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hu, MCT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	michu@mdanderson.org	Chung, Young Min/AAV-7656-2020		NCI NIH HHS [CA16772, R01 CA113859-03, R01 CA113859] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113859] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Matijasevic Z, 2001, CARCINOGENESIS, V22, P661, DOI 10.1093/carcin/22.4.661; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mu L, 2005, INT J PHARMACEUT, V306, P142, DOI 10.1016/j.ijpharm.2005.08.026; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Opanasopit P, 2007, COLLOID SURFACE B, V60, P117, DOI 10.1016/j.colsurfb.2007.06.001; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; TRA H, 2003, SCI STKE, pRE5; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	50	145	147	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					460	U215		10.1038/ncb1709	http://dx.doi.org/10.1038/ncb1709			48	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344987	Green Accepted			2022-12-27	WOS:000254561700017
J	Liu, DP; Ou, LD; Clemenson, GD; Chao, C; Lutske, ME; Zambetti, GP; Gage, FH; Xu, Y				Liu, Dongping; Ou, Linda; Clemenson, Gregory D., Jr.; Chao, Connie; Lutske, Marshall Eli; Zambetti, Gerard P.; Gage, Fred H.; Xu, Yang			Puma is required for p53-induced depletion of adult stem cells	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; TUMOR SUPPRESSION; P53; PHOSPHORYLATION; MICE; APOPTOSIS; AGE; EXPRESSION; RESPONSES; PATHWAY	Mammalian ageing is accompanied by accumulation of genomic DNA damage and progressive decline in the ability of tissues to regenerate(1). DNA damage activates the tumour suppressor p53, which leads to cell-cycle arrest, senescence or apoptosis. The stability and activity of p53 are induced by DNA damage through posttranslational modifications such as phosphorylation of Thr 21 and Ser 23 (refs 2-5). To investigate the roles of DNA damage and p53 in tissue-regenerative capability, two phosphorylation-site mutations (T21D and S23D) were introduced into the endogenous p53 gene in mice, so that the synthesized protein mimics phosphorylated p53. The knock-in mice exhibit constitutive p53 activation and segmental progeria that is correlated with the depletion of adult stem cells in multiple tissues, including bone marrow, brain and testes. Furthermore, a deficiency of Puma, which is required for p53-dependent apoptosis after DNA damage(6), rescues segmental progeria and prevents the depletion of adult stem cells. These findings suggest a key role of p53-dependent apoptosis in depleting adult stem cells after the accumulation of DNA damage, which leads to a decrease in tissue regeneration.	[Liu, Dongping; Ou, Linda; Chao, Connie; Lutske, Marshall Eli; Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Clemenson, Gregory D., Jr.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	University of California System; University of California San Diego; Salk Institute; St Jude Children's Research Hospital	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007; Xu, Yang/0000-0001-5574-921X	National Institutes of Health (NIH) [CA094254]; NATIONAL CANCER INSTITUTE [R01CA094254] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Tian and O. Gaidarenko for technical support, and N. Varki for help with mouse pathology. This work is supported by a National Institutes of Health (NIH) grant to Y.X. (CA094254).	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	28	86	91	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					993	998		10.1038/ncb2100	http://dx.doi.org/10.1038/ncb2100			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818388	Green Accepted			2022-12-27	WOS:000282363500014
J	Pereg, Y; Liu, BY; O'Rourke, KM; Sagolla, M; Dey, A; Komuves, L; French, DM; Dixit, VM				Pereg, Yaron; Liu, Bob Y.; O'Rourke, Karen M.; Sagolla, Meredith; Dey, Anwesha; Komuves, Laszlo; French, Dorothy M.; Dixit, Vishva M.			Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; PHOSPHATASES; CHECKPOINT; CANCER; PHOSPHORYLATION; TUMORIGENESIS; DISRUPTION; SYSTEM; GUARDS; CELLS	The dual specificity (Tyr/Thr) phosphatase Cdc25A activates cyclin-dependent kinases (Cdks) to promote cell-cycle progression and has significant oncogenic potential(1). Cdc25A protein levels are regulated tightly in normal tissues, but many human cancers overexpress Cdc25A. The underlying mechanism for overexpression has been enigmatic(2). Here we show that Cdc25A is stabilized by the ubiquitin hydrolase Dub3. Upon binding Cdc25A, Dub3 removes the polyubiquitin modifications that mark Cdc25A for proteasomal degradation. Dub3 knockdown in cells increased Cdc25A ubiquitylation and degradation, resulting in reduced Cdk/Cyclin activity and arrest at G1/S and G2/M phases of the cell cycle. In contrast, acute Dub3 overexpression produced a signature response to oncogene induction: cells accumulated in S and G2 because of replication stress, and activated a DNA damage response. Dub3 also transformed NIH-3T3 cells and cooperated with activated H-Ras to promote growth in soft agar. Importantly, we show that Dub3 overexpression is responsible for an abnormally high level of Cdc25A in a subset of human breast cancers. Moreover, Dub3 knockdown significantly retarded the growth of breast tumour xenografts in nude mice. As a major regulator of Cdc25A, Dub3 is an example of a transforming ubiquitin hydrolase that a key component of the cell cycle machinery.	[Pereg, Yaron; O'Rourke, Karen M.; Dey, Anwesha; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Liu, Bob Y.] Genentech Inc, Dept Canc Pathways & Targets, San Francisco, CA 94080 USA; [Sagolla, Meredith; Komuves, Laszlo; French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wallace RW, 1997, DRUG DISCOV TODAY, V2, P83, DOI 10.1016/S1359-6446(97)01004-0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	22	98	106	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					400	U226		10.1038/ncb2041	http://dx.doi.org/10.1038/ncb2041			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228808				2022-12-27	WOS:000276194600013
J	Ahmed, S; Brickner, DG; Light, WH; Cajigas, I; McDonough, M; Froyshteter, AB; Volpe, T; Brickner, JH				Ahmed, Sara; Brickner, Donna G.; Light, William H.; Cajigas, Ivelisse; McDonough, Michele; Froyshteter, Alexander B.; Volpe, Tom; Brickner, Jason H.			DNA zip codes control an ancient mechanism for gene targeting to the nuclear periphery	NATURE CELL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; REVERSE RECRUITMENT; ACTIVE GENES; PORE; EXPRESSION; TRANSCRIPTION; LOCALIZATION; ORGANIZATION; ASSOCIATION	Many genes in Saccharomyces cerevisiae are recruited to the nuclear periphery after transcriptional activation. We have identified two gene recruitment sequences (GRS I and II) from the promoter of the INO1 gene that target the gene to the nuclear periphery. These GRSs function as DNA zip codes and are sufficient to target a nucleoplasmic locus to the nuclear periphery. Targeting requires components of the nuclear pore complex (NPC) and a GRS is sufficient to confer a physical interaction with the NPC. GRS I elements are enriched in promoters of genes that interact with the NPC, and genes that are induced by protein folding stress. Full transcriptional activation of INO1 and another GRS-containing gene requires GRS-mediated targeting of the promoter to the nuclear periphery. Finally, GRS I also functions as a DNA zip code in Schizosaccharomyces pombe, suggesting that this mechanism of targeting to the nuclear periphery has been conserved over approximately one billion years of evolution.	[Ahmed, Sara; Brickner, Donna G.; Light, William H.; Cajigas, Ivelisse; Froyshteter, Alexander B.; Brickner, Jason H.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [McDonough, Michele; Volpe, Tom] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Brickner, JH (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-brickner@northwestern.edu		Brickner, Jason/0000-0001-8019-3743; McDonough, Michele/0000-0002-3718-6465	Searle Leadership Fund at Northwestern University; The Searle Funds at The Chicago Community Trust; American Cancer Society; National Institutes of Health [GM080484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080484] Funding Source: NIH RePORTER	Searle Leadership Fund at Northwestern University; The Searle Funds at The Chicago Community Trust; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Robert Lamb for generously sharing his confocal microscope. Also, we thank Audrey Gasch, Richard Carthew, Rick Gaber, Sandy Westerheide, Jonathan Widom, Susan Wente, Michael Rout and members of the Brickner lab for helpful discussions. This work was supported by the Searle Leadership Fund at Northwestern University, a gift of The Searle Funds at The Chicago Community Trust (J. H. B.), an Institutional Research Grant from the American Cancer Society (J. H. B.) and National Institutes of Health grant GM080484 (J. H. B.).	Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner Jason H, 2004, PLoS Biol, V2, pe342; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chekanova JA, 2008, RNA, V14, P66, DOI 10.1261/rna.764108; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sarma NJ, 2007, GENETICS, V175, P1127, DOI 10.1534/genetics.106.068932; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; SIKORSKI RS, 1989, GENETICS, V122, P19; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SWIFT S, 1995, NUCLEIC ACIDS RES, V23, P1426, DOI 10.1093/nar/23.8.1426; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0	39	140	142	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					111	U43		10.1038/ncb2011	http://dx.doi.org/10.1038/ncb2011			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098417	Green Accepted			2022-12-27	WOS:000274139400005
J	Rodeheffer, MS				Rodeheffer, Matthew S.			Tipping the scale: muscle versus fat	NATURE CELL BIOLOGY			English	Editorial Material							BONE-MARROW; STEM-CELLS; DIFFERENTIATION	Adipocytes and scar tissue form during skeletal muscle degeneration. Two new studies reveal that adipocytes and fibroblasts in skeletal muscle derive from a population of bipotent progenitors that reside within muscle, but are not derived from the muscle lineage. These progenitor cells also have a surprising role in stimulating the restoration of muscle mass during regeneration.	Yale Univ, Sch Med, Comparat Med Sect, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University	Rodeheffer, MS (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA.	matthew.rodeheffer@yale.edu						Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carpenter S, 2001, PATHOLOGY SKELETAL M; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Yeow K, 2001, FEBS LETT, V506, P157, DOI 10.1016/S0014-5793(01)02900-3	15	45	46	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					102	104		10.1038/ncb0210-102	http://dx.doi.org/10.1038/ncb0210-102			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081844				2022-12-27	WOS:000274139400002
J	Fujita, K; Mondal, AM; Horikawa, I; Nguyen, GH; Kumamoto, K; Sohn, JJ; Bowman, ED; Mathe, EA; Schetter, AJ; Pine, SR; Ji, H; Vojtesek, B; Bourdon, JC; Lane, DP; Harris, CC				Fujita, Kaori; Mondal, Abdul M.; Horikawa, Izumi; Nguyen, Giang H.; Kumamoto, Kensuke; Sohn, Jane J.; Bowman, Elise D.; Mathe, Ewy A.; Schetter, Aaron J.; Pine, Sharon R.; Ji, Helen; Vojtesek, Borivoj; Bourdon, Jean-Christophe; Lane, David P.; Harris, Curtis C.			p53 isoforms Delta 133p53 and p53 beta are endogenous regulators of replicative cellular senescence	NATURE CELL BIOLOGY			English	Article							ONCOGENE-INDUCED SENESCENCE; HUMAN-COLON; DNA-DAMAGE; DOWNSTREAM TARGET; EXPRESSION; MIR-34A; CANCER; GENE; APOPTOSIS; CELLS	The finite proliferative potential of normal human cells leads to replicative cellular senescence, which is a critical barrier to tumour progression in vivo(1-3). We show that the human p53 isoforms Delta 133p53 and p53 beta(4) function in an endogenous regulatory mechanism for p53-mediated replicative senescence. Induced p53 beta and diminished Delta 133p53 were associated with replicative senescence, but not oncogene-induced senescence, in normal human fibroblasts. The replicatively senescent fibroblasts also expressed increased levels of miR-34a, a p53-induced microRNA(5-9), the antisense inhibition of which delayed the onset of replicative senescence. The siRNA (short interfering RNA)-mediated knockdown of endogenous Delta 133p53 induced cellular senescence, which was attributed to the regulation of p21(WAF1) and other p53 transcriptional target genes. In overexpression experiments, whereas p53 beta cooperated with full-length p53 to accelerate cellular senescence, Delta 133p53 repressed miR-34a expression and extended the cellular replicative lifespan, providing a functional connection of this microRNA to the p53 isoform-mediated regulation of senescence. The senescence-associated signature of p53 isoform expression (that is, elevated p53 beta and reduced Delta 133p53) was observed in vivo in colon adenomas with senescent phenotypes(10,11). The increased Delta 133p53 and decreased p53 beta isoform expression found in colon carcinoma may signal an escape from the senescence barrier during the progression from adenoma to carcinoma.	[Fujita, Kaori; Mondal, Abdul M.; Horikawa, Izumi; Nguyen, Giang H.; Kumamoto, Kensuke; Sohn, Jane J.; Bowman, Elise D.; Mathe, Ewy A.; Schetter, Aaron J.; Pine, Sharon R.; Ji, Helen; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nguyen, Giang H.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20814 USA; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Brno 65653, Czech Republic; [Bourdon, Jean-Christophe; Lane, David P.] Univ Dundee, Ninewells Hosp, Dept Surg & Mol Oncol, Inserm European Associated Lab, Dundee DD1 9SY, Scotland; [Lane, David P.] Inst Mol & Cell Biol, Singapore 138673, Singapore	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; Masaryk Memorial Cancer Institute; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	JC, Bourdon/A-4439-2008; Mathe, Ewy/L-1616-2019	JC, Bourdon/0000-0003-4623-9386; Lane, David/0000-0003-0551-3545; Mathe, Ewy/0000-0003-4491-8107	NIH, National Cancer Institute (NCI); Grant Agency of the Czech Republic (GACR) [301/08/1468]; Internal Grant Agency of Health of Czech Republic (IGA MZ CR) [NS/9812-4]; Breast Cancer Campaign, Cancer-Research UK (CRUK); Institut National de la Same et de la Recherche Medicale (Inserm); NATIONAL CANCER INSTITUTE [ZIABC005795, ZIABC005480, Z01BC010878, Z01BC005480] Funding Source: NIH RePORTER	NIH, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Internal Grant Agency of Health of Czech Republic (IGA MZ CR); Breast Cancer Campaign, Cancer-Research UK (CRUK)(Cancer Research UK); Institut National de la Same et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Serrano, M. Tainsky, M. Oshimura, G. Hannon, T. de Lange and J. Khan for cells and reagents, X. Wang for helpful discussions, E. Spillare for continuous support and E. Michalova for technical assistance. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute (NCI). B.V. was supported by the grants from the Grant Agency of the Czech Republic (GACR; number 301/08/1468) and the Internal Grant Agency of Health of Czech Republic (IGA MZ CR; number NS/9812-4). J.C.B. was supported by Breast Cancer Campaign, Cancer-Research UK (CRUK) and the Institut National de la Same et de la Recherche Medicale (Inserm). D.L. is a Gibb fellow of CRUK. H. J. participated in the NIH Summer Internship Program.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; AUTRUP H, 1980, CARCINOGENESIS, V1, P375, DOI 10.1093/carcin/1.5.375; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; COSTA A, 1995, J PATHOL, V176, P45, DOI 10.1002/path.1711760108; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; Gjoerup OV, 2007, P NATL ACAD SCI USA, V104, P8334, DOI 10.1073/pnas.0703164104; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HORIKAWA I, 1995, HUM MOL GENET, V4, P313, DOI 10.1093/hmg/4.2.313; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang Q, 2007, CANCER RES, V67, P11677, DOI 10.1158/0008-5472.CAN-07-1390; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	44	228	233	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1135	U208		10.1038/ncb1928	http://dx.doi.org/10.1038/ncb1928			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701195	Green Accepted			2022-12-27	WOS:000269482500016
J	Ro, H; Dawid, IB				Ro, Hyunju; Dawid, Igor B.			Organizer restriction through modulation of Bozozok stability by the E3 ubiquitin ligase Lnx-like	NATURE CELL BIOLOGY			English	Article							NUMB PROTEIN-X; HOMEOBOX GENE; ANTERIOR NEUROECTODERM; PATTERN-FORMATION; DORSAL ORGANIZER; XENOPUS EMBRYOS; BETA-CATENIN; ZEBRAFISH; PATHWAY; AXIS	The organizer anchors the primary embryonic axis, and balance between dorsal (organizer) and ventral domains is fundamental to body patterning. LNX (ligand of Numb protein-X) is a RING finger and four PDZ domain-containing E3 ubiquitin ligase(1,2). LNX serves as a binding platform and may have a role in cell fate determination, but its in vivo functions are unknown(1-5). Here we show that Lnx-l (Lnx-like) functions as a critical regulator of dorso-ventral axis formation in zebrafish. Depletion of Lnx-l using specific antisense morpholinos (MOs) caused strong embryonic dorsalization. We identified Bozozok (Boz, also known as Dharma or Nieuwkoid) as a binding partner and substrate of Lnx-l. Boz is a homeodomain-containing transcriptional repressor induced by canonical Wnt signalling that is critical for dorsal organizer formation (6-12). Lnx-l induced K48-linked polyubiquitylation of Boz, leading to its proteasomal degradation in human 293T cells and in zebrafish embryos. Dorsalization induced by Boz overexpression was suppressed by raising the level of Lnx-l, but Lnx-l failed to counteract dorsalization caused by mutant Boz lacking a critical motif for Lnx-l binding. Furthermore, dorsalization induced by depletion of Lnx-l was alleviated by attenuation of Boz expression. We conclude that Lnx-l modulates Boz activity to prevent the invasion of ventral regions of the embryo by organizer tissue. These studies introduce a ubiquitin ligase, Lnx-l, as a balancing modulator of axial patterning in the zebrafish embryo.	[Ro, Hyunju; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Ro, Hyunju/0000-0002-0829-9639	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001002, ZIAHD008809] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Rath and J. Gonzales for help with fish maintenance, and S.-Y. Choi for helpful comments. This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health.	Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Gonzalez EM, 2000, GENE DEV, V14, P3087, DOI 10.1101/gad.852400; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koos DS, 1998, CURR BIOL, V8, P1199, DOI 10.1016/S0960-9822(07)00509-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Ro H, 2004, MOL CELLS, V17, P373; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zhu ZL, 2002, DEV CELL, V3, P557, DOI 10.1016/S1534-5807(02)00270-8	32	26	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1121	U165		10.1038/ncb1926	http://dx.doi.org/10.1038/ncb1926			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19668196	Green Accepted			2022-12-27	WOS:000269482500014
J	Phillips, CM; Meng, XD; Zhang, L; Chretien, JH; Urnov, FD; Dernburg, AF				Phillips, Carolyn M.; Meng, Xiangdong; Zhang, Lei; Chretien, Jacqueline H.; Urnov, Fyodor D.; Dernburg, Abby F.			Identification of chromosome sequence motifs that mediate meiotic pairing and synapsis in C. elegans	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; X-CHROMOSOME; RECOMBINATION; MEIOSIS; PROTEINS; COMPLEX; GENOME; MECHANISMS; MAP	Caenorhabditis elegans chromosomes contain specialized regions called pairing centres, which mediate homologous pairing and synapsis during meiosis. Four related proteins, ZIM-1, 2, 3 and HIM-8, associate with these sites and are required for their essential functions. Here we show that short sequence elements enriched in the corresponding chromosome regions selectively recruit these proteins in vivo. In vitro analysis using SELEX indicates that the binding specificity of each protein arises from a combination of two zinc fingers and an adjacent domain. Insertion of a cluster of recruiting motifs into a chromosome lacking its endogenous pairing centre is sufficient to restore homologous pairing, synapsis, crossover recombination and segregation. These findings help to illuminate how chromosome sites mediate essential aspects of meiotic chromosome dynamics.	[Phillips, Carolyn M.; Chretien, Jacqueline H.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Meng, Xiangdong; Zhang, Lei; Urnov, Fyodor D.] Sangamo BioSci, Pt Richmond Tech Ctr, Richmond, CA 94804 USA; [Chretien, Jacqueline H.; Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dernburg, Abby F.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA USA	University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Dernburg, AF (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 470 Stanley Hall,MC 3220, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011	Phillips, Carolyn/0000-0002-6228-6468; Dernburg, Abby/0000-0001-8037-1079	NSF; Burroughs Wellcome Career Award [1000950]; NIH [R01 GM065591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065591] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF Predoctoral Fellowship (C. M. P.) and by Burroughs Wellcome Career Award 1000950 and NIH R01 GM065591 (A. F. D.). We are grateful to Anne Villeneuve for SYP-1 antibodies, Barbara Meyer, Kevin Corbett and Ed Rebar for valuable suggestions, to members of the Meyer lab for assistance with the extrachromosomal array assay and to members of the Dernburg lab and anonymous referees for helpful comments on the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; HERMAN RK, 1989, GENETICS, V121, P723; HODGKIN J, 1979, GENETICS, V91, P67; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kelly WG, 2002, DEVELOPMENT, V129, P479; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; MCKIM KS, 1988, GENETICS, V120, P987; MCKIM KS, 1993, GENETICS, V134, P749; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Nicoll M, 1997, NATURE, V388, P200, DOI 10.1038/40645; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Sanford C, 2001, NUCLEIC ACIDS RES, V29, P2920, DOI 10.1093/nar/29.14.2920; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VILLENEUVE AM, 1994, GENETICS, V136, P887; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; ZETKA M, 1995, TRENDS GENET, V11, P27, DOI 10.1016/S0168-9525(00)88983-0; ZETKA MC, 1992, GENETICS, V131, P321	30	87	93	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					934	U66		10.1038/ncb1904	http://dx.doi.org/10.1038/ncb1904			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620970	Green Accepted, Green Submitted			2022-12-27	WOS:000268593200006
J	Fuchs, E				Fuchs, Elaine			Building confidence: the transition from student to professor	NATURE CELL BIOLOGY			English	Editorial Material									Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIAMS NIH HHS [R01 AR027883-27, R01 AR027883-25, R01 AR031737-27, R01 AR050452, R01 AR031737-17, R01 AR031737-21, R01 AR050452-05, R01 AR050452-03, R01 AR027883-26, R01 AR031737-23, R01 AR050452-04, R01 AR031737-24, R01 AR031737-20, R01 AR027883-28, R01 AR031737-21S1, R01 AR050452-01, R01 AR031737-22, R01 AR031737-19, R01 AR031737, R01 AR050452-02, R01 AR031737-26, R01 AR031737-27S1, R01 AR031737-25, R01 AR031737-18, R01 AR027883-29, R01 AR050452-06A2] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452, R01AR027883] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					786	786		10.1038/ncb0709-786	http://dx.doi.org/10.1038/ncb0709-786			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19568262	Bronze, Green Accepted			2022-12-27	WOS:000267603100002
J	Schatz, G				Schatz, Gottfried			Coming in from the cold: how answering a postcard can launch a scientific career	NATURE CELL BIOLOGY			English	Editorial Material									[Schatz, Gottfried] Univ Basel, Biozentrum, CH-5056 Basel, Switzerland	University of Basel	Schatz, G (corresponding author), Univ Basel, Biozentrum, Kingelbergstr 70, CH-5056 Basel, Switzerland.	gottfried.schatz@unibas.ch							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					364	364		10.1038/ncb0409-364	http://dx.doi.org/10.1038/ncb0409-364			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19337317	Bronze			2022-12-27	WOS:000265264900003
J	Simons, M; Gault, WJ; Gotthardt, D; Rohatgi, R; Klein, TJ; Shao, YM; Lee, HJ; Wu, AL; Fang, YM; Satlin, LM; Dow, JT; Chen, J; Zheng, J; Boutros, M; Mlodzik, M				Simons, Matias; Gault, William J.; Gotthardt, Daniel; Rohatgi, Rajeev; Klein, Thomas J.; Shao, Youming; Lee, Ho-Jin; Wu, Ai-Luen; Fang, Yimin; Satlin, Lisa M.; Dow, Julian T.; Chen, Jie; Zheng, Jie; Boutros, Michael; Mlodzik, Marek			Electrochemical cues regulate assembly of the Frizzled/Dishevelled complex at the plasma membrane during planar epithelial polarization	NATURE CELL BIOLOGY			English	Article							NA+/H+ EXCHANGER; CELL POLARITY; PHOSPHATIDIC-ACID; DROSOPHILA; BINDING; PROTEIN; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; MOTILITY	Dishevelled (Dsh) is a cytoplasmic multidomain protein that is required for all known branches of the Wnt signalling pathway(1-3). The Frizzled/planar cell polarity (Fz/PCP) signalling branch requires an asymmetric cortical localization of Dsh, but this process remains poorly understood. Using a genome-wide RNA interference (RNAi) screen in Drosophila melanogaster cells, we show that Dsh membrane localization is dependent on the Na+/H+ exchange activity of the plasma membrane exchanger Nhe2. Manipulating Nhe2 expression levels in the eye causes PCP defects, and Nhe2 interacts genetically with Fz. Our data show that the binding and surface recruitment of Dsh by Fz is pH- and charge-dependent. We identify a polybasic stretch within the Dsh DEP domain that binds to negatively charged phospholipids and appears to be mechanistically important. Dsh recruitment by Fz can be abolished by converting these basic amino-acid residues into acidic ones, as in the mutant, DshKR/E. In vivo, the DshKR/E(2x) mutant with two substituted residues fails to associate with the membrane during active PCP signalling but rescues canonical Wnt signalling defects in a dsh-background. These results suggest that direct interaction between Fz and Dsh is stabilized by a pH and charge-dependent interaction of the DEP domain with phospholipids. This stabilization is particularly important for the PCP signalling branch and, thus, promotes specific pathway selection in Wnt signalling.	[Simons, Matias; Gault, William J.; Klein, Thomas J.; Mlodzik, Marek] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Gotthardt, Daniel] Univ Heidelberg Hosp, Dept Med, Div Gastroenterol, D-69120 Heidelberg, Germany; [Rohatgi, Rajeev; Satlin, Lisa M.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Shao, Youming; Lee, Ho-Jin; Zheng, Jie] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Ai-Luen; Fang, Yimin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Dow, Julian T.] Univ Glasgow, Inst Biomed & Life Sci, Div Mol Genet, Glasgow, Lanark, Scotland; [Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany	Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ)	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	marek.mlodzik@mssm.edu	Boutros, Michael/C-3566-2008; Dow, Julian/M-2371-2019; Simons, Matias/I-2038-2017; Lee, Ho-Jin/O-9944-2014	Boutros, Michael/0000-0002-9458-817X; Dow, Julian/0000-0002-9595-5146; Simons, Matias/0000-0003-3959-6350; Lee, Ho-Jin/0000-0002-3251-4984; Gault, William/0000-0002-4470-8428; Chen, Jie/0000-0002-7887-3747; Zheng, Jie/0000-0001-6524-6800	NIH [RO1 GM62917]; EMBO; DFG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM062917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bloomington Stock Center for fly strains, S. Grinstein, J. Orlowski, T. Kirchhausen and R. Bizzarri for cDNA constructs. We are grateful to A. Jenny and Y. Wang for the cloning of cDNA constructs, and U. Weber for analysis of the embryonic/ early larval lethal phenotype. We thank C. Iomini, R. Krauss, S. Sokol and D. del Alamo for reading the manuscript, members of the Mlodzik laboratory for discussions and S. Okello, G. Garcia and M. Stricker for technical support. The work has been supported by NIH grant to M. M. RO1 GM62917. M. S. was a recipient of EMBO and DFG long-term fellowships.	Axelrod JD, 2001, GENE DEV, V15, P1182; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Giannakou ME, 2001, J EXP BIOL, V204, P3703; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; MUSTONEN P, 1993, BIOCHEMISTRY-US, V32, P5373, DOI 10.1021/bi00071a012; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Penton A, 2002, GENETICS, V161, P747; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	29	139	141	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					286	U142		10.1038/ncb1836	http://dx.doi.org/10.1038/ncb1836			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19234454	Green Accepted			2022-12-27	WOS:000263777900012
J	van den Bogaart, G; Meinema, AC; Krasnikov, V; Veenhoff, LM; Poolman, B				van den Bogaart, Geert; Meinema, Anne C.; Krasnikov, Victor; Veenhoff, Liesbeth M.; Poolman, Bert			Nuclear transport factor directs localization of protein synthesis during mitosis	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA TRANSLATION; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEINS; LIVING CELLS; YEAST; EXPORT; REQUIREMENT; MOBILITY; IMPORT; NAB2P	Export of messenger RNA from the transcription site in the nucleus and mRNA targeting to the translation site in the cytoplasm are key regulatory processes in protein synthesis. In yeast, the mRNA-binding proteins Nab2p and Nab4p/Hrp1p accompany transcripts to their translation site, where the karyopherin Kap104p mediates both their dissociation from the mRNA and their transport back into the nucleus. We found that Kap104p localized to the distal bud tip and the bud neck during cell division, resulting in a localized release of translation-competent mRNA and increased protein synthesis in the emerging daughter cell. Temporally and spatially coordinated localization of Kap104p is a new mechanism for the asymmetric distribution of protein synthesis in dividing cells.	[van den Bogaart, Geert; Meinema, Anne C.; Veenhoff, Liesbeth M.; Poolman, Bert] Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands; [van den Bogaart, Geert; Krasnikov, Victor; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Veenhoff, LM (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	l.m.veenhoff@rug.nl; b.poolman@rug.nl	van den Bogaart, Geert/GLV-3283-2022; Poolman, Bert/D-1882-2012; van den Bogaart, Geert/A-1089-2014; Institute, Zernike/W-7033-2019	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Veenhoff, Liesbeth/0000-0002-0158-4728	Netherlands Science Foundation NWO [814.02.002]; VENI fellowship; Netherlands Proteomics Centre; Zernike Institute for Advanced Materials	Netherlands Science Foundation NWO(Netherlands Organization for Scientific Research (NWO)); VENI fellowship; Netherlands Proteomics Centre; Zernike Institute for Advanced Materials	We thank M. P. Rout, B. L. Timney, C. Strambio- de- Castillia, J. J. Schuringa, J. D. Aitchison and P. Orlean for strains, plasmids and valuable comments. Financial support was provided by the Netherlands Science Foundation NWO ( ALW grant number 814.02.002; VENI fellowship to L. M. V.; TopSubsidy to B. P.), the Netherlands Proteomics Centre and the Zernike Institute for Advanced Materials.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Apponi LH, 2007, MOL CELL BIOL, V27, P6569, DOI 10.1128/MCB.00881-07; Asakawa K, 2002, GENETICS, V162, P1545; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Muller M, 2007, CELL MOL LIFE SCI, V64, P171, DOI 10.1007/s00018-006-6286-1; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van den Bogaart G, 2007, BIOPHYS J, V92, P1598, DOI 10.1529/biophysj.106.096461; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004	30	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					350	U269		10.1038/ncb1844	http://dx.doi.org/10.1038/ncb1844			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198597	Green Published			2022-12-27	WOS:000263777900020
J	Maetzel, D; Denzel, S; Mack, B; Canis, M; Went, P; Benk, M; Kieu, C; Papior, P; Baeuerle, PA; Munz, M; Gires, O				Maetzel, Dorothea; Denzel, Sabine; Mack, Brigitte; Canis, Martin; Went, Philip; Benk, Michael; Kieu, Cuong; Papior, Peer; Baeuerle, Patrick A.; Munz, Markus; Gires, Olivier			Nuclear signalling by tumour-associated antigen EpCAM	NATURE CELL BIOLOGY			English	Article							DEPENDENT GAMMA-SECRETASE; EP-CAM; BREAST-CANCER; BETA-CATENIN; CELL-PROLIFERATION; ADHESION MOLECULE; COLORECTAL-CANCER; STEM-CELLS; C-MYC; TARGET	EpCAM was found to be overexpressed on epithelial progenitors, carcinomas and cancer-initiating cells. The role of EpCAM in proliferation, and its association with cancer is poorly explained by proposed cell adhesion functions. Here we show that regulated intramembrane proteolysis activates EpCAM as a mitogenic signal transducer in vitro and in vivo. This involves shedding of its ectodomain EpEX and nuclear translocation of its intracellular domain EpICD. Cleavage of EpCAM is sequentially catalysed by TACE and presenilin-2. Pharmacological inhibition or genetic silencing of either protease impairs growth-promoting signalling by EpCAM, which is compensated for by EpICD. Released EpICD associates with FHL2, beta-catenin and Lef-1 to form a nuclear complex that contacts DNA at Lef-1 consensus sites, induces gene transcription and is oncogenic in immunodeficient mice. In patients, EpICD was found in nuclei of colon carcinoma but not of normal tissue. Nuclear signalling of EpCAM explains how EpCAM functions in cell proliferation.	[Maetzel, Dorothea; Denzel, Sabine; Benk, Michael; Munz, Markus; Gires, Olivier] Univ Munich, Helmholtz Zentrum Munchen, Clin Cooperat Grp Mol Oncol, German Res Ctr Environm Hlth, D-81377 Munich, Germany; [Maetzel, Dorothea; Denzel, Sabine; Benk, Michael; Munz, Markus; Gires, Olivier] Univ Munich, Head & Neck Res Dept, Munich, Germany; [Mack, Brigitte; Canis, Martin; Kieu, Cuong; Gires, Olivier] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-81377 Munich, Germany; [Went, Philip] Univ Zurich, Inst Pathol, CH-8063 Zurich, Switzerland; [Baeuerle, Patrick A.; Munz, Markus] Micromet Inc, Bethesda, MD 20817 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; University of Zurich	Gires, O (corresponding author), Univ Munich, Helmholtz Zentrum Munchen, Clin Cooperat Grp Mol Oncol, German Res Ctr Environm Hlth, D-81377 Munich, Germany.	olivier.gires@med.uni-muenchen.de	Went, Philip/C-8203-2009; Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064	Deutsche Krebshilfe; Mildred-Scheel-Stiftung; Ralf Schulz	Deutsche Krebshilfe(Deutsche Krebshilfe); Mildred-Scheel-Stiftung(Deutsche Krebshilfe); Ralf Schulz	Work was supported by funding from the Deutsche Krebshilfe, Mildred-Scheel-Stiftung to M. M. and O.G. We are indebted to Jurgen Haas for technical help. We thank Wenlong Bai for FHL-2-GST constructs. We thank Ralf Schulz for support with in vivo fluorescence imaging. Animal experiments were conducted at the Walter Brendel Center (Director, U. Pohl).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Birchmeier W, 2005, EMBO REP, V6, P413, DOI 10.1038/sj.embor.7400408; BOHM C, 2006, J BIOL CHEM; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; CANAULT M, 2006, J CELL PHYSL; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gires O, 2006, BIOCHEM BIOPH RES CO, V343, P252, DOI 10.1016/j.bbrc.2006.02.139; Gires O, 2008, ATLAS GENET CYTOGENE; Hampe W, 2000, J CELL SCI, V113, P4475; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kenny PA, 2007, DIFFERENTIATION, V75, P800, DOI 10.1111/j.1432-0436.2007.00198.x; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Merchant NB, 2008, CLIN CANCER RES, V14, P1182, DOI 10.1158/1078-0432.CCR-07-1216; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RUF P, 2007, BR J CANC; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmelzer E., 2006, STEM CELLS; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TRZPIS M, 2008, J PATHOL; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	49	512	536	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					162	U117		10.1038/ncb1824	http://dx.doi.org/10.1038/ncb1824			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136966				2022-12-27	WOS:000263285500014
J	Rustighi, A; Tiberi, L; Soldano, A; Napoli, M; Nuciforo, P; Rosato, A; Kaplan, F; Capobianco, A; Pece, S; Di Fiore, PP; Del Sal, G				Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Nuciforo, Paolo; Rosato, Antonio; Kaplan, Fred; Capobianco, Anthony; Pece, Salvatore; Di Fiore, Pier Paolo; Del Sal, Giannino			The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer	NATURE CELL BIOLOGY			English	Article							MEDIATED PROTEOLYSIS; BREAST-CANCER; CELL-CYCLE; PHOSPHORYLATION; RECEPTOR; ISOMERIZATION; LOCALIZATION; APOPTOSIS; REVEALS; PATHWAY	Signalling through Notch receptors requires ligand-induced cleavage to release the intracellular domain, which acts as a transcriptional activator in the nucleus. Deregulated Notch1 signalling has been implicated in mammary tumorigenesis; however the mechanisms underlying Notch activation in breast cancer remain unclear. Here, we demonstrate that the prolyl-isomerase Pin1 interacts with Notch1 and affects Notch1 activation. Pin1 potentiates Notch1 cleavage by gamma-secretase, leading to an increased release of the active intracellular domain and ultimately enhancing Notch1 transcriptional and tumorigenic activity. We found that Notch1 directly induces transcription of Pin1, thereby generating a positive loop. In human breast cancers, we observed a strong correlation between Pin1 overexpression and high levels of activated Notch1. Thus, the molecular circuitry established by Notch1 and Pin1 may have a key role in cancer.	[Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Del Sal, Giannino] Lab Nazl CIB LNCIB, I-34012 Trieste, Italy; [Rustighi, Alessandra; Tiberi, Luca; Soldano, Alessia; Napoli, Marco; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34128 Trieste, Italy; [Nuciforo, Paolo; Pece, Salvatore; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy; [Rosato, Antonio] Univ Padua, Dipartimento Sci Oncol & Chirurg, I-35128 Padua, Italy; [Rosato, Antonio] IOV, I-35128 Padua, Italy; [Kaplan, Fred; Capobianco, Anthony] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Pece, Salvatore; Di Fiore, Pier Paolo] Ist Europeo Oncol, I-20141 Milan, Italy; [Di Fiore, Pier Paolo] Inst Mol Oncol Fdn, FIRC, IFOM, I-20139 Milan, Italy	University of Trieste; University of Milan; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); The Wistar Institute; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology	Del Sal, G (corresponding author), Lab Nazl CIB LNCIB, Area Sci Pk,Padriciano 99, I-34012 Trieste, Italy.	delsal@lncib.it	Pece, Salvatore/B-9609-2013; Di Fiore, Pier Paolo/K-2130-2012; Rosato, Antonio/E-8626-2010; Nuciforo, Paolo/Q-2885-2019; Tiberi, Luca/AAQ-4253-2021	Pece, Salvatore/0000-0003-1764-3929; Di Fiore, Pier Paolo/0000-0002-2252-0950; Rosato, Antonio/0000-0002-5263-8386; Napoli, Marco/0000-0001-7192-5252; Tiberi, Luca/0000-0002-5983-3782; Soldano, Alessia/0000-0002-3120-9929; Nuciforo, Paolo/0000-0003-1380-0990; DEL SAL, GIANNINO/0000-0003-2185-6003	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian University and Research Ministerium (Cofin MIUR); Friuli-Venezia-Giulia; Association for International Cancer Research (AICR, UK); Fondazione Giancarla Vollaro; Fondazione Monzino; FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro);  [R01 CA-83736-07]; NATIONAL CANCER INSTITUTE [R01CA083736] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian University and Research Ministerium (Cofin MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Friuli-Venezia-Giulia(Regione Friuli Venezia Giulia); Association for International Cancer Research (AICR, UK); Fondazione Giancarla Vollaro(Fondazione CarifeFondazione Caritro); Fondazione Monzino; FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank LNCIB colleagues, F. Mantovani, L. Collavin and S. Piccolo for critical reading of the manuscript; R. Poddighe for technical support, and M. Stebel and C. Degrassi of the C.S.P.A., University of Trieste. We are grateful to M. Donzelli for generation of the pcDNA3<SUP>N1 Delta E</SUP>-Flag construct, to T. Sudo for the anti-HES-1 antibody, A. Israel for pGL2-HES-1/LUC, T. Uchida for providing Pin1 knockout mice and to ICGEB for access to their facilities. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), from Italian University and Research Ministerium (Cofin MIUR), from Friuli-Venezia-Giulia (regional grant), from Association for International Cancer Research (AICR, UK) to G.D.S., and from R01 CA-83736-07 to A.C, AIRC and Fondazione Giancarla Vollaro to S.P. and to Fondazione Monzino and AIRC to P.P.D.F.; M.N. is a FIRC fellow (Fondazione Italiana per la Ricerca sul Cancro). This paper is dedicated to the memory of Stefano Ferrari.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; [Anonymous], 1989, CANC METASTASIS REV, V8, P82; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; DE SB, 1999, NATURE, V398, P518; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Hopfer O, 2005, BRIT J CANCER, V93, P709, DOI 10.1038/sj.bjc.6602719; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ito T, 2000, DEVELOPMENT, V127, P3913; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; OSIPO C, 2008, ONCOGENE; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramdya P, 2003, J NEUROCHEM, V87, P843, DOI 10.1046/j.1471-4159.2003.02030.x; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takahashi K, 2007, ONCOGENE, V26, P3835, DOI 10.1038/sj.onc.1210153; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	55	140	143	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					133	U62		10.1038/ncb1822	http://dx.doi.org/10.1038/ncb1822			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151708	Green Published			2022-12-27	WOS:000263285500011
J	Ji, L; Lim, J; Danuser, G				Ji, Lin; Lim, James; Danuser, Gaudenz			Fluctuations of intracellular forces during cell protrusion	NATURE CELL BIOLOGY			English	Article							FLUORESCENT SPECKLE MICROSCOPY; ACTIN NETWORKS; ENDOTHELIAL-CELLS; F-ACTIN; TRACKING MICRORHEOLOGY; MIGRATING FIBROBLASTS; FOCAL ADHESIONS; LIVING CELLS; GENERATION; MECHANICS	We present a model to estimate intracellular force variations from live-cell images of actin filament (F-actin) flow during protrusion-retraction cycles of epithelial cells in a wound healing response. To establish a mechanistic relationship between force development and cytoskelal dynamics, force fluctuations were correlated with fluctuations in F-actin turnover, flow and F-actin-vinculin coupling. Our analyses suggest that force transmission at focal adhesions requires binding of vinculin to F-actin and integrin ( indirectly), which is modulated at the vinculin-integrin but not the vinculin-F-actin interface. Force transmission at focal adhesions is colocalized in space and synchronized in time with transient increases in the boundary force at the cell edge. Surprisingly, the maxima in adhesion and boundary forces lag behind maximal edge advancement by about 40 s. Maximal F-actin assembly was observed about 20 s after maximal edge advancement. On the basis of these findings, we propose that protrusion events are limited by membrane tension and that the characteristic duration of a protrusion cycle is determined by the efficiency in reinforcing F-actin assembly and adhesion formation as tension increases.	[Ji, Lin; Lim, James; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Danuser, G (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gdanuser@scripps.edu		Danuser, Gaudenz/0000-0001-8583-2014	NIH [R01 GM71868]; NIGMS [U54 GM064346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071868, U54GM064346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Clare Waterman and Ke Hu for continued discussion of and encouragement for this study. We gratefully acknowledge funding from NIH R01 GM71868 and the Cell Migration Consortium, Grant No U54 GM064346 from NIGMS.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Boal D. H., 2002, MECH CELL; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; ENGL HW, 1994, NUMER MATH, V69, P25, DOI 10.1007/s002110050078; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; HOWARD J, 2001, J MECH MOTOR PROTEIN; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Marion S, 2005, EUR BIOPHYS J BIOPHY, V34, P262, DOI 10.1007/s00249-004-0449-5; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Prigozhina NL, 2006, J CELL SCI, V119, P3571, DOI 10.1242/jcs.03066; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Sterba RE, 1998, METHOD CELL BIOL, V55, P29; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Wang N, 1998, HYPERTENSION, V32, P162, DOI 10.1161/01.HYP.32.1.162; Wang Q, 2001, BLOOD, V97, P660, DOI 10.1182/blood.V97.3.660; Waterman-Storer C, 2002, CURR PROTOC CELL BIO; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yanai M, 2004, AM J PHYSIOL-CELL PH, V287, pC603, DOI 10.1152/ajpcell.00347.2003	62	137	137	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1393	U38		10.1038/ncb1797	http://dx.doi.org/10.1038/ncb1797			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19011623	Green Accepted			2022-12-27	WOS:000261261800009
J	Higuchi, M; Onishi, K; Kikuchi, C; Gotoh, Y				Higuchi, Maiko; Onishi, Keisuke; Kikuchi, Chikako; Gotoh, Yukiko			Scaffolding function of PAK in the PDK1-Akt pathway	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; P21-ACTIVATED KINASE; CELL-MIGRATION; CDC42; AKT; ACTIVATION; PHOSPHORYLATION; MOTILITY; BINDING; RAC	Many extracellular signals stimulate phosphatidylinositol-3- kinase, which in turn activates the Rac1 GTPase, the protein kinase Akt and the Akt Thr 308 upstream kinase PDK1. Active Rac1 stimulates a number of events, including substrate phosphorylation by a subgroup of the PAK family of kinases. The combined effects of Rac1, PDK1 and Akt are crucial for cell migration, growth, survival, metabolism and tumorigenesis. Here we show that Rac1 stimulates a second, kinase-independent function of PAK1. The PAK1 kinase domain serves as a scaffold to facilitate Akt stimulation by PDK1 and to aid recruitment of Akt to the membrane. PAK differentially activates subpopulations of Akt. These findings reveal scaffolding functions of PAK that regulate the efficiency, localization and specificity of the PDK1-Akt pathway.	[Higuchi, Maiko; Onishi, Keisuke; Kikuchi, Chikako; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Gotoh, Yukiko] Japan Sci & Technol Corp, SORST Res Project, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ygotoh@iam.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; SORST of the Japan Science and Technology Corporation; MEXT; Mitsubishi Foundation; Uehara Foundation; Princess Takamatsu Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SORST of the Japan Science and Technology Corporation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Uehara Foundation(Uehara Memorial Foundation); Princess Takamatsu Foundation	We thank Jonathan A. Cooper, Michael E. Greenberg and members of the Gotoh Laboratory for critical reading of the manuscript, encouragement and helpful discussion. We also thank Michael E. Greenberg and Steve M. Shamah for phosphorylated Bad antibody and phosphorylated PAK1 antibody, and Masaki Inagaki for PAK construct. This work was supported in part by Grants-Aid from the Ministry of Education, Science, Sports and Culture of Japan, SORST of the Japan Science and Technology Corporation, Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, the Mitsubishi Foundation, the Uehara Foundation and the Princess Takamatsu Foundation.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gorlach A, 2005, THROMB HAEMOSTASIS, V93, P1168, DOI 10.1160/TH05-01-0006; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jakobi R, 2002, BIOTECHNIQUES, V33, P1218, DOI 10.2144/02336bm07; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Reeder MK, 2001, J BIOL CHEM, V276, P40606, DOI 10.1074/jbc.M103925200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	30	149	150	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1356	U257		10.1038/ncb1795	http://dx.doi.org/10.1038/ncb1795			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931661				2022-12-27	WOS:000260586700019
J	Yang, JS; Gad, H; Lee, SY; Mironov, A; Zhang, LL; Beznoussenko, GV; Valente, C; Turacchio, G; Bonsra, AN; Du, GW; Baldanzi, G; Graziani, A; Bourgoin, S; Frohman, MA; Luini, A; Hsu, VW				Yang, Jia-Shu; Gad, Helge; Lee, Stella Y.; Mironov, Alexander; Zhang, Leiliang; Beznoussenko, Galina V.; Valente, Carmen; Turacchio, Gabriele; Bonsra, Akua N.; Du, Guangwei; Baldanzi, Gianluca; Graziani, Andrea; Bourgoin, Sylvain; Frohman, Michael A.; Luini, Alberto; Hsu, Victor W.			A role for phosphatidic acid in COPI vesicle fission yields insights into Golgi maintenance	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; BREFELDIN-A; MEMBRANE CURVATURE; COATED VESICLES; PHOSPHOLIPASE-D; GUANINE-NUCLEOTIDE; MAMMALIAN-CELLS; PROTEIN COMPLEX; ARF PROTEINS; TRANSPORT	Proteins essential for vesicle formation by the Coat Protein I (COPI) complex are being identified, but less is known about the role of specific lipids. Brefeldin-A ADP-ribosylated substrate (BARS) functions in the fission step of COPI vesicle formation. Here, we show that BARS induces membrane curvature in cooperation with phosphatidic acid. This finding has allowed us to further delineate COPI vesicle fission into two sub-stages: 1) an earlier stage of bud-neck constriction, in which BARS and other COPI components are required, and 2) a later stage of bud-neck scission, in which phosphatidic acid generated by phospholipase D2 (PLD2) is also required. Moreover, in contrast to the disruption of the Golgi seen on perturbing the core COPI components (such as coatomer), inhibition of PLD2 causes milder disruptions, suggesting that such COPI components have additional roles in maintaining Golgi structure other than through COPI vesicle formation.	[Yang, Jia-Shu; Lee, Stella Y.; Zhang, Leiliang; Hsu, Victor W.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Yang, Jia-Shu; Lee, Stella Y.; Zhang, Leiliang; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gad, Helge; Mironov, Alexander; Beznoussenko, Galina V.; Valente, Carmen; Turacchio, Gabriele; Luini, Alberto] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Bonsra, Akua N.; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Bonsra, Akua N.; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Baldanzi, Gianluca; Graziani, Andrea] Univ Piemonte Orientale, Dept Clin & Expt Med, I-28100 Novara, Italy; [Bourgoin, Sylvain] Ctr Hosp Univ Quebec, Pavillon CHUL, Quebec City, PQ G1V 4G2, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Consorzio Mario Negri Sud; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Eastern Piedmont Amedeo Avogadro; Laval University	Hsu, VW (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA.	vhsu@rics.bwh.harvard.edu	Valente, Carmen/AAH-5261-2019; graziani, andrea/B-2554-2009; Baldanzi, Gianluca/AAO-7673-2021; Graziani, Andrea/AAB-6301-2022; Gad, Helge/J-2238-2014	Valente, Carmen/0000-0002-6244-9108; graziani, andrea/0000-0002-6302-2317; Baldanzi, Gianluca/0000-0002-1370-9903; Graziani, Andrea/0000-0002-6302-2317; Du, Guangwei/0000-0003-4193-6975; Bourgoin, Sylvain/0000-0001-9779-0368; Gad, Helge/0000-0001-6530-1443	NIH [GM058615, GM071520, GM071475]; Telethon (Italy); AIRC (Italy); Canadian Institutes of Health Research; Marie Curie Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071475, R01GM071520, R01GM058615, R37GM058615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon (Italy)(Fondazione Telethon); AIRC (Italy)(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jian Li and Ming Bai for advice and discussions, and Richard Premont for technical assistance. This work was funded by grants from the NIH to V. W. H. (GM058615), M. A. F. (GM071520) and G. D. (GM071475), from Telethon (Italy), AIRC (Italy) to A. L. and A. M., and from the Canadian Institutes of Health Research (S. B.). H. G. was supported by a Marie Curie Fellowship.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HIMPENS B, 1994, FASEB J, V8, P879, DOI 10.1096/fasebj.8.11.8070638; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Kweon HS, 2004, MOL BIOL CELL, V15, P4710, DOI 10.1091/mbc.E03-12-0881; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; ORCI L, 1991, CELL, V64, P1183; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	45	120	123	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1146	1153		10.1038/ncb1774	http://dx.doi.org/10.1038/ncb1774			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776900	Green Accepted			2022-12-27	WOS:000259682900008
J	Li, M; Shin, YH; Hou, LF; Huang, XX; Wei, ZB; Klann, E; Zhang, PM				Li, Min; Shin, Yong-Hyun; Hou, Lingfei; Huang, Xingxu; Wei, Zhubo; Klann, Eric; Zhang, Pumin			The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; DEPENDENT DEGRADATION; CONTEXTUAL FEAR; AURORA-B; S-PHASE; EXPRESSION; PHOSPHORYLATION; SENESCENCE; MUTATIONS; MITOSIS	The anaphase promoting complex (APC) or cyclosome is a multi-subunit E3 ubiquitin ligase. Cdc20 (fizzy (fzy)) or p55CDC, and Cdh1 (Hct1, srw1 or fizzy-related 1 (fzr1)) encode two adaptor proteins that bring substrates to the APC. Both APC-Cdc20 and APC-Cdh1 have been implicated in the control of mitosis through mediating ubiquitination of mitotic regulators, such as cyclin B1 and securin. However, the importance of Cdh1 function in vivo and whether its function is redundant with that of Cdc20 are unclear. Here we have analysed mice lacking Cdh1. We show that Cdh1 is essential for placental development and that its deficiency causes early lethality. Cdh1-deficient mouse embryonic fibroblasts (MEFs) entered replicative senescence prematurely because of stabilization of Ets2 and subsequent activation of p16(Ink4a) expression. These results have uncovered an unexpected role of the APC in maintaining replicative lifespan of MEFs. Further, Cdh1 heterozygous mice show defects in late-phase long-term potentiation (L-LTP) in the hippocampus and are deficient in contextual fear-conditioning, suggesting that Cdh1 has a role in learning and memory.	[Li, Min; Shin, Yong-Hyun; Huang, Xingxu; Wei, Zhubo; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Zhang, Pumin] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hou, Lingfei] NYU, Ctr Neural Sci, New York, NY 10003 USA	Baylor College of Medicine; Baylor College of Medicine; New York University	Zhang, PM (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	pzhang@bcm.tmc.edu	Holt, Janet E/B-2415-2013	huang, xingxu/0000-0001-8934-1247	NCI NIH HHS [R01 CA122623, R01 CA116097, CA116097, R01 CA116097-02] Funding Source: Medline; NINDS NIH HHS [R37 NS034007, NS047384, R29 NS034007, R01 NS047384, NS034007, R01 NS034007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R29NS034007, R01NS034007, R37NS034007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yang BS, 1996, MOL CELL BIOL, V16, P538	25	115	120	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1083	1089		10.1038/ncb1768	http://dx.doi.org/10.1038/ncb1768			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160489	Green Accepted			2022-12-27	WOS:000258910400014
J	Gardner, MK; Odde, DJ				Gardner, Melissa K.; Odde, David J.			Dam1 complexes go it alone on disassembling microtubules	NATURE CELL BIOLOGY			English	Editorial Material							RING COMPLEX; YEAST; DEPOLYMERIZATION; KINETOCHORES; MECHANISM; DYNAMICS; PROTEIN; MITOSIS	Kinetochores maintain a mechanical grip on disassembling microtubule plus ends, possibly through a 16-member Dam1 ring that acts as a sliding clamp. it turns out, however, that a ring is not required for maintaining grip: individual Dam1 complexes in vitro can diffuse on the microtubule lattice and track shortening microtubule tips.	[Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gardner, MK (corresponding author), Univ Minnesota, Dept Biomed Engn, 312 Church St SE,7-132 Hasselmo Hall, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/H-4925-2011; Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799				Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; McIntosh JR, 2005, NAT STRUCT MOL BIOL, V12, P210, DOI 10.1038/nsmb0305-210; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	17	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					379	381		10.1038/ncb0408-379	http://dx.doi.org/10.1038/ncb0408-379			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379597				2022-12-27	WOS:000254561700005
J	Krieg, M; Arboleda-Estudillo, Y; Puech, PH; Kafer, J; Graner, F; Muller, DJ; Heisenberg, CP				Krieg, M.; Arboleda-Estudillo, Y.; Puech, P. -H.; Kaefer, J.; Graner, F.; Mueller, D. J.; Heisenberg, C. -P.			Tensile forces govern germ-layer organization in zebrafish	NATURE CELL BIOLOGY			English	Article							CELL-ADHESION; CORTICAL TENSION; N-CADHERIN; GASTRULATION; MORPHOGENESIS; MICROSCOPY; REARRANGEMENT; HYPOTHESIS; MOVEMENTS; WNT11	Understanding the factors that direct tissue organization during development is one of the most fundamental goals in developmental biology. Various hypotheses explain cell sorting and tissue organization on the basis of the adhesive and mechanical properties of the constituent cells(1). However, validating these hypotheses has been difficult due to the lack of appropriate tools to measure these parameters. Here we use atomic force microscopy ( AFM) to quantify the adhesive and mechanical properties of individual ectoderm, mesoderm and endoderm progenitor cells from gastrulating zebrafish embryos. Combining these data with tissue self-assembly in vitro and the sorting behaviour of progenitors in vivo, we have shown that differential actomyosin-dependent cell-cortex tension, regulated by Nodal/ TGF beta-signalling ( transforming growth factor beta), constitutes a key factor that directs progenitor-cell sorting. These results demonstrate a previously unrecognized role for Nodal-controlled cell-cortex tension in germ-layer organization during gastrulation.	[Krieg, M.; Arboleda-Estudillo, Y.; Mueller, D. J.] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Arboleda-Estudillo, Y.; Heisenberg, C. -P.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Puech, P. -H.] INSERM, UMR 600, CNRS UMR6212, Case 937, F-13288 Marseille, France; [Kaefer, J.; Graner, F.] UJF Grenoble 1, UMR 5588, Spectrometrie Phys Lab, F-38402 St Martin Dheres, France; [Kaefer, J.; Graner, F.] Ecole Natl Super Electrochim & Electrome Grenoble, Thermodynam & Physicochim Met Lab, CNRS, F-38402 St Martin Dheres, France	Technische Universitat Dresden; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Muller, DJ (corresponding author), Tech Univ Dresden, BIOTEC, Tatzberg 47-51, D-01307 Dresden, Germany.	mueller@biotec.tu-dresden.de; heisenberg@mpi-cbg.de	Käfer, Jos/AAR-1547-2021; Müller, Daniel J./A-5967-2010; Puech, Pierre-henri/G-1744-2013; Käfer, Jos/E-7714-2017	Käfer, Jos/0000-0002-0561-8008; Müller, Daniel J./0000-0003-3075-0665; Puech, Pierre-henri/0000-0002-8521-0685; Käfer, Jos/0000-0002-0561-8008; Krieg, Michael/0000-0003-0501-5036; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Aoki TO, 2002, DEVELOPMENT, V129, P275; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; GEIGER B, 1990, J CELL SCI, V97, P607; GRANER F, 1993, J THEOR BIOL, V164, P455, DOI 10.1006/jtbi.1993.1167; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lomakina EB, 2004, BIOPHYS J, V87, P4246, DOI 10.1529/biophysj.103.031765; MAREE AFM, 2007, CELLULAR POTTS BIOPH; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; SCHOTZ EM, IN PRESS QUANTITATIV; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Thoumine O, 1999, EUR BIOPHYS J BIOPHY, V28, P222, DOI 10.1007/s002490050203; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Zhang XH, 2004, AM J PHYSIOL-HEART C, V286, pH359, DOI 10.1152/ajpheart.00491.2003	36	565	576	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					429	U122		10.1038/ncb1705	http://dx.doi.org/10.1038/ncb1705			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364700				2022-12-27	WOS:000254561700013
J	McCullagh, E; Seshan, A; El-Samad, H; Madhani, HD				McCullagh, Emma; Seshan, Anupama; El-Samad, Hana; Madhani, Hiten D.			Coordinate control of gene expression noise and interchromosomal interactions in a MAP kinase pathway	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DNA-BINDING; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INVASIVE GROWTH; YEAST; REPRESSOR; STE12; PHEROMONE; KSS1	In the Saccharomyces cerevisiae pheromone-response pathway, the transcription factor Ste12 is inhibited by two mitogen-activated protein (MAP)-kinase-responsive regulators, Dig1 and Dig2. These two related proteins bind to distinct regions of Ste12 but are redundant in their inhibition of Ste12-dependent gene expression. Here we describe three functions for Dig1 that are non-redundant with those of Dig2. First, the removal of Dig1 results in a specific increase in intrinsic and extrinsic noise in the transcriptional outputs of the mating pathway. Second, in dig1 Delta cells, Ste12 relocalizes from the nucleoplasmic distribution seen in wild-type cells into discrete subnuclear foci. Third, genome-wide insertional chromatin immunoprecipitation studies revealed that Ste12-dependent genes have increased interchromosomal interactions in dig1 Delta cells. These findings suggest that the regulation of gene expression through long-range gene interactions, a widely observed phenomenon, comes at the cost of increased noise. Consequently, cells may have evolved mechanisms to suppress noise by controlling these interactions.	[McCullagh, Emma; Seshan, Anupama; El-Samad, Hana; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94158 USA.	Hana.El-Samad@ucsf.edu; hitenmadhani@gmail.com		seshan, anupama/0000-0002-7713-8599; Madhani, Hiten/0000-0001-7400-6657	Genentech Fellowship; National Science Foundation; National Institutes of Health (NIH) [R01 GM086379]; University of California, San Francisco; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086379] Funding Source: NIH RePORTER	Genentech Fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. S. Weissman, E. K. O'Shea, J. E. Haber, W. A. Lim, A. D. Johnson and D. J. Sherratt for plasmids and protocols; C. D. Chun and P.D. Hartley for help in conducting and analysing the ChIP-chip experiments; W. F. Marshall and K. Wemmer for assistance with microscopy; and A. D. Johnson, S. Komili, W.F. Marshall and S. Shankar for helpful comments on the manuscript. This work was supported by a Genentech Fellowship and a National Science Foundation Predoctoral Fellowship to E.M., a National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award to A.S., and funding from the University of California, San Francisco, Program for Breakthrough Biomedical Research and a NIH grant (R01 GM086379) to H.D.M. and H.E.-S.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; DeGregori J, 2006, CURR MOL MED, V6, P739; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; EISMANN E, 1987, J MOL BIOL, V195, P949, DOI 10.1016/0022-2836(87)90499-2; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; FIELDS S, 1988, MOL CELL BIOL, V8, P551, DOI 10.1128/MCB.8.2.551; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Meister P, 2006, CELL, V125, P1233, DOI 10.1016/j.cell.2006.06.014; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; WHITSON PA, 1987, J BIOL CHEM, V262, P14592; WHITSON PA, 1987, J BIOL CHEM, V262, P4943; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	65	48	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					954	962		10.1038/ncb2097	http://dx.doi.org/10.1038/ncb2097			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852627	Green Accepted			2022-12-27	WOS:000282363500010
J	Silver, PA				Silver, Pamela A.			Knowing when to change: reprogramming (my) life	NATURE CELL BIOLOGY			English	Editorial Material									[Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02138 USA.	pamela_silver@hms.harvard.edu							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					730	730		10.1038/ncb0810-730	http://dx.doi.org/10.1038/ncb0810-730			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20680000	Bronze			2022-12-27	WOS:000280561600002
J	Ma, L; Young, J; Prabhala, H; Pan, E; Mestdagh, P; Muth, D; Teruya-Feldstein, J; Reinhardt, F; Onder, TT; Valastyan, S; Westermann, F; Speleman, F; Vandesompele, J; Weinberg, RA				Ma, Li; Young, Jennifer; Prabhala, Harsha; Pan, Elizabeth; Mestdagh, Pieter; Muth, Daniel; Teruya-Feldstein, Julie; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Westermann, Frank; Speleman, Frank; Vandesompele, Jo; Weinberg, Robert A.			miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis	NATURE CELL BIOLOGY			English	Article							MESENCHYMAL TRANSITION; TUMOR INVASION; N-MYC; C-MYC; EXPRESSION; ADHESION; GROWTH; CELLS; GENES; TRANSFORMATION	MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly targets CDH1, the E-cadherin-encoding messenger RNA, leading to increased cell motility and invasiveness. miR-9-mediated E-cadherin downregulation results in the activation of beta-catenin signalling, which contributes to upregulated expression of the gene encoding vascular endothelial growth factor (VEGF); this leads, in turn, to increased tumour angiogenesis. Overexpression of miR-9 in otherwise non-metastatic breast tumour cells enables these cells to form pulmonary micrometastases in mice. Conversely, inhibiting miR-9 by using a 'miRNA sponge' in highly malignant cells inhibits metastasis formation. Expression of miR-9 is activated by MYC and MYCN, both of which directly bind to the mir-9-3 locus. Significantly, in human cancers, miR-9 levels correlate with MYCN amplification, tumour grade and metastatic status. These findings uncover a regulatory and signalling pathway involving a metastasis-promoting miRNA that is predicted to directly target expression of the key metastasis-suppressing protein E-cadherin.	[Ma, Li; Young, Jennifer; Pan, Elizabeth; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ma, Li; Young, Jennifer; Pan, Elizabeth; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ma, Li; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02142 USA; [Prabhala, Harsha] Univ Virginia, Med Scientist Training Program, Charlottesville, VA 22908 USA; [Mestdagh, Pieter; Speleman, Frank; Vandesompele, Jo] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Muth, Daniel; Westermann, Frank] German Canc Res Ctr, Dept Tumor Genet, D-69120 Heidelberg, Germany; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Virginia; Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Onder, Tamer/O-3669-2019; Vandesompele, Jo/W-3411-2018; Ma, Li/GQR-1313-2022; Westermann, Frank/F-7509-2013; speleman, frank/AAR-5184-2020; Onder, Tamer T/H-3330-2013	Onder, Tamer/0000-0002-2372-9158; Vandesompele, Jo/0000-0001-6274-0184; Ma, Li/0000-0001-9965-989X; speleman, frank/0000-0002-6628-8559; Onder, Tamer T/0000-0002-2372-9158; Mestdagh, Pieter/0000-0001-7821-9684; Young-Glazer, Jennifer/0000-0002-3265-9112	Life Sciences Research Foundation; Margaret and Herman Sokol Award; National Institutes of Health (NIH) Pathway to Independence Award [K99/R00]; Howard Hughes Medical Institute; MSKCC Cancer Core Grant; US Department of Defense Breast Cancer; NATIONAL CANCER INSTITUTE [K99CA138572] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Margaret and Herman Sokol Award; National Institutes of Health (NIH) Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MSKCC Cancer Core Grant; US Department of Defense Breast Cancer(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Johannes Schulte, Martin Eilers, Rosa Noguera, Margaret Ebert and Phillip Sharp for providing tumour samples and reagents; the Histology Core Lab at Massachusetts Institute of Technology (MIT) and Memorial Sloan-Kettering Cancer Center (MSKCC) for assistance with sectioning and immunohistochemistry; and members of the Weinberg laboratory for useful discussions. L. M. is a recipient of a Life Sciences Research Foundation Fellowship, a Margaret and Herman Sokol Award, and a National Institutes of Health (NIH) Pathway to Independence Award (K99/R00). J. Y. and E. P. are supported by a Howard Hughes Medical Institute Undergraduate Fellowship. J. T.- F. is supported by the MSKCC Cancer Core Grant. T. T. O. and S. V. are recipients of a US Department of Defense Breast Cancer Research Program Predoctoral Fellowship. R. A. W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Cancer Research Professor. This research is supported by a NIH grant to R. A. W. and the Ludwig Center for Molecular Oncology at MIT.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; ETHIER SP, 1993, CANCER RES, V53, P627; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malynn BA, 2000, GENE DEV, V14, P1390; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MESTDAGH P, ONCOGENE IN PRESS, DOI DOI 10.1038/ONC.2009.429; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; RAK J, 1995, CANCER RES, V55, P4575; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	59	1063	1134	1	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					247	U52		10.1038/ncb2024	http://dx.doi.org/10.1038/ncb2024			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173740	Green Accepted, Green Submitted			2022-12-27	WOS:000275054200010
J	Rybak, A; Fuchs, H; Hadian, K; Smirnova, L; Wulczyn, EA; Michel, G; Nitsch, R; Krappmann, D; Wulczyn, FG				Rybak, Agnieszka; Fuchs, Heiko; Hadian, Kamyar; Smirnova, Lena; Wulczyn, Ellery A.; Michel, Geert; Nitsch, Robert; Krappmann, Daniel; Wulczyn, F. Gregory			The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; NEURONAL DIFFERENTIATION; RNA INTERFERENCE; REGULATORY RNA; SELF-RENEWAL; RING FINGER; MICRORNA; EXPRESSION; BRAIN	The let-7 miRNA and its target gene Lin-28 interact in a regulatory circuit controlling pluripotency. We investigated an additional let-7 target, mLin41 (mouse homologue of lin-41), as a potential contributor to this circuit. We demonstrate the presence of mLin41 protein in several stem cell niches, including the embryonic ectoderm, epidermis and male germ line. mLin41 colocalized to cytoplasmic foci with P-body markers and the miRNA pathway proteins Ago2, Mov10 and Tnrc6b. In co-precipitation assays, mLin41 interacted with Dicer and the Argonaute proteins Ago1, Ago2 and Ago4. Moreover, we show that mLin41 acts as an E3 ubiquitin ligase in an auto-ubiquitylation assay and that mLin41 mediates ubiquitylation of Ago2 in vitro and in vivo. Overexpression and depletion of mLin41 led to inverse changes in the level of Ago2 protein, implicating mLin41 in the regulation of Ago2 turnover. mLin41 interfered with silencing of target mRNAs for let-7 and miR-124, at least in part by antagonizing Ago2. Furthermore, mLin41 cooperated with the pluripotency factor Lin-28 in suppressing let-7 activity, revealing a dual control mechanism regulating let-7 in stem cells.	[Rybak, Agnieszka; Fuchs, Heiko; Wulczyn, Ellery A.; Wulczyn, F. Gregory] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Smirnova, Lena] Ctr Alternat Methods Animals Expt, Fed Inst Risk Assessment, Unit 37, Berlin, Germany; [Michel, Geert] Charite, Transgene Facil, Forsch Einrichtung Expt Med, D-13353 Berlin, Germany; [Nitsch, Robert] Univ Med Mainz, Inst Microscop Anat & Neurobiol, D-55128 Mainz, Germany; [Hadian, Kamyar; Krappmann, Daniel] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Toxicol, Neuherberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wulczyn, FG (corresponding author), Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.	gregory.wulczyn@charite.de	Nitsch, Robert/AAI-9129-2021; Hadian, Kamyar/B-6314-2013; Krappmann, Daniel/ABF-4038-2021; Krappmann, Daniel/AAT-4354-2021; Fuchs, Helmut/M-7347-2014	Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Fuchs, Helmut/0000-0002-5143-2677; Fuchs, Heiko/0000-0001-9142-4084; Rybak-Wolf, Agnieszka/0000-0002-1192-5290; Michel, Geert/0000-0002-3518-1185	Humboldt University Graduate [238, 1123]; SFB [665]	Humboldt University Graduate; SFB(Austrian Science Fund (FWF))	The authors would like to thank members of the Robert Nitsch laboratories, in particular Vincenzo Catanzariti for assistance with figure preparation, and Ari Liebkowsky, Elisa Cuevas, Eleonora Franzoni and Junko Toraiwa for critical reading of the manuscript. Christian Hagemeier kindly provided tissue-specific cDNAs used in preliminary work. Michele Salanova ( testis) and Sven Hendrix and Ruth Schmidt-Ulrich (skin) helped with methods and interpretation of immunohistochemistry results. Nicola Brandt and Kristin Franke generously provided cultured hippocampal neurons. We acknowledge the laboratory support of Brita Scholte. L. S. and A. R. were fellows of the Humboldt University Graduate Schools 238 and 1123, respectively. Additional support was provided by SFB grant 665 to F. G. W. and R. N.	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Diederichs S, 2008, P NATL ACAD SCI USA, V105, P9284, DOI 10.1073/pnas.0800803105; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanamoto T, 2006, DEV DYNAM, V235, P1142, DOI 10.1002/dvdy.20712; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Lancman JJ, 2005, DEV DYNAM, V234, P948, DOI 10.1002/dvdy.20591; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Loedige I, 2009, CELL, V136, P818, DOI 10.1016/j.cell.2009.02.030; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodriguez A, 1996, GENETICS, V143, P929; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulman BRM, 2008, CELL CYCLE, V7, P3935; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; TOKUMARU S, 2008, CARCINOGENESIS; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xu C, 2004, ASIAN J ANDROL, V6, P217; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	162	167	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1411	U58		10.1038/ncb1987	http://dx.doi.org/10.1038/ncb1987			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19898466				2022-12-27	WOS:000272251300006
J	Kwon, C; Qian, L; Cheng, P; Nigam, V; Arnold, J; Srivastava, D				Kwon, Chulan; Qian, Li; Cheng, Paul; Nigam, Vishal; Arnold, Joshua; Srivastava, Deepak			A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; SMOOTH-MUSCLE; HEART FIELD; DIFFERENTIATION; BETA; MULTIPOTENT; EXPRESSION; MYOCARDIN; PROTEIN; DEC1	Regulation of multipotent cardiac progenitor cell (CPC) expansion and subsequent differentiation into cardiomyocytes, smooth muscle or endothelial cells is a fundamental aspect of basic cardiovascular biology and cardiac regenerative medicine. However, the mechanisms governing these decisions remain unclear. Here, we show that Wnt/beta-catenin signalling, which promotes expansion of CPCs1-3, is negatively regulated by Notch1-mediated control of phosphorylated beta-catenin accumulation within CPCs, and that Notch1 activity in CPCs is required for their differentiation. Notch1 positively, and beta-catenin negatively, regulated expression of the cardiac transcription factors, Isl1, Myocd and Smyd1. Surprisingly, disruption of Isl1, normally expressed transiently in CPCs before their differentiation(4), resulted in expansion of CPCs in vivo and in an embryonic stem (ES) cell system. Furthermore, Isl1 was required for CPC differentiation into cardiomyocyte and smooth muscle cells, but not endothelial cells. These findings reveal a regulatory network controlling CPC expansion and cell fate that involves unanticipated functions of beta-catenin, Notch1 and Isl1 that may be leveraged for regenerative approaches involving CPCs.	[Kwon, Chulan] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kwon, C (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	ckwon@gladstone.ucsf.edu; dsrivastava@gladstone.ucsf.edu		Nigam, Vishal/0000-0002-9652-8146; Cheng, Paul/0000-0003-3429-2702	American Heart Association (AHA); California Institute for Regenerative Medicine (CIRM); NHLBI/NIH; CIRM; NIH/NCRR [C06 RR018928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R13HD046201] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, R01HL057181, R01HL080592, K99HL092234, P50HL061033, R01HL062591] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CIRM(California Institute for Regenerative Medicine); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Kopan (Washington Univeristy, St. Louis, MO) and M. M. Taketo (Kyoto University, Kyoto, Japan) for providing Notch1<SUP>flox</SUP> and beta-catenin/loxP(ex3)<SUP>loxP</SUP> mice, respectively. The authors thank G. Howard and S. Ordway for editorial assistance, R. F. Yeh for statistical analyses, K. Cordes for graphical assistance, B. Taylor for manuscript and figure preparation and Srivastava lab members for helpful discussions. C. K. was supported by a fellowship from the American Heart Association (AHA) and California Institute for Regenerative Medicine (CIRM); D. S. was an Established Investigator of the AHA and was supported by grants from NHLBI/NIH and CIRM. This work was also supported by NIH/NCRR grant (C06 RR018928) to the Gladstone Institutes.	Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Kwon C, 2004, DEVELOPMENT, V131, P2681, DOI 10.1242/dev.01127; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rones MS, 2000, DEVELOPMENT, V127, P3865; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	34	180	188	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					951	U96		10.1038/ncb1906	http://dx.doi.org/10.1038/ncb1906			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620969	Green Accepted			2022-12-27	WOS:000268593200008
J	[Anonymous]				[Anonymous]			Genetic privacy and piracy	NATURE CELL BIOLOGY			English	Editorial Material								On the eve of a decision on a new gene diagnostics law in Germany, the debate about risks and benefits, although important, must not derail essential legislation.											0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					509	509		10.1038/ncb0509-509a	http://dx.doi.org/10.1038/ncb0509-509a			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404329	Bronze			2022-12-27	WOS:000265640000001
J	Ma, L; Tsai, MY; Wang, SS; Lu, BW; Chen, R; Yates, JR; Zhu, XL; Zheng, YX				Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Lu, Bingwen; Chen, Rong; Yates, John R., III; Zhu, Xueliang; Zheng, Yixian			Requirement for Nudel and dynein for assembly of the lamin B spindle matrix	NATURE CELL BIOLOGY			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; CYTOPLASMIC DYNEIN; PROTEIN DATABASE; YEAST PROTEOME; AURORA-A; ORGANIZATION; MIGRATION; KINETOCHORES; ARCHITECTURE; ASSOCIATION	The small guanosine triphosphatase Ran loaded with GTP ( RanGTP) can stimulate assembly of the type V intermediate filament protein lamin B into a membranous lamin B spindle matrix, which is required for proper microtubule organization during spindle assembly. Microtubules in turn enhance assembly of the matrix. Here we report that the isolated matrix contains known spindle assembly factors such as dynein and Nudel. Using spindle assembly assays in Xenopus egg extracts, we show that Nudel regulates microtubule organization during spindle assembly independently of its function at kinetochores. Importantly, Nudel interacts directly with lamin B to facilitate the accumulation and assembly of lamin-B-containing matrix on microtubules in a dynein-dependent manner. Perturbing either Nudel or dynein inhibited the assembly of lamin B matrix. However, depleting lamin B still allowed the formation of matrices containing dynein and Nudel. Therefore, dynein and Nudel regulate assembly of the lamin B matrix. Interestingly, we found that whereas depleting lamin B resulted in disorganized spindle and spindle poles, disrupting the function of Nudel or dynein caused a complete lack of spindle pole focusing. We suggest that Nudel regulates microtubule organization in part by facilitating assembly of the lamin B spindle matrix in a dynein-dependent manner.	[Ma, Li; Zhu, Xueliang; Zheng, Yixian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; [Ma, Li; Zhu, Xueliang; Zheng, Yixian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr Cell Signaling, Shanghai, Peoples R China; [Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Chen, Rong; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Ma, Li; Tsai, Ming-Ying; Wang, Shusheng; Chen, Rong; Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Tsai, Ming-Ying] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Lu, Bingwen; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Carnegie Institution for Science; Howard Hughes Medical Institute; University of Nebraska System; University of Nebraska Medical Center; Scripps Research Institute	Zhu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	xlzhu@sibs.ac.cn; zheng@ciwemb.edu			National Institutes of Health [GM56312, MH067880, P41 RR011823]; Chinese Academy of Sciences [CXTD-S2005-3]; Ministry of Science and Technology of China [2007CB914501, 2005CB522703]; National Science Foundation of China [30721065, 30623003, 30830060]; Cystic Fibrosis Foundation Therapeutics, Inc [BALCH05X5]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cystic Fibrosis Foundation Therapeutics, Inc; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr Reimer Stick for LB3 monoclonal antibody, Dr Robert Goldman for the full- length LB3 construct, Ms Shufang He and Ms Xiaoyan Wang for help with the Biacore experiments, Mr Dan Ducat and Mr Ben Goodman for help with egg extracts, Ms Ona Martin for technical support, and Dr Max Guo and the members of the Zheng laboratory for critical comments. The work was supported by the National Institutes of Health (GM56312 to Y. Z.; MH067880 and P41 RR011823 to J.R.Y.), the Chinese Academy of Sciences (CXTD-S2005-3 to X. Z.), the Ministry of Science and Technology of China (2007CB914501 and 2005CB522703 to X. Z.), the National Science Foundation of China ( 30721065, 30623003 and 30830060 to X. Z.) and a Cystic Fibrosis Foundation Therapeutics, inc. computational fellowship (BALCH05X5 to B. L.). Y. Z. is an investigator of the Howard Hughes Medical Institute.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Cao K, 2004, CELL CYCLE, V3, P422; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Lourim D, 1996, J CELL SCI, V109, P1775; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Merdes A, 1997, J CELL BIOL, V138, P953, DOI 10.1083/jcb.138.5.953; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010; Yamamoto A, 2003, J CELL SCI, V116, P4501, DOI 10.1242/jcs.00835; Zheng YX, 2006, CELL CYCLE, V5, P2345, DOI 10.4161/cc.5.20.3365	36	80	80	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					246	U58		10.1038/ncb1832	http://dx.doi.org/10.1038/ncb1832			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198602	Green Accepted			2022-12-27	WOS:000263777900008
J	Devenport, D; Fuchs, E				Devenport, Danelle; Fuchs, Elaine			Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair follicles	NATURE CELL BIOLOGY			English	Article							NEURAL-TUBE DEFECTS; CELL POLARITY; CONVERGENT EXTENSION; SONIC HEDGEHOG; VAN-GOGH; LOCALIZATION; NOTCH; EXPRESSION; FLAMINGO; PATTERNS	Mammalian body hairs align along the anterior-posterior (A-P) axis and offer a striking but poorly understood example of global cell polarization, a phenomenon known as planar cell polarity (PCP). We have discovered that during embryogenesis, marked changes in cell shape and cytoskeletal polarization occur as nascent hair follicles become anteriorly angled, morphologically polarized and molecularly compartmentalized along the A-P axis. Hair follicle initiation coincides with asymmetric redistribution of Vangl2, Celsr1 and Fzd6 within the embryonic epidermal basal layer. Moreover, loss-of-function mutations in Vangl2 and Celsr1 show that they have an essential role in hair follicle polarization and orientation, which develop in part through non-autonomous mechanisms. Vangl2 and Celsr1 are both required for their planar localization in vivo, and physically associate in a complex in vitro. Finally, we provide in vitro evidence that homotypic intracellular interactions of Celsr1 are required to recruit Vangl2 and Fzd6 to sites of cell-cell contact.	[Devenport, Danelle; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Devenport, Danelle/0000-0002-5464-259X	National Institutes of Health [R01 AR27883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053019, R01AR027883, R01AR031737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Murdoch, K. Anderson, M. Kelley, R. Rachel, B. Lake and C. Tabin, for mice and embryos; M. Montcouquiol, S. Sokol and M. Takeiechi for antibodies and reagents; L. Polak, N. Stokes and LARC staff for care and breeding of mice; J. Zallen, S. Sokol and A. vandenBerg for helpful discussions; Alison North and Rockefeller's Bioimaging Resource Centre for assistance with image acquisition and analysis; J. Racelis and A. Firland-Schill for experimental assistance; B. Short, V. Horsley and J. Nowak for advice and critical reading of the manuscript. D. D. is a Ruth L. Kirschstein NRSA postdoctoral fellow. This work was supported by a grant from the National Institutes of Health (R01 AR27883). E. F. is an Investigator of the Howard Hughes Medical Institute.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Chen CWJ, 1997, DEV BIOL, V188, P181, DOI 10.1006/dbio.1997.8643; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hardy MH, 1996, ACTA ANAT, V157, P169; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Muller-Rover S, 1998, J HISTOCHEM CYTOCHEM, V46, P1401; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Taylor J, 1998, GENETICS, V150, P199; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	50	239	243	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1257	U12		10.1038/ncb1784	http://dx.doi.org/10.1038/ncb1784			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849982	Green Accepted			2022-12-27	WOS:000260586700008
J	Sanchez-Diaz, A; Marchesi, V; Murray, S; Jones, R; Pereira, G; Edmondson, R; Allen, T; Labib, K				Sanchez-Diaz, Alberto; Marchesi, Vanessa; Murray, Stephen; Jones, Richard; Pereira, Gislene; Edmondson, Ricky; Allen, Terry; Labib, Karim			Inn1 couples contraction of the actomyosin ring to membrane ingression during cytokinesis in budding yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; KINETOCHORE BIORIENTATION; ELECTRON MICROSCOPY; MITOTIC SPINDLE; CLEAVAGE FURROW; CELL CORTEX; COMPLEX; PROTEIN; TRAFFICKING; ANILLIN	By rapidly depleting each of the essential budding yeast proteins of unknown function, we identified a novel factor that we call Inn1, which associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. We show that Inn1 has a C2 domain at the amino terminus of the protein that is required for ingression of the plasma membrane, whereas the remainder of the protein recruits Inn1 to the actomyosin ring. The lethal effects of deleting the INN1 gene can be suppressed by artificial fusion of the C2 domain to other components of the actomyosin ring, restoring membrane ingression on contraction of the actomyosin ring. Our data indicate that recruitment of the C2 domain of Inn1 to the contractile actomyosin ring is crucial for ingression of the plasma membrane during cytokinesis in budding yeast.	[Sanchez-Diaz, Alberto; Marchesi, Vanessa; Murray, Stephen; Pereira, Gislene; Allen, Terry; Labib, Karim] Univ Manchester, Canc Res UK, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Jones, Richard; Edmondson, Ricky] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; US Food & Drug Administration (FDA)	Labib, K (corresponding author), Univ Manchester, Canc Res UK, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	klabib@picr.man.ac.uk	Pereira, Gislene/D-4024-2014; Sanchez-Diaz, Alberto/L-2320-2014	Sanchez-Diaz, Alberto/0000-0002-3308-4824	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roh DH, 2002, MOL BIOL CELL, V13, P2747, DOI 10.1091/mbc.E02-03-0158; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Strickland LI, 2004, TRENDS CELL BIOL, V14, P115, DOI 10.1016/j.tcb.2004.01.006; Tolliday N, 2001, CURR OPIN MICROBIOL, V4, P690, DOI 10.1016/S1369-5274(01)00270-3; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang G, 2006, J CELL BIOL, V174, P207, DOI 10.1083/jcb.200604094; Zhao WM, 2005, J BIOL CHEM, V280, P33516, DOI 10.1074/jbc.M504657200	46	58	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					395	U58		10.1038/ncb1701	http://dx.doi.org/10.1038/ncb1701			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344988				2022-12-27	WOS:000254561700009
J	Luciani, A; Villella, VR; Esposito, S; Brunetti-Pierri, N; Medina, D; Settembre, C; Gavina, M; Pulze, L; Giardino, I; Pettoello-Mantovani, M; D'Apolito, M; Guido, S; Masliah, E; Spencer, B; Quaratino, S; Raia, V; Ballabio, A; Maiuri, L				Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Gavina, Manuela; Pulze, Laura; Giardino, Ida; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Guido, Stefano; Masliah, Eliezer; Spencer, Brian; Quaratino, Sonia; Raia, Valeria; Ballabio, Andrea; Maiuri, Luigi			Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition	NATURE CELL BIOLOGY			English	Article							TISSUE TRANSGLUTAMINASE; BECLIN 1; NEURODEGENERATIVE DISEASES; NA+ ABSORPTION; GENE-TRANSFER; APOPTOSIS; UBIQUITIN; DELTA-F508-CFTR; ACCUMULATION; ACTIVATION	Accumulation of unwanted/misfolded proteins in aggregates has been observed in airways of patients with cystic fibrosis (CF), a life-threatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). Here we show how defective CFTR results in defective autophagy and decreases the clearance of aggresomes. Defective CFTR-induced upregulation of reactive oxygen species (ROS) and tissue transglutaminase (TG2) drive the crosslinking of beclin 1, leading to sequestration of phosphatidylinositol-3-kinase (PI(3)K) complex III and accumulation of p62, which regulates aggresome formation. Both CFTR knockdown and the overexpression of green fluorescent protein (GFP)-tagged-CFTRF508del induce beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-TG2 pathway. Restoration of beclin 1 and autophagy by either beclin 1 overexpression, cystamine or antioxidants rescues the localization of the beclin 1 interactome to the endoplasmic reticulum and reverts the CF airway phenotype in vitro, in vivo in Scnn1b-transgenic and Cftr(F508del) homozygous mice, and in human CF nasal biopsies. Restoring beclin 1 or knocking down p62 rescued the trafficking of CFTRF508del to the cell surface. These data link the CFTR defect to autophagy deficiency, leading to the accumulation of protein aggregates and to lung inflammation.	[Luciani, Alessandro; Gavina, Manuela; Pulze, Laura; Maiuri, Luigi] Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, I-20132 Milan, Italy; [Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Guido, Stefano] Univ Naples Federico II, Dept Chem Engn, I-80125 Naples, Italy; [Esposito, Speranza; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Maiuri, Luigi] Univ Foggia, Inst Pediat, I-71100 Foggia, Italy; [Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Raia, Valeria] Univ Naples Federico II, Dept Pediat, Cyst Fibrosis Unit, I-80131 Naples, Italy; [Giardino, Ida] Univ Foggia, Dept Lab Med, I-71100 Foggia, Italy; [Masliah, Eliezer; Spencer, Brian] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Quaratino, Sonia] Univ Southampton, Canc Res UK Oncol Unit, Southampton SO16 6YD, Hants, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Naples Federico II; University of Foggia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Foggia; University of California System; University of California San Diego; University of Southampton	Maiuri, L (corresponding author), Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, I-20132 Milan, Italy.	raia@unina.it; ballabio@tigem.it; maiuri@unina.it	MANTOVANI, Massimo PETTOELLO/AAC-1990-2019; BALLABIO, Andrea/AAL-2672-2020; esposito, speranza/AFT-9322-2022; Settembre, Carmine/AIA-9170-2022; Brunetti-Pierri, Nicola/K-8465-2016; Medina, Diego/AAC-9622-2020; Guido, Stefano/B-9928-2011; Villella, Valeria Rachela/AAC-1075-2019; Raia, Valeria/AAC-3029-2022; d'Apolito, Maria/AAQ-9290-2021	MANTOVANI, Massimo PETTOELLO/0000-0002-0688-1131; BALLABIO, Andrea/0000-0003-1381-4604; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Medina, Diego/0000-0002-7347-2645; Guido, Stefano/0000-0002-9247-6852; Villella, Valeria Rachela/0000-0003-4858-4853; SETTEMBRE, Carmine/0000-0002-5829-8589; Luciani, Alessandro/0000-0001-7219-3719; esposito, speranza/0000-0003-0269-4029	European Institute for Research in Cystic Fibrosis; Cancer Research UK; Rothschild Trust; Coeliac UK; Regione Campania [L. 229/99]; Fondazione Telethon Funding Source: Custom	European Institute for Research in Cystic Fibrosis; Cancer Research UK(Cancer Research UK); Rothschild Trust; Coeliac UK; Regione Campania(Regione Campania); Fondazione Telethon(Fondazione Telethon)	We thank Noboru Mizushima for the gift of the pEGFP-LC3 and pcDNA3-HA-beclin 1 expression vectors; Ron Kopito for the gift of the pGFP-F508del-CFTR expression vector; Michael Bownlee for the gift of the adenoviral vectors; Clan Maria Fimia for the gift of the TG2 plasmid; Dieter C. Gruenert for the gift of CFBE41o<SUP>-</SUP> and 16HBE14o<SUP>-</SUP> cell lines; Maria Carla Panzeri for support in electron microscopy and in the analysis of the data; Rosarita Tate for technical support in confocal microscopy; and Ilaria Russo for technical support in histology. Cftrtm1EUR (F508del (FVB/129) mice were obtained from Bob Scholte under European Economic Community European Coordination Action for Research in Cystic Fibrosis program EU FP6 LSHM-CT-2005-018932. This work was supported by the European Institute for Research in Cystic Fibrosis, Cancer Research UK, Rothschild Trust, Coeliac UK and Regione Campania (L. 229/99).	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452; Fu LW, 2009, EUR J CELL BIOL, V88, P215, DOI 10.1016/j.ejcb.2008.11.003; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muma NA, 2007, J NEUROPATH EXP NEUR, V66, P258, DOI 10.1097/nen.0b013e31803d3b02; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Raia V, 2005, THORAX, V60, P773, DOI 10.1136/thx.2005.042564; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rochat T, 2004, J CELL PHYSIOL, V201, P106, DOI 10.1002/jcp.20066; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Scott-Ward TS, 2009, FEBS J, V276, P7097, DOI 10.1111/j.1742-4658.2009.07421.x; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stocker AG, 2009, J GENE MED, V11, P861, DOI 10.1002/jgm.1368; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; TEBBENKAMP ATN, 2009, METH MOL B, V566, P85; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Trudel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006075; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	65	361	370	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					863	875		10.1038/ncb2090	http://dx.doi.org/10.1038/ncb2090			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20711182				2022-12-27	WOS:000281561900010
J	Yang, ZF; Klionsky, DJ				Yang, Zhifen; Klionsky, Daniel J.			Eaten alive: a history of macroautophagy	NATURE CELL BIOLOGY			English	Review							PHOSPHATIDYLINOSITOL KINASE HOMOLOG; CELL-DEATH; AUTOPHAGOSOME FORMATION; SIGNALING PATHWAYS; MAMMALIAN HOMOLOG; CRYSTAL-STRUCTURE; RAT-LIVER; PROTEIN; DEGRADATION; YEAST	Macroautophagy (hereafter autophagy), or 'self-eating', is a conserved cellular pathway that controls protein and organelle degradation, and has essential roles in survival, development and homeostasis. Autophagy is also integral to human health and is involved in physiology, development, lifespan and a wide range of diseases, including cancer, neurodegeneration and microbial infection. Although research on this topic began in the late 1950s, substantial progress in the molecular study of autophagy has taken place during only the past 15 years. This review traces the key findings that led to our current molecular understanding of this complex process.	[Yang, Zhifen; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Yang, Zhifen; Klionsky, Daniel J.] Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Yang, Zhifen; Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yang, ZF (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	klionsky@umich.edu			NIH [GM53396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM53396 to D.J.K.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bergamini E, 2005, EXPERT OPIN THER TAR, V9, P77, DOI 10.1517/14728222.9.1.77; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Cavallini Gabriella, 2008, Curr Aging Sci, V1, P4; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; DETER RL, 1967, J CELL BIOL, V35, pC11, DOI 10.1083/jcb.35.2.C11; Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; NOPANITAYA W, 1974, TISSUE CELL, V6, P487, DOI 10.1016/0040-8166(74)90040-8; NOVIKOFF AB, 1964, FED PROC, V23, P1010; NOVIKOFF AB, 1959, J BIOPHYS BIOCHEM CY, V6, P136, DOI 10.1083/jcb.6.1.136; NOVIKOFF AB, 1962, J CELL BIOL, V15, P140, DOI 10.1083/jcb.15.1.140; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; PFEIFER U, 1977, ACTA BIOL MED GER, V36, P1691; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; RIKIHISA Y, 1984, ANAT REC, V208, P319, DOI 10.1002/ar.1092080302; SCHIN KS, 1965, SCIENCE, V150, P1053, DOI 10.1126/science.150.3699.1053; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; TITORENKO VI, 1995, J BACTERIOL, V177, P357, DOI 10.1128/jb.177.2.357-363.1995; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246	119	1540	1686	6	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					814	822		10.1038/ncb0910-814	http://dx.doi.org/10.1038/ncb0910-814			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811353	Green Accepted			2022-12-27	WOS:000281561900002
J	Landeira, D; Sauer, S; Poot, R; Dvorkina, M; Mazzarella, L; Jorgensen, HF; Pereira, CF; Leleu, M; Piccolo, FM; Spivakov, M; Brookes, E; Pombo, A; Fisher, C; Skarnes, WC; Snoek, T; Bezstarosti, K; Demmers, J; Klose, RJ; Casanova, M; Tavares, L; Brockdorff, N; Merkenschlager, M; Fisher, AG				Landeira, David; Sauer, Stephan; Poot, Raymond; Dvorkina, Maria; Mazzarella, Luca; Jorgensen, Helle F.; Pereira, C. Filipe; Leleu, Marion; Piccolo, Francesco M.; Spivakov, Mikhail; Brookes, Emily; Pombo, Ana; Fisher, Cynthia; Skarnes, William C.; Snoek, Tim; Bezstarosti, Karel; Demmers, Jeroen; Klose, Robert J.; Casanova, Miguel; Tavares, Ligia; Brockdorff, Neil; Merkenschlager, Matthias; Fisher, Amanda G.			Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB GROUP PROTEINS; TRANSCRIPTION INITIATION; MOUSE DEVELOPMENT; GENE-EXPRESSION; PLURIPOTENCY; CHROMATIN; CIRCUITRY; IDENTITY; NETWORK	Polycomb Repressor Complexes (PRCs) are important regulators of embryogenesis. In embryonic stem (ES) cells many genes that regulate subsequent stages in development are enriched at their promoters for PRC1, PRC2 and Ser 5-phosphorylated RNA Polymerase II (RNAP), and contain domains of 'bivalent' chromatin (enriched for H3K4me3; histone H3 di- or trimethylated at Lys 4 and H3K27me3; histone H3 trimethylated at Lys 27). Loss of individual PRC components in ES cells can lead to gene de-repression and to unscheduled differentiation. Here we show that Jarid2 is a novel subunit of PRC2 that is required for the co-recruitment of PRC1 and RNAP to genes that regulate development in ES cells. Jarid2-deficient ES cells showed reduced H3K4me2/me3 and H3K27me3 marking and PRC1/PRC2 recruitment, and did not efficiently establish Ser 5-phosporylated RNAP at target genes. ES cells lacking Jarid2, in contrast to previously characterized PRC1 and PRC2 mutants, did not inappropriately express PRC2 target genes. Instead, they show a severely compromised capacity for successful differentiation towards neural or mesodermal fates and failed to correctly initiate lineage-specific gene expression in vitro. Collectively, these data indicate that transcriptional priming of bivalent genes in pluripotent ES cells is Jarid2-dependent, and suggests that priming is critical for subsequent multi-lineage differentiation.	[Landeira, David; Sauer, Stephan; Dvorkina, Maria; Mazzarella, Luca; Jorgensen, Helle F.; Pereira, C. Filipe; Leleu, Marion; Piccolo, Francesco M.; Spivakov, Mikhail; Fisher, Cynthia; Merkenschlager, Matthias; Fisher, Amanda G.] Hammersmith Hosp, Lymphocyte Dev Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, London W12 0NN, England; [Poot, Raymond; Snoek, Tim] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Brookes, Emily; Pombo, Ana] Hammersmith Hosp, Genome Funct Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, London W12 0NN, England; [Fisher, Cynthia; Skarnes, William C.] Wellcome Trust Sanger Inst, Mouse Dev Genet Grp, Cambridge CB10 1SA, England; [Bezstarosti, Karel; Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Klose, Robert J.] Univ Oxford, Dept Biochem, Epigenet Regulat Chromatin Funct Grp, Oxford OX1 3QU, England; [Casanova, Miguel; Tavares, Ligia; Brockdorff, Neil] Univ Oxford, Dept Biochem, Dev Epigenet Grp, Oxford OX1 3QU, England	Imperial College London; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of Oxford; University of Oxford	Fisher, AG (corresponding author), Hammersmith Hosp, Lymphocyte Dev Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, Campus,Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	mazzarella, luca/AAC-2391-2019; Pombo, Ana/A-1045-2010; Landeira, David/ADY-5662-2022; Pereira, Carlos-Filipe/B-8438-2013; Demmers, Jeroen AA/F-4046-2016; Landeira, David/F-5001-2018	mazzarella, luca/0000-0002-4043-3279; Pombo, Ana/0000-0002-7493-6288; Pereira, Carlos-Filipe/0000-0002-9724-1382; Demmers, Jeroen AA/0000-0002-8757-9611; Landeira, David/0000-0002-3267-454X; Brockdorff, Neil/0000-0003-4838-2653; Brookes, Emily/0000-0003-2175-4349; Casanova, Miguel/0000-0001-8622-6550; Fisher, Cynthia/0000-0001-6089-4868; Merkenschlager, Matthias/0000-0003-2889-3288; Snoek, Tim/0000-0002-5395-9034; Tavares, Ligia/0000-0001-9487-7978; Spivakov, Mikhail/0000-0002-0383-3943; Jorgensen, Helle/0000-0002-7909-2977	Medical Research Council (MRC); EU; MRC [MC_U120061476, MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120061476, MC_U120027516] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to our colleagues Y. Lee, V. Kouskoff and A. Otte for supplying reagents and advice. We thank N. Ryan, A. Terry and the MRC CSC flow cytometry facility for technical assistance. This work was funded by the Medical Research Council (MRC) and the EU Epigenome Network of Excellence.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; FAUST C, 1995, DEVELOPMENT, V121, P273; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fraser ST, 2003, METHOD ENZYMOL, V365, P59; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Ying QL, 2003, METHOD ENZYMOL, V365, P327	40	228	230	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					618	U214		10.1038/ncb2065	http://dx.doi.org/10.1038/ncb2065			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473294	Green Accepted, Green Published			2022-12-27	WOS:000278213400015
J	Dixit, VM				Dixit, Vishva M.			Signalling lessons from death receptors: the importance of cleavage	NATURE CELL BIOLOGY			English	Editorial Material									Genentech Inc, Early Discovery Res, San Francisco, CA 94080 USA	Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Early Discovery Res, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					415	415		10.1038/ncb0510-415	http://dx.doi.org/10.1038/ncb0510-415			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20442699				2022-12-27	WOS:000277283700003
J	Anitei, M; Stange, C; Parshina, I; Baust, T; Schenck, A; Raposo, G; Kirchhausen, T; Hoflack, B				Anitei, Mihaela; Stange, Christoph; Parshina, Irina; Baust, Thorsten; Schenck, Annette; Raposo, Graca; Kirchhausen, Tomas; Hoflack, Bernard			Protein complexes containing CYFIP/Sra/PIR121 coordinate Arf1 and Rac1 signalling during clathrin-AP-1-coated carrier biogenesis at the TGN	NATURE CELL BIOLOGY			English	Article							TRANS-GOLGI NETWORK; CLATHRIN-MEDIATED ENDOCYTOSIS; LINKED MENTAL-RETARDATION; MANNOSE 6-PHOSPHATE RECEPTORS; ACTIN DYNAMICS; ARP2/3 COMPLEX; AMPA RECEPTORS; NEURONAL CONNECTIVITY; VESICLE FORMATION; PLASMA-MEMBRANE	Actin dynamics is a tightly regulated process involved in various cellular events including biogenesis of clathrin-coated, AP-1 (adaptor protein 1)-coated transport carriers connecting the trans-Golgi network (TGN) and the endocytic pathway. However, the mechanisms coordinating coat assembly, membrane and actin remodelling during post-TGN transport remain poorly understood. Here we show that the Arf1 (ADP-ribosylation factor 1) GTPase synchronizes the TGN association of clathrin-AP-1 coats and protein complexes comprising CYFIP (cytoplasmic fragile-X mental retardation interacting protein; Sra, PIR121), a clathrin heavy chain binding protein associated with mental retardation. The Rac1 GTPase and its exchange factor beta-PIX (PAK-interacting exchange factor) activate these complexes, allowing N-WASP-dependent and Arp2/3-dependent actin polymerization towards membranes, thus promoting tubule formation. These phenomena can be recapitulated with synthetic membranes. This protein-network-based mechanism facilitates the sequential coordination of Arf1-dependent membrane priming, through the recruitment of coats and CYFIP-containing complexes, and of Rac1-dependent actin polymerization, and provides complementary but independent levels of regulation during early stages of clathrin-AP1-coated carrier biogenesis.	[Anitei, Mihaela; Stange, Christoph; Parshina, Irina; Baust, Thorsten; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Baust, Thorsten; Kirchhausen, Tomas] Harvard Univ, Sch Med, CBRI, Boston, MA 02115 USA; [Schenck, Annette] Nijmegen Ctr Mol Life Sci, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Raposo, Graca] Inst Curie, Ctr Rech, F-75231 Paris, France; [Raposo, Graca] CNRS, UMR144, F-75700 Paris, France; [Raposo, Graca] IBiSA, Cell & Tissue Imaging Facil, F-75248 Paris, France	Technische Universitat Dresden; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	Schenck, Annette/E-4514-2012; HOFLACK, Bernard/AAZ-6668-2020; Anitei, Mihaela/A-2541-2015	Schenck, Annette/0000-0002-6918-3314; Anitei, Mihaela/0000-0002-3156-7195; Raposo, graca/0000-0001-9590-1298	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM075252, R01 GM075252-04, GM075252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Egorov MV, 2009, MOL BIOL CELL, V20, P2413, DOI 10.1091/mbc.E08-11-1136; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; LeBorgne R, 1997, J CELL BIOL, V137, P335; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0	63	75	77	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					330	U65		10.1038/ncb2034	http://dx.doi.org/10.1038/ncb2034			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228810	Green Accepted			2022-12-27	WOS:000276194600006
J	Hayes, SD; Harper, JW				Hayes, Sebastian D.; Harper, J. Wade			Cdc25A and Dub3 in a high-stakes balancing act	NATURE CELL BIOLOGY			English	Editorial Material							BREAST-CANCER; CELL-DIVISION; PHOSPHATASE; DEGRADATION; GROWTH	The deubiquitylating enzyme Dub3 is found to have oncogenic potential by stabilizing the Cdc25A protein phosphatase, a crucial regulator of cell-cycle progression.	[Hayes, Sebastian D.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hayes, SD (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236; HAYES, SEBASTIAN/0000-0002-2383-9461	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NIGMS NIH HHS [R01 GM070565, R01 GM054137] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R01GM070565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290	15	5	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					311	313		10.1038/ncb2043	http://dx.doi.org/10.1038/ncb2043			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228807				2022-12-27	WOS:000276194600003
J	Mishra, RK; Chakraborty, P; Arnaoutov, A; Fontoura, BMA; Dasso, M				Mishra, Ram Kumar; Chakraborty, Papia; Arnaoutov, Alexei; Fontoura, Beatriz M. A.; Dasso, Mary			The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; NUCLEAR-PORE; MAMMALIAN-CELLS; MESSENGER-RNA; SPINDLE; SUBCOMPLEX; TUBULIN; MITOSIS; RAN; ORGANIZATION	The metazoan nuclear pore complex (NPC) disassembles during mitosis, and many of its constituents distribute onto spindles and kinetochores, including the Nup107-160 subcomplex(1,2). We have found that Nup107-160 interacts with the gamma-tubulin ring complex (gamma-TuRC), an essential and conserved microtubule nucleator(3,4), and recruits gamma-TuRC to unattached kinetochores. The unattached kinetochores nucleate microtubules in a manner that is regulated by Ran GTPase(5); such microtubules contribute to the formation of kinetochore fibres (k-fibres)(6), microtubule bundles connecting kinetochores to spindle poles. Our data indicate that Nup107-160 and gamma-TuRC act cooperatively to promote spindle assembly through microtubule nucleation at kinetochores: HeLa cells lacking Nup107-160 or gamma-TuRC were profoundly deficient in kinetochore-associated microtubule nucleation. Moreover, co-precipitated Nup107-160-gamma-TuRC complexes nucleated microtubule formation in assays using purified tubulin. Although Ran did not regulate microtubule nucleation by gamma-TuRC alone, Nup107-160-gamma-TuRC complexes required RanGTP for microtubule nucleation. Collectively, our observations show that Nup107-160 promotes spindle assembly through Ran-GTP-regulated nucleation of microtubules by gamma-TuRC at kinetochores, and reveal a relationship between nucleoporins and the microtubule cytoskeleton.	[Mishra, Ram Kumar; Arnaoutov, Alexei; Dasso, Mary] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Chakraborty, Papia; Fontoura, Beatriz M. A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas	Dasso, M (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	mdasso@helix.nih.gov	Mishra, Ram/AAJ-1538-2020; Mishra, Ram/ABA-6071-2020	Mishra, Ram/0000-0002-9528-0476; Dasso, Mary/0000-0002-5410-1371; Arnaoutov, Alexei/0000-0001-7647-7217	Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds [Z01 HD008816, Z01 HD008740]; National Institutes of Health [R01 GM07159]; Texas HEB [010019-0022-2006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008816, ZIAHD008740] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008740, Z01HD008816] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas HEB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	R. K. M., A. A. and M. D. were supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds (Z01 HD008816 and Z01 HD008740). B. M. A. F. and P. C. were supported by National Institutes of Health R01 GM07159 and Texas HEB (Higher Education Board) 010019-0022-2006.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Desai A, 1999, METHOD CELL BIOL, V61, P385; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Knop M, 1999, BIOL CELL, V91, P291, DOI 10.1016/S0248-4900(99)80090-2; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061; Rebollo E, 2004, PLOS BIOL, V2, P54, DOI 10.1371/journal.pbio.0020008; Resendes KK, 2008, MOL CELL BIOL, V28, P1755, DOI 10.1128/MCB.01697-07; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	29	129	132	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					164	U154		10.1038/ncb2016	http://dx.doi.org/10.1038/ncb2016			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081840	Green Accepted			2022-12-27	WOS:000274139400010
J	Renkawitz, J; Schumann, K; Weber, M; Lammermann, T; Pflicke, H; Piel, M; Polleux, J; Spatz, JP; Sixt, M				Renkawitz, Joerg; Schumann, Kathrin; Weber, Michele; Laemmermann, Tim; Pflicke, Holger; Piel, Matthieu; Polleux, Julien; Spatz, Joachim P.; Sixt, Michael			Adaptive force transmission in amoeboid cell migration	NATURE CELL BIOLOGY			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; RETROGRADE FLOW; DENDRITIC CELLS; LEADING-EDGE; F-ACTIN; GROWTH; LAMELLIPODIA; MECHANISMS; LOCOMOTION; MOTILITY	The leading front of a cell can either protrude as an actin-free membrane bleb that is inflated by actomyosin-driven contractile forces, or as an actin-rich pseudopodium, a site where polymerizing actin filaments push out the membrane(1-3). Pushing filaments can only cause the membrane to protrude if the expanding actin network experiences a retrograde counter-force, which is usually provided by transmembrane receptors of the integrin family(4). Here we show that chemotactic dendritic cells mechanically adapt to the adhesive properties of their substrate by switching between integrin-mediated and integrin-independent locomotion. We found that on engaging the integrin-actin clutch, actin polymerization was entirely turned into protrusion, whereas on disengagement actin underwent slippage and retrograde flow. Remarkably, accelerated retrograde flow was balanced by an increased actin polymerization rate; therefore, cell shape and protrusion velocity remained constant on alternating substrates. Due to this adaptive response in polymerization dynamics, tracks of adhesive substrate did not dictate the path of the cells. Instead, directional guidance was exclusively provided by a soluble gradient of chemoattractant, which endowed these 'amoeboid' cells with extraordinary flexibility, enabling them to traverse almost every type of tissue.	[Renkawitz, Joerg; Schumann, Kathrin; Weber, Michele; Laemmermann, Tim; Pflicke, Holger; Sixt, Michael] Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany; [Polleux, Julien] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75231 Paris, France; [Polleux, Julien; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany	Max Planck Society; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Max Planck Society	Sixt, M (corresponding author), Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany.	sixt@biochem.mpg.de	Renkawitz, Jörg/AAD-5932-2022; Spatz, Joachim P/A-1107-2017; Lämmermann, Tim/AAD-7453-2022; Schumann, Kathrin/HHZ-8041-2022; Sixt, Michael/F-3925-2010	Renkawitz, Jörg/0000-0003-2856-3369; Spatz, Joachim P/0000-0003-3419-9807; Weber, Michele/0000-0003-2056-3751; Sixt, Michael/0000-0002-6620-9179; Schumann, Kathrin/0000-0002-0993-3910	German Research Foundation; Peter Hans Hofschneider Foundation; Max Planck Society; Alexander von Humboldt Foundation	German Research Foundation(German Research Foundation (DFG)); Peter Hans Hofschneider Foundation; Max Planck Society(Max Planck Society); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank S. Cremer for statistical analysis, K. Hirsch for technical assistance, D. Critchley for talin1-deficient mice and R. F ssler for integrin-deficient mice, discussions and critical reading of the manuscript. This work was supported by the German Research Foundation, the Peter Hans Hofschneider Foundation for Experimental Biomedicine, the Max Planck Society, the Alexander von Humboldt Foundation and the allergology programme of the Landesstiftung Baden-Wurttemberg.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; HEIT B, 2003, SCI STKE, pPL5; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; McGrath JL, 2003, CURR BIOL, V13, P329, DOI 10.1016/S0960-9822(03)00051-4; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; RUTHERFORD MS, 1992, J LEUKOCYTE BIOL, V51, P69, DOI 10.1002/jlb.51.1.69; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200	28	203	203	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1438	U121		10.1038/ncb1992	http://dx.doi.org/10.1038/ncb1992			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915557	Green Published			2022-12-27	WOS:000272251300010
J	Kim, TW; Guan, SH; Sun, Y; Deng, ZP; Tang, WQ; Shang, JX; Sun, Y; Burlingame, AL; Wang, ZY				Kim, Tae-Wuk; Guan, Shenheng; Sun, Yu; Deng, Zhiping; Tang, Wenqiang; Shang, Jian-Xiu; Sun, Ying; Burlingame, Alma L.; Wang, Zhi-Yong			Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors	NATURE CELL BIOLOGY			English	Article							TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; PROTEIN-KINASE; PLANT-GROWTH; ARABIDOPSIS; BRI1; BZR1; FAMILY; GSK3; MECHANISMS	Brassinosteroid (BR) regulates gene expression and plant development through a receptor kinase-mediated signal transduction pathway(1). Despite the identification of many components of this pathway, it remains unclear how the BR signal is transduced from the cell surface to the nucleus(2). Here we describe a complete BR signalling pathway by elucidating key missing steps. We show that phosphorylation of BSK1 (BR-signalling kinase 1) by the BR receptor kinase BRI1 (BR-insensitive 1) promotes BSK1 binding to the BSU1 (BRI1 suppressor 1) phosphatase, and BSU1 inactivates the GSK3-like kinase BIN2 (BR-insensitive 2) by dephosphorylating a conserved phospho-tyrosine residue (pTyr 200). Mutations that affect phosphorylation/dephosphorylation of BIN2 pTyr200 (bin2-1, bin2-Y200F and quadruple loss-of-function of BSU1-related phosphatases) support an essential role for BSU1-mediated BIN2 dephosphorylation in BR-dependent plant growth. These results demonstrate direct sequential BR activation of BRI1, BSK1 and BSU1, and inactivation of BIN2, leading to accumulation of unphosphorylated BZR (brassinazole resistant) transcription factors in the nucleus. This study establishes a fully connected BR signalling pathway and provides new insights into the mechanism of GSK3 regulation.	[Kim, Tae-Wuk; Sun, Yu; Deng, Zhiping; Tang, Wenqiang; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Guan, Shenheng; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Shang, Jian-Xiu; Sun, Ying] Hebei Normal Univ, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China	Carnegie Institution for Science; University of California System; University of California San Francisco; Hebei Normal University	Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Tang, Wenqiang/0000-0002-2972-5748; Deng, zhiping/0000-0001-9663-3088	NIH [R01GM066258]; National Science Foundation [0724688]; US Department of Energy [DE-FG02-08ER15973]; Herman Frasch Foundation; National Center for Research Resources; NIH NCRR [RR01614, RR012961, RR019934]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019934, S10RR012961, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Herman Frasch Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chory for providing the bsu1-D seeds and BSU1 cDNA clone and D. Bhaya and K. Barton for comments on the manuscript. Research was supported by grants from NIH (R01GM066258), the National Science Foundation (0724688), the US Department of Energy (DE-FG02-08ER15973) and the Herman Frasch Foundation. The UCSF Mass Spectrometry Facility is supported by the Biomedical Research Technology Program of the National Center for Research Resources, NIH NCRR (RR01614, RR012961 and RR019934).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BELKHADIR Y, 2006, SCI STKE, pCM5; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson KL, 2005, CURR OPIN PLANT BIOL, V8, P648, DOI 10.1016/j.pbi.2005.09.007; Kim L, 2002, DEV CELL, V3, P523, DOI 10.1016/S1534-5807(02)00269-1; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599; Zhou A, 2004, PLANT J, V40, P399, DOI 10.1111/j.1365-313X.2004.02214.x	40	441	470	12	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1254	U233		10.1038/ncb1970	http://dx.doi.org/10.1038/ncb1970			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734888	Green Accepted			2022-12-27	WOS:000270382000016
J	Ishihara, N; Nomura, M; Jofuku, A; Kato, H; Suzuki, SO; Masuda, K; Otera, H; Nakanishi, Y; Nonaka, I; Goto, YI; Taguchi, N; Morinaga, H; Maeda, M; Takayanagi, R; Yokota, S; Mihara, K				Ishihara, Naotada; Nomura, Masatoshi; Jofuku, Akihiro; Kato, Hiroki; Suzuki, Satoshi O.; Masuda, Keiji; Otera, Hidenori; Nakanishi, Yae; Nonaka, Ikuya; Goto, Yu-ichi; Taguchi, Naoko; Morinaga, Hidetaka; Maeda, Maki; Takayanagi, Ryoichi; Yokota, Sadaki; Mihara, Katsuyoshi			Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice	NATURE CELL BIOLOGY			English	Article							DYNAMIN-RELATED PROTEIN; CYTOCHROME-C RELEASE; FUSION; OPA1; MORPHOLOGY; MEMBRANE; DIVISION; GTPASE; IDENTIFICATION; REVEALS	Mitochondrial morphology is dynamically controlled by a balance between fusion and fission. The physiological importance of mitochondrial fission in vertebrates is less clearly defined than that of mitochondrial fusion. Here we show that mice lacking the mitochondrial fission GTPase Drp1 have developmental abnormalities, particularly in the forebrain, and die after embryonic day 12.5. Neural cell-specific (NS) Drp1(-/-) mice die shortly after birth as a result of brain hypoplasia with apoptosis. Primary culture of NS-Drp1(-/-) mouse forebrain showed a decreased number of neurites and defective synapse formation, thought to be due to aggregated mitochondria that failed to distribute properly within the cell processes. These defects were reflected by abnormal forebrain development and highlight the importance of Drp1-dependent mitochondrial fission within highly polarized cells such as neurons. Moreover, Drp1(-/-) murine embryonic fibroblasts and embryonic stem cells revealed that Drp1 is required for a normal rate of cytochrome c release and caspase activation during apoptosis, although mitochondrial outer membrane permeabilization, as examined by the release of Smac/Diablo and Tim8a, may occur independently of Drp1 activity.	[Jofuku, Akihiro; Kato, Hiroki; Otera, Hidenori; Mihara, Katsuyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Ishihara, Naotada; Maeda, Maki] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Nomura, Masatoshi; Nakanishi, Yae; Morinaga, Hidetaka; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 8128582, Japan; [Masuda, Keiji] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka 8128582, Japan; [Nonaka, Ikuya; Goto, Yu-ichi] Natl Inst Neurosci, Dept Mental Retardat & Birth Dev Res, Kodaira, Tokyo 1878502, Japan; [Taguchi, Naoko] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Yokota, Sadaki] Nagasaki Int Univ, Sasebo 8593298, Japan	Kyushu University; Tokyo Medical & Dental University (TMDU); Kyushu University; Kyushu University; Kyushu University; National Center for Neurology & Psychiatry - Japan; Osaka University; Nagasaki International University	Mihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	mihara@cell.med.kyushu-u.ac.jp	Kato, Hiroki/N-3495-2019; Suzuki, Satoshi O/H-8367-2019; Kato, Hiroki/L-2346-2013	Kato, Hiroki/0000-0002-6529-659X; Suzuki, Satoshi O/0000-0002-0742-5680; Kato, Hiroki/0000-0002-3292-2160; Ishihara, Naotada/0000-0002-6305-7149	Ministry of Education, Science, and Culture of Japan; Human Frontier Science Program; Core Research from Evolutional Science and Technology; Takeda Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Core Research from Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr Toshihiko Oka, Dr Noboru Mizushima, Dr Akira Kondo and members of the Mihara laboratory for productive discussions. We also thank Dr Richard Youle and Dr Atsushi Tanaka for critical reading of the manuscript and for advice. This work was supported by grants from the Ministry of Education, Science, and Culture of Japan, from the Human Frontier Science Program, from Core Research from Evolutional Science and Technology, and from the Takeda Science Foundation.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; KOPPENOL WH, 1978, BIOCHIM BIOPHYS ACTA, V503, P499, DOI 10.1016/0005-2728(78)90149-4; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Uesaka N, 2007, J NEUROSCI, V27, P5215, DOI 10.1523/JNEUROSCI.4685-06.2007; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	54	709	730	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					958	U114		10.1038/ncb1907	http://dx.doi.org/10.1038/ncb1907			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578372				2022-12-27	WOS:000268593200009
J	Little, SC; Mullins, MC				Little, Shawn C.; Mullins, Mary C.			Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis	NATURE CELL BIOLOGY			English	Article							SERINE/THREONINE KINASE RECEPTOR; SPEMANNS ORGANIZER; ZEBRAFISH EMBRYO; BMP ACTIVITY; SIGNALS; DORSAL; BMP2B/SWIRL; CHORDIN; XENOPUS; BMP7/SNAILHOUSE	Patterning the embryonic dorsoventral axis of both vertebrates and invertebrates requires signalling through bone morphogenetic proteins (BMPs)(1). Although a well-studied process, the identity of the physiologically relevant BMP signalling complex in the Drosophila melanogaster embryo is controversial(2,3), is generally inferred from cell culture studies and has not been investigated in vertebrates. Here, we demonstrate that dorsoventral patterning in zebrafish, Danio rerio, requires two classes of non-redundant type I BMP receptors, Alk3/6 and Alk8 (activin-like kinases 3/6 and 8). We show, under physiological conditions in the embryo, that these two type I receptor classes form a complex in a manner that depends on Bmp2 and Bmp7. We found that both Bmp2-7 heterodimers, as well as Bmp2 and Bmp7 homodimers, form in the embryo. However, only recombinant ligand heterodimers can activate BMP signalling in the early embryo, whereas a combination of Bmp2 and Bmp7 homodimers cannot. We propose that only heterodimers, signalling through two distinct classes of type I receptor, possess sufficient receptor affinity in an environment of extracellular antagonists to elicit the signalling response required for dorsoventral patterning.	[Little, Shawn C.; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Mullins, MC (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1211 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu		Little, Shawn/0000-0002-2815-3696	NIH [GM56326, 5 T32 GM07229-28, 2 T32 HD007516-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM056326, R01GM056326, T32GM007229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Whitman for the Alk4(KR) HA construct; L. Jing and M. Granato for Myc-tagged Unplugged/ MuSK; B. Holloway and J. Tucker for technical advice; S. Lu for technical support; J. Xie and the UPenn zebrafish core facility for wild-type embryos and S. DiNardo, T. Gupta, F. Marlow and L. Kapp for comments on the manuscript. This work was funded by NIH grants to M. C. M. (GM56326) and to S. C. L. (5 T32 GM07229-28 and 2 T32 HD007516-05).	AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bauer H, 2001, DEVELOPMENT, V128, P849; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Imai Y, 2001, GENESIS, V30, P160, DOI 10.1002/gene.1055; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Nikaido M, 1999, DEVELOPMENT, V126, P181; Nikaido M, 1999, MECH DEVELOP, V82, P219, DOI 10.1016/S0925-4773(99)00023-4; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Suzuki A, 1997, DEV BIOL, V189, P112, DOI 10.1006/dbio.1997.8652; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yelick PC, 1998, DEV DYNAM, V211, P352, DOI 10.1002/(SICI)1097-0177(199804)211:4<352::AID-AJA6>3.0.CO;2-G; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	46	177	181	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					637	U439		10.1038/ncb1870	http://dx.doi.org/10.1038/ncb1870			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19377468	Green Accepted			2022-12-27	WOS:000265640000023
J	Gao, DM; Inuzuka, H; Tseng, A; Chin, RY; Toker, A; Wei, WY				Gao, Daming; Inuzuka, Hiroyuki; Tseng, Alan; Chin, Rebecca Y.; Toker, Alex; Wei, Wenyi			Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction	NATURE CELL BIOLOGY			English	Article							LIGASE SUBUNIT SKP2; UBIQUITIN LIGASE; BREAST-CANCER; TRANSCRIPTION FACTOR; INHIBITOR P27(KIP1); PROSTATE-CANCER; NUCLEAR IMPORT; KINASE-B; EXPRESSION; CELLS	Deregulated Skp2 function promotes cell transformation, and this is consistent with observations of Skp2 overexpression in many human cancers. However, the mechanisms underlying elevated Skp2 expression are still unknown. Here we show that the serine/threonine protein kinase Akt1, but not Akt2, directly controls Skp2 stability by a mechanism that involves degradation by the APC-Cdh1 ubiquitin ligase complex. We show further that Akt1 phosphorylates Skp2 at Ser 72, which is required to disrupt the interaction between Cdh1 and Skp2. In addition, we show that Ser 72 is localized within a putative nuclear localization sequence and that phosphorylation of Ser 72 by Akt leads to cytoplasmic translocation of Skp2. This finding expands our knowledge of how specific signalling kinase cascades influence proteolysis governed by APC-Cdh1 complexes, and provides evidence that elevated Akt activity and cytoplasmic Skp2 expression may be causative for cancer progression.	[Gao, Daming; Inuzuka, Hiroyuki; Tseng, Alan; Chin, Rebecca Y.; Toker, Alex; Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wei, WY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Holt, Janet E/B-2415-2013	Gao, Daming/0000-0003-4374-1055; CHIN, Yuet Ming Rebecca/0000-0001-8976-3466	Harvard Medical School Milton Fund; Emerald Foundation; National Institutes of Health [CA076120, CA122099]; Susan G. Komen Breast Cancer Foundation [0706963]; NATIONAL CANCER INSTITUTE [R01CA122099, R01CA076120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763] Funding Source: NIH RePORTER	Harvard Medical School Milton Fund; Emerald Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank William Kaelin Jr, Lewis Cantley, Roya Khosravi-Far and Susan Glueck for critical reading of the manuscript; James DeCaprio, Christoph Geisen, Ronald DePinho, Laura Benjamin, Suzanne Conzen, John Blenis and Peter Jackson for providing reagents; Ross Tomaino for his kind assistance on the mass spectrum analysis; Isaac Robinovitz for his technical support on the fluorescence microscopy; Pier Paolo Pandolfi for sharing unpublished data; and members of the Wei and Toker laboratories for useful discussions. W. W. is a Leukemia and Lymphoma Society Special Fellow, Kimmel Scholar and V Scholar. This work was supported in part by the Harvard Medical School Milton Fund (W.W.) and the Emerald Foundation, and by grants from the National Institutes of Health (W.G.K., CA076120; A.T., CA122099) and the Susan G. Komen Breast Cancer Foundation (R.Y.C., 0706963).	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dowen SE, 2003, INT J CANCER, V105, P326, DOI 10.1002/ijc.11066; Drobnjak M, 2003, CLIN CANCER RES, V9, P2613; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ji P, 2006, J BIOL CHEM, V281, P24058, DOI 10.1074/jbc.M603105200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Reichert M, 2007, CANCER RES, V67, P4149, DOI 10.1158/0008-5472.CAN-06-4484; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Shapira M, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1533; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	48	189	198	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					397	U92		10.1038/ncb1847	http://dx.doi.org/10.1038/ncb1847			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19270695	Green Accepted			2022-12-27	WOS:000265264900010
J	Wong, CH; Chan, H; Ho, CY; Lai, SK; Chan, KS; Koh, CG; Li, HY				Wong, Chi-Hang; Chan, Hei; Ho, Chin-Yee; Lai, Soak-Kuan; Chan, Kheng-Sze; Koh, Cheng-Gee; Li, Hoi-Yeung			Apoptotic histone modification inhibits nuclear transport by regulating RCC1	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; GUANINE-NUCLEOTIDE EXCHANGE; CHROMOSOME CONDENSATION; STERILE-20 KINASE; CELL-NUCLEUS; LIVING CELLS; RAN; CHROMATIN; IMPORT; PHOSPHORYLATION	A number of signalling pathways have been identified that regulate apoptosis, but the mechanism that initiates apoptosis remains incompletely understood. We have found that the nuclear RanGTP level is diminished during the early stages of apoptosis, which correlates with immobilization of RCC1 on the chromosomes. Furthermore, the expression of phosphomimetic histone H2B or caspase-activated Mst1 immobilizes RCC1 and causes reduction of nuclear RanGTP levels, which leads to inactivation of the nuclear transport machinery. As a consequence, nuclear localization signal (NLS)-containing proteins, including NF-kappa B-p65, remain bound to importins alpha and beta in the cytoplasm. Knocking down Mst1 allows resumption of nuclear transport and the nuclear entry of NF-kappa B-p65, which have important roles in rescuing cells from apoptosis. Therefore, we propose that RCC1 reads the histone code created by caspase-activated Mst1 to initiate apoptosis by reducing the level of RanGTP in the nucleus.	[Wong, Chi-Hang; Chan, Hei; Ho, Chin-Yee; Lai, Soak-Kuan; Chan, Kheng-Sze; Koh, Cheng-Gee; Li, Hoi-Yeung] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Koh, CG (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore.	cgkoh@ntu.edu.sg; hyli@ntu.edu.sg	Wong, Chi Hang/C-6909-2015; Li Hoi Yeung, ./A-2218-2011; Wong, Chi Hang/ABE-8673-2021; Koh, Cheng Gee/A-2215-2011	Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Koh, Cheng Gee/0000-0003-1905-8010; Li, Hoi Yeung/0000-0002-8603-1953; Chan, Anna/0000-0003-2176-5734	Academic Research Fund; Ministry of Education, Singapore [ARC 7/06]; Biomedical Research Council, A*STAR, Singapore [05/1/22/19/388]	Academic Research Fund(Ministry of Education, Singapore); Ministry of Education, Singapore(Ministry of Education, Singapore); Biomedical Research Council, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Fund, Ministry of Education, Singapore (ARC 7/06) and Biomedical Research Council, A*STAR, Singapore (05/1/22/19/388).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cushman I, 2004, MOL BIOL CELL, V15, P245, DOI 10.1091/mbc.e03-06-0409; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; FERRANDOMAY E, 2005, CELL DEATH DIFFER; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kihlmark M, 2004, EXP CELL RES, V293, P346, DOI 10.1016/j.yexcr.2003.10.019; Kihlmark M, 2001, J CELL SCI, V114, P3643; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Komeili A, 2001, ANNU REV GENET, V35, P341, DOI 10.1146/annurev.genet.35.102401.090720; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nomura M, 1999, CANCER RES, V59, P5542; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; UCHIDA S, 1990, MOL CELL BIOL, V10, P577, DOI 10.1128/MCB.10.2.577; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Wang CW, 2004, J ASSIST REPROD GEN, V21, P163, DOI 10.1023/B:JARG.0000031249.37862.3a	36	49	51	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					36	U65		10.1038/ncb1810	http://dx.doi.org/10.1038/ncb1810			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060893				2022-12-27	WOS:000262157000009
J	Namy, O; Galopier, A; Martini, C; Matsufuji, S; Fabret, C; Rousset, JP				Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Matsufuji, Senya; Fabret, Celine; Rousset, Jean-Pierre			Epigenetic control of polyamines by the prion [PSI(+)]	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; ORNITHINE DECARBOXYLASE; TRANSLATION TERMINATION; STOP CODON; GENETIC-VARIATION; ANTIZYME; YEAST; CONSERVATION; READTHROUGH; METABOLISM	Prion proteins are found in mammals and yeast, and can transmit diseases and encode heritable phenotypic traits(1). In Saccharomyces cerevisiae, eRF3, Rnq1, Ure2 and Swi1 are functional proteins with a soluble conformation that can switch to a non-functional, amyloid conformation denoted as [PSI(+)], [PIN(+)], [URE3] and [SWI(+)], respectively(2,3). The prion [PSI+] corresponds to an aggregated conformation of the translational release factor eRF3, which suppresses nonsense codons(2). [PSI(+)] modifies cellular fitness and induces several phenotypes according to the genetic background(4,5). An elegant series of studies has demonstrated that several [PSI(+)]-induced phenotypes occur as a consequence of decreased translational termination efficiency(6,7). However, the genes whose expression levels are controlled by [PSI(+)] remain largely unknown. Here, we show that [PSI(+)] enhances expression of antizyme, a negative regulator of cellular polyamines, by modulating the +1 frameshifting required for its expression(8). Our study also demonstrates that [PSI(+)] greatly affects cellular polyamines in yeast. We show that modification of the cellular content of polyamines by the prion accounts for half of the [PSI(+)]-induced phenotypes. Antizyme is the first protein to be described for which expression of its functional form is stimulated by [PSI(+)].	[Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Fabret, Celine; Rousset, Jean-Pierre] IGM, CNRS, UMR 8621, F-91405 Orsay, France; [Namy, Olivier; Galopier, Aurelie; Martini, Cyrielle; Fabret, Celine; Rousset, Jean-Pierre] Univ Paris 11, F-91405 Orsay, France; [Matsufuji, Senya] Jikei Univ, Sch Med, Dept Mol Biol, Minato Ku, Tokyo 1058461, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Jikei University	Namy, O (corresponding author), IGM, CNRS, UMR 8621, F-91405 Orsay, France.	olivier.namy@igmors.u-psud.fr	Namy, olivier/B-8906-2008; Namy, Olivier/ABD-4379-2020	Namy, Olivier/0000-0002-1143-5961	Agence Nationale pour la Recherche [ANR-06-BLAN-0391-01]; Association Pour la Recherche sur le Cancer [3849]; Ministry of Education, Sports, Culture, Science and Technology of Japan; ARC; French Ministry of Education and Research (MENESR)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry of Education, Sports, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ARC(Australian Research Council); French Ministry of Education and Research (MENESR)	We thank Hiroko Takizawa for technical assistance. English usage was corrected by Alex Edelman & Associates. This work was supported by grants from the Agence Nationale pour la Recherche to J.P.R. (ANR-06-BLAN-0391-01), the Association Pour la Recherche sur le Cancer to J.P.R. (Contract 3849) and by grants-in-aid to S. M. from the Ministry of Education, Sports, Culture, Science and Technology of Japan. O.N. was funded by a fellowship from the ARC for part of this study. A. G. is funded by a fellowship from the French Ministry of Education and Research (MENESR).	Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Karamysheva ZN, 2003, NUCLEIC ACIDS RES, V31, P5949, DOI 10.1093/nar/gkg789; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Morgan DML, 1999, MOL BIOTECHNOL, V11, P229, DOI 10.1007/BF02788682; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1989, EUR J BIOCHEM, V180, P181, DOI 10.1111/j.1432-1033.1989.tb14630.x; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2002, GENETICS, V161, P585; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Walters D, 1998, MICROBIOL RES, V153, P179, DOI 10.1016/S0944-5013(98)80038-4; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wilson MA, 2005, P NATL ACAD SCI USA, V102, P10244, DOI 10.1073/pnas.0504557102; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	32	87	87	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1069	1075		10.1038/ncb1766	http://dx.doi.org/10.1038/ncb1766			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160487				2022-12-27	WOS:000258910400012
J	Tatham, MH; Geoffroy, MC; Shen, L; Plechanovova, A; Hattersley, N; Jaffray, EG; Palvimo, JJ; Hay, RT				Tatham, Michael H.; Geoffroy, Marie-Claude; Shen, Linnan; Plechanovova, Anna; Hattersley, Neil; Jaffray, Ellis G.; Palvimo, Jorma J.; Hay, Ronald T.			RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation	NATURE CELL BIOLOGY			English	Article							NUCLEAR-BODIES; SNURF RNF4; PROTEIN; IDENTIFICATION; APOPTOSIS; TRIOXIDE; COREGULATOR; MOTIF	In acute promyelocytic leukaemia (APL), the promyelocytic leukaemia (PML) protein is fused to the retinoic acid receptor a (RAR). This disease can be treated effectively with arsenic, which induces PML modification by small ubiquitin-like modifiers ( SUMO) and proteasomal degradation. Here we demonstrate that the RING-domain-containing ubiquitin E3 ligase, RNF4 ( also known as SNURF), targets poly-SUMO-modified proteins for degradation mediated by ubiquitin. RNF4 depletion or proteasome inhibition led to accumulation of mixed, polyubiquitinated, poly-SUMO chains. PML protein accumulated in RNF4-depleted cells and was ubiquitinated by RNF4 in a SUMO-dependent fashion in vitro. In the absence of RNF4, arsenic failed to induce degradation of PML and SUMO-modified PML accumulated in the nucleus. These results demonstrate that poly-SUMO chains can act as discrete signals from mono-SUMOylation, in this case targeting a poly-SUMOylated substrate for ubiquitin-mediated proteolysis.	[Tatham, Michael H.; Geoffroy, Marie-Claude; Shen, Linnan; Plechanovova, Anna; Hattersley, Neil; Jaffray, Ellis G.; Hay, Ronald T.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Palvimo, Jorma J.] Univ Kuopio, Dept Med Biochem, FI-70211 Kuopio, Finland	University of Dundee; University of Eastern Finland	Hay, RT (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	r.t.hay@dundee.ac.uk	Tatham, Michael H/E-9622-2010; Hay, Ronald T/F-9338-2011; Hay, Ronald/S-3233-2019	Tatham, Michael H/0000-0001-6986-1691; Hay, Ronald T/0000-0001-7113-9024; Hay, Ronald/0000-0001-7113-9024; Geoffroy, Marie-Claude/0000-0001-8298-467X; Palvimo, Jorma/0000-0003-2373-0578	Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen GQ, 1996, BLOOD, V88, P1052; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Duprez E, 1999, J CELL SCI, V112, P381; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Muller S, 1998, BLOOD, V92, P4308, DOI 10.1182/blood.V92.11.4308.423k36_4308_4316; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	29	628	648	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					538	546		10.1038/ncb1716	http://dx.doi.org/10.1038/ncb1716			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18408734	Green Submitted			2022-12-27	WOS:000255502400010
J	Vuilleumier, R; Springhorn, A; Patterson, L; Koidl, S; Hammerschmidt, M; Affolter, M; Pyrowolakis, G				Vuilleumier, Robin; Springhorn, Alexander; Patterson, Lucy; Koidl, Stefanie; Hammerschmidt, Matthias; Affolter, Markus; Pyrowolakis, George			Control of Dpp morphogen signalling by a secreted feedback regulator	NATURE CELL BIOLOGY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CALCIUM-BINDING PROTEIN; WING IMAGINAL DISC; GRADIENT FORMATION; DROSOPHILA DEVELOPMENT; PATTERN-FORMATION; EXPRESSION; ZEBRAFISH; HEDGEHOG; BMP	In many instances during development, morphogens specify cell fates by forming concentration gradients. In the Drosophila melanogaster wing imaginal disc, Decapentaplegic (Dpp), a bone morphogenetic protein (BMP), functions as a long-range morphogen to control patterning and growth(1). Dpp is secreted from a stripe of cells at the anterior-posterior compartment boundary and spreads into both compartments to generate a characteristic BMP activity gradient(2-6). Ever since the identification of the morphogen activity of Dpp in the developing wing, the system has served as a paradigm to understand how long-range gradients are established and how cells respond to such gradients. Here we reveal the tight and direct connection of these two processes with the identification and characterization of pentagone (pent), a transcriptional target of BMP signalling encoding a secreted regulator of the pathway. Absence of pent in the wing disc causes a severe contraction of the BMP activity gradient resulting in patterning and growth defects. We show that Pent interacts with the glypican Dally to control Dpp distribution and provide evidence that proper establishment of the BMP morphogen gradient requires the inbuilt feedback loop embodied by Pent.	[Pyrowolakis, George] Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Patterson, Lucy; Hammerschmidt, Matthias] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Affolter, Markus] Biozentrum Univ Basel, CH-4056 Basel, Switzerland	University of Freiburg; Max Planck Society; University of Basel	Pyrowolakis, G (corresponding author), Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, Hauptstr 1, D-79104 Freiburg, Germany.	g.pyrowolakis@biologie.uni-freiburg.de	Patterson, Lucy/G-1803-2011	Patterson, Lucy/0000-0002-2578-381X; Affolter, Markus/0000-0002-5171-0016				Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012	51	98	98	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					611	U198		10.1038/ncb2064	http://dx.doi.org/10.1038/ncb2064			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453847				2022-12-27	WOS:000278213400014
J	Coolen, MW; Stirzaker, C; Song, JZ; Statham, AL; Kassir, Z; Moreno, CS; Young, AN; Varma, V; Speed, TP; Cowley, M; Lacaze, P; Kaplan, W; Robinson, MD; Clark, SJ				Coolen, Marcel W.; Stirzaker, Clare; Song, Jenny Z.; Statham, Aaron L.; Kassir, Zena; Moreno, Carlos S.; Young, Andrew N.; Varma, Vijay; Speed, Terence P.; Cowley, Mark; Lacaze, Paul; Kaplan, Warren; Robinson, Mark D.; Clark, Susan J.			Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity	NATURE CELL BIOLOGY			English	Article							CANDIDATE TUMOR-SUPPRESSOR; POLYCOMB GROUP PROTEIN; HUMAN PROSTATE-CANCER; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; DNA HYPERMETHYLATION; PROMOTER METHYLATION; COLORECTAL-CANCER; ABERRANT METHYLATION; BREAST-CANCER	Silencing of individual genes can occur by genetic and epigenetic processes during carcinogenesis, but the underlying mechanisms remain unclear. By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing (LRES). We identified 47 LRES regions in prostate cancer, typically spanning about 2 Mb and harbouring approximately 12 genes, with a prevalence of tumour suppressor and miRNA genes. Our data reveal that LRES is associated with regional histone deacetylation combined with subdomains of different epigenetic remodelling patterns, which include re-enforcement, gain or exchange of repressive histone, and DNA methylation marks. The transcriptional and epigenetic state of genes in normal prostate epithelial and human embryonic stem cells can play a critical part in defining the mode of cancer-associated epigenetic remodelling. We propose that consolidation or effective reduction of the cancer genome commonly occurs in domains through a combination of LRES and LOH or genomic deletion, resulting in reduced transcriptional plasticity within these regions.	[Coolen, Marcel W.; Stirzaker, Clare; Song, Jenny Z.; Statham, Aaron L.; Kassir, Zena; Robinson, Mark D.; Clark, Susan J.] Garvan Inst Med Res, Canc Program, Epigenet Lab, Sydney, NSW 2010, Australia; [Moreno, Carlos S.; Young, Andrew N.; Varma, Vijay] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Varma, Vijay] Atlanta VA Med Ctr, Atlanta, GA USA; [Speed, Terence P.; Robinson, Mark D.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Cowley, Mark; Lacaze, Paul; Kaplan, Warren] Garvan Inst Med Res, Peter Wills Bioinformat Ctr, Sydney, NSW 2010, Australia; [Clark, Susan J.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Walter & Eliza Hall Institute; Garvan Institute of Medical Research; University of New South Wales Sydney	Clark, SJ (corresponding author), Garvan Inst Med Res, Canc Program, Epigenet Lab, Sydney, NSW 2010, Australia.	s.clark@garvan.org.au	Robinson, Mark D/A-6432-2015; Cowley, Mark/D-4504-2012; Cowley, Mark/K-8731-2019; Moreno, Carlos S/B-3863-2009; Clark, Susan J/B-2272-2008; Clark, Susan J/U-7365-2019; Speed, Terence P/B-8085-2009; Simon, Simon/D-5128-2012; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Cowley, Mark/0000-0002-9519-5714; Moreno, Carlos S/0000-0002-5582-0028; Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030; Speed, Terence P/0000-0002-5403-7998; Robinson, Mark D./0000-0002-3048-5518; Lacaze, Paul/0000-0002-0902-6798; Coolen, Marcel/0000-0002-8188-8480; Stirzaker, Clare/0000-0001-5601-3140	Cancer Institute NSW (CINSW); National Health and Medical Research Council (NHMRC) [427614, 481347]; NBCF; NATIONAL CANCER INSTITUTE [K22CA096560, R01CA106826] Funding Source: NIH RePORTER	Cancer Institute NSW (CINSW); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NBCF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Patterson, P. Molloy and T. Hulf for reviewing the manuscript. We thank the Ramaciotti Centre, University of NSW (Sydney, Australia) for array hybridizations. This work is supported by Cancer Institute NSW (CINSW) program (S. J. C.), CINSW Fellowship (M. W. C.) and CINSW Student (A. L. S.) grants and National Health and Medical Research Council (NH&MRC) project (427614, 481347) and Fellowship grants (S. J. C. and T. S.) and NBCF program grant.	Bachmann N, 2008, CANCER GENET CYTOGEN, V182, P103, DOI 10.1016/j.cancergencyto.2008.01.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chene L, 2004, INT J CANCER, V111, P798, DOI 10.1002/ijc.20337; Cher ML, 1996, CANCER RES, V56, P3091; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Khalili A, 2007, CANCER INFORM, V3, P43; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Latil A, 1995, CLIN CANCER RES, V1, P1385; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Luo J, 2001, CANCER RES, V61, P4683; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Palmisano WA, 2003, CANCER RES, V63, P4620; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Smith JS, 2006, NAT GENET, V38, P504, DOI 10.1038/ng0506-504; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Welsh JB, 2001, CANCER RES, V61, P5974; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	69	129	134	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					235	U37		10.1038/ncb2023	http://dx.doi.org/10.1038/ncb2023			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173741	Green Accepted			2022-12-27	WOS:000275054200009
J	Oliveira, RA; Hamilton, RS; Pauli, A; Davis, I; Nasmyth, K				Oliveira, Raquel A.; Hamilton, Russell S.; Pauli, Andrea; Davis, Ilan; Nasmyth, Kim			Cohesin cleavage and Cdk inhibition trigger formation of daughter nuclei	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SISTER-CHROMATID COHESION; TOPOISOMERASE-II; DROSOPHILA CELLS; ANAPHASE; MITOSIS; PROTEIN; CENTROMERE; COMPLEXES; KINASE	The metaphase-anaphase transition is orchestrated through proteolysis of numerous proteins by a ubiquitin protein ligase called the anaphase-promoting complex or cyclosome (APC/C)(1). A crucial aspect of this process is sister chromatid separation, which is thought to be mediated by separase, a thiol protease activated by the APC/C. Separase cleaves cohesin, a ring-shaped complex that entraps sister DNAs2,3. It is a matter of debate whether cohesin-independent forces also contribute to sister chromatid cohesion(4-6). Using 4D live-cell imaging of Drosophila melanogaster syncytial embryos blocked in metaphase (via APC/C inhibition), we show that artificial cohesin cleavage(7) is sufficient to trigger chromosome disjunction. This is nevertheless insufficient for correct chromosome segregation. Kinetochore-microtubule attachments are rapidly destabilized by the loss of tension caused by cohesin cleavage in the presence of high Cdk1 (cyclin-dependent kinase 1) activity, as occurs when the APC/C cannot destroy mitotic cyclins. Metaphase chromosomes undergo a bona fide anaphase when cohesin cleavage is combined with Cdk1 inhibition. We conclude that only two key events, opening of cohesin rings and downregulation of Cdk1, are sufficient to drive proper segregation of chromosomes in anaphase.	[Oliveira, Raquel A.; Hamilton, Russell S.; Pauli, Andrea; Davis, Ilan; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Hamilton, Russell/T-7240-2019; Oliveira, Raquel A/F-4405-2012; Oliveira, Raquel A/AAE-8231-2022	Hamilton, Russell/0000-0002-0598-3793; Oliveira, Raquel A/0000-0002-8293-8603; Oliveira, Raquel A/0000-0002-8293-8603; Nasmyth, Kim/0000-0001-7030-4403; Davis, Ilan/0000-0002-5385-3053; Pauli, Andrea/0000-0001-9646-2303	Fundacao para a Ciencia e a Tecnologia of Portugal; Welcome Trust; Medical Research Council (MRC); MRC [G0001292] Funding Source: UKRI; Medical Research Council [G0001292, G0501615] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Welcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Heidmann, J. Mummery- Widmer, R. Karess, T. Hunt and M. Rape for fly strains and plasmids, A. Musacchio, T. Hunt and J.- M. Peters for helpful advice, S. Dixon, J. Metson and P. Guna for technical assistance, R. Parton for help with microscopy and microinjection and J. Raff, B. Novak and all the members of the K. N. laboratory for discussions and comments on the manuscript. R. A. O. holds a post-doctoral fellowship from the Fundacao para a Ciencia e a Tecnologia of Portugal. R. S. H. and I. D. were supported by a Senior Research Fellowship from the Welcome Trust to I. D. Work in the laboratory of K. N. is supported by grants from Medical Research Council (MRC) and Wellcome Trust.	BUCHENAU P, 1993, J CELL SCI, V104, P1175; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Coelho PA, 2008, PLOS BIOL, V6, P1758, DOI 10.1371/journal.pbio.0060207; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Guacci V, 2007, GENES CELLS, V12, P693, DOI 10.1111/j.1365-2443.2007.01093.x; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712	41	121	123	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					185	U211		10.1038/ncb2018	http://dx.doi.org/10.1038/ncb2018			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081838	Green Accepted			2022-12-27	WOS:000274139400013
J	Klamt, F; Zdanov, S; Levine, RL; Pariser, A; Zhang, YQ; Zhang, BL; Yu, LR; Veenstra, TD; Shacter, E				Klamt, Fabio; Zdanov, Stephanie; Levine, Rodney L.; Pariser, Ashley; Zhang, Yaqin; Zhang, Baolin; Yu, Li-Rong; Veenstra, Timothy D.; Shacter, Emily			Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin	NATURE CELL BIOLOGY			English	Article							HYPOCHLOROUS ACID; CELL-DEATH; PERMEABILITY TRANSITION; HYDROGEN-PEROXIDE; MITOCHONDRIAL PERMEABILITY; LYMPHOMA-CELLS; STRESS; CYSTEINE; CANCER; CHLORAMINES	Physiological oxidants that are generated by activated phagocytes comprise the main source of oxidative stress during inflammation(1,2). Oxidants such as taurine chloramine (TnCl) and hydrogen peroxide (H2O2) can damage proteins and induce apoptosis, but the role of specific protein oxidation in this process has not been defined. We found that the actin-binding protein cofilin is a key target of oxidation. When oxidation of this single regulatory protein is prevented, oxidant-induced apoptosis is inhibited. Oxidation of cofilin causes it to lose its affinity for actin and to translocate to the mitochondria, where it induces swelling and cytochrome c release by mediating opening of the permeability transition pore (PTP). This occurs independently of Bax activation and requires both oxidation of cofilin Cys residues and dephosphorylation at Ser 3. Knockdown of endogenous cofilin using targeted siRNA inhibits oxidant-induced apoptosis, which is restored by re-expression of wild-type cofilin but not by cofilin containing Cys to Ala mutations. Exposure of cofilin to TnCl results in intramolecular disulphide bonding and oxidation of Met residues to Met sulphoxide, but only Cys oxidation causes cofilin to induce mitochondrial damage.	[Klamt, Fabio; Zdanov, Stephanie; Pariser, Ashley; Zhang, Yaqin; Zhang, Baolin; Shacter, Emily] US FDA, Biochem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Klamt, Fabio] Univ Fed Rio Grande do Sul, Ctr Oxidat Stress Res, Dept Biochem, ICBS, BR-90035003 Porto Alegre, RS, Brazil; [Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li-Rong] US FDA, Ctr Prote, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Yu, Li-Rong; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA	US Food & Drug Administration (FDA); Universidade Federal do Rio Grande do Sul; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Shacter, E (corresponding author), US FDA, Biochem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA.	emily.shacter@fda.hhs.gov	Zdanov, Stephanie/G-2524-2012; Levine, Rodney L/D-9885-2011	Yu, Li-Rong/0000-0001-6084-991X; Pariser, Ashley/0000-0002-7993-6316	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HL000225-31] Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Englert RP, 2002, J BIOL CHEM, V277, P20518, DOI 10.1074/jbc.M200212200; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang DK, 2003, J BIOL CHEM, V278, P14857, DOI 10.1074/jbc.M300616200; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Klamt F, 2005, BBA-GEN SUBJECTS, V1726, P14, DOI 10.1016/j.bbagen.2005.07.016; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Levine RL, 2006, RAPID COMMUN MASS SP, V20, P1828, DOI 10.1002/rcm.2519; Mannherz HG, 2005, EUR J CELL BIOL, V84, P503, DOI 10.1016/j.ejcb.2004.11.008; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Senturker S, 2002, ARCH BIOCHEM BIOPHYS, V397, P262, DOI 10.1006/abbi.2001.2681; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yu LR, 2004, MOL CELL PROTEOMICS, V3, P896, DOI 10.1074/mcp.M400034-MCP200; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443	38	173	178	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1241	U193		10.1038/ncb1968	http://dx.doi.org/10.1038/ncb1968			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734890	Green Accepted			2022-12-27	WOS:000270382000014
J	Abdallah, P; Luciano, P; Runge, KW; Lisby, M; Geli, V; Gilson, E; Teixeira, MT				Abdallah, Pauline; Luciano, Pierre; Runge, Kurt W.; Lisby, Michael; Geli, Vincent; Gilson, Eric; Teixeira, M. Teresa			A two-step model for senescence triggered by a single critically short telomere	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DNA-DAMAGE; LENGTH; PATHWAY; MMS1; RECOMBINATION; MAINTENANCE; ELONGATION; PROTEINS	Telomeres protect chromosome ends from fusion and degradation(1). In the absence of a specific telomere elongation mechanism, their DNA shortens progressively with every round of replication, leading to replicative senescence(2). Here, we show that telomerase-deficient cells bearing a single, very short telomere senesce earlier, demonstrating that the length of the shortest telomere is a major determinant of the onset of senescence. We further show that Mec1p-ATR specifically recognizes the single, very short telomere causing the accelerated senescence. Strikingly, before entering senescence, cells divide for several generations despite complete erosion of their shortened telomeres. This pre-senescence growth requires RAD52 (radiation sensitive) and MMS1 (methyl methane sulfonate sensitive), and there is no evidence for major intertelomeric recombination. We propose that, in the absence of telomerase, a very short telomere is first maintained in a pre-signalling state by a RAD52-MMS1-dependent pathway and then switches to a signalling state leading to senescence through a Mec1p-dependent checkpoint.	[Abdallah, Pauline; Gilson, Eric; Teixeira, M. Teresa] Univ Lyon 1, CNRS, Ecole Normale Super, UMR 5239,LBMC, F-69364 Lyon 07, France; [Luciano, Pierre; Geli, Vincent] Univ Aix Marseille 2, Unite Propre Rech 3081, CNRS, F-13402 Marseille 20, France; [Runge, Kurt W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Lisby, Michael] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Cleveland Clinic Foundation; University of Copenhagen	Gilson, E (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super, UMR 5239,LBMC, 46 Allee Italie, F-69364 Lyon 07, France.	eric.gilson@ens-lyon.fr	Lisby, Michael/K-9814-2014; Teixeira, Maria Teresa/A-2100-2011; Runge, Kurt/AAW-9308-2021	Lisby, Michael/0000-0002-4830-5247; Teixeira, Maria Teresa/0000-0002-9466-7951; Runge, Kurt/0000-0001-8492-0530	La Ligue Contre le Cancer; INCa; The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER	La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); The Danish Agency for Science, Technology and Innovation; Villum Kann Rasmussen Foundation(Villum Fonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Wellinger and L. Rudolph for fruitful suggestions, G. Yvert and C. Lopes for advice in statistical analysis and A. Jacquier for sharing unpublished material. We also thank T. Petes, M. P. Longhese and S. Marcand for strains and plasmids. P. A. gratefully acknowledges the financial support of the Lebanese National council for Scientific Research (CNRSL) and the Association pour la Recherche sur le Cancer (ARC). This work was supported by La Ligue Contre le Cancer (E. G. and V. G., equipes labellisees), the INCa programmes TELINCA and TELOFUN ( E. G. and V. G.), The Danish Agency for Science, Technology and Innovation (M. L.), the Villum Kann Rasmussen Foundation (M. L.) and the National Institutes of Health (K. R.).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bianchi A, 2007, GENE DEV, V21, P1726, DOI 10.1101/gad.438907; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Duro E, 2008, DNA REPAIR, V7, P811, DOI 10.1016/j.dnarep.2008.01.007; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hryciw T, 2002, MOL GENET GENOMICS, V266, P848, DOI 10.1007/s00438-001-0605-x; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Longhese MP, 2000, GENETICS, V155, P1577; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Mantiero D, 2007, EMBO REP, V8, P380, DOI 10.1038/sj.embor.7400911; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Ui A, 2007, BIOCHEM BIOPH RES CO, V356, P1031, DOI 10.1016/j.bbrc.2007.03.088; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	35	120	124	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					988	U174		10.1038/ncb1911	http://dx.doi.org/10.1038/ncb1911			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597486	Green Accepted			2022-12-27	WOS:000268593200013
J	Peng, G; Yim, EK; Dai, H; Jackson, AP; van der Burgt, I; Pan, MR; Hu, RZ; Li, KY; Lin, SY				Peng, Guang; Yim, Eun-Kyoung; Dai, Hui; Jackson, Andrew P.; van der Burgt, Ineke; Pan, Mei-Ren; Hu, Ruozhen; Li, Kaiyi; Lin, Shiaw-Yih			BRIT1/MCPH1 links chromatin remodelling to DNA damage response	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; PROTEIN; REPAIR; COMPLEX; ATM; MICROCEPHALIN; PATHWAY; MECHANISM; INO80	To detect and repair damaged DNA, DNA-damage-response proteins need to overcome the barrier of condensed chromatin to gain access to DNA lesions(1). ATP-dependent chromatin remodelling is one of the fundamental mechanisms used by cells to relax chromatin in DNA repair(2,3). However, the mechanism mediating their recruitment to DNA lesions remains largely unknown. BRIT1 (also known as MCPH1) is an early DNA-damage- response protein that is mutated in human primary microcephaly(4-8). Here we report a previously unknown function of BRIT1 as a regulator of the ATP-dependent chromatin remodelling complex SWI-SNF in DNA repair. After damage to DNA, BRIT1 increases its interaction with SWI-SNF through ATM/ ATR-dependent phosphorylation on the BAF170 subunit. This increase in binding affinity provides a means by which SWI-SNF can be specifically recruited to and maintained at DNA lesions. Loss of BRIT1 causes impaired chromatin relaxation as a result of decreased association of SWI-SNF with chromatin. This explains the decreased recruitment of repair proteins to DNA lesions and the reduced efficiency of repair in BRIT1-deficient cells, resulting in impaired cell survival after DNA damage. Our findings therefore identify BRIT1 as a key molecule that links chromatin remodelling with response to DNA damage in the control of DNA repair, and its dysfunction contributes to human disease.	[Peng, Guang; Yim, Eun-Kyoung; Dai, Hui; Pan, Mei-Ren; Hu, Ruozhen; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Jackson, Andrew P.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [van der Burgt, Ineke] Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; [Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh; Radboud University Nijmegen; Baylor College of Medicine	Lin, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA.	sylin@mdanderson.org	Jackson, Andrew P/D-3442-2009; Pan, Mei-Ren/I-2021-2013	Jackson, Andrew P/0000-0002-8739-2646; 	National Cancer Institute [R01CA112291]; American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [R01CA112291] Funding Source: NIH RePORTER; Medical Research Council [MC_U127580972] Funding Source: researchfish; MRC [MC_U127580972] Funding Source: UKRI	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Rosenberg, X. Shen and F. Meric- Bernstam for critical reading of the manuscript; S. Deming for proofreading it; M. Jasin for reagents; E. Griffith for identifying the mutation in the MCPH no. 2 cell line; and the core facilities of the M. D. Anderson Cancer Center for mass spectrometry and fluorescence-activated cell sorting. This work was supported by a grant from the National Cancer Institute ( R01CA112291) and an American Cancer Society Research Scholar Award to S. Y. L.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Teraoka H, 1996, EXP CELL RES, V222, P218, DOI 10.1006/excr.1996.0027; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	35	154	159	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					865	U221		10.1038/ncb1895	http://dx.doi.org/10.1038/ncb1895			40	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525936	Green Accepted			2022-12-27	WOS:000267603100016
J	van der Voet, M; Berends, CWH; Perreault, A; Nguyen-Ngoc, T; Gonczy, P; Vidal, M; Boxem, M; van den Heuvel, S				van der Voet, Monique; Berends, Christian W. H.; Perreault, Audrey; Nguyen-Ngoc, Tu; Goenczy, Pierre; Vidal, Marc; Boxem, Mike; van den Heuvel, Sander			NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5/GPR/G alpha	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INTERFERENCE; INTERACTOME NETWORK; PLANAR DIVISIONS; CLEAVAGE PLANE; OOCYTE CORTEX; PROTEIN; EMBRYOS; ORGANIZATION	The spindle apparatus dictates the plane of cell cleavage, which is critical in the choice between symmetric or asymmetric division. spindle positioning is controlled by an evolutionarily conserved pathway, which involves LIN-5/GPr-1/2/G alpha in Caenorhabditis elegans, Mud/Pins/Ga in Drosophila and NuMA/IGN/G alpha in humans(1). GPr-1/2 and G alpha localize LIN-5 to the cell cortex, which engages dynein and controls the cleavage plane during early mitotic divisions in C. elegans(2-6). Here we identify AsPM-1 (abnormal spindle-like, microcephaly-associated) as a novel LIN-5 binding partner. AsPM-1, together with calmodulin (CMD-1), promotes meiotic spindle organization and the accumulation of LIN-5 at meiotic and mitotic spindle poles. spindle rotation during maternal meiosis is independent of GPR-1/2 and G alpha, yet requires LIN-5, AsPM-1, CMD-1 and dynein. Our data support the existence of two distinct LIN-5 complexes that determine localized dynein function: LIN-5/GPR-1/2/G alpha at the cortex, and LIN-5/AsPM-1/CMD-1 at spindle poles. these functional interactions may be conserved in mammals, with implications for primary microcephaly.	[van der Voet, Monique; Berends, Christian W. H.; Boxem, Mike; van den Heuvel, Sander] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Perreault, Audrey] MGH Canc Ctr, Charlestown, MA 02129 USA; [Nguyen-Ngoc, Tu; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1066 Lausanne, Switzerland; [Vidal, Marc; Boxem, Mike] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Vidal, Marc; Boxem, Mike] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Vidal, Marc; Boxem, Mike] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Utrecht University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	van den Heuvel, S (corresponding author), Univ Utrecht, Dept Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	s.j.l.vandenheuvel@uu.nl	van den Heuvel, Sander J.L./B-8892-2011; Boxem, Mike/B-8857-2011; van der Voet, Monique/F-5772-2012	van den Heuvel, Sander J.L./0000-0001-9015-7463; van der Voet, Monique/0000-0002-8829-1767; Nguyen-Ngoc, Tu/0000-0001-7574-2947; Gonczy, Pierre/0000-0002-6305-6883	National Institutes of Health [GM57990]; Swiss National Science Foundation [3100A0-102087]; Marie Curie International Reintegration [MIRG-CT-2007-046458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie International Reintegration(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Steve Gygi and Ross Tomaino ( Taplin Biological Mass Spectrometry, Harvard Medical School) for analysis of peptides by mass spectrometry ( HMS), to Sean O'Rourke and Bruce Bowerman for the GFP - DHC- 1 strain EU1561, to Inge The for assistance with ASPM- 1 antibody production, Kristiaan de Vries for scoring embryonic lethality, and the Caenorhabditis Genetics Center ( National Institutes of Health, National Center for Research Resources) for providing strains. We thank Adri Thomas and Marjolein Wildwater for critically reading the manuscript. This work was supported in part by National Institutes of Health grant GM57990 to S. v. d. H, Swiss National Science Foundation grant 3100A0-102087 to P. G., and Marie Curie International Reintegration grant MIRG-CT-2007-046458 to M. B.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; GONZALEZ C, 1990, J CELL SCI, V96, P605; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Green RF, 2004, MOL GENET GENOMICS, V271, P532, DOI 10.1007/s00438-004-1012-x; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kleijn M, 1995, J CELL BIOCHEM, V59, P443, DOI 10.1002/jcb.240590405; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; MAINS PE, 1990, GENETICS, V126, P593; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Park DH, 2008, DEV BIOL, V315, P42, DOI 10.1016/j.ydbio.2007.11.037; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Yang HY, 2003, DEV BIOL, V260, P245, DOI 10.1016/S0012-1606(03)00216-1; Yang HY, 2005, J CELL BIOL, V169, P447, DOI 10.1083/jcb.200411132	41	92	102	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					269	U101		10.1038/ncb1834	http://dx.doi.org/10.1038/ncb1834			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219036				2022-12-27	WOS:000263777900010
J	Kolev, V; Mandinova, A; Guinea-Viniegra, J; Hu, B; Lefort, K; Lambertini, C; Neel, V; Dummer, R; Wagner, EF; Dotto, GP				Kolev, Vihren; Mandinova, Anna; Guinea-Viniegra, Juan; Hu, Bing; Lefort, Karine; Lambertini, Chiara; Neel, Victor; Dummer, Reinhard; Wagner, Erwin F.; Dotto, G. Paolo			EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer	NATURE CELL BIOLOGY			English	Article							EPIDERMAL-GROWTH; C-JUN; P53 EXPRESSION; RECEPTOR; PATHWAY; PHOSPHORYLATION; SUPPRESSION; PROGRESSION; INTEGRATION; MECHANISMS	The Notch1 gene has an important role in mammalian cell-fate decision and tumorigenesis. Upstream control mechanisms for transcription of this gene are still poorly understood. In a chemical genetics screen for small molecule activators of Notch signalling, we identified epidermal growth factor receptor ( EGFR) as a key negative regulator of Notch1 gene expression in primary human keratinocytes, intact epidermis and skin squamous cell carcinomas ( SCCs). The underlying mechanism for negative control of the Notch1 gene in human cells, as well as in a mouse model of EGFR-dependent skin carcinogenesis, involves transcriptional suppression of p53 by the EGFR effector c-Jun. Suppression of Notch signalling in cancer cells counteracts the differentiation-inducing effects of EGFR inhibitors while, at the same time, synergizing with these compounds in induction of apoptosis. Thus, our data reveal a key role of EGFR signalling in the negative regulation of Notch1 gene transcription, of potential relevance for combinatory approaches for cancer therapy.	[Kolev, Vihren; Mandinova, Anna; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Guinea-Viniegra, Juan; Wagner, Erwin F.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Hu, Bing; Lefort, Karine; Lambertini, Chiara; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Neel, Victor; Dotto, G. Paolo] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Harvard University; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Lausanne; Harvard University; Massachusetts General Hospital; University of Zurich; University Zurich Hospital	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	Gian-Paolo.Dotto@unil.ch	Hu, Bing/K-3541-2019	Wagner, Erwin F/0000-0001-7872-0196	NCI NIH HHS [P01 CA016038] Funding Source: Medline; NIAMS NIH HHS [AR39190, R01 AR054856-03, AR 054856, R01 AR054856, R01 AR039190-21, R01 AR039190] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Boggs K, 2007, J BIOL CHEM, V282, P7982, DOI 10.1074/jbc.M611675200; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Jost M, 2000, EUR J DERMATOL, V10, P505; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kang JH, 2001, LAB INVEST, V81, P573, DOI 10.1038/labinvest.3780266; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Reuter CWM, 2007, BRIT J CANCER, V96, P408, DOI 10.1038/sj.bjc.6603566; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schad K, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9075; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	44	150	161	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8								10.1038/ncb1750	http://dx.doi.org/10.1038/ncb1750			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604200	Green Submitted, Green Accepted			2022-12-27	WOS:000258147100008
J	Miserey-Lenkei, S; Chalancon, G; Bardin, S; Formstecher, E; Goud, B; Echard, A				Miserey-Lenkei, S.; Chalancon, G.; Bardin, S.; Formstecher, E.; Goud, B.; Echard, A.			Rab and actomyosin-dependent fission of transport vesicles at the Golgi complex	NATURE CELL BIOLOGY			English	Article							NONMUSCLE MYOSIN-II; TO-TGN TRANSPORT; ACTIN DYNAMICS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; ARP2/3 COMPLEX; CIS-GOLGI; IN-VITRO; F-ACTIN; NETWORK	Trafficking between membrane compartments is a characteristic of eukaryotic cells and relies on transport carriers that bud and fission from a donor membrane, before being transported and fusing with the correct acceptor compartment. Rab GTPases ensure specificity and directionality of trafficking steps by regulating the movement of transport carriers along cytoskeletal tracks, and the recruitment of tethering factors required for the docking and fusion processes. Here we show that Rab6, a Golgi-associated Rab, forms a complex with myosin II, contributes to its localization at the Golgi complex and, unexpectedly, controls the fission of Rab6 vesicles. Inhibition of either Rab6 or myosin II function impairs both the fission of Rab6 transport carriers from Golgi membranes and the trafficking of anterograde and retrograde cargo from the Golgi. These effects are consistent with myosin II being an effector of Rab6 in these processes. Our results provide evidence that the actomyosin system is required in vesicle biogenesis at the Golgi, and uncover a function for Rab GTPases in vesicle fission.	[Miserey-Lenkei, S.; Chalancon, G.; Bardin, S.; Goud, B.; Echard, A.] Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, UMR 144, F-75248 Paris 05, France; [Formstecher, E.] Hybrigen SA, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Goud, B (corresponding author), Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.	bruno.goud@curie.fr; arnaud.echard@pasteur.fr	Goud, Bruno/GWC-4807-2022	Echard, Arnaud/0000-0001-7402-1398; FORMSTECHER, Etienne/0000-0002-6410-4365	Institut Curie; CNRS; GenHomme Network [02490-6088]; Agence Nationale pour la Recherche [ANR BLAN05 0107, ANR BLAN06-3-139786, ANR JC07-188506]; Association pour la Recherche sur le Cancer (ARC) [1095]	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); GenHomme Network; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	We thank R. S. Adelstein, P. Benaroch, A. Burgess, P. Chavrier, D. Dambournet, V. Doye, M. Heuze, F. Jollivet, A-M. Lennon, G. Montagnac, F. Perez, J. Saraste, J. Stow and J. Young for providing reagents and plasmids; A. Paoletti and P. Tran for the use of their spinning disk confocal microscope; V. Fraisier, J-B. Sibarita and the staff imagerie for their expertise in microscopy. We thank P. Bassereau, Y. Bellaiche, E. Crowell, A-M. Lennon, K. Schauer, P. Tran and J. Young for critical reading of the manuscript. This work has been supported by the Institut Curie, the CNRS, the GenHomme Network Grant 02490-6088 to Hybrigenics and Institut Curie, the Agence Nationale pour la Recherche (grants ANR BLAN05 0107 and ANR BLAN06-3-139786 to BG and ANR JC07-188506 to AE), the Association pour la Recherche sur le Cancer (ARC grant 1095 to SML).	Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; BROSCHAT KO, 1983, CELL, V35, P561, DOI 10.1016/0092-8674(83)90190-3; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Duran JM, 2003, MOL BIOL CELL, V14, P445, DOI 10.1091/mbc.E02-04-0214; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Ikonen E, 1997, J CELL SCI, V110, P2155; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MAUPIN P, 1994, J CELL SCI, V107, P3077; Miserey-Lenkei S, 2001, MOL ENDOCRINOL, V15, P294, DOI 10.1210/me.15.2.294; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rios RM, 2004, CELL, V118, P323; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Simon JP, 1998, P NATL ACAD SCI USA, V95, P1073, DOI 10.1073/pnas.95.3.1073; Smith RD, 2009, TRAFFIC, V10, P1502, DOI 10.1111/j.1600-0854.2009.00965.x; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	62	194	199	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					645	U49		10.1038/ncb2067	http://dx.doi.org/10.1038/ncb2067			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20562865				2022-12-27	WOS:000279374400008
J	Crickmore, M; Mann, RS				Crickmore, Michael; Mann, Richard S.			A new chisel for sculpting Darwin's endless forms	NATURE CELL BIOLOGY			English	Editorial Material							HEPARAN-SULFATE PROTEOGLYCANS; MORPHOGEN GRADIENT; HOX CONTROL; MOBILITY; SIZE	The distribution of secreted morphogens in a developing organ determines its form by instructing size, shape and pattern. Pentagone has been identified as a secreted factor that controls the distribution of the morphogen Decapentaplegic (Dpp) in the Drosophila melanogaster wing.	[Crickmore, Michael] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	Rockefeller University; Columbia University	Crickmore, M (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	mcrickmore@rockefeller.edu; rsm10@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Darwin C, 1859, ORIGIN SPECIES MEANS; Day SJ, 2000, DEVELOPMENT, V127, P2977; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064	12	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					528	529		10.1038/ncb0610-528	http://dx.doi.org/10.1038/ncb0610-528			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20517301				2022-12-27	WOS:000278213400004
J	Lecuit, T				Lecuit, Thomas			alpha-catenin mechanosensing for adherens junctions	NATURE CELL BIOLOGY			English	Editorial Material							CADHERIN; ACTIN; COMPLEX	The balance of cohesion and remodelling is essential for the integrity and morphogenesis of epithelia. This requires adhesion and transmission of actomyosin tension, both of which are mediated by E-cadherin. The finding that actomyosin tension reinforces mechanical coupling of actin to E-cadherin through alpha-catenin reveals similarities with integrin regulation.	Univ Aix Marseille 2, IBDML, CNRS, UMR6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, IBDML, CNRS, UMR6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lecuit@ibdml.univ-mrs.fr						Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; MARTIN AC, 2010, CELL BIOL, V188, P735; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	15	17	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					522	524		10.1038/ncb2066	http://dx.doi.org/10.1038/ncb2066			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453846				2022-12-27	WOS:000278213400002
J	Zaltsman, Y; Shachnai, L; Yivgi-Ohana, N; Schwarz, M; Maryanovich, M; Houtkooper, RH; Vaz, FM; De Leonardis, F; Fiermonte, G; Palmieri, F; Gillissen, B; Daniel, PT; Jimenez, E; Walsh, S; Koehler, CM; Roy, SS; Walter, L; Hajnoczky, G; Gross, A				Zaltsman, Yehudit; Shachnai, Liat; Yivgi-Ohana, Natalie; Schwarz, Michal; Maryanovich, Maria; Houtkooper, Riekelt H.; Vaz, Frederic Maxime; De Leonardis, Francesco; Fiermonte, Giuseppe; Palmieri, Ferdinando; Gillissen, Bernhard; Daniel, Peter T.; Jimenez, Erin; Walsh, Susan; Koehler, Carla M.; Roy, Soumya Sinha; Walter, Ludivine; Hajnoczky, Gyoergy; Gross, Atan			MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria	NATURE CELL BIOLOGY			English	Article							OUTER-MEMBRANE; CELL-DEATH; CRE RECOMBINASE; BCL-2 FAMILY; INDUCE APOPTOSIS; BARTH-SYNDROME; BAX; PROTEINS; PERMEABILIZATION; OLIGOMERIZATION	The BH3-only BID (BH3-interacting domain death agonist) protein has a critical function in the death-receptor pathway in the liver by triggering mitochondrial outer membrane permeabilization (MOMP). Here we show that MTCH2/MIMP (mitochondrial carrier homologue 2/Met-induced mitochondrial protein), a novel truncated BID (tBID)-interacting protein, is a surface-exposed outer mitochondrial membrane protein that facilitates the recruitment of tBID to mitochondria. Knockout of MTCH2/MIMP in embryonic stem cells and in mouse embryonic fibroblasts hinders the recruitment of tBID to mitochondria, the activation of Bax/Bak, MOMP, and apoptosis. Moreover, conditional knockout of MTCH2/MIMP in the liver decreases the sensitivity of mice to Fas-induced hepatocellular apoptosis and prevents the recruitment of tBID to liver mitochondria both in vivo and in vitro. In contrast, MTCH2/MIMP deletion had no effect on apoptosis induced by other pro-apoptotic Bcl-2 family members and no detectable effect on the outer membrane lipid composition. These loss-of-function models indicate that MTCH2/MIMP has a critical function in liver apoptosis by regulating the recruitment of tBID to mitochondria.	[Zaltsman, Yehudit; Shachnai, Liat; Yivgi-Ohana, Natalie; Schwarz, Michal; Maryanovich, Maria; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Houtkooper, Riekelt H.] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Vaz, Frederic Maxime] Univ Amsterdam, Dept Clin Chem & Pediat, NL-1100 DE Amsterdam, Netherlands; [De Leonardis, Francesco; Fiermonte, Giuseppe; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, I-70125 Bari, Italy; [Gillissen, Bernhard; Daniel, Peter T.] Humboldt Univ, Univ Med Ctr Charite, Dept Hematol Oncol & Tumor Immunol, D-13125 Berlin, Germany; [Jimenez, Erin; Walsh, Susan; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Roy, Soumya Sinha; Walter, Ludivine; Hajnoczky, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Weizmann Institute of Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Universita degli Studi di Bari Aldo Moro; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; Jefferson University	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il	Houtkooper, Riekelt/P-5001-2019; Gross, Atan/ABC-2640-2020; Fiermonte, Giuseppe/D-3680-2018; Fiermonte, Giuseppe/F-3159-2010; Walter, Ludivine/S-4456-2017; Houtkooper, Riekelt H/E-1602-2011	Fiermonte, Giuseppe/0000-0002-6764-9395; Walter, Ludivine/0000-0001-7214-0676; Houtkooper, Riekelt H/0000-0001-9961-0842; De Leonardis, Francesco/0000-0002-6278-1565; Jimenez, Erin/0000-0001-7655-8412; Schwarz, Michal/0000-0003-4358-7502; Sinha Roy, Soumya/0000-0002-4135-0141; Vaz, Frederic/0000-0002-9048-1041; Gillissen, Bernhard/0000-0002-1815-2091	USA-Israel Binational Science Foundation; Ministero dell'Universita e della Ricerca; Apulia Region; University of Bari; Prinses Beatrix Fonds; Barth Syndrome Foundation; National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM059419, R01GM061721] Funding Source: NIH RePORTER	USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Apulia Region; University of Bari; Prinses Beatrix Fonds; Barth Syndrome Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Jung for advice regarding the animal studies; A. Harmelin, R. Haffner, A. Maizenberg, G. Damari and T. Berkutzki for help with the animal and ES cell studies; H. van Lenthe and F. Stet for technical assistance with the phospholipid analysis; T. Langer (University of Cologne) for the TAT-Cre plasmid; T.S. Tanaka (University of Illinois at Urbana-Champaign) for DNA probes for Brachyury; D. Wallach (Weizmann Institute) for anti-Fas antibodies and Richard Marcellus (McGill University) for recombinant adenoviruses. This study was supported in part by the USA-Israel Binational Science Foundation, the Ministero dell'Universita e della Ricerca, the Apulia Region, and the University of Bari. It was also supported by a grant of the Prinses Beatrix Fonds to F.M.V. and grants of the Barth Syndrome Foundation to W.K. and F.M.V.A.G. is the incumbent of the Armour Family Career Development Chair of cancer research. E.A.J. is funded by a National Institutes of Health (NIH) Minority Access to Research Careers U*STAR Scholarship, and S.W. is funded by a NIH National Research Service Award.	Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; GALLITALIADOROS LA, 1995, J IMMUNOL METHODS, V181, P1, DOI 10.1016/0022-1759(95)00017-5; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Gross A, 2005, J BIOENERG BIOMEMBR, V37, P113, DOI 10.1007/s10863-005-6222-3; Hogan B, 1994, MANIPULATING MOUSE E; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Leibowitz-Amit R, 2006, CANCER RES, V66, P8687, DOI 10.1158/0008-5472.CAN-05-2294; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	40	125	127	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					553	562		10.1038/ncb2057	http://dx.doi.org/10.1038/ncb2057			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20436477	Green Accepted			2022-12-27	WOS:000278213400007
J	Mavrakis, KJ; Wolfe, AL; Oricchio, E; Palomero, T; de Keersmaecker, K; McJunkin, K; Zuber, J; James, T; Chang, K; Khan, AA; Leslie, CS; Parker, JS; Paddison, PJ; Tam, W; Ferrando, A; Wendel, HG				Mavrakis, Konstantinos J.; Wolfe, Andrew L.; Oricchio, Elisa; Palomero, Teresa; de Keersmaecker, Kim; McJunkin, Katherine; Zuber, Johannes; James, Taneisha; Chang, Kenneth; Khan, Aly A.; Leslie, Christina S.; Parker, Joel S.; Paddison, Patrick J.; Tam, Wayne; Ferrando, Adolfo; Wendel, Hans-Guido			Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia	NATURE CELL BIOLOGY			English	Article							ACTIVATING MUTATIONS; MICRORNAS; EXPRESSION; SURVIVAL; CLUSTER; GENE; MICE; AKT	MicroRNAs (miRNAs) have emerged as novel cancer genes. In particular, the miR-17-92 cluster, containing six individual miRNAs, is highly expressed in haematopoietic cancers and promotes lymphomagenesis in vivo. Clinical use of these findings hinges on isolating the oncogenic activity within the 17-92 cluster and defining its relevant target genes. Here we show that miR-19 is sufficient to promote leukaemogenesis in Notch1-induced T-cell acute lymphoblastic leukaemia (T-ALL) in vivo. In concord with the pathogenic importance of this interaction in T-ALL, we report a novel translocation that targets the 17-92 cluster and coincides with a second rearrangement that activates Notch1. To identify the miR-19 targets responsible for its oncogenic action, we conducted a large-scale short hairpin RNA screen for genes whose knockdown can phenocopy miR-19. Strikingly, the results of this screen were enriched for miR-19 target genes, and include Bim (Bcl2L11), AMP-activated kinase (Prkaa1) and the phosphatases Pten and PP2A (Ppp2r5e). Hence, an unbiased, functional genomics approach reveals a coordinate clampdown on several regulators of phosphatidylinositol-3-OH kinase-related survival signals by the leukaemogenic miR-19.	[Mavrakis, Konstantinos J.; Wolfe, Andrew L.; Oricchio, Elisa; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA; [Wolfe, Andrew L.; Khan, Aly A.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Palomero, Teresa; de Keersmaecker, Kim; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [McJunkin, Katherine] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27502 USA; [Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Tam, Wayne] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10025 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University; Columbia University; Cold Spring Harbor Laboratory; Fred Hutchinson Cancer Center; Cornell University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	wendelh@mskcc.org	Ferrando, Adolfo A/Q-7026-2016; De Keersmaecker, Kim/W-9702-2018; Zuber, Johannes/E-7517-2011; Parker, Joel/AAG-1108-2019	De Keersmaecker, Kim/0000-0002-7420-9531; Zuber, Johannes/0000-0001-8810-6835; McJunkin, Katherine/0000-0001-9730-442X; Wolfe, Andrew/0000-0003-0418-716X; Oricchio, Elisa/0000-0002-1690-0447	American Cancer Society; Geoffrey Beene Cancer Center; Leukemia Research Foundation; Louis V. Gerstner Foundation; May and Samuel Rudin Foundation; NY Community Trust; William and Blanche Foundation; Andrew Seligson Memorial Clinical Fellowship; NYStar; WOLF Foundation; Rally across America Foundation; Leukemia and Lymphoma Society [1287-08, 6237-08];  [R01CA120196]; NATIONAL CANCER INSTITUTE [R01CA142798, R01CA120196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Center; Leukemia Research Foundation; Louis V. Gerstner Foundation; May and Samuel Rudin Foundation; NY Community Trust; William and Blanche Foundation; Andrew Seligson Memorial Clinical Fellowship; NYStar; WOLF Foundation; Rally across America Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lin He, S. W. Lowe and G. Hannon for access to shRNA and miRNA screening technologies; W. Pear, J. Huse and E. C. Holland for plasmids; H. Zhu for technical assistance; the Memorial Sloan-Kettering (MSK) animal facility and Research Animal Resource Center (RARC), A. Viale of the MSK Genomics Core, H. Zhao of the cBIO program, and J. Schatz and J. Massague for editorial advice; and V. Murty for cytogenetic and fluorescence in situ hybridization analyses. This work was supported by grants from the American Cancer Society, the Geoffrey Beene Cancer Center, the Leukemia Research Foundation, the Louis V. Gerstner Foundation, the May and Samuel Rudin Foundation, the NY Community Trust and the William and Blanche Foundation (to H.-G. W.), from the Andrew Seligson Memorial Clinical Fellowship (to J.Z.), and NYStar (to P.J.P.). A.F. is supported by R01CA120196, the WOLF Foundation, the Rally across America Foundation and the Leukemia and Lymphoma Society (grants 1287-08 and 6237-08), and A.F. is a Leukemia & Lymphoma Society Scholar.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Calin GA, 2007, METHOD ENZYMOL, V427, P193, DOI 10.1016/S0076-6879(07)27011-9; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Palomero T, 2006, LEUKEMIA, V20, P1963, DOI 10.1038/sj.leu.2404409; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; YANG YH, 2006, R PACKAGE VERSION 1	35	249	269	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					372	U159		10.1038/ncb2037	http://dx.doi.org/10.1038/ncb2037			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20190740	Green Accepted			2022-12-27	WOS:000276194600010
J	Ishitani, T; Hirao, T; Suzuki, M; Isoda, M; Ishitani, S; Harigaya, K; Kitagawa, M; Matsumoto, K; Itoh, M				Ishitani, Tohru; Hirao, Tomoko; Suzuki, Maho; Isoda, Miho; Ishitani, Shizuka; Harigaya, Kenichi; Kitagawa, Motoo; Matsumoto, Kunihiro; Itoh, Motoyuki			Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex	NATURE CELL BIOLOGY			English	Article							DROSOPHILA MASTERMIND; PROTEIN; PHOSPHORYLATION; HOMOLOG; PATHWAY; NLK; DIFFERENTIATION; COACTIVATOR; EXPRESSION; RECEPTORS	The Notch signalling pathway has a crucial function in determining cell fates in multiple tissues within metazoan organisms(1). On binding to ligands, the Notch receptor is cleaved proteolytically and releases its intracellular domain (NotchICD). The NotchICD enters the nucleus and acts cooperatively with other factors to stimulate the transcription of target genes. High levels of Notch-mediated transcriptional activation require the formation of a ternary complex consisting of NotchICD, CSL (CBF-1, suppressor of hairless, LAG-1) and a Mastermind family member(2-5). However, it is still not clear how the formation of the ternary complex is regulated. Here we show that Nemo-like kinase (NLK) negatively regulates Notch-dependent transcriptional activation by decreasing the formation of this ternary complex. Using a biochemical screen, we identified Notch as a new substrate of NLK. NLK-phosphorylated Notch1ICD is impaired in its ability to form a transcriptionally active ternary complex. Furthermore, knockdown of NLK leads to hyperactivation of Notch signalling and consequently decreases neurogenesis in zebrafish. Our results both define a new function for NLK and reveal a previously unidentified mode of regulation in the Notch signalling pathway.	[Ishitani, Tohru; Hirao, Tomoko; Isoda, Miho; Itoh, Motoyuki] Nagoya Univ, Unit Nervous Dev Syst, Nagoya, Aichi 4648602, Japan; [Ishitani, Tohru; Suzuki, Maho; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Signal Transduct,Lab Cell Regulat, Nagoya, Aichi 4648602, Japan; [Itoh, Motoyuki] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Ishitani, Tohru; Ishitani, Shizuka] Kyushu Univ, Med Inst Bioregulat, Dept Postgenome Sci Ctr, Div Cell Regulat Syst, Fukuoka 8128582, Japan; [Harigaya, Kenichi; Kitagawa, Motoo] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba 2608670, Japan	Nagoya University; Nagoya University; Nagoya University; Kyushu University; Chiba University	Ishitani, T (corresponding author), Nagoya Univ, Unit Nervous Dev Syst, Nagoya, Aichi 4648602, Japan.	tish@bioreg.kyushu-u.ac.jp; mito@iar.nagoya-u.ac.jp	, Tohru/AAH-8979-2020; Kitagawa, Motoo/W-8468-2019; Ishitani, Tohru/E-9781-2014	, Tohru/0000-0002-6200-7043; Kitagawa, Motoo/0000-0003-1036-840X; 	Yamada Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT of Japan; Grants-in-Aid for Scientific Research programs in Japan	Yamada Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research programs in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Honjo, T. C. Sudhof, U. Lendahl, K. Yasutomo, C. Kintner, D. Hayward, J. D. Griffin, L. Wu, M. Takeichi, S. Chiba, A. Kikuchi, H. Fujisawa and K. Hozumi for providing plasmid vectors, antibody and cultured cells; H. Matsuo for technical assistance; members of the H. Aiba laboratory (especially T. Sunohara) for technical advice; and J. Ninomiya-Tsuji for helpful discussions. This research was supported by the Yamada Science Foundation (T. I.), the Astellas Foundation for Research on Metabolic Disorders (T. I. and M. I.), the Program for Improvement of Research Environment for Young Researchers from SCF commissioned by MEXT of Japan (T. I. and M. I.), and the Grants-in-Aid for Scientific Research programs in Japan (T. I., K. M. and M. I.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Takke C, 1999, DEVELOPMENT, V126, P1811; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Verheyen EM, 1996, GENETICS, V144, P1127; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	33	87	95	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					278	U84		10.1038/ncb2028	http://dx.doi.org/10.1038/ncb2028			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118921	Green Published			2022-12-27	WOS:000275054200014
J	Rusten, TE; Stenmark, H				Rusten, Tor Erik; Stenmark, Harald			p62, an autophagy hero or culprit?	NATURE CELL BIOLOGY			English	Editorial Material							NBR1; MICE	The p62 protein recognizes toxic cellular waste, which is then scavenged by a sequestration process known as self-eating or autophagy. Lack of autophagy leads to accumulation of p62, which is not good for liver cells, as it induces a cellular stress response that leads to disease.	[Rusten, Tor Erik; Stenmark, Harald] Univ Oslo, Ctr Canc Biomed, N-0310 Oslo, Norway; [Rusten, Tor Erik; Stenmark, Harald] Norwegian Radium Hosp Montebello, Dept Biochem, N-0310 Oslo, Norway	University of Oslo	Rusten, TE (corresponding author), Univ Oslo, Ctr Canc Biomed, N-0310 Oslo, Norway.	h.a.stenmark@medisin.uio.no	Stenmark, Harald/B-8868-2008	Rusten, Tor Erik/0000-0002-9150-2676				Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108	9	163	164	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					207	209		10.1038/ncb0310-207	http://dx.doi.org/10.1038/ncb0310-207			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20190829				2022-12-27	WOS:000275054200005
J	Jones, KT				Jones, Keith T.			Cohesin and Cdk1: an anaphase barricade	NATURE CELL BIOLOGY			English	Editorial Material							PROTEIN PHOSPHATASE 2A; CHROMOSOMES; ASSOCIATION; CHECKPOINT; MEIOSIS; MITOSIS; KINASE	Separation of sister chromatids at anaphase in metazoan cells requires only the cleavage of the kleisin subunit of centromeric cohesin, but efficient poleward movement of separated sisters requires the associated loss in Cdk1 activity. Activation of the anaphase-promoting complex/cyclosome ensures these events are coordinated.	Univ Newcastle, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia	University of Newcastle	Jones, KT (corresponding author), Univ Newcastle, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia.	keith.jones@newcastle.edu.au	Jones, Keith/AAA-3479-2021; Jones, Keith/C-9821-2013	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851				Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NASMYTH K, 2009, ANNU REV GENET, V525, P558; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712	16	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					106	U14		10.1038/ncb0210-106	http://dx.doi.org/10.1038/ncb0210-106			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20118997				2022-12-27	WOS:000274139400004
J	Bekker-Jensen, S; Danielsen, JR; Fugger, K; Gromova, I; Nerstedt, A; Bartek, J; Lukas, J; Mailand, N				Bekker-Jensen, Simon; Danielsen, Jannie Rendtlew; Fugger, Kasper; Gromova, Irina; Nerstedt, Annika; Bartek, Jiri; Lukas, Jiri; Mailand, Niels			HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes	NATURE CELL BIOLOGY			English	Article							LARGE PROTEIN; UBC13; ORGANIZATION; DEFICIENT; RECOVERY	Regulatory ubiquitylation is emerging as an important mechanism to protect genome integrity in cells exposed to DNA damage(1-9). However, the spectrum of known ubiquitin regulators of the DNA damage response (DDR) is limited and their functional interplay is poorly understood. Here, we identify HERC2 as a factor that regulates ubiquitin-dependent retention of repair proteins on damaged chromosomes. In response to ionising radiation (IR), HERC2 forms a complex with RNF8, a ubiquitin ligase involved in the DDR3-6. The HERC2-RNF8 interaction requires IR-inducible phosphorylation of HERC2 at Thr 4827, which in turn binds to the forkhead-associated (FHA) domain of RNF8. Mechanistically, we provide evidence that HERC2 facilitates assembly of the ubiquitin-conjugating enzyme Ubc13 with RNF8, thereby promoting DNA damage-induced formation of Lys 63-linked ubiquitin chains. We also show that HERC2 interacts with, and maintains the levels of, RNF168, another ubiquitin ligase operating downstream of RNF8 (refs 7, 8). Consequently, knockdown of HERC2 abrogates ubiquitin-dependent retention of repair factors such as 53BP1, RAP80 and BRCA1. Together with the increased radiosensitivity of HERC2-depleted cells, these results uncover a regulatory layer in the orchestration of protein interactions on damaged chromosomes and they underscore the role of ubiquitinmediated signalling in genome maintenance.	[Bekker-Jensen, Simon; Danielsen, Jannie Rendtlew; Fugger, Kasper; Nerstedt, Annika; Bartek, Jiri; Lukas, Jiri; Mailand, Niels] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Gromova, Irina] Danish Canc Soc, Inst Canc Biol, Dept Prote Canc, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; jil@cancer.dk	Fugger, Kasper/J-1231-2014; Bartek, Jiri/G-5870-2014	Fugger, Kasper/0000-0001-9811-3983; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; Gromova, Irina/0000-0003-4357-5958; Lukas, Claudia/0000-0001-7169-6883	Danish Cancer Society; Danish National Research Foundation; European Commission; Lundbeck Foundation; Danish Research Council; John and Birthe Meyer Foundation; Lundbeck Foundation [R34-2009-3790] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; Lundbeck Foundation(Lundbeckfonden)	We thank Z. Ronai and D. Durocher for reagents, and J Chen for sharing unpublished data. This work was supported by grants from the Danish Cancer Society, Danish National Research Foundation, European Commission (integrated projects GENICA and DNA Repair), Lundbeck Foundation, Danish Research Council and the John and Birthe Meyer Foundation.	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	23	214	222	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					80	U209		10.1038/ncb2008	http://dx.doi.org/10.1038/ncb2008			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20023648				2022-12-27	WOS:000272973800016
J	Campaner, S; Doni, M; Hydbring, P; Verrecchia, A; Bianchi, L; Sardella, D; Schleker, T; Perna, D; Tronnersjo, S; Murga, M; Fernandez-Capetillo, O; Barbacid, M; Larsson, LG; Amati, B				Campaner, Stefano; Doni, Mirko; Hydbring, Per; Verrecchia, Alessandro; Bianchi, Lucia; Sardella, Domenico; Schleker, Thomas; Perna, Daniele; Tronnersjo, Susanna; Murga, Matilde; Fernandez-Capetillo, Oscar; Barbacid, Mariano; Larsson, Lars-Gunnar; Amati, Bruno			Cdk2 suppresses cellular senescence induced by the c-myc oncogene	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; IN-VIVO; P53; PROLIFERATION; P16(INK4A); P27(KIP1); APOPTOSIS; LIMITS; CELLS; CYCLIN-DEPENDENT-KINASE-2	Activated oncogenes induce compensatory tumour-suppressive responses, such as cellular senescence or apoptosis, but the signals determining the main outcome remain to be fully understood(1,2). Here, we uncover a role for Cdk2 (cyclin-dependent kinase 2) in suppressing Myc-induced senescence. Short-term activation of Myc promoted cell-cycle progression(3) in either wild-type or Cdk2 knockout(4,5) mouse embryo fibroblasts (MEFs). In the knockout MEFs, however, the initial hyper-proliferative response was followed by cellular senescence. Loss of Cdk2 also caused sensitization to Myc-induced senescence in pancreatic beta-cells or splenic B-cells in vivo, correlating with delayed lymphoma onset in the latter. Cdk2(-/-) MEFs also senesced upon ectopic Wnt signalling or, without an oncogene, upon oxygen-induced culture shock(6). Myc also causes senescence in cells lacking the DNA repair protein Wrn(7). However, unlike loss of Wrn(8), loss of Cdk2 did not enhance Myc-induced replication stress, implying that these proteins suppress senescence through different routes. In MEFs, Myc-induced senescence was genetically dependent on the ARF-p53-p21(Clp1) and p16(INK4a)-pRb pathways, p21(Clp1) and p16(INK4a) being selectively induced in Cdk2(-/-) cells. Thus, although redundant for cell-cycle progression and development(4,5,9-12), Cdk2 has a unique role in suppressing oncogene- and/or stress-induced senescence(1). Pharmacological inhibition of Cdk2 induced Myc-dependent senescence in various cell types, including a p53-null human cancer cell line. Our data warrant re-assessment of Cdk2 as a therapeutic target in Myc- or Wnt-driven tumours.	[Campaner, Stefano; Doni, Mirko; Verrecchia, Alessandro; Bianchi, Lucia; Sardella, Domenico; Schleker, Thomas; Perna, Daniele; Amati, Bruno] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Hydbring, Per; Tronnersjo, Susanna; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden; [Hydbring, Per; Larsson, Lars-Gunnar] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, SE-75007 Uppsala, Sweden; [Sardella, Domenico] Cogentech, I-20139 Milan, Italy; [Murga, Matilde; Fernandez-Capetillo, Oscar] CNIO, Genom Instabil Grp, Mol Oncol Programme, Madrid 28029, Spain; [Barbacid, Mariano] CNIO, Expt Oncol Grp, Mol Oncol Programme, Madrid 28029, Spain	IRCCS European Institute of Oncology (IEO); Karolinska Institutet; Swedish University of Agricultural Sciences; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Doni, Mirko/AAN-6027-2020; Amati, Bruno/AAM-3418-2020; Verrecchia, Alessandro/AAQ-6454-2020; Murga, Matilde/B-3499-2018; Fernandez-Capetillo, Oscar/H-3508-2015; Larsson, Lars-Gunnar/D-9747-2012; Doni, Mirko/ABA-9174-2021	Verrecchia, Alessandro/0000-0002-8596-6650; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Doni, Mirko/0000-0001-7099-2701; Amati, Bruno/0000-0002-2958-1799; CAMPANER, Stefano/0000-0003-4547-6849	Italian Association for Cancer Research (AIRC); Italian Health Ministry; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; Olle Enqkvists's Foundation; Stockholm Cancer Society	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry(Ministry of Health, Italy); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation; Swedish Research Council; Olle Enqkvists's Foundation; Stockholm Cancer Society	We thank C. Gorrini, E. Guccione, A, Magnifico, G. Natoli, S. Piccolo and P.-G. Pelicci for discussions, comments and support, F. Contegno for laboratory management, A. Gobbi, M. Capillo and B. Giulini for mouse management, I. Muradore, S. Ronzoni and M. Faretta for FACS analysis, S. Volorio and S. Minardi for DNA sequencing, K. Igarashi (Hiroshima University Graduate School of Biomedical Sciences, Japan) for sharing unpublished information, F. Liu (The State University of New Jersey, USA) for antibodies, G. Evan and L. Brown-Swigart (both at the University of California, USA) for pIns-MycER<SUP>TAM</SUP> and RIP-Bcl-x<INF>L</INF> mice, J. Cleveland (The Scripps Research Institute, USA) and J.-C. Marine (VIB-UGent, Belgium) for E mu-myc mice, A. Berns for INK4a<SUP>-/-</SUP> mice (Netherlands Cancer Institute), C. Sherr and M. Roussel (both at St. Jude Children's Research Hospital, USA) for ARF<SUP>-/-</SUP> mice, and J. Zablocki at CV Therapeutics for compounds. This work was supported by grants from the Italian Association for Cancer Research (AIRC), the 'Ricerca Finalizzata' and 'Ricerca Corrente' programs of the Italian Health Ministry to B. A., and from the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, the Swedish Research Council, Olle Enqkvists's Foundation and the Stockholm Cancer Society. to L. G. L.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bahram F, 1999, BLOOD, V93, P3900, DOI 10.1182/blood.V93.11.3900.411a42_3900_3912; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Deb-Basu D, 2006, CELL CYCLE, V5, P1348, DOI 10.4161/cc.5.12.2860; Deb-Basu D, 2006, CELL CYCLE, V5, P1342, DOI 10.4161/cc.5.12.2859; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Macias E, 2007, CANCER RES, V67, P9713, DOI 10.1158/0008-5472.CAN-07-2119; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Schmitt C, 2006, BIOCHIM BIOPHYS ACTA, V1775, P5; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104	53	192	197	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					54	U132		10.1038/ncb2004	http://dx.doi.org/10.1038/ncb2004			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010815				2022-12-27	WOS:000272973800012
J	Oh, YM; Kwon, YE; Kim, JM; Bae, SJ; Lee, BK; Yoo, SJ; Chung, CH; Deshaies, RJ; Seol, JH				Oh, Young Mi; Kwon, Young Eun; Kim, Joo Mi; Bae, Sung Jun; Lee, Bo Keun; Yoo, Soon Ji; Chung, Chin Ha; Deshaies, Raymond J.; Seol, Jae Hong			Chfr is linked to tumour metastasis through the downregulation of HDAC1	NATURE CELL BIOLOGY			English	Article							MITOTIC CHECKPOINT PROTEIN; HISTONE DEACETYLASE-1; SUPPRESSOR GENE; E-CADHERIN; CANCER; DOMAIN; HYPERMETHYLATION; DEGRADATION; EXPRESSION; PROMOTER	Chfr is a ubiquitin ligase that functions in the mitotic checkpoint by delaying entry into metaphase in response to mitotic stress(1,2). It has been suggested that Chfr is a tumour suppressor as Chfr is frequently silenced in human cancers(3). To better understand how Chfr activity relates to cell-cycle progression and tumorigenesis, we sought to identify Chfr-interacting proteins using affinity purification combined with mass spectrometry. Histone deacetylase 1 (HDAC1), which represses transcription by deacetylating histones, was newly isolated as a Chfr-interacting protein. Chfr binds and downregulates HDAC1 by inducing its polyubiquitylation, both in vitro and in vivo. Ectopic expression of Chfr in cancer cells that normally do not express it results in downregulation of HDAC1, leading to upregulation of the Cdk inhibitor p21(CIP1/WAF1) and the metastasis suppressors KAI1 and E-cadherin. Coincident with these changes, cells arrest in the G1 phase of the cell cycle and become less invasive. Collectively, our data suggest that Chfr functions as a tumour suppressor by regulating HDAC1.	[Oh, Young Mi; Kwon, Young Eun; Kim, Joo Mi; Bae, Sung Jun; Lee, Bo Keun; Chung, Chin Ha; Seol, Jae Hong] Seoul Natl Univ, Sch Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Yoo, Soon Ji] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Yoo, Soon Ji] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea; [Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Seoul National University (SNU); Kyung Hee University; Kyung Hee University; California Institute of Technology	Seol, JH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea.	jhseol@snu.ac.kr	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Korea Science and Engineering Foundation [M10533010001-07N3301-00110]; SRC program [R11-2005-009-02002-0]; Korea Research Foundation [KRF2002-015-CS0069]; Seoul Science Fellowship	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); SRC program; Korea Research Foundation(National Research Foundation of Korea); Seoul Science Fellowship	We thank S. H. Baek ( SNU) for reagents. This work was supported by grants from the Korea Science and Engineering Foundation (M10533010001-07N3301-00110), the SRC program (R11-2005-009-02002-0), the Korea Research Foundation (KRF2002-015-CS0069) and the BK21 program. Y. E. K. was supported by the Seoul Science Fellowship.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chaturvedi P, 2002, CANCER RES, V62, P1797; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Li H, 2004, BIOCHEM BIOPH RES CO, V324, P860, DOI 10.1016/j.bbrc.2004.09.130; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tsai MD, 2002, STRUCTURE, V10, P887, DOI 10.1016/S0969-2126(02)00795-5; Wang AG, 2005, BIOL PHARM BULL, V28, P1966, DOI 10.1248/bpb.28.1966; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	25	64	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					295	U158		10.1038/ncb1837	http://dx.doi.org/10.1038/ncb1837			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182791				2022-12-27	WOS:000263777900013
J	Hanafusa, H; Matsumoto, K; Nishida, E				Hanafusa, Hiroshi; Matsumoto, Kunihiro; Nishida, Eisuke			Regulation of ERK activity duration by Sprouty contributes to dorsoventral patterning	NATURE CELL BIOLOGY			English	Article							SIGNAL; SPECIFICITY; PROTEINS; EMBRYOS	Distinct modes of ERK activation, sustained or transient, are essential for cell fate decision in cultured cells. Here we show that Xenopus laevis Sprouty2 (XSpry2) controls the duration of ERK activity and thereby contributes to the establishment of dorsoventral patterning during mesoderm formation. furthermore, Xenopus Fos (XFos) can function as a molecular sensor of the ERK signalling duration in Xenopus embryos. this work provides the first evidence that regulating the duration of ERK activity contributes to cell fate decisions in the context of the whole organism.	[Hanafusa, Hiroshi; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hanafusa, Hiroshi; Matsumoto, Kunihiro] JST, SORST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Japan Science & Technology Agency (JST); Kyoto University	Matsumoto, K (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44177a@nucc.cc.nagoya-u.ac.jp; L50174@sakura.kudpc.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Sasai, H. Kuroda, S. Kusakabe, M. Itoh and T. Ishitani for helpful discussion and suggestions. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. M., H. H. and E. N.).	Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Christen B, 1999, DEVELOPMENT, V126, P119; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4	11	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					106	U222		10.1038/ncb1820	http://dx.doi.org/10.1038/ncb1820			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19122596				2022-12-27	WOS:000262157000018
J	Steller, H				Steller, Hermann			Staying alive: apoptosome feedback inhibition	NATURE CELL BIOLOGY			English	Editorial Material							CELL-DEATH; CASPASE DRONC; DIAP1	Studies in Drosophila melanogaster reveal a mechanism for regulating caspases, the key executioners of the apoptotic cell-death program. An initiator caspase and its activating partner promote degradation of each other, thereby limiting the levels of the active protease complex. This negative-feedback inhibition helps to explain how cells avoid unwanted caspase activation and apoptosis.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	steller@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Herman-Bachinsky Y, 2007, CELL DEATH DIFFER, V14, P861, DOI 10.1038/sj.cdd.4402079; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Shapiro PJ, 2008, NAT CELL BIOL, V10, P1440, DOI 10.1038/ncb1803; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8	15	3	3	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1387	1388		10.1038/ncb1208-1387	http://dx.doi.org/10.1038/ncb1208-1387			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043432				2022-12-27	WOS:000261261800007
J	Liang, CY; Lee, JS; Inn, KS; Gack, MU; Li, QL; Roberts, EA; Vergne, I; Deretic, V; Feng, PH; Akazawa, C; Jung, JU				Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Roberts, Esteban A.; Vergne, Isabelle; Deretic, Vojo; Feng, Pinghui; Akazawa, Chihiro; Jung, Jae U.			Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking	NATURE CELL BIOLOGY			English	Article							HOMOTYPIC VACUOLE FUSION; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; PROTEIN-TRANSPORT; DEEP-ORANGE; YEAST; LYSOSOMES; HOMOLOG; RAB7	Autophagic and endocytic pathways are tightly regulated membrane rearrangement processes that are crucial for homeostasis, development and disease. Autophagic cargo is delivered from autophagosomes to lysosomes for degradation through a complex process that topologically resembles endosomal maturation. Here, we report that a Beclin1-binding autophagic tumour suppressor, UVRAG, interacts with the class C Vps complex, a key component of the endosomal fusion machinery. This interaction stimulates Rab7 GTPase activity and autophagosome fusion with late endosomes/lysosomes, thereby enhancing delivery and degradation of autophagic cargo. Furthermore, the UVRAG-class-C-Vps complex accelerates endosome-endosome fusion, resulting in rapid degradation of endocytic cargo. Remarkably, autophagosome/endosome maturation mediated by the UVRAG-class-C-Vps complex is genetically separable from UVRAG-Beclin1-mediated autophagosome formation. This result indicates that UVRAG functions as a multivalent trafficking effector that regulates not only two important steps of autophagy autophagosome formation and maturation-but also endosomal fusion, which concomitantly promotes transport of autophagic and endocytic cargo to the degradative compartments.	[Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Jung, Jae U.] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Liang, Chengyu; Lee, Jong-Soo; Inn, Kyung-Soo; Gack, Michaela U.; Li, Qinglin; Jung, Jae U.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Tumor Virol, Southborough, MA 01772 USA; [Roberts, Esteban A.; Vergne, Isabelle; Deretic, Vojo] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Feng, Pinghui] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Akazawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1138519, Japan	University of Southern California; Harvard University; Harvard University; University of New Mexico; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU)	Jung, JU (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	jaeujung@usc.edu	Li, Qinglin/K-2570-2015; Inn, Kyung-Soo/AAJ-4118-2020	Li, Qinglin/0000-0002-4125-1944; Deretic, Vojo/0000-0002-3624-5208; LIANG, CHENGYU/0000-0001-6082-2143; Lee, Jong-Soo/0000-0001-5119-0711; Vergne, Isabelle/0000-0003-1924-9474	NATIONAL CANCER INSTITUTE [R01CA031363, R01CA091819, R01CA082057, R01CA106156] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168, K26RR000168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042999, R01AI069345, R01AI073099] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106156, CA106156, R01 CA091819, CA91819, CA82057, R01 CA082057, CA31363, R01 CA031363] Funding Source: Medline; NCRR NIH HHS [P51 RR000168, RR00168, K26 RR000168] Funding Source: Medline; NHLBI NIH HHS [R01 HL110609] Funding Source: Medline; NIAID NIH HHS [R37 AI042999, R01 AI073099, AI069345, AI 42999, R01 AI042999, R01 AI073099-02, R01 AI069345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; EMANS N, 1995, BIOPHYS J, V69, P716, DOI 10.1016/S0006-3495(95)79947-7; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim BY, 2003, BIOCHEM BIOPH RES CO, V311, P577, DOI 10.1016/j.bbrc.2003.10.030; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Lucocq J, 1997, EUR J CELL BIOL, V72, P307; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; ROBINSON JS, 1991, MOL CELL BIOL, V11, P5813, DOI 10.1128/MCB.11.12.5813; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu JF, 2006, PIGM CELL RES, V19, P628, DOI 10.1111/j.1600-0749.2006.00346.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	46	563	605	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					776	787		10.1038/ncb1740	http://dx.doi.org/10.1038/ncb1740			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552835	Green Accepted			2022-12-27	WOS:000257268400008
J	Kitamura, T; Asai, N; Enomoto, A; Maeda, K; Kato, T; Ishida, M; Jiang, P; Watanabe, T; Usukura, J; Kondo, T; Costantini, F; Murohara, T; Takahashi, M				Kitamura, Tomoya; Asai, Naoya; Enomoto, Atsushi; Maeda, Kengo; Kato, Takuya; Ishida, Maki; Jiang, Ping; Watanabe, Takashi; Usukura, Jiro; Kondo, Takahisa; Costantini, Frank; Murohara, Toyoaki; Takahashi, Masahide			Regulation of VeGF-mediated angiogenesis by the Akt/PKB substrate Girdin	NATURE CELL BIOLOGY			English	Article							PATHOLOGICAL ANGIOGENESIS; ENDOTHELIAL-CELLS; AKT SIGNAL; GROWTH; KINASE; RAC; PERMEABILITY; MIGRATION; PATHWAY	The serine/threonine protein kinase Akt is involved in a variety of cellular processes including cell proliferation, survival, metabolism and gene expression. It is essential in vascular endothelial growth factor (VEGF)-mediated angiogenesis; however, it is not known how Akt regulates the migration of endothelial cells, a crucial process for vessel sprouting, branching and the formation of networks during angiogenesis. Here we report that Akt-mediated phosphorylation of Girdin, an actin-binding protein, promotes VEGF-dependent migration of endothelial cells and tube formation by these cells. We found that exogenously delivered adenovirus harbouring Girdin short interfering RNA in Matrigel embedded in mice, markedly inhibited VEGF-mediated angiogenesis. Targeted disruption of the Girdin gene in mice impaired vessel remodelling in the retina and angiogenesis from aortic rings, whereas Girdin was dispensable for embryonic vasculogenesis. These findings demonstrate that the Akt/Girdin signalling pathway is essential in VEGF-mediated postneonatal angiogenesis.	[Asai, Naoya; Enomoto, Atsushi; Kato, Takuya; Ishida, Maki; Jiang, Ping; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kitamura, Tomoya; Maeda, Kengo; Kondo, Takahisa; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Watanabe, Takashi] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi; Watanabe, Takashi] Nagoya Univ, Chikusa Ku, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Usukura, Jiro] Nagoya Univ, Div Associated Res Projects, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Costantini, Frank] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Div Mol Pathol, Ctr Neurol Dis & Canc,Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Columbia University; Nagoya University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mtakaha@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Enomoto, Atsushi/I-7272-2014	Takahashi, Masahide/0000-0002-2803-2683; Watanabe, Takashi/0000-0002-9015-5246; Takagishi, Maki/0000-0002-6745-3982; Usukura, Jiro/0000-0003-2286-5403; Enomoto, Atsushi/0000-0002-9206-6116				Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	27	174	195	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					329	U62		10.1038/ncb1695	http://dx.doi.org/10.1038/ncb1695			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264090				2022-12-27	WOS:000253778300015
J	Martinez, P; Thanasoula, M; Carlos, AR; Gomez-Lopez, G; Tejera, AM; Schoeftner, S; Dominguez, O; Pisano, DG; Tarsounas, M; Blasco, MA				Martinez, Paula; Thanasoula, Maria; Carlos, Ana R.; Gomez-Lopez, Gonzalo; Tejera, Agueda M.; Schoeftner, Stefan; Dominguez, Orlando; Pisano, David G.; Tarsounas, Madalena; Blasco, Maria A.			Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; PROTEIN; YEAST; COMPLEX; LENGTH; MICE; TRF2; MUTATIONS; RNA; HETEROCHROMATIN	Rap1 is a component of the shelterin complex at mammalian telomeres, but its in vivo role in telomere biology has remained largely unknown to date. Here we show that Rap1 deficiency is dispensable for telomere capping but leads to increased telomere recombination and fragility. We generated cells and mice deleted for Rap1; mice with Rap1 deletion in stratified epithelia were viable but had shorter telomeres and developed skin hyperpigmentation in adulthood. By performing chromatin immunoprecipitation coupled with ultrahigh-throughput sequencing, we found that Rap1 binds to both telomeres and to extratelomeric sites through the (TTAGGG)(2) consensus motif. Extratelomeric Rap1-binding sites were enriched at subtelomeric regions, in agreement with preferential deregulation of subtelomeric genes in Rap1-deficient cells. More than 70% of extratelomeric Rap1-binding sites were in the vicinity of genes, and 31% of the genes deregulated in Rap1-null cells contained Rap1-binding sites, suggesting a role for Rap1 in transcriptional control. These findings place a telomere protein at the interface between telomere function and transcriptional regulation.	[Martinez, Paula; Tejera, Agueda M.; Schoeftner, Stefan; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Thanasoula, Maria; Carlos, Ana R.; Tarsounas, Madalena] CR UK MRC Gray Inst Radiat Oncol & Biol, Telomere & Genome Stabil Grp, Oxford OX3 7DQ, England; [Gomez-Lopez, Gonzalo; Pisano, David G.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Program, Bioinformat Core Unit, E-28029 Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Biotechnol Program, Genom Core Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Tejera, Agueda/Z-1938-2019; Blasco, Maria A./M-1694-2014; Tejera, Agueda/L-1946-2015; Gomez-Lopez, Gonzalo/D-9123-2016; Tejera, Agueda M./AAU-2000-2021; Carlos, Ana Rita/K-6014-2019; Carlos, Ana Rita/N-1137-2016; Pisano, David/N-5817-2014; Dominguez, Orlando/M-7515-2018	Blasco, Maria A./0000-0002-4211-233X; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Carlos, Ana Rita/0000-0002-6953-1163; Carlos, Ana Rita/0000-0002-6953-1163; Pisano, David/0000-0002-4895-4124; SCHOEFTNER, Stefan/0000-0002-8918-6627; Tejera, Agueda M/0000-0002-6703-9466	Spanish Ministry of Innovation and Science; European Union; European Research Council (ERC); Spanish Association Against Cancer (AECC); Korber European Science Award; Cancer Research UK	Spanish Ministry of Innovation and Science(Spanish Government); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Association Against Cancer (AECC); Korber European Science Award; Cancer Research UK(Cancer Research UK)	We are indebted to L. Harrington for Tert-deficient MEFs; S. West for Rap1 antibodies; and R. Serrano for animal care. P.M. is funded by a 'Ramon y Cajal' grant from the Spanish Ministry of Innovation and Science. M.A.B.'s laboratory is funded by the Spanish Ministry of Innovation and Science, the European Union (FP7-Genica, Telomarker), the European Research Council (ERC Advance Grants), the Spanish Association Against Cancer (AECC) and a Korber European Science Award to M.A.B. The work in MT's laboratory is funded by Cancer Research UK.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Crowley VEE, 2002, NAT REV DRUG DISCOV, V1, P276, DOI 10.1038/nrd770; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Glez-Pena D, 2009, NUCLEIC ACIDS RES, V37, pW329, DOI 10.1093/nar/gkp263; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LONG JD, 2009, WORLDVIEWS IN PRESS; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mignon-Ravix C, 2002, EUR J HUM GENET, V10, P107, DOI 10.1038/sj.ejhg.5200775; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2009, P NATL ACAD SCI USA, V106, P19387, DOI 10.1073/pnas.0909265106; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tan M, 2003, GENE, V323, P1, DOI 10.1016/j.gene.2003.08.026; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048	68	175	181	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					768	U28		10.1038/ncb2081	http://dx.doi.org/10.1038/ncb2081			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622869	Green Accepted			2022-12-27	WOS:000280561600009
J	Dishinger, JF; Kee, HL; Jenkins, PM; Fan, SL; Hurd, TW; Hammond, JW; Truong, YNT; Margolis, B; Martens, JR; Verhey, KJ				Dishinger, John F.; Kee, Hooi Lynn; Jenkins, Paul M.; Fan, Shuling; Hurd, Toby W.; Hammond, Jennetta W.; Truong, Yen Nhu-Thi; Margolis, Ben; Martens, Jeffrey R.; Verhey, Kristen J.			Ciliary entry of the kinesin-2 motor KIF17 is regulated by importin-beta 2 and RanGTP	NATURE CELL BIOLOGY			English	Article							INTRAFLAGELLAR TRANSPORT MOTORS; OLFACTORY SENSORY CILIA; SMALL MOLECULES; RAN/TC4 GTPASE; PROTEIN; LOCALIZATION; MEMBRANE; CELLS; DISEASE; CILIOPATHIES	The biogenesis, maintenance and function of primary cilia are controlled through intraflagellar transport (IFT) driven by two kinesin-2 family members, the heterotrimeric KIF3A/KIF3B/KAP complex and the homodimeric KIF17 motor(1,2). How these motors and their cargoes gain access to the ciliary compartment is poorly understood. Here, we identify a ciliary localization signal (CLS) in the KIF17 tail domain that is necessary and sufficient for ciliary targeting. Similarities between the CLS and classic nuclear localization signals (NLSs) suggest that similar mechanisms regulate nuclear and ciliary import. We hypothesize that ciliary targeting of KIF17 is regulated by a ciliary-cytoplasmic gradient of the small GTPase Ran, with high levels of GTP-bound Ran (RanGTP) in the cilium. Consistent with this, cytoplasmic expression of GTP-locked Ran(G19V) disrupts the gradient and abolishes ciliary entry of KIF17. Furthermore, KIF17 interacts with the nuclear import protein importin-beta 2 in a manner dependent on the CLS and inhibited by RanGTP. We propose that Ran has a global role in regulating cellular compartmentalization by controlling the shuttling of cytoplasmic proteins into nuclear and ciliary compartments.	[Dishinger, John F.; Kee, Hooi Lynn; Hammond, Jennetta W.; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Jenkins, Paul M.; Truong, Yen Nhu-Thi; Martens, Jeffrey R.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Fan, Shuling; Margolis, Ben] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Margolis, Ben] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hurd, Toby W.] Univ Michigan, Sch Med, Div Paediat Nephrol, Dept Paediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823; Hammond, Jennetta/0000-0002-3949-1594; Katsanis, Nicholas/0000-0002-2480-0171	NIH [R01GM070862, R01GM083254, R01DC009606, R01DK084725, T32GM007767, T32DC00011]; NRSAs [F32GM089034, F31DC009524]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089034, R01GM083254, T32GM007767, R01GM070862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009606, F31DC009524, T32DC000011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSAs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants R01GM070862 and R01GM083254 (to K.J.V.), R01DC009606 (to J.R.M.), R01DK084725 (to B. M.), and T32GM007767 and T32DC00011 (to P.M.J.). Work was also supported by NRSAs F32GM089034 (to J.F.D.) and F31DC009524 (to P.M.J.). H.L.K. is supported as a Barbour Fellow at the University of Michigan. pGEX-Ran plasmids were a kind gift from Brian Burke (University of Florida) and rabbit anti-RanGTP antibody was a kind gift from Ian Macara (University of Virginia).	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; DAVIES S, 1987, J MICROSC-OXFORD, V147, P89, DOI 10.1111/j.1365-2818.1987.tb02821.x; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Luby-Phelps K, 2008, VISION RES, V48, P413, DOI 10.1016/j.visres.2007.08.022; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Morris RL, 2004, DEV BIOL, V274, P56, DOI 10.1016/j.ydbio.2004.06.017; Murrell JR, 1999, J NEUROSCI, V19, P8260; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tahara K, 2008, J CELL BIOL, V180, P493, DOI 10.1083/jcb.200708003; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	44	201	202	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					703	U164		10.1038/ncb2073	http://dx.doi.org/10.1038/ncb2073			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526328	Green Accepted			2022-12-27	WOS:000279374400014
J	Nakano, A; Kato, H; Watanabe, T; Min, KD; Yamazaki, S; Asano, Y; Seguchi, O; Higo, S; Shintani, Y; Asanuma, H; Asakura, M; Minamino, T; Kaibuchi, K; Mochizuki, N; Kitakaze, M; Takashima, S				Nakano, Atsushi; Kato, Hisakazu; Watanabe, Takashi; Min, Kyung-Duk; Yamazaki, Satoru; Asano, Yoshihiro; Seguchi, Osamu; Higo, Shuichiro; Shintani, Yasunori; Asanuma, Hiroshi; Asakura, Masanori; Minamino, Tetsuo; Kaibuchi, Kozo; Mochizuki, Naoki; Kitakaze, Masafumi; Takashima, Seiji			AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN; LKB1; POLARITY; ENDS	AMP-activated protein kinase ( AMPK) is an energy-sensing Ser/Thr protein kinase originally shown to be regulated by AMP(1). AMPK is activated by various cellular stresses that inhibit ATP production or stimulate ATP consumption(2). In addition to its role in metabolism, AMPK has recently been reported to reshape cells by regulating cell polarity and division(3-6). However, the downstream targets of AMPK that participate in these functions have not been fully identified. Here, we show that phosphorylation of the microtubule plus end protein CLIP-170 by AMPK is required for microtubule dynamics and the regulation of directional cell migration. Both inhibition of AMPK and expression of a non-phosphorylatable CLIP-170 mutant resulted in prolonged and enhanced accumulation of CLIP-170 at microtubule tips, and slower tubulin polymerization. Furthermore, inhibition of AMPK impaired microtubule stabilization and perturbed directional cell migration. All of these phenotypes were rescued by expression of a phosphomimetic CLIP-170 mutant. Our results demonstrate, therefore, that AMPK controls basic cellular functions by regulating microtubule dynamics through CLIP-170 phosphorylation.	[Kato, Hisakazu; Min, Kyung-Duk; Asano, Yoshihiro; Higo, Shuichiro; Shintani, Yasunori; Minamino, Tetsuo; Takashima, Seiji] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakano, Atsushi; Min, Kyung-Duk; Yamazaki, Satoru; Seguchi, Osamu; Asanuma, Hiroshi; Asakura, Masanori; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Div Cardiovasc Med, Osaka 5658565, Japan; [Mochizuki, Naoki] Natl Cardiovasc Ctr, Dept Struct Anal, Res Inst Suita, Osaka 5658565, Japan; [Nakano, Atsushi; Kato, Hisakazu; Asano, Yoshihiro; Takashima, Seiji] Osaka Univ, Dept Mol Cardiol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Watanabe, Takashi] Nagoya Univ, Grad Sch Med, Inst Adv Res, Aichi 4668550, Japan; [Watanabe, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Aichi 4668550, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; Nagoya University; Nagoya University	Takashima, S (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takasima@medone.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Shintani, Yasunori/0000-0001-9579-0727; Watanabe, Takashi/0000-0002-9015-5246	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical Association	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical Association	We thank M. Amano and S. Fukuhara for helpful discussions, and M. Koyama (Olympus Corporation) for technical advice regarding microscopy. This research was supported by: a Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Japan Heart Foundation; grants from the Japan Cardiovascular Research Foundation; a grant from the Japan Society for the Promotion of Science; a grant from the Mochida Memorial Foundation for Medical Association.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RICKARD JE, 1990, J CELL BIOL, V110, P1623, DOI 10.1083/jcb.110.5.1623; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Watts JL, 2000, DEVELOPMENT, V127, P1467; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	25	151	154	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					583	U139		10.1038/ncb2060	http://dx.doi.org/10.1038/ncb2060			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20495555				2022-12-27	WOS:000278213400010
J	Baker, SP; Phillips, J; Anderson, S; Qiu, QF; Shabanowitz, J; Smith, MM; Yates, JR; Hunt, DF; Grant, PA				Baker, Stephen P.; Phillips, Jennifer; Anderson, Scott; Qiu, Qifeng; Shabanowitz, Jeffrey; Smith, M. Mitchell; Yates, John R., III; Hunt, Donald F.; Grant, Patrick A.			Histone H3 Thr 45 phosphorylation is a replication-associated post-translational modification in S. cerevisiae	NATURE CELL BIOLOGY			English	Article							DAMAGE CHECKPOINT RECOVERY; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; LYSINE-56 ACETYLATION; DNA-REPLICATION; KINASE; CHROMATIN; CDC7; COMPLEXES; PROTEIN	Post-translational histone modifications are crucial for the regulation of numerous DNA-templated processes, and are thought to mediate both alteration of chromatin dynamics and recruitment of effector proteins to specific regions of the genome(1). In particular, histone Ser/Thr phosphorylation regulates multiple nuclear functions in the budding yeast Saccharomyces cerevisiae, including transcription, DNA damage repair, mitosis, apoptosis and sporulation(2). Although modifications to chromatin during replication remain poorly understood, a number of recent studies have described acetylation of the histone H3 N-terminal alpha-helix (alpha N helix) at Lys 56 as a modification that is important for maintenance of genomic integrity during DNA replication and repair(3,4). Here, we report phosphorylation of H3 Thr 45 (H3-T45), a histone modification also located within the H3 alpha N helix in S. cerevisiae. Thr 45 phosphorylation peaks during DNA replication, and is mediated by the S phase kinase Cdc7-Dbf4 as part of a multiprotein complex identified in this study. Furthermore, loss of phosphorylated H3-T45 causes phenotypes consistent with replicative defects, and prolonged replication stress results in H3-T45 phosphorylation accumulation over time. Notably, the phenotypes described here are independent of Lys 56 acetylation status, and combinatorial mutations to both Thr 45 and Lys 56 of H3 cause synthetic growth defects. Together, these data identify and characterize H3-T45 phosphorylation as a replication-associated histone modification in budding yeast.	[Baker, Stephen P.; Phillips, Jennifer; Grant, Patrick A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Anderson, Scott; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Qiu, Qifeng; Smith, M. Mitchell] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA	University of Virginia; Scripps Research Institute; University of Virginia; University of Virginia; University of Virginia	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pag9n@virginia.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368	NIH [5 T32 CA009109-30, 5 P30 CA044579-18, R56 DK082673-01, GM37537, P41 RR011823, GM60444]; NATIONAL CANCER INSTITUTE [P30CA044579, T32CA009109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK082673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060444, R56GM060444, R01GM037537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Grant and Hunt labs for helpful discussion and technical assistance; R. Sclafani for yeast strains and reagents; G. Kupfer for reagents; J. Smith and J. Reese for yeast strains; and D. Auble for yeast strains, helpful discussion and reading of this manuscript. We also thank J. Bone (Active Motif) for assistance with antibody generation. S. P. B. was supported in part by NIH pre-doctoral cancer training grant no. 5 T32 CA009109-30. This work was supported by grants from the NIH to P. A. G. (5 P30 CA044579-18 and R56 DK082673-01), D. F. H. (GM37537), J. R. Y. (P41 RR011823), and M. M. S. (GM60444).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Brachmann CB, 1998, YEAST, V14, P115; CHAPMAN JW, 1989, EXP CELL RES, V180, P419, DOI 10.1016/0014-4827(89)90068-2; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, METH MOL B, V119, P311; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Owen-Hughes T, 1999, METH MOL B, V119, P319; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sclafani RA, 2000, J CELL SCI, V113, P2111; SLATER ML, 1977, P NATL ACAD SCI USA, V74, P3850, DOI 10.1073/pnas.74.9.3850; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207	35	61	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					294	U103		10.1038/ncb2030	http://dx.doi.org/10.1038/ncb2030			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20139971	Green Accepted			2022-12-27	WOS:000275054200016
J	Chaudhury, A; Hussey, GS; Ray, PS; Jin, G; Fox, PL; Howe, PH				Chaudhury, Arindam; Hussey, George S.; Ray, Partho S.; Jin, Ge; Fox, Paul L.; Howe, Philip H.			TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-MIGRATION; MESSENGER-RNA; KINASE; ACTIVATION; EXPRESSION; PATHWAY; CANCER; GENE; AKT	Transforming growth factor-beta (TGF-beta) induces epithelial-mesenchymal transdifferentiation (EMT) accompanied by cellular differentiation and migration(1-5). Despite extensive transcriptomic profiling, the identification of TGF-beta-inducible, EMT-specific genes has met with limited success. Here we identify a post-transcriptional pathway by which TGF-beta modulates the expression of EMT-specific proteins and of EMT itself. We show that heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) binds a structural, 33-nucleotide TGF-beta-activated translation (BAT) element in the 3' untranslated region of disabled-2 (Dab2) and interleukin-like EMT inducer (ILEI) transcripts, and represses their translation. TGF-beta activation leads to phosphorylation at Ser 43 of hnRNP E1 by protein kinase B beta/Akt2, inducing its release from the BAT element and translational activation of Dab2 and ILEI messenger RNAs. Modulation of hnRNP E1 expression or its post-translational modification alters the TGF-beta-mediated reversal of translational silencing of the target transcripts and EMT. These results suggest the existence of a TGF-beta-inducible post-transcriptional regulon that controls EMT during the development and metastatic progression of tumours.	[Chaudhury, Arindam; Hussey, George S.; Jin, Ge; Howe, Philip H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Ray, Partho S.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Chaudhury, Arindam; Hussey, George S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Ray, Partho S.] Indian Inst Sci Educ & Res, Dept Biol, Kolkata 700106, India	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Case Western Reserve University; Indian Institute of Science Education & Research (IISER) - Kolkata	Howe, PH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	howep@ccf.org	Ray, Partho Sarothi/H-3020-2019	Ray, Partho Sarothi/0000-0002-8795-3060; CHAUDHURY, ARINDAM/0000-0002-5625-5278; Chaudhury, Arindam/0000-0001-5916-4534	National Cancer Institute [CA55536, CA80095]; American Heart Association [075080B]; NATIONAL CANCER INSTITUTE [R01CA080095, R01CA154663, R29CA055536, R01CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Donna M. Driscoll, Barsanjit Mazumder and members of our laboratory for helpful discussions and critical insights. We value the assistance of Michael T. Kinter and Belinda Willard for liquid chromatography-mass spectrometry; of Judith A. Drazba and John Peterson for imaging; and of Michael Budiman for fast performance liquid chromatography. We thank Rakesh Kumar for the gift of the GST-hnRNP E1 construct, Takashi Kobayashi for the gifts of mouse pCMV14-hnRNP E1-Flag and psiRNA-hH1neo-mouse hnRNP E1, and Harold Moses for giving us the EpRas cell line. This work was supported by grants CA55536 and CA80095 from the National Cancer Institute to P. H. H. A. C. is supported by an American Heart Association (Ohio Valley Affiliate) Pre-doctoral Fellowship 075080B.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Greinwald JH, 1998, AM J MED GENET, V78, P107, DOI 10.1002/(SICI)1096-8628(19980630)78:2<107::AID-AJMG2>3.3.CO;2-9; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; Hampton MB, 1998, BIOCHEM J, V329, P95; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kato S, 2007, BIOCHEM BIOPH RES CO, V354, P1061, DOI 10.1016/j.bbrc.2007.01.094; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; LEGAGNEUX V, 1992, DEVELOPMENT, V116, P1193; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	227	232	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					286	U94		10.1038/ncb2029	http://dx.doi.org/10.1038/ncb2029			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154680	Green Accepted			2022-12-27	WOS:000275054200015
J	Rajabian, T; Gavicherla, B; Heisig, M; Muller-Altrock, S; Goebel, W; Gray-Owen, SD; Ireton, K				Rajabian, Tina; Gavicherla, Balramakrishna; Heisig, Martin; Mueller-Altrock, Stefanie; Goebel, Werner; Gray-Owen, Scott D.; Ireton, Keith			The bacterial virulence factor InlC perturbs apical cell junctions and promotes cell-to-cell spread of Listeria	NATURE CELL BIOLOGY			English	Article							ACTIN-BASED MOTILITY; LEUCINE-RICH REPEAT; MONOCYTOGENES; PROTEINS; DOMAINS; FAMILY; TUBA; PATHOGENESIS; CYTOSKELETON; INTERNALINS	Several pathogenic bacteria, including Listeria monocytogenes, use an F-actin motility process to spread between mammalian cells1. Actin 'comet tails' propel Listeria through the cytoplasm, resulting in bacteria-containing membrane protrusions that are internalized by neighbouring cells. The mechanism by which Listeria overcomes cortical tension to generate protrusions is unknown. Here, we identify bacterial and host proteins that directly regulate protrusions. We show that efficient spreading between polarized epithelial cells requires the secreted Listeria virulence protein InlC (internalin C). We next identify the mammalian adaptor protein Tuba as a ligand of InlC. InlC binds to a carboxy-terminal SH3 domain in Tuba, which normally engages the human actin regulatory protein N-WASP(2). InlC promotes protrusion formation by inhibiting Tuba and N-WASP activity, probably by impairing binding of N-WASP to the Tuba SH3 domain. Tuba and N-WASP are known to control the structure of apical junctions in epithelial cells(3). We demonstrate that, by inhibiting Tuba and N-WASP, InlC makes taut apical junctions become slack. Experiments with myosin II inhibitors indicate that InlC-mediated perturbation of apical junctions accounts for the role of this bacterial protein in protrusion formation. Collectively, our results suggest that InlC promotes bacterial dissemination by relieving cortical tension, thereby enhancing the ability of motile bacteria to deform the plasma membrane into protrusions.	[Rajabian, Tina; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gavicherla, Balramakrishna; Ireton, Keith] Univ Cent Florida, Dept Mol Biol & Microbiol, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Heisig, Martin] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97078 Wurzburg, Germany; [Mueller-Altrock, Stefanie; Goebel, Werner] Univ Wurzburg, Bioctr Microbiol, D-97074 Wurzburg, Germany	University of Toronto; State University System of Florida; University of Central Florida; University of Wurzburg; University of Wurzburg	Ireton, K (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kireton@mail.ucf.edu	McDivitt, Tina Rajabian/HGC-5127-2022; Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Canadian Institutes of Health Research (CIHR) [MT-15497, MOP-15499]; National Institutes of Health [1R21AI076881-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076881] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Brumell, H. Sarantis, A. Wilde and R. Collins for reviewing the manuscript, N. Freitag, T. Otani, E. Leung and K. Nemec for advice on assays or protein purification and Y. Shen for help with plasmid construction. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (MT-15497) and National Institutes of Health (1R21AI076881-01) to K. I., and a CIHR grant (MOP-15499) to S. D. G.	Auerbuch V, 2003, MOL MICROBIOL, V49, P1361, DOI 10.1046/j.1365-2958.2003.03639.x; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Engelbrecht F, 1996, MOL MICROBIOL, V21, P823, DOI 10.1046/j.1365-2958.1996.541414.x; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; PETERSON MD, 1992, J CELL SCI, V102, P581; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; RIENTO K, 2003, NATURE REV MOL CELL, V4, P456; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sechi AS, 1997, J CELL BIOL, V137, P155, DOI 10.1083/jcb.137.1.155; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Sun H, 2005, CELL MICROBIOL, V7, P443, DOI 10.1111/j.1462-5822.2004.00475.x; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; WUENSCHER MD, 1991, MOL GEN GENET, V228, P177, DOI 10.1007/BF00282463	28	126	130	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1212	U104		10.1038/ncb1964	http://dx.doi.org/10.1038/ncb1964			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767742	Green Accepted			2022-12-27	WOS:000270382000010
J	Hansen, CG; Bright, NA; Howard, G; Nichols, BJ				Hansen, Carsten G.; Bright, Nicholas A.; Howard, Gillian; Nichols, Benjamin J.			SDPR induces membrane curvature and functions in the formation of caveolae	NATURE CELL BIOLOGY			English	Article							DEPRIVATION-RESPONSE-GENE; TRANSCRIPT RELEASE FACTOR; COILED-COIL PROTEIN; SHIGA TOXIN; INDEPENDENT ENDOCYTOSIS; SERUM STARVATION; BINDING PROTEIN; POLYMERASE-I; PATHWAYS; CELLS	Caveolae are plasma membrane invaginations with a characteristic flask-shaped morphology. They function in diverse cellular processes, including endocytosis. The mechanism by which caveolae are generated is not fully understood, but both caveolin proteins and PTRF (polymerase I and transcript release factor, also known as cavin) are important. Here we show that loss of SDPR (serum deprivation protein response) causes loss of caveolae. SDPR binds directly to PTRF and recruits PTRF to caveolar membranes. Overexpression of SDPR, unlike PTRF, induces deformation of caveolae and extensive tubulation of the plasma membrane. The B-subunit of Shiga toxin (STB) also induces membrane tubulation and these membrane tubes also originate from caveolae. STB colocalizes extensively with both SDPR and caveolin 1. Loss of caveolae reduces the propensity of STB to induce membrane tubulation. We conclude that SDPR is a membrane-curvature-inducing component of caveolae, and that STB-induced membrane tubulation is facilitated by caveolae.	[Hansen, Carsten G.; Howard, Gillian; Nichols, Benjamin J.] MRC LMB, Cambridge CB2 0QH, England; [Bright, Nicholas A.] Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 0XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Nichols, BJ (corresponding author), MRC LMB, Hills Rd, Cambridge CB2 0QH, England.	ben@mrc-lmb.cam.ac.uk		Hansen, Carsten/0000-0003-0746-7482	MRC; Cowi Foundation; Ulla og Mogens Andersens Fond; Oticon Fonden; Julie Von Mullens Fond; Fuhrmann-Fonden; Krista og Viggo Petersen's Fond; Reinholdt W Jorck og Hustrus Fond; Niels Bohr Fond; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [G9310915, MC_U105178778] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cowi Foundation; Ulla og Mogens Andersens Fond; Oticon Fonden; Julie Von Mullens Fond; Fuhrmann-Fonden; Krista og Viggo Petersen's Fond; Reinholdt W Jorck og Hustrus Fond; Niels Bohr Fond; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Riento, H. Pelham and S. Munro for comments on the manuscript. C. G. H. is supported by the MRC, Cowi Foundation, Ulla og Mogens Andersens Fond, Oticon Fonden, Julie Von Mullens Fond, Fuhrmann-Fonden, Krista og Viggo Petersen's Fond, Reinholdt W Jorck og Hustrus Fond, Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmoend-og Kvinder, Niels Bohr Fond and Henry Shaw's Legat. N. A. B. is supported by the MRC.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Razani B, 2001, J BIOL CHEM, V276, P38121; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	39	194	198	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					807	U60		10.1038/ncb1887	http://dx.doi.org/10.1038/ncb1887			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525939	Green Accepted			2022-12-27	WOS:000267603100008
J	Luce, K; Osiewacz, HD				Luce, Karin; Osiewacz, Heinz D.			Increasing organismal healthspan by enhancing mitochondrial protein quality control	NATURE CELL BIOLOGY			English	Article							ASCOMYCETE PODOSPORA-ANSERINA; LIFE-SPAN; LON PROTEASE; DNA REARRANGEMENTS; OXIDATIVE STRESS; RESPIRATORY CHAINS; FUNGAL; GENES; SENESCENCE; EXPRESSION	Degradation of damaged proteins by members of the protein quality control system is of fundamental importance in maintaining cellular homeostasis. In mitochondria, organelles which both generate and are targets of reactive oxygen species (ROS), a number of membrane bound and soluble proteases are essential components of this system. Here we describe the regulation of Podospora anserina LON (PaLON) levels, an AAA(+) family serine protease localized in the matrix fraction of mitochondria. Constitutive overexpression of PaLon results in transgenic strains of the fungal ageing model P. anserina showing increased ATP-dependent serine protease activity. These strains display lower levels of carbonylated (aconitase) and carboxymethylated proteins, reduced secretion of hydrogen peroxide and a higher resistance against exogenous oxidative stress. Moreover, they are characterized by an extended lifespan without impairment of vital functions such as respiration, growth and fertility. The reported genetic manipulation proved to be a successful intervention in organismal ageing and it led to an increase in the healthy lifespan, the healthspan, of P. anserina.	[Luce, Karin; Osiewacz, Heinz D.] Univ Frankfurt, Fac Biosci & Cluster Excellence Macromol Complexe, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Osiewacz, HD (corresponding author), Univ Frankfurt, Fac Biosci & Cluster Excellence Macromol Complexe, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	osiewacz@bio.uni-frankfurt.de	Osiewacz, Heinz D./D-3454-2011		Deutsche Forschungsgemeinschaft; European Commission [FP6-518230]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	was supported by a grant from the Deutsche Forschungsgemeinschaft. Part of the work of H. D. O. was supported by the European Commission ( FP6-518230; Proteomage).	Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x; Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Hamann A, 2005, CURR GENET, V48, P270, DOI 10.1007/s00294-005-0018-1; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Jung C, 2000, ANAL BIOCHEM, V286, P214, DOI 10.1006/abio.2000.4813; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; OSIEWACZ HD, 1994, CURR GENET, V26, P87, DOI 10.1007/BF00326309; OSIEWACZ HD, 1992, AGING-CLIN EXP RES, V4, P273, DOI 10.1007/BF03324108; OSIEWACZ HD, 1991, APPL MICROBIOL BIOT, V35, P38; Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7; Osiewacz HD, 2000, ANN NY ACAD SCI, V908, P31; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scheckhuber Christian Q., 2008, Biotechnology Journal, V3, P781, DOI 10.1002/biot.200800010; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	38	111	118	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					852	U168		10.1038/ncb1893	http://dx.doi.org/10.1038/ncb1893			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543272				2022-12-27	WOS:000267603100014
J	Gillette, JM; Larochelle, A; Dunbar, CE; Lippincott-Schwartz, J				Gillette, Jennifer M.; Larochelle, Andre; Dunbar, Cynthia E.; Lippincott-Schwartz, Jennifer			Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC-STEM-CELL; PROGENITOR CELLS; SURFACE PROTEINS; STROMAL CELLS; INTERNALIZATION; OSTEOBLASTS; MIGRATION; MEMBRANE; PATHWAYS; ADHESION	Haematopoietic stem-progenitor cells (HSPCs) reside in the bone marrow niche, where interactions with osteoblasts provide essential cues for their proliferation and survival. Here, we use live-cell imaging to characterize both the site of contact between osteoblasts and haematopoietic progenitor cells (HPCs) and events at this site that result in downstream signalling responses important for niche maintenance. HPCs made prolonged contact with the osteoblast surface through a specialized membrane domain enriched in prominin 1, CD63 and rhodamine PE. At the contact site, portions of the specialized domain containing these molecules were taken up by the osteoblast and internalized into SARA-positive signalling endosomes. This caused osteoblasts to downregulate Smad signalling and increase production of stromal-derived factor-1 (SDF-1), a chemokine responsible for HSPC homing to bone marrow. These findings identify a mechanism involving intercellular transfer to signalling endosomes for targeted regulation of signalling and remodelling events within an ex vivo osteoblastic niche.	[Gillette, Jennifer M.; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Larochelle, Andre; Dunbar, Cynthia E.] NHLBI, Mol Hematopoiesis Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Larochelle, Andre/P-1342-2016	Larochelle, Andre/0000-0003-0685-2186; Dunbar, Cynthia/0000-0002-7645-838X	Intramural Research Program of the US National Institute of Child Health and Human Development; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006063, ZIAHL002339] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Victoria Cogger ( University of Sydney, ANZAC Research Institute, Australia) for assistance with scanning electron microscopy. We would also like to thank Denis Corbeil ( University of Dresden, Germany) for providing the prominin 1 - GFP construct, and Suliana Manley and George Patterson ( NIH) for critical reading of the manuscript. This project was supported by the Intramural Research Program of the US National Institute of Child Health and Human Development, National Institutes of Health.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BAUER N, 2007, CELLS TISSUES OR DEC; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CORVERA S, 2000, SCI STKE, pPE1; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wagner W, 2005, STEM CELLS, V23, P1180, DOI 10.1634/stemcells.2004-0361; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	32	72	75	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					303	U168		10.1038/ncb1838	http://dx.doi.org/10.1038/ncb1838			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198600	Green Accepted			2022-12-27	WOS:000263777900014
J	Ren, PH; Lauckner, JE; Kachirskaia, I; Heuser, JE; Melki, R; Kopito, RR				Ren, Pei-Hsien; Lauckner, Jane E.; Kachirskaia, Ioulia; Heuser, John E.; Melki, Ronald; Kopito, Ron R.			Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates	NATURE CELL BIOLOGY			English	Article							PROTEIN MISFOLDING DISEASES; YEAST PRION; IN-VITRO; HUNTINGTIN; TOXICITY; PROPAGATION; MECHANISM; PEPTIDES; FIBRILS	Sequence-specific nucleated protein aggregation is closely linked to the pathogenesis of most neurodegenerative diseases and constitutes the molecular basis of prion formation(1). Here we report that fibrillar polyglutamine peptide aggregates can be internalized by mammalian cells in culture where they gain access to the cytosolic compartment and become co-sequestered in aggresomes together with components of the ubiquitin-proteasome system and cytoplasmic chaperones. Remarkably, these internalized fibrillar aggregates are able to selectively recruit soluble cytoplasmic proteins with which they share homologous but not heterologous amyloidogenic sequences, and to confer a heritable phenotype on cells expressing the homologous amyloidogenic protein from a chromosomal locus.	[Ren, Pei-Hsien; Lauckner, Jane E.; Kachirskaia, Ioulia; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94035 USA; [Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL)	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94035 USA.	kopito@stanford.edu	Heuser, John/H-5940-2012		NINDS; Stanford Graduate Fellowship; CNRS; ANR [ANR-06-BLAN-0266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Graduate Fellowship(Stanford University); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Perrino and J. Mulholland for help with electron and confocal microscopy; K. Kirkegaard for comments on the manuscript and G. Chang and T. Hastie for statistical analysis. This research was supported in part by a grant from the NINDS and a Stanford Graduate Fellowship to P.-H.R.; R.M. is supported by the CNRS and the ANR contract no. ANR-06-BLAN-0266.	Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sousa MM, 2001, AM J PATHOL, V159, P1993; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	27	320	324	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					219	U232		10.1038/ncb1830	http://dx.doi.org/10.1038/ncb1830			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151706	Green Accepted			2022-12-27	WOS:000263285500021
J	Tian, B; Yang, QA; Mao, ZX				Tian, Bo; Yang, Qian; Mao, Zixu			Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; INDUCED CELL-DEATH; ATAXIA-TELANGIECTASIA; NERVOUS-SYSTEM; ACTIVATION; APOPTOSIS; TRANSCRIPTION; AUTOPHOSPHORYLATION; P53; REQUIREMENT	The phosphatidylinositol-3-kinase-like kinase ATM (ataxia-telangiectasia mutated) has a central role in coordinating DNA damage responses, including cell-cycle checkpoint control, DNA repair and apoptosis. Mutations of ATM cause a spectrum of defects ranging from neurodegeneration to cancer predisposition. However, the mechanism by which DNA damage activates ATM is poorly understood. Here we show that Cdk5 (cyclin-dependent kinase 5), activated by DNA damage, directly phosphorylates ATM at Ser 794 in post-mitotic neurons. Phosphorylation at Ser 794 precedes, and is required for, ATM autophosphorylation at Ser 1981, and activates ATM kinase activity. The Cdk5-ATM signal regulates phosphorylation and function of the ATM targets p53 and H2AX. Interruption of the Cdk5-ATM pathway attenuates DNA-damage-induced neuronal cell cycle re-entry and expression of the p53 targets PUMA and Bax, protecting neurons from death. Thus, activation of Cdk5 by DNA damage serves as a critical signal to initiate the ATM response and regulate ATM dependent cellular processes.	[Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Tian, Bo; Yang, Qian; Mao, Zixu] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	TIAN, BO/G-2354-2011	TIAN, BO/0000-0002-8318-3046	NIH [R01 NS048254, R01 AG023695]; Robert W. Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Bert Vogelstein, Richard Gatti, Michael Kastan, Martin Lavin and Shuki Mizutani for p53 reporter constructs, purified ATM protein, ATM mammalian expression constructs, GST-ATM expression constructs, and A-T cell lines, respectively. This work was partially supported by NIH grants R01 NS048254 (Z.M.) and R01 AG023695 (Z.M.) and The Robert W. Woodruff Health Sciences Center Fund (Z.M.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; EL DW, 1993, CELL, V75, P817; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Li BS, 2000, J NEUROSCI, V20, P6055, DOI 10.1523/JNEUROSCI.20-16-06055.2000; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100	37	129	135	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					211	U221		10.1038/ncb1829	http://dx.doi.org/10.1038/ncb1829			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19151707	Green Accepted			2022-12-27	WOS:000263285500020
J	Wagner, TFJ; Loch, S; Lambert, S; Straub, I; Mannebach, S; Mathar, I; Dufer, M; Lis, A; Flockerzi, V; Philipp, SE; Oberwinkler, J				Wagner, Thomas F. J.; Loch, Sabine; Lambert, Sachar; Straub, Isabelle; Mannebach, Stefanie; Mathar, Ilka; Duefer, Martina; Lis, Annette; Flockerzi, Veit; Philipp, Stephan E.; Oberwinkler, Johannes			Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells	NATURE CELL BIOLOGY			English	Article							D-ASPARTATE RECEPTOR; PREGNENOLONE SULFATE; NEUROACTIVE STEROIDS; TRP CHANNELS; ADRENAL-HYPERPLASIA; INSULIN-SECRETION; ACTIVATION; NEUROSTEROIDS; PLASMA; RAT	Transient receptor potential (TRP) cation channels are renowned for their ability to sense diverse chemical stimuli. Still, for many members of this large and heterogeneous protein family it is unclear how their activity is regulated and whether they are influenced by endogenous substances. On the other hand, steroidal compounds are increasingly recognized to have rapid effects on membrane surface receptors that often have not been identified at the molecular level. We show here that TRPM3, a divalent-permeable cation channel, is rapidly and reversibly activated by extracellular pregnenolone sulphate, a neuroactive steroid. We show that pregnenolone sulphate activates endogenous TRPM3 channels in insulin-producing beta cells. Application of pregnenolone sulphate led to a rapid calcium influx and enhanced insulin secretion from pancreatic islets. Our results establish that TRPM3 is an essential component of an ionotropic steroid receptor enabling unanticipated crosstalk between steroidal and insulin-signalling endocrine systems.	[Wagner, Thomas F. J.; Loch, Sabine; Lambert, Sachar; Straub, Isabelle; Oberwinkler, Johannes] Univ Saarland, Emmy Noether Res Grp, D-66421 Homburg, Germany; [Duefer, Martina] Pharmakol & Toxikol Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Saarland University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Oberwinkler, J (corresponding author), Univ Saarland, Emmy Noether Res Grp, D-66421 Homburg, Germany.	johannes.oberwinkler@uniklinikum-saarland.de	Philipp, Stephan/AAR-7519-2020	Oberwinkler, Johannes/0000-0002-8541-3626; Philipp, Stephan/0000-0003-1959-9167	DFG [SFB530]; HOMFOR	DFG(German Research Foundation (DFG)); HOMFOR	We thank S. Plant, M. Portz, H. Lohr, K. Kraushaar, U. Soltek and M. Simon-Thomas for technical support; U. Wissenbach for TRPV6 and TRPM8 expressing cells; V. Chubanov for the TRPM7 expression vector; A. Luckhoff and F.J.P. Kuhn for the TRPM2 expression vector; M. Menger and P. Weissgerber for initial help with isolating pancreatic islets. We also thank A. Beck, D. Beech, B. Fakler, M. Flick, M. Freichel, B. Niemeyer and F. Zufall for discussions and for reading an earlier version of the manuscript. Financial support was provided by DFG (Emmy Noether program, J.O., and SFB530, S. E. P. and V. F.) and HOMFOR.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bicikova M, 2002, STEROIDS, V67, P399, DOI 10.1016/S0039-128X(01)00196-9; Bicikova M, 2000, NEUROCHEM RES, V25, P1623, DOI 10.1023/A:1026622704704; BILLIAR RB, 1974, J CLIN ENDOCR METAB, V39, P27, DOI 10.1210/jcem-39-1-27; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Charmandari E, 2002, J CLIN ENDOCR METAB, V87, P2114, DOI 10.1210/jc.87.5.2114; CHATTORAJ SC, 1970, STEROIDS, V16, P523, DOI 10.1016/S0039-128X(70)80134-9; Chen SC, 2004, BRAIN RES, V1027, P196, DOI 10.1016/j.brainres.2004.08.053; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; DEPERETTI E, 1986, ACTA ENDOCRINOL-COP, V113, P259; DEPERETTI E, 1983, J CLIN ENDOCR METAB, V57, P550, DOI 10.1210/jcem-57-3-550; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; GILLIS KD, 1992, PFLUG ARCH EUR J PHY, V420, P121, DOI 10.1007/BF00378654; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hige T, 2006, EUR J NEUROSCI, V24, P1955, DOI 10.1111/j.1460-9568.2006.05080.x; Hill M, 2002, J STEROID BIOCHEM, V82, P241, DOI 10.1016/S0960-0760(02)00188-7; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jacobson D. A., 2007, V179, P409; Jang MK, 2004, P NATL ACAD SCI USA, V101, P8198, DOI 10.1073/pnas.0401838101; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; MATHUR RS, 1980, J CLIN ENDOCR METAB, V51, P1235, DOI 10.1210/jcem-51-6-1235; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mennerick S, 2008, BIOPHYS J, V95, P176, DOI 10.1529/biophysj.107.124768; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; SCOMMEGNA A, 1971, J CLIN ENDOCR METAB, V33, P787, DOI 10.1210/jcem-33-5-787; SCOMMEGNA A, 1970, AM J OBSTET GYNECOL, V108, P1023, DOI 10.1016/0002-9378(70)90447-3; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; SPEISER PW, 1992, J CLIN ENDOCR METAB, V75, P1421, DOI 10.1210/jc.75.6.1421; Tagawa N, 2000, CLIN CHEM, V46, P523; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; WU FS, 1991, MOL PHARMACOL, V40, P333	61	271	275	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1421	U103		10.1038/ncb1801	http://dx.doi.org/10.1038/ncb1801			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18978782				2022-12-27	WOS:000261261800012
J	Hilliker, A; Parker, R				Hilliker, Angela; Parker, Roy			Stressed out? Make some modifications!	NATURE CELL BIOLOGY			English	Editorial Material							PROCESSING BODIES; GRANULES; CELLS	stress granules and processing bodies are related mRNA-containing granules implicated in controlling mRNA translation and decay. a genomic screen identifies numerous factors affecting granule formation, including proteins involved in O-GlcNAc modifications. These results highlight the importance of post-translational modifications in translational control and mRNP granule formation.	[Hilliker, Angela] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Hilliker, A (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu	Hilliker, Angie/GSI-6750-2022		Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM045443, R37 GM045443-18] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arnold CS, 1999, TRENDS GLYCOSCI GLYC, V11, P355, DOI 10.4052/tigg.11.355; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	17	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1129	1130		10.1038/ncb1008-1129	http://dx.doi.org/10.1038/ncb1008-1129			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18830219	Green Accepted			2022-12-27	WOS:000259682900005
J	Ebisuya, M; Yamamoto, T; Nakajima, M; Nishida, E				Ebisuya, Miki; Yamamoto, Takuya; Nakajima, May; Nishida, Eisuke			Ripples from neighbouring transcription	NATURE CELL BIOLOGY			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; GENE-EXPRESSION; CELL-CYCLE; IDENTIFICATION; PROMOTERS; SEQUENCES; DATABASE; RNA; MAP	Transcriptional initiation of each gene is assumed to be independently controlled in mammals. On the other hand, recent large-scale transcriptome analyses have shown that the genome is pervasively transcribed, such that the most of its DNA gives rise to RNAs1-4. This raises the question of whether it is possible to pinpoint and activate a particular locus without perturbing numerous neighbouring transcripts. Here we show that intensive transcription at one locus frequently spills over into its physical neighbouring loci. Rapid induction of immediate-early genes (IEGs) in response to growth factor stimulation(5) is accompanied by co-upregulation of their neighbouring genes. Profiling the primary transcripts in the nucleus with whole-genome tiling arrays delineated simultaneous activation of transcription centred on IEGs. Even in surrounding intergenic regions, transcriptional activation took place at the same time. Acetylation levels of histone H3 and H4 are elevated along with the IEG induction and neighbouring co-upregulation. Inhibition of the mitogen-activated protein kinase (MAPK) pathway or the transcription factor SRF suppresses all transcriptional upregulation. These results suggest that transcriptional activation has a ripple effect, which may be advantageous for coordinated expression.	[Ebisuya, Miki; Yamamoto, Takuya; Nakajima, May; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	150174@sakura.kudpc.kyoto-u.ac.jp	Ebisuya, Miki/N-5388-2015; Yamamoto, Takuya/H-2792-2017	Ebisuya, Miki/0000-0003-1854-7496; Yamamoto, Takuya/0000-0002-0022-3947	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank I. Smith for helpful discussion and M. McMahon for Delta B-Raf-ER cells. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N.).	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	30	190	196	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1106	1113		10.1038/ncb1771	http://dx.doi.org/10.1038/ncb1771			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160492				2022-12-27	WOS:000258910400017
J	Kang, JS; Saunier, EF; Akhurst, RJ; Derynck, R				Kang, Jong Seok; Saunier, Elise F.; Akhurst, Rosemary J.; Derynck, Rik			The type I TGF-beta receptor is covalently modified and regulated by sumoylation	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; SUMO-1 MODIFICATION; SIGNALING PATHWAYS; HUMAN CANCER; C-JUN; SMAD3; P53; TRANSCRIPTION; DEGRADATION; METASTASIS	Post- translational sumoylation, the covalent attachment of a small ubiquitin-like modifier (SUMO), regulates the functions of proteins engaged in diverse processes. Often associated with nuclear and perinuclear proteins, such as transcription factors, it is not known whether SUMO can conjugate to cell-surface receptors for growth factors to regulate their functions. Here we show that the type I transforming growth factor-beta (TGF-beta) receptor, T beta RI, is sumoylated in response to TGF-beta and that its sumoylation requires the kinase activities of both T beta RI and the type II TGF-beta receptor, T beta RII. Sumoylation of T beta RI enhances receptor function by facilitating the recruitment and phosphorylation of Smad3, consequently regulating TGF-beta-induced transcription and growth inhibition. T beta RI sumoylation modulates the dissemination of transformed cells in a mouse model of T beta RI-stimulated metastasis. T beta RI sumoylation therefore controls responsiveness to TGF-beta, with implications for tumour progression. Sumoylation of cell-surface receptors may regulate other growth factor responses.	[Kang, Jong Seok; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA; [Saunier, Elise F.; Akhurst, Rosemary J.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Akhurst, Rosemary J.; Derynck, Rik] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Akhurst, Rosemary J.] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu		AKHURST, ROSEMARY/0000-0002-4474-9668	NCI NIH HHS [R01-CA63101, R21 CA125190, R01 CA063101, R01 CA116019-03, R01 CA116019, R21-CA125190, R21 CA125190-02, R21 CA125190-01] Funding Source: Medline; NHLBI NIH HHS [R01 HL078564] Funding Source: Medline; NIAMS NIH HHS [P01 AR050440] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063101, R01CA116019, R21CA125190] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chen TP, 1998, CANCER RES, V58, P4805; Chen TP, 2001, INT J CANCER, V93, P653, DOI 10.1002/ijc.1381; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Goto D, 1998, FEBS LETT, V430, P201, DOI 10.1016/S0014-5793(98)00658-9; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1989, BIOTECHNIQUES, V7, P984; MILLER AD, 1989, BIOTECHNIQUES, V7, P989; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, SCIENCE, V8, P2879; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x	45	107	113	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					654	664		10.1038/ncb1728	http://dx.doi.org/10.1038/ncb1728			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469808	Green Accepted			2022-12-27	WOS:000256350100012
J	Solomon, MJ; Burton, JL				Solomon, Mark J.; Burton, Janet L.			Securin' M-phase entry	NATURE CELL BIOLOGY			English	Editorial Material							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; SPINDLE ASSEMBLY CHECKPOINT; PSEUDOSUBSTRATE INHIBITOR; BUDDING YEAST; MITOTIC EXIT; APC/C; DEGRADATION; MITOSIS; EMI1	The anaphase-promoting complex ( aPC) mediates the ubiquitination and degradation of key M-phase regulators, including cyclins and the anaphase inhibitor securin. intriguingly, securin can also inhibit the degradation of cyclin B. This competition between substrates permits the accumulation of enough cyclin to drive entry into M phase.	[Solomon, Mark J.; Burton, Janet L.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Solomon, MJ (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.	Mark.Solomon@yale.edu						Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; HALL MC, 2008, J BIOL CHEM, V283; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936	13	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					381	383		10.1038/ncb0408-381	http://dx.doi.org/10.1038/ncb0408-381			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379598				2022-12-27	WOS:000254561700006
J	Ishiguro, T; Tanaka, K; Sakuno, T; Watanabe, Y				Ishiguro, Tadashi; Tanaka, Koichi; Sakuno, Takeshi; Watanabe, Yoshinori			Shugoshin-PP2A counteracts casein-kinase-1-dependent cleavage of Rec8 by separase	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; CHROMOSOME SEGREGATION; MONOPOLAR ATTACHMENT; FISSION YEAST; KINASE CDC5; MEIOSIS; PHOSPHORYLATION; COHESIN; CENTROMERES; SUBUNIT	During meiosis, the cohesin complexes that maintain sister chromatid cohesion are lost in a stepwise manner(1,2). At meiosis I the cohesin subunit Rec8 is cleaved only along the chromosome arms; until meiosis II it is protected at centromeres by the action of shugoshin (Sgo1)-protein phosphatase 2A (PP2A)(3-5). Although this regulation hypothetically involves phosphorylation that is antagonized by Sgo1-PP2A, the kinase and substrate that are responsible are as yet unknown(6,7). Using a genetic screen for 'anti-shugoshin', we identify Hhp2, an orthologue of casein kinase 1 delta/epsilon (CK1), as a factor required for Rec8 cleavage in fission yeast. We show that CK1, rather than a Polo-like kinase that is widely believed to do so, acts as the cohesin kinase to promote this cleavage during meiosis. Crucially, forced localization of excess Hhp2 at the pericentromeric region abrogates the ability of Sgo1-PP2A to protect centromeric Rec8. Thus, our studies prove the key notion that the balance between Rec8 phosphorylation and its dephosphorylation by Sgo1-PP2A regulates the step-wise loss of chromosomal cohesion in meiosis.	[Ishiguro, Tadashi; Tanaka, Koichi; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Ishiguro, Tadashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Special Coordination Funds for Promoting Science and Technology; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Silke Hauf for critically reading the manuscript; Iain Hagan and the Yeast Genetic Resource Center (YGRC) for yeast strains; and all the members of our laboratory for their valuable support and discussion. We also thank Kim Nasmyth and Wolfgang Zachariae for communicating unpublished results. This work was supported in part by Special Coordination Funds for Promoting Science and Technology (to T. S.) and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) and a Grant-in-Aid for Scientific research on Priority Areas (to K. T. and T. S.) and for Specially Promoted Research (to Y.W.), MEXT, Japan.	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	35	117	119	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					500	U201		10.1038/ncb2052	http://dx.doi.org/10.1038/ncb2052			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383139				2022-12-27	WOS:000277283700016
J	Guirao, B; Meunier, A; Mortaud, S; Aguilar, A; Corsi, JM; Strehl, L; Hirota, Y; Desoeuvre, A; Boutin, C; Han, YG; Mirzadeh, Z; Cremer, H; Montcouquiol, M; Sawamoto, K; Spassky, N				Guirao, Boris; Meunier, Alice; Mortaud, Stephane; Aguilar, Andrea; Corsi, Jean-Marc; Strehl, Laetitia; Hirota, Yuki; Desoeuvre, Angelique; Boutin, Camille; Han, Young-Goo; Mirzadeh, Zaman; Cremer, Harold; Montcouquiol, Mireille; Sawamoto, Kazunobu; Spassky, Nathalie			Coupling between hydrodynamic forces and planar cell polarity orients mammalian motile cilia	NATURE CELL BIOLOGY			English	Article							NEURAL STEM-CELLS; INTRAFLAGELLAR TRANSPORT; EPENDYMAL CELLS; DYSFUNCTIONAL CILIA; CEREBROSPINAL-FLUID; BASAL BODY; EXPRESSION; MOUSE; POLARIZATION; PROTEINS	In mammals, motile cilia cover many organs, such as fallopian tubes, respiratory tracts and brain ventricles. The development and function of these organs critically depend on efficient directional fluid flow ensured by the alignment of ciliary beating. To identify the mechanisms involved in this process, we analysed motile cilia of mouse brain ventricles, using biophysical and molecular approaches. Our results highlight an original orientation mechanism for ependymal cilia whereby basal bodies first dock apically with random orientations, and then reorient in a common direction through a coupling between hydrodynamic forces and the planar cell polarity (PCP) protein Vangl2, within a limited time-frame. This identifies a direct link between external hydrodynamic cues and intracellular PCP signalling. Our findings extend known PCP mechanisms by integrating hydrodynamic forces as long-range polarity signals, argue for a possible sensory role of ependymal cilia, and will be of interest for the study of fluid flow-mediated morphogenesis.	[Guirao, Boris; Meunier, Alice; Mortaud, Stephane; Aguilar, Andrea; Corsi, Jean-Marc; Strehl, Laetitia; Spassky, Nathalie] CNRS, UMR8197, Inst Natl Sante & Rech Med U1024, IBENS, F-75005 Paris, France; [Guirao, Boris] Inst Curie, UMR 168, Lab Physicochim Curie, F-75248 Paris, France; [Hirota, Yuki; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol, Nagoya, Aichi 4678601, Japan; [Desoeuvre, Angelique; Boutin, Camille; Cremer, Harold] Univ Mediterranee, CNRS, IBDML, Marseille, France; [Han, Young-Goo; Mirzadeh, Zaman] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Montcouquiol, Mireille] INSERM, U862, Neuroctr Magendie, Mol Basis Planar Polar Grp, F-33000 Bordeaux, France; [Montcouquiol, Mireille] Univ Bordeaux, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Nagoya City University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Spassky, N (corresponding author), CNRS, UMR8197, Inst Natl Sante & Rech Med U1024, IBENS, F-75005 Paris, France.	spassky@biologie.ens.fr	Spassky, Nathalie/E-3932-2016; Hirota, Yuki/A-9736-2015; Han, Young-Goo/N-2664-2018; montcouquiol, mireille/L-6199-2017	Hirota, Yuki/0000-0001-9629-0038; Han, Young-Goo/0000-0002-4008-294X; montcouquiol, mireille/0000-0001-8739-6519; Mortaud, Stephane/0000-0003-0873-4781; Guirao, Boris/0000-0002-5583-0226; spassky, nathalie/0000-0003-4722-6464; Meunier, Alice/0000-0001-6131-7747; Aguilar, Andrea/0000-0002-6115-0040; Sawamoto, Kazunobu/0000-0003-1984-5129; Cremer, Harold/0000-0002-8673-5176	Agence Nationale de la Recherche; International Human Frontier Science Program Organization; Fondation NRJ-Institut de France; Mairie de Paris start-up Grant; Fondation pour la Recherche Medicale; AXA Research Funds	Agence Nationale de la Recherche(French National Research Agency (ANR)); International Human Frontier Science Program Organization(Human Frontier Science Program); Fondation NRJ-Institut de France(Fondation de France); Mairie de Paris start-up Grant; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AXA Research Funds(AXA Research Fund)	We thank A. Buguin, B. Lemaire and J.-H. Codarbox for their help with the flow set-up realization. We thank Marie-Paule Muriel for excellent technical assistance and for having shared her T. E. M. background. We thank the Pitie-Salpetrisre and Cochin hospitals imaging centres. We thank B. Yoder (University of Alabama, Birmingham) and L. S. Goldstein (University of California San Diego) for providing us with Ift88<SUP>fl/fl</SUP> and Kif3a<SUP>fl/KO</SUP> mice, respectively. We thank A. Alvarez-Buylla for making Ift88<SUP>fl/fl</SUP> mice available. We thank M. Bornens for the gift of CTR453 antibody, X. Morin for the gift of pCX plasmid and MH. Bre for the gift of TAP antibody. We also thank M. Bornens, B. Durand, J.-F. Joanny and Y. Bellaiche for discussions and reading of this manuscript. This work was supported by grants from the Agence Nationale de la Recherche (to N.S.), The International Human Frontier Science Program Organization (to N.S. and K. S.), the Fondation NRJ-Institut de France (to N.S.), the Mairie de Paris start-up Grant ( to N.S.), by Fondation pour la Recherche Medicale and AXA Research Funds fellowships to A. M. and Neuropole de Recherche Francilien fellowship to J.-M.C.B.G. and A. A. were fellows of the Ministere de l'enseignement superieur et de la recherche.	Afzelius B A, 1979, Int Rev Exp Pathol, V19, P1; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cartwright JHE, 2009, HFSP J, V3, P77, DOI 10.2976/1.3043738; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; El Zein L, 2009, J CELL SCI, V122, P3180, DOI 10.1242/jcs.048348; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Genzen JR, 2009, PURINERG SIGNAL, V5, P299, DOI 10.1007/s11302-009-9143-5; Gosgnach W, 2000, AM J PHYSIOL-CELL PH, V279, pC1880, DOI 10.1152/ajpcell.2000.279.6.C1880; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Iftode F, 2003, BIOL CELL, V95, P39, DOI 10.1016/S0248-4900(03)00005-4; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; MACHEMER H, 1972, J EXP BIOL, V57, P239; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May-Simera HL, 2009, J COMP NEUROL, V514, P174, DOI 10.1002/cne.22001; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Miyan JA, 2003, CAN J PHYSIOL PHARM, V81, P317, DOI 10.1139/Y03-027; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Paltieli Y, 2000, J ASSIST REPROD GEN, V17, P103, DOI 10.1023/A:1009465900824; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; RAUTIAINEN M, 1990, EUR ARCH OTO-RHINO-L, V247, P100; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; TAMM SL, 1975, J CELL BIOL, V64, P98, DOI 10.1083/jcb.64.1.98; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; VANABEEL.JH, 1968, EXPERIENTIA, V24, P191; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	59	271	276	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					341	U86		10.1038/ncb2040	http://dx.doi.org/10.1038/ncb2040			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305650				2022-12-27	WOS:000276194600007
J	Woo, CW; Cui, DY; Arellano, J; Dorweiler, B; Harding, H; Fitzgerald, KA; Ron, D; Tabas, I				Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Harding, Heather; Fitzgerald, Katherine A.; Ron, David; Tabas, Ira			Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; IN-VIVO; TRANSLATION; CELLS; CHOP; EXPRESSION; APOPTOSIS; PHOSPHORYLATION; REINITIATION	The endoplasmic reticulum ( ER) unfolded protein response (UPR) restores equilibrium to the ER, but prolonged expression of the UPR effector CHOP (GADD153) is cytotoxic. We found that CHOP expression induced by ER stress was suppressed by prior engagement of toll-like receptor (TLR) 3 or 4 through a TRIF-dependent pathway. TLR engagement did not suppress phosphorylation of PERK or eIF-2 alpha, which are upstream of CHOP, but phospho-eIF-2 alpha failed to promote translation of the CHOP activator ATF4. In mice subjected to systemic ER stress, pretreatment with low dose lipopolysaccharide (LPS), a TLR4 ligand, suppressed CHOP expression and apoptosis in splenic macrophages, renal tubule cells and hepatocytes, and prevented renal dysfunction and hepatosteatosis. This protective effect of LPS did not occur in Trif(-/-) mice or in wildtype mice in which CHOP expression was genetically restored. Thus, TRIF-mediated signals from TLRs selectively attenuate translational activation of ATF4 and its downstream target gene CHOP. We speculate that this mechanism evolved to promote survival of TLR-expressing cells that experience prolonged levels of physiological ER stress in the course of the host response to invading pathogens.	[Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Woo, Connie W.; Cui, Dongying; Arellano, Jerry; Dorweiler, Bernhard; Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Harding, Heather; Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Dept Cardiothorac & Vasc Surg, Mainz, Germany	Columbia University; Columbia University; Columbia University; New York University; University of Massachusetts System; University of Massachusetts Worcester; Johannes Gutenberg University of Mainz	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	iat1@columbia.edu	Fitzgerald, Katherine/ABE-6317-2020; Woo, Connie/AAX-2588-2020	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Fitzgerald, Kate/0000-0003-3175-609X; Woo, Connie Wai Hong/0000-0002-9574-9828	German Research Foundation; NIH [HL75662, HL57560, DK47119, ES08681]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL057560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047119, R29DK047119, R01DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a German Research Foundation Grant ( B. D.), NIH grants HL75662, HL57560 ( I. T.), DK47119 and ES08681( D. R.). We thank Alice Prince and Vincent Racaniello ( Columbia University) for helpful discussions related to the high-dose LPS mouse experiments and biological effects of TRIF signalling, respectively.	Boelens J, 2007, IN VIVO, V21, P215; DUKSIN D, 1982, EUR J BIOCHEM, V129, P77, DOI 10.1111/j.1432-1033.1982.tb07022.x; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma T, 2008, EUR SURG RES, V41, P219, DOI 10.1159/000135631; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	220	232	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1473	U203		10.1038/ncb1996	http://dx.doi.org/10.1038/ncb1996			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19855386	Green Accepted			2022-12-27	WOS:000272251300015
J	Jones, CA; Nishiya, N; London, NR; Zhu, WQ; Sorensen, LK; Chan, AC; Lim, CJ; Chen, HY; Zhang, QS; Schultz, PG; Hayallah, AM; Thomas, KR; Famulok, M; Zhang, K; Ginsberg, MH; Li, DY				Jones, Christopher A.; Nishiya, Naoyuki; London, Nyall R.; Zhu, Weiquan; Sorensen, Lise K.; Chan, Aubrey C.; Lim, Chinten J.; Chen, Haoyu; Zhang, Qisheng; Schultz, Peter G.; Hayallah, Alaa M.; Thomas, Kirk R.; Famulok, Michael; Zhang, Kang; Ginsberg, Mark H.; Li, Dean Y.			Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity	NATURE CELL BIOLOGY			English	Article							REPULSIVE AXON GUIDANCE; RHO-GTPASES; ROUNDABOUT; SLIT; RECEPTORS; PAXILLIN; MIDLINE; ANGIOGENESIS; DROSOPHILA; EXPRESSION	Slit-Roundabout (Robo) signalling has a well-understood role in axon guidance(1-5). Unlike in the nervous system, however, Slit-dependent activation of an endothelial-specific Robo, Robo4, does not initiate a guidance program. Instead, Robo4 maintains the barrier function of the mature vascular network by inhibiting neovascular tuft formation and endothelial hyperpermeability induced by pro-angiogenic factors(6). In this study, we used cell biological and biochemical techniques to elucidate the molecular mechanism underlying the maintenance of vascular stability by Robo4. Here, we demonstrate that Robo4 mediates Slit2-dependent suppression of cellular protrusive activity through direct interaction with the intracellular adaptor protein paxillin and its paralogue, Hic-5. Formation of a Robo4-paxillin complex at the cell surface blocks activation of the small GTPase Arf6 and, consequently, Rac by recruitment of Arf-GAPs (ADP-ribosylation factor-directed GTPase-activating proteins) such as GIT1. Consistent with these in vitro studies, inhibition of Arf6 activity in vivo phenocopies Robo4 activation by reducing pathologic angiogenesis in choroidal and retinal vascular disease and VEGF-165 (vascular endothelial growth factor-165)-induced retinal hyperpermeability. These data reveal that a Slit2-Robo4-paxillin-GIT1 network inhibits the cellular protrusive activity underlying neovascularization and vascular leak, and identify a new therapeutic target for ameliorating diseases involving the vascular system.	[Jones, Christopher A.; London, Nyall R.; Zhu, Weiquan; Chan, Aubrey C.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, Christopher A.; London, Nyall R.; Zhu, Weiquan; Sorensen, Lise K.; Chan, Aubrey C.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [Nishiya, Naoyuki; Lim, Chinten J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Haoyu; Zhang, Kang] Univ Utah, Dept Ophthalmol, Salt Lake City, UT 84112 USA; [Zhang, Qisheng] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA; [Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hayallah, Alaa M.; Famulok, Michael] Univ Bonn, LIMES Program, Unit Chem Biol & Med Chem, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Thomas, Kirk R.] Univ Utah, Div Haematol, Dept Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Dept Med, Div Cardiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; Scripps Research Institute; University of Bonn; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Li, DY (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	mhginsberg@ucsd.edu; dean.li@hmbg.utah.edu	Chen, Haoyu/A-7432-2013; Chu, Kai On/E-2325-2016; Lim, Chinten James/G-3777-2013; Zhang, Kang/Y-2740-2019	Chen, Haoyu/0000-0003-0676-4610; Lim, Chinten James/0000-0001-6381-7585; Zhang, Kang/0000-0002-4549-1697; Chan, Aubrey/0000-0002-9191-2173; Sorensen, Lise K./0000-0003-3250-4564; Zhang, Qisheng/0000-0001-9808-5038; Nishiya, Naoyuki/0000-0003-1575-9944	H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense; National Heart Lung and Blood Institute; National Eye Institute; Deutsche Forschungsgemeinschaft [SFB 704]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Disease [AI065357]; US National Institutes of Health, Ruth L. Kirschstein National Research Service Award [T32-GM007464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671, R01HL068873, R01HL084516, R01HL065648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense(American Heart AssociationJuvenile Diabetes Research Foundation); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health, Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wythe for critical reading of the manuscript, and D. Lim for expert graphical assistance. J. Bonafacino provided the GST-GGA3 expression plasmid. This work was funded by grants from the H. A. and Edna Benning Foundation, the Juvenile Diabetes Research Foundation, the American Heart Association, the Burroughs Wellcome Fund and the Department of Defense (D.Y.L.); the National Heart Lung and Blood Institute (D.Y.L. and M. H. G.); the National Eye Institute (K.Z.); the Deutsche Forschungsgemeinschaft SFB 704 (M. F.); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (M. H. G.); the National Institute of Allergy and Disease AI065357 (D.Y.L.) and by the US National Institutes of Health, Ruth L. Kirschstein National Research Service Award (N.R.L.) and training grant T32-GM007464 (A. C. C.).	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; JONES CA, 2008, NATURE MED; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	23	160	175	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1325	U146		10.1038/ncb1976	http://dx.doi.org/10.1038/ncb1976			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19855388	Green Accepted, Green Published			2022-12-27	WOS:000271425800012
J	Pegoraro, G; Kubben, N; Wickert, U; Gohler, H; Hoffmann, K; Misteli, T				Pegoraro, Gianluca; Kubben, Nard; Wickert, Ute; Goehler, Heike; Hoffmann, Katrin; Misteli, Tom			Ageing-related chromatin defects through loss of the NURD complex	NATURE CELL BIOLOGY			English	Article							PROTEIN-INTERACTION NETWORK; TRANSCRIPTION; ENHANCER; GENOME; BREAKS; CAF-1	Physiological and premature ageing are characterized by multiple defects in chromatin structure and accumulation of persistent DNA damage. Here we identify the NURD chromatin remodelling complex as a key modulator of these ageing-associated chromatin defects. We demonstrate loss of several NURD components during premature and normal ageing and we find an ageing-associated reduction in HDAC1 activity. Silencing of individual NURD subunits recapitulated chromatin defects associated with ageing and we provide evidence that structural chromatin defects precede DNA damage accumulation. These results outline a molecular mechanism for chromatin defects during ageing.	[Pegoraro, Gianluca; Kubben, Nard; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Kubben, Nard] Maastricht Univ, Dept Expt & Mol Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Wickert, Ute] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Goehler, Heike] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hoffmann, Katrin] Humboldt Univ, Inst Med Genet, Charite Berlin, D-13353 Berlin, Germany; [Hoffmann, Katrin] Max Planck Inst Mol Genet Dev & Dis, D-14195 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maastricht University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pegoraro, Gianluca/K-4233-2016	Pegoraro, Gianluca/0000-0003-2843-9464	Telethon Italy Foundation; Italian Association for Cancer Research (AIRC); Deutsche Forschungsgemeinschaft (DFG) [A4, Z2]; NIH; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Telethon Italy Foundation(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Scaffidi and A. Marcello for critical reading of the manuscript, and P. Scaffidi for sharing data and providing numerous suggestions during the course of the experiments. Fluorescence imaging was performed with the assistance of T. Karpova at the NCI Fluorescence Imaging Microscopy Facility. FACS cell cycle acquisition and analysis was performed with the help of K. McKinnon at the NCI FACS facility. We also thank T. Jenuwein, B. Stillman and T. Dittmer for providing reagents. We thank H. Herrmann and E. Wanker for their support with the Y2H screening and subsequent confirmation studies. G. P. was partly supported by postdoctoral fellowships from the Telethon Italy Foundation and the Italian Association for Cancer Research (AIRC). K. H. and H. G. were supported by The Deutsche Forschungsgemeinschaft (DFG, SFB 577, projects A4 and Z2). This work was supported by an Intramural Research Program of the NIH, NCI, Center for Cancer Research.	Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	26	198	205	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1261	U251		10.1038/ncb1971	http://dx.doi.org/10.1038/ncb1971			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734887	Green Accepted			2022-12-27	WOS:000270382000017
J	Persson, H; Kvist, A; Vallon-Christersson, J; Medstrand, P; Borg, A; Rovira, C				Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Medstrand, Patrik; Borg, Ake; Rovira, Carlos			The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs	NATURE CELL BIOLOGY			English	Article							RIBONUCLEOPROTEIN PARTICLE; EXPRESSION; PROTEIN; YEAST	Vault particles are conserved organelles implicated in multidrug resistance and intracellular transport. They contain three different proteins and non-coding vault RNAs (vRNAs). Here we show that human vRNAs produce several small RNAs (svRNAs) by mechanisms different from those in the canonical microRNA (miRNA) pathway. At least one of these svRNAs, svRNAb, associates with Argonaute proteins to guide sequence-specific cleavage and regulate gene expression similarly to miRNAs. We demonstrate that svRNAb downregulates CYP3A4, a key enzyme in drug metabolism. Our findings expand the repertoire of small regulatory RNAs and assign, for the first time, a function to vRNAs that may help explain the association between vault particles and drug resistance.	[Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, Dept Oncol, BMC, S-22184 Lund, Sweden; [Persson, Helena; Kvist, Anders; Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, CREATE Hlth Strateg Ctr Clin Canc Res, BMC, S-22184 Lund, Sweden; [Medstrand, Patrik] Lund Univ, Dept Expt Med Sci, BMC, S-22184 Lund, Sweden; [Vallon-Christersson, Johan; Borg, Ake; Rovira, Carlos] Lund Univ, BMC, SCIBLU Genom, S-22184 Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Rovira, C (corresponding author), Lund Univ, Dept Oncol, BMC, S-22184 Lund, Sweden.	carlos.rovira@med.lu.se	Persson, Helena/ABE-5003-2020	Vallon-Christersson, Johan/0000-0002-2195-0385; Kvist, Anders/0000-0002-1358-0695; Persson, Helena/0000-0002-5187-6446	Royal Physiographic Society in Lund; Berta Kamprad Foundation; Lund Center for Stem Cell Biology and Cell Therapy; Swedish Cancer Society; Swedish Knowledge Foundation	Royal Physiographic Society in Lund; Berta Kamprad Foundation; Lund Center for Stem Cell Biology and Cell Therapy; Swedish Cancer Society(Swedish Cancer Society); Swedish Knowledge Foundation(General Electric)	This work was supported by grants from The Royal Physiographic Society in Lund, the Berta Kamprad Foundation, the Lund Center for Stem Cell Biology and Cell Therapy, and the Swedish Cancer Society. We thank M. Siomi and H. Siomi for the gift of the Ago antibodies, and A. Brun and C. Welinder for technical advice. HP was supported by the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Strategy and Development Office at the Karolinska Institute.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duncan DD, 2006, ANAL BIOCHEM, V359, P268, DOI 10.1016/j.ab.2006.08.022; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; Izquierdo MA, 1996, AM J PATHOL, V148, P877; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kitazono M, 2001, INT J CANCER, V91, P126, DOI 10.1002/1097-0215(20010101)91:1<126::AID-IJC1018>3.0.CO;2-8; Kitazono M, 1999, JNCI-J NATL CANCER I, V91, P1647, DOI 10.1093/jnci/91.19.1647; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; Saal LH, 2002, GENOME BIOL, V3; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Yang IV, 2002, GENOME BIOL, V3	28	121	127	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1268	U265		10.1038/ncb1972	http://dx.doi.org/10.1038/ncb1972			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749744				2022-12-27	WOS:000270382000018
J	Schweisguth, F				Schweisguth, Francois			When you are Dishevelled, fat is good and acid is bad!	NATURE CELL BIOLOGY			English	Editorial Material							SIGNALING PATHWAY; CELL POLARITY; SPECIFICITY; BIOLOGY	Frizzled receptors regulate cell fate decisions and planar cell polarity by means of distinct intracellular effectors. The choice between these two signalling outputs may involve a pH-dependent interaction between dishevelled and negatively charged lipids at the plasma membrane.	Inst Pasteur, CNRS, URA2578, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schweisguth, F (corresponding author), Inst Pasteur, CNRS, URA2578, 25 Rue Dr Roux, F-75015 Paris, France.	francois.schweisguth@pasteur.fr						Axelrod JD, 2001, GENE DEV, V15, P1182; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu J, 2004, PLOS BIOL, V2, P1004, DOI 10.1371/journal.pbio.0020158; Wu J, 2008, MECH DEVELOP, V125, P30, DOI 10.1016/j.mod.2007.10.006	9	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					237	239		10.1038/ncb0309-237	http://dx.doi.org/10.1038/ncb0309-237			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255568				2022-12-27	WOS:000263777900004
J	Smith, E; Dejsuphong, D; Balestrini, A; Hampel, M; Lenz, C; Takeda, S; Vindigni, A; Costanzo, V				Smith, Eloise; Dejsuphong, Donniphat; Balestrini, Alessia; Hampel, Martin; Lenz, Christof; Takeda, Shunichi; Vindigni, Alessandro; Costanzo, Vincenzo			An ATM- and ATR-dependent checkpoint inactivates spindle assembly by targeting CEP63	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MITOTIC SPINDLE; CELL-CYCLE; CENTROSOME AMPLIFICATION; PROTEIN-PHOSPHORYLATION; SELF-ORGANIZATION; VERTEBRATE CELLS; IDENTIFICATION	Activation of the protein kinases ATM and ATR following chromosomal breakage prevents initiation of DNA replication and entry into mitosis. However, the effects of ATM and ATR activation in cells already progressing through mitosis are poorly understood. Here we report that ATM and ATR activation induced by DNA double-strand breaks (DSBs) inhibits centrosome-driven spindle assembly in Xenopus laevis mitotic egg extract and somatic cells, delaying mitotic progression. Using a cDNA expression library to screen for ATM and ATR substrates, we identified centrosomal protein CEP63 as an ATM and ATR target required for normal spindle assembly. ATM and ATR phosphorylate Xenopus CEP63 (XCEP63) on Ser 560 and promote its delocalization from the centrosome. Suppression of ATM and ATR activity or mutation of XCEP63 Ser 560 to Ala prevented spindle assembly defects. Consistently, inactivation of the CEP63 gene in avian DT40 cells impaired spindle assembly and prevented ATM- and ATR-dependent effects on mitosis. These data indicate that ATM and ATR control mitotic events in vertebrate cells by targeting CEP63 and centrosome dependent spindle assembly.	[Smith, Eloise; Dejsuphong, Donniphat; Balestrini, Alessia; Costanzo, Vincenzo] Clare Hall Labs, London Res Inst, Genome Stabil Unit, S Mimms EN6 3LD, Herts, England; [Dejsuphong, Donniphat; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan; [Hampel, Martin; Vindigni, Alessandro] ICGEB, Trieste, Italy; [Lenz, Christof] Appl Biosyst Inc, D-64293 Frankfurt Darmstadt, Germany	Kyoto University; International Center for Genetic Engineering & Biotechnology (ICGEB); Thermo Fisher Scientific; Applied Biosystems	Costanzo, V (corresponding author), Clare Hall Labs, London Res Inst, Genome Stabil Unit, S Mimms EN6 3LD, Herts, England.	Vincenzo.Costanzo@cancer.org.uk		Costanzo, Vincenzo/0000-0002-2920-9508; Dejsuphong, Donniphat/0000-0001-8367-9415; Takeda, Shunichi/0000-0002-7924-7991	Cancer Research UK; Lister Institute of Preventive Medicine; European Research Council ( ERC); EMBO Young Investigator Program (YIP).; AIRC	Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; European Research Council ( ERC)(European Research Council (ERC)European Commission); EMBO Young Investigator Program (YIP).(European Molecular Biology Organization (EMBO)); AIRC(Fondazione AIRC per la ricerca sul cancro)	We thank Tim Hunt, members of Clare Hall Laboratories and of the Genome Stability Unit for their comments. We thank H Mahbubani and J Kirk for technical support with Xenopus laevis. This work was funded by Cancer Research UK. V. Costanzo is also supported by the Lister Institute of Preventive Medicine, the European Research Council ( ERC) start up grant and the EMBO Young Investigator Program (YIP). A. Vindigni thanks AIRC for its support.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Buim ME, 2005, ONCOLOGY-BASEL, V69, P445, DOI 10.1159/000090984; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Cox David M, 2005, J Biomol Tech, V16, P83; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Liu JJ, 2005, ONCOGENE, V24, P238, DOI 10.1038/sj.onc.1208220; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Maller JL, 2002, MOL CELL ENDOCRINOL, V187, P173, DOI 10.1016/S0303-7207(01)00695-5; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Morrison C, 2004, DNA REPAIR, V3, P1133, DOI 10.1016/j.dnarep.2004.03.005; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	36	52	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					278	U125		10.1038/ncb1835	http://dx.doi.org/10.1038/ncb1835			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182792	Green Submitted, Green Published			2022-12-27	WOS:000263777900011
J	Maeda, Y; Ide, T; Koike, M; Uchiyama, Y; Kinoshita, T				Maeda, Yusuke; Ide, Toru; Koike, Masato; Uchiyama, Yasuo; Kinoshita, Taroh			GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus	NATURE CELL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEINS; VACUOLAR H+-ATPASE; CELL-SURFACE; LIVING CELLS; ENDOSOMAL ACIDIFICATION; ENDOPLASMIC-RETICULUM; COLORECTAL-CANCER; SECRETORY PATHWAY; ION CHANNELS; PH	The organelles within secretory and endocytotic pathways in mammalian cells have acidified lumens, and regulation of their acidic pH is critical for the trafficking, processing and glycosylation of cargo proteins and lipids, as well as the morphological integrity of the organelles. How organelle lumen acidification is regulated, and how luminal pH elevation disturbs these fundamental cellular processes, is largely unknown. Here, we describe a novel molecule involved in Golgi acidification. First, mutant cells defective in Golgi acidification were established that exhibited delayed protein transport, impaired glycosylation and Golgi disorganization. Using expression cloning, a novel Golgi-resident multi-transmembrane protein, named Golgi pH regulator (GPHR), was identified as being responsible for the mutant cells. After reconstitution in planar lipid bilayers, GPHR exhibited a voltage-dependent anion-channel activity that may function in counterion conductance. Thus, GPHR modulates Golgi functions through regulation of acidification.	[Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Maeda, Yusuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ide, Toru] Osaka Univ, Grad Sch Frontier Biosci, Labs Nanobiol, Suita, Osaka 5650871, Japan; [Ide, Toru] RIKEN, Mol Informat Life Sci Res Grp, Wako, Saitama 3510198, Japan; [Koike, Masato; Uchiyama, Yasuo] Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; [Kinoshita, Taroh] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Maeda, Y (corresponding author), Osaka Univ, Res Inst Microbial Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ymaeda@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Ide, Toru/L-7110-2015; Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684				ANDRESSON T, 1995, J BIOL CHEM, V270, P6830, DOI 10.1074/jbc.270.12.6830; Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Ide T, 1999, BIOCHEM BIOPH RES CO, V265, P595, DOI 10.1006/bbrc.1999.1720; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kellokumpu S, 2002, FEBS LETT, V516, P217, DOI 10.1016/S0014-5793(02)02535-8; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Laver DR, 1997, PROG BIOPHYS MOL BIO, V67, P99, DOI 10.1016/S0079-6107(97)00008-4; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; Nagasawa M, 2001, J BIOL CHEM, V276, P20413, DOI 10.1074/jbc.M100366200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nordeen MH, 2000, BIOPHYS J, V78, P2918, DOI 10.1016/S0006-3495(00)76832-9; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Pusch M, 2006, EXP PHYSIOL, V91, P149, DOI 10.1113/expphysiol.2005.031799; REAVES B, 1994, FEBS LETT, V345, P61, DOI 10.1016/0014-5793(94)00437-4; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; TARTAKOFF A, 1978, J CELL BIOL, V79, P694, DOI 10.1083/jcb.79.3.694; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; XIE XS, 1983, J BIOL CHEM, V258, P4834; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723	44	119	127	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1135	1145		10.1038/ncb1773	http://dx.doi.org/10.1038/ncb1773			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18794847				2022-12-27	WOS:000259682900007
J	Taddei, A; Giampietro, C; Conti, A; Orsenigo, F; Breviario, F; Pirazzoli, V; Potente, M; Daly, C; Dimmeler, S; Dejana, E				Taddei, Andrea; Giampietro, Costanza; Conti, Annarita; Orsenigo, Fabrizio; Breviario, Ferruccio; Pirazzoli, Valentina; Potente, Michael; Daly, Christopher; Dimmeler, Stefanie; Dejana, Elisabetta			Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5	NATURE CELL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; BETA-CATENIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; MOLECULAR-BASIS; GROWTH-FACTOR; FKHR FOXO1; IN-VIVO; ANGIOGENESIS	Intercellular junctions mediate adhesion and communication between adjoining cells. Although formed by different molecules, tight junctions (TJs) and adherens junctions (AJs) are functionally and structurally linked, but the signalling pathways behind this interaction are unknown. Here we describe a cell-specific mechanism of crosstalk between these two types of structure. We show that endothelial VE-cadherin at AJs upregulates the gene encoding the TJ adhesive protein claudin-5. This effect requires the release of the inhibitory activity of forkhead box factor FoxO1 and the Tcf-4-beta-catenin transcriptional repressor complex. Vascular endothelial (VE)-cadherin acts by inducing the phosphorylation of FoxO1 through Akt activation and by limiting the translocation of beta-catenin to the nucleus. These results offer a molecular basis for the link between AJs and TJs and explain why VE-cadherin inhibition may cause a marked increase in permeability.	[Taddei, Andrea; Giampietro, Costanza; Conti, Annarita; Orsenigo, Fabrizio; Pirazzoli, Valentina; Dejana, Elisabetta] FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Breviario, Ferruccio; Dejana, Elisabetta] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy; [Potente, Michael; Dimmeler, Stefanie] Univ Frankfurt, Dept Internal Med 3, D-60590 Frankfurt, Germany; [Daly, Christopher] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Dejana, Elisabetta] Univ Milan, Sch Sci, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Goethe University Frankfurt; Regeneron; University of Milan	Dejana, E (corresponding author), FIRC Inst Mol Oncol, I-20139 Milan, Italy.	elisabetta.dejana@ifom-ieo-campus.it	Giampietro, Costanza/D-4643-2016	Giampietro, Costanza/0000-0001-5229-3835; Orsenigo, Fabrizio/0000-0001-9135-8478; Daly, Christopher/0000-0003-3800-8174; DEJANA, ELISABETTA/0000-0002-0007-0426; Potente, Michael/0000-0002-5689-0036; Dimmeler, Stefanie/0000-0002-1045-2436	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Grueneberg DA, 2003, MOL CELL BIOL, V23, P3936, DOI 10.1128/MCB.23.11.3936-3950.2003; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	50	448	460	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					923	934		10.1038/ncb1752	http://dx.doi.org/10.1038/ncb1752			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604199				2022-12-27	WOS:000258147100010
J	Skaar, JR; Pagano, M				Skaar, Jeffrey R.; Pagano, Michele			Cdh1: a master G0/G1 regulator	NATURE CELL BIOLOGY			English	Editorial Material							CELL-CYCLE		[Skaar, Jeffrey R.; Pagano, Michele] NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA	New York University	Skaar, JR (corresponding author), NYU, Dept Pathol, Inst Canc, Sch Med, 550 1St Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@nyumc.org		pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM057587, R01 GM057587-11] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Dai W, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-9; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Jacobs HW, 2002, CURR BIOL, V12, P1435, DOI 10.1016/S0960-9822(02)01074-6; Kim AH, 2007, MOL CELL NEUROSCI, V34, P281, DOI 10.1016/j.mcn.2006.11.019; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404	16	49	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					755	757		10.1038/ncb0708-755	http://dx.doi.org/10.1038/ncb0708-755			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18591966	Green Accepted			2022-12-27	WOS:000257268400003
J	Kobayashi, H; Butler, JM; O'Donnell, R; Kobayashi, M; Ding, BS; Bonner, B; Chiu, VK; Nolan, DJ; Shido, K; Benjamin, L; Rafii, S				Kobayashi, Hideki; Butler, Jason M.; O'Donnell, Rebekah; Kobayashi, Mariko; Ding, Bi-Sen; Bonner, Bryant; Chiu, Vi K.; Nolan, Daniel J.; Shido, Koji; Benjamin, Laura; Rafii, Shahin			Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells	NATURE CELL BIOLOGY			English	Article							EX-VIVO EXPANSION; VASCULAR NICHE; GROWTH-FACTOR; ANGIOGENESIS; REGENERATION	Endothelial cells establish an instructive vascular niche that reconstitutes haematopoietic stem and progenitor cells (HSPCs) through release of specific paracrine growth factors, known as angiocrine factors. However, the mechanism by which endothelial cells balance the rate of proliferation and lineage-specific differentiation of HSPCs is unknown. Here, we demonstrate that Akt activation in endothelial cells, through recruitment of mTOR, but not the FoxO pathway, upregulates specific angiocrine factors that support expansion of CD34-F1t3-KLS HSPCs with long-term haematopoietic stem cell (LT-HSC) repopulation capacity. Conversely, co-activation of Akt-stimulated endothelial cells with p42/44 MAPK shifts the balance towards maintenance and differentiation of the HSPCs. Selective activation of Akt1 in the endothelial cells of adult mice increased the number of colony forming units in the spleen and CD34-F1t3- KLS HSPCs with LT-HSC activity in the bone marrow, accelerating haematopoietic recovery. Therefore, the activation state of endothelial cells modulates reconstitution of HSPCs through the modulation of angiocrine factors, with Akt mTOR-activated endothelial cells supporting the self-renewal of LT-HSCs and expansion of HSPCs, whereas MAPK co-activation favours maintenance and lineagespecific differentiation of HSPCs.	[Kobayashi, Hideki; Butler, Jason M.; Kobayashi, Mariko; Ding, Bi-Sen; Bonner, Bryant; Chiu, Vi K.; Nolan, Daniel J.; Shido, Koji; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [O'Donnell, Rebekah; Benjamin, Laura] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rafii, Shahin] Shahin Rafii MD Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu		O'Donnell, Rebekah/0000-0001-5878-7510	Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institute of Health [HL097797, U01 HL66592-03, RC1 AI080309]; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952, P01HL059312, R01HL097797, P50HL084936, R01HL075234, R21HL083222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.R. is supported by Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institute of Health grants HL097797, U01 HL66592-03, RC1 AI080309; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board and the New York State Department of Health grant NYS C024180. We thank G. Lam (Weill Cornell Medical College) for HUVEC culture.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; DING B, 2010, NATURE; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; KOL LET, 2006, Nat Med, V12, P657; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; RAFII S, 1994, BLOOD, V84, P10; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Yeoh JSG, 2006, STEM CELLS, V24, P1564, DOI 10.1634/stemcells.2005-0439; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	39	275	286	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1046	U32		10.1038/ncb2108	http://dx.doi.org/10.1038/ncb2108			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972423	Green Accepted			2022-12-27	WOS:000283711500007
J	Ingerson-Mahar, M; Briegel, A; Werner, JN; Jensen, GJ; Gitai, Z				Ingerson-Mahar, Michael; Briegel, Ariane; Werner, John N.; Jensen, Grant J.; Gitai, Zemer			The metabolic enzyme CTP synthase forms cytoskeletal filaments	NATURE CELL BIOLOGY			English	Article							CYTIDINE TRIPHOSPHATE SYNTHETASE; CAULOBACTER-CRESCENTUS; CRYSTAL-STRUCTURE; PROTEIN; DIVISION; ACTIN; FTSZ; PROTEOLYSIS; ALIGNMENT; LOCATION	Filament-forming cytoskeletal proteins are essential for the structure and organization of all cells. Bacterial homologues of the major eukaryotic cytoskeletal families have now been discovered, but studies suggest that yet more remain to be identified. We demonstrate that the metabolic enzyme CTP synthase (CtpS) forms filaments in Caulobacter crescent us. CtpS is bifunctional, as the filaments it forms regulate the curvature of C. crescentus cells independently of its catalytic function. The morphogenic role of CtpS requires its functional interaction with the intermediate filament, crescentin (CreS). Interestingly, the Escherichia coli CtpS homologue also forms filaments both in vivo and in vitro, suggesting that CtpS polymerization may be widely conserved. E. coli CtpS can replace the enzymatic and morphogenic functions of C. crescentus CtpS, indicating that C. crescentus has adapted a conserved filament-forming protein for a secondary role. These results implicate CtpS as a novel bifunctional member of the bacterial cytoskeleton and suggest that localization and polymerization may be important properties of metabolic enzymes.	[Ingerson-Mahar, Michael; Werner, John N.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Lewis Thomas Labs, Princeton, NJ 08544 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Labs, Washington Rd, Princeton, NJ 08544 USA.	zgitai@princeton.edu	Briegel, Ariane/AAC-1085-2021; Gitai, Zemer/AAI-6989-2021	Briegel, Ariane/0000-0003-3733-3725; 	National Institute of Allergy and Infectious Diseases [1F32A1073043-01A1]; National Institutes of Health (NIH) [R01 AI067548]; Howard Hughes Medical Institute; U.S. Department of Energy Office of Science [DE-FG02-05ER64136]; NIH [1DP2OD004389-01]; Human Frontiers Science Program; Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548, F32AI073043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004389] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to B. Bassler, C. Murphy, E. Klein and K. Cowles for critical reading of the manuscript. We thank M. Cabeen, C. Jacobs-Wagner, J. Williamson, Alison Michaelis and other members of the Gitai lab for reagents and discussions. J.N.W. is supported by a postdoctoral fellowship from the National Institute of Allergy and Infectious Diseases (grant 1F32A1073043-01A1). A.B. and G.J.J. were supported in part by the National Institutes of Health (NIH) grant R01 AI067548, the Howard Hughes Medical Institute, and a gift to Caltech from the Gordon and Betty Moore Foundation. Z.G. is supported by funding from the U.S. Department of Energy Office of Science (Biological and Environmental Research; grant DE-FG02-05ER64136), NIH grant 1DP2OD004389-01, the Human Frontiers Science Program and the Beckman Foundation.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Briegel A, 2008, MOL MICROBIOL, V69, P30, DOI 10.1111/j.1365-2958.2008.06219.x; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carrey EA, 2002, REPRODUCTION, V123, P757, DOI 10.1530/rep.0.1230757; Charbon G, 2009, GENE DEV, V23, P1131, DOI 10.1101/gad.1795509; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELLGAARD AK, 1989, ANNU M AM SOC MICROB, V209, P208; ELY B, 1991, METHOD ENZYMOL, V204, P372; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; HARTMAN SC, 1963, J BIOL CHEM, V238, P3036; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KLEINSCH.AK, 1969, SCIENCE, V166, P1276, DOI 10.1126/science.166.3910.1276; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3365, DOI 10.1021/bi00794a008; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; LONG CW, 1970, J BIOL CHEM, V245, P80; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lunn FA, 2008, BIOCHEM J, V412, P113, DOI 10.1042/BJ20071163; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; PALUH JL, 1985, J BIOL CHEM, V260, P1889; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Simard D, 2003, EUR J BIOCHEM, V270, P2195, DOI 10.1046/j.1432-1033.2003.03588.x; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Srinivasan R, 2007, CURR BIOL, V17, P266, DOI 10.1016/j.cub.2006.11.069; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005; ZIGLER JS, 1991, FASEB J, V5, P223, DOI 10.1096/fasebj.5.2.2004667	40	188	191	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					739	U4		10.1038/ncb2087	http://dx.doi.org/10.1038/ncb2087			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639870	Green Accepted			2022-12-27	WOS:000280561600006
J	Leatherman, JL; DiNardo, S				Leatherman, Judith L.; DiNardo, Stephen			Germline self-renewal requires cyst stem cells and stat regulates niche adhesion in Drosophila testes	NATURE CELL BIOLOGY			English	Article							BAG-OF-MARBLES; JAK/STAT PATHWAY; IN-VIVO; DIVISION; TRANSCRIPTION; MAINTENANCE; CENTROSOME; SPERMATOGENESIS; PROLIFERATION; OVARY	Adults maintain tissue-specific stem cells through niche signals. A model for niche function is the Drosophila melanogaster testis, where a small cluster of cells called the hub produce locally available signals that allow only adjacent cells to self-renew. We show here that the principal signalling pathway implicated in this niche, chemokine activation of STAT(1,2), does not primarily regulate self-renewal of germline stem cells (GSCs), but rather governs GSC adhesion to hub cells. In fact, GSC renewal does not require hub cell contact, as GSCs can be renewed solely by contact with the second resident stem cell population, somatic cyst stem cells (CySCs), and this involves BMP signalling. These data suggest a modified model whereby the hub cells function as architects of the stem cell environment, drawing into proximity cellular components necessary for niche function. Self-renewal functions are shared by the hub cells and the CySCs. This work also reconciles key differences in GSC renewal between Drosophila testis and ovary niches, and highlights how a niche can coordinate the production of distinct lineages by having one stem cell type rely on a second cell type.	[Leatherman, Judith L.; DiNardo, Stephen] Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania	DiNardo, S (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA.	sdinardo@mail.med.upenn.edu	Leatherman, Judith/HDN-5767-2022	DiNardo, Stephen/0000-0003-4131-5511	NIH [R01GM8060804, 060804-10S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the fly community, Bloomington Stock Center, Vienna Drosophila Resource Center, and the Developmental Studies Hybridoma Bank for reagents. We thank Erika Matunis for helpful comments on the manuscript, and Seth Donoughe for technical assistance. This work was supported by NIH R01GM8060804 and 060804-10S1 to S.D.	Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Evans TA, 2009, DEV BIOL, V326, P36, DOI 10.1016/j.ydbio.2008.10.002; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; SINGH SR, J CELL PHYSL, V223, P500; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wang LW, 2008, J CELL BIOL, V180, P721, DOI 10.1083/jcb.200711022; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yu K, 2000, DEVELOPMENT, V127, P2143	27	174	179	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					806	U59		10.1038/ncb2086	http://dx.doi.org/10.1038/ncb2086			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622868	Green Accepted			2022-12-27	WOS:000280561600013
J	Boulter, E; Garcia-Mata, R; Guilluy, C; Dubash, A; Rossi, G; Brennwald, PJ; Burridge, K				Boulter, Etienne; Garcia-Mata, Rafael; Guilluy, Christophe; Dubash, Adi; Rossi, Guendalina; Brennwald, Patrick J.; Burridge, Keith			Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1	NATURE CELL BIOLOGY			English	Article							BINDING PROTEIN; FAMILY GTPASES; CELL; DISSOCIATION; CDC42; GDP; ACTIVATION; ADHESION; CYTOSOL; RAC1	At steady state, most Rho GTPases are bound in the cytosol to Rho guanine nucleotide dissociation inhibitors (RhoGDIs)(1). RhoGDIs have generally been considered to hold Rho proteins passively in an inactive state within the cytoplasm. Here we describe an evolutionarily conserved mechanism by which RhoGDI1 controls the homeostasis of Rho proteins in eukaryotic cells. We found that depletion of RhoGDI1 promotes misfolding and degradation of the cytosolic geranylgeranylated pool of Rho GTPases while activating the remaining membrane-bound fraction. Because RhoGDI1 levels are limiting, and Rho proteins compete for binding to RhoGDI1, overexpression of an exogenous Rho GTPase displaces endogenous Rho proteins bound to RhoGDI1, inducing their degradation and inactivation. These results raise important questions about the conclusions drawn from studies that manipulate Rho protein levels. In many cases the response observed may arise not simply from the overexpression itself but from additional effects on the levels and activity of other Rho GTPases as a result of competition for binding to RhoGDI1; this may require a re-evaluation of previously published studies that rely exclusively on these techniques.	[Boulter, Etienne; Garcia-Mata, Rafael; Guilluy, Christophe; Dubash, Adi; Rossi, Guendalina; Brennwald, Patrick J.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burridge, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.		Guilluy, Christophe/Z-1015-2019; guilluy, christophe/C-6002-2014; Boulter, Etienne/R-1737-2016	Guilluy, Christophe/0000-0003-1141-0809; guilluy, christophe/0000-0003-1141-0809; Boulter, Etienne/0000-0001-6597-9086; Garcia-Mata, Rafael/0000-0002-7116-4411	National Institutes of Health [GM029860, GM054712]; Department of Defense [BC051092]; Susan Komen Foundation; AHA [5-40078, 0825333E]; Fondation pour la Recherche Medicale Fellowship; Allocation INSERM InCa/AVENIR [R08227AS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, R01GM054712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); AHA(American Heart Association); Fondation pour la Recherche Medicale Fellowship(Fondation pour la Recherche Medicale); Allocation INSERM InCa/AVENIR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lisa Sharek for her technical support, and Channing Der, Jim Bear and Chloe Feral for comments. This study was supported by National Institutes of Health Grants GM029860 (to K. B.) and GM054712 (to P. B.), a Department of Defense Breast Cancer Predoctoral Fellowship (BC051092 to A. D.), a Susan Komen Foundation Postdoctoral Fellowship and a AHA Beginning Grant in Aid (5-40078 to R. G. M.) and a Fondation pour la Recherche Medicale Fellowship (to E. B.), an AHA Postdoctoral Fellowship (0825333E to E. B.) and an Allocation INSERM InCa/AVENIR (R08227AS to E. B.).	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; [Anonymous], 1991, Methods Enzymol, V194, P1; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bielek H, 2009, CELL SIGNAL, V21, P1974, DOI 10.1016/j.cellsig.2009.09.008; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dransart E, 2005, J BIOL CHEM, V280, P4674, DOI 10.1074/jbc.M409741200; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; UEDA T, 1990, J BIOL CHEM, V265, P9373; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vouret-Craviari V, 2004, J CELL SCI, V117, P4559, DOI 10.1242/jcs.01331; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	28	232	237	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					477	U136		10.1038/ncb2049	http://dx.doi.org/10.1038/ncb2049			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20400958	Green Accepted, Green Submitted			2022-12-27	WOS:000277283700013
J	Borovina, A; Superina, S; Voskas, D; Ciruna, B				Borovina, Antonia; Superina, Simone; Voskas, Daniel; Ciruna, Brian			Vangl2 directs the posterior tilting and asymmetric localization of motile primary cilia	NATURE CELL BIOLOGY			English	Article							PLANAR CELL POLARITY; EMBRYONIC-DEVELOPMENT; CONVERGENT EXTENSION; KUPFFERS VESICLE; NODAL FLOW; ZEBRAFISH; DISEASE; GASTRULATION; MOVEMENTS; MORPHOGENESIS	Cilia are microtubule-based organelles that project into the extracellular space, function in the perception and integration of environmental cues(1), and regulate Hedgehog signal transduction(2). The emergent association of ciliary defects with diverse and pleiotropic human disorders(3,4) has fuelled investigation into the molecular genetic regulation of ciliogenesis. Although recent studies implicate planar cell polarity (PCP) in cilia formation, this conclusion is based on analyses of proteins that are not specific to, or downstream effectors of PCP signal transduction(5-10). Here we characterize zebrafish embryos devoid of all Vangl2 function(11), a core and specific component of the PCP signalling pathway. Using Arl13b-GFP as a live marker of the ciliary axoneme, we demonstrate that Vangl2 is not required for ciliogenesis. Instead, Vangl2 controls the posterior tilting of primary motile cilia lining the neurocoel, Kupffer's vesicle and pronephric duct. Furthermore, we show that Vangl2 is required for asymmetric localization of cilia to the posterior apical membrane of neuroepithelial cells. Our results indicate a and essential role for PCP in the asymmetric localization and orientation of motile primary cilia, establishing directional flow implicated in normal embryonic development and	[Borovina, Antonia; Superina, Simone; Voskas, Daniel; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Borovina, Antonia; Superina, Simone; Ciruna, Brian] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ciruna@sickkids.ca						Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Jessen JR, 2004, GENE EXPR PATTERNS, V4, P339, DOI 10.1016/j.modgep.2003.09.012; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Okabe N, 2008, DEV DYNAM, V237, P3602, DOI 10.1002/dvdy.21730; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; RIDA P, 2009, SEMIN CELL DEV BIOL; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	40	241	244	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					407	U242		10.1038/ncb2042	http://dx.doi.org/10.1038/ncb2042			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305649				2022-12-27	WOS:000276194600014
J	Ding, J; Huang, SL; Wu, SQ; Zhao, YJ; Liang, LH; Yan, MX; Ge, C; Yao, J; Chen, TY; Wan, DF; Wang, HY; Gu, JR; Yao, M; Li, JJ; Tu, H; He, XH				Ding, Jie; Huang, Shenglin; Wu, Shunquan; Zhao, Yingjun; Liang, Linhui; Yan, Mingxia; Ge, Chao; Yao, Jian; Chen, Taoyang; Wan, Dafang; Wang, Hongyang; Gu, Jianren; Yao, Ming; Li, Jinjun; Tu, Hong; He, Xianghuo			Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA	NATURE CELL BIOLOGY			English	Article							FOCAL-ADHESION KINASE; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN HEPATOCELLULAR-CARCINOMA; ALLELIC IMBALANCE; CLINICOPATHOLOGICAL SIGNIFICANCE; GENETIC ALTERATIONS; PROGNOSTIC VALUE; HETEROZYGOSITY; CANCER; IDENTIFICATION	Recurrent chromosomal aberrations are often observed in hepatocellular carcinoma (HCC), but little is known about the functional non-coding sequences, particularly microRNAs (miRNAs), at the chromosomal breakpoints in HCC. Here we show that 22 miRNAs are often amplified or deleted in HCC. MicroRNA-151 (miR-151), a frequently amplified miRNA on 8q24.3, is correlated with intrahepatic metastasis of HCC. We further show that miR-151, which is often expressed together with its host gene FAK, encoding focal adhesion kinase, significantly increases HCC cell migration and invasion in vitro and in vivo, mainly through miR-151-5p, but not through miR-151-3p. Moreover, miR-151 exerts this function by directly targeting RhoGDIA, a putative metastasis suppressor in HCC, thus leading to the activation of Rac1, Cdc42 and Rho GTPases. In addition, miR-151 can function synergistically with FAK to enhance HCC cell motility and spreading. Thus, our findings indicate that chromosome gain of miR-151 is a crucial stimulus for tumour invasion and metastasis of HCC.	[Ding, Jie; Huang, Shenglin; Wu, Shunquan; Zhao, Yingjun; Liang, Linhui; Ge, Chao; Yao, Jian; Wan, Dafang; Wang, Hongyang; Gu, Jianren; Li, Jinjun; Tu, Hong; He, Xianghuo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China; [Zhao, Yingjun; Yao, Jian] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Yan, Mingxia; Yao, Ming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Dept Expt Pathol, Shanghai 200032, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong 226200, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China.	xhhe@shsci.org	Huang, Shenglin/N-9472-2018; He, Xianghuo/I-1497-2014; Jian, YAO/AAT-4231-2021	Huang, Shenglin/0000-0003-1279-0794; He, Xianghuo/0000-0001-8872-668X; Jian, YAO/0000-0002-3746-1279; Tu, Hong/0000-0002-8298-5207				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Blackhall FH, 2004, LUNG CANCER, V46, P197, DOI 10.1016/j.lungcan.2004.04.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan KL, 2002, CANCER, V94, P3179, DOI 10.1002/cncr.10612; Chen YJ, 2000, GASTROENTEROLOGY, V119, P431, DOI 10.1053/gast.2000.9373; Chow VTK, 1998, GENOME, V41, P543, DOI 10.1139/gen-41-4-543; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dykema KJ, 2004, GENE CHROMOSOME CANC, V41, P390, DOI 10.1002/gcc.20090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang W, 2000, GENE CHROMOSOME CANC, V28, P269, DOI 10.1002/1098-2264(200007)28:3<269::AID-GCC4>3.3.CO;2-B; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Hammond C, 1999, HEPATOLOGY, V29, P1479, DOI 10.1002/hep.510290513; HE L, 2004, NAT REV GENET, V5, P522; Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Kahng YS, 2003, J GASTROEN HEPATOL, V18, P430, DOI 10.1046/j.1440-1746.2003.02997.x; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Koshikawa K, 2004, HEPATO-GASTROENTEROL, V51, P186; Lau SH, 2005, ACTA PHARMACOL SIN, V26, P659, DOI 10.1111/j.1745-7254.2005.00126.x; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Liew CT, 1999, INT J CANCER, V81, P319, DOI 10.1002/(SICI)1097-0215(19990505)81:3<319::AID-IJC1>3.0.CO;2-K; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maddala R, 2008, DEV BIOL, V315, P217, DOI 10.1016/j.ydbio.2007.12.039; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mihara M, 1999, BRIT J CANCER, V79, P164, DOI 10.1038/sj.bjc.6690027; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishimura T, 2005, GENE CHROMOSOME CANC, V42, P34, DOI 10.1002/gcc.20117; Okabe H, 2000, HEPATOLOGY, V31, P1073, DOI 10.1053/he.2000.6409; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parada LA, 1998, GENE CHROMOSOME CANC, V23, P26; Piao Z, 1999, BRIT J CANCER, V80, P850, DOI 10.1038/sj.bjc.6690431; Piao Z, 1998, CANCER LETT, V122, P201, DOI 10.1016/S0304-3835(97)00403-5; Pineau P, 1999, ONCOGENE, V18, P3127, DOI 10.1038/sj.onc.1202648; Ricketts SL, 2003, MOL CARCINOGEN, V36, P90, DOI 10.1002/mc.10101; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; von Sengbusch A, 2005, AM J PATHOL, V166, P585, DOI 10.1016/S0002-9440(10)62280-8; Wang G, 2001, GENE CHROMOSOME CANC, V31, P221, DOI 10.1002/gcc.1138; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Xu ZH, 2003, BIOCHEM BIOPH RES CO, V311, P1057, DOI 10.1016/j.bbrc.2003.10.109; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yeh SH, 2004, HEPATOLOGY, V40, P847, DOI 10.1002/hep.20409; Yeh SH, 2001, GASTROENTEROLOGY, V121, P699, DOI 10.1053/gast.2001.27211; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; Zhang LH, 2003, J CANCER RES CLIN, V129, P279, DOI 10.1007/s00432-002-0407-5; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang SH, 2005, WORLD J GASTROENTERO, V11, P3034, DOI 10.3748/wjg.v11.i20.3034; Zhu GN, 2004, WORLD J GASTROENTERO, V10, P1975	64	262	297	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					390	U208		10.1038/ncb2039	http://dx.doi.org/10.1038/ncb2039			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305651				2022-12-27	WOS:000276194600012
J	Singh, RK; Kabbaj, MHM; Paik, J; Gunjan, A				Singh, Rakesh Kumar; Kabbaj, Marie-Helene Miquel; Paik, Johanna; Gunjan, Akash			Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; S-PHASE; DNA-SYNTHESIS; CELL-CYCLE; RAD53 KINASE; H3 VARIANT; IN-VIVO; YEAST	Histone levels are tightly regulated to prevent harmful effects such as genomic instability and hypersensitivity to DNA-damaging agents due to the accumulation of these highly basic proteins when DNA replication slows down or stops. Although chromosomal histones are stable, excess (non-chromatin bound) histones are rapidly degraded in a Rad53 (radiation sensitive 53) kinase-dependent manner in Saccharomyces cerevisiae. Here we demonstrate that excess histones associate with Rad53 in vivo and seem to undergo modifications such as tyrosine phosphorylation and polyubiquitylation, before their proteolysis by the proteasome. We have identified the Tyr 99 residue of histone H3 as being critical for the efficient ubiquitylation and degradation of this histone. We have also identified the ubiquitin conjugating enzymes (E2) Ubc4 and Ubc5, as well as the ubiquitin ligase (E3) Tom1 (temperature dependent organization in mitotic nucleus 1), as enzymes involved in the ubiquitylation of excess histones. Regulated histone proteolysis has major implications for the maintenance of epigenetic marks on chromatin, genomic stability and the packaging of sperm DNA.	[Singh, Rakesh Kumar; Kabbaj, Marie-Helene Miquel; Paik, Johanna; Gunjan, Akash] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Gunjan, A (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA.	akash.gunjan@med.fsu.edu		Gunjan, Akash/0000-0001-8478-3978	Florida Department of Health [07BN-02]; NIH [R15GM079678-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079678] Funding Source: NIH RePORTER	Florida Department of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Diffley, D. Finley, M. Hochstrasser, S. Jentsch, N. Lowndes, C. Mann, H. Masumoto, M. A. Osley, R. Rothstein, D. Stern, D. Stillman, J. Svejstrup, A. Verreault and Y. Wang for strains and reagents, A. Verreault and D. Brown for critical reading of this manuscript, M. Abdul-Rauf for construction of the pYES2-HTH and pYES2-HTH-HHT2 plasmids, as well as the H4 mutants used in the Supplementary Information and undergraduate students S. Eckley and M. Gonzalez for technical assistance with the collection of many litres of yeast cultures for our experiments. We thank M. Blaber for assistance with the structural modelling of the Y 99 residue of histone H3, shown in Supplementary Information, Fig. S8. Research in AG's laboratory is supported by a Bankhead-Coley Cancer Research Program grant (07BN-02) from the Florida Department of Health and research in JP's laboratory is funded by a NIH grant (R15GM079678-01).	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; BONNER WM, 1988, BIOCHEMISTRY-US, V27, P6542, DOI 10.1021/bi00417a052; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; DAVIE JR, 1985, ANAL BIOCHEM, V144, P522, DOI 10.1016/0003-2697(85)90149-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Eriksson PR, 2005, MOL CELL BIOL, V25, P9127, DOI 10.1128/MCB.25.20.9127-9137.2005; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Gunjan A, 2006, CURR OPIN GENET DEV, V16, P112, DOI 10.1016/j.gde.2006.02.010; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HILT W, 1993, J BIOL CHEM, V268, P3479; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rajapurohitam V, 1999, DEV BIOL, V212, P217, DOI 10.1006/dbio.1999.9342; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SHAN XY, 1994, J CELL BIOL, V126, P853, DOI 10.1083/jcb.126.4.853; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; SPENCER F, 1990, GENETICS, V124, P237; Steger DJ, 1999, METHODS, V19, P410, DOI 10.1006/meth.1999.0877; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; TSVETKOV S, 1989, EXP CELL RES, V180, P94, DOI 10.1016/0014-4827(89)90215-2; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Utsugi T, 1999, GENE, V234, P285, DOI 10.1016/S0378-1119(99)00197-3; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wing SS, 1996, MOL CELL BIOL, V16, P4064; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; WUNSCH AM, 1989, J CELL PHYSIOL, V141, P97, DOI 10.1002/jcp.1041410115; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	65	144	147	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					925	U40		10.1038/ncb1903	http://dx.doi.org/10.1038/ncb1903			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578373	Green Accepted			2022-12-27	WOS:000268593200005
J	Cai, S; O'Connell, CB; Khodjakov, A; Walczak, CE				Cai, Shang; O'Connell, Christopher B.; Khodjakov, Alexey; Walczak, Claire E.			Chromosome congression in the absence of kinetochore fibres	NATURE CELL BIOLOGY			English	Article							NEWT LUNG-CELLS; CENP-E; MICROTUBULE ATTACHMENT; MAMMALIAN-CELLS; SPINDLE; MECHANISMS; CAPTURE; PROTEIN; METAPHASE; INSTABILITY	Proper chromosome congression (the process of aligning chromosomes on the spindle) contributes to accurate and faithful chromosome segregation. It is widely accepted that congression requires kinetochore fibres (K-fibres), microtubule bundles that extend from the kinetochores to spindle poles(1,2). Here, we demonstrate that chromosomes in human cells co-depleted of HSET (human kinesin-14)(3,4) and hNuf2 (human Ndc80/Hec1-complex component) 5 can congress to the metaphase plate in the absence of K-fibres. However, the chromosomes are not stably maintained at the metaphase plate under these conditions. Chromosome congression in HSET + hNuf2 co-depleted cells required the plus-end directed motor CENP-E (centromere protein E; kinesin-7 family member) 6, which has been implicated in the gliding of mono-oriented kinetochores alongside adjacent K-fibres(7). Thus, proper end-on attachment of kinetochores to microtubules is not necessary for chromosome congression. Instead, our data support the idea that congression allows unattached chromosomes to move to the middle of the spindle where they have a higher probability of establishing connections with both spindle poles. These bi-oriented connections are also used to maintain stable chromosome alignment at the spindle equator.	[Walczak, Claire E.] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; [Cai, Shang] Indiana Univ, Biochem Program, Bloomington, IN 47405 USA; [O'Connell, Christopher B.; Khodjakov, Alexey] New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; Wadsworth Center	Walczak, CE (corresponding author), Indiana Univ, Med Sci Program, Myers Hall 262,915 E 3rd St, Bloomington, IN 47405 USA.	cwalczak@indiana.edu		Cai, Shang/0000-0003-0630-7719	NIH [GM59618, GM59363, GM077911]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618, R01GM059363, F32GM077911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ems-McClung and J. Powers for discussions and critical comments on the manuscript, G. Fang for HURP antibodies, D. Compton for HSET constructs, B. Sullivan for the GFP-CENP A construct and T. Yen for the CENP-E antibody. S. C. is grateful to members of the Marine Biological Laboratory Physiology course for instruction in imaging and many thoughtful discussions. The Indiana University Bloomington Light Microscopy Imaging Center and Wadsworth Center's electron microscopy Core facility provided microscopy resources. This work was supported by NIH grants (GM59618) to C. E. W. and (GM59363) A. K; C. B. O. was supported by a Kirschstein- National Research Service Award post-doctoral fellowship (GM077911).	Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Heald Rebecca, 2009, P231, DOI 10.1007/978-0-387-69076-6_8; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Maiato H, 2004, CHROMOSOME RES, V12, P585, DOI 10.1023/B:CHRO.0000036587.26566.81; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; NICKLAS RB, 1992, J CELL SCI, V102, P681; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	30	118	120	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					832	U118		10.1038/ncb1890	http://dx.doi.org/10.1038/ncb1890			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19525938	Green Accepted			2022-12-27	WOS:000267603100011
J	Lee, TH; Tun-Kyi, A; Shi, R; Lim, J; Soohoo, C; Finn, G; Balastik, M; Pastorino, L; Wulf, G; Zhou, XZ; Lu, KP				Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping			Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance	NATURE CELL BIOLOGY			English	Article							PROLYL ISOMERASE PIN1; PROTEIN PIN2/TRF1; MOUSE CELLS; LENGTH; DISEASE; MITOSIS; BETA; RNA	Telomeres are essential for maintaining cellular proliferative capacity and their loss has been implicated in ageing. A key regulator in telomere maintenance is the telomeric protein TRF1, which was also identified as Pin2 in a screen for Pin1. Pin1 is a unique prolyl isomerase that regulates protein conformation and function after phosphorylation. However, little is known about the role of Pin1 in telomere regulation or the modulation of TRF1 by upstream signals. Here we identify TRF1 as a major conserved substrate for Pin1 during telomere maintenance and ageing. Pin1 inhibition renders TRF1 resistant to protein degradation, enhances TRF1 binding to telomeres, and leads to gradual telomere loss in human cells and in mice. Pin1-deficient mice also show widespread premature ageing phenotypes within just one generation, similar to those in telomerase-deficient mice after 4-5 consecutive generations. Thus, Pin1 is an essential regulator of TRF1 stability, telomere maintenance and ageing.	[Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, Boston, MA 02215 USA; [Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Biol Aging Program,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, 330 Brookline Ave,CLS 0408, Boston, MA 02215 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Lim, Jormay/A-7257-2011; Balastik, Martin/C-4410-2014; Wulf, Gerburg/AAS-6713-2021; Lee, Tae Ho/AAT-1721-2020	Lim, Jormay/0000-0001-7191-545X; Balastik, Martin/0000-0001-5833-9996; 	Human Frontiers Science Program Fellow; DOD Breast Cancer Research Program; NIH [K01, R01CA122434, R01GM058556, AG017870]; NATIONAL CANCER INSTITUTE [R01CA122434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017870] Funding Source: NIH RePORTER	Human Frontiers Science Program Fellow(Human Frontier Science Program); DOD Breast Cancer Research Program(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Frangioni and R. Bronson for assistance in determining bonerelated and ageing phenotypes in Pin1 knockout mice, and W. Hahn for TERT and TER expression vectors. J. L. is a Human Frontiers Science Program Fellow, C. Y. S. is a Predoctoral Fellow of the DOD Breast Cancer Research Program and L. P. is a recipient of a Mentored Research Scientist Development Award from the NIH (K01). The work was supported by NIH grants to X. Z. Z. (R01CA122434) and K. P. L. (R01GM058556 and AG017870).	Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Milyavsky M, 2003, CANCER RES, V63, P7147; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	87	89	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					97	U212		10.1038/ncb1818	http://dx.doi.org/10.1038/ncb1818			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19060891	Green Accepted			2022-12-27	WOS:000262157000017
J	Nilsson, J; Yekezare, M; Minshull, J; Pines, J				Nilsson, Jakob; Yekezare, Mona; Minshull, Jeremy; Pines, Jonathon			The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; CYCLIN-A; CHROMOSOME ALIGNMENT; MITOTIC CHECKPOINT; PROTEIN BUBR1; KINETOCHORES; BINDING; MAD2; MITOSIS; CELLS	The spindle assembly checkpoint (SAC) is required to block sister chromatid separation until all chromosomes are properly attached to the mitotic apparatus. The SAC prevents cells from entering anaphase by inhibiting the ubiquitylation of cyclin B1 and securin by the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase. The target of the SAC is the essential APC/C activator Cdc20. It is unclear how the SAC inactivates Cdc20 but most current models suggest that Cdc20 forms a stable complex with the Mad2 checkpoint protein. Here we show that most Cdc20 is not in a complex with Mad2; instead Mad2 is required for Cdc20 to form a complex with another checkpoint protein, BubR1. We further show that during the SAC, the APC/C ubiquitylates Cdc20 to target it for degradation. Thus, ubiquitylation of human Cdc20 is not required to release it from the checkpoint complex, but to degrade it to maintain mitotic arrest.	[Nilsson, Jakob; Yekezare, Mona; Pines, Jonathon] Wellcome CR UK Gurdon Inst, Cambridge CB2 1QN, England; [Nilsson, Jakob; Yekezare, Mona; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England; [Minshull, Jeremy] DNA 2 0 Inc, Menlo Pk, CA 94025 USA		Pines, J (corresponding author), Wellcome CR UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Pines, Jonathon/0000-0002-5227-6004; Nilsson, Jakob/0000-0003-4100-1125	Carlsberg Foundation; Danish Cancer Society; Yousef Jameel scholarship; Cancer Research UK [C29/A3211]	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Yousef Jameel scholarship(American University Cairo); Cancer Research UK(Cancer Research UK)	We thank Daisuke Izawa for pioneering APC3 and APC11 siRNA depletion, Paola Marco for help with the BubR1 constructs, Stephen Taylor, Gowei Fang and Andrea Musacchio for reagents, Athanassios Giannis for dimethylanastron, Mercedes Pardo and Lu Yu of the Mass Spectroscopy group at the Sanger Centre for mass spectroscopy, and Andrea Musacchio and members of our laboratory for helpful discussions. M.Y. is particularly grateful to Takahiro Matsusaka for help with microscopy and microinjection. J.N. was supported by fellowships from the Carlsberg Foundation and the Danish Cancer Society, M. Y. was supported by a Yousef Jameel scholarship. This work was supported by a Program Grant from Cancer Research UK to J.P. (C29/A3211).	Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; BRITO DA, 2008, J CELL BIOL; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027	37	227	236	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1411	U74		10.1038/ncb1799	http://dx.doi.org/10.1038/ncb1799			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18997788	Green Accepted			2022-12-27	WOS:000261261800011
J	Vitaliano-Prunier, A; Menant, A; Hobeika, M; Geli, V; Gwizdek, C; Dargemont, C				Vitaliano-Prunier, Adeline; Menant, Alexandra; Hobeika, Maria; Geli, Vincent; Gwizdek, Carole; Dargemont, Catherine			Ubiquitylation of the COMPASS component Swd2 links H2B ubiquitylation to H3K4 trimethylation	NATURE CELL BIOLOGY			English	Article							HISTONE-3 LYSINE-4 METHYLATION; TRANSCRIPTION TERMINATION; MOLECULAR RECOGNITION; STRUCTURAL BASIS; PROTEIN WDR5; COMPLEX; UBIQUITINATION; RECRUITMENT; SET1; MONOUBIQUITINATION	Mono-ubiquitylation of histone H2B correlates with transcriptional activation and is required for di- and trimethylation at Lys 4 on the histone H3 tail (H3K4) by the SET1/COMPASS methyltransferase complex through a poorly characterized trans-tail pathway(1,2). Here we show that mono-ubiquitylation of histone H2B promotes ubiquitylation at Lys 68 and Lys 69 of Swd2, the essential component of SET1/COMPASS in Saccharomyces cerevisiae. We found that Rad6/Bre1 ubiquitylation enzymes responsible for H2B ubiquitylation also participate directly in Swd2 modification. Preventing Swd2 or H2B ubiquitylation did not affect Set1 stability, interaction of Swd2 with Set1 or the ability of Swd2 to interact with chromatin. However, we found that mutation of Lys 68 and Lys 69 of Swd2 markedly reduced trimethylation, and to a lesser extent dimethylation, of H3K4 at the 5'- end of transcribing genes without affecting monomethylation. This effect results from the ability of Swd2 ubiquitylation to control recruitment of Spp1, a COMPASS subunit necessary for trimethylation. Our results further indicate that Swd2 is a major H3-binding component of COMPASS. Swd2 thus represents a key factor that mediates crosstalk between H2B ubiquitylation and H3K4 trimethylation on chromatin.	[Vitaliano-Prunier, Adeline; Menant, Alexandra; Hobeika, Maria; Gwizdek, Carole; Dargemont, Catherine] Univ Paris 06, Univ Paris 07, Inst Jacques Monod, CNRS, F-75251 Paris 05, France; [Geli, Vincent] CNRS, Inst Biol Struct & Microbiol, UPR3081, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Gwizdek, C (corresponding author), Univ Paris 06, Univ Paris 07, Inst Jacques Monod, CNRS, 2 Pl Jussieu,Tour 43, F-75251 Paris 05, France.	gwizdek@ijm.jussieu.fr; dargemont@ijm.jussieu.fr			Agence Nationale pour la Recherche [BLAN06-1_ 134099]; Ligue contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Association de Recherche contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche; Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We would like to thank P. Nagy for antibodies, G. Divita for help with molecular modelling and V. Oreal for reagents. We are most grateful to S. Dokudovskaya and A. Morillon for very helpful discussions and critical reading of the manuscript. This study was funded by grants from the Agence Nationale pour la Recherche (grant BLAN06-1_ 134099 to CD) and the Ligue contre le Cancer (C. D. and V. G. laboratories are 'Equipes labellisees'). A. V. P. and M. H. are supported by the Ministere de l'Enseignement Superieur et de la Recherche and the Association de Recherche contre le Cancer respectively.	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	32	76	76	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1365	U269		10.1038/ncb1796	http://dx.doi.org/10.1038/ncb1796			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849979				2022-12-27	WOS:000260586700020
J	Ukai-Tadenuma, M; Kasukawa, T; Ueda, HR				Ukai-Tadenuma, Maki; Kasukawa, Takeya; Ueda, Hiroki R.			Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks	NATURE CELL BIOLOGY			English	Article							RECEPTOR REV-ERBA; GENE-EXPRESSION; MOUSE-LIVER; CKI-DELTA; COMPONENT; PROTEINS; MUTATION; PAR; CLONING; CRYPTOCHROMES	Mammalian circadian clocks consist of complex regulatory loops mediated through-at least-morning, daytime and night-time DNA elements. To prove the transcriptional logic of mammalian clocks, we developed an in cellulo mammalian cell-culture system that allowed us to design and implement artificial transcriptional circuits. Here we show that morning activation and night-time repression can yield the transcriptional output during the daytime, and similarly that daytime activation and morning repression can yield night-time transcriptional output. We also observed that the diverse transcriptional outputs of other phases can be generated through the expression of simple combinations of transcriptional activators and repressors. These results reveal design principles not only for understanding the continuous transcriptional outputs observed in vivo but also for the logical construction of artificial promoters working at novel phases. Logical synthesis of artificial circuits, with an identified structure and observed dynamics, provides an alternative strategy applicable to the investigation of complex biological systems.	[Ukai-Tadenuma, Maki; Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kasukawa, Takeya; Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Ueda, HR (corresponding author), RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Kasukawa, Takeya/N-5070-2015; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Ueda, Hiroki R/0000-0001-8342-9176				Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Dunlap JC, 2007, COLD SH Q B, V72, P57; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Falvey E, 1996, BIOL CHEM, V377, P797; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojima S, 2003, BIOCHEM BIOPH RES CO, V301, P1, DOI 10.1016/S0006-291X(02)02938-8; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Okano T, 2001, NEUROSCI LETT, V300, P111, DOI 10.1016/S0304-3940(01)01581-6; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	81	81	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1154	1163		10.1038/ncb1775	http://dx.doi.org/10.1038/ncb1775			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18806789				2022-12-27	WOS:000259682900009
J	Candeias, MM; Malbert-Colas, L; Powell, DJ; Daskalogianni, C; Maslon, MM; Naski, N; Bourougaa, K; Calvo, F; Fahraeus, R				Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin			p53 mrNA controls p53 activity by managing Mdm2 functions	NATURE CELL BIOLOGY			English	Article							PROTEIN INTERACTIONS; TRANSACTIVATION; TRANSLATION; MUTATIONS; STABILITY; APOPTOSIS; DOMAIN; PHOSPHORYLATION; EXPRESSION; COMPLEXES	The E3 ubiquitin ligase Mdm2 is a focal regulator of p53 tumour suppressor activity. It binds p53, promoting its polyubiquitination and degradation, and also controls p53 synthesis. However, it is not known how this dual function of Mdm2 on p53 synthesis and degradation is achieved. Here we show that the p53 mRNA region encoding the Mdm2-binding site interacts directly with the RING domain of Mdm2. This impairs the E3 ligase activity of Mdm2 and promotes p53 mRNA translation. We also show that introduction of cancer-derived single silent point-mutations in the p53 mRNA weakens its binding to Mdm2 and results in reduced p53 activity. These data are consistent with a mechanism by which changes in silent nucleotides can affect the function of the encoded protein, and indicate that Mdm2-mediated control of p53 synthesis and degradation has evolved in the p53 mRNA sequence and its encoded amino acids.	[Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin] Hop St Louis, Inst Genet Mol, INSERM, U716, F-75010 Paris, France; [Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Maslon, Magda M.; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fahraeus, Robin] Univ Paris, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fahraeus, R (corresponding author), Hop St Louis, Inst Genet Mol, INSERM, U716, 27 Rue Juliette Dodu, F-75010 Paris, France.	robinfahraeus@yahoo.co.uk	Maslon, Magdalena/AAC-4790-2022; Maslon, Magdalena/AAB-9609-2020; fahraeus, robin/K-8726-2014; Powell, Darren Jmaes/GOE-5236-2022	Powell, Darren Jmaes/0000-0001-9439-5880; Maslon, Magdalena/0000-0002-1050-1306; calvo, fabien/0000-0002-0298-7633; Candeias, Marco/0000-0002-5731-0179; daskalogianni, chrysoula/0000-0001-8177-3141; Bourougaa, Karima/0000-0003-0339-962X; , robin/0000-0003-0402-8492	AICR; AVENIR/INSERM; La Ligue Contre le Cancer; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/16697/2004]	AICR; AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	This work was supported by AICR, AVENIR/INSERM and La Ligue Contre le Cancer. M.M.C. was supported by grant SFRH/BD/16697/2004 from the Fundacao para a Ciencia e a Tecnologia of Portugal. Bacterial purified hMdm2 was a gift from D. Xirodimas and we are thankful to Chris M. Brown and Nattanan Panjaworayan, Dunedin, New Zealand for providing the TriFC constructs. Anti-p53 and anti-Mdm2 antibodies were a gift from B. Vojtesek. Flow cytometry and immunofluorescence microscopy experiments were performed at the Imagery Department of the Institut Universitaire d'Hematologie-IFR105.	Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Cheng TH, 2007, MOL CELL BIOL, V27, P111, DOI 10.1128/MCB.00235-06; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fahraeus R, 2005, NAT REV MOL CELL BIO, V6, P263, DOI 10.1038/nrm1590; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayes VM, 1999, DIAGN MOL PATHOL, V8, P2, DOI 10.1097/00019606-199903000-00002; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Jin SK, 2001, J CELL SCI, V114, P4139; JUVEN T, 1993, ONCOGENE, V8, P3411; KANJILAL S, 1995, CANCER RES, V55, P3604; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lima SMB, 2004, EUR J BIOCHEM, V271, P135, DOI 10.1046/j.1432-1033.2003.03911.x; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Perry ME, 2004, MOL CANCER RES, V2, P9; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	31	168	173	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1098	1105		10.1038/ncb1770	http://dx.doi.org/10.1038/ncb1770			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160491				2022-12-27	WOS:000258910400016
J	Crasta, K; Lim, HH; Giddings, TH; Winey, M; Surana, U				Crasta, Karen; Lim, Hong Hwa; Giddings, Thomas H., Jr.; Winey, Mark; Surana, Uttam			Inactivation of Cdh1 by synergistic action of Cdk1 and polo kinase is necessary for proper assembly of the mitotic spindle	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST; CENTROSOME; CYCLIN; PHOSPHORYLATION; MITOSIS; PLK1; SEPARATION; MACHINERY; REVEALS; COMPLEX	Separation of duplicated centrosomes (spindle-pole bodies or SPBs in yeast) is a crucial step in the biogenesis of the mitotic spindle. In vertebrates, centrosome separation requires the BimC family kinesin Eg5 and the activities of Cdk1 and polo kinase; however, the roles of these kinases are not fully understood. In Saccharomyces cerevisiae, SPB separation also requires activated Cdk1 and the plus-end kinesins Cin8 (homologous to vertebrate Eg5) and Kip1. Here we report that polo kinase has a role in the separation of SPBs. We show that adequate accumulation of Cin8 and Kip1 requires inactivation of the anaphase-promoting complex-activator Cdh1 through sequential phosphorylation by Cdk1 and polo kinase. In this process, Cdk1 functions as a priming kinase in that Cdk1-mediated phosphorylation creates a binding site for polo kinase, which further phosphorylates Cdh1. Thus, Cdh1 inactivation through the synergistic action of Cdk1 and polo kinase provides a new model for inactivation of cell-cycle effectors.	[Crasta, Karen; Lim, Hong Hwa; Surana, Uttam] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Giddings, Thomas H., Jr.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Colorado System; University of Colorado Boulder	Surana, U (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbucs@imcb.a-star.edu.sg	Crasta, Karen C/F-8752-2015; Surana, Uttam/H-1142-2011	Lim, Hong Hwa/0000-0002-0951-7220; Surana, Uttam/0000-0002-4785-6514; Crasta, Karen/0000-0001-9849-6080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051312, R01 GM051312-14, GM51312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartholomew CR, 2001, MOL CELL BIOL, V21, P4949, DOI 10.1128/MCB.21.15.4949-4959.2001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; Dai W, 2002, ONCOGENE, V21, P6195, DOI 10.1038/sj.onc.1205710; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	28	51	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					665	675		10.1038/ncb1729	http://dx.doi.org/10.1038/ncb1729			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18500339	Green Accepted			2022-12-27	WOS:000256350100013
J	Al-Nedawi, K; Meehan, B; Micallef, J; Lhotak, V; May, L; Guha, A; Rak, J				Al-Nedawi, Khalid; Meehan, Brian; Micallef, Johann; Lhotak, Vladimir; May, Linda; Guha, Abhijit; Rak, Janusz			Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells	NATURE CELL BIOLOGY			English	Article							ACTIVATED PLATELETS; CANCER; EXPRESSION; ANGIOGENESIS	Aggressive human brain tumours ( gliomas) often express a truncated and oncogenic form of the epidermal growth factor receptor, known as EGFRvIII. Within each tumour only a small percentage of glioma cells may actually express EGFRvIII; however, most of the cells exhibit a transformed phenotype(1). Here we show that EGFRvIII can be 'shared' between glioma cells by intercellular transfer of membrane-derived microvesicles ('oncosomes'). EGFRvIII expression in indolent glioma cells stimulates formation of lipid-raft related microvesicles containing EGFRvIII. Microvesicles containing this receptor are then released to cellular surroundings and blood of tumour-bearing mice, and can merge with the plasma membranes of cancer cells lacking EGFRvIII. This event leads to the transfer of oncogenic activity, including activation of transforming signalling pathways ( MAPK and Akt), changes in expression of EGFRvIII-regulated genes (VEGF, Bcl- x(L), p27), morphological transformation and increase in anchorage-independent growth capacity. Thus, membrane microvesicles of cancer cells can contribute to a horizontal propagation of oncogenes and their associated transforming phenotype among subsets of cancer cells.	[Al-Nedawi, Khalid; Meehan, Brian; Rak, Janusz] McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Lhotak, Vladimir; May, Linda] McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; [Micallef, Johann; Guha, Abhijit] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatts Brain Tumor Ctr, Toronto, ON M5G 1L7, Canada	McGill University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rak, J (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, 4060 Ste Catherine W, Montreal, PQ H3Z 2Z3, Canada.	janusz.rak@mcgill.ca		Rak, Janusz/0000-0002-2912-5566; , Khalid/0000-0001-5140-3799				Al-Nedawi K, 2005, ARTERIOSCL THROM VAS, V25, P1744, DOI 10.1161/01.ATV.0000172007.86541.76; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cavenee WK, 2002, CARCINOGENESIS, V23, P683, DOI 10.1093/carcin/23.5.683; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; VILORIAPETIT AM, 1997, AM J PATHOL, V151, P1523; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	14	1341	1421	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					619	U24		10.1038/ncb1725	http://dx.doi.org/10.1038/ncb1725			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425114				2022-12-27	WOS:000255502400019
J	Mitchell, KJ; Pannerec, A; Cadot, B; Parlakian, A; Besson, V; Gomes, ER; Marazzi, G; Sassoon, DA				Mitchell, Kathryn J.; Pannerec, Alice; Cadot, Bruno; Parlakian, Ara; Besson, Vanessa; Gomes, Edgar R.; Marazzi, Giovanna; Sassoon, David A.			Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; STEM-CELLS; SELF-RENEWAL; MYOGENIC SPECIFICATION; MORPHOMETRIC-ANALYSIS; INTERSTITIAL SPACES; BONE-MARROW; PEG3/PW1; EXPRESSION; DISTINCT	Satellite cells are resident myogenic progenitors in postnatal skeletal muscle involved in muscle postnatal growth and adult regenerative capacity. Here, we identify and describe a population of muscle-resident stem cells, which are located in the interstitium, that express the cell stress mediator PW1 but do not express other markers of muscle stem cells such as Pax7. PW1(+)/Pax7(-) interstitial cells (PICs) are myogenic in vitro and efficiently contribute to skeletal muscle regeneration in vivo as well as generating satellite cells and PICs. Whereas Pax7 mutant satellite cells show robust myogenic potential, Pax7 mutant PICs are unable to participate in myogenesis and accumulate during postnatal growth. Furthermore, we found that PICs are not derived from a satellite cell lineage. Taken together, our findings uncover a new and anatomically identifiable population of muscle progenitors and define a key role for Pax7 in a non-satellite cell population during postnatal muscle growth.	[Mitchell, Kathryn J.; Pannerec, Alice; Cadot, Bruno; Parlakian, Ara; Besson, Vanessa; Gomes, Edgar R.; Marazzi, Giovanna; Sassoon, David A.] Univ Paris 06, INSERM, Myol Grp, F-75634 Paris, France; [Cadot, Bruno; Gomes, Edgar R.] Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sassoon, DA (corresponding author), Univ Paris 06, INSERM, Myol Grp, F-75634 Paris, France.	david.a.sassoon@gmail.com	CADOT, bruno/E-1710-2013; Gomes, Edgar/ABH-7441-2020; SASSOON, David A/G-2502-2013; Gomes, Edgar r/D-9000-2015	CADOT, bruno/0000-0002-1888-3898; Gomes, Edgar/0000-0002-6941-4872; SASSOON, David A/0000-0001-6074-048X; Gomes, Edgar r/0000-0002-6941-4872; ARA, PARLAKIAN/0000-0002-0928-2185; Marazzi, giovanna/0000-0002-5388-1038	NIH [NCI PO1 CA80058-06]; French Ministry of Research; Muscular Dystrophy Association of America; INSERM; Fondation pour la Recherche Medicale (FRM); European Community [Health-F5-2009-223098]; Association Francaise contre les Myopathies (AFM); NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Muscular Dystrophy Association of America(Muscular Dystrophy Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Community(European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully thank F. Relaix for fruitful discussions and critical reading of the manuscript. We thank A. Galy, E. Negroni and L. Arandel for technical advice and C. Blanc (Cytometrie en Flux platform, Institut Federatif de Recherche 113) for FACs assistance. This work was supported by a grant from the NIH (NCI PO1 CA80058-06, subproject 3), a French Ministry of Research 'Chaire d'Excellence' to D. S. and the Muscular Dystrophy Association of America to D. S. and E. R. G. K. M. is a recipient of an INSERM 'contrat de jeunes chercheurs'. B. C. is a recipient of a grant from Fondation pour la Recherche Medicale (FRM). E. R. G. is supported in part by the Inserm Avenir Program. This work benefited from funding from the European Community's Seventh Framework Programme project OPTISTEM (Optimization of stem cell therapy for degenerative epithelial and muscle diseases contract number Health-F5-2009-223098). The Myology Group is the beneficiary of a Strategic Plan Support from the Association Francaise contre les Myopathies (AFM) and is affiliated with the Institute of Myology/Association Institut Myologie.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Asakura A, 2003, TRENDS CARDIOVAS MED, V13, P123, DOI 10.1016/S1050-1738(03)00024-0; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; CAMPION D R, 1979, Journal of Animal Science, V48, P1109; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Jennifer C J, 2003, Reprod Biol Endocrinol, V1, P101, DOI 10.1186/1477-7827-1-101; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Endo T, 2007, REGEN MED, V2, P243, DOI 10.2217/17460751.2.3.243; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; HUGHES DS, 1992, DEV DYNAM, V193, P175, DOI 10.1002/aja.1001930209; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mansouri A, 1996, DEVELOPMENT, V122, P831; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; MouraNeto V, 1996, GENE, V168, P261, DOI 10.1016/0378-1119(95)00789-X; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; ONTELL M, 1988, AM J ANAT, V181, P279, DOI 10.1002/aja.1001810306; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SAX CM, 1989, GENE, V78, P235, DOI 10.1016/0378-1119(89)90226-6; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; TAMAKI T, 2008, STEM CELLS DEV; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	61	297	303	2	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					257	U56		10.1038/ncb2025	http://dx.doi.org/10.1038/ncb2025			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118923	Green Published			2022-12-27	WOS:000275054200011
J	Qiu, T; Wu, XW; Zhang, FJ; Clemens, TL; Wan, M; Cao, X				Qiu, Tao; Wu, Xiangwei; Zhang, Fengjie; Clemens, Thomas L.; Wan, Mei; Cao, Xu			TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling	NATURE CELL BIOLOGY			English	Article							PARATHYROID-HORMONE RECEPTOR; GROWTH-FACTOR-BETA; PROTEIN-COUPLED RECEPTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; (PTH)/PTH-RELATED PEPTIDE; EXPRESSION CLONING; CRYSTAL-STRUCTURE; LINKED RECEPTOR; CELLS; INTERNALIZATION	Parathyroid hormone (PTH) regulates calcium homeostasis and bone metabolism by activating PTH type I receptor (PTH1R). Here we show that transforming growth factor (TGF)-beta type II receptor (T beta RII) forms an endocytic complex with PTH1R in response to PTH and regulates signalling by PTH and TGF-beta. T beta RII directly phosphorylates the PTH1R cytoplasmic domain, which modulates PTH-induced endocytosis of the PTH1R-T beta RII complex. Deletion of T beta RII in osteoblasts increases the cell-surface expression of PTH1R and augments PTH signalling. Conditional knockout of T beta RII in osteoblasts in mice results in a high bone mass with increased trabecular bone and decreased cortical bone, similar to the bone phenotype in mice expressing a constitutively active PTH1R. Disruption of PTH signalling by injection of PTH(7-34) or ablation of PTH1R rescues the bone phenotype of T beta RII knockout mice. These studies reveal a previously unrecognized function for T beta RII and a mechanism for integration of PTH and local growth factor at the membrane receptor level.	[Qiu, Tao; Wu, Xiangwei; Clemens, Thomas L.; Wan, Mei; Cao, Xu] Johns Hopkins Med Inst, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Wu, Xiangwei; Zhang, Fengjie] Shihezi Univ, Sch Med, Shihezi 832000, Xinjiang, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Shihezi University	Cao, X (corresponding author), Johns Hopkins Med Inst, Dept Orthopaed Surg, 720 Rutland Ave,Ross Bldg 232, Baltimore, MD 21205 USA.	xcao11@jhmi.edu			National Institutes of Health [DK080898, DK057501]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057501, Z01DK057501, R01DK080898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge Stephen Michnick and Odyssey Thera, Inc., for YFP-based PCA constructs; Harold Moses for T beta RH<SUP>flox/flox</SUP> mice; Henry Kronenberg for PTH1R<SUP>flox/flox</SUP> mice; Lijuan Pang and Hui Deng for technical assistance; Robert Cole and Tatiana Boronina for mass spectrometry analysis; and Elaine Henz for editorial service. This work was supported by National Institutes of Health grant DK080898 and DK057501 (X. C).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hardie LJ, 1998, CYTOKINE, V10, P555, DOI 10.1006/cyto.1997.0334; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Juppner H, 1994, Curr Opin Nephrol Hypertens, V3, P371; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Laing KJ, 1999, VET IMMUNOL IMMUNOP, V72, P45, DOI 10.1016/S0165-2427(99)00116-6; Langub MC, 2003, ENDOCRINOLOGY, V144, P1135, DOI 10.1210/en.2002-221026; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Potts JT, 1997, OSTEOPOROSIS INT, V7, P169, DOI 10.1007/BF03194366; Qiu T, 2007, EMBO J, V26, P346, DOI 10.1038/sj.emboj.7601499; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reinecke M, 1998, INT REV CYTOL, V183, P1, DOI 10.1016/S0074-7696(08)60142-4; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; SCHIPANI E, 1993, ENDOCRINOLOGY, V132, P2157, DOI 10.1210/en.132.5.2157; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Sebastian EM, 2008, BONE, V43, P1022, DOI 10.1016/j.bone.2008.07.250; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhan Y, 2000, FISH SHELLFISH IMMUN, V10, P309, DOI 10.1006/fsim.1999.0239; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	53	103	110	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					224	U29		10.1038/ncb2022	http://dx.doi.org/10.1038/ncb2022			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20139972	Green Accepted			2022-12-27	WOS:000275054200008
J	Joe, AWB; Yi, L; Natarajan, A; Le Grand, F; So, L; Wang, J; Rudnicki, MA; Rossi, FMV				Joe, Aaron W. B.; Yi, Lin; Natarajan, Anuradha; Le Grand, Fabien; So, Leslie; Wang, Joy; Rudnicki, Michael A.; Rossi, Fabio M. V.			Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; SATELLITE-CELL; STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION; REGENERATION; MYOFIBROBLASTS; IDENTIFICATION; PROLIFERATION; HETEROGENEITY	Efficient tissue regeneration is dependent on the coordinated responses of multiple cell types. Here, we describe a new subpopulation of fibro/adipogenic progenitors (FAPs) resident in muscle tissue but arising from a distinct developmental lineage. Transplantation of purified FAPs results in the generation of ectopic white fat when delivered subcutaneously or intramuscularly in a model of fatty infiltration, but not in healthy muscle, suggesting that the environment controls their engraftment. These cells are quiescent in intact muscle but proliferate efficiently in response to damage. FAPs do not generate myofibres, but enhance the rate of differentiation of primary myogenic progenitors in co-cultivation experiments. In summary, FAPs expand upon damage to provide a transient source of pro-differentiation signals for proliferating myogenic progenitors.	[Joe, Aaron W. B.; Yi, Lin; Natarajan, Anuradha; So, Leslie; Wang, Joy; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Joe, Aaron W. B.] Univ British Columbia, MD PhD Program, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Rossi, Fabio M. V.] Univ British Columbia, Dept Med Genet, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Le Grand, Fabien; Rudnicki, Michael A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fabio@brc.ubc.ca	Le Grand, Fabien/D-8803-2019; Rossi, Fabio MV/B-5587-2013	Le Grand, Fabien/0000-0002-7843-3899; Rossi, Fabio MV/0000-0002-0368-2620; Rudnicki, Michael/0000-0002-3866-5249	Foundation for Cell therapy (Jesse's Journey); Canadian Institute for Health Research (CIHR) [MOP-97856, CSB-94219, MUS-94019]; Michael Smith Foundation for Health Research; Heart and Stroke Foundation of Canada; NSERC [PGSD2-362406-2008]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Foundation for Cell therapy (Jesse's Journey); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Qiao, C. Chang, J. M. Joe, the BRC Animal Facility, the BRC Core Staff and A. Johnson and J. Duenas of the UBC FACS Facility for their expert technical assistance. We are also grateful to A. Uezumi for advice on modelling fatty degeneration in murine skeletal muscle. This research was supported by grants from The Foundation for Cell therapy (Jesse's Journey) and The Canadian Institute for Health Research (CIHR MOP-97856; CSB-94219; MUS-94019) to F. M. V. R. who holds a Canada Research Chair in Regenerative medicine and is a fellow of the Michael Smith Foundation for Health Research. A. W. B. J. is supported by a fellowship from CIHR, A. N. from the Heart and Stroke Foundation of Canada and L. S. from NSERC (PGSD2-362406-2008).	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Goss R., 1992, WOUND HEALING BIOCHE, P20; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Harris JB, 2003, J ANAT, V202, P363, DOI 10.1046/j.1469-7580.2003.00171.x; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; LIPTON BH, 1979, MUSCLE REGENERATION, P31; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216	46	965	983	8	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					153	U144		10.1038/ncb2015	http://dx.doi.org/10.1038/ncb2015			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081841	Green Accepted			2022-12-27	WOS:000274139400009
J	Uezumi, A; Fukada, S; Yamamoto, N; Takeda, S; Tsuchida, K				Uezumi, Akiyoshi; Fukada, So-ichiro; Yamamoto, Naoki; Takeda, Shin'ichi; Tsuchida, Kunihiro			Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR; INSULIN-RESISTANCE; STEM-CELLS; RECEPTOR; DIFFERENTIATION; POPULATION; ALPHA; REGENERATION; PURIFICATION; FIBROBLASTS	Ectopic fat deposition in skeletal muscle is closely associated with several disorders, however, the origin of these adipocytes is not clear, nor is the mechanism of their formation. Satellite cells function as adult muscle stem cells but are proposed to possess multipotency. Here, we identify PDGFR alpha(+) mesenchymal progenitors as being distinct from satellite cells and located in the muscle interstitium. We show that, of the muscle-derived cell populations, only PDGFRa+ cells show efficient adipogenic differentiation both in vitro and in vivo. Reciprocal transplantation between regenerating and degenerating muscles, and co-culture experiments revealed that adipogenesis of PDGFR alpha(+) cells is strongly inhibited by the presence of satellite cell-derived myofibres. These results suggest that PDGFR alpha(+) mesenchymal progenitors are the major contributor to ectopic fat cell formation in skeletal muscle, and emphasize that interaction between muscle cells and PDGFRa+ mesenchymal progenitors, not the fate decision of satellite cells, has a considerable impact on muscle homeostasis.	[Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, Aichi 4701192, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Lab Mol Biol & Histochem, Joint Res Lab, Aichi 4701192, Japan; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan	Fujita Health University; Osaka University; Fujita Health University; National Center for Neurology & Psychiatry - Japan	Uezumi, A (corresponding author), Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, 1-98 Dengakugakubo, Aichi 4701192, Japan.	uezumi@fujita-hu.ac.jp	Yamamoto, Naoki/L-2603-2019; Uezumi, Akiyoshi/ABF-7359-2020; Fukada, So-ichiro/AAI-9151-2020; Tsuchida, Kunihiro/A-4501-2012	Uezumi, Akiyoshi/0000-0003-4294-0116; Fukada, So-ichiro/0000-0003-4051-5108; Tsuchida, Kunihiro/0000-0002-3983-5756	JSPS KAKENHI [18890216]; MEXT KAKENHI [21790884, H20-018]; Ministry of Health, Labour and Welfare [20B-13]; Grants-in-Aid for Scientific Research [21300149] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Miura, M. Nakatani and T. Sato for technical assistance, F. Rossi for providing DyLight 649-conjugated rat anti-integrin alpha 7, A. Miyajima for providing a rat anti-Dlk1 antibody and N. Hashimoto for providing a rabbit anti-myogenin antibody. This work was supported by JSPS KAKENHI (18890216; to A. U.), MEXT KAKENHI (21790884; to A. U.), a research grant (H20-018) on psychiatric and neurological diseases and mental health and a research grant (20B-13) for nervous and mental disorders from the Ministry of Health, Labour and Welfare.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Banker B.Q., 2004, MYOLOGY, V3rd ed., P691; Bischoff R., 2004, MYOLOGY, V1, P66; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Carpenter S., 2001, PATHOLOGY SKELETAL M, P314; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2008, EXP CELL RES, V314, P193, DOI 10.1016/j.yexcr.2007.09.020; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Greco AV, 2002, DIABETES, V51, P144, DOI 10.2337/diabetes.51.1.144; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; SHINBROT E, 1994, DEV DYNAM, V199, P169, DOI 10.1002/aja.1001990302; Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128	36	774	788	8	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					143	U116		10.1038/ncb2014	http://dx.doi.org/10.1038/ncb2014			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081842				2022-12-27	WOS:000274139400008
J	Merte, J; Jensen, D; Wright, K; Sarsfield, S; Wang, YS; Schekman, R; Ginty, DD				Merte, Janna; Jensen, Devon; Wright, Kevin; Sarsfield, Sarah; Wang, Yanshu; Schekman, Randy; Ginty, David D.			Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure	NATURE CELL BIOLOGY			English	Article							CONVERGENT EXTENSION; MEMBRANE-PROTEINS; EMBRYONIC-DEVELOPMENT; COPII VESICLES; MOUSE STRAINS; GENETIC-BASIS; HAIR-CELLS; DEFECTS; MUTATION; COAT	Craniorachischisis is a rare but severe birth defect that results in a completely open neural tube. Mouse mutants in planar cell polarity (PCP) signalling components have deficits in the morphological movements of convergent extension that result in craniorachischisis. Using a forward genetic screen in mice, we identified Sec24b, a cargo-sorting member of the core complex of the endoplasmic reticulum (ER)-to-Golgi transport vesicle COPII, as critical for neural tube closure. Sec24b(Y613) mutant mice exhibit craniorachischisis, deficiencies in convergent extension and other PCP-related phenotypes. Vangl2, a key component of the PCP-signalling pathway critical for convergent extension, is selectively sorted into COPII vesicles by Sec24b. Moreover, Sec24b(Y613) genetically interacts with a loss-of-function Vangl2 allele (Vangl2(LP)), causing a marked increase in the prevalence of spina bifida. Interestingly, the Vangl2 looptail point mutants Vangl2(D255E) and Vangl2(S464N), known to cause defects in convergent extension, fail to sort into COPII vesicles and are trapped in the ER. Thus, during COPII vesicle formation, Sec24b shows cargo specificity for a core PCP component, Vangl2, of which proper ER-to-Golgi transport is essential for the establishment of PCP, convergent extension and closure of the neural tube.	[Merte, Janna; Wright, Kevin; Sarsfield, Sarah; Ginty, David D.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Merte, Janna; Wright, Kevin; Sarsfield, Sarah; Wang, Yanshu; Ginty, David D.] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Jensen, Devon; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jensen, Devon; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wang, Yanshu] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Sarsfield, Sarah/Y-5113-2019	Wright, Kevin/0000-0001-5094-5270	NIH [NS34814]; Johns Hopkins Mind Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R37NS034814, R29NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Mind Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Nathans, T. Makita, A. Kolodkin, and members of the Ginty laboratory for discussions and critical reading of this manuscript; P. Gros for providing the Vangl2 antibody; J. C. Fromme, B. Kleizen and A. Schindler for Anti-Sec13 and AntiSec-22 antiserum; C. Chan for recombinant Sec23A/Sec24A and Sec23A/Sec24C; B. Yang and Y. Wu for excellent technical help. This work was funded by NIH grants NS34814 (D.D.G.) and the Johns Hopkins Mind Brain Institute. D.D.G. and R.S. are investigators of the Howard Hughes Medical Institute.	Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; De Marco P, 2006, NEUROGENETICS, V7, P201, DOI 10.1007/s10048-006-0052-2; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	32	155	158	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					41	U94		10.1038/ncb2002	http://dx.doi.org/10.1038/ncb2002			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966784	Green Accepted			2022-12-27	WOS:000272973800010
J	Hase, K; Kimura, S; Takatsu, H; Ohmae, M; Kawano, S; Kitamura, H; Ito, M; Watarai, H; Hazelett, CC; Yeaman, C; Ohno, H				Hase, Koji; Kimura, Shunsuke; Takatsu, Hiroyuki; Ohmae, Masumi; Kawano, Sayaka; Kitamura, Hiroshi; Ito, Masatoshi; Watarai, Hiroshi; Hazelett, C. Clayton; Yeaman, Charles; Ohno, Hiroshi			M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex	NATURE CELL BIOLOGY			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; PRIMARY RESPONSE GENE; NECROSIS-FACTOR-ALPHA; M-CELLS; IMMUNE CELLS; CUTTING EDGE; ANIMAL-CELLS; GTPASE; FILOPODIA; TRANSMISSION	Cell-cell communication is essential for the development and homeostasis of multicellular organisms. Recently, a new type of cell-cell communication was discovered that is based on the formation of thin membranous nanotubes between remote cells(1,2). These long membrane tethers, termed tunneling nanotubes (TNTs), form an intercellular conduit and have been shown to enable the transport of various cellular components and signals. However, the molecular basis for TNT formation remains to be elucidated. Here we report that a mammalian protein, M-Sec, induces de novo formation of numerous membrane protrusions extending from the plasma membrane, some of which tether onto adjacent cells and subsequently form TNT-like structures. Depletion of M-Sec by RNA interference (RNAi) greatly reduced endogenous TNT formation as well as intercellular propagation of a calcium flux in a macrophage cell line. Furthermore, blockage of the interaction of M-Sec with Ral and the exocyst complex, which serves as a downstream effector of Ral, attenuated the formation of membrane nanotubes. Our results reveal that M-Sec functions as a key regulator of membrane nanotube formation through interaction with the Ral-exocyst pathway.	[Hase, Koji; Kimura, Shunsuke; Takatsu, Hiroyuki; Ohmae, Masumi; Kawano, Sayaka; Ohno, Hiroshi] RIKEN, Lab Epithelial Immunobiol, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Kitamura, Hiroshi; Ito, Masatoshi] RIKEN, Lab Immunogenom, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Watarai, Hiroshi] RIKEN, Lab Immune Regulat, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Ito, Masatoshi; Ohno, Hiroshi] Yokohama City Univ, Dept Supramol Biol, Grad Sch Nanobiosci, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN; University of Iowa; Yokohama City University	Ohno, H (corresponding author), RIKEN, Lab Epithelial Immunobiol, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan.	ohno@rcai.riken.jp	Watarai, Hiroshi/G-9894-2012; Kimura, Shunsuke/D-7093-2012; Yeaman, Charles A/A-1624-2009; Ohno, Hiroshi/L-7899-2014	Watarai, Hiroshi/0000-0003-1511-2593; Kimura, Shunsuke/0000-0001-9408-2884; Ohno, Hiroshi/0000-0001-8776-9661; Yeaman, Charles/0000-0001-6149-628X; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institutes of Health [GM067002]; Takeda Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank I. Yamashita and Y. Fujimura for technical assistance, and. P. Burrows and C. Blaumueller for critically reviewing the manuscript. This study was supported in part by Grants-in-Aid for Young Scientists ( B) ( K. H.), Scientific Research ( B) (H.O.), Scientific Research in Priority Areas ( H.O. and K. H.) and Scientific Research on Innovative Areas ( H.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the National Institutes of Health (GM067002; C. Y.) and the Takeda Science Foundation ( K. H.).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SARMA V, 1992, J IMMUNOL, V148, P3302; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WOLF FW, 1994, J BIOL CHEM, V269, P3633; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	33	222	233	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1427	U91		10.1038/ncb1990	http://dx.doi.org/10.1038/ncb1990			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935652				2022-12-27	WOS:000272251300008
J	Keren, K; Yam, PT; Kinkhabwala, A; Mogilner, A; Theriot, JA				Keren, Kinneret; Yam, Patricia T.; Kinkhabwala, Anika; Mogilner, Alex; Theriot, Julie A.			Intracellular fluid flow in rapidly moving cells	NATURE CELL BIOLOGY			English	Article							MIGRATING CELLS; MYOSIN-II; ANOMALOUS DIFFUSION; WATER PERMEABILITY; LEADING-EDGE; MONTE-CARLO; ACTIN; MOTILITY; KERATOCYTES; TRACKING	Cytosolic fluid dynamics have been implicated in cell motility(1-5) because of the hydrodynamic forces they induce and because of their influence on transport of components of the actin machinery to the leading edge. To investigate the existence and the direction of fluid flow in rapidly moving cells, we introduced inert quantum dots into the lamellipodia of fish epithelial keratocytes and analysed their distribution and motion. Our results indicate that fluid flow is directed from the cell body towards the leading edge in the cell frame of reference, at about 40% of cell speed. We propose that this forward-directed flow is driven by increased hydrostatic pressure generated at the rear of the cell by myosin contraction, and show that inhibition of myosin II activity by blebbistatin reverses the direction of fluid flow and leads to a decrease in keratocyte speed. We present a physical model for fluid pressure and flow in moving cells that quantitatively accounts for our experimental data.	[Keren, Kinneret; Yam, Patricia T.; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Keren, Kinneret; Yam, Patricia T.; Theriot, Julie A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Keren, Kinneret] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Keren, Kinneret] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Yam, Patricia T.] Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Kinkhabwala, Anika] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Technion Israel Institute of Technology; Technion Israel Institute of Technology; McGill University; Stanford University; University of California System; University of California Davis; University of California System; University of California Davis; Stanford University	Keren, K (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	kinneret@ph.technion.ac.il	Kinkhabwala, Anika/A-8214-2010; Theriot, Julie/HHN-2034-2022; Mogilner, Alex/A-3135-2008	Yam, Patricia/0000-0002-3631-3151; Keren, Kinneret/0000-0002-2962-6977; Theriot, Julie/0000-0002-2334-2535	Damon Runyon Postdoctoral Fellowship; Technion; Israel Council for Higher Education; Israel Science Foundation; Wolfson Foundation; European Research Council; National Institutes of Health; National Science Foundation; American Heart Association and the Howard Hughes Medical Institute; Howard Hughes Medical Institute; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; Technion; Israel Council for Higher Education; Israel Science Foundation(Israel Science Foundation); Wolfson Foundation; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association and the Howard Hughes Medical Institute(Howard Hughes Medical InstituteAmerican Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Theresa Harper and Marcel Bruchez from Quantum Dot Corporation (Molecular Probes, Invitrogen) for providing the quantum dot probes; W. E. Moerner for advice on the single-particle tracking experiments; Paul Wiseman, Ben Hebert and Lia Gracey for their contributions to the initial phase of this project; Michael Saxton and Cyrus Wilson for useful discussions; and Boris Slepchenko for help with Virtual Cell. K. K. was supported by a Damon Runyon Postdoctoral Fellowship, a Horev fellowship from the Technion, an Allon Fellowship from the Israel Council for Higher Education, and by grants from the Morasha Program of the Israel Science Foundation, the Converging Technologies Program of The Israel Council for Higher Education, the Wolfson Foundation, and a European Research Council Starting Grant. A. M. was supported by grants from the National Institutes of Health and the National Science Foundation. J. A. T. was supported by grants from the National Institutes of Health, the American Heart Association and the Howard Hughes Medical Institute. P. T. Y. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship and Stanford Graduate Fellowship.	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; ALLEN RD, 1978, ANNU REV BIOPHYS BIO, V7, P469, DOI 10.1146/annurev.bb.07.060178.002345; Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Khan S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041915; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Loitto VM, 2009, CELL MOTIL CYTOSKEL, V66, P237, DOI 10.1002/cm.20357; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Metzler R, 2000, PHYS REV E, V61, P6308, DOI 10.1103/PhysRevE.61.6308; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; OSTER GF, 1987, J CELL SCI, P35; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rubinstein B, 2005, MULTISCALE MODEL SIM, V3, P413, DOI 10.1137/04060370X; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Saxton MJ, 2007, BIOPHYS J, V92, P1178, DOI 10.1529/biophysj.106.092619; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schaub S, 2007, MOL BIOL CELL, V18, P3723, DOI 10.1091/mbc.E06-09-0859; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Verkman AS, 2000, J MEMBRANE BIOL, V173, P73, DOI 10.1007/s002320001009; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; WILSON CA, 2006, THESIS STANFORD U; WILSON CA, 2006, THESIS STANFORD U, P1; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	50	135	136	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1219	U137		10.1038/ncb1965	http://dx.doi.org/10.1038/ncb1965			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767741	Green Accepted			2022-12-27	WOS:000270382000011
J	Butler, LC; Blanchard, GB; Kabla, AJ; Lawrence, NJ; Welchman, DP; Mahadevan, L; Adams, RJ; Sanson, B				Butler, Lucy C.; Blanchard, Guy B.; Kabla, Alexandre J.; Lawrence, Nicola J.; Welchman, David P.; Mahadevan, L.; Adams, Richard J.; Sanson, Benedicte			Cell shape changes indicate a role for extrinsic tensile forces in Drosophila germ-band extension	NATURE CELL BIOLOGY			English	Article							EPITHELIAL MORPHOGENESIS; GASTRULATION; INTERCALATION; REARRANGEMENT; INVAGINATION; MELANOGASTER; ELONGATION; DIVISIONS; NOTOCHORD; POLARITY	Drosophila germ-band extension (GBE) is an example of the convergence and extension movements that elongate and narrow embryonic tissues. To understand the collective cell behaviours underlying tissue morphogenesis, we have continuously quantified cell intercalation and cell shape change during GBE. We show that the fast, early phase of GBE depends on cell shape change in addition to cell intercalation. In antero-posterior patterning mutants such as those for the gap gene Kruppel, defective polarized cell intercalation is compensated for by an increase in antero-posterior cell elongation, such that the initial rate of extension remains the same. Spatio-temporal patterns of cell behaviours indicate that an antero-posterior tensile force deforms the germ band, causing the cells to change shape passively. The rate of anteroposterior cell elongation is reduced in twist mutant embryos, which lack mesoderm. We propose that cell shape change contributing to germ-band extension is a passive response to mechanical forces caused by the invaginating mesoderm.	[Butler, Lucy C.; Blanchard, Guy B.; Adams, Richard J.; Sanson, Benedicte] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Kabla, Alexandre J.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Lawrence, Nicola J.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Welchman, David P.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard University; Harvard Medical School	Sanson, B (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	bs251@cam.ac.uk	Kabla, Alexandre/AAF-3993-2019	Kabla, Alexandre/0000-0002-0280-3531; Blanchard, Guy/0000-0002-3689-0522; Adams, Richard/0000-0003-0280-0901; Sanson, Benedicte/0000-0002-2782-4195; Lawrence, Nicola/0000-0001-9773-2360	Human Frontier Science Program; Wellcome Trust; Medical Research Council; Harvard-National Science Foundation; MRC [G0400709] Funding Source: UKRI; Medical Research Council [G0400709] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harvard-National Science Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Claire Lye, Bruno Monier and Daniel St Johnston for comments on the manuscript and discussions. We thank the Bloomington Drosophila Stock Centre for fly strains. This work was supported by a Human Frontier Science Program grant to B. S., a Wellcome Trust studentship to L. C. B., a Medical Research Council grant to R. J. A. and a Harvard-National Science Foundation Materials Research Science and Engineering Center award to M. L.	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Costa Michael, 1993, P425; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P181; IRVINE KD, 1994, DEVELOPMENT, V120, P827; KAM Z, 1991, DEVELOPMENT, V112, P365; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; KELLER RE, 1987, DEV BIOL, V120, P12, DOI 10.1016/0012-1606(87)90099-6; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Munro EM, 2002, DEVELOPMENT, V129, P13; Oda H, 2001, J CELL SCI, V114, P493; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; *R RES DEV TEAM, 2008, R LANG ENV STAT COMP; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SWEETON D, 1991, DEVELOPMENT, V112, P775; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Vincent A, 1997, DEVELOPMENT, V124, P3747; Weaire DL., 2001, PHYS FOAMS; WELIKY M, 1990, DEVELOPMENT, V109, P373; WICKHAM H, 2008, R PACKAGE VERSION 0; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	31	166	166	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					859	U181		10.1038/ncb1894	http://dx.doi.org/10.1038/ncb1894			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19503074				2022-12-27	WOS:000267603100015
J	Barroca, V; Lassalle, B; Coureuil, M; Louis, JP; Le Page, F; Testart, J; Allemand, I; Riou, L; Fouchet, P				Barroca, Vilma; Lassalle, Bruno; Coureuil, Mathieu; Louis, Jean Paul; Le Page, Florence; Testart, Jacques; Allemand, Isabelle; Riou, Lydia; Fouchet, Pierre			Mouse differentiating spermatogonia can generate germinal stem cells in vivo	NATURE CELL BIOLOGY			English	Article							UNDIFFERENTIATED SPERMATOGONIA; GENETIC-ANALYSIS; SELF-RENEWAL; KIT-LIGAND; C-KIT; SPERMATOGENESIS; TESTIS; NICHE; PROLIFERATION; PLURIPOTENCY	In adults, stem cells are responsible for the maintenance of many actively renewing tissues, such as haematopoietic, skin, gut and germinal tissues. These stem cells can self-renew or be committed to becoming progenitors. Stem-cell commitment is thought to be irreversible but in male and female Drosophila melanogaster, it was shown recently that differentiating germ cells can revert to functional stem cells that can restore germinal lineage(1,2). Whether progenitors are also able to generate stem cells in mammals remains unknown. Here we show that purified mouse spermatogonial progenitors committed to differentiation can generate functional germinal stem cells that can repopulate germ-cell-depleted testes when transplanted into adult mice. We found that GDNF, a key regulator of the stem-cell niche, and FGF2 are able to reprogram in vitro spermatogonial progenitors for reverse differentiation. This study supports the emerging concept that the stem-cell identity is not restricted in adults to a definite pool of cells that self-renew, but that stemness could be acquired by differentiating progenitors after tissue injury and throughout life.	[Barroca, Vilma; Lassalle, Bruno; Coureuil, Mathieu; Le Page, Florence; Testart, Jacques; Allemand, Isabelle; Riou, Lydia; Fouchet, Pierre] CEA, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol,U566, Lab Gametogenese Apoptose & Genotoxicite,INSERM, F-92265 Fontenay Aux Roses, France; [Louis, Jean Paul] CNRS, UMR 6218, F-45071 Orleans, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Fouchet, P (corresponding author), CEA, Direct Sci Vivant, Inst Radiobiol Cellulaire & Mol,U566, Lab Gametogenese Apoptose & Genotoxicite,INSERM, F-92265 Fontenay Aux Roses, France.	pierre.fouchet@cea.fr	Coureuil, Mathieu/D-4793-2017	Coureuil, Mathieu/0000-0001-7655-9685; RIOU, Lydia/0000-0002-3878-7844; Fouchet, Pierre/0000-0003-0891-079X; allemand, isabelle/0000-0002-8861-7632	Electricite De France	Electricite De France	We thank P.H. Romeo for critical review of the manuscript and helpful comments. We thank M. Okabe for the generous gift of the EGFP transgenic mice; S. Leblay and V. Neuville for their technical assistance in the animal facilities, and T. Andrieu for assistance with Aria, LSR and LSRII. This work was supported in part by a grant from Electricite De France.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; AOI T, 2008, SCIENCE, V26, P101; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Bedell MA, 2004, J ANDROL, V25, P188; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Ohta H, 2000, DEVELOPMENT, V127, P2125; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Zhang XF, 2003, BIOL REPROD, V69, P1872, DOI 10.1095/biolreprod.103.019273	33	128	135	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					190	U173		10.1038/ncb1826	http://dx.doi.org/10.1038/ncb1826			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098901				2022-12-27	WOS:000263285500017
J	Verweij, W; Spelt, C; Di Sansebastiano, GP; Vermeer, J; Reale, L; Ferranti, F; Koes, R; Quattrocchio, F				Verweij, Walter; Spelt, Cornelis; Di Sansebastiano, Gian-Pietro; Vermeer, Joop; Reale, Lara; Ferranti, Francesco; Koes, Ronald; Quattrocchio, Francesca			An H+ P-ATPase on the tonoplast determines vacuolar pH and flower colour	NATURE CELL BIOLOGY			English	Article							GFP-FUSION PROTEINS; PLASMA-MEMBRANE; SEED COAT; ARABIDOPSIS; PETUNIA; ACIDIFICATION; TRANSCRIPTION; ANTHOCYANIN1; EVOLUTION; PATHWAY	The regulation of pH in cellular compartments is crucial for intracellular trafficking of vesicles and proteins and the transport of small molecules, including hormones. In endomembrane compartments, pH is regulated by vacuolar H+-ATPase(1) (V-ATPase), which, in plants, act together with H+-pyrophosphatases(2) (PPase), whereas distinct P-type H+-ATPases in the cell membrane control the pH in the cytoplasm and energize the plasma membrane(3). Flower colour mutants have proved useful in identifying genes controlling the pH of vacuoles where anthocyanin pigments accumulate(4,5). Here we show that PH5 of petunia encodes a P-3A-ATPase proton pump that, unlike other P-type H+-ATPases, resides in the vacuolar membrane. Mutation of PH5 reduces vacuolar acidification in petals, resulting in a blue flower colour and abolishes the accumulation of proanthocyanindins (condensed tannins) in seeds. Expression of PH5 is directly activated by transcription regulators of the anthocyanin pathway, in conjunction with PH3 and PH4. Thus, flower coloration, a key-factor in plant reproduction, involves the coordinated activation of pigment synthesis and a specific pathway for vacuolar acidification.	[Verweij, Walter; Spelt, Cornelis; Koes, Ronald; Quattrocchio, Francesca] Vrije Univ Amsterdam, Inst Mol Cell Biol, Grad Sch Expt Plant Sci, NL-1081 HV Amsterdam, Netherlands; [Di Sansebastiano, Gian-Pietro] Univ Lecce, Lab Bot DiSTeBA, I-73100 Lecce, Italy; [Vermeer, Joop] Univ Amsterdam, Ctr Adv Microscopy, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Reale, Lara; Ferranti, Francesco] Univ Perugia, Dept Appl Biol, I-06121 Perugia, Italy	Vrije Universiteit Amsterdam; University of Salento; University of Amsterdam; University of Perugia	Quattrocchio, F (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Grad Sch Expt Plant Sci, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	francesca.quattrocchio@falw.vu.nl	Koes, Ronald/AAB-1716-2021; Vermeer, Joop E.M./J-2232-2014; Di Sansebastiano, Gian Pietro/I-7193-2012; Quattrocchio, Francesca M./N-6658-2019	Koes, Ronald/0000-0003-3793-5072; Vermeer, Joop E.M./0000-0001-8876-5873; Di Sansebastiano, Gian Pietro/0000-0001-5388-0695; Quattrocchio, Francesca M./0000-0001-8040-4061; REALE, Lara/0000-0001-7570-3972; FERRANTI, Francesco/0000-0002-2548-3868	The Netherlands Organization of Scientific Research (NWO-ALW)	The Netherlands Organization of Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	We are grateful to. Inhwan Hwang (Pohang, Korea) and Katrin Czempinski (Golm, Germany) for AHA2-GFP and KCO1-GFP constructs, and to Dorus Gadella (University of Amsterdam, The Netherlands) for the use of confocal microscopy facilities. We thank Pieter Hoogeveen, Martina Meesters and Daisy Kloos for plant care. This work was supported by a grant from The Netherlands Organization of Scientific Research (NWO-ALW).	Ando T, 2005, ANN BOT-LONDON, V96, P887, DOI 10.1093/aob/mci241; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2005, P NATL ACAD SCI USA, V102, P2649, DOI 10.1073/pnas.0406377102; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Fluckiger R, 2003, J EXP BOT, V54, P1577, DOI 10.1093/jxb/erg160; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Gaxiola RA, 2002, PLANT PHYSIOL, V129, P967, DOI 10.1104/pp.020009; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim DH, 2001, PLANT CELL, V13, P287, DOI 10.1105/tpc.13.2.287; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Lefebvre B, 2005, PLANT MOL BIOL, V58, P775, DOI 10.1007/s11103-005-7875-3; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Tobena-Santamaria R, 2002, GENE DEV, V16, P753, DOI 10.1101/gad.219502; Vermeer JEM, 2004, J MICROSC-OXFORD, V214, P190, DOI 10.1111/j.0022-2720.2004.01318.x; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033	30	141	156	10	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1456	1462		10.1038/ncb1805	http://dx.doi.org/10.1038/ncb1805			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18997787				2022-12-27	WOS:000261261800017
J	Gyrd-Hansen, M; Darding, M; Miasari, M; Santoro, MM; Zender, L; Xue, W; Tenev, T; da Fonseca, PCA; Zvelebil, M; Bujnicki, JM; Lowe, S; Silke, J; Meier, P				Gyrd-Hansen, Mads; Darding, Maurice; Miasari, Maria; Santoro, Massimo M.; Zender, Lars; Xue, Wen; Tenev, Tencho; da Fonseca, Paula C. A.; Zvelebil, Marketa; Bujnicki, Janusz M.; Lowe, Scott; Silke, John; Meier, Pascal			IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappa B as well as cell survival and oncogenesis	NATURE CELL BIOLOGY			English	Article							ALPHA-DEPENDENT APOPTOSIS; SIGNALING PATHWAY; LINKED INHIBITOR; STRUCTURAL BASIS; PROTEIN LIGASE; MALT LYMPHOMA; UBA DOMAIN; ACTIVATION; XIAP; BCL10	The covalent attachment of ubiquitin to target proteins influences various cellular processes, including DNA repair, NF-kappa B signalling and cell survival(1). The most common mode of regulation by ubiquitin-conjugation involves specialized ubiquitin-binding proteins that bind to ubiquitylated proteins and link them to downstream biochemical processes. Unravelling how the ubiquitin-message is recognized is essential because aberrant ubiquitin-mediated signalling contributes to tumour formation(2). Recent evidence indicates that inhibitor of apoptosis (IAP) proteins are frequently overexpressed in cancer and their expression level is implicated in contributing to tumorigenesis, chemoresistance, disease progression and poor patient-survival(3). Here, we have identified an evolutionarily conserved ubiquitin-associated (UBA) domain in IAPs, which enables them to bind to Lys 63-linked polyubiquitin. We found that the UBA domain is essential for the oncogenic potential of cIAP1, to maintain endothelial cell survival and to protect cells from TNF-alpha-induced apoptosis. Moreover, the UBA domain is required for XIAP and cIAP2-MALT1 to activate NF-kappa B. Our data suggest that the UBA domain of cIAP2-MALT1 stimulates NF-kappa B signalling by binding to polyubiquitylated NEMO. Significantly, 98% of all cIAP2-MALT1 fusion proteins retain the UBA domain, suggesting that ubiquitin-binding contributes to the oncogenic potential of cIAP2-MALT1 in MALT lymphoma. Our data identify IAPs as ubiquitin-binding proteins that contribute to ubiquitin-mediated cell survival, NF-kappa B signalling and oncogenesis.	[Gyrd-Hansen, Mads; Darding, Maurice; Tenev, Tencho; Zvelebil, Marketa; Meier, Pascal] Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; [Miasari, Maria; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Santoro, Massimo M.] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Santoro, Massimo M.] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; [Zender, Lars; Xue, Wen; Lowe, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xue, Wen] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Xue, Wen] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [da Fonseca, Paula C. A.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ Poznan, PL-61614 Poznan, Poland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; La Trobe University; University of Turin; University of Eastern Piedmont Amedeo Avogadro; Cold Spring Harbor Laboratory; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Gyrd-Hansen, M (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloees Vej 5, DK-2200 Copenhagen, Denmark.	mads.gyrd@bric.dk; pmeier@icr.ac.uk	Silke, John/B-7622-2008	Silke, John/0000-0002-7611-5774; Meier, Pascal/0000-0003-2760-6523; Zvelebil, Marketa/0000-0001-8018-5591; da Fonseca, Paula/0000-0001-8656-5747; Tenev, Tencho/0000-0001-8762-1069; SANTORO, Massimo Mattia/0000-0003-4605-5085; Gyrd-Hansen, Mads/0000-0001-5641-5019	Danish Cancer Society; HFSP Career Developmental Award; Fondazione San Paolo and Regione Piemonte; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); HFSP Career Developmental Award; Fondazione San Paolo and Regione Piemonte(Compagnia di San Paolo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Xiaolu Yang, David Komander, David Barford, Thomas Farkas, Ivan Dikic and Marja Jaattela for reagents, discussions and invaluable technical support. We thank Irene Scarf for help with the cIAP1 zebrafish experiments, and Hyejin Cho and Beicong Ma for excellent technical assistance and help with the mouse tumour model. We thank Alan Ashworth and members of the Meier laboratory for critical reading of the manuscript and helpful discussions. We thank Vishva Dixit for sharing unpublished results. M. G.- H. is supported by a fellowship from the Danish Cancer Society. M. M. S. is supported by a HFSP Career Developmental Award, Fondazione San Paolo and Regione Piemonte.	Baens M, 2000, GENE CHROMOSOME CANC, V29, P281, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1036>3.0.CO;2-I; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; COOK WJ, 1992, J BIOL CHEM, V267, P15116; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Isaacson PG, 2005, J PATHOL, V205, P255, DOI 10.1002/path.1703; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Young SS, 1999, MAMM GENOME, V10, P44; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	41	186	189	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1309	U130		10.1038/ncb1789	http://dx.doi.org/10.1038/ncb1789			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931663	Green Accepted			2022-12-27	WOS:000260586700013
J	Naetar, N; Korbei, B; Kozlov, S; Kerenyi, MA; Dorner, D; Kral, R; Gotic, I; Fuchs, P; Cohen, TV; Bittner, R; Stewart, CL; Foisner, R				Naetar, Nana; Korbei, Barbara; Kozlov, Serguei; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Cohen, Tatiana V.; Bittner, Reginald; Stewart, Colin L.; Foisner, Roland			Loss of nucleoplasmic LAP2 alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation	NATURE CELL BIOLOGY			English	Article							STEM-CELL DIFFERENTIATION; LAMIN-A; ERYTHROPOIESIS; RB; PROTEINS; MOUSE; GENE; PROLIFERATION; ASSOCIATION; EXPRESSION	Lamina-associated polypeptide (LAP) 2 alpha is a chromatin-associated protein that binds A-type lamins(1,2). Mutations in both LAP2 alpha and A-type lamins are linked to human diseases called laminopathies(3), but the molecular mechanisms are poorly understood. The A-type lamin-LAP2a complex interacts with and regulates retinoblastoma protein (pRb)(4,5), but the significance of this interaction in vivo is unknown. Here we address the function of the A-type lamin-LAP2a complex with the use of LAP2 alpha-deficient mice. We show that LAP2a loss causes relocalization of nucleoplasmic A-type lamins to the nuclear envelope and impairs pRb function. This causes inefficient cell-cycle arrest in dense fibroblast cultures and hyperproliferation of epidermal and erythroid progenitor cells in vivo, leading to tissue hyperplasia. Our results support a disease-relevant model(6) in which LAP2a defines A-type lamin localization in the nucleoplasm, which in turn affects pRb-mediated regulation of progenitor cell proliferation and differentiation in highly regenerative tissues.	[Naetar, Nana; Korbei, Barbara; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Naetar, Nana; Korbei, Barbara; Kerenyi, Marc A.; Dorner, Daniela; Kral, Rosana; Gotic, Ivana; Fuchs, Peter; Foisner, Roland] Univ Vienna, A-1030 Vienna, Austria; [Kozlov, Serguei; Cohen, Tatiana V.; Stewart, Colin L.] NCI, Adv BioSci Labs, Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Kerenyi, Marc A.] Vienna Bioctr, Inst Mol Pathol, A-1030 Vienna, Austria; [Bittner, Reginald] Med Univ Vienna, Neuromuscular Res Ctr, Ctr Anat & Cell Biol, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna	Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019	Naetar, Nana/0000-0002-8978-466X; Foisner, Roland/0000-0003-4734-4647; Fuchs, Peter/0000-0003-3933-7674; Kral, Rosana Maria/0000-0003-4775-4398; Korbei, Barbara/0000-0002-0439-0435; Gotic, Ivana/0000-0003-1111-871X	Austrian Science Research Fund [FWF P17871]; European Commission [LSHM-CT-2005-018690]; L'Oreal/UNESCO/OADW/BMWF	Austrian Science Research Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); L'Oreal/UNESCO/OADW/BMWF	We thank W. Muller for the Cre-deleter mouse strain, Larry Gerace for the genomic BAC clone, T. Jacks for triple knockout mouse embryonic fibroblasts, P. Luvalle for providing paws from lamin A/C-deficient mice, K. Biadasiewicz for expert technical assistance, and H. Beug and E. W. Mullner for helpful discussions. This study was supported by grants from the Austrian Science Research Fund (FWF P17871) and the EURO-Laminopathies research project of the European Commission (contract LSHM-CT-2005-018690) to R. F. and a postdoctoral fellowship from L'Oreal/UNESCO/OADW/BMWF to N. N.	Andra K, 1998, GENE DEV, V12, P3442, DOI 10.1101/gad.12.21.3442; Berger R, 1996, GENOME RES, V6, P361, DOI 10.1101/gr.6.5.361; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250; Vlcek S, 1999, EMBO J, V18, P6370, DOI 10.1093/emboj/18.22.6370; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103	33	119	120	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1341	U213		10.1038/ncb1793	http://dx.doi.org/10.1038/ncb1793			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18849980				2022-12-27	WOS:000260586700017
J	Fu, Z; Malureanu, L; Huang, J; Wang, W; Li, H; Van Deursen, JM; Tindall, DJ; Chen, J				Fu, Zheng; Malureanu, Liviu; Huang, Jun; Wang, Wei; Li, Hao; Van Deursen, Jan M.; Tindall, Donald J.; Chen, Junjie			Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE-1; SCF-BETA-TRCP; CELL-CYCLE; BOX DOMAIN; PLK1; CYTOKINESIS; PROTEIN; INHIBITOR; SUBSTRATE; DIVISION	Proper control of entry into and progression through mitosis is essential for normal cell proliferation and the maintenance of genome stability(1-4). The mammalian mitotic kinase Polo-like kinase 1 (Plk1) is involved in multiple stages of mitosis(5). Here we report that Forkhead Box M1 (FoxM1), a substrate of Plk1 (refs 6-8), controls a transcriptional programme that mediates Plk1-dependent regulation of cell-cycle progression. The carboxy-terminal domain of FoxM1 binds Plk1, and phosphorylation of two key residues in this domain by Cdk1 is essential for Plk1-FoxM1 interaction. Formation of the Plk1-FoxM1 complex allows for direct phosphorylation of FoxM1 by Plk1 at G2/M and the subsequent activation of FoxM1 activity, which is required for expression of key mitotic regulators, including Plk1 itself. Thus, Plk1-dependent regulation of FoxM1 activity provides a positive-feedback loop ensuring tight regulation of transcriptional networks essential for orderly mitotic progression.	[Huang, Jun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Fu, Zheng; Tindall, Donald J.] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA; [Malureanu, Liviu; Van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; [Fu, Zheng; Malureanu, Liviu; Van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, Wei; Li, Hao] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	Yale University; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of New Mexico	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	tindall.donald@mayo.edu; junjie.chen@yale.edu	li, hao/J-6585-2012; CHEN, JUNJIE/HHM-8428-2022		National Institutes of Health [NIH RO1 CA113381]; Mayo SPORE P50 [CA116201]; T.J. Martell Foundation; DOD; NATIONAL CANCER INSTITUTE [R01CA113381, P50CA116201, P50CA091956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo SPORE P50; T.J. Martell Foundation; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for extensive discussions with R. H. Medema and J. Laoukili and their input. We thank H. M. Thompson for editing the manuscript. Mass spectrometry analysis was performed by Taplin Biological Mass Spectrometry Facility at Harvard University. This work was supported in part by grants from the National Institutes of Health (NIH RO1 CA113381 to JC), Mayo SPORE P50 (CA116201 project no. 1 to J. C.) and the T.J. Martell Foundation (to D.J.T.). J.C. is a recipient of an Era of Hope Scholars award from DOD. Z.F. is a recipient of a Ruth L. Kirschstein NRSA individual Fellowship from NIH.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	28	240	245	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1076	1082		10.1038/ncb1767	http://dx.doi.org/10.1038/ncb1767			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160488	Green Accepted			2022-12-27	WOS:000258910400013
J	Labbaye, C; Spinello, I; Quaranta, MT; Pelosi, E; Pasquini, L; Petrucci, E; Biffoni, M; Nuzzolo, ER; Billi, M; Foa, R; Brunetti, E; Grignani, F; Testa, U; Peschle, C				Labbaye, Catherine; Spinello, Isabella; Quaranta, Maria Teresa; Pelosi, Elvira; Pasquini, Luca; Petrucci, Eleonora; Biffoni, Mauro; Nuzzolo, Eugenia Rosa; Billi, Monia; Foa, Robin; Brunetti, Ercole; Grignani, Francesco; Testa, Ugo; Peschle, Cesare			A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis	NATURE CELL BIOLOGY			English	Article							MYELOID CELLS; STEM-CELLS; HEMATOPOIETIC PROGENITORS; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; SDF-1-CXCR4 AXIS; DOWN-REGULATION; PLZF PROTEIN; PIVOTAL ROLE	MicroRNAs ( miRNAs or miRs) regulate diverse normal and abnormal cell functions. We have identified a regulatory pathway in normal megakaryopoiesis, involving the PLZF transcription factor, miR-146a and the SDF-1 receptor CXCR4. In leukaemic cell lines PLZF overexpression downmodulated miR-146a and upregulated CXCR4 protein, whereas PLZF knockdown induced the opposite effects. In vitro assays showed that PLZF interacts with and inhibits the miR-146a promoter, and that miR-146a targets CXCR4 mRNA, impeding its translation. In megakaryopoietic cultures of CD34(+) progenitors, PLZF was upregulated, whereas miR-146a expression decreased and CXCR4 protein increased. MiR-146a overexpression and PLZF or CXCR4 silencing impaired megakaryocytic (Mk) proliferation, differentiation and maturation, as well as Mk colony formation. Mir-146a knockdown induced the opposite effects. Rescue experiments indicated that the effects of PLZF and miR-146a are mediated by miR-146a and CXCR4, respectively. Our data indicate that megakaryopoiesis is controlled by a cascade pathway, in which PLZF suppresses miR-146a transcription and thereby activates CXCR4 translation.	[Labbaye, Catherine; Spinello, Isabella; Quaranta, Maria Teresa; Pelosi, Elvira; Pasquini, Luca; Petrucci, Eleonora; Biffoni, Mauro; Nuzzolo, Eugenia Rosa; Testa, Ugo; Peschle, Cesare] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Foa, Robin] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy; [Brunetti, Ercole] San Pietro FBF, Ctr Ric AFaR, I-00100 Rome, Italy; [Billi, Monia; Grignani, Francesco] Univ Perugia, Dept Gen Pathol, I-06122 Perugia, Italy; [Peschle, Cesare] IRCCS MultiMed, I-20138 Milan, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; University of Perugia; IRCCS Multimedica	Labbaye, C (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	catherine.labbaye@iss.it; cesare.peschle@iss.it	Testa, Ugo/J-6472-2016; SPINELLO, ISABELLA/J-8779-2016; PETRUCCI, ELEONORA/J-8778-2016; pelosi, elvira/J-7298-2016; Grignani, Francesco/AAC-2565-2022; Labbaye, Catherine/J-9930-2016; pasquini, luca/J-8319-2016; Biffoni, Mauro/J-8318-2016; Quaranta, Maria Teresa/AAC-2134-2019	Testa, Ugo/0000-0001-7900-8942; PETRUCCI, ELEONORA/0000-0001-6459-490X; pelosi, elvira/0000-0002-3043-6249; pasquini, luca/0000-0002-3484-6288; Biffoni, Mauro/0000-0002-1304-9060; Quaranta, Maria Teresa/0000-0002-5886-507X; Labbaye, Catherine/0000-0003-1255-4396; Billi, Monia/0000-0002-5284-7380	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Ball HJ, 1999, NUCLEIC ACIDS RES, V27, P4106, DOI 10.1093/nar/27.20.4106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cottler-Fox Michele H, 2003, Hematology Am Soc Hematol Educ Program, P419; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; de Almodovar CR, 2006, CELL, V124, P18, DOI 10.1016/j.cell.2005.12.023; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; GABBIANELLI M, 1990, SCIENCE, V249, P1561, DOI 10.1126/science.2218497; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Guerriero R, 2001, BLOOD, V97, P2587, DOI 10.1182/blood.V97.9.2587; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; HE L, 2004, NAT REV GENET, V5, P522; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; Parrado A, 2000, Hematol J, V1, P15, DOI 10.1038/sj.thj.6200012; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Quaranta MT, 2006, ONCOGENE, V25, P399, DOI 10.1038/sj.onc.1209060; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; TABILIO A, 1983, CANCER RES, V43, P4569; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tamamura H, 2005, EXPERT OPIN THER TAR, V9, P1267, DOI 10.1517/14728222.9.6.1267; Testa U, 1998, LEUKEMIA, V12, P563, DOI 10.1038/sj.leu.2400967; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	49	187	203	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					788	801		10.1038/ncb1741	http://dx.doi.org/10.1038/ncb1741			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18568019				2022-12-27	WOS:000257268400009
J	Minsky, N; Shema, E; Field, Y; Schuster, M; Segal, E; Oren, M				Minsky, Neri; Shema, Efrat; Field, Yair; Schuster, Meromit; Segal, Eran; Oren, Moshe			Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells	NATURE CELL BIOLOGY			English	Article							RNA-POLYMERASE-II; UBIQUITINATED HISTONE H2B; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; S-PHASE; UBIQUITYLATION; METHYLATION; DEUBIQUITYLATION; COMPLEX	Histone modifications have emerged as important regulators of transcription(1,2). Histone H2B monoubiquitination has also been implicated in transcription(3,4); however, better understanding of the biological significance of this modification in mammalian cells has been hindered by the lack of suitable reagents, particularly antibodies capable of specifically recognizing ubiquitinated H2B ( ubH2B). Here, we report the generation of anti-ubH2B monoclonal antibodies using a branched peptide as immunogen. These antibodies provide a powerful tool for exploring the biochemical functions of H2B monoubiquitination at both a genome-wide and gene-specific level. Application of these antibodies in high resolution chromatin immunoprecipitation ( ChIP)-chip experiments in human cells, using tiling arrays, revealed preferential association of ubiquitinated H2B with the transcribed regions of highly expressed genes. Unlike dimethylated H3K4, ubH2B was not associated with distal promoter regions. Furthermore, experimental modulation of the transcriptional activity of the tumour suppressor p53 was accompanied by rapid changes in the H2B ubiquitination status of its target gene p21, attesting to the dynamic nature of this process. It has recently been demonstrated that the apparent extent of gene expression often reflects elongation rather than initiation rates(5); thus, our findings suggest that H2B ubiquitination is intimately linked with global transcriptional elongation in mammalian cells.	[Minsky, Neri; Shema, Efrat; Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Field, Yair; Schuster, Meromit; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	moshe.oren@weizmann.ac.il	Segal, Eran/AAF-4855-2019; Shema, Efrat/AHC-5041-2022	Shema, Efrat/0000-0002-3718-593X; Segal, Eran/0000-0002-6859-1164; Oren, Moshe/0000-0003-4311-7172	NATIONAL CANCER INSTITUTE [R37CA040099] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA40099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; DAVIE JR, 1994, BIOCHEM BIOPH RES CO, V203, P344, DOI 10.1006/bbrc.1994.2188; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PLAUE S, 1989, J EXP MED, V169, P1607, DOI 10.1084/jem.169.5.1607; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, J BIOL CHEM, V281, P19045, DOI 10.1074/jbc.M513533200; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; THORNE AW, 1987, EMBO J, V6, P1005, DOI 10.1002/j.1460-2075.1987.tb04852.x; VASSILEV AP, 1995, J CELL SCI, V108, P1205; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	30	262	274	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					483	490		10.1038/ncb1712	http://dx.doi.org/10.1038/ncb1712			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344985				2022-12-27	WOS:000254561700020
J	Yao, G; Lee, TJ; Mori, S; Nevins, JR; You, LC				Yao, Guang; Lee, Tae Jun; Mori, Seiichi; Nevins, Joseph R.; You, Lingchong			A bistable Rb-E2F switch underlies the restriction point	NATURE CELL BIOLOGY			English	Article							MYC PROTEIN STABILITY; MAMMALIAN-CELL CYCLE; TRANSCRIPTION FACTORS; NEGATIVE REGULATORS; PROTEASOME PATHWAY; POSITIVE-FEEDBACK; ESCHERICHIA-COLI; GENE-EXPRESSION; G(1) CONTROL; D1 COMPLEX	The restriction point ( R-point) marks the critical event when a mammalian cell commits to proliferation and becomes independent of growth stimulation. It is fundamental for normal differentiation and tissue homeostasis, and seems to be dysregulated in virtually all cancers(1,2). Although the R-point has been linked to various activities involved in the regulation of G1-S transition of the mammalian cell cycle(2-6), the underlying mechanism remains unclear(1,7). Using single-cell measurements, we show here that the Rb-E2F pathway functions as a bistable switch to convert graded serum inputs into all-or-none E2F responses. Once turned ON by sufficient serum stimulation, E2F can memorize and maintain this ON state independently of continuous serum stimulation. We further show that, at critical concentrations and duration of serum stimulation, bistable E2F activation correlates directly with the ability of a cell to traverse the R-point.	[Yao, Guang; Mori, Seiichi; Nevins, Joseph R.; You, Lingchong] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Yao, Guang; Mori, Seiichi; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Tae Jun; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Nevins, JR (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	j.nevins@duke.edu; you@duke.edu		, Guang/0000-0003-0167-777X	NCI NIH HHS [U54 CA112952, 5-U24-CA112952-03] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Doedel EJ., 1981, CONG NUMER, V30, P265; ERMENTROUT B, 2002, SIAM PRESS PHILADEPH; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Grafstrom RH, 1999, CARCINOGENESIS, V20, P193, DOI 10.1093/carcin/20.2.193; Hatzimanikatis V, 1999, BIOTECHNOL BIOENG, V65, P631; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; LEUNG JY, 2008, IN PRESS ONCOGENE; LOGAN J, 1981, VIROLOGY, V115, P419, DOI 10.1016/0042-6822(81)90126-4; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MOTOKURA T, 1993, GENE CHROMOSOME CANC, V7, P89, DOI 10.1002/gcc.2870070205; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Qu ZL, 2003, BIOPHYS J, V85, P3600, DOI 10.1016/S0006-3495(03)74778-X; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Weinberg RA, 2007, BIOL CANC; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; You LC, 2003, BIOINFORMATICS, V19, P435, DOI 10.1093/bioinformatics/btg009; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	52	275	280	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					476	U255		10.1038/ncb1711	http://dx.doi.org/10.1038/ncb1711			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364697				2022-12-27	WOS:000254561700019
J	Lippincott-Schwartz, J				Lippincott-Schwartz, Jennifer			The long road: peering into live cells	NATURE CELL BIOLOGY			English	Editorial Material									Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lippincott-Schwartz, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					918	918		10.1038/ncb1010-918	http://dx.doi.org/10.1038/ncb1010-918			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20885416	Bronze			2022-12-27	WOS:000282363500002
J	Wu, M; Huang, B; Graham, M; Raimondi, A; Heuser, JE; Zhuang, XW; De Camilli, P				Wu, Min; Huang, Bo; Graham, Morven; Raimondi, Andrea; Heuser, John E.; Zhuang, Xiaowei; De Camilli, Pietro			Coupling between clathrin-dependent endocytic budding and F-BAR-dependent tubulation in a cell-free system	NATURE CELL BIOLOGY			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; WASP-WIP COMPLEX; MEDIATED ENDOCYTOSIS; COATED PITS; MEMBRANE INVAGINATION; ACTIN CYTOSKELETON; DYNAMIN; PROTEINS; CURVATURE; DOMAIN	Cell-free reconstitution of membrane traffic reactions and the morphological characterization of membrane intermediates that accumulate under these conditions have helped to elucidate the physical and molecular mechanisms involved in membrane transport(1-3). To gain a better understanding of endocytosis, we have reconstituted vesicle budding and fission from isolated plasma membrane sheets and imaged these events. Electron and fluorescence microscopy, including subdiffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)(4-6), revealed F-BAR (FBP17) domain coated tubules nucleated by clathrin-coated buds when fission was blocked by GTP gamma S. Triggering fission by replacing GTP gamma S with GTP led not only to separation of clathrin-coated buds, but also to vesicle formation by fragmentation of the tubules. These results suggest a functional link between FBP17-dependent membrane tubulation and clathrin-dependent budding. They also show that clathrin spatially directs plasma membrane invaginations that lead to the generation of endocytic vesicles larger than those enclosed by the coat.	[Wu, Min; Huang, Bo; Raimondi, Andrea; Zhuang, Xiaowei; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Wu, Min; Graham, Morven; Raimondi, Andrea; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Raimondi, Andrea; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard University; Washington University (WUSTL)	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	pietro.decamilli@yale.edu	Wu, Min/H-8048-2012; Raimondi, Andrea/AAN-2475-2020; Huang, Bo/D-4854-2009; Heuser, John/H-5940-2012; Wu, Min/AAK-8627-2020	Wu, Min/0000-0002-9161-7940; Wu, Min/0000-0002-9161-7940; Raimondi, Andrea/0000-0002-4563-386X	G. Harold and Leila Y. Mathers Charitable Foundation; W.M. Keck Foundation; National Institutes of Health [NS36251, DK45735, GM068518]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; W.M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Aurelien Roux and Yuxin Mao for advice and help; Lijun Liu, Frank Wilson and Christoph Rahner for critical technical assistance. This work was supported in part by the G. Harold and Leila Y. Mathers Charitable Foundation, the W.M. Keck Foundation and the National Institutes of Health grants (NS36251 and DK45735) to P.D.C., and National Institutes of Health grant (GM068518) to X.Z.; P.D.C. and X.Z. are Howard Hughes Medical Institute Investigators.	Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; WILLINGHAM MC, 1981, J HISTOCHEM CYTOCHEM, V29, P1003, DOI 10.1177/29.9.6169759; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	30	115	118	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					902	908		10.1038/ncb2094	http://dx.doi.org/10.1038/ncb2094			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729836	Green Accepted			2022-12-27	WOS:000281561900014
J	Zhao, Y; Yang, J; Liao, WJ; Liu, XY; Zhang, H; Wang, S; Wang, DL; Feng, JN; Yu, L; Zhu, WG				Zhao, Ying; Yang, Jing; Liao, Wenjuan; Liu, Xiangyu; Zhang, Hui; Wang, Shan; Wang, Donglai; Feng, Jingnan; Yu, Li; Zhu, Wei-Guo			Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTORS; CELL-DEATH; LIFE-SPAN; ACTIVATION; BECLIN-1; TARGET; GENE; TUMORIGENESIS; EXPRESSION; PROTEINS	Autophagy is characterized by the sequestration of bulk cytoplasm, including damaged proteins and organelles, and delivery of the cargo to lysosomes for degradation. Although the autophagic pathway is also linked to tumour suppression activity, the mechanism is not yet clear. Here we report that cytosolic FoxO1, a forkhead O family protein, is a mediator of autophagy. Endogenous FoxO1 was required for autophagy in human cancer cell lines in response to oxidative stress or serum starvation, but this process was independent of the transcriptional activity of FoxO1. In response to stress, FoxO1 was acetylated by dissociation from sirtuin-2 (SIRT2), a NAD(+)-dependent histone deacetylase, and the acetylated FoxO1 bound to Atg7, an E1-following protein, to influence the autophagic process leading to cell death. This FoxO1-modulated cell death is associated with tumour suppressor activity in human colon tumours and a xenograft mouse model. Our finding links the anti-neoplastic activity of FoxO1 and the process of autophagy.	[Zhao, Ying; Yang, Jing; Liao, Wenjuan; Liu, Xiangyu; Zhang, Hui; Wang, Donglai; Feng, Jingnan; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Zhang, Hui; Wang, Shan] Peking Univ, Hlth Sci Ctr, Dept Surg, Affiliated Hosp 2, Beijing 100044, Peoples R China; [Yu, Li] Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China; Peking Univ, Beijing 00142, Peoples R China; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Sch Oncol, Beijing 00142, Peoples R China	Peking University; Peking University; Tsinghua University; Peking University; Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn	liu, xiangyu/D-8213-2014; zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581				Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Al-Mubarak B, 2009, CHANNELS, V3, P233; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Juhasz G, 2007, CELL DEATH DIFFER, V14, P1181, DOI 10.1038/sj.cdd.4402123; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	65	430	461	3	91	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					665	U88		10.1038/ncb2069	http://dx.doi.org/10.1038/ncb2069			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20543840				2022-12-27	WOS:000279374400010
J	Chan, CH; Lee, SW; Li, CF; Wang, J; Yang, WL; Wu, CY; Wu, J; Nakayama, KI; Kang, HY; Huang, HY; Hung, MC; Pandolfi, PP; Lin, HK				Chan, Chia-Hsin; Lee, Szu-Wei; Li, Chien-Feng; Wang, Jing; Yang, Wei-Lei; Wu, Ching-Yuan; Wu, Juan; Nakayama, Keiichi I.; Kang, Hong-Yo; Huang, Hsuan-Ying; Hung, Mien-Chie; Pandolfi, Pier Paolo; Lin, Hui-Kuan			Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis	NATURE CELL BIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; C-MYC; TUMOR PROGRESSION; LUNG METASTASIS; SKP2; REPRESSION; UBIQUITIN; TRANSFORMATION; PROTEOLYSIS; PROTEINS	The RhoA GTPase is crucial in numerous biological functions and is linked to cancer metastasis. However, the understanding of the molecular mechanism responsible for RhoA transcription is still very limited. Here we show that RhoA transcription is orchestrated by the Myc-Skp2-Miz1-p300 transcriptional complex. Skp2 cooperates with Myc to induce RhoA transcription by recruiting Miz1 and p300 to the RhoA promoter independently of Skp1-Cullin-F-box protein containing complex (SCF)-Skp2 E3 ligase activity. Deficiency of this complex results in impairment in RhoA expression, cell migration, invasion, and breast cancer metastasis, recapitulating the phenotypes observed in RhoA knockdown, and RhoA restoration rescues the defect in cell invasion. Overexpression of the Myc-Skp2-Miz1 complex is found in metastatic human cancers and is correlated with RhoA expression. Our study provides insight into how oncogenic Skp2 and Myc coordinate to induce RhoA transcription and establishes a novel SCF-Skp2 E3-ligase-independent function for oncogenic Skp2 in transcription and cancer metastasis.	[Chan, Chia-Hsin; Lee, Szu-Wei; Wang, Jing; Yang, Wei-Lei; Wu, Ching-Yuan; Wu, Juan; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lee, Szu-Wei; Yang, Wei-Lei; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas Houston, Sch Biomed Sci, Houston, TX 77030 USA; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Wu, Ching-Yuan] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Chinese Med,Med Ctr, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Kang, Hong-Yo] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Grad Inst Clin Med Sci,Med Ctr, Kaohsiung 833, Taiwan; [Wang, Jing; Wu, Juan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Peoples R China; [Wang, Jing; Wu, Juan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Peoples R China; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Huang, Hsuan-Ying] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Pathol,Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02115 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol & Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Chi Mei Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Sun Yat Sen University; Sun Yat Sen University; Kyushu University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Chan, Chia-Hsin/F-2272-2011; Yang, Wei-Lei/E-2598-2012; Hung, Mien-Chie/ABD-5911-2021; Kang, Hong-Yo/W-9031-2019; Chan, Chia-Hsin/AAT-7782-2020	Hung, Mien-Chie/0000-0003-4317-4740; Kang, Hong-Yo/0000-0003-0626-5037; Chan, Chia-Hsin/0000-0001-8506-7500	M. D. Anderson Cancer Center; National Cancer Institute; Department of Defense; Department of Health, Taiwan; NATIONAL CANCER INSTITUTE [R01CA136787] Funding Source: NIH RePORTER	M. D. Anderson Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Department of Health, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Weinberg, W. Sellers, D. Bohmann, W. Tansey, J. M. Sedivy, W. Wei, M. Pagano, M. Eilers, W. S. El-Deiry, L. Yao and D. Sarbassov for reagents. We also thank D. Sarbassov, M. H. Lee and M. G. Lee for comments and suggestions. Special thanks are extended to S. Patterson for editing and critical reading of the manuscript. This work was supported by Research Trust Scholar funds from the M. D. Anderson Cancer Center, the National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) at the M. D. Anderson Cancer Center, a Department of Defense Prostate Cancer New Investigator Award (to H. K. L.) and a grant from the Department of Health, Taiwan (to C. F. L.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bellizzi A, 2008, INT J MOL MED, V22, P25; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faried A, 2005, EJSO, V31, P410, DOI 10.1016/j.ejso.2004.12.014; Faried A, 2007, ANN SURG ONCOL, V14, P3593, DOI 10.1245/s10434-007-9562-x; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kamai T, 2003, BJU INT, V91, P234, DOI 10.1046/j.1464-410X.2003.03063.x; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOSCOW JA, 1994, ONCOGENE, V9, P189; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Rihet S, 2001, J CANCER RES CLIN, V127, P733; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Smit MA, 2008, CANCER CELL, V14, P5, DOI 10.1016/j.ccr.2008.06.012; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907	44	171	175	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					457	U103		10.1038/ncb2047	http://dx.doi.org/10.1038/ncb2047			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383141	Green Accepted			2022-12-27	WOS:000277283700011
J	Takeichi, M				Takeichi, Masatoshi			Accidental encounters: the chance to solve a mystery	NATURE CELL BIOLOGY			English	Editorial Material									RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Takeichi, M (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378					0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					2	2		10.1038/ncb0110-2	http://dx.doi.org/10.1038/ncb0110-2			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20027196	Bronze			2022-12-27	WOS:000272973800003
J	Schekman, R				Schekman, Randy			Change is good: life outside the nucleus	NATURE CELL BIOLOGY			English	Editorial Material									Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	schekman@berkeley.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1274	1274		10.1038/ncb1109-1274	http://dx.doi.org/10.1038/ncb1109-1274			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19884881	Bronze			2022-12-27	WOS:000271425800003
J	Lopez, RG; Garcia-Silva, S; Moore, SJ; Bereshchenko, O; Martinez-Cruz, AB; Ermakova, O; Kurz, E; Paramio, JM; Nerlov, C				Lopez, Rodolphe G.; Garcia-Silva, Susana; Moore, Susan J.; Bereshchenko, Oksana; Martinez-Cruz, Ana B.; Ermakova, Olga; Kurz, Elke; Paramio, Jesus M.; Nerlov, Claus			C/EBP alpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation	NATURE CELL BIOLOGY			English	Article							CCAAT/ENHANCER-BINDING-PROTEINS; TRANSCRIPTION FACTORS C/EBP; STEM-CELLS; GENE-EXPRESSION; BARRIER FUNCTION; HAIR FOLLICLE; LIGASE ITCH; IN-VIVO; SKIN; P63	The transcriptional regulators that couple interfollicular basal keratinocyte proliferation arrest to commitment and differentiation are yet to be identified. Here we report that the basic region leucine zipper transcription factors C/EBP alpha and C/EBP beta are co-expressed in basal keratinocytes, and are coordinately upregulated as keratinocytes exit the basal layer and undergo terminal differentiation. Mice lacking both C/EBP alpha and beta in the epidermis showed increased proliferation of basal keratinocytes and impaired commitment to differentiation. This led to ectopic expression of keratin 14 (K14) and Delta Np63 in suprabasal cells, decreased expression of spinous and granular layer proteins, parakeratosis and defective epidermal water barrier function. Knock-in mutagenesis revealed that C/EBP-E2F interaction was required for control of interfollicular epidermis (IFE) keratinocyte proliferation, but not for induction of spinous and granular layer markers, whereas C/EBP DNA binding was required for Delta Np63 downregulation and K1/K10 induction. Finally, loss of C/EBP alpha/beta induced stem cell gene expression signatures in the epidermis. C/EBPs, therefore, couple basal keratinocyte cell cycle exit to commitment to differentiation through E2F repression and DNA binding, respectively, and may act to restrict the epidermal stem cell compartment.	[Lopez, Rodolphe G.; Garcia-Silva, Susana; Moore, Susan J.; Bereshchenko, Oksana; Ermakova, Olga; Kurz, Elke; Nerlov, Claus] EMBL Mouse Biol Unit, I-00016 Monterotondo, Italy; [Martinez-Cruz, Ana B.; Paramio, Jesus M.] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH8 9YL, Midlothian, Scotland; [Nerlov, Claus] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH8 9YL, Midlothian, Scotland	European Molecular Biology Laboratory (EMBL); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of Edinburgh; University of Edinburgh	Nerlov, C (corresponding author), EMBL Mouse Biol Unit, I-00016 Monterotondo, Italy.	cnerlov@staffmail.ed.ac.uk	Garcia-Silva, Susana/AAW-8528-2021; Ermakova, Olga/Z-2037-2018; Ermakova, Olga/K-5712-2019; Paramio, Jesus M/M-8482-2014	Garcia-Silva, Susana/0000-0003-1065-0245; Ermakova, Olga/0000-0001-8365-4904; Ermakova, Olga/0000-0001-8365-4904; Paramio, Jesus M/0000-0001-7520-3177; Bereshchenko, Oxana/0000-0002-2772-6042	MRC [G0701761] Funding Source: UKRI; Medical Research Council [G0701761] Funding Source: Medline; Medical Research Council [G0700711B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Maytin EV, 1999, DEV BIOL, V216, P164, DOI 10.1006/dbio.1999.9460; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Rounbehler RJ, 2001, ONCOGENE, V20, P5341, DOI 10.1038/sj.onc.1204691; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	58	86	89	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1181	U40		10.1038/ncb1960	http://dx.doi.org/10.1038/ncb1960			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19749746				2022-12-27	WOS:000270382000006
J	Lacefield, S; Lau, DTC; Murray, AW				Lacefield, Soni; Lau, Derek T. C.; Murray, Andrew W.			Recruiting a microtubule-binding complex to DNA directs chromosome segregation in budding yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PRECOCIOUS SEPARATION; PLASMID SEGREGATION; CENTROMERE FUNCTION; KINETOCHORE; SPINDLE; BIORIENTATION; ATTACHMENT; CHROMATIN; MITOSIS	Accurate chromosome segregation depends on the kinetochore, which is the complex of proteins that link microtubules to centromeric DNA(1). The kinetochore of the budding yeast Saccharomyces cerevisiae consists of more than 80 proteins assembled on a 125-bp region of DNA(1). We studied the assembly and function of kinetochore components by fusing individual kinetochore proteins to the lactose repressor (LacI) and testing their ability to improve segregation of a plasmid carrying tandem repeats of the lactose operator (LacO). Targeting Ask1, a member of the Dam1-DASH microtubule-binding complex, creates a synthetic kinetochore that performs many functions of a natural kinetochore: it can replace an endogenous kinetochore on a chromosome, bi-orient sister kinetochores at metaphase during the mitotic cycle, segregate sister chromatids, and repair errors in chromosome attachment. We show the synthetic kinetochore functions do not depend on the DNA-binding components of the natural kinetochore but do require other kinetochore proteins. We conclude that tethering a single kinetochore protein to DNA triggers assembly of the complex structure that directs mitotic chromosome segregation.	[Lacefield, Soni; Lau, Derek T. C.; Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu			US National Institutes of Health (NIH) National Research Service Award [GM043987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043987, R01GM043987] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Greg Lang, Joana Gonyalves-Sa, John Koschwanez, Gregg Wildenberg and Dai Tsuchiya for technical advice; Charles Asbury, Ted Salmon, Steve Elledge, Ajit Joglekar, Frank Solomon, Amy Rowat and members of the Murray lab for critical reading of the manuscript; and Steve Elledge, John Kilmartin and Sue Biggins for strains. This work was supported by a US National Institutes of Health (NIH) National Research Service Award fellowship to S.L. and an NIH grant to A.W.M. (GM043987).	Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; GAUDET A, 1987, MOL CELL BIOL, V7, P68, DOI 10.1128/MCB.7.1.68; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; HABER JE, 1984, GENETICS, V106, P207; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hajra S, 2006, J CELL BIOL, V174, P779, DOI 10.1083/jcb.200603042; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; Kiermaier E, 2009, NAT CELL BIOL, V11, P1109, DOI 10.1038/ncb1924; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Li YM, 2003, CELL CYCLE, V2, P143, DOI 10.4161/cc.2.2.336; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Sherman F, 1979, METHODS YEAST GENETI; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Velmurugan S, 2000, J CELL BIOL, V149, P553, DOI 10.1083/jcb.149.3.553; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019	36	43	43	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1116	U150		10.1038/ncb1925	http://dx.doi.org/10.1038/ncb1925			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19684576	Green Accepted, Green Submitted			2022-12-27	WOS:000269482500013
J	Li, QX; Lin, SY; Wang, X; Lian, GL; Lu, ZL; Guo, HL; Ruan, K; Wang, YH; Ye, ZY; Han, JH; Lin, SC				Li, Qinxi; Lin, Shuyong; Wang, Xuan; Lian, Guili; Lu, Zailian; Guo, Huiling; Ruan, Ka; Wang, Yanhai; Ye, Zhiyun; Han, Jiahuai; Lin, Sheng-Cai			Axin determines cell fate by controlling the p53 activation threshold after DNA damage	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN KINASE-2; APOPTOSIS; DEGRADATION; HIPK2; WNT; PATHWAY; LIGASE; PHOSPHORYLATION; ACETYLATION; INHIBITOR	Cells can undergo either cell-cycle arrest or apoptosis after genotoxic stress, based on p53 activity(1-6). Here we show that cellular fate commitment depends on Axin forming distinct complexes with Pirh2, Tip60, HIPK2 and p53. In cells treated with sublethal doses of ultra-violet (UV) radiation or doxorubicin (Dox), Pirh2 abrogates Axin-induced p53 phosphorylation at Ser 46 catalysed by HIPK2, by competing with HIPK2 for binding to Axin. However, on lethal treatment, Tip60 interacts with Axin and abrogates Pirh2-Axin binding, forming an Axin-Tip60-HIPK2-p53 complex that allows maximal p53 activation to trigger apoptosis. We also provide evidence that the ATM/ATR pathway mediates the Axin-Tip60 complex assembly. An axin mutation promotes carcinogenesis in Axin(Fu)/+ (Axin-Fused) mice, consistent with a dominant-negative role for Axin(Fu) in p53 activation. Thus, Axin is a critical determinant in p53-dependent tumour suppression in which Pirh2 and Tip60 have different roles in triggering cell-cycle arrest or apoptosis depending on the severity of genotoxic stress.	[Li, Qinxi; Lin, Shuyong; Wang, Xuan; Lian, Guili; Lu, Zailian; Guo, Huiling; Ruan, Ka; Wang, Yanhai; Ye, Zhiyun; Han, Jiahuai; Lin, Sheng-Cai] Xiamen Univ, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Lin, SC (corresponding author), Xiamen Univ, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	linsc@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Han, J/G-4671-2010; Lin, SC/G-4666-2010; Li, QX/G-4669-2010	Lin, Shu-Yong/0000-0002-4419-1713; Wang, Yanhai/0000-0002-0002-2467	973 Program and 863 Program [2007CB914602, 2006CB503900, 2006AA02A303]; National Natural Science Foundation of China [30730025, 30871280, 30770454]; Ministry of Education of China [705030, B06016]; National Basic Research Program of the Ministry of Science and Technology; National Science Foundation of Fujian Province [2009J06021]	973 Program and 863 Program(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Basic Research Program of the Ministry of Science and Technology(National Basic Research Program of China); National Science Foundation of Fujian Province	This work was supported by grants from the 973 Program and 863 Program (2007CB914602, 2006CB503900 and 2006AA02A303), the National Natural Science Foundation of China (30730025, 30871280 and 30770454), the Ministry of Education of China (705030 and B06016), the National Basic Research Program of the Ministry of Science and Technology and the National Science Foundation of Fujian Province (2009J06021). We thank H. You for commenting on the manuscript.	Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Lu ZL, 2008, J BIOL CHEM, V283, P13132, DOI 10.1074/jbc.M710595200; MASHA V, 2006, GENE DEV, V20, P125; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	29	65	70	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1128	U184		10.1038/ncb1927	http://dx.doi.org/10.1038/ncb1927			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19731416				2022-12-27	WOS:000269482500015
J	Shan, SW; Lee, DY; Deng, ZQ; Shatseva, T; Jeyapalan, Z; Du, WW; Zhang, Y; Xuan, JW; Yee, SP; Siragam, V; Yang, BB				Shan, Sze Wan; Lee, Daniel Y.; Deng, Zhaoqun; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Zhang, Yaou; Xuan, Jim W.; Yee, Siu-Pok; Siragam, Vinayakumar; Yang, Burton B.			MicroRNA MiR-17 retards tissue growth and represses fibronectin expression	NATURE CELL BIOLOGY			English	Article							CELL-PROLIFERATION; LUNG CANCERS; CLUSTER; VERSICAN; DIFFERENTIATION; ANGIOGENESIS; APOPTOSIS; SURVIVAL; FAMILY; ROLES	MicroRNAs (miRNAs) are single-stranded regulatory RNAs, frequently expressed as clusters. Previous studies have demonstrated that the six-miRNA cluster miR-17 similar to 92 has important roles in tissue development and cancers. However, the precise role of each miRNA in the cluster is unknown. Here we show that overexpression of miR-17 results in decreased cell adhesion, migration and proliferation. Transgenic mice overexpressing miR-17 showed overall growth retardation, smaller organs and greatly reduced haematopoietic cell lineages. We found that fibronectin and the fibronectin type-III domain containing 3A (FNDC3A) are two targets that have their expression repressed by miR-17, both in vitro and in transgenic mice. Several lines of evidence support the notion that miR-17 causes cellular defects through its repression of fibronectin expression. Our single miRNA expression assay may be evolved to allow the manipulation of individual miRNA functions in vitro and in vivo. We anticipate that this could serve as a model for studying gene regulation by miRNAs in the development of gene therapy.	[Shan, Sze Wan; Lee, Daniel Y.; Deng, Zhaoqun; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Siragam, Vinayakumar; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Zhang, Yaou] Grad Sch, Div Life Sci, Shenzhen, Peoples R China; [Xuan, Jim W.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Yee, Siu-Pok] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Yee, Siu-Pok] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Shan, Sze Wan; Lee, Daniel Y.; Jeyapalan, Zina; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON, Canada.	byang@sri.utoronto.ca		SHAN, SW/0000-0001-6876-9914	Heart and Stroke Foundation of Ontario [CI 5958]; Canadian Institutes of Health Research; National Natural Science Foundation of China; Canada Graduate Scholarship;  [NA 6282]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canada Graduate Scholarship; 	We thank J. Ma for assistance in real-time PCR experiments, G. Knowles for flow cytometry analysis at the Core Facilities of Sunnybrook Research Institute, S. Gatchell and K. Green for the generation and maintenance of transgenic mice at UWO, D. Wei for technical assistance in molecular cloning, and J. Yang for editing the manuscript. This work was supported by a grant (NA 6282) and a Career Investigator Award (CI 5958) from Heart and Stroke Foundation of Ontario to B. B. Y. and a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to B. B. Y. and Y. Z.). D. Y. L. is the recipient of a Canada Graduate Scholarship.	Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; GREGORY PA, 2008, NATURE CELL BIOL; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	38	177	182	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1031	U278		10.1038/ncb1917	http://dx.doi.org/10.1038/ncb1917			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19633662				2022-12-27	WOS:000268593200019
J	Siepe, D; Jentsch, S				Siepe, Dirk; Jentsch, Stefan			Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; P53; UBIQUITIN; ISOMERIZATION; DEGRADATION; MECHANISM; PROTEIN; MDM2; MULTIUBIQUITYLATION; LOCALIZATION	Pin1, a conserved eukaryotic peptidyl-prolyl cis/trans isomerase, has important roles in cellular regulation(1,2). Because of its activity to switch the conformation of peptidyl-proline bonds in polypeptide chains, Pin1 operates as a binary switch, often in fate-determining pathways. Pin1 activity is usually controlled by substrate phosphorylation(1,2), but how Pin1 switches protein fates has been unclear. Here we show that Pin1 controls the degree of substrate ubiquitylation and thereby protein functions. We found that yeast Pin1 (Ess1) is essential for viability because it controls the NF-kappa B-related Spt23 transcription factor involved in unsaturated fatty-acid synthesis(3). High Pin1 activity results in low ubiquitylation of Spt23, which triggers Spt23 precursor processing and hence transcription factor activation. By contrast, decreased Pin1 activity leads to robust Spt23 polyubiquitylation and subsequent proteasomal degradation. Inhibition of Pin1 in mammalian cells changes the ubiquitylation status of the tumour suppressor protein p53 from oligoubiquitylation, which is known to trigger nuclear export(4), to polyubiquitylation, which causes nuclear p53 degradation. This suggests that the Pin1 activity is often translated into a fate-determining ubiquitylation switch, and that Pin1 may affect the degree of substrate ubiquitylation in other pathways as well.	[Siepe, Dirk; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de			Max Planck Society; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank T. Ammon, A. Buchberger, M. Kalocsay, S. Muller, W. Piwko and C. Pohl for discussions, and M. Kalocsay for the pOLE1 reporter construct. S. J. is supported by the Max Planck Society, the Center for Integrated Protein Science Munich, the RUBICON EU Network of Excellence, and Fonds der Chemischen Industrie.	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Coutts AS, 2009, DNA REPAIR, V8, P483, DOI 10.1016/j.dnarep.2009.01.008; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	36	44	45	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					967	U127		10.1038/ncb1908	http://dx.doi.org/10.1038/ncb1908			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597489				2022-12-27	WOS:000268593200010
J	Thoma, CR; Toso, A; Gutbrodt, KL; Reggi, SP; Frew, IJ; Schraml, P; Hergovich, A; Moch, H; Meraldi, P; Krek, W				Thoma, Claudio R.; Toso, Alberto; Gutbrodt, Katrin L.; Reggi, Sabina P.; Frew, Ian J.; Schraml, Peter; Hergovich, Alexander; Moch, Holger; Meraldi, Patrick; Krek, Wilhelm			VHL loss causes spindle misorientation and chromosome instability	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; HELA-CELLS; PVHL; PROTEINS; ACTIVATION; CHECKPOINT; EXPRESSION; ANEUPLOIDY; MUTATIONS; STABILITY	Error-free mitosis depends on fidelity-monitoring checkpoint systems that ensure correct temporal and spatial coordination of chromosome segregation by the microtubule spindle apparatus. Defects in these checkpoint systems can lead to genomic instability, an important aspect of tumorigenesis. Here we show that the von Hippel-Lindau (VHL) tumour suppressor protein, pVHL, which is inactivated in hereditary and sporadic forms of renal cell carcinoma, localizes to the mitotic spindle in mammalian cells and its functional inactivation provokes spindle misorientation, spindle checkpoint weakening and chromosomal instability. Spindle misorientation is linked to unstable astral microtubules and is supressed by the restoration of wild-type pVHL in pVHL-deficient cells, but not in naturally-occurring VHL disease mutants that are defective in microtubule stabilization. Impaired spindle checkpoint function and chromosomal instability are the result of reduced Mad2 (mitotic arrest deficient 2) levels actuated by pVHL-inactivation and are rescued by re-expression of either Mad2 or pVHL in VHL-defective cells. An association between VHL inactivation, reduced Mad2 levels and increased aneuploidy was also found in human renal cancer, implying that the newly identified functions of pVHL in promoting proper spindle orientation and chromosomal stability probably contribute to tumour suppression.	[Thoma, Claudio R.; Gutbrodt, Katrin L.; Frew, Ian J.; Hergovich, Alexander; Krek, Wilhelm] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Toso, Alberto; Reggi, Sabina P.; Meraldi, Patrick] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Schraml, Peter; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Krek, W (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	patrick.meraldi@bc.biol.ethz.ch; wilhelm.krek@cell.biol.ethz.ch	Meraldi, Patrick/D-6190-2013	Hergovich, Alexander/0000-0001-7018-5635; Frew, Ian/0000-0003-2735-5509; Meraldi, Patrick/0000-0001-9742-8756	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank all members of our laboratories for helpful discussions. The authors are grateful to P. Sorger and A. Musacchio for their generous gifts of reagents, R. Carazo Salas and M. Bortfeld-Miller for helping with microtubule assays, C. Azzalin and M. Patil for helping with chromosome spreads, the Light Microscopy Centre ETH Zurich, in particular G. Csucs and J. Kusch, for help with microscopy, M. Storz and S. Behnke for preparing the tissue array and the immunostaining and J. Schelldorfer for advise in statistical data analysis. C. R. T. and A. T. are members of the Life Science Zurich Graduate School Zurich, Program in Molecular Life Sciences. P. M. is recipient of a SNF Assistant Professorship and is supported by the Swiss National Science Foundation. W. K. is supported by a grant from the Swiss National Science Foundation.	Abou-Rebyeh H, 2001, CANCER-AM CANCER SOC, V92, P2280, DOI 10.1002/1097-0142(20011101)92:9<2280::AID-CNCR1574>3.0.CO;2-2; Dalquen P, 1997, VIRCHOWS ARCH, V431, P173, DOI 10.1007/s004280050085; DE AA, 2005, CURR BIOL, V15, P214; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Frew IJ, 2008, MOL CELL BIOL, V28, P4536, DOI 10.1128/MCB.02132-07; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Mertz KD, 2008, INT J CANCER, V123, P569, DOI 10.1002/ijc.23565; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pepe S, 2000, CANCER, V89, P1065, DOI 10.1002/1097-0142(20000901)89:5<1065::AID-CNCR16>3.0.CO;2-T; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; SOLOMON D, 1988, HUM PATHOL, V19, P1072, DOI 10.1016/S0046-8177(88)80089-3; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	27	119	119	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					994	U200		10.1038/ncb1912	http://dx.doi.org/10.1038/ncb1912			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19620968				2022-12-27	WOS:000268593200014
J	Sun, SY; Chao, DY; Li, XM; Shi, M; Gao, JP; Zhu, MZ; Yang, HQ; Luan, S; Lin, HX				Sun, Shi-Yong; Chao, Dai-Yin; Li, Xin-Min; Shi, Min; Gao, Ji-Ping; Zhu, Mei-Zhen; Yang, Hong-Quan; Luan, Sheng; Lin, Hong-Xuan			OsHAL3 mediates a new pathway in the light-regulated growth of rice	NATURE CELL BIOLOGY			English	Article							COENZYME-A BIOSYNTHESIS; SALT TOLERANCE; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; INHIBITORY SUBUNIT; GENE; PROTEIN; OVEREXPRESSION; 4'-PHOSPHOPANTOTHENOYLCYSTEINE; 4'-PHOSPHOPANTETHEINE	Plants show distinct morphologies in different light conditions through a process called photomorphogenesis. A predominant feature of photomorphogenesis is the reduced growth of seedlings under light conditions compared with darkness. For this adaptive event, the most well-known molecular mechanism involves photoreceptor-mediated inhibition of cell elongation(1-4). However, it is not known whether additional pathways exist. Here, we describe a newly discovered pathway of light-modulated plant growth mediated by the halotolerance protein HAL3, a flavin mononucleotide (FMN)-binding protein involved in cell division(5-8). We found that light, especially blue light, suppresses growth of rice seedlings by reducing the activity of Oryza sativa (Os) HAL3. Both in vitro and in vivo studies showed that OsHAL3 is structurally inactivated by light through photo-oxidation and by direct interaction with photons. In addition, the transcriptional expression of OsHAL3 is synergistically regulated by different light conditions. Further investigation suggested that OsHAL3 promotes cell division by recruiting a ubiquitin system, rather than by its 4'-phosphopantothenoylcysteine (PPC) decarboxylase activity. Our results uncover a new mechanism for light-regulated plant growth, namely, light not only inhibits cell elongation but also suppresses cell division through HAL3 and E3 ubiquitin ligase. This study thus brings new insights into our understanding of plant photomorphogenesis.	[Sun, Shi-Yong; Chao, Dai-Yin; Li, Xin-Min; Shi, Min; Gao, Ji-Ping; Zhu, Mei-Zhen; Yang, Hong-Quan; Lin, Hong-Xuan] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Luan, Sheng; Lin, Hong-Xuan] Chinese Acad Sci, SIBS, SIBS UC Berkeley Ctr Mol Life Sci, Shanghai 200032, Peoples R China; [Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Lin, HX (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Zhang, Ning/F-1387-2014; Chao, Dai-Yin/H-1357-2012; Chao, Daiyin/A-5213-2013; Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X; ?, ??/0000-0003-2832-4800; Gao, Ji-Ping/0000-0002-8968-4423; Yang, Hong-Quan/0000-0001-6215-2665	Ministry of Science and Technology of China [2006CB100100, 2006AA10A102]; Chinese Academy of Sciences [KSCX2-YW-N-011]; National Natural Science Foundation of China [30730058, 30821004]; Ministry of Agriculture of China [2009EX08009-0678]; Shanghai Science and Technology Development Fund	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Shanghai Science and Technology Development Fund	We thank Q..-H. Yao for providing a rice cDNA library and T. G. Sors for revising the manuscript. This work was supported by grants from the Ministry of Science and Technology of China (2006CB100100 and 2006AA10A102), the Chinese Academy of Sciences (KSCX2-YW-N-011), the National Natural Science Foundation of China (30730058 and 30821004), the Ministry of Agriculture of China (2009EX08009-0678) and the Shanghai Science and Technology Development Fund.	Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Clotet J, 1999, MOL CELL BIOL, V19, P2408; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; DICOMO CJ, 1995, GENETICS, V139, P95; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Hernandez-Acosta P, 2002, J BIOL CHEM, V277, P20490, DOI 10.1074/jbc.M201557200; HIEL Y, 1994, PLANT J, V6, P271; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mei Chuansheng, 2007, Methods Mol Biol, V354, P161; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rodriguez PL, 1996, YEAST, V12, P1321, DOI 10.1002/(SICI)1097-0061(199610)12:13<1321::AID-YEA27>3.0.CO;2-6; Rubio S, 2006, PLANT PHYSIOL, V140, P830, DOI 10.1104/pp.105.072066; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Steinbacher S, 2003, J MOL BIOL, V327, P193, DOI 10.1016/S0022-2836(03)00092-5; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Yonamine I, 2004, J EXP BOT, V55, P387, DOI 10.1093/jxb/erh043; Zhang N, 2009, BIOCHEMISTRY-MOSCOW+, V74, P61, DOI 10.1134/S000629790901009X; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	32	29	44	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					845	U148		10.1038/ncb1892	http://dx.doi.org/10.1038/ncb1892			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543273				2022-12-27	WOS:000267603100013
J	Eiseler, T; Doppler, H; Yan, IK; Kitatani, K; Mizuno, K; Storz, P				Eiseler, Tim; Doeppler, Heike; Yan, Irene K.; Kitatani, Kanae; Mizuno, Kensaku; Storz, Peter			Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; LEADING-EDGE; TYROSINE PHOSPHORYLATION; PHOSPHATASE SLINGSHOT; ARP2/3 COMPLEX; LIM-KINASE; ACTIVATION; MIGRATION; PATHWAY; TRANSPORT	Dynamic actin remodelling processes at the leading edge of migrating tumour cells are concerted events controlled by a fine-tuned temporal and spatial interplay of kinases and phosphatases. Actin severing is regulated by actin depolymerizing factor (ADF)/cofilin, which regulates stimulus-induced lamellipodia protrusion and directed cell motility. Cofilin is activated by dephosphorylation through phosphatases of the slingshot (SSH) family. SSH activity is strongly increased by its binding to filamentous actin (F-actin); however, other upstream regulators remain unknown. Here we show that in response to RhoA activation, protein kinase D1 (PKD1) phosphorylates the SSH enzyme SSH1L at a serine residue located in its actin-binding motif. This generates a 14-3-3-binding motif and blocks the localization of SSH1L to F-actin-rich structures in the lamellipodium by sequestering it in the cytoplasm. Consequently, expression of constitutively active PKD1 in invasive tumour cells enhanced the phosphorylation of cofilin and effectively blocked the formation of free actin-filament barbed ends and directed cell migration.	[Eiseler, Tim; Doeppler, Heike; Yan, Irene K.; Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Kitatani, Kanae; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Mayo Clinic; Tohoku University	Storz, P (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu	Mizuno, Kensaku/G-8631-2015		Mayo Foundation; Mayo Comprehensive Cancer Center; Mayo Clinic Breast Cancer SPORE [CA116201-03DR4]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER	Mayo Foundation; Mayo Comprehensive Cancer Center; Mayo Clinic Breast Cancer SPORE; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Lewis-Tuffin for help with the video microscopy, and R. Mooney (University of Rochester Medical Center, New York) for providing MTLn3 cells. This work was sponsored in part by funds from the Mayo Foundation and the Mayo Comprehensive Cancer Center, the Mayo Clinic Breast Cancer SPORE (CA116201-03DR4), a 'Friends for an Earlier Breast Cancer Test' Grant (all to P. S.) and by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. M.).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jaggi M, 2005, CANCER RES, V65, P483; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullin MJ, 2006, J BIOL CHEM, V281, P25089, DOI 10.1074/jbc.M603591200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	46	180	182	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					545	U64		10.1038/ncb1861	http://dx.doi.org/10.1038/ncb1861			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19329994	Green Accepted			2022-12-27	WOS:000265640000014
J	Winter, J; Jung, S; Keller, S; Gregory, RI; Diederichs, S				Winter, Julia; Jung, Stephanie; Keller, Sarina; Gregory, Richard I.; Diederichs, Sven			Many roads to maturity: microRNA biogenesis pathways and their regulation	NATURE CELL BIOLOGY			English	Review							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; RNA-INTERFERENCE; BINDING PROTEIN; LET-7 MICRORNA; NUCLEAR EXPORT; HUMAN CANCER; ARGONAUTE COMPLEXES; PASSENGER-STRAND; DICER	MicroRNAs are important regulators of gene expression that control both physiological and pathological processes such as development and cancer. Although their mode of action has attracted great attention, the principles governing their expression and activity are only beginning to emerge. Recent studies have introduced a paradigm shift in our understanding of the microRNA biogenesis pathway, which was previously believed to be universal to all microRNAs. Maturation steps specific to individual microRNAs have been uncovered, and these offer a plethora of regulatory options after transcription with multiple proteins affecting microRNA processing efficiency. Here we review the recent advances in knowledge of the microRNA biosynthesis pathways and discuss their impact on post-transcriptional microRNA regulation during tumour development.	[Winter, Julia; Jung, Stephanie; Keller, Sarina; Diederichs, Sven] German Canc Res Ctr, Helmholtz Univ Grp Mol RNA Biol & Canc, D-69120 Heidelberg, Germany; [Winter, Julia; Jung, Stephanie; Keller, Sarina; Diederichs, Sven] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Gregory, Richard I.] Harvard Univ, Sch Med, Childrens Hosp Boston,Stem Cell Program, Dept Biol Chem & Mol Pharmacol,Harvard Stem Cell, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Boston Children's Hospital; Harvard Medical School	Diederichs, S (corresponding author), German Canc Res Ctr, Helmholtz Univ Grp Mol RNA Biol & Canc, B150 INF 581, D-69120 Heidelberg, Germany.	s.diederichs@dkfz.de	Jung, Stephanie/AAC-4902-2022; Jung, Stephanie/D-1351-2013; Diederichs, Sven/J-6237-2012	Jung, Stephanie/0000-0002-1454-9358; Diederichs, Sven/0000-0001-7901-4752	Helmholtz Society [VH-NG-504]; German Cancer Research Center DKFZ; Institute of Pathology; University of Heidelberg; Marie Curie Programme of the European Commission; Children's Hospital, Boston; Harvard Stem Cell Institute; March of Dimes Basil O'Conner award; Charles H. Hood Foundation; Emerald Foundation	Helmholtz Society(Helmholtz Association); German Cancer Research Center DKFZ(Helmholtz Association); Institute of Pathology; University of Heidelberg; Marie Curie Programme of the European Commission(European Commission); Children's Hospital, Boston; Harvard Stem Cell Institute; March of Dimes Basil O'Conner award(March of Dimes); Charles H. Hood Foundation; Emerald Foundation	We apologize to all scientists whose work could not be cited in this review as a result of space constraints. Research in the Diederichs laboratory is funded by grants from the Helmholtz Society (VH-NG-504), the German Cancer Research Center DKFZ, the Institute of Pathology, University of Heidelberg, and the Marie Curie Programme of the European Commission. Research in the Gregory laboratory is supported by the Children's Hospital, Boston, the Harvard Stem Cell Institute, the March of Dimes Basil O'Conner award, the Charles H. Hood Foundation, and the Emerald Foundation. R. I. G. is a Pew Research Scholar.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2008, P NATL ACAD SCI USA, V105, P9284, DOI 10.1073/pnas.0800803105; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Salzman DW, 2007, J BIOL CHEM, V282, P32773, DOI 10.1074/jbc.M705054200; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WEINMANN L, CELL IN PRESS, DOI DOI 10.1016/J.CELL.2008.12.023; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	122	1947	2039	1	354	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					228	234		10.1038/ncb0309-228	http://dx.doi.org/10.1038/ncb0309-228			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255566				2022-12-27	WOS:000263777900002
J	Tokunaga, F; Sakata, S; Saeki, Y; Satomi, Y; Kirisako, T; Kamei, K; Nakagawa, T; Kato, M; Murata, S; Yamaoka, S; Yamamoto, M; Akira, S; Takao, T; Tanaka, K; Iwai, K				Tokunaga, Fuminori; Sakata, Shin-ichi; Saeki, Yasushi; Satomi, Yoshinori; Kirisako, Takayoshi; Kamei, Kiyoko; Nakagawa, Tomoko; Kato, Michiko; Murata, Shigeo; Yamaoka, Shoji; Yamamoto, Masahiro; Akira, Shizuo; Takao, Toshifumi; Tanaka, Keiji; Iwai, Kazuhiro			Involvement of linear polyubiquitylation of NEMO in NF-kappa B activation	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYME; PROTEIN-KINASE-C; LIGASE COMPLEX; DEUBIQUITINATING ENZYMES; CANCER DEVELOPMENT; CHAIN; IDENTIFICATION; REQUIRES; BINDING; SITE	Nuclear factor-kappa B (NF-kappa B) is a key transcription factor in inflammatory, anti-apoptotic and immune processes. The ubiquitin pathway is crucial in regulating the NF-kappa B pathway. We have found that the LUBAC ligase complex, composed of the two RING finger proteins HOIL-1L and HOIP, conjugates a head-to-tail- linked linear polyubiquitin chain to substrates. Here, we demonstrate that LUBAC activates the canonical NF-kappa B pathway by binding to NEMO (NF-kappa B essential modulator, also called IKK gamma) and conjugates linear polyubiquitin chains onto specific Lys residues in the CC2-LZ domain of NEMO in a Ubc13-independent manner. Moreover, in HOIL-1 knockout mice and cells derived from these mice, NF-kappa B signalling induced by pro-inflammatory cytokines such as TNF-alpha and IL-1 beta was suppressed, resulting in enhanced TNF-alpha-induced apoptosis in hepatocytes of HOIL-1 knockout mice. These results indicate that LUBAC is involved in the physiological regulation of the canonical NF-kappa B activation pathway through linear polyubiquitylation of NEMO.	[Tokunaga, Fuminori; Sakata, Shin-ichi; Kamei, Kiyoko; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Dept Biochem & Biophys, Grad Sch Med & Cell Biol, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Kamei, Kiyoko; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Metab Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Iwai, Kazuhiro] Japan Sci Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Tokunaga, Fuminori; Sakata, Shin-ichi; Kirisako, Takayoshi; Kamei, Kiyoko; Nakagawa, Tomoko; Kato, Michiko; Iwai, Kazuhiro] Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Abeno Ku, Osaka 5458585, Japan; [Saeki, Yasushi; Murata, Shigeo; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; [Satomi, Yoshinori; Takao, Toshifumi] Osaka Univ, Inst Prot Res, Lab Prot Profiling & Funct Prote, Suita, Osaka 5650871, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan; [Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Lab Immune Regulat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tokyo Metropolitan Institute of Medical Science; Osaka University; University of Tokyo; Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University	Iwai, K (corresponding author), Osaka Univ, Dept Biochem & Biophys, Grad Sch Med & Cell Biol, Suita, Osaka 5650871, Japan.	kiwai@cellbio.med.osaka-u.ac.jp	Murata, Shigeo/A-1426-2010; Saeki, Yasushi/AAR-8198-2021; IWAI, KAZUHIRO/GSN-7385-2022; Akira, Shizuo/C-3134-2009	Murata, Shigeo/0000-0002-3177-3503; Saeki, Yasushi/0000-0002-9202-5453; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Satomi, Yoshinori/0000-0002-8991-1040	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Health Sciences Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Naito Foundation(Naito Memorial Foundation)	We would like to thank Nobuhito Goda and Natsuko Fujiki for instruction in mouse primary hepatocyte preparation; Ayumi Taya for supporting the LC and MS analyses; and Koichi Nakajima for reagents. This work was partly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (F.T., T.T. and K.I.), the Japan Health Sciences Foundation (F.T.) and the Naito Foundation (F.T.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen F, 2006, CELL DEATH DIFFER, V13, P1835, DOI 10.1038/sj.cdd.4402014; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cong YS, 1997, J BIOL CHEM, V272, P16482, DOI 10.1074/jbc.272.26.16482; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DWORKINRASTL E, 1984, CELL, V39, P321, DOI 10.1016/0092-8674(84)90010-2; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; EINSPANIER R, 1987, BIOCHEM BIOPH RES CO, V147, P581, DOI 10.1016/0006-291X(87)90970-3; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Fernandez-de-Cossio J, 2000, ELECTROPHORESIS, V21, P1694, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1694::AID-ELPS1694>3.0.CO;2-W; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Nakamura M, 2006, BIOCHEM BIOPH RES CO, V351, P340, DOI 10.1016/j.bbrc.2006.09.163; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	40	720	747	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					123	U40		10.1038/ncb1821	http://dx.doi.org/10.1038/ncb1821			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136968				2022-12-27	WOS:000263285500010
J	Rauzi, M; Verant, P; Lecuit, T; Lenne, PF				Rauzi, Matteo; Verant, Pascale; Lecuit, Thomas; Lenne, Pierre-Francois			Nature and anisotropy of cortical forces orienting Drosophila tissue morphogenesis	NATURE CELL BIOLOGY			English	Article							DIFFERENTIAL ADHESION; CONVERGENT EXTENSION; CELL INTERCALATION; SURFACE MECHANICS; POTTS-MODEL; ELONGATION; HYPOTHESIS; PATTERNS; CADHERIN; RETINA	The morphogenesis of developing embryos and organs relies on the ability of cells to remodel their contacts with neighbouring cells. Using quantitative modelling and laser nano-dissection, we probed the mechanics of a morphogenetic process, the elongation of Drosophila melanogaster embryos, which results from polarized cell neighbour exchanges. We show that anisotropy of cortical tension at apical cell junctions is sufficient to drive tissue elongation. We estimated its value through comparisons between in silico and in vivo data using various tissue descriptors. Nano-dissection of the actomyosin network indicates that tension is anisotropically distributed and depends on myosin II accumulation. Junction relaxation after nano-dissection also suggests that cortical elastic forces are dominant in this process. Interestingly, fluctuations in vertex position ( points where three or more cells meet) facilitate neighbour exchanges. We delineate the contribution of subcellular tensile activity polarizing junction remodelling, and the permissive role of vertex fluctuations during tissue elongation.	[Rauzi, Matteo; Verant, Pascale; Lecuit, Thomas] Univ Aix Marseille 2, IBDML, CNRS, UMR 6216, Marseille 09, France; [Rauzi, Matteo; Verant, Pascale; Lenne, Pierre-Francois] Univ Aix Marseille 3, Inst Fresnel, CNRS, Ecole Cent Marseille,UMR 6133, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, IBDML, CNRS, UMR 6216, Campus Luminy Case 907, Marseille 09, France.	lecuit@ibdm.univ-mrs.fr; lenne@fresnel.fr		Rauzi, Matteo/0000-0002-6313-0668; Lenne, Pierre-Francois/0000-0003-1066-7506	CNRS and an ANR-Blanc; Bourse Region Entreprise	CNRS and an ANR-Blanc(French National Research Agency (ANR)); Bourse Region Entreprise	We thank all the members of the Lenne and Lecuit labs for technical help in particular M. Cavey and C. Bertet. We thank C. Bertet for Fig. 1c. We are grateful for D. Kiehart H. Oda and C. Field for the gift of flies and antibodies. We thank everyone especially Loic Le Goff for fruitful discussions during the course of this project. K. Brakke is acknowledged for help with Surface Evolver F. Graner and A. Nicolas for insights and useful suggestions on the manuscript and J. Axelrod E. Munro O. Pourqui and members of the Lenne and Lecuit labs for critical reading of the manuscript. Supported by the CNRS and an ANR-Blanc grant to T. L. and P.-F.L.M. R. is supported by a Bourse Region Entreprise (Amplitude Systems) and P. V. is supported by a Postdoctoral Fellowship from ANR.	Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRAKKE K, 1990, EXP MATH, V1, P41; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Graner F, 2008, EUR PHYS J E, V25, P349, DOI 10.1140/epje/i2007-10298-8; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; MOMBACH JCM, 1995, PHYS REV LETT, V75, P2244, DOI 10.1103/PhysRevLett.75.2244; Oda H, 2001, J CELL SCI, V114, P493; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Rasband W, IMAGEJ; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Zajac M, 2000, PHYS REV LETT, V85, P2022, DOI 10.1103/PhysRevLett.85.2022; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X; Zallen JA, 2004, J PHYS-CONDENS MAT, V16, pS5073, DOI 10.1088/0953-8984/16/44/005; [No title captured]	32	416	421	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1401	U57		10.1038/ncb1798	http://dx.doi.org/10.1038/ncb1798			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	18978783				2022-12-27	WOS:000261261800010
J	Behrens, J				Behrens, Juergen			One hit, two outcomes for VHL-mediated tumorigenesis	NATURE CELL BIOLOGY			English	Editorial Material							TUMOR-SUPPRESSOR; CONDITIONAL INACTIVATION; RENAL-CARCINOMA; BETA-CATENIN; MUTATION; DISEASE; JADE-1; CANCER; MOUSE; MICE	The tumour suppressor vHL is known to suppress hypoxia-induced gene expression by degrading HIF family transcription factors. evidence that vHL also targets the oncoprotein beta-catenin for degradation highlights a new road to transformation by loss of vHL.	Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91341 Erlangen, Germany	University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Gluckstr 6, D-91341 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de						Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Giles RH, 2006, ONCOGENE, V25, P3065, DOI 10.1038/sj.onc.1209330; Haase VH, 2005, SEMIN CELL DEV BIOL, V16, P564, DOI 10.1016/j.semcdb.2005.03.006; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Polakis P, 2000, GENE DEV, V14, P1837; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Russell RC, 2007, CELL CYCLE, V6, P56, DOI 10.4161/cc.6.1.3668; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884	15	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1127	1128		10.1038/ncb1008-1127	http://dx.doi.org/10.1038/ncb1008-1127			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18830218				2022-12-27	WOS:000259682900004
J	Zhang, X; Jiang, G; Cai, Y; Monkley, SJ; Critchley, DR; Sheetz, MP				Zhang, Xian; Jiang, Guoying; Cai, Yunfei; Monkley, Susan J.; Critchley, David R.; Sheetz, Michael P.			Talin depletion reveals independence of initial cell spreading from integrin activation and traction	NATURE CELL BIOLOGY			English	Article							ADHESION; DOMAIN; CYTOSKELETON; MIGRATION; BINDING; FIBERS; TAILS; FORCE; SRC	Cell spreading, adhesion and remodelling of the extracellular matrix (ECM) involve bi-directional signalling and physical linkages between the ECM, integrins and the cell cytoskeleton(1-3). the actin-binding proteins talin1 and 2 link ligand-bound integrins to the actin cytoskeleton and increase the affinity of integrin for the ECM4-6. Here we report that depletion of talin2 in talin1-null (talin1(-/-)) cells did not affect the initiation of matrix-activated spreading or Src family kinase (sFK) activation, but abolished the ECM-integrin-cytoskeleton linkage and sustained cell spreading and adhesion. specifically, focal adhesion assembly, focal adhesion kinase (FAK) signalling and traction force generation on substrates were severely affected. the talin1 head domain restored beta 1 integrin activation but only full-length talin1 restored the ECM-cytoskeleton linkage and normal cytoskeleton organization. Our results demonstrate three biochemically distinct steps in fibronectin-activated cell spreading and adhesion: 1) fibronectin-integrin binding and initiation of spreading, 2) fast cell spreading and 3) focal adhesion formation and substrate traction. We suggest that talin is not required for initial cell spreading. However, talin provides the important mechanical linkage between ligand-bound integrins and the actin cytoskeleton required to catalyse focal adhesion-dependent pathways.	[Zhang, Xian; Jiang, Guoying; Cai, Yunfei; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Columbia University; University of Leicester	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ms2001@columbia.edu		Monkley, Susan/0000-0001-9174-6278	National Institutes of Health [PN2 EY016586]; Wellcome Trust;  [GM-003267]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. De Camilli for talin2-specific antibody, N. Bate for various talin1 constructs and A.J. Woods for the talin1<SUP>ABS</SUP> construct. We thank N. Gauthier, T. Perez and O. Rossier for helpful discussions, and the continuing help from all members of the Sheetz laboratory. Work in the laboratory of M.P.S. was supported by the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY016586) and X.Z. was supported by GM-003267. Work in the D.R.C. laboratory was funded by the Wellcome Trust.	Bailly M, 1998, MICROSC RES TECHNIQ, V43, P433, DOI 10.1002/(SICI)1097-0029(19981201)43:5<433::AID-JEMT9>3.0.CO;2-2; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061	30	334	357	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1062	1068		10.1038/ncb1765	http://dx.doi.org/10.1038/ncb1765			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160486	Green Accepted			2022-12-27	WOS:000258910400011
J	Sen, N; Hara, MR; Kornberg, MD; Cascio, MB; Bae, BI; Shahani, N; Thomas, B; Dawson, TM; Dawson, VL; Snyder, SH; Sawa, A				Sen, Nilkantha; Hara, Makoto R.; Kornberg, Michael D.; Cascio, Matthew B.; Bae, Byoung-Il; Shahani, Neelam; Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira			Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis	NATURE CELL BIOLOGY			English	Article							NERVE GROWTH-FACTOR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; COACTIVATORS P300; CELL-DEATH; P53; CBP; TRANSCRIPTION; PROTEIN; INVOLVEMENT; CBP/P300	Besides its role in glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) initiates a cell death cascade(1-9). Diverse apoptotic stimuli activate inducible nitric oxide synthase ( iNOS) or neuronal NOS ( nNOS), with the generated nitric oxide ( NO) S-nitrosylating GAPDH, abolishing its catalytic activity and conferring on it the ability to bind to Siah1, an E3-ubiquitin-ligase with a nuclear localization signal (NLS). The GAPDH-Siah1 protein complex, in turn, translocates to the nucleus and mediates cell death; these processes are blocked by procedures that interfere with GAPDH-Siah1 binding. Nuclear events induced by GAPDH to kill cells have been obscure. Here we show that nuclear GAPDH is acetylated at Lys 160 by the acetyltransferase p300/CREB binding protein (CBP) through direct protein interaction, which in turn stimulates the acetylation and catalytic activity of p300/CBP. Consequently, downstream targets of p300/CBP, such as p53 (refs 10-15), are activated and cause cell death. A dominant-negative mutant GAPDH with the substitution of Lys 160 to Arg (GAPDH-K160R) prevents activation of p300/CBP, blocks induction of apoptotic genes and decreases cell death. Our findings reveal a pathway in which NO-induced nuclear GAPDH mediates cell death through p300/CBP.	[Sen, Nilkantha; Hara, Makoto R.; Kornberg, Michael D.; Cascio, Matthew B.; Bae, Byoung-Il; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Shahani, Neelam; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Thomas, Bobby; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Hara, Makoto R.; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu; asawa1@jhmi.edu	Kornberg, Michael Davin/K-3329-2019; Dawson, Valina/Y-9757-2019; Sen, Nilkantha/AAW-9788-2020	Kornberg, Michael Davin/0000-0003-2588-7325; Dawson, Valina/0000-0002-2915-3970; BAE, BYOUNG-IL/0000-0002-9958-678X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS048206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, Z01DA000226, P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [K05 DA000074-29, K05 DA000074, P50 DA000266-37, DA-00074, DA-00266, P50 DA000266, DA-00226] Funding Source: Medline; NIMH NIH HHS [R01 MH069853, MH-069853] Funding Source: Medline; NINDS NIH HHS [NS-38377, P50 NS038377, R01 NS048206, NS-48206] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen RW, 1999, J NEUROSCI, V19, P9654; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dhakshinamoorthy S, 2007, NUCLEIC ACIDS RES, V35, P5439, DOI 10.1093/nar/gkm594; Frade JM, 1996, NATURE, V383, P166; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ishitani R, 1996, J NEUROCHEM, V66, P928; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Kung AL, 2000, GENE DEV, V14, P272; Li CQ, 2004, CANCER RES, V64, P3022, DOI 10.1158/0008-5472.CAN-03-1880; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648	38	301	317	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					866	873		10.1038/ncb1747	http://dx.doi.org/10.1038/ncb1747			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552833	Green Accepted			2022-12-27	WOS:000257268400016
J	Gestaut, DR; Graczyk, B; Cooper, J; Widlund, PO; Zelter, A; Wordeman, L; Asbury, CL; Davis, TN				Gestaut, Daniel R.; Graczyk, Beth; Cooper, Jeremy; Widlund, Per O.; Zelter, Alex; Wordeman, Linda; Asbury, Charles L.; Davis, Trisha N.			Phosphoregulation and depolymerization-driven movement of the Dam1 complex do not require ring formation	NATURE CELL BIOLOGY			English	Article							KINETOCHORE-MICROTUBULE INTERFACE; MITOTIC SPINDLE INTEGRITY; YEAST DASH COMPLEX; PROTEIN INTERACTIONS; DUO1P/DAM1P COMPLEX; KINASE; FORCE; MECHANISMS; ATTACHMENT; SUBUNITS	During mitosis, kinetochores form persistent attachments to microtubule tips and undergo corrective detachment in response to phosphorylation by Ipl1 ( Aurora B) kinase(1). the Dam1 complex is required to establish and maintain bi-oriented attachment to microtubule tips in vivo, and it contains multiple sites phosphorylated by Ipl1 ( refs 2-10). Moreover, a number of kinetochore-like functions can be reconstituted in vitro with pure Dam1 complex(11-14). these functions are believed to derive from the ability of the complex to self-assemble into rings(12,13,15-17). Here we show that rings are not necessary for dynamic microtubule attachment, Ipl1-dependent modulation of microtubule affinity or the ability of Dam1 to move processively with disassembling microtubule tips. Using two fluorescence-based assays, we found that the complex exhibited a high affinity for microtubules ( K-d of approximately 6 nM) that was reduced by phosphorylation at ser 20, a single Ipl1 target residue in Dam1. Moreover, individual complexes underwent one-dimensional diffusion along microtubules and detached 2.5-fold more frequently after phosphorylation by Ipl1. Particles consisting of one to four Dam1 complexes - too few to surround a microtubule - were captured and carried by disassembling tips. thus, even a small number of binding elements could provide a dynamic, phosphoregulated microtubule attachment and thereby facilitate accurate chromosome segregation.	[Gestaut, Daniel R.; Graczyk, Beth; Widlund, Per O.; Zelter, Alex; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Cooper, Jeremy; Wordeman, Linda; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Davis, TN (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	tdavis@u.washington.edu	Davis, Trisha/F-8584-2010; Widlund, Per/J-1238-2019	Widlund, Per/0000-0002-3645-0009; Wordeman, Linda/0000-0002-9444-0650; Davis, Trisha/0000-0003-4797-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, R01GM040506, R01GM069429] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM79373, R01 GM079373, R01 GM040506, R01GM69429, R01 GM069429, R01 GM040506-19, R01GM40506] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cantor C. R., 1980, BIOPHYSICAL CHEM, VI; CANTOR CR, 1980, BIOPHYSICAL CHEM, V3; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franco A, 2007, J CELL SCI, V120, P3345, DOI 10.1242/jcs.013698; Gunawardane RN, 2001, METHOD CELL BIOL, V67, P1; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Jones MH, 2001, P NATL ACAD SCI USA, V98, P13675, DOI 10.1073/pnas.241417098; Karp G., 2007, CELL MOL BIOL; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McIntosh JR, 2005, NAT STRUCT MOL BIOL, V12, P210, DOI 10.1038/nsmb0305-210; Miranda JJL, 2007, MOL BIOL CELL, V18, P2503, DOI 10.1091/mbc.E07-02-0135; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Press W.H., 1996, NUMERICAL RECIPES FO, Vsecond; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Wang HW, 2007, NAT STRUCT MOL BIOL, V14, P721, DOI 10.1038/nsmb1274; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	41	119	122	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					407	U70		10.1038/ncb1702	http://dx.doi.org/10.1038/ncb1702			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364702	Green Accepted			2022-12-27	WOS:000254561700010
J	Nakamura, M; Ehrhardt, DW; Hashimoto, T				Nakamura, Masayoshi; Ehrhardt, David W.; Hashimoto, Takashi			Microtubule and katanin-dependent dynamics of microtubule nucleation complexes in the acentrosomal Arabidopsis cortical array	NATURE CELL BIOLOGY			English	Article							GAMMA-TUBULIN COMPLEX; ORGANIZATION; CYTOSKELETON; FUSION; SITES	Microtubule nucleation in interphase plant cells primarily occurs through branching from pre-existing microtubules at dispersed sites in the cell cortex(1,2,3). The minus ends of new microtubules are often released from the sites of nucleation, and the free microtubules are then transported to new locations by polymer treadmilling(1). These nucleation-and-release events are characteristic features of plant arrays in interphase cells, but little is known about the spatiotemporal control of these events by nucleating protein complexes. We visualized the dynamics of two fluorescently-tagged gamma-tubulin complex proteins, GCP2 and GCP3, in Arabidopsis thaliana. These probes labelled motile complexes in the cytosol that transiently stabilized at fixed locations in the cell cortex. Recruitment of labelled complexes occurred preferentially along existing cortical microtubules, from which new microtubule was synthesized in a branching manner, or in parallel to the existing microtubule. Complexes localized to microtubules were approximately 10-fold more likely to display nucleation than were complexes recruited to other locations. Nucleating complexes remained stable until daughter microtubules were either completely depolymerized from their plus ends or released by katanin-dependent severing activity. These observations suggest that the nucleation complexes are primarily activated on association with microtubule lattices, and that nucleation complex stability depends on association with daughter microtubules and is regulated in part by katanin activity.	[Nakamura, Masayoshi; Hashimoto, Takashi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nara Institute of Science & Technology; Carnegie Institution for Science; Stanford University	Hashimoto, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan.	ehrhardt@stanford.edu; hasimoto@bs.naist.jp	Nakamura, Masayoshi/D-1979-2017	Nakamura, Masayoshi/0000-0002-7107-4942	JSPS; NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan; Carnegie Institution for Science;  [20370023]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Carnegie Institution for Science; 	We thank Y. Fukao and M. Fujiwara (The Plant Science Education Unit, NAIST) for the mass spectrometry analysis, T. Kato for providing the katanin alleles, and D. Moss and R. Gutierrez for helpful discussions. The Arabidopsis Biological Resource Center is acknowledged for providing the genomic clones. M.N. was supported by a JSPS Research Fellowship for Young Scientist. The work was partly supported by a grant (20370023) and Global CUE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan, to T.H., and by endowment funds of the Carnegie Institution for Science to D.W.E.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Binarova P, 2006, PLANT CELL, V18, P1199, DOI 10.1105/tpc.105.038364; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Ehrhardt DW, 2006, ANNU REV PLANT BIOL, V57, P859, DOI 10.1146/annurev.arplant.57.032905.105329; Erhardt M, 2002, J CELL SCI, V115, P2423; FU VGUV, 2005, ARABIDOPSIS */* CELL, V120, P687; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Galatis B, 2004, NEW PHYTOL, V161, P613, DOI 10.1046/j.1469-8137.2003.00986.x; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kong ZS, 2010, PLANT CELL, V22, P191, DOI 10.1105/tpc.109.071191; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; MAZIA D, 1984, EXP CELL RES, V153, P1, DOI 10.1016/0014-4827(84)90442-7; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pastuglia M, 2006, PLANT CELL, V18, P1412, DOI 10.1105/tpc.105.039644; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; WASTENEYS GO, 1989, J CELL SCI, V93, P705; Wasteneys GO, 2002, J CELL SCI, V115, P1345; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953	39	161	164	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1064	U49		10.1038/ncb2110	http://dx.doi.org/10.1038/ncb2110			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935636				2022-12-27	WOS:000283711500009
J	Mizushima, N; Levine, B				Mizushima, Noboru; Levine, Beth			Autophagy in mammalian development and differentiation	NATURE CELL BIOLOGY			English	Review							BROWN ADIPOSE-TISSUE; TRANSCRIPTION FACTOR NRF2; LIPID DROPLET FORMATION; BETA-CELL MASS; ERYTHROID-CELLS; MITOCHONDRIAL CLEARANCE; RETICULOCYTE MATURATION; ORGANELLE DEGRADATION; EMBRYONIC-DEVELOPMENT; PROTEIN-DEGRADATION	It has been known for many decades that autophagy, a conserved lysosomal degradation pathway, is highly active during differentiation and development. However, until the discovery of the autophagy-related (ATG) genes in the 1990s, the functional significance of this activity was unknown. Initially, genetic knockout studies of ATG genes in lower eukaryotes revealed an essential role for the autophagy pathway in differentiation and development. In recent years, the analyses of systemic and tissue-specific knockout models of ATG genes in mice has led to an explosion of knowledge about the functions of autophagy in mammalian development and differentiation. Here we review the main advances in our understanding of these functions.	[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Tokyo Medical & Dental University (TMDU); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444	Ministry of Education, Culture, Sports, Science and Technology, Japan; Toray Science Foundation; Takeda Science Foundation; National Institutes of Health [RO1 CA85254, RO1 CA109618, U54 AI057156]; NATIONAL CANCER INSTITUTE [R01CA084254, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Chick Kishi and Satoshi Tsukamoto for preparation of the images in Fig. 1a and Fig. 1b, respectively. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to N.M.), the Toray Science Foundation (to N.M.), the Takeda Science Foundation (to N.M.) and National Institutes of Health grants RO1 CA85254, RO1 CA109618 and U54 AI057156 (to B.L.).	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GRONOWICZ G, 1984, J CELL SCI, V71, P177; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; HEYNEN MJ, 1985, CELL TISSUE RES, V239, P235, DOI 10.1007/BF00214924; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; KENT G, 1966, AM J PATHOL, V48, P831; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kotoulas OB, 2006, PATHOL RES PRACT, V202, P631, DOI 10.1016/j.prp.2006.04.001; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MERZ EA, 1981, J REPROD FERTIL, V61, P415, DOI 10.1530/jrf.0.0610415; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Nolting N, 2009, FUNGAL GENET BIOL, V46, P531, DOI 10.1016/j.fgb.2009.03.008; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schiaffino S, 2008, AUTOPHAGY, V4, P727, DOI 10.4161/auto.6143; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121; Shibata M, 2009, BIOCHEM BIOPH RES CO, V382, P419, DOI 10.1016/j.bbrc.2009.03.039; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Takano-Ohmuro H, 2000, EUR J CELL BIOL, V79, P759, DOI 10.1078/0171-9335-00096; TOOZE J, 1965, J CELL BIOL, V24, P146, DOI 10.1083/jcb.24.1.146; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VANBLERKOM J, 1975, DEV BIOL, V44, P148, DOI 10.1016/0012-1606(75)90382-6; Vijayvergiya C, 2004, BIOCHEMISTRY-US, V43, P15296, DOI 10.1021/bi048745v; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	118	1082	1136	2	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					823	830		10.1038/ncb0910-823	http://dx.doi.org/10.1038/ncb0910-823			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811354	Green Published, Green Accepted			2022-12-27	WOS:000281561900003
J	Teo, HL; Ghosh, S; Luesch, H; Ghosh, A; Wong, ET; Malik, N; Orth, A; de Jesus, P; Perry, AS; Oliver, JD; Tran, NL; Speiser, LJ; Wong, M; Saez, E; Schultz, P; Chanda, SK; Verma, IM; Tergaonkar, V				Teo, Hsiangling; Ghosh, Sourav; Luesch, Hendrik; Ghosh, Arkasubhra; Wong, Ee Tsin; Malik, Najib; Orth, Anthony; de Jesus, Paul; Perry, Anthony S.; Oliver, Jeffrey D.; Tran, Nhan L.; Speiser, Lisa J.; Wong, Marc; Saez, Enrique; Schultz, Peter; Chanda, Sumit K.; Verma, Inder M.; Tergaonkar, Vinay			Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappa B-dependent gene expression	NATURE CELL BIOLOGY			English	Article							PATTERN-RECOGNITION RECEPTORS; IDENTIFICATION; APOPTOSIS; PATHWAYS; INNATE; CELLS; END; PHOSPHORYLATION; PROLIFERATION; PHOSPHATASE	We describe a genome-wide gain-of-function screen for regulators of NF-kappa B, and identify Rap1 (Trf2IP), as an essential modulator of NF-kappa B-mediated pathways. NF-kappa B is induced by ectopic expression of Rap1, whereas its activity is inhibited by Rap1 depletion. In addition to localizing on telomeres, mammalian Rap1 forms a complex with IKKs (I kappa B kinases), and is crucial for the ability of IKKs to be recruited to, and phosphorylate, the p65 subunit of NF-kappa B to make it transcriptionally competent. Rap1-mutant mice display defective NF-kappa B activation and are resistant to endotoxic shock. Furthermore, levels of Rap1 are positively regulated by NF-kappa B, and human breast cancers with NF-kappa B hyperactivity show elevated levels of cytoplasmic Rap1. Similar to inhibiting NF-kappa B, knockdown of Rap1 sensitizes breast cancer cells to apoptosis. These results identify the first cytoplasmic role of Rap1 and provide a mechanism through which it regulates an important signalling cascade in mammals, independent of its ability to regulate telomere function.	[Teo, Hsiangling; Ghosh, Arkasubhra; Wong, Ee Tsin; Malik, Najib; Wong, Marc; Tergaonkar, Vinay] Lab NFkB Signaling, Singapore 138673, Singapore; [Ghosh, Sourav; Speiser, Lisa J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85440 USA; [Luesch, Hendrik] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA; [Orth, Anthony; de Jesus, Paul; Saez, Enrique; Schultz, Peter; Chanda, Sumit K.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Perry, Anthony S.; Oliver, Jeffrey D.] St Josephs Hosp, Dept Pathol, Phoenix, AZ 85004 USA; [Perry, Anthony S.; Oliver, Jeffrey D.] Med Ctr, Phoenix, AZ 85004 USA; [Tran, Nhan L.] Translat Genom Res Inst, CNS Tumour Res Lab, Phoenix, AZ 85004 USA; [Chanda, Sumit K.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of Arizona; State University System of Florida; University of Florida; Novartis; St. Joseph's Hospital and Medical Center; Translational Genomics Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute	Tergaonkar, V (corresponding author), Lab NFkB Signaling, Singapore 138673, Singapore.	vinayt@imcb.a-star.edu.sg		Ghosh, Sourav/0000-0001-5990-8708; Teo, Hsiang Ling/0000-0002-3849-809X; Ghosh, Arkasubhra/0000-0002-6570-5891	Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star); Leducq Foundation; Meriaux Foundation; Ellison Medical Foundation; Ipsen/Biomeasure; Sanofi Aventis; H.N. and Frances C. Berger Foundation	Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star)(Agency for Science Technology & Research (A*STAR)); Leducq Foundation(Leducq Foundation); Meriaux Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); Sanofi Aventis(Sanofi-Aventis); H.N. and Frances C. Berger Foundation	We wish to thank the Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star) for funding and support to the V.T. laboratory. I.M.V. is an American Cancer Society Professor of Molecular Biology, and holds the Joan and Irwin Jacobs Chair in Exemplary Life Sciences. This work was supported in part by grants from the Leducq Foundation, Meriaux Foundation, Ellison Medical Foundation, Ipsen/Biomeasure, Sanofi Aventis, and the H.N. and Frances C. Berger Foundation. We thank T. Murphy and N. Tonnu for help with the intial investigations involved in this work. We are grateful to B. Li and T. De Lange for Rap1, deletion constructs and P. Lieberman for the Rap1 shRNA vector. We thank J. Karlseder for helpful discussions.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BATES PW, 2004, SCI STKE, pPE48, DOI DOI 10.1126/STKE.2542004PE48; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Dey A, 2008, CELL DEATH DIFFER, V15, P263, DOI 10.1038/sj.cdd.4402257; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Luesch H, 2006, NAT CHEM BIOL, V2, P158, DOI 10.1038/nchembio769; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Price CM, 2007, MOL CELL, V26, P463, DOI 10.1016/j.molcel.2007.05.005; Rao CV, 2004, J BIOL CHEM, V279, P25503, DOI 10.1074/jbc.M400683200; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; XIA Y, 2009, P NATL ACAD SCI US; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044	63	147	156	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					758	U26		10.1038/ncb2080	http://dx.doi.org/10.1038/ncb2080			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622870				2022-12-27	WOS:000280561600008
J	Nozawa, RS; Nagao, K; Masuda, HT; Iwasaki, O; Hirota, T; Nozaki, N; Kimura, H; Obuse, C				Nozawa, Ryu-Suke; Nagao, Koji; Masuda, Hiro-Taka; Iwasaki, Osamu; Hirota, Toru; Nozaki, Naohito; Kimura, Hiroshi; Obuse, Chikashi			Human POGZ modulates dissociation of HP1 alpha from mitotic chromosome arms through Aurora B activation	NATURE CELL BIOLOGY			English	Article							HP1 PROTEINS; PERICENTRIC HETEROCHROMATIN; KINETOCHORE PROTEIN; OUTER KINETOCHORE; HUMAN-CELLS; COMPLEX; METHYLATION; DOMAIN; GENE; CENTROMERE	Heterochromatin protein 1 (HP1) has an essential role in heterochromatin formation and mitotic progression through its interaction with various proteins. We have identified a unique HP1 alpha-binding protein, POGZ (pogo transposable element-derived protein with zinc finger domain), using an advanced proteomics approach. Proteins generally interact with HP1 through a PxVxL (where x is any amino-acid residue) motif; however, POGZ was found to bind to HP1 alpha through a zinc-finger-like motif. Binding by POGZ, mediated through its zinc-finger-like motif, competed with PxVxL proteins and destabilized the HP1 alpha-chromatin interaction. Depletion experiments confirmed that the POGZ HP1-binding domain is essential for normal mitotic progression and dissociation of HP1 alpha from mitotic chromosome arms. Furthermore, POGZ is required for the correct activation and dissociation of Aurora B kinase from chromosome arms during M phase. These results reveal POGZ as an essential protein that links HP1 alpha dissociation with Aurora B kinase activation during mitosis.	[Nozawa, Ryu-Suke; Nagao, Koji; Masuda, Hiro-Taka; Iwasaki, Osamu; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Nagao, Koji] Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan; [Hirota, Toru] Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan; [Nozaki, Naohito] Kanagawa Dent Coll, Yokosuka, Kanagawa 2388580, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Hokkaido University; Okinawa Institute of Science & Technology Graduate University; Japanese Foundation for Cancer Research; Kanagawa Dental College; Osaka University	Obuse, C (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan.	obuse@sci.hokudai.ac.jp	Kimura, Hiroshi/B-9524-2015; Nagao, Koji/F-5281-2011; Obuse, Chikashi/F-5273-2011	Kimura, Hiroshi/0000-0003-0854-083X; Nagao, Koji/0000-0003-1418-6988	JSPS (Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Inamori; Matrix Science K.K. Foundations; Uehara Memorial; Naito; Mochida Memorial	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Inamori; Matrix Science K.K. Foundations; Uehara Memorial; Naito; Mochida Memorial	We thank D. Goto, J. Nakayama, K. Hamada, Y. Murakami, G. Almouzni and M. Yanagida for comments, Y. Shinkai, M. Tachibana, M. Yanagida, T. Kiyomitsu, K. Yoda, S. Hatakeyama, K. Hanada, T. Kitamura, A. Imura and J-M. Peters for materials, T. Iwanaga and N. Sakai for technical instruction, and E. Ono for administration. R-S.N. was supported by a JSPS (Japan Society for the Promotion of Science) special fellowship. This work was supported by grants-in-aid from MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan, and by Inamori, Uehara Memorial, Naito, Mochida Memorial and Matrix Science K.K. Foundations (C.O.).	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; HAYASHITAKANAKA Y, 2009, J CELL BIOL; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KIYOMITSU T, 2010, J CELL BIOL; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Pouwels J, 2007, CELL CYCLE, V6, P1579, DOI 10.4161/cc.6.13.4442; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	58	168	181	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					719	U212		10.1038/ncb2075	http://dx.doi.org/10.1038/ncb2075			35	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20562864				2022-12-27	WOS:000279374400016
J	Noble, KN; Wente, SR				Noble, Kristen N.; Wente, Susan R.			Nuclear mRNA on the move	NATURE CELL BIOLOGY			English	Editorial Material							TRANSLOCATION; TRACKS; EXPORT	Innovations in live-cell microscopy and single-molecule analysis have allowed a new direct view of nuclear messenger RNA dynamics. A new study extends previous analyses of mRNA-protein intranuclear transport and links this critical step to the kinetics of moving through nuclear pore complexes. Seeing nuclear mRNA on the move will impact future work on pore translocation and nuclear organization.	[Noble, Kristen N.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Noble, Kristen N.] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; Meharry Medical College	Noble, KN (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu		Noble, Kristen/0000-0003-3396-3172	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM051219] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; MEIER UT, 1992, CELL, V70, P127; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; YAMADA J, 2010, MOL CELL PR IN PRESS	15	5	5	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					525	527		10.1038/ncb0610-525	http://dx.doi.org/10.1038/ncb0610-525			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20517300				2022-12-27	WOS:000278213400003
J	Pant, S; Sharma, M; Patel, K; Caplan, S; Carr, CM; Grant, BD				Pant, Saumya; Sharma, Mahak; Patel, Kruti; Caplan, Steve; Carr, Chavela M.; Grant, Barth D.			AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling	NATURE CELL BIOLOGY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; EARLY ENDOSOMAL TRANSPORT; CAENORHABDITIS-ELEGANS; EH-DOMAIN; DROSOPHILA AMPHIPHYSIN; MEDIATED ENDOCYTOSIS; MEMBRANE FISSION; SH3 DOMAIN; C-ELEGANS; DYNAMIN	RME-1/EHD1 (receptor mediated endocytosis/Eps15 homology-domain containing 1) family proteins are key residents of the recycling endosome, which are required for endosome-to-plasma membrane transport in Caenorhabditis elegans and mammals. Recent studies suggest similarities between the RME-1/EHD proteins and the Dynamin GTPase superfamily of mechanochemical pinchases, which promote membrane fission. Here we show that endogenous C. elegans AMPH-1, the only C. elegans member of the Amphiphysin/ BIN1 family of BAR (Bin1-Amphiphysin-Rvs161p/167p)-domain-containing proteins, colocalizes with RME-1 on recycling endosomes in vivo, that amph-1-deletion mutants are defective in recycling endosome morphology and function, and that binding of AMPH-1 Asn-Pro-Phe(Asp/Glu) sequences to the RME-1 EH-domain promotes the recycling of transmembrane cargo. We also show a requirement for human BIN1 ( also known as Amphiphysin 2) in EHD1-regulated endocytic recycling. In vitro, we find that purified recombinant AMPH-1-RME-1 complexes produce short, coated membrane tubules that are qualitatively distinct from those produced by either protein alone. Our results indicate that AMPH-1 and RME-1 cooperatively regulate endocytic recycling, probably through functions required for the production of cargo carriers that exit the recycling endosome for the cell surface.	[Pant, Saumya; Patel, Kruti; Grant, Barth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Carr, Chavela M.] Univ Med & Dent New Jersey, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Sharma, Mahak; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Nebraska System; University of Nebraska Medical Center	Grant, BD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	grant@biology.rutgers.edu	Sharma, Mahak/AAE-9071-2019	Sharma, Mahak/0000-0002-4117-4790; Grant, Barth/0000-0002-5943-8336	NIH [GM67237, GM074876]; NJCSCR [06-2915-SCR-E-0]; Anne B. and James B. Leathem Fellowship; McCallum Fund Fellowship; American Heart Association; Rutgers Summer Undergraduate Research Fellowship (SURF);  [R24RR22234]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237, R01GM074876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCSCR; Anne B. and James B. Leathem Fellowship; McCallum Fund Fellowship; American Heart Association(American Heart Association); Rutgers Summer Undergraduate Research Fellowship (SURF); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. McPherson, Z. Zhou, B. Kay, G. Prandergast and S. Mitani for important reagents. The monoclonal against RME- 1 was made at Washington University School of Medicine and funded by Grant R24RR22234 ( PI M. L. Nonet). We also thank C. Martin, P. Yurchenco, D. Winkelman, F. Matsumura, S. Yamashiro and S. H. deGregori for sharing their instruments, reagents and protocols; A. Shi for the construction and gift of the GFP-SDPN-1 strain; R. Patel and V. Starovoytov for expert assistance with electron microscopy protocols and Z. Pan for usage of the confocal microscopy facility; O. Daumke and T. Pucadyil for discussions and advice on liposome tubulation experiments; P. Schweinsberg for technical assistance. This work was supported by NIH Grants GM67237 to B. D. G and GM074876 to S. C., a NJCSCR Graduate Fellowship 06-2915-SCR-E-0, an Anne B. and James B. Leathem Fellowship, a McCallum Fund Fellowship Grant to S. P., an American Heart Association student fellowship to M. S. and a Rutgers Summer Undergraduate Research Fellowship (SURF) to K. P.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BASHKIROV PV, 2008, CELL; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; BRENNER S, 1974, GENETICS, V77, P71; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Choi JY, 1996, J BIOL CHEM, V271, P3581; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Farsad K, 2003, NEUROPHARMACOLOGY, V45, P787, DOI 10.1016/S0028-3908(03)00306-X; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; GRANT BD, 2008, TRAFFIC; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leventis PA, 2001, TRAFFIC, V2, P839; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Olesen LE, 2008, J BIOL CHEM, V283, P5099, DOI 10.1074/jbc.M708621200; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Praitis V, 2001, GENETICS, V157, P1217; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takei K, 2001, METHOD ENZYMOL, V329, P478; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	50	138	142	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1399	U38		10.1038/ncb1986	http://dx.doi.org/10.1038/ncb1986			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19915558	Green Accepted			2022-12-27	WOS:000272251300005
J	Rodier, F; Coppe, JP; Patil, CK; Hoeijmakers, WAM; Munoz, DP; Raza, SR; Freund, A; Campeau, E; Davalos, AR; Campisi, J				Rodier, Francis; Coppe, Jean-Philippe; Patil, Christopher K.; Hoeijmakers, Wieteke A. M.; Munoz, Denise P.; Raza, Saba R.; Freund, Adam; Campeau, Eric; Davalos, Albert R.; Campisi, Judith			Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion	NATURE CELL BIOLOGY			English	Article							ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; GROWTH-FACTOR; HUMAN-CELLS; P53; CANCER; TUMORIGENESIS; BARRIER; ROLES	Cellular senescence suppresses cancer by stably arresting the proliferation of damaged cells(1). Paradoxically, senescent cells also secrete factors that alter tissue microenvironments(2). The pathways regulating this secretion are unknown. We show that damaged human cells develop persistent chromatin lesions bearing hallmarks of DNA double-strand breaks (DSBs), which initiate increased secretion of inflammatory cytokines such as interleukin-6 (IL-6). Cytokine secretion occurred only after establishment of persistent DNA damage signalling, usually associated with senescence, not after transient DNA damage responses (DDRs). Initiation and maintenance of this cytokine response required the DDR proteins ATM, NBS1 and CHK2, but not the cell-cycle arrest enforcers p53 and pRb. ATM was also essential for IL-6 secretion during oncogene-induced senescence and by damaged cells that bypass senescence. Furthermore, DDR activity and IL-6 were elevated in human cancers, and ATM-depletion suppressed the ability of senescent cells to stimulate IL-6-dependent cancer cell invasiveness. Thus, in addition to orchestrating cell-cycle checkpoints and DNA repair, a new and important role of the DDR is to allow damaged cells to communicate their compromised state to the surrounding tissue.	[Rodier, Francis; Coppe, Jean-Philippe; Patil, Christopher K.; Hoeijmakers, Wieteke A. M.; Raza, Saba R.; Freund, Adam; Campeau, Eric; Davalos, Albert R.; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Rodier, Francis; Munoz, Denise P.; Campisi, Judith] Buck Inst Age Res, Novato, CA 94545 USA; [Freund, Adam] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; University of California System; University of California Berkeley	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jcampisi@lbl.gov	Raza, Rizwan/B-4526-2012; Hoeijmakers, Wieteke/E-4022-2012	Raza, Rizwan/0000-0003-0599-3630; Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG017242, AG025708]; CABCRP [11IB-0153]; Larry L. Hillblom Foundation; Netherlands Organization for International Cooperation in Higher Education [HSP-TP 06/78]; Dutch Cancer Society; Department of Energy [DE-AC03-76SF00098]; NATIONAL INSTITUTE ON AGING [P01AG017242, P30AG025708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CABCRP; Larry L. Hillblom Foundation; Netherlands Organization for International Cooperation in Higher Education; Dutch Cancer Society(KWF Kankerbestrijding); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Beausejour (grant CIHR # MPO-79317) for help in the design of a modified lentiviral expression system, R. Teachenor, V. Chu and G. Tang for valuable technical assistance, and P. Desprez for insightful comments on the manuscript. This work was supported by National Institutes of Health grants AG017242 (J.C.) and AG025708 (Buck Institute), a CABCRP grant 11IB-0153 (A. R. D.), a Larry L. Hillblom Foundation fellowship (C. K. P.), the Netherlands Organization for International Cooperation in Higher Education (Nuffic, HSP-TP 06/78), the Dutch Cancer Society (W. A. M. H.), and the Department of Energy under contract DE-AC03-76SF00098 to the University of California.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caruso C, 2004, ANN NY ACAD SCI, V1028, P1, DOI 10.1196/annals.1322.001; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	31	1359	1400	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					973	U142		10.1038/ncb1909	http://dx.doi.org/10.1038/ncb1909			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19597488	Green Accepted			2022-12-27	WOS:000268593200011
J	Kato, M; Putta, S; Wang, M; Yuan, H; Lanting, L; Nair, I; Gunn, A; Nakagawa, Y; Shimano, H; Todorov, I; Rossi, JJ; Natarajan, R				Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Lanting, Linda; Nair, Indu; Gunn, Amanda; Nakagawa, Yoshimi; Shimano, Hitoshi; Todorov, Ivan; Rossi, John J.; Natarajan, Rama			TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; DIABETIC KIDNEY-DISEASE; FIBRONECTIN PRODUCTION; EXPRESSION; HYPERTROPHY; NEPHROPATHY; PATHWAY; TRANSCRIPTION; CELLS; TFE3	Akt kinase is activated by transforming growth factor-beta 1 (TGF-beta) in diabetic kidneys, and has important roles in fibrosis, hypertrophy and cell survival in glomerular mesangial cells(1-11). However, the mechanisms of Akt activation by TGF-beta are not fully understood. Here we show that TGF-beta activates Akt in glomerular mesangial cells by inducing the microRNAs (miRNAs) miR-216a and miR-217, both of which target PTEN (phosphatase and tensin homologue), an inhibitor of Akt activation. These miRNAs are located within the second intron of a non-coding RNA (RP23-298H6.1-001). The RP23 promoter was activated by TGF-beta and miR-192 through E-box-regulated mechanisms, as shown previously(3). Akt activation by these miRs led to glomerular mesangial cell survival and hypertrophy, which were similar to the effects of activation by TGF-beta. These studies reveal a mechanism of Akt activation through PTEN downregulation by two miRs, which are regulated by upstream miR-192 and TGF-beta. Due to the diversity of PTEN function(12,13), this miR-amplifying circuit may have key roles, not only in kidney disorders, but also in other diseases.	[Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Lanting, Linda; Nair, Indu; Todorov, Ivan; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Gonda Diabet Ctr, Duarte, CA 91010 USA; [Putta, Sumanth; Gunn, Amanda; Rossi, John J.; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Metab & Endocrinol, Tsukuba, Ibaraki 3058575, Japan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Tsukuba	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Gonda Diabet Ctr, Duarte, CA 91010 USA.	mkato@coh.org; rnatarajan@coh.org	Kato, Mitsuo/D-5411-2009; Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020; putta, sumanth/E-3933-2010	Shimano, Hitoshi/0000-0002-5562-5572; Kato, Mitsuo/0000-0002-1783-1084	NIH; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081705, R21DK076669] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH-National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation (to RN). We are grateful to M.C.-T. Hu for a generous gift of plasmids (pFRE-Luc and FoxO3a-GFP), L. Wang and J. Arizala for technical assistance and S. DaCosta for editing the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Omori K, 2007, AM J TRANSPLANT, V7, P1224, DOI 10.1111/j.1600-6143.2007.01741.x; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200	34	481	508	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					881	U263		10.1038/ncb1897	http://dx.doi.org/10.1038/ncb1897			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543271	Green Accepted			2022-12-27	WOS:000267603100018
J	Lee, M; Choi, Y; Burla, B; Kim, YY; Jeon, B; Maeshima, M; Yoo, JY; Martinoia, E; Lee, Y				Lee, Miyoung; Choi, Yongwook; Burla, Bo; Kim, Yu-Young; Jeon, Byeongwook; Maeshima, Masayoshi; Yoo, Joo-Yeon; Martinoia, Enrico; Lee, Youngsook			The ABC transporter AtABCB14 is a malate importer and modulates stomatal response to CO2	NATURE CELL BIOLOGY			English	Article							BINDING CASSETTE TRANSPORTER; GUARD-CELLS; PLASMA-MEMBRANE; ANION CHANNELS; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; DICARBOXYLATE TRANSPORTER; ABSCISIC-ACID; ATMRP5; HOMEOSTASIS	Carbon dioxide uptake and water vapour release in plants occur through stomata, which are formed by guard cells. These cells respond to light intensity, CO2 and water availability, and plant hormones(1,2). The predicted increase in the atmospheric concentration of CO2 is expected to have a profound effect on our ecosystem. However, many aspects of CO2-dependent stomatal movements are still not understood(3). Here we show that the ABC transporter AtABCB14 modulates stomatal closure on transition to elevated CO2. Stomatal closure induced by high CO2 levels was accelerated in plants lacking AtABCB14. Apoplastic malate has been suggested to be one of the factors mediating the stomatal response to CO2 (refs 4, 5) and indeed, exogenously applied malate induced a similar AtABCB14-dependent response as high CO2 levels. In isolated epidermal strips that contained only guard cells, malate-dependent stomatal closure was faster in plants lacking the AtABCB14 and slower in AtABCB14-overexpressing plants, than in wild-type plants, indicating that AtABCB14 catalyses the transport of malate from the apoplast into guard cells. Indeed, when AtABCB14 was heterologously expressed in Escherichia coli and HeLa cells, increases in malate transport activity were observed. We therefore suggest that AtABCB14 modulates stomatal movement by transporting malate from the apoplast into guard cells, thereby increasing their osmotic pressure.	[Lee, Miyoung; Burla, Bo; Kim, Yu-Young; Jeon, Byeongwook; Martinoia, Enrico; Lee, Youngsook] Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea; [Lee, Miyoung; Choi, Yongwook; Kim, Yu-Young; Jeon, Byeongwook; Yoo, Joo-Yeon; Martinoia, Enrico; Lee, Youngsook] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Burla, Bo; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bio Agr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Zurich; Nagoya University	Lee, Y (corresponding author), Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea.	ylee@postech.ac.kr	Martinoia, Enrico/AAH-8712-2021; Maeshima, Masayoshi/D-3073-2013; Burla, Bo/J-2850-2013; Lee, Youngsook/E-6578-2016	Maeshima, Masayoshi/0000-0002-1611-5481; Burla, Bo/0000-0002-5918-3249; Lee, Youngsook/0000-0002-5808-9613	Ministry of Science and Technology of Korea; Swiss National Foundation	Ministry of Science and Technology of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Swiss National Foundation(Swiss National Science Foundation (SNSF))	We thank N. Amrhein, Swiss Federal School of Technology for reading the manuscript, A. Vavasseur for helpful discussion on gas-exchange measurements and M. Schellenberg for making section images of AtABCB14:GUS. This project was supported by the Global Research Laboratory programme of the Ministry of Science and Technology of Korea. The work in the laboratory of E. M. was partially supported by the Swiss National Foundation.	Abel S, 1998, METH MOL B, V82, P209; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; HEDRICH R, 1994, PLANT J, V6, P741, DOI 10.1046/j.1365-313X.1994.6050741.x; HEDRICH R, 1993, EMBO J, V12, P897, DOI 10.1002/j.1460-2075.1993.tb05730.x; Hedrich R, 2001, PLANTA, V213, P594, DOI 10.1007/s004250100524; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Holland I. B., 2003, ABC PROTEINS BACTERI; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Hwang JU, 1997, PLANT PHYSIOL, V115, P335, DOI 10.1104/pp.115.2.335; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jeong JY, 2004, PLANT PHYSIOL, V134, P969, DOI 10.1104/pp.103.032102; KELLER BU, 1989, NATURE, V341, P450, DOI 10.1038/341450a0; Kimoto E, 2007, DRUG METAB PHARMACOK, V22, P307, DOI 10.2133/dmpk.22.307; Klein M, 2003, PLANT J, V33, P119, DOI 10.1046/j.1365-313X.2003.016012.x; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Raschke K, 2003, PLANTA, V217, P651, DOI 10.1007/s00425-003-1034-3; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHROEDER JI, 1995, PLANT MOL BIOL, V28, P353, DOI 10.1007/BF00020385; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VANKIRK CA, 1978, PLANT PHYSIOL, V61, P474, DOI 10.1104/pp.61.3.474; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103	35	199	211	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1217	1223		10.1038/ncb1782	http://dx.doi.org/10.1038/ncb1782			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18776898	Green Accepted			2022-12-27	WOS:000259682900016
J	Wanzel, M; Russ, AC; Kleine-Kohlbrecher, D; Colombo, E; Pelicci, PG; Eilers, M				Wanzel, Michael; Russ, Annika C.; Kleine-Kohlbrecher, Daniela; Colombo, Emanuela; Pelicci, Pier-Guiseppe; Eilers, Martin			A ribosomal protein L23-nucleophosmin circuit coordinates Miz1 function with cell growth	NATURE CELL BIOLOGY			English	Article							ARF TUMOR-SUPPRESSOR; RNA-POLYMERASE-I; NUCLEOPHOSMIN B23; DNA-DAMAGE; MYC TARGET; P53; TRANSCRIPTION; EXPRESSION; GENES; IDENTIFICATION	The Myc-associated zinc-finger protein, Miz1, is a negative regulator of cell proliferation and induces expression of the cell-cycle inhibitors p15(Ink4b) and p21(Cip1). Here we identify the ribosomal protein L23 as a negative regulator of Miz1-dependent transactivation. L23 exerts this function by retaining nucleophosmin, an essential co-activator of Miz1 required for Miz1-induced cell-cycle arrest, in the nucleolus. Mutant forms of nucleophosmin found in acute myeloid leukaemia fail to co-activate Miz1 and re-localize it to the cytosol. As L23 is encoded by a direct target gene of Myc, this regulatory circuit may provide a feedback mechanism that links translation of Myc target genes and cell growth to Miz1-dependent cell-cycle arrest.	[Wanzel, Michael; Russ, Annika C.; Eilers, Martin] Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany; [Kleine-Kohlbrecher, Daniela] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Colombo, Emanuela; Pelicci, Pier-Guiseppe] Inst Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Eilers, M (corresponding author), Inst Mol Biol & Tumor Res IMT, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	eilers@imt.uni-marburg.de	Pelicci, Pier Giuseppe/AAL-6572-2020; Colombo, Emanuela/AAO-8113-2020	Colombo, Emanuela/0000-0003-2079-7398; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft; Research Group Chromatin-mediated Biological Decisions	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Group Chromatin-mediated Biological Decisions	This study was supported by grants from the Deutsche Forschungsgemeinschaft through the Transregio 17 (Ras-dependent Pathways in Human Tumorigenesis) and the Research Group Chromatin-mediated Biological Decisions. The authors thank Katrien Berns and Rene Bernards for help with retroviral cloning techniques and Bianca Jebavy and Doris Dobrin for excellent technical support.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; den Besten W, 2005, CELL CYCLE, V4, P1593; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo QM, 2000, CANCER RES, V60, P5922; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78	44	84	88	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1051	1061		10.1038/ncb1764	http://dx.doi.org/10.1038/ncb1764			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160485				2022-12-27	WOS:000258910400010
J	Baker, DJ; Perez-Terzic, C; Jin, F; Pitel, K; Niederlander, NJ; Jeganathan, K; Yamada, S; Reyes, S; Rowe, L; Hiddinga, HJ; Eberhardt, NL; Terzic, A; van Deursen, JM				Baker, Darren J.; Perez-Terzic, Carmen; Jin, Fang; Pitel, Kevin; Niederlaender, Nicolas J.; Jeganathan, Karthik; Yamada, Satsuki; Reyes, Santiago; Rowe, Lois; Hiddinga, H. Jay; Eberhardt, Norman L.; Terzic, Andre; van Deursen, Jan M.			Opposing roles for p16(Ink4a) and p19(Arf) in senescence and ageing caused by BubR1 insufficiency	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; GENE-EXPRESSION; MICE DEFICIENT; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; ARF/P53 PATHWAY; MUTANT MICE; CANCER; CELLS; TUMORIGENESIS	Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.	[Baker, Darren J.; Jin, Fang; Pitel, Kevin; Jeganathan, Karthik; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediatr & Adolescent Med, Rochester, MN 55905 USA; [Perez-Terzic, Carmen] Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Niederlaender, Nicolas J.; Yamada, Satsuki; Reyes, Santiago; Rowe, Lois; Terzic, Andre] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; [Hiddinga, H. Jay; Eberhardt, Norman L.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Pediatr & Adolescent Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Baker, Darren/0000-0001-9006-1939; Jeganathan, KARTHIK/0000-0001-5587-1266; Niederlander, Nicolas/0000-0003-1323-8387	NATIONAL CANCER INSTITUTE [R01CA096985] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096985, R01 CA096985-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asahi M, 2005, J CEREBR BLOOD F MET, V25, P722, DOI 10.1038/sj.jcbfm.9600070; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Hengstschlager M, 1996, DNA CELL BIOL, V15, P41, DOI 10.1089/dna.1996.15.41; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Ohlson N, 2006, PROSTATE, V66, P1687, DOI 10.1002/pros.20368; Price S R, 1998, Curr Opin Clin Nutr Metab Care, V1, P79, DOI 10.1097/00075197-199801000-00013; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 1996, MECH AGEING DEV, V92, P121, DOI 10.1016/S0047-6374(96)01814-3; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	49	264	277	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					825	836		10.1038/ncb1744	http://dx.doi.org/10.1038/ncb1744			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18516091	Green Accepted			2022-12-27	WOS:000257268400012
J	Peplowska, K; Cabrera, M; Ungermann, C				Peplowska, Karolina; Cabrera, Margarita; Ungermann, Christian			UVRAG reveals its second nature	NATURE CELL BIOLOGY			English	Editorial Material							AUTOPHAGY; PROTEIN; COMPLEX		[Peplowska, Karolina; Cabrera, Margarita; Ungermann, Christian] Univ Osnabruck, Dept Biol, D-49076 Osnabruck, Germany	University Osnabruck	Peplowska, K (corresponding author), Univ Osnabruck, Dept Biol, Barbarastr 13, D-49076 Osnabruck, Germany.	ungermann@Biologie.uni-osnabrueck.de	Cabrera, Margarita/Y-1225-2019; Cabrera, Margarita/F-3306-2016	Cabrera, Margarita/0000-0002-2978-8255; Cabrera, Margarita/0000-0002-2978-8255				Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, AUTOPHAGY, V2, P321, DOI 10.4161/auto.3091; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551	12	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					759	761		10.1038/ncb0708-759	http://dx.doi.org/10.1038/ncb0708-759			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18591968				2022-12-27	WOS:000257268400005
J	Scaffidi, P; Misteli, T				Scaffidi, Paola; Misteli, Tom			Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing	NATURE CELL BIOLOGY			English	Article							HUTCHINSON-GILFORD-PROGERIA; NOTCH; PROTEIN; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; PHENOTYPE; HES; INHIBITION; EXPRESSION	The premature-ageing disease Hutchinson-Gilford Progeria Syndrome ( HGPS) is caused by constitutive production of progerin, a mutant form of the nuclear architectural protein lamin A(1,2). Progerin is also expressed sporadically in wildtype cells and has been linked to physiological ageing(3). Cells from HGPS patients exhibit extensive nuclear defects, including abnormal chromatin structure(4,5) and increased DNA damage(6). At the organismal level, HGPS affects several tissues, particularly those of mesenchymal origin(7). How the cellular defects of HGPS cells lead to the organismal defects has been unclear. Here, we provide evidence that progerin interferes with the function of human mesenchymal stem cells ( hMSCs). We find that expression of progerin activates major downstream effectors of the Notch signalling pathway. Induction of progerin in hMSCs changes their molecular identity and differentiation potential. Our results support a model in which accelerated ageing in HGPS patients, and possibly also physiological ageing, is the result of adult stem cell dysfunction and progressive deterioration of tissue functions.	[Scaffidi, Paola; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scaffidi, P (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	scaffidp@mail.nih.gov	Scaffidi, Paola/GRS-9019-2022	Scaffidi, Paola/0000-0002-3642-4193	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cau E, 2000, DEVELOPMENT, V127, P2323; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hansson EM, 2006, DEV NEUROSCI-BASEL, V28, P118, DOI 10.1159/000090758; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; PARADA LA, 2002, ESSENTIAL CELL BIOL, pCH2; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Vujovic S, 2007, CELL PROLIFERAT, V40, P185, DOI 10.1111/j.1365-2184.2007.00426.x; Wallis CV, 2004, EXP GERONTOL, V39, P461, DOI 10.1016/j.exger.2003.12.015; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	35	381	393	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					452	U167		10.1038/ncb1708	http://dx.doi.org/10.1038/ncb1708			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18311132	Green Accepted			2022-12-27	WOS:000254561700016
J	Loncarek, J; Hergert, P; Magidson, V; Khodjakov, A				Loncarek, Jadranka; Hergert, Polla; Magidson, Valentin; Khodjakov, Alexey			Control of daughter centriole formation by the pericentriolar material	NATURE CELL BIOLOGY			English	Article							DE-NOVO FORMATION; CELL-CYCLE PROGRESSION; HAMSTER OVARY CELLS; CENTROSOME DUPLICATION; VERTEBRATE CELLS; GAMMA-TUBULIN; ANIMAL-CELLS; HELA-CELLS; IN-VIVO; REPLICATION	Controlling the number of its centrioles is vital for the cell, as supernumerary centrioles cause multipolar mitosis and genomic instability(1,2). Normally, one daughter centriole forms on each mature (mother) centriole(3,4); however, a mother centriole can produce multiple daughters within a single cell cycle(5,6). The mechanisms that prevent centriole 'overduplication' are poorly understood. Here we use laser microsurgery to test the hypothesis that attachment of the daughter centriole to the wall of the mother inhibits formation of additional daughters(7,8). We show that physical removal of the daughter induces reduplication of the mother in S-phase-arrested cells. Under conditions when multiple daughters form simultaneously on a single mother, all of these daughters must be removed to induce reduplication. The number of daughter centrioles that form during reduplication does not always match the number of ablated daughter centrioles. We also find that exaggeration of the pericentriolar material (PCM) by overexpression of the PCM protein pericentrin(9) in S-phase-arrested CHO cells induces formation of numerous daughter centrioles. We propose that that the size of the PCM cloud associated with the mother centriole restricts the number of daughters that can form simultaneously.	[Loncarek, Jadranka; Hergert, Polla; Magidson, Valentin; Khodjakov, Alexey] New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA; [Khodjakov, Alexey] Woods Hole, Marine Biol Lab, Woods Hole, MA 02543 USA	State University of New York (SUNY) System; Wadsworth Center; Marine Biological Laboratory - Woods Hole; Woods Hole Oceanographic Institution	Khodjakov, A (corresponding author), New York State Dept Hlth, Div Mol Med, Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org		Loncarek, Jadranka/0000-0003-1879-5473; Magidson, Valentin/0000-0002-0780-9123	NIGMS NIH HHS [GM GM59363, R01 GM059363, R01 GM059363-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balczon R, 2001, CHROMOSOMA, V110, P381, DOI 10.1007/s004120100157; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Duensing A, 2007, ONCOGENE, V26, P6280, DOI 10.1038/sj.onc.1210456; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kim HK, 2005, J CELL BIOL, V169, P719, DOI 10.1083/jcb.200410052; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Paoletti A, 1996, J CELL SCI, V109, P3089; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Sluder G, 1996, CELL MOTIL CYTOSKEL, V33, P1, DOI 10.1002/(SICI)1097-0169(1996)33:1<1::AID-CM1>3.0.CO;2-H; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; STRNAD P, 2007, CELL, V13, P203; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Vidwans SJ, 2003, J CELL SCI, V116, P137, DOI 10.1242/jcs.00204; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047	37	159	163	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					322	U55		10.1038/ncb1694	http://dx.doi.org/10.1038/ncb1694			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297061	Green Accepted, Green Submitted			2022-12-27	WOS:000253778300014
J	Dumont, J; Oegema, K; Desai, A				Dumont, Julien; Oegema, Karen; Desai, Arshad			A kinetochore-independent mechanism drives anaphase chromosome separation during acentrosomal meiosis	NATURE CELL BIOLOGY			English	Article							AURORA-B KINASE; MEIOTIC SPINDLE; CAENORHABDITIS-ELEGANS; HOLOCENTRIC CHROMOSOMES; C-ELEGANS; SEGREGATION; COHESION; OOCYTES; MITOSIS	Although assembly of acentrosomal meiotic spindles has been extensively studied(1), little is known about the segregation of chromosomes on these spindles. Here, we show in Caenorhabditis elegans oocytes that the kinetochore protein, KNL-1, directs assembly of meiotic kinetochores that orient chromosomes. However, in contrast to mitosis, chromosome separation during meiotic anaphase is kinetochore-independent. Before anaphase, meiotic kinetochores and spindle poles disassemble along with the microtubules on the poleward side of chromosomes. During anaphase, microtubules then form between the separating chromosomes. Functional analysis implicated a set of proteins that localize to a ring-shaped domain between kinetochores during pre-anaphase spindle assembly and anaphase separation. These proteins are localized by the chromosomal passenger complex, which regulates the loss of meiotic chromosome cohesion(2-4). Thus, meiotic segregation in C. elegans is a two-stage process, where kinetochores orient chromosomes, but are then dispensable for their separation. We suggest that separation is controlled by a meiosis-specific chromosomal domain to coordinate cohesin removal and chromosome segregation.	[Dumont, Julien; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Dumont, Julien/G-6624-2013	Dumont, Julien/0000-0001-5312-9770	EMBO long-term postdoctoral fellowship; Human Frontiers Science Program [RGY0084]; NIH [GM074215]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Canman and R. Green for critical reading of the manuscript. This work was supported by an EMBO long-term postdoctoral fellowship to J.D., grants from Human Frontiers Science Program (RGY0084) and the NIH (GM074215) to A.D., and funding from the Ludwig Institute for Cancer Research to A.D. and K.O.	Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; de Carvalho CE, 2008, GENE DEV, V22, P2869, DOI 10.1101/gad.1691208; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005249; Dumont J, 2010, OOGENESIS UNIVERSAL, P269; Gilliland WD, 2007, PLOS GENET, V3, P1178, DOI 10.1371/journal.pgen.0030113; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	26	131	138	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					894	901		10.1038/ncb2093	http://dx.doi.org/10.1038/ncb2093			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729837	Green Accepted			2022-12-27	WOS:000281561900013
J	Urban, E; Jacob, S; Nemethova, M; Resch, GP; Small, JV				Urban, Edit; Jacob, Sonja; Nemethova, Maria; Resch, Guenter P.; Small, J. Victor			Electron tomography reveals unbranched networks of actin filaments in lamellipodia	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; LEADING-EDGE; DENDRITIC ORGANIZATION; CULTURED-CELLS; FILOPODIA; PROTRUSION; NUCLEATION; PROTEIN; POLYMERIZATION; LOCALIZATION	Eukaryotic cells can initiate movement using the forces exerted by polymerizing actin filaments to extend lamellipodial and filopodial protrusions. In the current model, actin filaments in lamellipodia are organized in a branched, dendritic network. We applied electron tomography to vitreously frozen 'live' cells, fixed cells and cytoskeletons, embedded in vitreous ice or in deep-negative stain. In lamellipodia from four cell types, including rapidly migrating fish keratocytes, we found that actin filaments are almost exclusively unbranched. The vast majority of apparent filament junctions proved to be overlapping filaments, rather than branched end-to-side junctions. Analysis of the tomograms revealed that actin filaments terminate at the membrane interface within a zone several hundred nanometres wide at the lamellipodium front, and yielded the first direct measurements of filament densities. Actin filament pairs were also identified as lamellipodium components and bundle precursors. These data provide a new structural basis for understanding actin-driven protrusion during cell migration.	[Urban, Edit; Jacob, Sonja; Nemethova, Maria; Resch, Guenter P.; Small, J. Victor] Inst Mol Biotechnol, A-1030 Vienna, Austria; [Resch, Guenter P.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Small, JV (corresponding author), Inst Mol Biotechnol, Dr Bohr Gasse 3-7, A-1030 Vienna, Austria.	vic.small@imba.oeaw.ac.at			Austrian Science Research Council; Vienna Science Research and Technology Fund (WWTF); City of Vienna/Zentrum fur Innovation und Technologie; Austrian Science Fund (FWF) [P 21292] Funding Source: researchfish	Austrian Science Research Council(Austrian Science Fund (FWF)); Vienna Science Research and Technology Fund (WWTF); City of Vienna/Zentrum fur Innovation und Technologie; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank T. Kulcsar for help with graphics, M. Brandstaetter for support in electron microscopy, T. Stradal and K. Rottner for the p16 ArpC5 construct, and R. Tsien for mCherry. J.V.S. was supported by the Austrian Science Research Council and the Vienna Science Research and Technology Fund (WWTF). G. P. R and J.V.S. acknowledge the support by the City of Vienna/Zentrum fur Innovation und Technologie through the spot of excellence grant "Center of Molecular and Cellular Nanostructure".	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Anderson KI, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P372; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Dickinson RB, 2009, J MATH BIOL, V58, P81, DOI 10.1007/s00285-008-0200-4; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Flinn HM, 1996, J CELL SCI, V109, P1133; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Hoglund A S, 1980, J Muscle Res Cell Motil, V1, P127, DOI 10.1007/BF00711795; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; LANGANGER G, 1984, J CELL BIOL, V99, P1324, DOI 10.1083/jcb.99.4.1324; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Small J V, 1988, Electron Microsc Rev, V1, P155; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; SMALL JV, 1981, COLD SPRING HARB SYM, V46, P599, DOI 10.1101/SQB.1982.046.01.056; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873; Steven AC, 2003, TRENDS CELL BIOL, V13, P107, DOI 10.1016/S0962-8924(03)00023-0; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vallotton P, 2009, J CELL SCI, V122, P1955, DOI 10.1242/jcs.042036; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317	67	152	158	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					429	U36		10.1038/ncb2044	http://dx.doi.org/10.1038/ncb2044			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418872				2022-12-27	WOS:000277283700008
J	Geisler, S; Holmstrom, KM; Skujat, D; Fiesel, FC; Rothfuss, OC; Kahle, PJ; Springer, W				Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter			PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CELL-DEATH; PINK1; DEGRADATION; MUTATIONS; AUTOPHAGY; DOMAIN; GENE	Parkinson's disease is the most common neurodegenerative movement disorder. Mutations in PINK1 and PARKIN are the most frequent causes of recessive Parkinson's disease. However, their molecular contribution to pathogenesis remains unclear. Here, we reveal important mechanistic steps of a PINK1/Parkin-directed pathway linking mitochondrial damage, ubiquitylation and autophagy in non-neuronal and neuronal cells. PINK1 kinase activity and its mitochondrial localization sequence are prerequisites to induce translocation of the E3 ligase Parkin to depolarized mitochondria. Subsequently, Parkin mediates the formation of two distinct poly-ubiquitin chains, linked through Lys 63 and Lys 27. In addition, the autophagic adaptor p62/SQSTM1 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria. Strikingly, we identified VDAC1 (voltage-dependent anion channel 1) as a target for Parkin-mediated Lys 27 poly-ubiquitylation and mitophagy. Moreover, pathogenic Parkin mutations interfere with distinct steps of mitochondrial translocation, ubiquitylation and/or final clearance through mitophagy. Thus, our data provide functional links between PINK1, Parkin and the selective autophagy of mitochondria, which is implicated in the pathogenesis of Parkinson's disease.	[Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Kahle, Philipp J.; Springer, Wolfdieter] Univ Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de; wolfdieter.springer@klinikum.uni-tuebingen.de	Holmstrom, Kira/G-1158-2010	Springer, Wolfdieter/0000-0002-1178-3149; Fiesel, Fabienne/0000-0002-1919-9676; Holmstrom, Kira/0000-0001-6434-7909	Medical Faculty of the University of Tubingen [1667-0-0, 1842-0-0]; German National Genome Research Network [01GS08134]; Hertie Foundation; European Union research program FP6	Medical Faculty of the University of Tubingen; German National Genome Research Network; Hertie Foundation; European Union research program FP6	We are grateful to O. Corti and R. Baer for providing Parkin and ubiquitin mutants, and to R. de Silva for providing the pDsRed2-Mito construct. We thank Thomas Gasser for support. This work was supported by grants from the fortune-program of the Medical Faculty of the University of Tubingen to W. S. (1667-0-0 and 1842-0-0), by the German National Genome Research Network (NGFNplus, 01GS08134) to P. J. K., and by the Hertie Foundation. K. M. H. is a NEUROTRAIN Early Stage Research Training fellow funded through the European Union research program FP6.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	39	1920	1988	15	464	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					119	U70		10.1038/ncb2012	http://dx.doi.org/10.1038/ncb2012			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098416				2022-12-27	WOS:000274139400006
J	Hashimoto, M; Shinohara, K; Wang, JB; Ikeuchi, S; Yoshiba, S; Meno, C; Nonaka, S; Takada, S; Hatta, K; Wynshaw-Boris, A; Hamada, H				Hashimoto, Masakazu; Shinohara, Kyosuke; Wang, Jianbo; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Nonaka, Shigenori; Takada, Shinji; Hatta, Kohei; Wynshaw-Boris, Anthony; Hamada, Hiroshi			Planar polarization of node cells determines the rotational axis of node cilia	NATURE CELL BIOLOGY			English	Article							LEFT-RIGHT ASYMMETRY; MOUSE; FLOW; POLARITY; SEGMENTATION; ORIENTATION; MAINTENANCE; EXPRESSION; GENERATION; FLUID	Rotational movement of the node cilia generates a leftward fluid flow in the mouse embryo(1) because the cilia are posteriorly tilted(2,3). However, it is not known how anterior-posterior information is translated into the posterior tilt of the node cilia. Here, we show that the basal body of node cilia is initially positioned centrally but then gradually shifts toward the posterior side of the node cells. Positioning of the basal body and unidirectional flow were found to be impaired in compound mutant mice lacking Dvl genes. Whereas the basal body was normally positioned in the node cells of Wnt3a(-/-) embryos, inhibition of Rac1, a component of the noncanonical Wnt signalling pathway, impaired the polarized localization of the basal body in wild-type embryos. Dvl2 and Dvl3 proteins were found to be localized to the apical side of the node cells, and their location was polarized to the posterior side of the cells before the posterior positioning of the basal body. These results suggest that posterior positioning of the basal body, which provides the posterior tilt to node cilia, is determined by planar polarization mediated by noncanonical Wnt signalling.	[Hashimoto, Masakazu; Shinohara, Kyosuke; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Hamada, Hiroshi] Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hashimoto, Masakazu; Shinohara, Kyosuke; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Hamada, Hiroshi] Japan Sci & Technol Corp JST, CREST, Suita, Osaka 5650871, Japan; [Wang, Jianbo; Wynshaw-Boris, Anthony] Univ Calif San Diego, Dept Pediat & Med, La Jolla, CA 92093 USA; [Nonaka, Shigenori] Natl Inst Basic Biol, Dev Biol Sect, Okazaki, Aichi 4448585, Japan; [Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Hatta, Kohei] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Osaka University; Japan Science & Technology Agency (JST); University of California System; University of California San Diego; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Hyogo; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hamada, H (corresponding author), Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	wynshawborist@peds.ucsf.edu; hamada@fbs.osaka-u.ac.jp	Yoshiba, Satoko/AAD-1546-2019; Nonaka, Shigenori/I-2132-2013; Hamada, Hiroshi/N-6374-2015; Shinohara, Kyosuke/I-1470-2016; Shinohara, Kyosuke/AAU-2471-2020	Nonaka, Shigenori/0000-0002-8093-0325; Hamada, Hiroshi/0000-0002-7196-5948; Shinohara, Kyosuke/0000-0002-6350-1684; Takada, Shinji/0000-0003-4125-6056; Yoshiba, Satoko/0000-0002-9415-3619	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institutes of Health [HD43173]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043173] Funding Source: NIH RePORTER	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Gleeson (University of California, San Diego) for Centrin2-EGFP transgenic mice, K. Nakao (RIKEN, CDB) for KikGR mice, S. Piccolo (University of Padua) for BAT-gal, Y. Ikawa and S. Ohishi (Osaka University) for technical assistance and J. Axelrod and D. Antic (UCSF) for communicating their results on Prickle2 before publication. This work was supported by a grant from CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. H.) as well as grants from the National Institutes of Health (HD43173) and March of Dimes (to A. W.-B.).	BLUM M, 2008, SEMIN CELL DEV BIOL; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Raffel M., 1998, EXP FLUID MECH; Shinohara K, 2004, MEAS SCI TECHNOL, V15, P1965, DOI 10.1088/0957-0233/15/10/003; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	26	148	154	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					170	U172		10.1038/ncb2020	http://dx.doi.org/10.1038/ncb2020			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098415				2022-12-27	WOS:000274139400011
J	Giles, KE; Ghirlando, R; Felsenfeld, G				Giles, Keith E.; Ghirlando, Rodolfo; Felsenfeld, Gary			Maintenance of a constitutive heterochromatin domain in vertebrates by a Dicer-dependent mechanism	NATURE CELL BIOLOGY			English	Article							BETA-GLOBIN LOCUS; HUMAN-CELLS; RNA INTERFERENCE; GENE; TRANSCRIPTION; INSULATOR	The 16 kilobase (kb) heterochromatin domain between the chicken beta-globin locus and the folate receptor gene is used here to study the roles of RNA-dependent mechanisms and histone modifications in the maintenance of a constitutive heterochromatic structure. Inhibition of histone deacetylase (HDAC) activity is shown to both increase intergenic transcription and render the heterochromatin more accessible to MspI digestion. We show that short interfering RNA (siRNA)-mediated downregulation of the enzyme Dicer has similar effects: histone acetylation is increased, transcript levels rise and the compact chromatin structure becomes more accessible to restriction endonucleases. We also show that the chicken Argonaute 2 homologue binds the 16 kb region in a Dicer-dependent manner and is necessary for a condensed chromatin structure. Heterochromatic domains of this kind, which are widely distributed in vertebrate genomes, thus seem to be maintained in their condensed form by highly conserved mechanisms.	[Giles, Keith E.; Ghirlando, Rodolfo; Felsenfeld, Gary] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov	Ghirlando, Rodolfo/A-8880-2009		NIH, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK036151] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases.	Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Giles KE, 2004, RNA, V10, P299, DOI 10.1261/rna.2150604; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	15	43	43	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					94	U246		10.1038/ncb2010	http://dx.doi.org/10.1038/ncb2010			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010811	Green Accepted			2022-12-27	WOS:000272973800018
J	da Costa, CA; Sunyach, C; Giaime, E; West, A; Corti, O; Brice, A; Safe, S; Abou-Sleiman, PM; Wood, NW; Takahashi, H; Goldberg, MS; Shen, J; Checler, F				da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; West, Andrew; Corti, Olga; Brice, Alexis; Safe, Stephen; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Takahashi, Hitoshi; Goldberg, Mathew S.; Shen, Jie; Checler, Frederic			Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; GENE-EXPRESSION; LOCALIZATION; CELLS; SOLUBILITY; ACTIVATION; PROMOTES; SURVIVAL; PRODUCT; NEURONS	Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile Parkinson's disease (AR-JP). Several studies have suggested that parkin possesses DNA-binding and transcriptional activity. We report here that parkin is a p53 transcriptional repressor. First, parkin prevented 6-hydroxydopamine-induced caspase-3 activation in a p53-dependent manner. Concomitantly, parkin reduced p53 expression and activity, an effect abrogated by familial parkin mutations known to either abolish or preserve its ligase activity. ChIP experiments indicate that overexpressed and endogenous parkin interact physically with the p53 promoter and that pathogenic mutations abolish DNA binding to and promoter transactivation of p53. Parkin lowered p53 mRNA levels and repressed p53 promoter transactivation through its Ring1 domain. Conversely, parkin depletion enhanced p53 expression and mRNA levels in fibroblasts and mouse brains, and increased cellular p53 activity and promoter transactivation in cells. Finally, familial parkin missense and deletion mutations enhanced p53 expression in human brains affected by AR-JP. This study reveals a ubiquitin ligase-independent function of parkin in the control of transcription and a functional link between parkin and p53 that is altered by AR-JP mutations.	[da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; Checler, Frederic] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee,Fdn Rech Med,UMR6097, F-06560 Valbonne, France; [da Costa, Cristine Alves; Sunyach, Claire; Giaime, Emilie; Checler, Frederic] UNSA, CNRS, Inst NeuroMed Mol, Equipe Labellisee,Fdn Rech Med,UMR6097, F-06560 Valbonne, France; [West, Andrew] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21287 USA; [Corti, Olga; Brice, Alexis] Hop La Pitie Salpetriere, INSERM, U679, F-75013 Paris, France; [Safe, Stephen] Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX USA; [Abou-Sleiman, Patrick M.; Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Niigata 9518585, Japan; [Goldberg, Mathew S.; Shen, Jie] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Niigata University; Harvard University; Harvard Medical School	da Costa, CA (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee,Fdn Rech Med,UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	acosta@ipmc.cnrs.fr; checler@ipmc.cnrs.fr	Goldberg, Matthew/T-7827-2019; Wood, Nicholas W/C-2505-2009; Checler, Frederic/C-1241-2009; Shen, Jie/GXH-9449-2022; da Costa, Cristine Alves/G-8075-2011; Corti, Olga/I-4981-2016; Corti, Olga/AAC-3160-2019; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	Wood, Nicholas W/0000-0002-9500-3348; Checler, Frederic/0000-0003-2098-1750; da Costa, Cristine Alves/0000-0002-7777-005X; Corti, Olga/0000-0003-2093-7389; brice, alexis/0000-0002-0941-3990; West, Andrew/0000-0002-3034-4061; Goldberg, Matthew/0000-0002-5172-9841	Fondation pour la Recherche Medicale; MRC [G0400000] Funding Source: UKRI; Medical Research Council [G0400000] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Amanda Patel for helpful discussion concerning gel shift analyses. We wish to thank M. Oren, B. Vogelstein and T. Dawson for providing us with the p53 promoter, PG13 and parkin-deleted constructs. M. Roussel and T. Dawson are thanked for providing the p19<SUP>Arf-1-/-</SUP> and p19<SUP>Arf-1-/-</SUP>p53<SUP>-/-</SUP> and parkin knockout cells, and parkin-deletion constructs, respectively. We thank J. C. Bourdon for providing polyclonal p53-directed antibodies. We wish to thank F. Brau for help in confocal analysis and F. Aguila for artwork. This work was supported by the Fondation pour la Recherche Medicale.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; BERTOLIAVELLA AM, 2004, MOV DISORD; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Coleman JE, 2003, PHYSIOL GENOMICS, V12, P221, DOI 10.1152/physiolgenomics.00135.2002; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Horowitz JM, 2001, DEV BRAIN RES, V126, P31, DOI 10.1016/S0165-3806(00)00133-4; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Tatehata A, 1998, INORG CHEM COMMUN, V1, P392, DOI 10.1016/S1387-7003(98)00105-1; Unschuld PG, 2006, MOL BIOL REP, V33, P13, DOI 10.1007/s11033-005-3961-5; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	36	150	154	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1370	U255		10.1038/ncb1981	http://dx.doi.org/10.1038/ncb1981			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801972	Green Accepted			2022-12-27	WOS:000271425800018
J	Zhou, YG; Schmitz, KM; Mayer, C; Yuan, XJ; Akhtar, A; Grummt, I				Zhou, Yonggang; Schmitz, Kerstin-Maike; Mayer, Christine; Yuan, Xuejun; Akhtar, Asifa; Grummt, Ingrid			Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing	NATURE CELL BIOLOGY			English	Article							RIBOSOMAL GENE-TRANSCRIPTION; DROSOPHILA MSL COMPLEX; DOSAGE COMPENSATION; HISTONE H4; EPIGENETIC STATE; MOF; ACETYLTRANSFERASE; RDNA; LYSINE-16; PROMOTER	The SNF2h (sucrose non-fermenting protein 2 homologue)-containing chromatin-remodelling complex NoRC silences a fraction of ribosomal RNA genes (rDNA) by establishing a heterochromatic structure at the rDNA promoter(1-3). Here we show that the acetyltransferase MOF (males absent on the first) acetylates TIP5, the largest subunit of NoRC, at a single lysine residue, K633, adjacent to the TIP5 RNA-binding domain, and that the NAD(+)-dependent deacetylase SIRT1 (sirtuin-1) removes the acetyl group from K633. Acetylation regulates the interaction of NoRC with promoter-associated RNA (pRNA), which in turn affects heterochromatin formation, nucleosome positioning and rDNA silencing. Significantly, NoRC acetylation is responsive to the intracellular energy status and fluctuates during S phase. Activation of SIRT1 on glucose deprivation leads to deacetylation of K633, enhanced pRNA binding and an increase in heterochromatic histone marks. These results suggest a mechanism that links the epigenetic state of rDNA to cell metabolism and reveal another layer of epigenetic control that involves post-translational modification of a chromatin remodelling complex.	[Zhou, Yonggang; Schmitz, Kerstin-Maike; Mayer, Christine; Yuan, Xuejun; Grummt, Ingrid] DKFZ ZMBH Alliance, Div Mol Biol Cell 2, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Akhtar, Asifa] European Mol Biol Lab, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Grummt, I (corresponding author), DKFZ ZMBH Alliance, Div Mol Biol Cell 2, German Canc Res Ctr, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	i.grummt@dkfz.de		Mayer, Christine/0000-0003-3936-7670				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	28	85	90	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2009	11	8					1010	U229		10.1038/ncb1914	http://dx.doi.org/10.1038/ncb1914			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	478MU	19578370				2022-12-27	WOS:000268593200016
J	Jones, AR; Kramer, EM; Knox, K; Swarup, R; Bennett, MJ; Lazarus, CM; Leyser, HMO; Grierson, CS				Jones, Angharad R.; Kramer, Eric M.; Knox, Kirsten; Swarup, Ranjan; Bennett, Malcolm J.; Lazarus, Colin M.; Leyser, H. M. Ottoline; Grierson, Claire S.			Auxin transport through non-hair cells sustains root-hair development	NATURE CELL BIOLOGY			English	Article							LATERAL ROOT; ARABIDOPSIS; EFFLUX; PIN; TRAFFICKING; POLARITY; LOCALIZATION; INFORMATION; ELONGATION; EPIDERMIS	The plant hormone auxin controls root epidermal cell development in a concentration-dependent manner(1-3). Root hairs are produced on a subset of epidermal cells as they increase in distance from the root tip. Auxin is required for their initiation(4-7) and continued growth(8-11), but little is known about its distribution in this region of the root. Contrary to the expectation that hair cells might require active auxin influx to ensure auxin supply, we did not detect the auxin-influx transporter AUX1 in root-hair cells. A high level of AUX1 expression was detected in adjacent non-hair cell files. Non-hair cells were necessary to achieve wild-type root-hair length, although an auxin response was not required in these cells. Three-dimensional modelling of auxin flow in the root tip suggests that AUX1-dependent transport through non-hair cells maintains an auxin supply to developing hair cells as they increase in distance from the root tip, and sustains root-hair outgrowth. Experimental data support the hypothesis that instead of moving uniformly though the epidermal cell layer(3,12), auxin is mainly transported through canals that extend longitudinally into the tissue.	[Jones, Angharad R.; Lazarus, Colin M.; Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Kramer, Eric M.] Bard Coll Simons Rock, Dept Phys, Massachusetts, MA 01230 USA; [Kramer, Eric M.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Knox, Kirsten; Leyser, H. M. Ottoline] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Knox, Kirsten] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Swarup, Ranjan; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Plant Sci Div, Loughborough LE12 5RD, Leics, England	University of Bristol; University of Nottingham; University of York - UK; University of Edinburgh; University of Nottingham	Grierson, CS (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	Claire.Grierson@bristol.ac.uk	Leyser, Ottoline/AAC-5577-2019; Lazarus, Colin M/B-9474-2011; Bennett, Malcolm/G-4004-2010; Kramer, Eric M/B-9752-2008	Bennett, Malcolm/0000-0003-0475-390X; Leyser, Ottoline/0000-0003-2161-3829; Kramer, Eric/0000-0002-1424-2356; Knox, Kirsten/0000-0002-5487-1763; Jones, Angharad/0000-0001-7493-9625; swarup, Ranjan/0000-0002-6438-9188	BBSRC studentship; Lady Emily Smyth Agricultural Research Station; BBSRC Case Award; Centre for Plant Integrative Biology; Biotechnology and Biological Sciences Research Council [BB/C514958/1, BB/D019613/1] Funding Source: researchfish; BBSRC [BB/D019613/1] Funding Source: UKRI	BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lady Emily Smyth Agricultural Research Station; BBSRC Case Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Plant Integrative Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Schiefelbein for sharing material before publication, and Alan Champneys and Robert Payne for insightful discussions. A. R. J. was supported by a BBSRC studentship awarded to C. M. L. and C. S. G., and by the Lady Emily Smyth Agricultural Research Station; K. K. was supported by a BBSRC Case Award to H. M. O. L. and C. S. G.; M. B., R. S. and E. K. received support from the Centre for Plant Integrative Biology, which is a BBSRC/EPSRC Centre for Integrative Systems Biology.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Berger F, 1998, CURR BIOL, V8, P421, DOI 10.1016/S0960-9822(98)70176-9; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grierson CS, 1997, PLANT PHYSIOL, V115, P981, DOI 10.1104/pp.115.3.981; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2007, J EXP BOT, V58, P3005, DOI 10.1093/jxb/erm155; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Kramer EM, 2006, PLANT PHYSIOL, V141, P1233, DOI 10.1104/pp.106.083790; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356	36	175	184	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					78	U156		10.1038/ncb1815	http://dx.doi.org/10.1038/ncb1815			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079245	Green Submitted, Green Accepted			2022-12-27	WOS:000262157000014
J	Fry, AM; Yamano, H				Fry, Andrew M.; Yamano, Hiroyuki			Under arrest in mitosis: Cdc20 dies twice	NATURE CELL BIOLOGY			English	Editorial Material							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; PROTEIN BUBR1; MAD3; UBIQUITINATION; APC(CDC20); MACHINE	The spindle assembly checkpoint is crucial for maintaining genome integrity in dividing cells by preventing premature chromosome segregation. Degradation of the APC/C activator Cdc20 seems to be an essential and conserved mechanism to maintain this checkpoint in the presence of chromosomes that are not attached to the mitotic spindle.	[Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Yamano, Hiroyuki] Marie Curie Res Inst, Oxted RH8 0TL, Surrey, England	University of Leicester	Fry, AM (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	amf5@le.ac.uk; h.yamano@mcri.ac.uk						Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	15	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1385	1387		10.1038/ncb1208-1385	http://dx.doi.org/10.1038/ncb1208-1385			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043431				2022-12-27	WOS:000261261800006
J	Arimoto, K; Fukuda, H; Imajoh-Ohmi, S; Saito, H; Takekawa, M				Arimoto, Kyoko; Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu; Saito, Haruo; Takekawa, Mutsuhiro			Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways	NATURE CELL BIOLOGY			English	Article							KINASE KINASE; PROTEIN; ACTIVATION; MTK1/MEKK4; RACK1; P38; JNK; IDENTIFICATION; TRANSLATION; RECEPTOR	When confronted with environmental stress, cells either activate defence mechanisms to survive, or initiate apoptosis, depending on the type of stress. Certain types of stress, such as hypoxia, heatshock and arsenite (type 1 stress), induce cells to assemble cytoplasmic stress granules (SGs), a major adaptive defence mechanism. SGs are multimolecular aggregates of stalled translation pre-initiation complexes that prevent the accumulation of mis-folded proteins(1). Type 2 stress, which includes X-rays and genotoxic drugs, induce apoptosis through the stress-activated p38 and JNK MAPK (SAPK) pathways. A functional relationship between the SG and SAPK responses is unknown. Here, we report that SG formation negatively regulates the SAPK apoptotic response, and that the signalling scaffold protein RACK1 functions as a mediator between the two responses. RACK1 binds to the stress-responsive MTK1 MAPKKK and facilitates its activation by type 2 stress; however, under conditions of type 1 stress, RACK1 is sequestered into SGs. Thus, type 1 conditions suppress activation of the MTK1-SAPK pathway and apoptosis induced by type 2 stress. These findings may be relevant to the problem of hypoxia-induced resistance to cancer chemotherapy.	[Arimoto, Kyoko; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Arimoto, Kyoko; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Saito, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	saito@ims.u-tokyo.ac.jp; takekawa@ims.u-tokyo.ac.jp	Saito, Haruo/AAF-6113-2019	Saito, Haruo/0000-0001-7891-1689; Takekawa, Mutsuhiro/0000-0002-8027-3847	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by several grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M. T. and H. S.), and by a PRESTO programme from the Japan Science and Technology Agency (M. T.). We thank P. O'Grady for critical reading of the manuscript and T. Chano (Shiga University of Medical Science), S. Iwata (University of Tokyo), K. Matsumoto ( Nagoya University) and H. Ichijo (University of Tokyo) for plasmids.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; KIMBALL SR, 2002, AM J PHYSIOL-CELL PH, V284, P273; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	30	387	398	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1324	U167		10.1038/ncb1791	http://dx.doi.org/10.1038/ncb1791			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18836437				2022-12-27	WOS:000260586700015
J	Levayer, R; Lecuit, T				Levayer, Romain; Lecuit, Thomas			Breaking down EMT	NATURE CELL BIOLOGY			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITIONS; MORPHOGENESIS		[Levayer, Romain; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, IBDML, UMR6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Levayer, R (corresponding author), Univ Aix Marseille 2, CNRS, IBDML, UMR6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lecuit@ibdm.univ-mrs.fr	Levayer, Romain/V-3665-2019	Levayer, Romain/0000-0001-6769-1465				BAUM B, 2008, CELL DEV BIOL, V19, P294; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Linker C, 2005, DEVELOPMENT, V132, P3895, DOI 10.1242/dev.01961; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Simoes S, 2006, DEVELOPMENT, V133, P4257, DOI 10.1242/dev.02588; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802	15	47	48	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					757	759		10.1038/ncb0708-757	http://dx.doi.org/10.1038/ncb0708-757			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18591967				2022-12-27	WOS:000257268400004
J	Bryant, DM; Datta, A; Rodriguez-Fraticelli, AE; Peranen, J; Martin-Belmonte, F; Mostov, KE				Bryant, David M.; Datta, Anirban; Rodriguez-Fraticelli, Alejo E.; Peranen, Johan; Martin-Belmonte, Fernando; Mostov, Keith E.			A molecular network for de novo generation of the apical surface and lumen	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE ORIENTATION; POLARIZED EPITHELIAL-CELLS; MDCK CELLS; PRIMARY CILIOGENESIS; EXCHANGE FACTOR; PRIMARY CILIUM; RAB GTPASES; CDC42 GEF; MORPHOGENESIS; TRAFFICKING	To form epithelial organs cells must polarize and generate de novo an apical domain and lumen. Epithelial polarization is regulated by polarity complexes that are hypothesized to direct downstream events, such as polarized membrane traffic, although this interconnection is not well understood. We have found that Rab11a regulates apical traffic and lumen formation through the Rab guanine nucleotide exchange factor (GEF), Rabin8, and its target, Rab8a. Rab8a and Rab11a function through the exocyst to target Par3 to the apical surface, and control apical Cdc42 activation through the Cdc42 GEF, Tuba. These components assemble at a transient apical membrane initiation site to form the lumen. This Rab11a-directed network directs Cdc42-dependent apical exocytosis during lumen formation, revealing an interaction between the machineries of vesicular transport and polarization.	[Bryant, David M.; Datta, Anirban; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rodriguez-Fraticelli, Alejo E.; Martin-Belmonte, Fernando] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Helsinki	Mostov, KE (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	keith.mostov@ucsf.edu	Bryant, David/AAH-5620-2019; Rodriguez-Fraticelli, Alejo/AAG-7462-2020; Martin-Belmonte, Fernando/J-8029-2014	Bryant, David/0000-0003-2721-5012; Rodriguez-Fraticelli, Alejo/0000-0002-4017-8714; mostov, keith/0000-0002-8123-6247; Martin-Belmonte, Fernando/0000-0002-2564-4430	Susan G Komen Foundation; DOD; NIH [R01DK074398, R01AI25144, P01AI53194]; Human Frontiers Science Program [HFSP-CDA00011/2009]; MICINN [BFU2008-01916, CSD2009-00016]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194, R01AI025144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK067153] Funding Source: NIH RePORTER	Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. Barr, E. Brown, J. Stow, W Guo, I. Macara, K. Simons, J. Wilson, T. Weimbs, and A. Zahraoui for gifts of reagents and unpublished data, and the Mostov lab for kind assistance. Supported by a Susan G Komen Foundation Fellowship (D.M.B.), a DOD Breast Cancer Concept Award (A.D.), NIH grants R01DK074398, R01AI25144 and P01AI53194 (K.E.M.), grants of the Human Frontiers Science Program (HFSP-CDA00011/2009), Marie Curie (IRG-209382), MICINN (BFU2008-01916) and (CONSOLIDER CSD2009-00016) to F.M.-B.; and a JAE fellowship (MICINN) to A.E.R.F.	Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BRIGNONI M, 1993, EXP CELL RES, V205, P171, DOI 10.1006/excr.1993.1072; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Ferrari A, 2008, J CELL SCI, V121, P3649, DOI 10.1242/jcs.018648; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Liu KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633, DOI 10.1152/ajprenal.00053.2007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mangravite LM, 2001, AM J PHYSIOL-RENAL, V280, pF879, DOI 10.1152/ajprenal.2001.280.5.F879; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matheson J, 2005, BIOCHEM SOC T, V33, P1290, DOI 10.1042/BST0331290; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Sato Y, 2007, STRUCTURE, V15, P245, DOI 10.1016/j.str.2007.01.003; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tanimizu N, 2009, MOL BIOL CELL, V20, P2486, DOI 10.1091/mbc.E08-02-0177; Walther RF, 2010, CURR BIOL, V20, P1065, DOI 10.1016/j.cub.2010.04.049; WANG AZ, 1994, AM J PHYSIOL, V267, pC473, DOI 10.1152/ajpcell.1994.267.2.C473; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	53	402	413	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1035	U24		10.1038/ncb2106	http://dx.doi.org/10.1038/ncb2106			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20890297	Green Accepted			2022-12-27	WOS:000283711500006
J	Patla, I; Volberg, T; Elad, N; Hirschfeld-Warneken, V; Grashoff, C; Fassler, R; Spatz, JP; Geiger, B; Medalia, O				Patla, Israel; Volberg, Tova; Elad, Nadav; Hirschfeld-Warneken, Vera; Grashoff, Carsten; Faessler, Reinhard; Spatz, Joachim P.; Geiger, Benjamin; Medalia, Ohad			Dissecting the molecular architecture of integrin adhesion sites by cryo-electron tomography	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESIONS; STRESS FIBERS; DYNAMICS; FIBROBLASTS; CELLS; CYTOSKELETON; MATRIX; FORCE; ORGANIZATION; INHIBITION	Focal adhesions are integrin-based multiprotein complexes, several micrometres in diameter, that mechanically link the extracellular matrix with the termini of actin bundles. The molecular diversity of focal adhesions and their role in cell migration and matrix sensing has been extensively studied, but their ultrastructural architecture is still unknown. We present the first three-dimensional structural reconstruction of focal adhesions using cryo-electron tomography. Our analyses reveal that the membrane-cytoskeleton interaction at focal adhesions is mediated through particles located at the cell membrane and attached to actin fibres. The particles have diameters of 25 +/- 5 nm, and an average interspacing of approximately 45 nm. Treatment with the Rho-kinase inhibitor Y-27632 induces a rapid decrease in particle diameter, suggesting that they are highly mechanosensitive. Our findings clarify the internal architecture of focal adhesions at molecular resolution, and provide insights into their scaffolding and mechanosensory functions.	[Patla, Israel; Elad, Nadav; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel; [Patla, Israel; Elad, Nadav; Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84120 Beer Sheva, Israel; [Volberg, Tova; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hirschfeld-Warneken, Vera; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Hirschfeld-Warneken, Vera] Univ Heidelberg, Dept Biophys Chem, D-70569 Stuttgart, Germany; [Grashoff, Carsten; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Ben Gurion University; Ben Gurion University; Weizmann Institute of Science; Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Medalia, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.	omedalia@bgu.ac.il	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807; Medalia, Ohad/0000-0003-0994-2937; Elad, Nadav/0000-0001-6222-2280	German-Israeli Cooperation Project [DIP H.2.2]; National Institutes of Health Cell Migration Consortium [U54 GM64346]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	German-Israeli Cooperation Project; National Institutes of Health Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the German-Israeli Cooperation Project (DIP H.2.2) to O. M., R. F., J. S. and B. G., an NIGMS grant from the National Institutes of Health Cell Migration Consortium (Grant No. U54 GM64346) to B. G. and an ERC Starting Grant to O. M. The authors express gratitude to B. Morgenstern for help in editing the manuscript. B. G. holds the Erwin Neter Professorial Chair in Cell and Tumor Biology.	ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; FELTKAMP CA, 1991, J CELL SCI, V100, P579; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FRANK J, 1992, ELECT TOMOGRAPHY, P1; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; JIMENEZ J, 1986, SCIENCE, V232, P1113, DOI 10.1126/science.3754654; Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; NICOL A, 1987, J HISTOCHEM CYTOCHEM, V35, P499, DOI 10.1177/35.4.2880891; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; RINNERTHALER G, 1988, J CELL BIOL, V106, P747, DOI 10.1083/jcb.106.3.747; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SINGER II, 1979, CELL, V16, P675, DOI 10.1016/0092-8674(79)90040-0; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; TURNER CE, 1994, J CELL SCI, V107, P1583; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiesner S, 2006, TRENDS CELL BIOL, V16, P327, DOI 10.1016/j.tcb.2006.05.002; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901	40	170	172	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					909	915		10.1038/ncb2095	http://dx.doi.org/10.1038/ncb2095			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20694000				2022-12-27	WOS:000281561900015
J	Youssef, KK; Van Keymeulen, A; Lapouge, G; Beck, B; Michaux, C; Achouri, Y; Sotiropoulou, PA; Blanpain, C				Youssef, Khalil Kass; Van Keymeulen, Alexandra; Lapouge, Gaeelle; Beck, Benjamin; Michaux, Cindy; Achouri, Younes; Sotiropoulou, Panagiota A.; Blanpain, Cedric			Identification of the cell lineage at the origin of basal cell carcinoma	NATURE CELL BIOLOGY			English	Article							HAIR FOLLICLE BULGE; STEM-CELLS; SONIC HEDGEHOG; HUMAN HOMOLOG; MOUSE SKIN; EPIDERMIS; POPULATION; CANCER; KERATINOCYTES; EXPRESSION	For most types of cancers, the cell at the origin of tumour initiation is still unknown. Here, we used mouse genetics to identify cells at the origin of basal cell carcinoma (BCC), which is one of the most frequently occurring types of cancer in humans, and can result from the activation of the Hedgehog signalling pathway. Using mice conditionally expressing constitutively active Smoothened mutant (SmoM2), we activated Hedgehog signalling in different cellular compartments of the skin epidermis and determined in which compartments Hedgehog activation induces BCC formation. Activation of SmoM2 in hair follicle bulge stem cells and their transient amplifying progenies did not induce cancer formation, demonstrating that BCC does not originate from bulge stem cells, as previously thought. Using clonal analysis, we found that BCC arises from long-term resident progenitor cells of the interfollicular epidermis and the upper infundibulum. Our studies uncover the cells at the origin of BCC in mice and demonstrate that expression of differentiation markers in tumour cells is not necessarily predictive of the cancer initiating cells.	[Youssef, Khalil Kass; Van Keymeulen, Alexandra; Lapouge, Gaeelle; Beck, Benjamin; Michaux, Cindy; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Achouri, Younes] Catholic Univ Louvain, B-1200 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021	Youssef, Khalil Kass/0000-0002-4572-3160; Beck, Benjamin/0000-0001-8162-7566; ACHOURI, Younes/0000-0001-7409-1441	FNRS; Human Frontier Science Program Organization; Schlumberger Foundation; CIBLES of the Wallonia Region; EMBO Young Investigator program; European Research Council	FNRS(Fonds de la Recherche Scientifique - FNRS); Human Frontier Science Program Organization(Human Frontier Science Program); Schlumberger Foundation(Schlumberger); CIBLES of the Wallonia Region; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided reagents, and whose gifts are cited in the text. We thank C. Govaerts, H. Nguyen, P. Vanderhaeghen and G. Vassart for their critical comments on the manuscript. C. B. and A. V. K. are Chercheur Qualifie of the FRS/FNRS; K. K. Y is a Research Fellow of the FRIA; and G. L. is Collaborateur Scientifique of the FRS/FNRS. This work was supported by a Mandat D'impulsion Scientifique of the FNRS, a career development award of the Human Frontier Science Program Organization, a research grant of the Schlumberger Foundation, the programme CIBLES of the Wallonia Region, the EMBO Young Investigator program and from a starting grant of the European Research Council.	Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CAMPBELL C, 1993, CANCER RES, V53, P2697; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Crowson AN, 2006, MODERN PATHOL, V19, pS127, DOI 10.1038/modpathol.3800512; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	42	275	286	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					299	U111		10.1038/ncb2031	http://dx.doi.org/10.1038/ncb2031			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154679				2022-12-27	WOS:000275054200017
J	Zhang, JM; Ji, JY; Yu, M; Overholtzer, M; Smolen, GA; Wang, R; Brugge, JS; Dyson, NJ; Haber, DA				Zhang, Jianmin; Ji, Jun-Yuan; Yu, Min; Overholtzer, Michael; Smolen, Gromoslaw A.; Wang, Rebecca; Brugge, Joan S.; Dyson, Nicholas J.; Haber, Daniel A.			YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; ORGAN SIZE; GROWTH-CONTROL; DROSOPHILA; PROLIFERATION; APOPTOSIS; SALVADOR; FAT; ACTIVATION; ONCOGENE	The Hippo signalling pathway regulates cellular proliferation and survival, thus has profound effects on normal cell fate and tumorigenesis(1-3). The pivotal effector of this pathway is YAP (yes-associated protein), a transcriptional co-activator amplified in mouse and human cancers, where it promotes epithelial to mesenchymal transition (EMT) and malignant transformation(4-10). So far, studies of YAP target genes have focused on cell-autonomous mediators; here we show that YAP-expressing MCF10A breast epithelial cells enhance the proliferation of neighbouring untransfected cells, implicating a non-cell-autonomous mechanism. We identify the gene for the epidermal growth factor receptor ( EGFR) ligand amphiregulin (AREG) as a transcriptional target of YAP, whose induction contributes to YAP-mediated cell proliferation and migration, but not EMT. Knockdown of AREG or addition of an EGFR kinase inhibitor abrogates the proliferative effects of YAP expression. Suppression of the negative YAP regulators LATS1 and 2 ( large tumour suppressor 1 and 2) is sufficient to induce AREG expression, consistent with physiological regulation of AREG by the Hippo pathway. Genetic interaction between the Drosophila YAP orthologue Yorkie and Egfr signalling components supports the link between these two highly conserved signalling pathways. Thus, YAP-dependent secretion of AREG indicates that activation of EGFR signalling is an important non-cell-autonomous effector of the Hippo pathway, which has implications for the regulation of both physiological and malignant cell proliferation.	[Zhang, Jianmin; Ji, Jun-Yuan; Yu, Min; Smolen, Gromoslaw A.; Wang, Rebecca; Dyson, Nicholas J.; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yu, Min; Haber, Daniel A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Overholtzer, Michael; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu	Zhang, Jianmin/AAN-2931-2020	Yu, Min/0000-0002-3969-8720; Ji, Jun-yuan/0000-0002-4483-4336	National Institutes of Health (NIH) [R01 95281]; Doris Duke Foundation Distinguished Clinical Investigator Award; National Foundation for Cancer Research; Howard Hughes Medical Institute; NIH [CA080111, CA089393, CA09361-27, CA09361, F32 CA117737, GM81607, GM053203]; Breast Cancer Research Foundation; Saltonstall Foundation; Tosteson postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009361, P01CA080111, P50CA089393, F32CA117737, F32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053203, R01GM081607] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation Distinguished Clinical Investigator Award(Doris Duke Charitable Foundation (DDCF)); National Foundation for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Saltonstall Foundation; Tosteson postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pan, M. Frolov, G. Halder and Z. Lai for providing Drosophila stocks. We appreciate discussions with J. Wells, F. Yang and T. Zhang and thank B. Fowle for assistance with electron microscopy. This work was supported by the National Institutes of Health (NIH) grant R01 95281, the Doris Duke Foundation Distinguished Clinical Investigator Award, the National Foundation for Cancer Research grant and the Howard Hughes Medical Institute ( to D. A. H.); NIH grants CA080111 and CA089393 and the Breast Cancer Research Foundation ( to J. S. B.); NIH T32 training grants CA09361-27 ( to J. Z.) and CA09361 ( to M. O.); NIH grants F32 CA117737 ( to G. A. S.); NIH grants GM81607 and GM053203 and the Saltonstall Foundation ( to N. J. D.); and the Tosteson postdoctoral Fellowship ( to J. Y. J.).	Berasain C, 2005, J BIOL CHEM, V280, P19012, DOI 10.1074/jbc.M413344200; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SOULE HD, 1990, CANCER RES, V50, P6075; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	31	307	315	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1444	U134		10.1038/ncb1993	http://dx.doi.org/10.1038/ncb1993			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935651	Green Accepted			2022-12-27	WOS:000272251300011
J	Melixetian, M; Klein, DK; Sorensen, CS; Helin, K				Melixetian, Marina; Klein, Ditte Kjaersgaard; Sorensen, Claus Storgaard; Helin, Kristian			NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint	NATURE CELL BIOLOGY			English	Article							S-PHASE; BETA-TRCP; CHK1; PHOSPHORYLATION; KINASE; BRCA1; INHIBITION; EVENTS; ATR	DNA damage-induced cell-cycle checkpoints have a critical role in maintaining genomic stability(1,2). A key target of the checkpoints is the CDC25A (cell division cycle 25 homologue A) phosphatase, which is essential for the activation of cyclin-dependent kinases and cell-cycle progression(3-5). To identify new genes involved in the G2/M checkpoint we performed a large-scale short hairpin RNA (shRNA) library screen. We show that NIMA (never in mitosis gene A)-related kinase 11 (NEK11) is required for DNA damage-induced G2/M arrest. Depletion of NEK11 prevents proteasome-dependent degradation of CDC25A, both in unperturbed and DNA-damaged cells. We show that NEK11 directly phosphorylates CDC25A on residues whose phosphorylation is required for beta-TrCP (beta-transducin repeat-containing protein)-mediated polyubiquitylation and degradation of CDC25A. Furthermore, we demonstrate that CHK1 (checkpoint kinase 1) directly activates NEK11 by phosphorylating it on Ser 273, indicating that CHK1 and NEK11 operate in a single pathway that controls proteolysis of CDC25A. Taken together, these results demonstrate that NEK11 is an important component of the pathway enforcing the G2/M checkpoint, suggesting that genetic mutations in NEK11 may contribute to the development of human cancer.	[Klein, Ditte Kjaersgaard; Sorensen, Claus Storgaard; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Melixetian, Marina; Helin, Kristian] European Inst Oncol, Dept Expt Oncol, I-20135 Milan, Italy	University of Copenhagen; University of Copenhagen; IRCCS European Institute of Oncology (IEO)	Sorensen, CS (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	claus.storgaard@bric.ku.dk; kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Melixetian, Marine/AAR-1524-2020	Helin, Kristian/0000-0003-1975-6097; Melixetian, Marine/0000-0002-8454-8262; Sorensen, Claus/0000-0001-6022-9710	EU-framework 6; Danish Cancer Society; Novo Nordisk Foundation; Danish National Research Foundation	EU-framework 6; Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank R. Bernards for the NKI shRNA library, M. Donzelli and L. Busino for reagents and helpful discussions, G. Ossolengo for purification of the antibodies, S. Ronzoni for FACS sorting, S. Bossi for recombinant NEK11 production and P. G. Pelicci for his continuous support. This work was supported by grants from the EU-framework 6 program to INTACT, the Danish Cancer Society, the Novo Nordisk Foundation and the Danish National Research Foundation.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Donzelli M, 2004, CELL CYCLE, V3, P469; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kohn EA, 2003, CANCER RES, V63, P31; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	24	94	100	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1247	U212		10.1038/ncb1969	http://dx.doi.org/10.1038/ncb1969			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19734889				2022-12-27	WOS:000270382000015
J	Murakami, T; Saito, A; Hino, SI; Kondo, S; Kanemoto, S; Chihara, K; Sekiya, H; Tsumagari, K; Ochiai, K; Yoshinaga, K; Saitoh, M; Nishimura, R; Yoneda, T; Kou, I; Furuichi, T; Ikegawa, S; Ikawa, M; Okabe, M; Wanaka, A; Imaizumi, K				Murakami, Tomohiko; Saito, Atsushi; Hino, Shin-ichiro; Kondo, Shinichi; Kanemoto, Soshi; Chihara, Kazuyasu; Sekiya, Hiroshi; Tsumagari, Kenji; Ochiai, Kimiko; Yoshinaga, Kazuya; Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki; Kou, Ikuyo; Furuichi, Tatsuya; Ikegawa, Shiro; Ikawa, Masahito; Okabe, Masaru; Wanaka, Akio; Imaizumi, Kazunori			Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR OASIS; OSTEOBLAST DIFFERENTIATION; ER STRESS; OSTEOGENESIS IMPERFECTA; COLLAGEN PROMOTER; CREB/ATF-FAMILY; TRANSGENIC MICE; I COLLAGEN; EXPRESSION; ASTROCYTES	Eukaryotic cells have signalling pathways from the endoplasmic reticulum (ER) to cytosol and nuclei, to avoid excess accumulation of unfolded proteins in the ER. We previously identified a new type of ER stress transducer, OASIS, a bZIP (basic leucine zipper) transcription factor, which is a member of the CREB/ATF family and has a transmembrane domain(1-6). OASIS is processed by regulated intramembrane proteolysis (RIP) in response to ER stress, and is highly expressed in osteoblasts. OASIS(-/-) mice exhibited severe osteopenia, involving a decrease in type I collagen in the bone matrix and a decline in the activity of osteoblasts, which showed abnormally expanded rough ER, containing of a large amount of bone matrix proteins. Here we identify the gene for type 1 collagen, Col1a1, as a target of OASIS, and demonstrate that OASIS activates the transcription of Col1a1 through an unfolded protein response element (UPRE)-like sequence in the osteoblast-specific Col1a1 promoter region. Moreover, expression of OASIS in osteoblasts is induced by BMP2 (bone morphogenetic protein 2), the signalling of which is required for bone formation. Additionally, RIP of OASIS is accelerated by BMP2 signalling, which causes mild ER stress. Our studies show that OASIS is critical for bone formation through the transcription of Col1a1 and the secretion of bone matrix proteins, and they reveal a new mechanism by which ER stress-induced signalling mediates bone formation.	[Murakami, Tomohiko; Saito, Atsushi; Hino, Shin-ichiro; Kondo, Shinichi; Kanemoto, Soshi; Chihara, Kazuyasu; Sekiya, Hiroshi; Tsumagari, Kenji; Ochiai, Kimiko; Imaizumi, Kazunori] Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, Miyazaki 8891692, Japan; [Yoshinaga, Kazuya] Kumamoto Univ, Sch Hlth Sci, Dept Anat & Pathol, Kumamoto 8620976, Japan; [Saitoh, Masahiro; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kou, Ikuyo; Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Nara 6348521, Japan	University of Miyazaki; Kumamoto University; Osaka University; RIKEN; Osaka University; Osaka University; Nara Medical University	Imaizumi, K (corresponding author), Miyazaki Univ, Div Mol & Cellular Biol, Dept Anat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	imaizumi@med.miyazaki-u.ac.jp	Wanaka, Akio/GPW-8926-2022; ikawa, masahito/A-5315-2009; Wanaka, Akio/ABE-4671-2020; Ikegawa, Shiro/N-6895-2015; Wanaka, Akio/AAC-9754-2019; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ikegawa, Shiro/0000-0003-0316-2147; Wanaka, Akio/0000-0001-9951-9862; Nishimura, Riko/0000-0001-7279-8363; Okabe, Masaru/0000-0002-0803-9044	Japan Society for the Promotion of Science KAKENHI [20059028, 21790184, 20890175, 21790323, 21700410]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Takeda Medical Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Medical Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis)	We thank G. Karsenty (Columbia University) for providing plasmids (Col1a1 and Osteocalcin as probes for in situ hybridization, and pCMV-ATF4), G. Xiao (University of Pittsburgh, PA, USA) for providing a plasmid (pCMV-Runx2) and L. W. Fisher (National Institutes of Health, USA) for providing an LF41 antibody, M. Tohyama and S. Shiosaka for helpful discussions and critical reading of the manuscript, E. Nishida for technical advice and H. Yamato, H. Murayama,. W. Soma, M. Shimbara, I. Tsuchimochi, T. Kawanami, A. Ikeda, A. Kawai, and Y. Maruyama for technical support. This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI (# 20059028, # 21790184, # 20890175, # 21790323, # 21700410), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Takeda Medical Research Foundation and NOVARTIS Foundation (Japan) for the Promotion of Science.	Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	32	243	251	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2009	11	10					1205	U90		10.1038/ncb1963	http://dx.doi.org/10.1038/ncb1963			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	501KZ	19767743				2022-12-27	WOS:000270382000009
J	Zou, K; Yuan, Z; Yang, ZJ; Luo, HC; Sun, KJ; Zhou, L; Xiang, J; Shi, LJ; Yu, QS; Zhang, Y; Hou, RY; Wu, J				Zou, Kang; Yuan, Zhe; Yang, Zhaojuan; Luo, Huacheng; Sun, Kejing; Zhou, Li; Xiang, Jie; Shi, Lingjun; Yu, Qingsheng; Zhang, Yong; Hou, Ruoyu; Wu, Ji			Production of offspring from a germline stem cell line derived from neonatal ovaries	NATURE CELL BIOLOGY			English	Article							PB-CADHERIN; MOUSE; EXPRESSION; PROTEIN; GENE; VASA; HOMOLOG; OOCYTES; GENERATION; GONOCYTES	The idea that females of most mammalian species have lost the capacity for oocyte production at birth(1-5) has been challenged recently by the finding that juvenile and adult mouse ovaries possess mitotically active germ cells(6). However, the existence of female germline stem cells (FGSCs) in postnatal mammalian ovaries still remains a controversial issue among reproductive biologists and stem cell researchers(6-10). We have now established a neonatal mouse FGSC line, with normal karyotype and high telomerase activity, by immunomagnetic isolation and culture for more than 15 months. FGSCs from adult mice were isolated and cultured for more than 6 months. These FGSCs were infected with GFP virus and transplanted into ovaries of infertile mice. Transplanted cells underwent oogenesis and the mice produced offspring that had the GFP transgene. These findings contribute to basic research into oogenesis and stem cell self-renewal and open up new possibilities for use of FGSCs in biotechnology and medicine.	[Zou, Kang; Yuan, Zhe; Yang, Zhaojuan; Luo, Huacheng; Sun, Kejing; Zhou, Li; Xiang, Jie; Shi, Lingjun; Yu, Qingsheng; Zhang, Yong; Hou, Ruoyu; Wu, Ji] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Wu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.	jiwu@sjtu.edu.cn	Hou, Ruoyu/B-4661-2008; yuan, zhe/GYE-0922-2022; Zou, Kang/ABB-2412-2020; Yuan, Zhe/H-1169-2018; Zou, Kang/R-6626-2019; yu, qing/HGC-4611-2022	Hou, Ruoyu/0000-0002-9891-8834; Yuan, Zhe/0000-0002-8674-9287; Zou, Kang/0000-0002-1253-1816; 	Key Program of National Natural Scientific Foundation of China [30630012]; Shanghai Pujiang Program, China [06PJ14058]; Shanghai Leading Academic Discipline [B205]	Key Program of National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program, China(Shanghai Pujiang Program); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	The authors would like to thank Il-Hoan Oh for providing the MSCV-PGK-GFP vector used in this study. This work was supported by Key Program of National Natural Scientific Foundation of China (No. 30630012), and sponsored by Shanghai Pujiang Program, China (No. 06PJ14058) and Shanghai Leading Academic Discipline Project (No. B205).	Anderson L D, 1992, Md Med J, V41, P614; Bortvin Alex, 2004, BMC Developmental Biology, V4; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gosden RG, 2004, HUM REPROD UPDATE, V10, P193, DOI 10.1093/humupd/dmh023; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; HU B, 2008, AM J PHYSIOL-GASTR L, V295, P45; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wu J, 2005, DEV BIOL, V284, P437, DOI 10.1016/j.ydbio.2005.05.042; Wu J, 2003, J ENDOCRINOL, V176, P381, DOI 10.1677/joe.0.1760381; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu J, 2008, J MOL BIOL, V377, P28, DOI 10.1016/j.jmb.2007.12.038; Yang ZJ, 2008, DNA CELL BIOL, V27, P479, DOI 10.1089/dna.2008.0752; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	37	426	476	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					631	U424		10.1038/ncb1869	http://dx.doi.org/10.1038/ncb1869			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363485				2022-12-27	WOS:000265640000022
J	Feng, B; Jiang, JM; Kraus, P; Ng, JH; Heng, JCD; Chan, YS; Yaw, LP; Zhang, WW; Loh, YH; Han, JY; Vega, VB; Cacheux-Rataboul, V; Lim, B; Lufkin, T; Ng, HH				Feng, Bo; Jiang, Jianming; Kraus, Petra; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Yaw, Lai-Ping; Zhang, Weiwei; Loh, Yuin-Han; Han, Jianyong; Vega, Vinsensius B.; Cacheux-Rataboul, Valere; Lim, Bing; Lufkin, Thomas; Ng, Huck-Hui			Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; ERR-BETA; MOUSE; GENERATION; NETWORK; MYC; EXPRESSION; GENES	The dominant effect of transcription factors in imparting expanded potency is best exemplified by the reprogramming of fibroblasts to pluripotent cells using retrovirus-mediated transduction of defined transcription factors. In the murine system, Oct4, Sox2, c-Myc and KIf4 are sufficient to convert fibroblasts to induced pluripotent stem (iPS) cells that have many characteristics of embryonic stem (ES) cells. Here we show that the orphan nuclear receptor Esrrb functions in conjunction with Oct4 and Sox2 to mediate reprogramming of mouse embryonic fibroblasts (MEFs) to iPS cells. Esrrb-reprogrammed cells share similar expression and epigenetic signatures as ES cells. These cells are also pluripotent and can differentiate in vitro and in vivo into the three major embryonic cell lineages. Furthermore, these cells contribute to mouse chimaeras and are germline transmissible. In ES cells, Esrrb targets many genes involved in self-renewal and pluripotency. This suggests that Esrrb may mediate reprogramming through the upregulation of ES-cell-specific genes. Our findings also indicate that it is possible to reprogram MEFs without exogenous KIf transcription factors and link a nuclear receptor to somatic cell reprogramming.	[Feng, Bo; Jiang, Jianming; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Yaw, Lai-Ping; Zhang, Weiwei; Loh, Yuin-Han; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Jiang, Jianming; Heng, Jian-Chien Dominic; Chan, Yun-Shen; Zhang, Weiwei; Loh, Yuin-Han; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Harvard University; Harvard Medical School	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Lufkin, Thomas/AAG-7476-2019; Loh, Yuin-Han/E-1096-2014; Ng, Huck Hui/A-1135-2009; Feng, Bo/D-7831-2014; Lufkin, Thomas/B-5352-2011; Kraus, Petra/I-5849-2014; jiang, jianming/B-3421-2012; Chan, Yun-Shen/GWC-4616-2022	Lufkin, Thomas/0000-0002-7902-4771; Loh, Yuin-Han/0000-0002-4715-6454; Feng, Bo/0000-0002-4018-3257; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; jiang, jianming/0000-0003-3251-2716; 	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Stem Cell Consortium; Singapore Millennium Foundation; NUS	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; Singapore Millennium Foundation(Singapore Millennium Foundation); NUS(National University of Singapore)	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR) and Singapore Stem Cell Consortium for funding. J.J is supported by the Singapore Millennium Foundation graduate scholarship and the NUS graduate scholarship. Y.L. and J.N. are supported by the A*STAR graduate scholarship. J.H and Y.C are supported by the NUS graduate school scholarship. We are grateful to Kuee-Theng Kuay for technical support. We thank Andrew Hutchins, Tara Huber and Edwin Cheung for critical comments on the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2007, NAT CELL BIOL, V9, P871, DOI 10.1038/ncb0807-871; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	32	348	426	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					197	U193		10.1038/ncb1827	http://dx.doi.org/10.1038/ncb1827			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19136965				2022-12-27	WOS:000263285500018
J	Sabatini, DD				Sabatini, David D.			George Palade 1912-2008 OBITUARY	NATURE CELL BIOLOGY			English	Biographical-Item									NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Sabatini, DD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	david.sabatini@nyumc.org							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2008	10	12					1374	1374		10.1038/ncb1208-1374	http://dx.doi.org/10.1038/ncb1208-1374			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	377OZ	19043427	Bronze			2022-12-27	WOS:000261261800002
J	Xing, HY; Vanderford, NL; Sarge, KD				Xing, Hongyan; Vanderford, Nathan L.; Sarge, Kevin D.			The TBP-PP2A mitotic complex bookmarks genes by preventing condensin action	NATURE CELL BIOLOGY			English	Article							CHROMOSOME CONDENSATION; TRANSCRIPTION FACTOR; IN-VIVO; PROTEIN; CHROMATIN; TBP; LOCALIZATION; ASSOCIATION; INHIBITION; ACTIVATION	To maintain phenotypes of cell lineages, cells must 'remember' which genes were active before mitosis entry and transmit this information to their daughter cells so that expression patterns can be faithfully re-established in G1. This phenomenon is called gene bookmarking. However, during mitosis transcription ceases, most sequence-specific proteins dissociate from DNA and the chromatin is tightly compacted, making it difficult to understand how gene activity 'memory' is maintained through this stage of the cell cycle(1,2). A feature of gene bookmarking is that in mitotic cells, the promoters of formerly active genes lack compaction, but how compaction of these regions is inhibited is unknown(3,4). Here we show that during mitosis, TATA-binding protein (TBP), which remains bound to DNA during mitosis, recruits PP2A. TBP also interacts with condensin to allow efficient dephosphorylation and inactivation of condensin near these promoters to inhibit their compaction. Further, ChIP-on-chip data show that TBP is bound to many chromosomal sites during mitosis, and is higher in transcribed regions but low in regions containing pseudogenes and genes whose expression is tissue-restricted. These results suggest that TBP is involved not only in gene transcription during interphase but also in preserving the memory of gene activity through mitosis to daughter cells.	[Xing, Hongyan; Vanderford, Nathan L.; Sarge, Kevin D.] Univ Kentucky, Dept Mol & Cellular Biochem, Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Chandler Med Ctr, Lexington, KY 40536 USA.	kdsarge@uky.edu			NIH [GM61053, GM64606]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to Sui Huang and Arnold Berk for their generous gifts of GFP-TBP and GST-TBP plasmids, respectively, and to lab members for insightful discussions. This research was supported by NIH grants to K. D. S. (GM61053 and GM64606).	Allegrucci C, 2004, LANCET, V364, P206, DOI 10.1016/S0140-6736(04)16636-1; Armstrong L, 2006, STEM CELLS, V24, P805, DOI 10.1634/stemcells.2005-0350; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Fairley JA, 2003, EMBO J, V22, P5841, DOI 10.1093/emboj/cdg544; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gulledge BM, 2002, CURR MED CHEM, V9, P1991, DOI 10.2174/0929867023368845; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006	28	73	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2008	10	11					1318	U150		10.1038/ncb1790	http://dx.doi.org/10.1038/ncb1790			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	367XU	18931662	Green Accepted			2022-12-27	WOS:000260586700014
J	Lee, KS; Kwon, OY; Lee, JH; Kwon, K; Min, KJ; Jung, SA; Kim, AK; You, KH; Tatar, M; Yu, K				Lee, Kyu-Sun; Kwon, O-Yu; Lee, Joon H.; Kwon, Kisang; Min, Kyung-Jin; Jung, Sun-Ah; Kim, Ae-Kyeong; You, Kwan-Hee; Tatar, Marc; Yu, Kweon			Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN; CELL-LINES; RECEPTOR; DOWNSTREAM; EXPRESSION; PHENOTYPES; PEPTIDES; ABLATION; PATHWAY; BODY	Insulin and insulin growth factor have central roles in growth(1,2), metabolism(3) and ageing(4,5) of animals, including Drosophila melanogaster. In Drosophila, insulin-like peptides ( Dilps) are produced by specialized neurons in the brain(3,6). Here we show that Drosophila short neuropeptide F ( sNPF), an orthologue of mammalian neuropeptide Y ( NPY), and sNPF receptor sNPFR1 regulate expression of Dilps. Body size was increased by overexpression of sNPF or sNPFR1. The fat body of sNPF mutant Drosophila had downregulated Akt, nuclear localized FOXO, upregulated translational inhibitor 4E-BP and reduced cell size. Circulating levels of glucose were elevated and lifespan was also extended in sNPF mutants. We show that these effects are mediated through activation of extracellular signal-related kinases ( ERK) in insulin-producing cells of larvae and adults. Insulin expression was also increased in an ERK-dependent manner in cultured Drosophila central nervous system ( CNS) cells and in rat pancreatic cells treated with sNPF or NPY peptide, respectively. Drosophila sNPF and the evolutionarily conserved mammalian NPY seem to regulate ERK- mediated insulin expression and thus to systemically modulate growth, metabolism and lifespan.	[Lee, Kyu-Sun; Kim, Ae-Kyeong; Yu, Kweon] Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305333, South Korea; [You, Kwan-Hee] Chungnam Natl Univ, Sch Biosci & Biotechnol, Taejon, South Korea; [Lee, Joon H.; Jung, Sun-Ah] Konyang Univ, Coll Med, Kims Eye Hosp, Myung Gok Eye Res Inst, Chungnam, South Korea; [Min, Kyung-Jin; Tatar, Marc] Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Konyang University; Konyang University Hospital; Brown University	Yu, K (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305333, South Korea.	kweonyu@kribb.re.kr	Min, Kyung-Jin/AAG-5774-2020	Min, Kyung-Jin/0000-0001-5829-6842; Tatar, Marc/0000-0003-3232-6884; Yu, Kweon/0000-0002-4942-2576				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; EMESON RB, 2005, SCI STKE, pPE12; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kim M, 2004, MOL CELL BIOL, V24, P573, DOI 10.1128/MCB.24.2.573-583.2004; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; WAHLESTEDT C, 1993, SCIENCE, V259, P528, DOI 10.1126/science.8380941; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang S, 2007, P NATL ACAD SCI USA, V104, P19873, DOI 10.1073/pnas.0707465104; Yu K, 2000, DEVELOPMENT, V127, P2143; Zimanyi IA, 1998, CURR PHARM DESIGN, V4, P349	27	165	168	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					468	U230		10.1038/ncb1710	http://dx.doi.org/10.1038/ncb1710			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18344986				2022-12-27	WOS:000254561700018
J	David, R; Brenner, C; Stieber, J; Schwarz, F; Brunner, S; Vollmer, M; Mentele, E; Muller-Hocker, J; Kitajima, S; Lickert, H; Rupp, R; Franz, WM				David, R.; Brenner, C.; Stieber, J.; Schwarz, F.; Brunner, S.; Vollmer, M.; Mentele, E.; Mueller-Hoecker, J.; Kitajima, S.; Lickert, H.; Rupp, R.; Franz, W. -M.			MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; HEART PRECURSOR CELLS; IN-VITRO; CARDIAC MESODERM; XENOPUS-LAEVIS; CARDIOMYOCYTES; SPECIFICATION; GENE; CARDIOMYOGENESIS; CARDIOGENESIS	ES-cell-based cardiovascular repair requires an in-depth understanding of the molecular mechanisms underlying the differentiation of cardiovascular ES cells. A candidate cardiovascular-fate inducer is the bHLH transcription factor MesP1(1,2). As one of the earliest markers, it is expressed specifically in almost all cardiovascular precursors and is required for cardiac morphogenesis(2,3). Here we show that MesP1 is a key factor sufficient to induce the formation of ectopic heart tissue in vertebrates and increase cardiovasculogenesis by ES cells. Electrophysiological analysis showed all subtypes of cardiac ES-cell differentiation(4). MesP1 overexpression and knockdown experiments revealed a prominent function of MesP1 in a gene regulatory cascade, causing Dkk-1-mediated blockade of canonical Wnt-signalling. Independent evidence from ChIP and in vitro DNA-binding studies, expression analysis in wild-type and MesP knockout mice, and reporter assays confirm that Dkk-1 is a direct target of MesP1. Further analysis of the regulatory networks involving MesP1 will be required to preprogramme ES cells towards a cardiovascular fate for cell therapy and cardiovascular tissue engineering. This may also provide a tool to elicit cardiac transdifferentiation in native human adult stem cells.	[David, R.; Brenner, C.; Schwarz, F.; Brunner, S.; Franz, W. -M.] Klinikum Grosshadern LMU, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Stieber, J.] Univ Erlangen Nurnberg, Lehrstuhl Pharmakol & Toxikol, D-91054 Erlangen, Germany; [Vollmer, M.] GSF, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; [Mentele, E.; Rupp, R.] Adolph Butenandt Inst LMU, D-80336 Munich, Germany; [Mueller-Hoecker, J.] Pathol Inst LMU, D-80337 Munich, Germany; [Kitajima, S.] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan	University of Munich; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; National Institute of Health Sciences - Japan	David, R (corresponding author), Klinikum Grosshadern LMU, Med Klin & Poliklin 1, D-81377 Munich, Germany.	robert.david@med.uni-muenchen.de; wolfgang.franz@med.uni-muenchen.de	Schwarz, Florian/AAE-5840-2022; Lickert, Heiko/K-9045-2013	Schwarz, Florian/0000-0001-9889-5153; rupp, ralph/0000-0002-8068-9957				David R, 1998, MECH DEVELOP, V79, P137, DOI 10.1016/S0925-4773(98)00181-6; David R, 2005, STEM CELLS, V23, P477, DOI 10.1634/stemcells.2004-0177; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kitajima S, 2006, DEV DYNAM, V235, P395, DOI 10.1002/dvdy.20640; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Nir SG, 2003, CARDIOVASC RES, V58, P313, DOI 10.1016/S0008-6363(03)00264-5; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tillet E, 2005, EXP CELL RES, V310, P392, DOI 10.1016/j.yexcr.2005.08.021; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433	30	176	190	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					338	U75		10.1038/ncb1696	http://dx.doi.org/10.1038/ncb1696			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18297060				2022-12-27	WOS:000253778300016
J	Davies, CC; Chakraborty, A; Cipriani, F; Haigh, K; Haigh, JJ; Behrens, A				Davies, Clare C.; Chakraborty, Atanu; Cipriani, Filippo; Haigh, Katharina; Haigh, Jody J.; Behrens, Axel			Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; TRANSCRIPTION FACTOR AP-1; C-JUN; UBIQUITIN LIGASE; TERMINAL PHOSPHORYLATION; MAP KINASES; JNK; RAS; PROTEIN; FOS	The AP-1 transcription factor c-Jun is essential for cellular proliferation in many cell types, but the molecular link between growth factors and c-Jun activation has been enigmatic. In this study we identify a previously uncharacterized RING-domain-containing protein, RACO-1 (RING domain AP-1 co-activator-1), as a c-Jun co-activator that is regulated by growth factor signalling. RACO-1 interacted with c-Jun independently of amino-terminal phosphorylation, and was both necessary and sufficient for c-Jun/AP-1 activation. Growth factor-mediated stimulation of AP-1 was attributable to MEK/ERK-dependent stabilization of RACO-1 protein. Stimulation of the MEK/ERK pathway strongly promoted Lys 63-linked ubiquitylation of RACO-1, which antagonized Lys 48-linked degradative auto-ubiquitylation of the same Lys residues. RACO-1 depletion reduced cellular proliferation and decreased expression of several growth-associated AP-1 target genes, such as cdc2, cyclinD1 and hb-egf. Moreover, transgenic overexpression of RACO-1 augmented intestinal tumour formation triggered by aberrant Wnt signalling and cooperated with oncogenic Ras in colonic hyperproliferation. Thus RACO-1 is a co-activator that links c-Jun to growth factor signalling and is essential for AP-1 function in proliferation.	[Davies, Clare C.; Chakraborty, Atanu; Cipriani, Filippo; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Haigh, Katharina; Haigh, Jody J.] Univ Ghent VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, B-9052 Ghent, Belgium; [Haigh, Katharina; Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Cancer Research UK; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk		haigh, jody/0000-0002-7319-8922; Davies, Clare/0000-0003-3097-1791; Behrens, Axel/0000-0002-1557-1143	Cancer Research UK; Medical Research Council [G0901677] Funding Source: researchfish; MRC [G0901677] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to N. Ahn, M. Cobb and A. Hock for providing reagents. We thank B. Spencer-Dean, E. Nye and R. Mitter for technical support; the Molecular Biology Core Facility, Paterson Institute for Cancer Research, Manchester, UK for microarray analysis; and H. Walden for critical reading of the manuscript. The London Research Institute is funded by Cancer Research UK.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; DECESARE D, 1995, ONCOGENE, V11, P365; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Johnson R, 1996, MOL CELL BIOL, V16, P4504; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Mansour SJ, 1996, CELL GROWTH DIFFER, V7, P243; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	47	33	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					963	972		10.1038/ncb2098	http://dx.doi.org/10.1038/ncb2098			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852630				2022-12-27	WOS:000282363500011
J	Yang, MH; Hsu, DSS; Wang, HW; Wang, HJ; Lan, HY; Yang, WH; Huang, CH; Kao, SY; Tzeng, CH; Tai, SK; Chang, SY; Lee, OKS; Wu, KJ				Yang, Muh-Hwa; Hsu, Dennis Shin-Shian; Wang, Hsei-Wei; Wang, Hsiao-Jung; Lan, Hsin-Yi; Yang, Wen-Hao; Huang, Chi-Hung; Kao, Shou-Yen; Tzeng, Cheng-Hwai; Tai, Shyh-Kuan; Chang, Shyue-Yih; Lee, Oscar Kuang-Sheng; Wu, Kou-Juey			Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition	NATURE CELL BIOLOGY			English	Article							CANCER STEM-CELLS; E-CADHERIN REPRESSION; NECK-CANCER; GENE-EXPRESSION; SELF-RENEWAL; METHYLTRANSFERASE ACTIVITY; IN-VIVO; KAPPA-B; HEAD; HYPOXIA	The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.	[Yang, Muh-Hwa; Hsu, Dennis Shin-Shian; Wang, Hsei-Wei; Wang, Hsiao-Jung; Lan, Hsin-Yi; Yang, Wen-Hao; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Yang, Muh-Hwa; Huang, Chi-Hung; Tzeng, Cheng-Hwai] Taipei Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Wang, Hsei-Wei; Chang, Shyue-Yih; Wu, Kou-Juey] Taipei Vet Gen Hosp, Genom Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wu, Kou-Juey] Taiwan Adv Biopharm Inc, Xizhi City 221, Taipei County, Taiwan; [Kao, Shou-Yen] Taipei Vet Gen Hosp, Dept Dent, Taipei 112, Taiwan; [Tai, Shyh-Kuan; Chang, Shyue-Yih] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei 112, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.	mhyang2@vghtpe.gov.tw; kjwu2@ym.edu.tw	Yang, Muh-Hwa/AAE-4691-2020; Wu, Kou-Juey/P-4654-2015; Yang, wenhao/GXG-5965-2022		National Science Council [96-2314-B-075-013, 97-2314-B-010-003, 97-2320-B-010-029]; National Research Program for Genomic Medicine [DOH98-TD-G-111-027, DOH99-TD-G-111-024]; Ministry of Education [VGH 98-C1-050, 98-ER2-008, 99-C1-077, 99-ER2-007, 99-ER2-009]	National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); Ministry of Education	We would like to thank M. C. Hung (M. D. Anderson Cancer Center) for critical comments on the manuscript. We thank L. E. Huang (University of Utah) for pHA-HIF1 alpha(Delta ODD) plasmid. We are grateful to T.Y. Chou and W.Y. Li of the Department of Pathology, Taipei Veterans General Hospital for providing advice on IHC analysis. This work was supported in part by National Science Council grants to M.H.Y. (96-2314-B-075-013 and 97-2314-B-010-003) and K.J.W.(97-2320-B-010-029), National Research Program for Genomic Medicine grants to K.J.W (DOH98-TD-G-111-027 and DOH99-TD-G-111-024); Taipei Veterans General Hospital grants to M.H.Y (VGH 98-C1-050; 98-ER2-008, 99-C1-077 and 99-ER2-007) and K.J.W (99-ER2-009), grants from Ministry of Education, Aim for the Top University Plan to M.H.Y (98A-C-T510 and 99A-C-T509) and to K.J.W (99A-C-T508), National Health Research Institutes grants to K.J.W (NHRI-EX-98-9611BI and NHRI-EX-99-9931BI) and a grant from Department of Health, Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH99-TD-C-111-007) to M.H.Y.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Foschini MP, 2008, HEAD NECK-J SCI SPEC, V30, P1475, DOI 10.1002/hed.20908; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vormittag L, 2009, INT J RADIAT ONCOL, V73, P913, DOI 10.1016/j.ijrobp.2008.10.040; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yang MH, 2006, CLIN CANCER RES, V12, P507, DOI 10.1158/1078-0432.CCR-05-1231; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	51	511	529	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					982	992		10.1038/ncb2099	http://dx.doi.org/10.1038/ncb2099			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818389				2022-12-27	WOS:000282363500013
J	Santenard, A; Ziegler-Birling, C; Koch, M; Tora, L; Bannister, AJ; Torres-Padilla, ME				Santenard, Angele; Ziegler-Birling, Celine; Koch, Marc; Tora, Laszlo; Bannister, Andrew J.; Torres-Padilla, Maria-Elena			Heterochromatin formation in the mouse embryo requires critical residues of the histone variant H3.3	NATURE CELL BIOLOGY			English	Article							CHROMATIN MODIFICATIONS; MATERNAL CHROMATIN; DNA-REPLICATION; TRANSCRIPTION; ASYMMETRY; METHYLATION; ACTIVATION; COMPLEXES; PROTEINS	In mammals, oocyte fertilization by sperm initiates development. This is followed by epigenetic reprogramming of both parental genomes, which involves the de novo establishment of chromatin domains. In the mouse embryo, methylation of histone H3 establishes an epigenetic asymmetry and is predominant in the maternal pronucleus. However, the roles of differential incorporation of histone H3 variants in the parental chromatin, and of modified residues within specific histone variants, have not been addressed. Here we show that the histone variant H3.3, and in particular lysine 27, is required for the establishment of heterochromatin in the mouse embryo. H3.3 localizes to paternal pericentromeric chromatin during S phase at the time of transcription of pericentromeric repeats. Mutation of H3.3 K27, but not of H3.1 K27, results in aberrant accumulation of pericentromeric transcripts, HP1 mislocalization, dysfunctional chromosome segregation and developmental arrest. This phenotype is rescued by injection of double-stranded RNA (dsRNA) derived from pericentromeric transcripts, indicating a functional link between H3.3K27 and the silencing of such regions by means of an RNA-interference (RNAi) pathway. Our work demonstrates a role for a modifiable residue within a histone-variant-specific context during reprogramming and identifies a novel function for mammalian H3.3 in the initial formation of dsRNA-dependent heterochromatin.	[Santenard, Angele; Ziegler-Birling, Celine; Koch, Marc; Tora, Laszlo; Torres-Padilla, Maria-Elena] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Bannister, Andrew J.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cambridge	Torres-Padilla, ME (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,U964, F-67404 Illkirch Graffenstaden, France.	metp@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Koch, Marc/0000-0002-2678-235X; Bannister, Andrew/0000-0002-6312-4436	Cancer Research U.K.; Programme National de Recherche Reproduction Endocrinologie (PNRRE); INSERM;  [ANR-09-Blanc-0114]	Cancer Research U.K.(Cancer Research UK); Programme National de Recherche Reproduction Endocrinologie (PNRRE); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 	We thank Kami Ahmad for providing H3.3 constructs, Florence Cammas and Tony Kouzarides for HP1 beta cDNAs, Natacha Dreumont and James Stevenin for advice on RNA-shift, and Olivier Pourquie for critical reading of the manuscript. A.J.B. acknowledges funding from Cancer Research U.K.; M.E.T.-P. acknowledges funding from Programme National de Recherche Reproduction Endocrinologie (PNRRE) and the Avenir programme from INSERM, and ANR-09-Blanc-0114.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Arney KL, 2002, INT J DEV BIOL, V46, P317; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wiekowski M, 1997, J CELL SCI, V110, P1147; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Wright SJ, 1999, CURR TOP DEV BIOL, V46, P133, DOI 10.1016/S0070-2153(08)60328-2	28	216	228	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					853	862		10.1038/ncb2089	http://dx.doi.org/10.1038/ncb2089			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20676102	Green Accepted			2022-12-27	WOS:000281561900009
J	Ravikumar, B; Moreau, K; Jahreiss, L; Puri, C; Rubinsztein, DC				Ravikumar, Brinda; Moreau, Kevin; Jahreiss, Luca; Puri, Claudia; Rubinsztein, David C.			Plasma membrane contributes to the formation of pre-autophagosomal structures	NATURE CELL BIOLOGY			English	Article							MUTANT HUNTINGTIN; PROTEIN; CELL; PHOSPHOINOSITIDES; AGGREGATION; ENDOCYTOSIS; BIOGENESIS; LIPIDATION; MATURATION; DISEASE	Autophagy is a catabolic process in which lysosomes degrade cytoplasmic contents transported in double-membraned autophagosomes. Autophagosomes are formed by the elongation and fusion of phagophores, which derive from pre-autophagosomal structures. The membrane origins of autophagosomes are unclear and may involve multiple sources, including the endoplasmic reticulum and mitochondria. Here we show in mammalian cells that the heavy chain of clathrin interacts with Atg16L1 and is involved in the formation of Atg16L1-positive early autophagosome precursors. Atg16L1 associated with clathrin-coated structures, and inhibition of clathrin-mediated internalization decreased the formation of both Atg16L1-positive precursors and mature autophagosomes. We demonstrated that the plasma membrane contributes directly to the formation of early Atg16L1-positive autophagosome precursors. This may be particularly important during periods of increased autophagosome formation, because the plasma membrane may serve as a large membrane reservoir that allows periods of autophagosome synthesis at levels many-fold higher than under basal conditions, without compromising other processes.	[Ravikumar, Brinda; Moreau, Kevin; Jahreiss, Luca; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; [Puri, Claudia] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011		Wellcome Trust; MRC; Cancer Research UK; MRC [G0600194] Funding Source: UKRI; Medical Research Council [G0600194] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to P. Luzio, V. Korolchuk, F. Menzies and S. Sarkar, Cambridge Institute for Medical Research, Cambridge for helpful comments, and for funding from a Wellcome Trust Senior Clinical Research Fellowship (D.C.R.), a MRC Programme grant (D.C.R.), Cancer Research UK (CP.). We thank M. Mizuguchi, Toyama Medical and Pharmaceutical University, Toyama, for hLC3B; R. Tsien, University of California, San Diego, for tdTomato; R. Xavier, Massachusetts General Hospital, Boston, for 3 x Flag Atg16L1; T. Yoshimori, Osaka University, Osaka, for cyan fluorescent protein (CFP)-LC3 and GFP Atg5; B. Beaumelle, Universite Montpellier 2, France, for dominant-negative dynamin II; T. Meyer, Stanford University Medical Center, Stanford, for PLC(PH); and M. Harbour, Cambridge Institute for Medical Research, Cambridge, for help with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	31	627	646	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					747	U15		10.1038/ncb2078	http://dx.doi.org/10.1038/ncb2078			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639872	Green Accepted			2022-12-27	WOS:000280561600007
J	Das-Bradoo, S; Nguyen, HD; Wood, JL; Ricke, RM; Haworth, JC; Bielinsky, AK				Das-Bradoo, Sapna; Nguyen, Hai Dang; Wood, Jamie L.; Ricke, Robin M.; Haworth, Justin C.; Bielinsky, Anja-Katrin			Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; CELL-CYCLE ARREST; POSTREPLICATION REPAIR; REPLICATION; PROTEINS; DOMAIN; MCM10; GENE; MUTAGENESIS; MUTATIONS	In all eukaryotes, the ligation of newly synthesized DNA, also known as Okazaki fragments, is catalysed by DNA ligase I (ref. 1). An individual with a DNA ligase I deficiency exhibits growth retardation, sunlight sensitivity and severe immunosuppression(2), probably due to accumulation of DNA damage. Surprisingly, not much is known about the DNA damage response (DDR) in DNA ligase I-deficient cells. As DNA replication and DDR pathways are highly conserved in eukaryotes, we used Saccharomyces cerevisiae as a model system to address this issue. We uncovered a new pathway, which facilitates ubiquitylation at Lys 107 of proliferating cell nuclear antigen (PCNA). Unlike ubiquitylation at Lys 164 of PCNA in response to UV irradiation, which triggers translesion synthesis(3), modification of Lys 107 is not dependent on the ubiquitin conjugating enzyme (E2) Rad6 (ref. 4) nor the ubiquitin ligase (E3) Rad18 (ref. 5), but requires the E2 variant Mms2 (ref. 6) in conjunction with Ubc4 (ref. 7) and the E3 Rad5 (refs 8, 9). Surprisingly, DNA ligase I-deficient S. cerevisiae cdc9-1 cells that carry a PCNA(K107R) mutation are inviable, because they cannot activate a robust DDR. Furthermore, we show that ubiquitylation of PCNA in response to DNA ligase I deficiency is conserved in humans, yet the lysine residue that is modified remains to be determined. We propose that PCNA ubiquitylation provides a 'DNA damage code' that allows cells to categorize different types of defects that arise during DNA replication.	[Das-Bradoo, Sapna; Nguyen, Hai Dang; Wood, Jamie L.; Haworth, Justin C.; Bielinsky, Anja-Katrin] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Ricke, Robin M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Bielinsky, AK (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bieli003@umn.edu		Bielinsky, Anja/0000-0003-1783-619X; Nguyen, Dang/0000-0002-4200-8778	NIH [P41 RR-01081, CA009138, GM074917]; University of Minnesota; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. J. Clarke, J. F. X. Diffley, D. Durocher, S. J. Elledge, M. Hochstrasser, S. Jentsch, D. Koepp and D. M. Livingston for strains and plasmids and J. F. X. Diffley, A. E. Tomkinson and Z. Zhang for antibodies against Rad53, Cdc9 and PCNA. We acknowledge the assistance of the Flow Cytometry Core Facility at the University of Minnesota. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081). J. C. H. was supported by NIH training grant CA009138. This work was supported by a Grant-in-Aid from the University of Minnesota and NIH grant ( GM074917) to A. K. B. who is a Scholar of the Leukemia and Lymphoma Society.	Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; DORNFELD KJ, 1991, MOL CELL BIOL, V11, P2013, DOI 10.1128/MCB.11.4.2013; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ireland MJ, 2000, GENETICS, V155, P1657; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JOHNSTON LH, 1978, NATURE, V274, P891, DOI 10.1038/274891a0; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCHIESTL RH, 1989, MOL CELL BIOL, V9, P1882, DOI 10.1128/MCB.9.5.1882; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; van der Kemp PA, 2009, NUCLEIC ACIDS RES, V37, P2549, DOI 10.1093/nar/gkp105; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEINERT TA, 1993, GENETICS, V134, P63; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	40	53	54	11	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					74	U190		10.1038/ncb2007	http://dx.doi.org/10.1038/ncb2007			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010813	Green Accepted			2022-12-27	WOS:000272973800015
J	Wellner, U; Schubert, J; Burk, UC; Schmalhofer, O; Zhu, F; Sonntag, A; Waldvogel, B; Vannier, C; Darling, D; zur Hausen, A; Brunton, VG; Morton, J; Sansom, O; Schuler, J; Stemmler, MP; Herzberger, C; Hopt, U; Keck, T; Brabletz, S; Brabletz, T				Wellner, Ulrich; Schubert, Joerg; Burk, Ulrike C.; Schmalhofer, Otto; Zhu, Feng; Sonntag, Annika; Waldvogel, Bettina; Vannier, Corinne; Darling, Douglas; zur Hausen, Axel; Brunton, Valerie G.; Morton, Jennifer; Sansom, Owen; Schueler, Julia; Stemmler, Marc P.; Herzberger, Christoph; Hopt, Ulrich; Keck, Tobias; Brabletz, Simone; Brabletz, Thomas			The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MALIGNANT-TUMOR PROGRESSION; PANCREATIC-CANCER; MIR-200 FAMILY; E-CADHERIN; COLORECTAL-CANCER; DOWN-REGULATION; BETA-CATENIN; CELLS; EXPRESSION	Invasion and metastasis of carcinomas is promoted by the activation of the embryonic 'epithelial to mesenchymal transition' (EMT) program, which triggers cellular mobility and subsequent dissemination of tumour cells. We recently showed that the EMT-activator ZEB1 (zinc finger E-box binding homeobox 1) is a crucial promoter of metastasis and demonstrated that ZEB1 inhibits expression of the microRNA-200 (miR-200) family, whose members are strong inducers of epithelial differentiation. Here, we report that ZEB1 not only promotes tumour cell dissemination, but is also necessary for the tumour-initiating capacity of pancreatic and colorectal cancer cells. We show that ZEB1 represses expression of stemness-inhibiting miR-203 and that candidate targets of miR-200 family members are also stem cell factors, such as Sox2 and Klf4. Moreover, miR-200c, miR-203 and miR-183 cooperate to suppress expression of stem cell factors in cancer cells and mouse embryonic stem (ES) cells, as demonstrated for the polycomb repressor Bmi1. We propose that ZEB1 links EMT-activation and stemness-maintenance by suppressing stemness-inhibiting microRNAs (miRNAs) and thereby is a promoter of mobile, migrating cancer stem cells. Thus, targeting the ZEB1-miR-200 feedback loop might form the basis of a promising treatment for fatal tumours, such as pancreatic cancer.	[Wellner, Ulrich; Schubert, Joerg; Burk, Ulrike C.; Schmalhofer, Otto; Zhu, Feng; Sonntag, Annika; Waldvogel, Bettina; Vannier, Corinne; Herzberger, Christoph; Hopt, Ulrich; Keck, Tobias; Brabletz, Simone; Brabletz, Thomas] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany; [Schubert, Joerg] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Darling, Douglas] Univ Louisville, Dept Periodont, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [zur Hausen, Axel] Univ Freiburg, Dept Pathol, D-79106 Freiburg, Germany; [Brunton, Valerie G.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Morton, Jennifer; Sansom, Owen] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Schueler, Julia] Oncotest GmbH, Inst Expt Oncol, D-79108 Freiburg, Germany; [Stemmler, Marc P.] Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany; [Brabletz, Thomas] Univ Freiburg, Ctr Comprehens Canc, D-7910 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Louisville; University of Freiburg; University of Edinburgh; Beatson Institute; Oncotest GmbH; Max Planck Society; University of Freiburg	Brabletz, T (corresponding author), Univ Freiburg, Dept Visceral Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.	thomas.brabletz@uniklinik-freiburg.de	Morton, Jennifer/AAJ-5113-2021; Morton, Jennifer P/E-1633-2011; Darling, Douglas S/D-4573-2009; Wellner, Ulrich Friedrich/B-1388-2019	Morton, Jennifer/0000-0001-5766-9141; Morton, Jennifer P/0000-0001-5766-9141; Wellner, Ulrich Friedrich/0000-0002-8632-166X; Darling, Douglas/0000-0002-9039-1169; Keck, Tobias/0000-0001-7651-6183; Sansom, Owen J./0000-0001-9540-3010	EU [037297]; DFG [BR 1399/4-3, BR 1399/5-1]; Deutsche Krebshilfe [106958]; Cancer Research UK [C157/A9148]	EU(European Commission); DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK)	We thank J. Pfannstiel, K. Meyer, M. Berthold, S. Hempel and A. Schmitt for expert technical assistance. This work was supported by grants to T. B. from the EU MCSC contract no. 037297, the DFG ( no. BR 1399/4-3 and BR 1399/5-1) and the Deutsche Krebshilfe ( no. 106958), and to V. G. B. from Cancer Research UK (C157/A9148).	Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Brabletz T, 2004, CANCER RES, V64, P6973, DOI 10.1158/0008-5472.CAN-04-1132; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hlubek F, 2001, CANCER RES, V61, P8089; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Romero C, 2009, J PATHOL, V219, P205, DOI 10.1002/path.2585; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	45	1307	1354	1	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1487	U236		10.1038/ncb1998	http://dx.doi.org/10.1038/ncb1998			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935649				2022-12-27	WOS:000272251300017
J	Gumireddy, K; Li, AP; Gimotty, PA; Klein-Szanto, AJ; Showe, LC; Katsaros, D; Coukos, G; Zhang, L; Huang, QH				Gumireddy, Kiranmai; Li, Anping; Gimotty, Phyllis A.; Klein-Szanto, Andres J.; Showe, Louise C.; Katsaros, Dionyssios; Coukos, George; Zhang, Lin; Huang, Qihong			KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer	NATURE CELL BIOLOGY			English	Article							FUNCTIONAL GENOMIC ANALYSIS; ID PROTEINS; TRANSCRIPTIONAL REGULATOR; MAMMARY-TUMOR; GENES; SUPPRESSOR; GROWTH; CELLS; RNA; SUBPOPULATIONS	Metastasis is a complex multistep process, which requires the concerted action of many genes and is the primary cause of cancer death. Both pathways that regulate metastasis enhancement and those that regulate its suppression contribute to the tumour dissemination process. To identify new metastasis suppressors, we set up a forward genetic screen in a mouse model. We transduced a genome-wide RNA interference (RNAi) library into the non-metastatic 168FARN breast cancer cell line and orthotopically transplanted the cells into mouse mammary fat pads. We then selected cells that could metastasize to the lung and identified an RNAi for the KLF17 gene. Conversely, we demonstrate that ectopic expression of KLF17 in a highly metastatic 4T1 breast cancer cell line inhibits the ability of cells to metastasize from the mammary fat pad to the lung. We also show that suppression of KLF17 expression promotes breast cancer cell invasion and epithelial-mesenchymal transition (EMT), and that KLF17 protein functions by directly binding to the promoter region of Id1 (which encodes a key metastasis regulator in breast cancer) to inhibit its transcription. Finally, we demonstrate that KLF17 expression is significantly downregulated in primary human breast cancer samples and that the combined expression pattern of KLF17 and Id1 can serve as a potential biomarker for lymph node metastasis in breast cancer.	[Gumireddy, Kiranmai; Li, Anping; Showe, Louise C.; Huang, Qihong] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Fox Chase Cancer Center; University of Turin; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Huang, QH (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	qhuang@wistar.org	Gimotty, Phyllis/GWZ-4136-2022; Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Gimotty, Phyllis/0000-0002-3850-9799; Coukos, George/0000-0001-8813-7367	Breast Cancer Alliance; Pardee Foundation; V Foundation; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health (PA DOH) [P30 CA10815, SAP 4100020718]; NCI ovarian SPORE [P50-CA83638]; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA148759, P50CA083638] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059478] Funding Source: NIH RePORTER	Breast Cancer Alliance; Pardee Foundation; V Foundation; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health (PA DOH); NCI ovarian SPORE; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank F. Miller for providing 168FARN and 4T1 cells, R. Weinberg for providing the HMEL cell line, J. Price for providing the MDA-MB-435 cell line, C. Chang and W. Horng for assistance with microarray analysis and J. Hayden and F. Keeney for assistance with microscopy. Q. H. is supported by the Breast Cancer Alliance, Pardee Foundation, V Foundation. Q. H. and L. C. S. are supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (PA DOH; P30 CA10815) and L. C. S. is supported by a PA DOH grant (SAP 4100020718). G. C. and L. Z. are supported by NCI ovarian SPORE (P50-CA83638), Ovarian Cancer Research Fund and Mary Kay Ash Charitable Foundation.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; ASLAKSON CJ, 1991, INT J CANCER, V47, P466, DOI 10.1002/ijc.2910470327; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DEXTER DL, 1978, CANCER RES, V38, P3174; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foster KW, 2000, CANCER RES, V60, P6488; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kataoka M, 1998, CANCER RES, V58, P4761; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lin CQ, 2000, CANCER RES, V60, P1332; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; Miller Fred, 2004, Breast Dis, V20, P43; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; PERKINS AC, 1995, NATURE, V375, P318; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; VLIET JV, 2005, GENOMICS, V87, P474; Yan W, 2002, MECH DEVELOP, V118, P233, DOI 10.1016/S0925-4773(02)00258-7; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida BA, 2000, JNCI-J NATL CANCER I, V92, P1717, DOI 10.1093/jnci/92.21.1717; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	55	153	163	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1297	U69		10.1038/ncb1974	http://dx.doi.org/10.1038/ncb1974			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19801974	Green Accepted			2022-12-27	WOS:000271425800009
J	Alvarado-Kristensson, M; Rodriguez, MJ; Silio, V; Valpuesta, JM; Carrera, AC				Alvarado-Kristensson, Maria; Josefa Rodriguez, Maria; Silio, Virginia; Valpuesta, Jose M.; Carrera, Ana C.			SADB phosphorylation of gamma-tubulin regulates centrosome duplication	NATURE CELL BIOLOGY			English	Article							MICROTUBULE NUCLEATION; CELL-CYCLE; CENTRIOLE DUPLICATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; BUDDING YEAST; RING COMPLEX; PROTEIN; KINASE; RECRUITMENT	Symmetrical cell division requires duplication of DNA and protein content to generate two daughter cells. Centrosomes also duplicate during cell division, but the mechanism controlling this process is incompletely understood. We describe an alternative splice form of SadB encoding a short SADB Ser/Thr kinase whose activity fluctuates during the cell cycle, localizes to centrosomes, and controls centrosome duplication. Reduction of endogenous SADB levels diminished centrosome numbers, whereas enhanced SADB expression induced centrosome amplification. SADB exerted this action through phosphorylation of gamma-tubulin on Ser 131, as expression of a phosphomimetic Ser 131-to-Asp gamma-tubulin mutant alone increased centrosome numbers, whereas non-phosphorylatable Ala 131-gamma-tubulin impaired centrosome duplication. We propose that SADB kinase activity controls centrosome homeostasis by regulating phosphorylation of gamma-tubulin.	[Alvarado-Kristensson, Maria; Silio, Virginia; Carrera, Ana C.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; [Josefa Rodriguez, Maria; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, E-28049 Madrid, Spain; [Alvarado-Kristensson, Maria] Lund Univ, Malmoe Univ Hosp, Dept Lab Med, Ctr Mol Pathol, S-22100 Lund, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Lund University	Alvarado-Kristensson, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3, E-28049 Madrid, Spain.	maria.alvarado-kristensson@med.lu.se; acarrera@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Alvarado-Kristensson, Maria T./C-4543-2014	Valpuesta, José M/0000-0001-7468-8053; Carrera, Ana/0000-0002-3999-5434; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986; Silio, Virginia/0000-0002-3169-336X	Spanish Ministry of Science and Innovation [SAF200405955, 200763624, CSD 2006-00023]; Spanish Association against Cancer; Spanish Ministry of Health [PI050964]; Royal Physiographic Society in Lund; Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons; U-MAS Cancer Research Found; Teggers Fond, EMBO; Swedish Society for Medical Research	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association against Cancer; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Royal Physiographic Society in Lund; Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons; U-MAS Cancer Research Found; Teggers Fond, EMBO(European Molecular Biology Organization (EMBO)); Swedish Society for Medical Research	We thank York-Dieter Stierhof and Dagmar Ripper for their generous help with electron microscopy. We thank Y. Shi, M. van de Wetering, M. Marques, M. Bornens and T. Strearns for reagents, J. Sanes and B. Lilley for SADB-deficient cells and comments, L. Kremer and L. Gomez for antibody production, C. Hernandez for help in biochemistry assays, C. Mark and R. Hartong for editorial assistance. This work was supported by the Spanish Ministry of Science and Innovation (SAF200405955, 200763624 to ACC, CSD 2006-00023 to JMV), the Spanish Association against Cancer, the Spanish Ministry of Health (PI050964), the Royal Physiographic Society in Lund, the Ake Wibergs, Thelma Zoegas, OE och Edla Johanssons and U-MAS Cancer Research Found, and fellowships from Teggers Fond, EMBO and the Swedish Society for Medical Research.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Barbosa V, 2000, GENE DEV, V14, P3126, DOI 10.1101/gad.182800; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; HESSE J, 1987, J BIOL CHEM, V262, P15472; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Kim HK, 2005, J CELL BIOL, V169, P719, DOI 10.1083/jcb.200410052; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Marques M, 2008, MOL CELL BIOL, V28, P2803, DOI 10.1128/MCB.01786-07; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	41	64	67	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1081	U86		10.1038/ncb1921	http://dx.doi.org/10.1038/ncb1921			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19648910				2022-12-27	WOS:000269482500009
J	Miller, PM; Folkmann, AW; Maia, ARR; Efimova, N; Efimov, A; Kaverina, I				Miller, Paul M.; Folkmann, Andrew W.; Maia, Ana R. R.; Efimova, Nadia; Efimov, Andrey; Kaverina, Irina			Golgi-derived CLASP-dependent microtubules control Golgi organization and polarized trafficking in motile cells	NATURE CELL BIOLOGY			English	Article							RIBBON FORMATION; TRANS-GOLGI; COMPLEX; DYNAMICS; DYNEIN; APPARATUS; SITES; MORPHOGENESIS; CENTROSOMES; MECHANISMS	Microtubules are indispensable for Golgi complex assembly and maintenance, which are integral parts of cytoplasm organization during interphase in mammalian cells. Here, we show that two discrete microtubule subsets drive two distinct, yet simultaneous, stages of Golgi assembly. In addition to the radial centrosomal microtubule array, which positions the Golgi in the centre of the cell, we have identified a role for microtubules that form at the Golgi membranes in a manner dependent on the microtubule regulators CLASPs. These Golgi-derived microtubules draw Golgi ministacks together in tangential fashion and are crucial for establishing continuity and proper morphology of the Golgi complex. We propose that specialized functions of these two microtubule arrays arise from their specific geometries. Further, we demonstrate that directional post-Golgi trafficking and cell migration depend on Golgi-associated CLASPs, suggesting that correct organization of the Golgi complex by microtubules is essential for cell polarization and motility.	[Miller, Paul M.; Folkmann, Andrew W.; Maia, Ana R. R.; Efimova, Nadia; Efimov, Andrey; Kaverina, Irina] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Maia, Ana R. R.] Univ Porto, Inst Mol & Cell Biol, P-4150180 Oporto, Portugal	Vanderbilt University; Universidade do Porto	Kaverina, I (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	irina.kaverina@vanderbilt.edu			NIH NIGMS [1R01GM078373-01]; NIH NCI GI SPORE [P50CA095103]; Fundacao Para a Ciencia e Tecnologia [SFRH/BD/32976/2006]; Fundacao Para a Ciencia e a Tecnologia of Portugal [PTDC/SAU-OBD/66113/2006]; American Heart Predoctoral [09PRE2260729]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078373] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NCI GI SPORE; Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); American Heart Predoctoral; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Goldenring, Mathew Tyska and Ryoma Ohi for helpful discussions, and Anna Akhmanova, Laura A. Lee and Steven K. Hanks for critical reading of the manuscript. This study was funded by NIH NIGMS grant 1R01GM078373-01 to I.K. and a pilot project to LK. from NIH NCI GI SPORE grant P50CA095103. A.R.R.M. was supported by Fundacao Para a Ciencia e Tecnologia fellowship SFRH/BD/32976/2006 and by grant PTDC/SAU-OBD/66113/2006 from Fundacao Para a Ciencia e a Tecnologia of Portugal. P.M.M. was supported by American Heart Predoctoral grant 09PRE2260729.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; BRUUN A, 1986, HISTOCHEMISTRY, V86, P135, DOI 10.1007/BF00493378; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cytrynbaum EN, 2004, J CELL SCI, V117, P1381, DOI 10.1242/jcs.00919; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Faire K, 1999, J CELL SCI, V112, P4243; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Patel H, 2008, J CELL SCI, V121, P1159, DOI 10.1242/jcs.021725; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Roghi C, 1999, J CELL SCI, V112, P4673; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Storrie B, 1998, BBA-MOL CELL RES, V1404, P127, DOI 10.1016/S0167-4889(98)00053-6; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	43	220	225	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1069	U69		10.1038/ncb1920	http://dx.doi.org/10.1038/ncb1920			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701196	Green Accepted			2022-12-27	WOS:000269482500008
J	Braun, M; Drummond, DR; Cross, RA; McAinsh, AD				Braun, Marcus; Drummond, Douglas R.; Cross, Robert A.; McAinsh, Andrew D.			The kinesin-14 Klp2 organizes microtubules into parallel bundles by an ATP-dependent sorting mechanism	NATURE CELL BIOLOGY			English	Article							SELF-ORGANIZATION; INTERPHASE MICROTUBULES; NCD TAIL; FISSION; ARRAYS; TUBULIN; DYNAMICS; BINDING; MOTORS; HEAD	The dynamic organization of microtubules into parallel arrays allows interphase cells to set up multi-lane highways for intracellular transport and M-phase cells to build the mitotic and meiotic spindles. Here we show that a minimally reconstituted system composed of Klp2, a kinesin-14 from the fission yeast Schizosaccharomyces pombe, together with microtubules assembled from purified S. pombe tubulin, autonomously assembles bundles of parallel microtubules. Bundles form by an ATP-dependent sorting mechanism that requires the full-length Klp2 motor. By this mechanism, antiparallel-overlapped microtubules slide over one another until they dissociate from the bundles, whereas parallel-overlapped microtubules are selectively trapped by an energy-dissipating force-balance mechanism. Klp2-driven microtubule sorting provides a robust pathway for the organization of microtubules into parallel arrays. In vivo evidence indicates that Klp2 is required for the proper organization of S. pombe interphase microtubules into bipolar arrays of parallel-overlapped microtubules(1-4), suggesting that kinesin-14-dependent microtubule sorting may have wide biological importance.	[Braun, Marcus; McAinsh, Andrew D.] Marie Curie Res Inst, Chromosome Segregat Lab, Surrey RH8 0TL, England; [Drummond, Douglas R.; Cross, Robert A.] Marie Curie Res Inst, Mol Motors Lab, Surrey RH8 0TL, England		McAinsh, AD (corresponding author), Marie Curie Res Inst, Chromosome Segregat Lab, Surrey RH8 0TL, England.	a.mcainsh@mcri.ac.uk	McAinsh, Andrew/C-6438-2012; Cross, Robert A/F-1798-2011; Braun, Marcus/L-8931-2018	Cross, Robert A/0000-0002-0004-7832; Braun, Marcus/0000-0003-2026-2238; Drummond, Douglas/0000-0003-4155-3747; McAinsh, Andrew/0000-0001-6808-0711	Marie Curie Cancer Care; Medical Research Council; MRC [G0200542] Funding Source: UKRI; Medical Research Council [G0200542] Funding Source: researchfish	Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Joe Howard for the full-length Drosophila kinesin-1 construct and Michael Osei for purification of S. pombe tubulin and EGFP-tubulin. This work was supported by Marie Curie Cancer Care (A. D. M. and R. A. C.) and the Medical Research Council (R. A. C.).	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brunner D, 2000, PHILOS T ROY SOC B, V355, P873, DOI 10.1098/rstb.2000.0622; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; DAVIS A, 1993, BIOCHEMISTRY-US, V32, P8823, DOI 10.1021/bi00085a013; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1995, BIOPHYS J, V68, pS267; Hagan IM, 1998, J CELL SCI, V111, P1603; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051	27	87	87	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					724	U55		10.1038/ncb1878	http://dx.doi.org/10.1038/ncb1878			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19430466				2022-12-27	WOS:000266503700017
J	Mille, F; Thibert, C; Fombonne, J; Rama, N; Guix, C; Hayashi, H; Corset, V; Reed, JC; Mehlen, P				Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Hayashi, Hideki; Corset, Veronique; Reed, John C.; Mehlen, Patrick			The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex	NATURE CELL BIOLOGY			English	Article							PRODUCT INDUCES APOPTOSIS; SONIC HEDGEHOG; CASPASE ACTIVATION; NEURONAL DEATH; CELL-DEATH; KAPPA-B; PROTEIN; GENE; MECHANISM; INHIBITION	Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis(1,2). Besides its classic morphogenic activity, Shh is also a survival factor(3,4). Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh(5). Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2). DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos. We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain containing proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain containing 1) and apical caspase-9. Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism. Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.	[Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Corset, Veronique; Mehlen, Patrick] Univ Lyon, CNRS, UMR5238,Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue,Ctr Leon Berard, F-69008 Lyon, France; [Hayashi, Hideki; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard; Sanford Burnham Prebys Medical Discovery Institute	Mehlen, P (corresponding author), Univ Lyon, CNRS, UMR5238,Apoptosis Canc & Dev Lab, Equipe Labellisee La Ligue,Ctr Leon Berard, F-69008 Lyon, France.	mehlen@lyon.fnclcc.fr	Hideki, Hayashi/AAW-9081-2021; THIBERT, Chantal/N-1828-2013; Thibert, Chantal/D-4367-2019	Thibert, Chantal/0000-0002-1516-5671; Rama, Nicolas/0000-0003-1614-7755; Hayashi, Hideki/0000-0003-4585-6542	Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National du Cancer; Rhone-Alpes Region; Centre National de la Recherche Scientifique; EU; NIH [NS45093, AI56324]; Rhone-Alpes Region fellowship; Association pour la Recherche sur le Cancer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045093] Funding Source: NIH RePORTER	Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhone-Alpes Region fellowship(Region Auvergne-Rhone-Alpes); Association pour la Recherche sur le Cancer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Briscoe and N. Le Douarin for advice and reagents, B. W. Schafer, C. Sardet and R. Sadoul for reagents, K. Cywinska for technical work on immunoprecipitation experiments and L. Kremer for the 5e1 hybridoma cell line (protein tools service at the Centro Nacional de Biotecnologia of Madrid). This work was supported by the Ligue Contre le Cancer, the Agence Nationale de la Recherche, the Institut National du Cancer, the Rhone-Alpes Region, the Centre National de la Recherche Scientifique, the EU grants Hermione and APO-SYS, NIH grants to P. M. (NS45093) and J. C. R. (AI56324), and a Rhone-Alpes Region fellowship and an Association pour la Recherche sur le Cancer fellowship to F. M.	Bartholin L, 2007, GENE, V393, P153, DOI 10.1016/j.gene.2007.02.007; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bredesen DE, 2004, PHYSIOL REV, V84, P411, DOI 10.1152/physrev.00027.2003; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Furne C, 2006, P NATL ACAD SCI USA, V103, P4128, DOI 10.1073/pnas.0507864103; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	39	100	103	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					739	U93		10.1038/ncb1880	http://dx.doi.org/10.1038/ncb1880			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465923	Green Submitted, Green Accepted			2022-12-27	WOS:000266503700019
J	Siegel, G; Obernosterer, G; Fiore, R; Oehmen, M; Bicker, S; Christensen, M; Khudayberdiev, S; Leuschner, PF; Busch, CJL; Kane, C; Hubel, K; Dekker, F; Hedberg, C; Rengarajan, B; Drepper, C; Waldmann, H; Kauppinen, S; Greenberg, ME; Draguhn, A; Rehmsmeier, M; Martinez, J; Schratt, GM				Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Oehmen, Martin; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Leuschner, Philipp F.; Busch, Clara J. L.; Kane, Christina; Huebel, Katja; Dekker, Frank; Hedberg, Christian; Rengarajan, Balamurugan; Drepper, Carsten; Waldmann, Herbert; Kauppinen, Sakari; Greenberg, Michael E.; Draguhn, Andreas; Rehmsmeier, Marc; Martinez, Javier; Schratt, Gerhard M.			A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis	NATURE CELL BIOLOGY			English	Article							NEURONAL RNA GRANULES; PROTEIN-SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; MICRORNAS; EXPRESSION; BRAIN; CELLS; PALMITOYLATION; POLYRIBOSOMES	The microRNA pathway has been implicated in the regulation of synaptic protein synthesis and ultimately in dendritic spine morphogenesis, a phenomenon associated with long-lasting forms of memory. However, the particular microRNAs (miRNAs) involved are largely unknown. Here we identify specific miRNAs that function at synapses to control dendritic spine structure by performing a functional screen. One of the identified miRNAs, miR-138, is highly enriched in the brain, localized within dendrites and negatively regulates the size of dendritic spines in rat hippocampal neurons. miR-138 controls the expression of acyl protein thioesterase 1 (APT1), an enzyme regulating the palmitoylation status of proteins that are known to function at the synapse, including the alpha(13) subunits of G proteins (G alpha(13)). RNA-interference-mediated knockdown of APT1 and the expression of membrane-localized G alpha(13) both suppress spine enlargement caused by inhibition of miR-138, suggesting that APT1-regulated depalmitoylation of G alpha(13) might be an important downstream event of miR-138 function. Our results uncover a previously unknown miRNA-dependent mechanism in neurons and demonstrate a previously unrecognized complexity of miRNA-dependent control of dendritic spine morphogenesis.	[Leuschner, Philipp F.; Busch, Clara J. L.; Martinez, Javier] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Schratt, Gerhard M.] Heidelberg Univ, Interdisziplinares Zentrum Neurowissensch, Jr Grp SFB488, D-69120 Heidelberg, Germany; [Siegel, Gabriele; Obernosterer, Gregor; Fiore, Roberto; Bicker, Silvia; Christensen, Mette; Khudayberdiev, Sharof; Schratt, Gerhard M.] Univ Klinikum Heidelberg, Inst Neuroanat, D-69120 Heidelberg, Germany; [Oehmen, Martin; Draguhn, Andreas] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Christensen, Mette; Kauppinen, Sakari] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Cph N, Denmark; [Kane, Christina; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Huebel, Katja; Dekker, Frank; Rengarajan, Balamurugan; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44227 Dortmund, Germany; [Huebel, Katja; Dekker, Frank; Rengarajan, Balamurugan; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, D-44227 Dortmund, Germany; [Drepper, Carsten; Rehmsmeier, Marc] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33594 Bielefeld, Germany; [Kauppinen, Sakari] Santaris Pharma, DK-2970 Horsholm, Denmark	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Copenhagen; Harvard University; Harvard Medical School; Max Planck Society; Dortmund University of Technology; University of Bielefeld	Martinez, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; schratt@ana.uni-heidelberg.de	Rehmsmeier, Marc/A-4982-2013; Waldmann, Herbert/B-7406-2017; Dekker, Frank J./H-2544-2014; Drepper, Carsten/GSN-2009-2022	Waldmann, Herbert/0000-0002-9606-7247; Dekker, Frank J./0000-0001-7217-9300; Drepper, Carsten/0000-0002-7883-6479; Siegel, Gabriele/0000-0002-9501-7061; Khudayberdiev, Sharof/0000-0003-0349-116X; Martinez, Javier/0000-0001-9152-7323	Deutsche Forschungsgemeinschaft [SFB488]; Human Frontier Science Program; National Institute on Drug Abuse [1R21DA025102-01]; National Institutes of Health [NS045500]; Bioinformatics Initiative; Austrian Academy of Sciences; Austrian Government; GEN-AU initiative; Alexander von Humboldt foundation; Netherlands Organization for Scientific Research (NWO); European Union; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025102] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Initiative; Austrian Academy of Sciences; Austrian Government; GEN-AU initiative; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank O. Rocks and P. Wedegaertner for providing reagents; R. Heinen for suggestions on the luciferase reporter assays; T. Wust for technical assistance; and M. Alenius and A. Keene for critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (SFB488; to G. M. S.), the Human Frontier Science Program (Career Development Award; to G. M. S.), the National Institute on Drug Abuse (1R21DA025102-01; to G. M. S.), the National Institutes of Health (NS045500; to M. E. G.) the Bioinformatics Initiative (to C. D. and M. R.), the Austrian Academy of Sciences (to J.M. and S. B. (DOC-fFORTE-fellowship)) and the Austrian Government, GEN-AU initiative (to G. O.). C. H. acknowledges the Alexander von Humboldt foundation for a postdoctoral fellowship. F. D. is a recipient of a TALENT-stipendium from the Netherlands Organization for Scientific Research (NWO)and a Marie-Curie fellowship from the European Union.	AEL DE, 2002, CELL, V108, P849; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Etournay R, 2005, J CELL SCI, V118, P2891, DOI 10.1242/jcs.02424; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; RAO A, 1991, J NEUROSCI, V11, P2881; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	52	371	389	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					705	U36		10.1038/ncb1876	http://dx.doi.org/10.1038/ncb1876			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19465924	Green Accepted			2022-12-27	WOS:000266503700015
J	Masui, Y				Masui, Yoshio			From cell differentiation to the cell cycle: how failing in biochemistry led to success in morphology	NATURE CELL BIOLOGY			English	Editorial Material									Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto	Masui, Y (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	masui@rogers.com							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					535	535		10.1038/ncb0509-535	http://dx.doi.org/10.1038/ncb0509-535			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404333				2022-12-27	WOS:000265640000006
J	Gerdes, HH				Gerdes, Hans-Hermann			Prions tunnel between cells	NATURE CELL BIOLOGY			English	Editorial Material							MEMBRANE NANOTUBES; TRANSMISSION; MECHANISM; SCRAPIE	Prions are abnormal isoforms of host proteins that are the infectious agents in certain mammalian neurodegenerative diseases. How prions travel from their peripheral entry sites to the brain where they cause disease is poorly understood. a new study finds that tunnelling nanotubes are important for the intercellular transfer of prions during neuroinvasion.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Gerdes, HH (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	hans-hermann.gerdes@biomed.uib.no						Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	14	19	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					235	236		10.1038/ncb0309-235	http://dx.doi.org/10.1038/ncb0309-235			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255567				2022-12-27	WOS:000263777900003
J	Patel, BK; Gavin-Smyth, J; Liebman, SW				Patel, Basant K.; Gavin-Smyth, Jackie; Liebman, Susan W.			The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; INVERTASE SYNTHESIS; NUCLEAR-FUSION; SWI-SNF; GENE; PIN+; MUTATIONS; MECHANISM; TOXICITY; REGION	Although many proteins can misfold into a self-seeding amyloid-like conformation(1), only six are known to be infectious, that is prions. The prions [PSI+], [PIN+], [URE3], [SWI+] and [HET-s] cause distinct heritable physiological changes in fungi(2-4), whereas PrPSc causes infectious encephalopathies in mammals(5). It is unknown whether 'protein-only' inheritance is limited to these exceptional cases or whether it represents a widespread mechanism of epigenetic control. Towards this goal, we now describe a new prion formed by the Cyc8 (Ssn6) protein of Saccharomyces cerevisiae. Analogously to other yeast prions, transient overproduction of a glutamine-rich region of Cyc8 induced a heritable dominant cyc8-phenotype that is transmitted cytoplasmically and is dependent on the chaperone Hsp104 and the continued presence of the Cyc8 protein. The evolutionarily conserved Cyc8-Tup1 global transcriptional repressor complex(6) forms one of the largest gene regulatory circuits, controlling the expression of more than 7% of yeast genes(7). Our finding that Cyc8 can propagate as a prion, together with a recent report that Swi1 of the Swi-Snf global transcriptional regulatory complex also has a prion form(4), shows that prionization can lead to mass activation or repression of yeast genes and is suggestive of a link between the epigenetic phenomena of chromatin remodelling and prion formation.	[Patel, Basant K.; Gavin-Smyth, Jackie; Liebman, Susan W.] Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave, Chicago, IL 60607 USA.	suel@uic.edu	Patel, basant/Y-8732-2019	Patel, basant/0000-0001-9465-4803	NIH [GM-56350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Sherman and R. Zitomer for yeast strains; R. Trumbly, H. Ronne, Y. Chernoff, S. Lindquist, M. Duennwald, M. D. Rose, S. Ruby, H. van Vuuren, I. Derkatch and M. Carlson for plasmids; and S. Y. R. Dent for anti- cyc8 and anti- Tup1 antibodies. We also thank K. Kirkland, V. Mathur, J. Hong and O. Appelebe for help with experiments; A. O'Dell for helpful suggestions; and S.- K. Park, A. Manogaran and N. Vishveshwara for commenting on the manuscript. This work was supported by NIH grant GM-56350 to S. W. L. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; CARLSON M, 1984, GENETICS, V107, P19; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; MIKI BLA, 1982, J BACTERIOL, V150, P878, DOI 10.1128/JB.150.2.878-889.1982; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROTHSTEIN RJ, 1980, GENETICS, V94, P871; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; Sherman F., 1986, METHODS YEAST GENETI; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; TRUMBLY RJ, 1986, J BACTERIOL, V166, P1123, DOI 10.1128/jb.166.3.1123-1127.1986; TUITE MF, 1981, GENETICS, V98, P691; VALLEN EA, 1992, J CELL BIOL, V117, P1277, DOI 10.1083/jcb.117.6.1277; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner Reed B., 2004, VVolume 41, P305; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	37	191	195	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					344	U255		10.1038/ncb1843	http://dx.doi.org/10.1038/ncb1843			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19219034	Green Accepted			2022-12-27	WOS:000263777900019
J	Simpson, KJ; Selfors, LM; Bui, J; Reynolds, A; Leake, D; Khvorova, A; Brugge, JS				Simpson, Kaylene J.; Selfors, Laura M.; Bui, James; Reynolds, Angela; Leake, Devin; Khvorova, Anastasia; Brugge, Joan S.			Identification of genes that regulate epithelial cell migration using an siRNA screening approach	NATURE CELL BIOLOGY			English	Article							RNA INTERFERENCE; MOVEMENT; CARCINOMA; ADHESION; GTPASES; TARGET; ROLES; POLARIZATION; SUPPRESSORS; ONCOGENESIS	To provide a systematic analysis of genes that regulate epithelial cell migration, we performed a high throughput wound healing screen with MCF-10A breast epithelial cells, using siRNAs targeting 1,081 human genes encoding phosphatases, kinases and proteins predicted to influence cell migration and adhesion. The primary screen identified three categories of hits: those that accelerate, those that inhibit and those that impair migration with associated effects on cell proliferation or metabolism. Extensive validation of all the hits yielded 66 high confidence genes that, when downregulated, either accelerated or impaired migration; 42 of these high confidence genes have not been previously associated with motility or adhesion. Time-lapse video microscopy revealed a broad spectrum of phenotypic changes involving alterations in the extent and nature of disruption of cell-cell adhesion, directionality of motility, cell polarity and shape, and protrusion dynamics. Informatics analysis highlighted three major signalling nodes, beta-catenin, beta-integrin and actin, and a large proportion of the genes that accelerated migration impaired cell-cell adhesion.	[Simpson, Kaylene J.; Selfors, Laura M.; Bui, James; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Reynolds, Angela; Leake, Devin; Khvorova, Anastasia] Dharmacon, Thermo Fisher Sci, Lafayette, CO 80026 USA	Harvard University; Harvard Medical School; Thermo Fisher Scientific	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		Simpson, Kaylene/0000-0001-9136-1781; SELFORS, LAURA/0000-0002-1317-7353	DOD [W81XWH-04-1-0360]; Cell Migration Consortium; NIH/NIGMS [GM064346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Cell Migration Consortium; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Stewart Rudnicki and Caroline Shamu (Institute for Chemical and Cell Biology) for screening assistance; Jim Horn (Department of Cell Biology) for manufacturing the wound healing pin; William Pearson for conceptualizing and generating the interactive website hosted by the Cell Migration Consortium; Sabina Winograd-Katz and Benjamin Geiger (Weizmann Institute) for collaborative creation of the MAR custom siRNA library; Rick Horwitz, Alan Hall, Gaudenz Danuser and Ghassan Mouneimne for stimulating and helpful discussions and critical reading of the manuscript and Lara Petrak (Nikon Imaging Centre) for assistance with time-lapse microscopy. We are also grateful to William Hahn, David Root and The RNAi Consortium for providing shRNA vectors. Funding was from the DOD W81XWH-04-1-0360 (K.J.S.) and the Cell Migration Consortium, supported by a grant from the NIH/NIGMS GM064346 (J.S.B.). A.R., D.L. and A.K. are employees of Thermo Fisher Scientific, which supported this work in part by supplying a subset of the siRNA reagents.	Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rupp PA, 2007, DEV BIOL, V311, P159, DOI 10.1016/j.ydbio.2007.08.027; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	34	316	318	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1027	1038		10.1038/ncb1762	http://dx.doi.org/10.1038/ncb1762			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160483				2022-12-27	WOS:000258910400008
J	Wang, XW; Zuo, XM; Kucejova, B; Chen, XJ				Wang, Xiaowen; Zuo, Xiaoming; Kucejova, Blanka; Chen, Xin Jie			Reduced cytosolic protein synthesis suppresses mitochondrial degeneration	NATURE CELL BIOLOGY			English	Article							REPLICATIVE LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; ADP/ATP CARRIER; YEAST; EXTENDS; MUTATIONS; EXTENSION; GENES; RESPIRATION	Mitochondrial function degenerates with ageing and in ageing-related neuromuscular degenerative diseases, causing physiological decline of the cell(1). Factors that can delay the degenerative process are actively sought after. Here, we show that reduced cytosolic protein synthesis is a robust cellular strategy that suppresses ageing-related mitochondrial degeneration. We modelled autosomal dominant progressive external ophthalmoplegia (adPEO), an adult- or later-onset degenerative disease, by introducing the A128P mutation into the adenine nucleotide translocase Aac2p of Saccharomyces cerevisiae. The aac2(A128P) allele dominantly induces ageing-dependent mitochondrial degeneration and phenotypically tractable degenerative cell death, independently of its ADP/ATP exchange activity. Mitochondrial degeneration was suppressed by lifespan-extending nutritional interventions and by eight longevity mutations, which are all known to reduce cytosolic protein synthesis. These longevity interventions also independently suppressed ageing-related mitochondrial degeneration in the pro-ageing prohibitin mutants. The aac2(A128P) mutant has reduced mitochondrial membrane potential (Delta psi(m)) and is synthetically lethal to low Delta psi(m) conditions, including the loss of prohibitin. Mitochondrial degeneration was accelerated by defects in protein turnover on the inner membrane and was suppressed by cycloheximide, a specific inhibitor of cytosolic ribosomes. Reduced cytosolic protein synthesis suppressed membrane depolarization and defects in mitochondrial gene expression in aac2(A128P) cells. Our finding thus establishes a link between protein homeostasis (proteostasis), cellular bioenergetics and mitochondrial maintenance during ageing.	[Wang, Xiaowen; Chen, Xin Jie] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Wang, Xiaowen; Zuo, Xiaoming; Kucejova, Blanka; Chen, Xin Jie] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, XJ (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	chenx@upstate.edu		Kucejova, Blanka/0000-0002-5058-330X	National Institutes of Health [AG023731]; American Heart Association [0435047N]; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Schmitt and M. Kucej for critical reading of the manuscript, and L. Sabova and C. Koehler for providing the anti-Aac2 antibody. This work was supported by grants from National Institutes of Health (AG023731) and the American Heart Association (0435047N).	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Chen XJ, 2002, HUM MOL GENET, V11, P1835, DOI 10.1093/hmg/11.16.1835; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Lai CY, 2002, GENETICS, V162, P73; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Meskauskas A, 2003, MOL CELL BIOL, V23, P1602, DOI 10.1128/MCB.23.5.1602-1613.2003; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	35	66	67	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1090	1097		10.1038/ncb1769	http://dx.doi.org/10.1038/ncb1769			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160490	Green Accepted			2022-12-27	WOS:000258910400015
J	Kraft, C; Deplazes, A; Sohrmann, M; Peter, M				Kraft, Claudine; Deplazes, Anna; Sohrmann, Marc; Peter, Matthias			Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; DEUBIQUITINATING ENZYMES; FUNCTIONAL-ANALYSIS; MESSENGER-RNA; YEAST; PROTEINS; KINASE; SUBUNITS; COMPLEX	Eukaryotic cells use autophagy and the ubiquitin-proteasome system ( UPS) as their major protein degradation pathways. Whereas the UPS is required for the rapid degradation of proteins when fast adaptation is needed, autophagy pathways selectively remove protein aggregates and damaged or excess organelles(1). However, little is known about the targets and mechanisms that provide specificity to this process. Here we show that mature ribosomes are rapidly degraded by autophagy upon nutrient starvation in Saccharomyces cerevisiae. Surprisingly, this degradation not only occurs by a nonselective mechanism, but also involves a novel type of selective autophagy, which we term 'ribophagy'. A genetic screen revealed that selective degradation of ribosomes requires catalytic activity of the Ubp3p/Bre5p ubiquitin protease. Although ubp3 Delta and bre5 Delta cells strongly accumulate 60S ribosomal particles upon starvation, they are proficient in starvation sensing and in general trafficking and autophagy pathways. Moreover, ubiquitination of several ribosomal subunits and/or ribosome-associated proteins was specifically enriched in ubp3 Delta cells, suggesting that the regulation of ribophagy by ubiquitination may be direct. Interestingly, ubp3 Delta cells are sensitive to rapamycin and nutrient starvation, implying that selective degradation of ribosomes is functionally important in vivo. Taken together, our results suggest a link between ubiquitination and the regulated degradation of mature ribosomes by autophagy.	[Kraft, Claudine; Deplazes, Anna; Sohrmann, Marc; Peter, Matthias] ETH Honggerberg, Inst Biochem, HPM, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kraft, C (corresponding author), ETH Honggerberg, Inst Biochem, HPM, CH-8093 Zurich, Switzerland.	claudine.kraft@bc.biol.ethz.ch; matthias.peter@bc.biol.ethz.ch		Deplazes Zemp, Anna/0000-0002-1992-1622; Peter, Matthias/0000-0002-2160-6824				BAKER RT, 1992, J BIOL CHEM, V267, P23364; Baxter BK, 2005, J BIOL CHEM, V280, P39067, DOI 10.1074/jbc.M508064200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brew CT, 2002, GENETICS, V162, P1079; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Espert L, 2007, J MOL MED, V85, P811, DOI 10.1007/s00109-007-0173-6; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Mizushima N, 2007, AUTOPHAGY, V3, P179, DOI 10.4161/auto.4051; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; PICKART CM, 1985, J BIOL CHEM, V260, P7903; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Valtz N, 1997, METHOD ENZYMOL, V283, P350; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018	40	519	534	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					602	610		10.1038/ncb1723	http://dx.doi.org/10.1038/ncb1723			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18391941				2022-12-27	WOS:000255502400017
J	Ubeda-Tomas, S; Swarup, R; Coates, J; Swarup, K; Laplaze, L; Beemster, GTS; Hedden, P; Bhalerao, R; Bennett, MJ				Ubeda-Tomas, Susana; Swarup, Ranjan; Coates, Juliet; Swarup, Kamal; Laplaze, Laurent; Beemster, Gerrit T. S.; Hedden, Peter; Bhalerao, Rishikesh; Bennett, Malcolm J.			Root growth in Arabidopsis requires gibberellin/DELLA signalling in the endodermis	NATURE CELL BIOLOGY			English	Article							PROTEIN; RECEPTOR; AUXIN; GAI; RGA; DEGRADATION; REPRESSOR; THALIANA; GID1	Gibberellins ( Gas) are key regulators of plant growth and development. they promote growth by targeting the degradation of DELLA repressor proteins; however, their site of action at the cellular, tissue or organ levels remains unknown. to map the site of GA action in regulating root growth, we expressed gai, a non-degradable, mutant DELLA protein, in selected root tissues. root growth was retarded specifically when gai was expressed in endodermal cells. our results demonstrate that the endodermis represents the primary GA-responsive tissue regulating organ growth and that endodermal cell expansion is rate-limiting for elongation of other tissues and therefore of the root as a whole.	[Bhalerao, Rishikesh] SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Ubeda-Tomas, Susana; Swarup, Ranjan; Swarup, Kamal; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Coates, Juliet] Univ Birmingham, Sch Biosci, Edgbaston B15 2TT, England; [Laplaze, Laurent] Inst Rech Dev, UMR 1097, F-34394 Montpellier 5, France; [Beemster, Gerrit T. S.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beemster, Gerrit T. S.] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Hedden, Peter] Rothamsted Res, Harpenden AL5 2JQ, Herts, England	Swedish University of Agricultural Sciences; Umea University; University of Nottingham; University of Birmingham; Institut de Recherche pour le Developpement (IRD); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Bhalerao, R (corresponding author), SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden.	Rishi.Bhalerao@genfys.slu.se; malcolm.bennett@nottingham.ac.uk	Beemster, Gerrit/E-6668-2016; Coates, Juliet C/A-3608-2013; Laplaze, Laurent/I-5435-2016; Bennett, Malcolm/G-4004-2010	Beemster, Gerrit/0000-0001-6014-053X; Coates, Juliet C/0000-0002-2381-0298; Laplaze, Laurent/0000-0002-6568-6504; Bennett, Malcolm/0000-0003-0475-390X; Ubeda Tomas, Susanna/0000-0001-9012-2412; swarup, Ranjan/0000-0002-6438-9188; Bhalerao, Rishikesh/0000-0003-4384-7036	BBSRC [BBS/E/C/00004954, BB/D007550/1, BB/D019613/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004162, BB/D019613/1, REI20541, BBS/E/C/00004954, BBS/E/C/00004161, BB/D007550/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; King KE, 2001, GENETICS, V159, P767; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	18	216	229	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					625	628		10.1038/ncb1726	http://dx.doi.org/10.1038/ncb1726			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425113				2022-12-27	WOS:000255502400020
J	Vitre, B; Coquelle, FM; Heichette, C; Garnier, C; Chretien, D; Arnal, I				Vitre, Benjamin; Coquelle, Frederic M.; Heichette, Claire; Garnier, Cyrille; Chretien, Denis; Arnal, Isabelle			EB1 regulates microtubule dynamics and tubulin sheet closure in vitro	NATURE CELL BIOLOGY			English	Article							PLUS-END-TRACKING; PROTOFILAMENT NUMBERS; STRUCTURAL BASIS; PROTEINS; INSTABILITY; MECHANISM; APC; STABILIZATION; MODULATION; CLIP-170	End binding 1 ( EB1) is a plus-end-tracking protein (+TIP) that localizes to microtubule plus ends where it modulates their dynamics and interactions with intracellular organelles(1,2). Although the regulating activity of EB1 on microtubule dynamics has been studied in cells(3-6) and purified systems(7-13), the molecular mechanisms involved in its specific activity are still unclear. Here, we describe how EB1 regulates the dynamics and structure of microtubules assembled from pure tubulin. We found that EB1 stimulates spontaneous nucleation and growth of microtubules, and promotes both catastrophes ( transitions from growth to shrinkage) and rescues ( reverse events). Electron cryomicroscopy showed that EB1 induces the initial formation of tubulin sheets, which rapidly close into the common 13-protofilament-microtubule architecture. Our results suggest that EB1 favours the lateral association of free tubulin at microtubule-sheet edges, thereby stimulating nucleation, sheet growth and closure. The reduction of sheet length at microtubule growing-ends together with the elimination of stressed microtubule lattices may account for catastrophes. Conversely, occasional binding of EB1 to the microtubule lattice may induce rescues.	[Vitre, Benjamin; Coquelle, Frederic M.; Heichette, Claire; Garnier, Cyrille; Chretien, Denis; Arnal, Isabelle] Univ Rennes 1, CNRS, Unite Mixte Rech 6026, Inst Federatif Rech 140, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Chretien, D (corresponding author), Univ Rennes 1, CNRS, Unite Mixte Rech 6026, Inst Federatif Rech 140, Campus Beaulieu,263 Ave Gen Leclerc, F-35042 Rennes, France.	denis.chretien@univ-rennes1.fr; isabelle.arnal@univ-rennes1.fr	Arnal, Isabelle/X-6559-2019; Vitre, Benjamin/R-2169-2019	Chretien, Denis/0000-0001-8261-4396; GARNIER, Cyrille/0000-0002-5715-8218; Arnal, Isabelle/0000-0001-6149-8189; Vitre, Benjamin/0000-0001-5954-4270; COQUELLE, Frederic/0000-0002-5483-8787				Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Chretien D, 1999, CELL STRUCT FUNCT, V24, P299, DOI 10.1247/csf.24.299; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Chretien D, 2000, J MOL BIOL, V298, P663, DOI 10.1006/jmbi.2000.3696; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DETRICH HW, 1985, J BIOL CHEM, V260, P9479; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hunyadi V, 2005, J MOL BIOL, V348, P927, DOI 10.1016/j.jmb.2005.03.019; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Mahadevan L, 2005, NATURE, V435, P895, DOI 10.1038/435895a; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; TILNEY LG, 1973, J CELL BIOL, V59, P267, DOI 10.1083/jcb.59.2.267; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	35	183	186	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					415	U81		10.1038/ncb1703	http://dx.doi.org/10.1038/ncb1703			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18364701	Green Submitted			2022-12-27	WOS:000254561700011
J	Ma, QH; Futagawa, T; Yang, WL; Jiang, XD; Zeng, L; Takeda, Y; Xu, RX; Bagnard, D; Schachner, M; Furley, AJ; Karagogeos, D; Watanabe, K; Dawe, GS; Xiao, ZC				Ma, Quan-Hong; Futagawa, Toshitaka; Yang, Wu-Lin; Jiang, Xiao-Dan; Zeng, Li; Takeda, Yasuo; Xu, Ru-Xiang; Bagnard, Dominique; Schachner, Melitta; Furley, Andrew J.; Karagogeos, Domna; Watanabe, Kazutada; Dawe, Gavin S.; Xiao, Zhi-Cheng			A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis	NATURE CELL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; DEPENDENT TRANSCRIPTIONAL CONTROL; DEGRADING ENZYME NEPRILYSIN; REGULATED INTRAMEMBRANE PROTEOLYSIS; CARBOXYL-TERMINAL DOMAIN; PIQUARD ET-AL.; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; A-BETA; ADHESION MOLECULES	The release of amyloid precursor protein (APP) intracellular domain (AICD) may be triggered by extracellular cues through gamma-secretase-dependent cleavage. AICD binds to Fe65, which may have a role in AICD-dependent signalling; however, the functional ligand has not been characterized. In this study, we have identified TAG1 as a functional ligand of APP. We found that, through an extracellular interaction with APP, TAG1 increased AICD release and triggered Fe65-dependent activity in gamma-secretase-dependent manner. TAG1, APP and Fe65 colocalized in the neural stem cell niche of the fetal ventricular zone. Neural precursor cells from TAG1(-/-), APP(-/-) and TAG1(-/-); APP(-/-) mice had aberrantly enhanced neurogenesis, which was significantly reversed in TAG1(-/-) mice by TAG1 or AICD but not by AICD mutated at the Fe65 binding site. Notably, TAG1 reduced normal neurogenesis in Fe65(+/+) mice. Abnormally enhanced neurogenesis also occurred in Fe65(-/-) mice but could not be reversed by TAG1. These results describe a TAG1-APP signalling pathway that negatively modulates neurogenesis through Fe65.	[Ma, Quan-Hong; Zeng, Li; Xiao, Zhi-Cheng] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Ma, Quan-Hong; Futagawa, Toshitaka; Yang, Wu-Lin; Xiao, Zhi-Cheng] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Ma, Quan-Hong; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; [Ma, Quan-Hong; Bagnard, Dominique] Ctr Neurochim, INSERM, U Physiopathol Syst Nerveux 575, F-67084 Strasbourg, France; [Futagawa, Toshitaka; Takeda, Yasuo] Kagoshima Univ, Dept Clin Pharm & Parmacol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Jiang, Xiao-Dan; Xu, Ru-Xiang] So Med Univ, Zhujiang Hosp, Neuromed Inst, Guangzhou 510282, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Furley, Andrew J.] Univ Sheffield, Ctr Dev Genet, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Karagogeos, Domna] Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Karagogeos, Domna] Univ Crete, Sch Med, Iraklion 71110, Crete, Greece; [Watanabe, Kazutada] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Dawe, Gavin S.] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore; [Xiao, Zhi-Cheng] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Singapore General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kagoshima University; Southern Medical University - China; Rutgers State University New Brunswick; University of Sheffield; University of Crete; Nagaoka University of Technology; National University of Singapore; National University of Singapore	Dawe, GS (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	gavindawe@nus.edu.sg; xiao.zhi.cheng@sgh.com.sg	xiao, zhicheng/A-1529-2011; Bagnard, Dominique/I-6535-2013; Furley, Andrew JW/B-7316-2012; Furley, Andrew J. W./D-4798-2013	Furley, Andrew JW/0000-0001-5549-8668; Bagnard, Dominique/0000-0002-5261-902X; Dawe, Gavin/0000-0001-6119-701X; xiao, zhicheng/0000-0001-5172-762X; Ma, Quanhong/0000-0001-9392-8956; Karagogeos, Domna/0000-0002-8129-9731				Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Evin G, 2003, J NEUROSCI RES, V74, P386, DOI 10.1002/jnr.10745; FISHER S, 1991, P NATL ACAD SCI USA, V88, P1779, DOI 10.1073/pnas.88.5.1779; Fukamauchi F, 2001, BIOCHEM BIOPH RES CO, V281, P220, DOI 10.1006/bbrc.2001.4334; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; HEMANN C, 1994, DNA CELL BIOL, V13, P437, DOI 10.1089/dna.1994.13.437; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Karagogeos D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1304, DOI 10.2741/1214; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; KUHN HG, 2007, EUR ARCH PSYCHIAT CL; Lopez-Sanchez N, 2005, NEUROSCIENCE, V130, P51, DOI 10.1016/j.neuroscience.2004.09.020; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Ozaki T, 2006, BIOCHEM BIOPH RES CO, V351, P57, DOI 10.1016/j.bbrc.2006.09.162; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2007, NEURON, V53, P483, DOI 10.1016/j.neuron.2007.01.024; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; RODIER PM, 1977, TERATOLOGY, V16, P235, DOI 10.1002/tera.1420160220; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tanahashi H, 2002, BIOCHEM J, V367, P687, DOI 10.1042/BJ20020562; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	47	157	163	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					283	U29		10.1038/ncb1690	http://dx.doi.org/10.1038/ncb1690			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18278038	Green Submitted			2022-12-27	WOS:000253778300010
J	Tardat, M; Brustel, J; Kirsh, O; Lefevbre, C; Callanan, M; Sardet, C; Julien, E				Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Lefevbre, Christine; Callanan, Mary; Sardet, Claude; Julien, Eric			The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells	NATURE CELL BIOLOGY			English	Article							S-PHASE; METHYLATION; UBIQUITYLATION; REREPLICATION; TRANSCRIPTION; LOCALIZATION; DEGRADATION; INITIATION; REGIONS; PREVENT	The initiation of DNA synthesis is governed by the licensing of replication origins, which consists of assembling a pre-replication complex (pre-RC) on origins during late M- and G1-phases(1,2). In metazoans, functional replication origins do not show defined DNA consensus sequences, thus evoking the involvement of chromatin determinants in the selection of these origins(3). Here, we show that the onset of licensing in mammalian cells coincides with an increase in histone H4 Lys 20 monomethylation (H4K20me1) at replication origins by the methyltransferase PR-Set7 (also known as Set8 or KMT5A). Indeed, tethering PR-Set7 methylase activity to a specific genomic locus promotes the loading of pre-RC proteins on chromatin. In addition, we demonstrate that PR-Set7 undergoes a PCNA- and Cul4-Ddb1-driven degradation during S phase that contributes to the disappearance of H4K20me1 at origins and the inhibition of replication licensing. Strikingly, expression of a PR-Set7 mutant insensitive to this degradation causes the maintenance of H4K20me1 and repeated DNA replication at origins. These results elucidate a critical role for PR-Set7 and H4K20me1 in the chromatin events that regulate replication origins.	[Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] CNRS, IGMM, UMR 5535, Montpellier, France; [Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] Univ Montpellier 2, Montpellier, France; [Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] Univ Montpellier I, Montpellier, France; [Lefevbre, Christine; Callanan, Mary] Inst Albert Bonniot, INSERM, U823, Grenoble, France; [Lefevbre, Christine; Callanan, Mary] Univ Grenoble 1, Grenoble, France; [Lefevbre, Christine; Callanan, Mary] CHU Grenoble, Oncohematol Unit, Dept Hematol Oncogenet & Immunol, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Sardet, C (corresponding author), CNRS, IGMM, UMR 5535, Montpellier, France.	claude.sardet@igmm.cnrs.fr; eric.julien@igmm.cnrs.fr	JULIEN, ERIC/Y-5873-2019; mary, CALLANAN/M-5193-2013; Lefebvre, Christine/G-7280-2014	JULIEN, ERIC/0000-0003-2976-666X; mary, CALLANAN/0000-0003-0210-9600; Callanan, Mary/0000-0002-9088-0720; Kirsh, Olivier/0000-0001-6200-5681; Tardat, Mathieu/0000-0001-6689-7373	Ministere de la Recherche; Association de la Recherche contre le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche (ANR); CNRS; Institut National du Cancer Canceropole Grand Sud-Ouest; ANR [ANR-09-JCJC-0014-01]; INSERM; University Joseph Fourier; Fondation de France	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer Canceropole Grand Sud-Ouest; ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Joseph Fourier; Fondation de France(Fondation de France)	We thank K. Helin, C. S. Sorensen, S. Jorgensen, K. Hansen, M. DePamphilis, D. Tempe and G. Bossis for providing reagents, L. Linares for technical help with ubiquitylation assay, P. Coulombe for technical help with the CsCl gradient centrifugation experiments, and G. Pawlak, E. Fabbrizio, R. Hipskind, and E. Schwob for critical reading of the manuscript. M.T. was supported by a fellowship from Ministere de la Recherche and from Association de la Recherche contre le Cancer (ARC). J.B. was supported by a fellowship from Fondation pour la Recherche Medicale (FRM). O.K. was supported by a fellowship from Agence Nationale de la Recherche (ANR). This work was supported by the institutional support of the CNRS and a grant from the Institut National du Cancer Canceropole Grand Sud-Ouest to C.S. and E.J., by an ANR grant (ANR-09-JCJC-0014-01) to ET, and by institutional grants from INSERM, the University Joseph Fourier, and the Fondation de France to C.L. and M.C.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FOUNIER A, 2010, EMBO MOL MED, V2, P159; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; I I, 2006, REGULATION */* HBOL, V26, P1098; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kakino S, 1996, CYTOMETRY, V24, P49, DOI 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO;2-D; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MIOTTO B, 2010, DNA REPLICATION */*, V57; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Saha T, 2006, J CELL SCI, V119, P1371, DOI 10.1242/jcs.02851; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005	39	207	210	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1086	U82		10.1038/ncb2113	http://dx.doi.org/10.1038/ncb2113			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20953199				2022-12-27	WOS:000283711500012
J	Wild, P; Dikic, I				Wild, Philipp; Dikic, Ivan			Mitochondria get a Parkin' ticket	NATURE CELL BIOLOGY			English	Editorial Material							SELECTIVE AUTOPHAGY; UBIQUITIN; MITOPHAGY; PROTEIN; ATG32	Recent studies have revealed a prominent role of mitochondrial dysfunction in the development of one of the most common neurodegenerative disorders, Parkinson's disease. The ubiquitin ligase Parkin and the protein kinase PINK1, whose mutations are associated with Parkinson's disease, function in a pathway that links ubiquitylation with selective autophagy of damaged mitochondria.	[Wild, Philipp] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Sch Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Wild, P (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Wild, Philipp S./M-2106-2019; Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	15	44	48	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					104	106		10.1038/ncb0210-104	http://dx.doi.org/10.1038/ncb0210-104			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20118996				2022-12-27	WOS:000274139400003
J	Garnett, MJ; Mansfeld, J; Godwin, C; Matsusaka, T; Wu, JH; Russell, P; Pines, J; Venkitaraman, AR				Garnett, Mathew J.; Mansfeld, Joerg; Godwin, Colin; Matsusaka, Takahiro; Wu, Jiahua; Russell, Paul; Pines, Jonathon; Venkitaraman, Ashok R.			UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; CHROMOSOME ALIGNMENT; CONJUGATING ENZYME; FISSION YEAST; KINESIN EG5; CYCLIN-A; ANAPHASE; DESTRUCTION; MITOSIS	The anaphase-promoting complex (APC/C), a ubiquitin ligase, is the target of the spindle-assembly checkpoint (SAC), and it ubiquitylates protein substrates whose degradation regulates progress through mitosis(1-3). The identity of the ubiquitin-conjugating (E2) enzymes that work with the APC/C is unclear. In an RNA interference (RNAi) screen for factors that modify release from drug-induced SAC activation, we identified the E2 enzyme UBE2S as an APC/C auxiliary factor that promotes mitotic exit. UBE2S is dispensable in a normal mitosis, but its depletion prolongs drug-induced mitotic arrest and suppresses mitotic slippage. In vitro, UBE2S elongates ubiquitin chains initiated by the E2 enzymes UBCH10 and UBCH5, enhancing the degradation of APC/C substrates by the proteasome. Indeed, following release from SAC-induced mitotic arrest, UBE2S-depleted cells neither degrade crucial APC/C substrates, nor silence this checkpoint, whereas bypassing the SAC through BUBR1 depletion or Aurora-B inhibition negates the requirement for UBE2S. Thus, UBE2S functions with the APC/C in a two-step mechanism to control substrate ubiquitylation that is essential for mitotic exit after prolonged SAC activation, providing a new model for APC/C function in human cells.	[Garnett, Mathew J.; Godwin, Colin; Wu, Jiahua; Russell, Paul; Venkitaraman, Ashok R.] Univ Cambridge, Dept Oncol, Cambridge CB2 0XZ, England; [Garnett, Mathew J.; Godwin, Colin; Wu, Jiahua; Russell, Paul; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council, Canc Cell Unit, Cambridge CB2 0XZ, England; [Mansfeld, Joerg; Matsusaka, Takahiro; Pines, Jonathon] Wellcome Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mansfeld, Joerg; Matsusaka, Takahiro; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Garnett, MJ (corresponding author), Univ Cambridge, Dept Oncol, Hills Rd, Cambridge CB2 0XZ, England.	arv22@cam.ac.uk	Mansfeld, Joerg/B-4154-2014	Pines, Jonathon/0000-0002-5227-6004; Mansfeld, Jorg/0000-0002-0562-8206	Newton Trust; Canadian Institute of Health Research; FEBS; Churchill Foundation Scholarship; UK Medical Research Council (MRC); Wellcome Trust; Cancer Research UK; MRC [G0600332, G0700651, G9900064, MC_U105359877] Funding Source: UKRI; Medical Research Council [G0700651, G9900064, MC_U105359877, G0600332] Funding Source: researchfish	Newton Trust; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FEBS; Churchill Foundation Scholarship; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Lehner (Cambridge Institute of Medical Research) for providing the ubiquitin-proteasome siRNA library, the Newton Trust for funding its purchase, and L. Passmore for helpful discussions. M.J.G. was supported by a Canadian Institute of Health Research fellowship, J.M., by a FEBS fellowship and C. G., by a Churchill Foundation Scholarship. M.J.G., C. G. and P. R. were also supported by a UK Medical Research Council (MRC) grant to A. R. V., and J.W. and by a Wellcome Trust grant to A. R. V. Work in J.P.'s laboratory is supported by Cancer Research UK, and in A.R.V.'s, by the MRC.	Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; CHOI E, 2009, EMBO J; DeBonis S, 2004, MOL CANCER THER, V3, P1079; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Mathe E, 2004, CURR BIOL, V14, P1723, DOI 10.1016/j.cub.2004.09.023; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	32	192	211	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1363	U241		10.1038/ncb1983	http://dx.doi.org/10.1038/ncb1983			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19820702	Green Accepted			2022-12-27	WOS:000271425800017
J	Sun, YL; Jiang, XF; Xu, Y; Ayrapetov, MK; Moreau, LA; Whetstine, JR; Price, BD				Sun, Yingli; Jiang, Xiaofeng; Xu, Ye; Ayrapetov, Marina K.; Moreau, Lisa A.; Whetstine, Johnathan R.; Price, Brendan D.			Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; ATM ACTIVATION; CHROMATIN; ACETYLATION; BINDING; GENE; PROTEINS; REPAIR	DNA double-strand break (DSB) repair involves complex interactions between chromatin and repair proteins, including Tip60, a tumour suppressor(1). Tip60 is an acetyltransferase that acetylates both histones(2-5) and ATM (ataxia telangiectasia mutated) kinase(6,7). Inactivation of Tip60 leads to defective DNA repair(2-4) and increased cancer risk(8-11). However, how DNA damage activates the acetyltransferase activity of Tip60 is not known. Here, we show that direct interaction between the chromodomain of Tip60 and histone H3 trimethylated on lysine 9 (H3K9me3) at DSBs activates the acetyltransferase activity of Tip60. Depletion of intracellular H3K9me3 blocks activation of the acetyltransferase activity of Tip60, resulting in defective ATM activation and widespread defects in DSB repair. In addition, the ability of Tip60 to access H3K9me3 is dependent on the DNA damage-induced displacement of HP1 beta (heterochromatin protein 1 beta) from H3K9me3. Finally, we demonstrate that the Mre11-Rad50-Nbs1 (MRN) complex targets Tip60 to H3K9me3, and is required to activate the acetyltransferase activity of Tip60. These results reveal a new function for H3K9me3 in coordinating activation of Tip60-dependent DNA repair pathways, and imply that aberrant patterns of histone methylation may contribute to cancer by altering the efficiency of DSB repair.	[Sun, Yingli; Jiang, Xiaofeng; Xu, Ye; Ayrapetov, Marina K.; Moreau, Lisa A.; Price, Brendan D.] Harvard Univ, Sch Med, Div Genom Stabil & DNA Repair, Dept Radiat Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Whetstine, Johnathan R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Price, BD (corresponding author), Harvard Univ, Sch Med, Div Genom Stabil & DNA Repair, Dept Radiat Oncol,Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	brendan_price@dfci.harvard.edu			NCI [CA64585, CA93602]; DOD Breast Cancer Program; NIAID [U19AI067751];  [T32 CA09078]; NATIONAL CANCER INSTITUTE [R01CA064585, T32CA009078, R01CA093602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD Breast Cancer Program(United States Department of Defense); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Jenuwein for providing Suv39h1/2 cells, D. Ferguson for providing Rad50-deficient HCT116 cells, and H. Chan, J. Cote, D. Chowdhury and A. D'Andrea for critical discussions and reading of the manuscript. This work was supported by grants from the NCI (CA64585 and CA93602) and the DOD Breast Cancer Program to B. D. P., and by NCI training grants to Y.S. and M. K. A. (T32 CA09078). Y.X. is supported by a U19 Center grant from NIAID (U19AI067751).	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUSCH T, 2004, SCIENCE; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lleonart ME, 2006, ONCOL REP, V16, P603; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; SQUATRITO M, 2006, TRENDS CELL BIOL; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302	38	310	320	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1376	U273		10.1038/ncb1982	http://dx.doi.org/10.1038/ncb1982			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19783983	Green Accepted			2022-12-27	WOS:000271425800019
J	Cahalan, MD				Cahalan, Michael D.			STIMulating store-operated Ca2+ entry	NATURE CELL BIOLOGY			English	Review							STROMAL INTERACTION MOLECULE-1; CALCIUM SENSOR STIM1; CA2+-SELECTIVE ARC CHANNELS; PLASMA MEMBRANE JUNCTIONS; ACTIVATES CRAC CHANNELS; SMOOTH-MUSCLE-CELLS; CURRENT I-CRAC; ENDOPLASMIC-RETICULUM; TRPC CHANNELS; NEOINTIMA FORMATION	Calcium influx through plasma membrane store-operated Ca2+ (SOC) channels is triggered when the endoplasmic reticulum (ER) Ca2+ store is depleted - a homeostatic Ca2+ signalling mechanism that remained enigmatic for more than two decades. RNA-interference (RNAi) screening and molecular and cellular physiological analysis recently identified STIM1 as the mechanistic 'missing link' between the ER and the plasma membrane. STIM proteins sense the depletion of Ca2+ from the ER, oligomerize, translocate to junctions adjacent to the plasma membrane, organize Orai or TRPC (transient receptor potential cation) channels into clusters and open these channels to bring about SOC entry.	[Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Cahalan, Michael D.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS014609, R37 NS014609-30] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Aromataris EC, 2008, BBA-MOL CELL RES, V1783, P874, DOI 10.1016/j.bbamcr.2008.02.011; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; LEWIS RR, 1989, WETLAND CREATION RES, V2, P1; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Litjens T, 2007, BIOCHEM J, V405, P269, DOI 10.1042/BJ20061762; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Oka T, 2005, J IMMUNOL, V174, P4584, DOI 10.4049/jimmunol.174.8.4584; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parker NJ, 1996, GENOMICS, V37, P253, DOI 10.1006/geno.1996.0553; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1999, CYTOGENET CELL GENET, V86, P214, DOI 10.1159/000015341; Sabbioni S, 1997, CANCER RES, V57, P4493; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V361, P934, DOI 10.1016/j.bbrc.2007.07.096; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Thompson MA, 2009, CELL MOL NEUROBIOL, V29, P193, DOI 10.1007/s10571-008-9311-0; Tolhurst G, 2008, PLATELETS, V19, P308, DOI 10.1080/09537100801935710; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	108	339	351	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2009	11	6					669	677		10.1038/ncb0609-669	http://dx.doi.org/10.1038/ncb0609-669			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	451XH	19488056	Green Accepted			2022-12-27	WOS:000266503700005
J	Tear, G				Tear, Guy			Dynein branches out	NATURE CELL BIOLOGY			English	Editorial Material							CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; NEURONS; DENDRITE; POLARITY; MICROTUBULES; TRAFFICKING; KINESIN	individual neurons form specific elaborate dendritic structures that receive presynaptic information. The pattern of dendritic branching is regulated by the microtubule-associated motor protein dynein, which is responsible for the transport of essential endosomes and other organelles into the dendrites.	Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Tear, G (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, New Hunts House,Guys Campus, London SE1 1UL, England.	guy.tear@kcl.ac.uk	Tear, Guy/C-5444-2009	Tear, Guy/0000-0002-3114-7537	MRC [G0401440] Funding Source: UKRI; Medical Research Council [G0401440] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Sugimura K, 2003, J NEUROSCI, V23, P3752; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	13	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2008	10	10					1131	1132		10.1038/ncb1008-1131	http://dx.doi.org/10.1038/ncb1008-1131			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	355BF	18830220				2022-12-27	WOS:000259682900006
J	Beli, P; Mascheroni, D; Xu, DL; Innocenti, M				Beli, Petra; Mascheroni, Debora; Xu, Dalu; Innocenti, Metello			WAVE and Arp2/3 jointly inhibit filopodium formation by entering into a complex with mDia2	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; N-WASP; FORMIN; NUCLEATION; MECHANISM; PROTEINS; REVEALS; ABI1; IDENTIFICATION; ACTIVATION	Lamellipodia/ruffles and filopodia are protruding organelles containing short and highly branched or long and unbranched actin filaments, respectively(1-3). the microscopic morphology, dynamic development and protein signature of both lamellipodia/ruffles and filopodia have been investigated(2,3); however, little is known about the mechanisms by which cells coordinate the formation of these actin-based extensions. Here, we show that WAVE holds mDia2 and the Arp2/3 complex in a multimolecular complex. WAVE- and Arp2/3-dependent ruffling induced by EGF does not require mDia2. Conversely, the emission of mDia2-dependent filopodia correlates with its disengagement from WAVe. Consistently, the ability of eGF, Cdc42 and serum to induce mDia2-dependent formation of filopodia is increased in the absence of either the WAVe/Abi1/Nap1/PIR121 (WANP) or the Arp2/3 complex. reintroduction of WAVE2 into WANP-complex knockdown cells markedly reduces filopodia formation independently of actin polymerization. thus, WAVe and the Arp2/3 complex jointly orchestrate different types of actin-based plasma membrane protrusions by promoting ruffling and inhibiting mDia2-induced filopodia.	[Beli, Petra; Mascheroni, Debora; Xu, Dalu; Innocenti, Metello] Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Innocenti, M (corresponding author), Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	innocenti@biochem2.de	Innocenti, Metello/X-2182-2019	Innocenti, Metello/0000-0002-7455-2559; Beli, Petra/0000-0001-9507-9820				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Harris ES, 2004, CURR BIOL, V14, pR520, DOI 10.1016/j.cub.2004.06.043; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	29	80	80	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					849	857		10.1038/ncb1745	http://dx.doi.org/10.1038/ncb1745			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18516090				2022-12-27	WOS:000257268400014
J	Garcia-Higuera, I; Manchado, E; Dubus, P; Canamero, M; Mendez, J; Moreno, S; Malumbres, M				Garcia-Higuera, Irene; Manchado, Eusebio; Dubus, Pierre; Canamero, Marta; Mendez, Juan; Moreno, Sergio; Malumbres, Marcos			Genomic stability and tumour suppression by the APC/C cofactor Cdh1	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANSGENIC MOUSE STRAIN; CELL-CYCLE; UBIQUITIN LIGASE; S-PHASE; CHROMOSOMAL INSTABILITY; POSTMITOTIC NEURONS; SUBVENTRICULAR ZONE; MITOSIS; PROTEIN	The anaphase promoting complex or cyclosome (APC/C) is a ubiquitin protein ligase that, together with Cdc20 or Cdh1, targets cell-cycle proteins for degradation. APC/C-Cdh1 specifically promotes protein degradation in late mitosis and G1. Mutant embryos lacking Cdh1 die at E9.5-E10.5 due to defects in the endoreduplication of trophoblast cells and placental malfunction. This lethality is prevented when Cdh1 is expressed in the placenta. Cdh1-deficient cells proliferate inefficiently and accumulate numeric and structural chromosomal aberrations, indicating that Cdh1 contributes to the maintenance of genomic stability. Cdh1 heterozygous animals show increased susceptibility to spontaneous tumours, suggesting that Cdh1 functions as a haploinsufficient tumour suppressor. These heterozygous mice also show several defects in behaviour associated with increased proliferation of stem cells in the nervous system. These results indicate that Cdh1 is required for preventing unscheduled proliferation of specific progenitor cells and protecting mammalian cells from genomic instability.	[Garcia-Higuera, Irene; Moreno, Sergio] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Garcia-Higuera, Irene; Manchado, Eusebio; Malumbres, Marcos] CNIO, Cell Div, Madrid, Spain; [Garcia-Higuera, Irene; Manchado, Eusebio; Malumbres, Marcos] CNIO, Canc Grp, Madrid, Spain; [Dubus, Pierre] Univ Bordeaux 2, F-33076 Bordeaux, France; [Canamero, Marta] CNIO, Comparat Pathol Unit, Madrid, Spain; [Mendez, Juan] CNIO, DNA Replicat Grp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Moreno, S (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Miguel Unamuno, Salamanca 37007, Spain.	malumbres@cnio.es; smo@usal.es	Mendez, Juan/K-8001-2014; 2008, Ibsal/A-1268-2012; /AAI-3238-2021; Moreno, Sergio/K-3671-2014; Garcia-Higuera, Irene/L-5004-2014; Holt, Janet E/B-2415-2013; Malumbres, Marcos/E-8834-2011	Mendez, Juan/0000-0002-3235-2559; Moreno, Sergio/0000-0002-8039-1413; Garcia-Higuera, Irene/0000-0001-6331-075X; Malumbres, Marcos/0000-0002-0829-6315; Dubus, Pierre/0000-0003-1803-4711				Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ANG XL, 2004, SCI STKE, pPE31; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MIQUEL J, 1978, EXP GERONTOL, V13, P389, DOI 10.1016/0531-5565(78)90049-9; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Quereda V, 2007, ONCOGENE, V26, P7665, DOI 10.1038/sj.onc.1210578; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yamaguchi S, 1997, MOL BIOL CELL, V8, P2475, DOI 10.1091/mbc.8.12.2475	46	280	284	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					802	811		10.1038/ncb1742	http://dx.doi.org/10.1038/ncb1742			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552834				2022-12-27	WOS:000257268400010
J	Nakaya, Y; Sukowati, EW; Wu, Y; Sheng, GJ				Nakaya, Yukiko; Sukowati, Erike W.; Wu, Yuping; Sheng, Guojun			RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NUCLEOTIDE EXCHANGE FACTOR; MOUSE GASTRULATION; EPITHELIOMESENCHYMAL TRANSFORMATION; FAMILY GTPASES; ACTIVE RHOA; E-CADHERIN; TGF-BETA; MORPHOGENESIS; ACTIVATION	Molecular and cellular mechanisms of epithelial-mesenchymal transition (EMT), crucial in development and pathogenesis, are still poorly understood. Here we provide evidence that distinct cellular steps of EMT occur sequentially during gastrulation. Basement membrane ( BM) breakdown is the first recognizable step and is controlled by loss of basally localized RhoA activity and its activator neuroepithelial-transforming- protein-1 (Net1). Failure of RhoA downregulation during EMT leads to BM retention and reduction of its activity in normal epithelium leads to BM breakdown. We also show that this is in part mediated by RhoA-regulated basal microtubule stability. Microtubule disruption causes BM breakdown and its stabilization results in BM retention. We propose that loss of Net1 before EMT reduces basal RhoA activity and destabilizes basal microtubules, causing disruption of epithelial cell-BM interaction and subsequently, breakdown of the BM.	[Nakaya, Yukiko; Sukowati, Erike W.; Wu, Yuping; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan	RIKEN	Sheng, GJ (corresponding author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo 6500047, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/G-4116-2014; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-8746-2013					AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan AML, 1996, ONCOGENE, V12, P1259; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; GUSTAFSON T, 1961, EXP CELL RES, V22, P437, DOI 10.1016/0014-4827(61)90120-3; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Halfter W, 2002, J NEUROSCI, V22, P6029; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hay ED, 1995, ACTA ANAT, V154, P8; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu JP, 1998, DEVELOPMENT, V125, P5055; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Sasai N, 2004, NAT CELL BIOL, V6, P741, DOI 10.1038/ncb1158; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Simoes S, 2006, DEVELOPMENT, V133, P4257, DOI 10.1242/dev.02588; Stern C.D., 2004, GASTRULATION CELLS E; STERN CD, 1985, J EMBRYOL EXP MORPH, V88, P365; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	50	212	220	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2008	10	7					765	775		10.1038/ncb1739	http://dx.doi.org/10.1038/ncb1739			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	320XL	18552836				2022-12-27	WOS:000257268400007
J	Tang, XL; Jang, SW; Okada, M; Chan, CB; Feng, Y; Liu, Y; Luo, SW; Hong, Y; Rama, N; Xiong, WC; Mehlen, P; Ye, KQ				Tang, Xiaoling; Jang, Sung-Wuk; Okada, Masashi; Chan, Chi-Bun; Feng, Yue; Liu, Yu; Luo, Shi-Wen; Hong, Yan; Rama, Nicolas; Xiong, Wen-Cheng; Mehlen, Patrick; Ye, Keqiang			Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; CELL-DEATH; APOPTOTIC CLEAVAGE; NUCLEAR GTPASE; AXON GUIDANCE; DCC; PROTEIN; SRC; PHOSPHORYLATION	Netrins, a family of secreted molecules, have critical functions in axon guidance and cell migration during neuronal development(1,2). In addition to its role as a chemotropic molecule, netrin-1 also acts as a survival factor(3-7). Both UNC5 (that is, UNC5A, UNC5B, UNC5C or UNC5D) and DCC are transmembrane receptors for netrin-1 (refs 8, 9). In the absence of netrin-1, DCC and UNC5 act as dependence receptors and trigger apoptosis(3,6,10). However, how netrin-1 suppresses the apoptotic activity of the receptors remains elusive. Here we show that netrin-1 induces interaction of UNC5B with the brain-specific GtPase PIKe-L. this interaction triggers the activation of PtdIns-3-OH kinase signalling, prevents UNC5B's pro-apoptotic activity and enhances neuronal survival. Moreover, this process relies strongly on Fyn because PIKe-L is tyrosine phosphorylated in response to netrin-1, and the netrin-1-mediated interaction of UNC5B with PIKe-l is inhibited in Fyn-null mice. thus, PIKe-L acts as a downstream survival effector for netrin-1 through UNC5B in the nervous system.	[Tang, Xiaoling; Jang, Sung-Wuk; Okada, Masashi; Chan, Chi-Bun; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Liu, Yu; Luo, Shi-Wen; Hong, Yan; Xiong, Wen-Cheng] Med Coll Georgia, Dept Neurol, Augusta, GA 30809 USA; [Liu, Yu; Luo, Shi-Wen; Hong, Yan; Xiong, Wen-Cheng] Med Coll Georgia, Inst Mol Med & Genom, Augusta, GA 30809 USA; [Rama, Nicolas; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Euipe La Ligue, CNRS,UMR5328, F-69008 Lyon, France	Emory University; Emory University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Okada, Masashi/AAC-2171-2021	Xiong, Wen-Cheng/0000-0001-9071-7598; Rama, Nicolas/0000-0003-1614-7755; Feng, Yue/0000-0002-7905-2182	NINDS NIH HHS [R01 NS045627, R01 NS045627-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Tang X, 2007, CELL DEATH DIFFER, V14, P368, DOI 10.1038/sj.cdd.4402011; Tang XL, 2006, ADV ENZYME REGUL, V46, P289, DOI 10.1016/j.advenzreg.2006.01.017; Tang XL, 2004, J MOL MED, V82, P383, DOI 10.1007/s00109-004-0535-2; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Williams ME, 2003, J NEUROSCI, V23, P11279; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Williams ME, 2006, NAT NEUROSCI, V9, P996, DOI 10.1038/nn1736; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a	30	77	81	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2008	10	6					698	706		10.1038/ncb1732	http://dx.doi.org/10.1038/ncb1732			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	307WP	18469807	Green Accepted			2022-12-27	WOS:000256350100016
J	Lallemand-Breitenbach, V; Jeanne, M; Benhenda, S; Nasr, R; Lei, M; Peres, L; Zhou, J; Zhu, J; Raught, B; de The, H				Lallemand-Breitenbach, Valerie; Jeanne, Marion; Benhenda, Shirine; Nasr, Rihab; Lei, Ming; Peres, Laurent; Zhou, Jun; Zhu, Jun; Raught, Brian; de The, Hugues			Arsenic degrades PML or PML - RAR alpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway	NATURE CELL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR-BODY FORMATION; MASS-SPECTROMETRY; SNURF RNF4; PROTEIN; IDENTIFICATION; DEGRADATION; TRIOXIDE; LOCALIZATION; SUMOYLATION	In acute promyelocytic leukaemia (APL), arsenic trioxide induces degradation of the fusion protein encoded by the PML-RARA oncogene, differentiation of leukaemic cells and produces clinical remissions. SUMOylation of its PML moiety was previously implicated, but the nature of the degradation pathway involved and the role of PML-RAR alpha catabolism in the response to therapy have both remained elusive. Here, we demonstrate that arsenic-induced PML SUMOylation triggers its Lys 48-linked polyubiquitination and proteasome-dependent degradation. When exposed to arsenic, SUMOylated PML recruits RNF4, the human orthologue of the yeast SUMO-dependent E3 ubiquitin-ligase, as well as ubiquitin and proteasomes onto PML nuclear bodies. Arsenic-induced differentiation is impaired in cells transformed by a non-degradable PML-RAR alpha SUMOylation mutant or in APL cells transduced with a dominant-negative RNF4, directly implicating PML w-RAR alpha catabolism in the therapeutic response. We thus identify PML as the first protein degraded by SUMO-dependent polyubiquitination. As PML SUMOylation recruits not only RNF4, ubiquitin and proteasomes, but also many SUMOylated proteins onto PML nuclear bodies, these domains could physically integrate the SUMOylation, ubiquitination and degradation pathways.	[Lallemand-Breitenbach, Valerie; Jeanne, Marion; Benhenda, Shirine; Nasr, Rihab; Lei, Ming; Peres, Laurent; Zhou, Jun; Zhu, Jun; de The, Hugues] Univ Paris 07, CNRS, UMR 7151, Hop St Louis,Equipe Labellisee Ligue Natl Canc 11, F-75475 Paris 10, France; [Zhou, Jun; Zhu, Jun; de The, Hugues] Rui Jin Hosp, CNRS, Lab Associe MPC, Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Raught, Brian] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Raught, Brian] McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [de The, Hugues] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Institut Universitaire de France	de The, H (corresponding author), Univ Paris 07, CNRS, UMR 7151, Hop St Louis,Equipe Labellisee Ligue Natl Canc 11, 1 Av C Vellefaux, F-75475 Paris 10, France.	dethe@univ-paris-diderot.fr	Nasr, Rihab/AAF-1606-2020	Lallemand, Valerie/0000-0001-9852-204X; Nasr, Rihab/0000-0003-1166-4999; Jeanne, Marion/0000-0001-7334-3061	NCI NIH HHS [R37 CA49152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Boddy MN, 1996, ONCOGENE, V13, P971; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Chen GQ, 1997, BLOOD, V89, P3345; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Duprez E, 1999, J CELL SCI, V112, P381; Fabunmi RP, 2001, J CELL SCI, V114, P29; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Miller WH, 2002, CANCER RES, V62, P3893; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; TATHAM MH, 2008, NATURE CELL BIOL; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	34	540	556	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					547	555		10.1038/ncb1717	http://dx.doi.org/10.1038/ncb1717			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18408733				2022-12-27	WOS:000255502400011
J	Jermy, A				Jermy, Andrew			STIM1 tracks growing microtubule ends	NATURE CELL BIOLOGY			English	Editorial Material														Jermy, Andrew/0000-0002-7454-0670					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					384	384		10.1038/ncb0408-384	http://dx.doi.org/10.1038/ncb0408-384			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379599	Bronze			2022-12-27	WOS:000254561700007
J	Koestler, SA; Auinger, S; Vinzenz, M; Rottner, K; Small, JV				Koestler, Stefan A.; Auinger, Sonja; Vinzenz, Marlene; Rottner, Klemens; Small, J. Victor			Differentially oriented populations of actin filaments generated in lamellipodia collaborate in pushing and pausing at the cell front	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; MONOMERIC RED; LEADING-EDGE; ORGANIZATION; DYNAMICS; MECHANISMS; NETWORKS; MOVEMENT; DRIVEN; FLOW	eukaryotic cells advance in phases of protrusion, pause and withdrawal(1). Protrusion occurs in lamellipodia, which are composed of diagonal networks of actin filaments, and withdrawal terminates with the formation of actin bundles parallel to the cell edge. Using correlated live-cell imaging and electron microscopy, we have shown that actin filaments in protruding lamellipodia subtend angles from 15-90 degrees to the front, and that transitions from protrusion to pause are associated with a proportional increase in filaments oriented more parallel to the cell edge. Microspike bundles of actin filaments also showed a wide angular distribution and correspondingly variable bilateral polymerization rates along the cell front. We propose that the angular shift of filaments in lamellipodia serves in adapting to slower protrusion rates while maintaining the filament densities required for structural support; further, we suggest that single filaments and microspike bundles contribute to the construction of the lamella behind and to the formation of the cell edge when protrusion ceases. Our findings provide an explanation for the variable turnover dynamics of actin filaments in lamellipodia observed by fluorescence speckle microscopy(2) and are inconsistent with a current model of lamellipodia structure that features actin filaments branching at 70 degrees in a dendritic array(3).	[Koestler, Stefan A.; Auinger, Sonja; Vinzenz, Marlene; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Rottner, Klemens] Helmholtz Ctr Infect Res HZI, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Helmholtz Association; Helmholtz-Center for Infection Research	Small, JV (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	vic.small@imba.oeaw.ac.at		Koestler, Stefan/0000-0002-7223-8291; Rottner, Klemens/0000-0003-4244-4198				ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; AUINGER S, 2007, IN PRESS METHODS CEL; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HEATH JP, 1993, SYM SOC EXP BIOL, V47, P35; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Muller-Taubenberger A, 2006, EUR J CELL BIOL, V85, P1119, DOI 10.1016/j.ejcb.2006.05.006; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2001, J CELL SCI, V114, P3; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Resch GP, 2002, J STRUCT BIOL, V137, P305, DOI 10.1016/S1047-8477(02)00005-9; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Small J V, 1988, Electron Microsc Rev, V1, P155; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615	34	148	148	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					306	U33		10.1038/ncb1692	http://dx.doi.org/10.1038/ncb1692			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18278037	Green Submitted			2022-12-27	WOS:000253778300012
J	Yonemura, S; Wada, Y; Watanabe, T; Nagafuchi, A; Shibata, M				Yonemura, Shigenobu; Wada, Yuko; Watanabe, Toshiyuki; Nagafuchi, Akira; Shibata, Mai			alpha-Catenin as a tension transducer that induces adherens junction development	NATURE CELL BIOLOGY			English	Article							CELL-CELL CONTACTS; E-CADHERIN; EPITHELIAL-CELLS; F-ACTIN; ADHESION; VINCULIN; COMPLEX; MORPHOGENESIS; DYNAMICS; DOMAINS	Adherens junctions (AJs), which are organized by adhesion proteins and the underlying actin cytoskeleton, probably sense pulling forces from adjacent cells and modulate opposing forces to maintain tissue integrity, but the regulatory mechanism remains unknown at the molecular level. Although the possibility that alpha-catenin acts as a direct linker between the membrane and the actin cytoskeleton for AJ formation and function has been minimized, here we show that alpha-catenin recruits vinculin, another main actin-binding protein of AJs, through force-dependent changes in alpha-catenin conformation. We identified regions in the alpha-catenin molecule that are required for its force-dependent binding of vinculin by introducing mutant alpha-catenin into cells and using in vitro binding assays. Fluorescence recovery after photobleaching analysis for alpha-catenin mobility and the existence of an antibody recognizing alpha-catenin in a force-dependent manner further supported the notion that alpha-catenin is a tension transducer that translates mechanical stimuli into a chemical response, resulting in AJ development.	[Yonemura, Shigenobu; Wada, Yuko; Watanabe, Toshiyuki; Shibata, Mai] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan; [Watanabe, Toshiyuki] Kobe Univ, Dept Life Sci, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Nagafuchi, Akira] Kumamoto Univ, Dept Cellular Interact, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan	RIKEN; Kobe University; Kumamoto University	Yonemura, S (corresponding author), RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan.	yonemura@cdb.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18657065, 17048034]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank F. van Roy, E. Reichman and the Health Science Research Resources Bank for cells; M. Takeichi for cells, antibodies and plasmids; Sa. Tsukita for antibodies; R. Y. Tsien (Howard Hughes Medical Institute, University of California San Diego) for a plasmid; M. Furuse for discussions; and T. Hakoshima and H. Hiraga for critical reading of the manuscript. We also thank Y. Hayashizaki (RIKEN GSC) for a mouse vinculin complementary DNA from FANTOM2 clones. This work was supported by grants-in-aid for Exploratory Research (18657065) and Scientific Research in Priority Areas (17048034) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; AMERONGEN HM, 1989, J CELL BIOL, V109, P2129, DOI 10.1083/jcb.109.5.2129; BAKER PC, 1967, DEV BIOL, V15, P432, DOI 10.1016/0012-1606(67)90036-X; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 2006, NATURE, V440, P38, DOI 10.1038/440038b; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEVI G, 1991, DEVELOPMENT, V111, P159; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; MORTENSEN RM, 1991, P NATL ACAD SCI USA, V88, P7036, DOI 10.1073/pnas.88.16.7036; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Xu WM, 1998, DEVELOPMENT, V125, P327; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; YONEMURA S, 1995, J CELL SCI, V108, P127	51	639	648	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					533	U35		10.1038/ncb2055	http://dx.doi.org/10.1038/ncb2055			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453849				2022-12-27	WOS:000278213400005
J	Gastaldello, S; Hildebrand, S; Faridani, O; Callegari, S; Palmkvist, M; Di Guglielmo, C; Masucci, MG				Gastaldello, Stefano; Hildebrand, Sebastian; Faridani, Omid; Callegari, Simone; Palmkvist, Mia; Di Guglielmo, Claudia; Masucci, Maria G.			A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-SPECIFIC PROTEASE; CYSTEINE PROTEASE; STRUCTURAL BASIS; S-PHASE; PHOSPHORYLATION; DEGRADATION; COMPLEX; ENZYME; NEDD8; ACTIVATION	The large tegument proteins of herpesviruses encode conserved cysteine proteases of unknown function. Here we show that BPLF1, the Epstein-Barr-virus-encoded member of this protease family, is a deneddylase that regulates virus production by modulating the activity of cullin-RING ligases (CRLs). BPLF1 hydrolyses NEDD8 conjugates in vitro, acts as a deneddylase in vivo, binds to cullins and stabilizes CRL substrates. Expression of BPLF1 alone or in the context of the productive virus cycle induces accumulation of the licensing factor CDT1 and deregulates S-phase DNA synthesis. Inhibition of BPLF1 during the productive virus cycle prevents cellular DNA re-replication and inhibits virus replication. Viral DNA synthesis is restored by overexpression of CDT1. Homologues encoded by other herpesviruses share the deneddylase activity. Thus, these enzymes are likely to have a key function in the virus life cycle by inducing a replication-permissive S-phase-like cellular environment.	[Gastaldello, Stefano; Hildebrand, Sebastian; Faridani, Omid; Callegari, Simone; Palmkvist, Mia; Di Guglielmo, Claudia; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Gastaldello, Stefano/AAD-3788-2020; Gastaldello, Stefano/AAM-6768-2020; Masucci, Maria/AAC-6666-2019	Gastaldello, Stefano/0000-0001-7369-8452; Masucci, Maria/0000-0002-5541-2809; Di Guglielmo, Claudia/0000-0002-2846-3731; Faridani, Omid/0000-0001-9330-887X				Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Boettcher S, 2008, J VIROL, V82, P6009, DOI 10.1128/JVI.00280-08; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; CHRISP P, 1991, DRUGS, V41, P104, DOI 10.2165/00003495-199141010-00009; Ciechanover A, 2000, J CELL BIOCHEM, P40; Cook JG, 2009, FRONT BIOSCI-LANDMRK, V14, P5013, DOI 10.2741/3584; DAIBATA M, 1990, J IMMUNOL, V144, P4788; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gredmark-Russ S, 2009, J VIROL, V83, P10644, DOI 10.1128/JVI.01017-09; Guerreiro-Cacais AO, 2007, J VIROL, V81, P1390, DOI 10.1128/JVI.01999-06; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jarosinski K, 2007, P NATL ACAD SCI USA, V104, P20025, DOI 10.1073/pnas.0706295104; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Ohta T, 2001, CANCER RES, V61, P1347; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Sompallae R, 2008, J VIROL, V82, P10477, DOI 10.1128/JVI.01113-08; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wilsker D, 2009, CELL CYCLE, V8, P1161, DOI 10.4161/cc.8.8.8148; YAO GQ, 1993, ANTIMICROB AGENTS CH, V37, P1420, DOI 10.1128/AAC.37.7.1420; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	50	78	86	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					351	U110		10.1038/ncb2035	http://dx.doi.org/10.1038/ncb2035			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20190741				2022-12-27	WOS:000276194600008
J	Komatsu, M; Kurokawa, H; Waguri, S; Taguchi, K; Kobayashi, A; Ichimura, Y; Sou, YS; Ueno, I; Sakamoto, A; Tong, KI; Kim, M; Nishito, Y; Iemura, S; Natsume, T; Ueno, T; Kominami, E; Motohashi, H; Tanaka, K; Yamamoto, M				Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki			The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1	NATURE CELL BIOLOGY			English	Article							CUL3-BASED E3 LIGASE; BETA-CELL MASS; OXIDATIVE STRESS; STRUCTURAL BASIS; DLG MOTIFS; PROTEIN; DEGRADATION; INDUCTION; MICE; MECHANISM	Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-positive inclusions and upregulation of detoxifying enzymes. These phenotypes correspond closely to the pathological conditions seen in human liver diseases, including alcoholic hepatitis and hepatocellular carcinoma. However, the molecular mechanisms and pathophysiological processes in these events are still unknown. Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2. Thus, an overproduction of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes. Our findings indicate that the pathological process associated with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defence enzyme genes.	[Komatsu, Masaaki; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Nishito, Yasumasa; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kurokawa, Hirofumi; Taguchi, Keiko; Tong, Kit I.; Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurokawa, Hirofumi; Taguchi, Keiko; Tong, Kit I.; Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO JST, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Kobayashi, Akira; Kim, Mihee] Doshisha Univ, Dept Med Life Syst, Kyoto 6100394, Japan; [Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Takashi; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr JBIRC, Kohtoh Ku, Tokyo 1350064, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Fukushima Medical University; Doshisha University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST)	Komatsu, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	komatsu-ms@igakuken.or.jp; tanaka-kj@igakuken.or.jp; masiyamamoto@m.tains.tohoku.ac.jp	Kurokawa, Hirofumi/A-7231-2010; Yamamoto, Masayuki/A-4873-2010; Komatsu, Masaaki/B-8321-2011; Natsume, Tohru/M-7627-2018; Kobayashi, Akira/AAN-8003-2020; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Komatsu, Masaaki/0000-0001-7672-7722; Natsume, Tohru/0000-0002-1510-2582; Kobayashi, Akira/0000-0001-9727-1218; Sou, Yu-shin/0000-0002-7219-9106; Taguchi, Keiko/0000-0002-5798-0076	Japan Science and Technology Agency; Ministry of Education, Science and Culture of Japan; Targeted Proteins Research Program	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Kouno and K. Endo (Tokyo Metropolitan Institute of Medical Science) for technical assistance, and the beamline staff at NW12 of PF-AR (Tsukuba, Japan) for technical help in data collection. We also thank A. Yamada, K. Kanno and A. Yabashi (Fukushima Medical University School of Medicine) for their help in histological studies; J. Yanagisawa (Tsukuba University) and Y. Saeki (Tokyo Metropolitan Institute of Medical Science) for mass spectrometric analyses; Y. Kawatani (Tohoku University) for technical assistance in microarray analyses; and R. Kopito and B. E. Riley (Stanford University) and T. Mizushima and T. Kumanomidou (Nagoya University) for helpful discussion. p62-knockout mice were provided by T. Ishii (Tsukuba University). The Biomedical Research Core of Tohoku University Graduate School of Medicine provided DRI-CHEM 7000V (Fuji Film Corp.). This work was supported by grants from the Japan Science and Technology Agency (M. K.), the Ministry of Education, Science and Culture of Japan (M. K., K. T. and M. Y.) and the Targeted Proteins Research Program (H. K., K. T. and M. Y.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Matsumoto N, 2008, BIOCHEM BIOPH RES CO, V368, P643, DOI 10.1016/j.bbrc.2008.01.112; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	54	1519	1579	8	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					213	U17		10.1038/ncb2021	http://dx.doi.org/10.1038/ncb2021			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173742				2022-12-27	WOS:000275054200007
J	Lei, XF; Bai, ZQ; Ye, FC; Xie, JP; Kim, CG; Huang, YF; Gao, SJ				Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Kim, Chan-Gil; Huang, Yufei; Gao, Shou-Jiang			Regulation of NF-kappa B inhibitor I kappa B alpha and viral replication by a KSHV microRNA	NATURE CELL BIOLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; KAPOSIS-SARCOMA; TRANSCRIPTIONAL PROGRAM; GENE-EXPRESSION; LATENT; IDENTIFICATION; INFECTION; PATHWAY; TARGETS	Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several acquired immune deficiency syndrome-related malignancies, including Kaposi's sarcoma, primary effusion lymphoma (PEL) and a subset of multicentric Castleman's disease(1). Control of viral lytic replication is essential for KSHV latency, evasion of the host immune system and induction of tumours(1). Here, we show that deletion of a 14 microRNA (miRNA) cluster from the KSHV genome significantly enhances viral lytic replication as a result of reduced NF-kappa B activity. The miRNA cluster regulates the NF-kappa B pathway by reducing expression of I kappa B alpha protein, an inhibitor of NF-kappa B complexes. Computational and miRNA seed mutagenesis analyses were used to identify KSHV miR-K1, which directly regulates the I kappa B alpha protein level by targeting the 3'UTR of its transcript. Expression of miR-K1 is sufficient to rescue NF-kappa B activity and inhibit viral lytic replication, whereas inhibition of miR-K1 in KSHV-infected PEL cells has the opposite effect. Thus, KSHV encodes an miRNA to control viral replication by activating the NF-kappa B pathway. These results demonstrate an important role for KSHV miRNAs in regulating viral latency and lytic replication by manipulating the host survival pathway.	[Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Kim, Chan-Gil; Huang, Yufei; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, Tumor Virol Program, San Antonio, TX 78229 USA; [Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat Microbiol & Immunol Med & Mol Med, San Antonio, TX 78229 USA; [Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Bai, Zhiqiang; Gao, Shou-Jiang] Chinese Acad Sci, Wuhan Inst Virol, Tumor Virol Grp, Wuhan 430071, Hubei, Peoples R China; [Bai, Zhiqiang; Gao, Shou-Jiang] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Kim, Chan-Gil] Konkuk Univ, Dept Biotechnol, Chungju 380701, South Korea; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Konkuk University; University of Texas System; University of Texas at San Antonio (UTSA)	Gao, SJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, Tumor Virol Program, San Antonio, TX 78229 USA.	gaos@uthscsa.edu	Gao, Shou-Jiang/B-8641-2012; xu, li/AAO-4684-2021; Huang, Yufei/AAU-2891-2021; xu, li/GNH-3667-2022	Gao, Shou-Jiang/0000-0001-6194-1742	American Cancer Society [RSG-04-195]; National Institutes of Health [CA096512, CA124332, CA132637, DE017333]; National Science Foundation [CCF-0546345]; Konkuk University; NATIONAL CANCER INSTITUTE [R01CA096512, R01CA124332, R01CA132637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017333] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Konkuk University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank K. Izumi and A. Griffiths for their valuable suggestions. This work was supported by grants from the American Cancer Society (#RSG-04-195) and the National Institutes of Health (CA096512, CA124332, CA132637 and DE017333) to S.-J. G, and the National Science Foundation (CCF-0546345) to Y. F. H. C.-G. K. was supported by Konkuk University in 2008.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Hara AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000389; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; UMBACH JL, 2008, NATURE; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Yoo SM, 2005, VIROLOGY, V343, P47, DOI 10.1016/j.virol.2005.08.018; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	39	205	217	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					193	U232		10.1038/ncb2019	http://dx.doi.org/10.1038/ncb2019			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081837	Green Accepted			2022-12-27	WOS:000274139400014
J	Lee, JS; Li, QL; Lee, JY; Lee, SH; Jeong, JH; Lee, HR; Chang, H; Zhou, FC; Gao, SJ; Liang, CY; Jung, JU				Lee, Jong-Soo; Li, Qinglin; Lee, June-Yong; Lee, Sun-Hwa; Jeong, Joseph H.; Lee, Hye-Ra; Chang, Heesoon; Zhou, Fu-Chun; Gao, Shou-Jiang; Liang, Chengyu; Jung, Jae U.			FLIP-mediated autophagy regulation in cell death control	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CRYSTAL-STRUCTURE; CONJUGATION SYSTEMS; MOLECULAR-MECHANISM; IN-VIVO; INHIBITION; ACTIVATION; APOPTOSIS; LYMPHOMAS; PROTEINS	Autophagy is an active homeostatic degradation process for the removal or turnover of cytoplasmic components wherein the LC3 ubiquitin-like protein undergoes an Atg7 E1-like enzyme/Atg3 E2-like enzyme-mediated conjugation process to induce autophagosome biogenesis(1-4). Besides its cytoprotecive role, autophagy acts on cell death when it is abnormally upregulated. Thus, the autophagy pathway requires tight regulation to ensure that this degradative process is well balanced. Two death effector domains (DED1/2) containing cellular FLICE-like inhibitor protein (cFLIP) and viral FLIP (vFLIP) of Kaposi's sarcoma-associated herpesvirus (KSHV), Herpesvirus saimiri (HVS), and Molluscum contagiosum virus (MCV) protect cells from apoptosis mediated by death receptors(5,6). Here, we report that cellular and viral FLIPs suppress autophagy by preventing Atg3 from binding and processing LC3. Consequently, FLIP expression effectively represses cell death with autophagy, as induced by rapamycin, an mTor inhibitor and an effective anti-tumour drug against KSHV-induced Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL)(7,8). Remarkably, either a DED1 alpha 2-helix ten amino-acid (alpha 2) peptide or a DED2 alpha 4-helix twelve amino-acid (alpha 4) peptide of FLIP is individually sufficient for binding FLIP itself and Atg3, with the peptide interactions effectively suppressing Atg3-FLIP interaction without affecting Atg3-LC3 interaction, resulting in robust cell death with autophagy. Our study thus identifies a checkpoint of the autophagy pathway where cellular and viral FLIPs limit the Atg3-mediated step of LC3 conjugation to regulate autophagosome biogenesis. Furthermore, the FLIP-derived short peptides induce growth suppression and cell death with autophagy, representing biologically active molecules for potential anti-cancer therapies.	[Lee, Jong-Soo; Lee, June-Yong; Lee, Sun-Hwa; Jeong, Joseph H.; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Lee, Jong-Soo; Li, Qinglin; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Primate Res Ctr, Southborough, MA 01772 USA; [Lee, Jong-Soo; Li, Qinglin; Lee, Hye-Ra; Chang, Heesoon; Liang, Chengyu; Jung, Jae U.] Harvard Univ, Sch Med, Div Tumor Virol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Zhou, Fu-Chun; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	University of Southern California; Harvard University; Harvard University; University of Texas System; University of Texas Health San Antonio	Jung, JU (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Harlyne J Norris Canc Res Tower,1450 Biggy St, Los Angeles, CA 90033 USA.	jaeujung@usc.edu	Li, Qinglin/K-2570-2015; Gao, Shou-Jiang/B-8641-2012	Li, Qinglin/0000-0002-4125-1944; Lee, Jong-Soo/0000-0001-5119-0711; LIANG, CHENGYU/0000-0001-6082-2143; Gao, Shou-Jiang/0000-0001-6194-1742; Lee, June-Yong/0000-0002-4476-725X	US. Public Health Service [CA82057, CA91819, CA31363, CA115284, AI073099, RR00168]; Hastings Foundation; Korean GRL Program [K20815000001]; Lymphoma and Leukemia Society of USA; Wright Foundation; Baxter Foundation;  [AI083841];  [CA140964]; NATIONAL CANCER INSTITUTE [R01CA124332, R01CA091819, R01CA096512, R01CA115284, R01CA082057, R01CA140964, R01CA132637, R01CA031363] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099, R21AI083841] Funding Source: NIH RePORTER	US. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Hastings Foundation; Korean GRL Program; Lymphoma and Leukemia Society of USA; Wright Foundation; Baxter Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by US. Public Health Service grants CA82057, CA91819, CA31363, CA115284, AI073099, RR00168, Hastings Foundation, Korean GRL Program K20815000001 (J.J.), AI083841, CA140964, the Lymphoma and Leukemia Society of USA, the Wright Foundation, and the Baxter Foundation (C.L.). We thank Don Ganem, Noboru Mizushima, Preet Chaudhary and Jeff Cohen for reagents, Ernesto Barron for EM analysis, and Steven Lee for manuscript preparation. Finally, we thank all of J.J.'s lab members for their discussions.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Izzedine H, 2005, NEW ENGL J MED, V353, P2088, DOI 10.1056/NEJM200511103531922; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura H, 2007, ATHEROSCLEROSIS SUPP, V8, P13, DOI 10.1016/j.atherosclerosissup.2007.02.003; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu W, 2005, LEUKEMIA RES, V29, P545, DOI 10.1016/j.leukres.2004.11.010; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07	32	294	309	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1355	U225		10.1038/ncb1980	http://dx.doi.org/10.1038/ncb1980			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19838173	Green Accepted			2022-12-27	WOS:000271425800016
J	Jones, MR; Quinton, LJ; Blahna, MT; Neilson, JR; Fu, SN; Ivanov, AR; Wolf, DA; Mizgerd, JP				Jones, Matthew R.; Quinton, Lee J.; Blahna, Matthew T.; Neilson, Joel R.; Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.; Mizgerd, Joseph P.			Zcchc11-dependent uridylation of microRNA directs cytokine expression	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; MESSENGER-RNA; MECHANISMS; FAMILY; MIRNA; IDENTIFICATION; DETERMINANTS; INVOLVEMENT; INHIBITION; PROTEINS	Mounting an effective host immune response without incurring inflammatory injury requires the precise regulation of cytokine expression(1,2). To achieve this, cytokine mRNAs are post-transcriptionally regulated by diverse RNA-binding proteins and microRNAs (miRNAs) targeting their 3' untranslated regions (UTRS)(3,4). Zcchc11 (zinc-finger, CCHC domain-containing protein 11) contains RNA-interacting motifs(5), and has been implicated in signalling pathways involved in cytokine expression(6). The nature of the Zcchc11 protein and how it influences cytokine expression are unknown. Here we show that Zcchc11 directs cytokine expression by uridylating cytokine-targeting miRNAs. Zcchc11 is a ribonucleotidyltransferase with a preference for uridine and is essential for maintaining the poly(A) tail length and stability of transcripts for interleukin-6 (IL-6) and other specific cytokines. The miR-26 family of miRNAs targets IL-6, and the addition of terminal uridines to the miR-26 3' end abrogates IL-6 repression. Whereas 78% of miR-26a sequences in control cells contained 1-3 uridines on their 3' ends, less than 0.1% did so in Zcchc11-knockdown cells. Thus, Zcchc11 fine tunes IL-6 production by uridylating miR-26a, which we propose is an enzymatic modification of the terminal nucleotide sequence of mature miRNA as a means to regulate gene expression.	[Jones, Matthew R.; Quinton, Lee J.; Blahna, Matthew T.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Fu, Suneng; Ivanov, Alexander R.; Wolf, Dieter A.] Harvard Univ, Sch Publ Hlth, Complex Dis & NIEHS Ctr, Prote Facil, Boston, MA 02115 USA; [Neilson, Joel R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT)	Mizgerd, JP (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	jmizgerd@bu.edu	Mizgerd, Joseph/GRY-6369-2022; Wolf, Dieter/AAE-5890-2021; Blahna, Matthew T/F-3172-2013	Wolf, Dieter/0000-0002-3761-1070; Quinton, Lee/0000-0003-1938-2507; Jones, Matthew/0000-0003-4647-2962; Neilson, Joel R./0000-0002-3408-608X; Mizgerd, Joseph/0000-0002-4042-3169	NATIONAL CANCER INSTITUTE [P01CA042063, K99CA131474] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019028] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL092956, R01HL068153, R01HL079392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059780] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA042063-249002, K99 CA131474-02, P01 CA42063, P01 CA042063, K99 CA131474] Funding Source: Medline; NCRR NIH HHS [S10 RR019028] Funding Source: Medline; NHLBI NIH HHS [R01 HL079392, R01 HL068153-06, R01 HL068153, R01 HL079392-04, K99 HL092956, K99 HL092956-02] Funding Source: Medline; NIEHS NIH HHS [P01 ES00002, P30 ES000002] Funding Source: Medline; NIGMS NIH HHS [R01 GM059780] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	40	233	253	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2009	11	9					1157	U258		10.1038/ncb1931	http://dx.doi.org/10.1038/ncb1931			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490EW	19701194	Green Accepted			2022-12-27	WOS:000269482500019
J	Kajiro, M; Hirota, R; Nakajima, Y; Kawanowa, K; So-Ma, K; Ito, I; Yamaguchi, Y; Ohie, S; Kobayashi, Y; Seino, Y; Kawano, M; Kawabe, Y; Takei, H; Hayashi, S; Kurosumi, M; Murayama, A; Kimura, K; Yanagisawa, J				Kajiro, Masashi; Hirota, Ryuichi; Nakajima, Yuka; Kawanowa, Kaori; So-ma, Kae; Ito, Ichiaki; Yamaguchi, Yuri; Ohie, Sho-hei; Kobayashi, Yasuhito; Seino, Yuko; Kawano, Miwako; Kawabe, Yoh-ichi; Takei, Hiroyuki; Hayashi, Shin-ichi; Kurosumi, Masafumi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn			The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEAT-SHOCK PROTEINS; MEDIATED DEGRADATION; ESTROGEN-RECEPTOR; PROTEASOMAL DEGRADATION; SIGNALING PATHWAY; COACTIVATOR; CHAPERONE; BREAST; CANCER	CHIP is a U-box-type ubiquitin ligase that induces ubiquitylation and degradation of its substrates, which include several oncogenic proteins(1-12). The relationship between CHIP and tumour progression, however, has not been elucidated. Here, we show that CHIP suppresses tumour progression in human breast cancer by inhibiting oncogenic pathways. CHIP levels were negatively correlated with the malignancy of human breast tumour tissues. In a nude mouse xenograft model, tumour growth and metastasis were significantly inhibited by CHIP expression. In contrast, knockdown of CHIP (shCHIP) in breast cancer cells resulted in rapid tumour growth and metastastic phenotypes in mice. In cell-based experiments, anchorage-independent growth and invasiveness of shCHIP cells was significantly elevated due to increased expression of Bcl2, Akt1, Smad and Twist. Proteomic analysis identified the transcriptional co-activator SRC-3 (refs13-19) as a direct target for ubiquitylation and degradation by CHIP. Knocking down SRC-3 in shCHIP cells reduced the expression of Smad and Twist, and suppressed tumour metastasis in vivo. Conversely, SRC-3 co-expression prevented CHIP-induced suppression of metastasis formation. These observations demonstrate that CHIP inhibits anchorage-independent cell growth and metastatic potential by degrading oncogenic proteins including SRC-3.	[Kajiro, Masashi; Hirota, Ryuichi; Nakajima, Yuka; So-ma, Kae; Ito, Ichiaki; Ohie, Sho-hei; Kawano, Miwako; Kawabe, Yoh-ichi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kawanowa, Kaori; Kobayashi, Yasuhito; Takei, Hiroyuki; Kurosumi, Masafumi] Saitama Canc Ctr, Dept Pathol, Ina, Saitama 3620806, Japan; [Yamaguchi, Yuri; Seino, Yuko] Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama 3620806, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Sch Med, Course Hlth Sci, Dept Med Technol,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, TARA, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; Tohoku University; University of Tsukuba	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	junny@agbi.tsukuba.ac.jp	Hirota, Ryuichi/Q-3138-2016	Hirota, Ryuichi/0000-0003-3959-5892	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	30	127	131	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					312	U190		10.1038/ncb1839	http://dx.doi.org/10.1038/ncb1839			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19198599				2022-12-27	WOS:000263777900015
J	Patterson, C; Ronnebaum, S				Patterson, Cam; Ronnebaum, Sarah			Breast cancer quality control	NATURE CELL BIOLOGY			English	Editorial Material							UBIQUITIN LIGASE; CHIP; ACCUMULATION; CHAPERONE	Tumorigenesis is regulated by several mechanisms including signalling, transcription and DNA replication. now a cytoplasmic protein quality-control pathway is implicated in the suppression of breast cancer cell growth, suggesting a new role for quality-control mechanisms in suppressing cells with malignant potential.	[Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Patterson, C (corresponding author), Univ N Carolina, Div Cardiol, 8200 Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu		Ronnebaum, Sarah/0000-0003-4787-754X				Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200	14	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					239	241		10.1038/ncb0309-239	http://dx.doi.org/10.1038/ncb0309-239			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19255569				2022-12-27	WOS:000263777900005
J	Luo, KT; Yuan, J; Chen, JJ; Lou, ZK				Luo, Kuntian; Yuan, Jian; Chen, Junjie; Lou, Zhenkun			Topoisomerase II alpha controls the decatenation checkpoint	NATURE CELL BIOLOGY			English	Article							CASEIN KINASE-II; DNA STRAND BREAKS; MAMMALIAN-CELLS; CYCLE CHECKPOINT; G(2) CHECKPOINT; BINDING DOMAIN; IN-VITRO; DAMAGE; PHOSPHORYLATION; INHIBITION	Topoisomerase II (Topo II) is required to separate intertwined sister chromatids before chromosome segregation can occur in mitosis(1). However, it remains to be resolved whether Topo II has any role in checkpoint control. Here we report that when phosphorylated, Ser 1524 of Topo II alpha acts as a binding site for the BRCT domain of MDC1 (mediator of DNA damage checkpoint protein-1), thereby recruiting MDC1 to chromatin. Although Topo II alpha-MDC1 interaction is not required for checkpoint activation induced by DNA damage, it is required for activation of the decatenation checkpoint. Mutation of Ser 1524 results in a defective decatenation checkpoint. These results reveal an important role of Topo II in checkpoint activation and in the maintenance of genomic stability.	[Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Luo, Kuntian; Yuan, Jian; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu; Lou.Zhenkun@mayo.edu	Yuan, Jian/B-1310-2012	Yuan, Jian/0000-0002-2801-8849	National Institutes of Health (NIH); Richard Schulze Family Foundation; Susan G. Komen Breast Cancer Foundation; NIH [CA130996]; Department of Defense,; Mayo Clinic Breast SPORE; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Schulze Family Foundation; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense,(United States Department of Defense); Mayo Clinic Breast SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants to J.C. from the National Institutes of Health (NIH). Z.L. was supported by grants from the Richard Schulze Family Foundation, Susan G. Komen Breast Cancer Foundation and NIH (CA130996). J.C. is a recipient of an Era of Hope Scholars award from the Department of Defense, and a member of the Mayo Clinic Breast SPORE program.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; Andrews CA, 2006, GENE DEV, V20, P1162, DOI 10.1101/gad.1367206; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; CLARKE DJ, 1993, J CELL SCI, V105, P563; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Doherty SC, 2003, J NATL CANCER I, V95, P1859, DOI 10.1093/jnci/djg120; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Franchitto A, 2003, CANCER RES, V63, P3289; Gimenez-Abian JF, 2000, CHROMOSOMA, V109, P235, DOI 10.1007/s004120000065; Hajji N, 2003, MUTAT RES-FUND MOL M, V530, P35, DOI 10.1016/S0027-5107(03)00135-0; HOLM C, 1994, CELL, V77, P955, DOI 10.1016/0092-8674(94)90433-2; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kimura K, 1996, J BIOL CHEM, V271, P10990, DOI 10.1074/jbc.271.18.10990; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Park I, 2006, EXP CELL RES, V312, P1996, DOI 10.1016/j.yexcr.2006.02.029; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Redwood C, 1998, J BIOL CHEM, V273, P3635, DOI 10.1074/jbc.273.6.3635; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Wessel I, 1999, CANCER RES, V59, P3442; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	30	75	78	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					204	U196		10.1038/ncb1828	http://dx.doi.org/10.1038/ncb1828			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098900	Green Accepted			2022-12-27	WOS:000263285500019
J	Pohl, C; Jentsch, S				Pohl, Christian; Jentsch, Stefan			Midbody ring disposal by autophagy is a post-abscission event of cytokinesis	NATURE CELL BIOLOGY			English	Article							PROTEIN-DEGRADATION; CENTRAL SPINDLE; MACROAUTOPHAGY; TUMORIGENESIS; MITOCHONDRIA; INHIBITION; MECHANISMS; INDUCTION; DEATH; BCL-2	At the end of cytokinesis, the dividing cells are connected by an intercellular bridge, containing the midbody along with a single, densely ubiquitylated, circular structure called the midbody ring (Mr)(1-3). recent studies revealed that the Mr serves as a target site for membrane delivery and as a physical barrier between the prospective daughter cells(2,3). the Mr materializes in telophase, localizes to the intercellular bridge during cytokinesis, and moves asymmetrically into one cell after abscission(2,3). Daughter cells rarely accumulate MRs of previous divisions(2,3), but how these large structures finally disappear remains unknown. Here, we show that MRs are discarded by autophagy, which involves their sequestration into autophagosomes and delivery to lysosomes for degradation. Notably, autophagy factors, such as the ubiquitin adaptor p62 (refs 4, 5) and the ubiquitin-related protein Atg8 (ref. 6), associate with the Mr during abscission, suggesting that autophagy is coupled to cytokinesis. Moreover, MRs accumulate in cells of patients with lysosomal storage disorders, indicating that defective Mr disposal is characteristic of these diseases. thus our findings suggest that autophagy has a broader role than previously assumed, and that cell renovation by clearing from superfluous large macromolecular assemblies, such as MRs, is an important autophagic function.	[Pohl, Christian; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Pohl, Christian/D-4700-2011		Max Planck Society; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	Max Planck Society(Max Planck Society); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	We thank Masaaki Komatsu and Keiji Tanaka for providing Atg7 knockout MEFs and controls, the Bryan Tsou laboratory and Tim Ammon for technical support and help, and Alex Buchberger for comments on the manuscript. S. J. is supported by the Max Planck Society, Center for Integrated Protein Science Munich, and RUBICON EU Network of Excellence.	Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hein LK, 2004, J MOL BIOL, V338, P453, DOI 10.1016/j.jmb.2004.03.012; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mach L, 2002, BIOL CHEM, V383, P751, DOI 10.1515/BC.2002.078; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681	27	145	150	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					65	U122		10.1038/ncb1813	http://dx.doi.org/10.1038/ncb1813			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19079246				2022-12-27	WOS:000262157000012
J	Tooley, AJ; Gilden, J; Jacobelli, J; Beemiller, P; Trimble, WS; Kinoshita, M; Krummel, MF				Tooley, Aaron J.; Gilden, Julia; Jacobelli, Jordan; Beemiller, Peter; Trimble, William S.; Kinoshita, Makoto; Krummel, Matthew F.			Amoeboid T lymphocytes require the septin cytoskeleton for cortical integrity and persistent motility	NATURE CELL BIOLOGY			English	Article							MAMMALIAN SEPTINS; GENE FAMILY; FILAMENT FORMATION; CELL MOTILITY; ACTIN; YEAST; COMPARTMENTALIZATION; POLARIZATION; MICROTUBULES; EXPRESSION	The systems that refine actomyosin forces during motility remain poorly understood. Septins assemble on the T-cell cortex and are enriched at the mid-zone in filaments. Septin knockdown causes membrane blebbing, excess leading-edge protrusions and lengthening of the trailing-edge uropod. The associated loss of rigidity permits motility, but cells become uncoordinated and poorly persistent. This also relieves a previously unrecognized restriction to migration through small pores. Pharmacologically rigidifying cells counteracts this effect, and relieving cytoskeletal rigidity synergizes with septin depletion. These data suggest that septins tune actomyosin forces during motility and probably regulate lymphocyte trafficking in confined tissues.	[Tooley, Aaron J.; Gilden, Julia; Jacobelli, Jordan; Beemiller, Peter; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Kinoshita, Makoto] Kyoto Univ, Grad Sch Med, HMRO, Biochem & Cell Biol Unit,Sakyo Ku, Kyoto 6068501, Japan	University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Kyoto University	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu		KINOSHITA, MAKOTO/0000-0002-7592-2400; Beemiller, Peter/0000-0002-2736-3405	NIH [R21-AI062899]; Sandler family fund; National Science Foundation; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116, R21AI062899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler family fund; National Science Foundation(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Weiss and M. T. McManus for insight and critical discussions, ShuWei Jiang and Cliff McArthur for expert technical assistance with cell sorting and Christine Lin and Ed Shimazu for computer support. We also thank Cynthia Voong for critical reading of the manuscript and members of the Krummel lab for thoughtful discussions. This work was supported by the NIH(R21-AI062899), the Sandler family fund, the National Science Foundation and the Leukemia and Lymphoma Society.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; NOTTENBURG C, 1990, GENE, V95, P279, DOI 10.1016/0378-1119(90)90372-X; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ratner S, 1997, J IMMUNOL, V159, P1063; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sorensen AB, 2000, J VIROL, V74, P2161, DOI 10.1128/JVI.74.5.2161-2168.2000; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tooley AJ, 2005, SEMIN IMMUNOL, V17, P65, DOI 10.1016/j.smim.2004.09.006; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350	38	125	128	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2009	11	1					17	U37		10.1038/ncb1808	http://dx.doi.org/10.1038/ncb1808			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	390IH	19043408	Green Accepted			2022-12-27	WOS:000262157000007
J	Frame, M; Norman, J				Frame, Margaret; Norman, Jim			A tal(in) of cell spreading	NATURE CELL BIOLOGY			English	Editorial Material							INTEGRIN ACTIVATION; FOCAL ADHESIONS; TALIN; CYTOSKELETON; BINDING; DOMAIN	Talin can activate integrins to bind the extracellular matrix and also connect matrix-engaged integrins to the actin cytoskeleton. New work shows that cell spreading can be dissected into three distinct phases according to their differential requirements for talin function.	[Frame, Margaret] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Norman, Jim] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Edinburgh; Beatson Institute	Frame, M (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	m.frame@ed.ac.uk; j.norman@beatson.gla.ac.uk		NORMAN, Jim/0000-0002-0098-3014; Frame, Margaret/0000-0001-5882-1942				Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; ZHANG P, 2008, NATURE CELL BIOL, V10, P1083	17	15	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1017	1019		10.1038/ncb0908-1017	http://dx.doi.org/10.1038/ncb0908-1017			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	18758489				2022-12-27	WOS:000258910400004
J	Green, JBA				Green, Jeremy B. A.			Sophistications of cell sorting	NATURE CELL BIOLOGY			English	Editorial Material							DIFFERENTIAL ADHESION; CONVERGENT EXTENSION; MORPHOGENESIS; HYPOTHESIS	The self-sorting of early embryonic cells is mediated not only by pure differential adhesion but also involves other processes. direct force measurements reveal the role of cell-cortical tension, whereas epithelial-wrapping dominates the sorting of enclosed mesenchymal cells.	Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England	University of London; King's College London	Green, JBA (corresponding author), Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England.	Jeremy.green@kcl.ac.uk	Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620				Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Davidson LA, 2008, DEV CELL, V14, P152, DOI 10.1016/j.devcel.2008.01.012; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Green JBA, 2004, DEV DYNAM, V231, P576, DOI 10.1002/dvdy.20163; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; Reintsch WE, 2005, J CELL BIOL, V170, P675, DOI 10.1083/jcb.200503009; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Steinberg MS, 2004, J EXP ZOOL PART A, V301A, P701, DOI 10.1002/jez.a.114; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105	15	17	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					375	377		10.1038/ncb0408-375	http://dx.doi.org/10.1038/ncb0408-375			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	282IS	18379595				2022-12-27	WOS:000254561700003
J	Huang, E; Qu, DAB; Zhang, Y; Venderova, K; Haque, ME; Rousseaux, MWC; Slack, RS; Woulfe, JM; Park, DS				Huang, En; Qu, Dianbo; Zhang, Yi; Venderova, Katerina; Haque, M. Emdadul; Rousseaux, Maxime W. C.; Slack, Ruth S.; Woulfe, John M.; Park, David S.			The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; BASE EXCISION-REPAIR; MYOCYTE ENHANCER FACTOR-2; DNA-DAMAGE; PARKINSONS-DISEASE; CELL-DEATH; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CDK5 ACTIVITY; MOUSE MODEL	Accumulating evidence suggests that deregulated cyclin-dependent kinase 5 (Cdk5) plays a critical part in neuronal death. However, the pathogenic targets of Cdk5 are not fully defined. Here we demonstrate that the Cdk5 activator p35 interacts directly with apurinic/apyrimidinic endonuclease 1 (Ape1), a protein crucial for base excision repair (BER) following DNA damage. Cdk5 complexes phosphorylate Ape1 at Thr 232 and thereby reduces its apurinic/apyrimidinic (AP) endonuclease activity. Ape1 phosphorylation is dependent on Cdk5 in in vitro and in vivo. The reduced endonuclease activity of phosphorylated Ape1 results in accumulation of DNA damage and contributes to neuronal death. Overexpression of Ape1(WT) and Ape1(T232A), but not the phosphorylation mimic Ape1(T232E), protects neurons against MPP(+)/MPTP. Loss of Ape1 sensitizes neurons to death. Importantly, increased phosphorylated Ape1 was also observed in post-mortem brain tissue from patients with Parkinson's and Alzheimer's diseases, suggesting a potential link between Ape1 phosphorylation and the pathogenesis of neurodegenerative diseases.	[Huang, En; Qu, Dianbo; Zhang, Yi; Venderova, Katerina; Haque, M. Emdadul; Rousseaux, Maxime W. C.; Slack, Ruth S.; Park, David S.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada; [Woulfe, John M.] Univ Ottawa, Dept Pathol & Lab Med, Canc Res Grp, OHRI,Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada; [Woulfe, John M.] Univ Ottawa, Dept Biochem, Canc Res Grp, OHRI,Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada; [Park, David S.] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	, Dianbo/AAU-8480-2021; Qu, Dianbo/C-5121-2011	, Dianbo/0000-0002-0435-9585; Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784; Rousseaux, Maxime/0000-0002-2737-6193	Parkinson Society Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Parkinson's Disease Foundation; Parkinson Research Consortium; Brain Repair Program-Neuroscience Canada; National Research Foundation, Ministry of Education, Science & Technology, South Korea [R31-2008-000-20009-0]	Parkinson Society Canada; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson's Disease Foundation; Parkinson Research Consortium; Brain Repair Program-Neuroscience Canada; National Research Foundation, Ministry of Education, Science & Technology, South Korea	This work was partially supported by Parkinson Society Canada (E.H., D. Q.); by the Heart and Stroke Foundation of Ontario (M.W.C.R); and by funds from the Canadian Institutes of Health Research, Parkinson Society Canada, Parkinson's Disease Foundation, Parkinson Research Consortium, Heart and Stroke Foundation of Ontario, Brain Repair Program-Neuroscience Canada, and World Class University Program, National Research Foundation, Ministry of Education, Science & Technology, South Korea, Grant (R31-2008-000-20009-0) (D.S.P.). D.S.P. is a Heart and Stroke Foundation of Ontario career investigator.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; CHEN TS, 1995, J NEURAL TRANSM-GEN, V100, P153, DOI 10.1007/BF01271538; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Deganuto M, 2007, J CELL PHYSIOL, V212, P223, DOI 10.1002/jcp.21023; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; Hallows JL, 2003, J NEUROSCI, V23, P10633; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Keramaris E, 2008, J BIOL CHEM, V283, P405, DOI 10.1074/jbc.M701552200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1992, J BIOL CHEM, V267, P13383; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Maly DJ, 2004, J AM CHEM SOC, V126, P9160, DOI 10.1021/ja048659i; Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Nakamura J, 1998, CANCER RES, V58, P222; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Robertson KA, 2001, CANCER RES, V61, P2220; Rudolph J, 2007, NAT REV CANCER, V7, P202, DOI 10.1038/nrc2087; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xiang H, 1996, J NEUROSCI, V16, P6753; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	54	88	91	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					563	U100		10.1038/ncb2058	http://dx.doi.org/10.1038/ncb2058			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473298				2022-12-27	WOS:000278213400008
J	Sotiropoulou, PA; Candi, A; Mascre, G; De Clercq, S; Youssef, KK; Lapouge, G; Dahl, E; Semeraro, C; Denecker, G; Marine, JC; Blanpain, C				Sotiropoulou, Panagiota A.; Candi, Aurelie; Mascre, Guilhem; De Clercq, Sarah; Youssef, Khalil Kass; Lapouge, Gaelle; Dahl, Ellen; Semeraro, Claudio; Denecker, Geertrui; Marine, Jean-Christophe; Blanpain, Cedric			Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death	NATURE CELL BIOLOGY			English	Article							RADIATION-INDUCED APOPTOSIS; STRAND BREAK REPAIR; SCID MUTATION; P53; EXPRESSION; MICE; HYPERSENSITIVITY; IDENTIFICATION; KERATINOCYTES; MAINTENANCE	Adult stem cells (SCs) are at high risk of accumulating deleterious mutations because they reside and self-renew in adult tissues for extended periods. Little is known about how adult SCs sense and respond to DNA damage within their natural niche. Here, using mouse epidermis as a model, we define the functional consequences and the molecular mechanisms by which adult SCs respond to DNA damage. We show that multipotent hair-follicle-bulge SCs have two important mechanisms for increasing their resistance to DNA-damage-induced cell death: higher expression of the anti-apoptotic gene Bcl-2 and transient stabilization of p53 after DNA damage in bulge SCs. The attenuated p53 activation is the consequence of a faster DNA repair activity, mediated by a higher non-homologous end joining (NHEJ) activity, induced by the key protein DNA-PK. Because NHEJ is an error-prone mechanism, this novel characteristic of adult SCs may have important implications in cancer development and ageing.	[Sotiropoulou, Panagiota A.; Candi, Aurelie; Mascre, Guilhem; Youssef, Khalil Kass; Lapouge, Gaelle; Dahl, Ellen; Semeraro, Claudio; Blanpain, Cedric] Univ Libre Bruxelles, Interdisciplinary Res Inst IRIBHM, B-1070 Brussels, Belgium; [De Clercq, Sarah; Denecker, Geertrui; Marine, Jean-Christophe] Univ Gent VIB, Lab Mol Canc Biol, Brussels, Belgium	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University	Blanpain, C (corresponding author), Univ Libre Bruxelles, Interdisciplinary Res Inst IRIBHM, 808,Route Lennik,BatC,C6-130, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021; Marine, Jean-Christophe/K-3292-2016; Denecker, Geertrui/E-8134-2010; Marine, Jean Christophe/J-2237-2015	Youssef, Khalil Kass/0000-0002-4572-3160; Marine, Jean-Christophe/0000-0003-2433-9837; Denecker, Geertrui/0000-0002-2515-2911	FNRS; Human Frontier Science Program Organization (HFSPO); Schlumberger Foundation; Wallonia Region; Fondation Contre le Cancer; Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program	FNRS(Fonds de la Recherche Scientifique - FNRS); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Schlumberger Foundation(Schlumberger); Wallonia Region; Fondation Contre le Cancer; Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We thank the members of the Blanpain and Vanderhaeghen laboratories for comments during the realization of this study. We thank V. de Maertelaer for help with the statistical analyses. C.B. is a chercheur qualifie of the Fonds de la Recherche Scientifique (F.R.S.)/Fonds National de la Recherche Scientifique (FNRS). A.C. is a research fellow of the F.R.S./Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). This work was supported by a 'mandat d'impulsion scientifique' of the FNRS, a career development award of the Human Frontier Science Program Organization (HFSPO), a research grant of the Schlumberger Foundation, the programme CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer and the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Botchkarev VA, 2000, CANCER RES, V60, P5002; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dorr W, 2005, FRONT RADIAT THER ON, V39, P96, DOI 10.1159/000090854; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; FitzGerald TJ, 2008, DERMATOL CLIN, V26, P161, DOI 10.1016/j.det.2007.08.005; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kemp CJ, 1999, CARCINOGENESIS, V20, P2051, DOI 10.1093/carcin/20.11.2051; Kim DJ, 2009, MOL CARCINOGEN, V48, P873, DOI 10.1002/mc.20527; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MERRITT AJ, 1995, J CELL SCI, V108, P2261; MERRITT AJ, 1994, CANCER RES, V54, P614; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; PLOEMACHER RE, 1992, INT J RADIAT BIOL, V61, P489, DOI 10.1080/09553009214551251; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Song SY, 1999, AM J PATHOL, V155, P1121, DOI 10.1016/S0002-9440(10)65215-7; STENN KS, 1994, J INVEST DERMATOL, V103, P107, DOI 10.1111/1523-1747.ep12391844; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weil MM, 1996, RADIAT RES, V146, P646, DOI 10.2307/3579380; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	57	188	195	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					572	U121		10.1038/ncb2059	http://dx.doi.org/10.1038/ncb2059			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473297				2022-12-27	WOS:000278213400009
J	Amaro, AC; Samora, CP; Holtackers, R; Wang, E; Kingston, IJ; Alonso, M; Lampson, M; McAinsh, AD; Meraldi, P				Amaro, Ana C.; Samora, Catarina P.; Holtackers, Rene; Wang, Enxiu; Kingston, Isabel J.; Alonso, Maria; Lampson, Michael; McAinsh, Andrew D.; Meraldi, Patrick			Molecular control of kinetochore-microtubule dynamics and chromosome oscillations	NATURE CELL BIOLOGY			English	Article							CENP-A; AURORA-B; OUTER KINETOCHORE; CENTROMERIC DNA; HUMAN-CELLS; COMPLEX; SPINDLE; PROTEINS; ANAPHASE; MCAK	Chromosome segregation in metazoans requires the alignment of sister kinetochores on the metaphase plate. During chromosome alignment, bioriented kinetochores move chromosomes by regulating the plus-end dynamics of the attached microtubules. The bundles of kinetochore-bound microtubules alternate between growth and shrinkage, leading to regular oscillations along the spindle axis. However, the molecular mechanisms that coordinate microtubule plus-end dynamics remain unknown. Here we show that centromere protein (CENP)-H, a subunit of the CENP-A nucleosome-associated and CENP-A distal complexes (CENP-A NAC/CAD), is essential for this coordination, because kinetochores lacking CENP-H establish bioriented attachments but fail to generate regular oscillations, as a result of an uncontrolled rate of microtubule plus-end turnover. These alterations lead to rapid erratic movements that disrupt metaphase plate organization. We also show that the abundance of the CENP-A NAC/CAD subunits CENP-H and CENP-I dynamically change on individual sister kinetochores in vivo, because they preferentially bind the sister kinetochore attached to growing microtubules, and that one other subunit, CENP-Q, binds microtubules in vitro. We therefore propose that CENP-A NAC/CAD is a direct regulator of kinetochore-microtubule dynamics, which physically links centromeric DNA to microtubule plus ends.	[Amaro, Ana C.; Holtackers, Rene; Meraldi, Patrick] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Samora, Catarina P.; McAinsh, Andrew D.] Marie Curie Res Inst, Chromosome Segregat Lab, Oxted RH8 0TL, Surrey, England; [Wang, Enxiu; Lampson, Michael] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kingston, Isabel J.] Canc Res UK, Lincolns Inn Fields Labs, London Res Inst, London, England; [Alonso, Maria] Marie Curie Res Inst, Mol Motors Grp, Oxted RH8 0TL, Surrey, England; [Samora, Catarina P.; Alonso, Maria; McAinsh, Andrew D.] Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Pennsylvania; Cancer Research UK; University of Warwick	Meraldi, P (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	a.d.mcainsh@warwick.ac.uk; patrick.meraldi@bc.biol.ethz.ch	Meraldi, Patrick/D-6190-2013; McAinsh, Andrew/C-6438-2012	Meraldi, Patrick/0000-0001-9742-8756; McAinsh, Andrew/0000-0001-6808-0711	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083988, R01 GM083988-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; HUGHES AF, 1948, J EXP BIOL, V25, P45; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; LEWIS WH, 1939, SCIENCE, V89, P400; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu J, 2008, P NATL ACAD SCI USA, V105, P13752, DOI 10.1073/pnas.0807007105; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; McClelland SE, 2009, METHODS MOL BIOL, V545, P81, DOI 10.1007/978-1-60327-993-2_5; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; SALMON ED, 1980, J CELL BIOL, V86, P355, DOI 10.1083/jcb.86.2.355; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schuyler SC, 2002, METHOD ENZYMOL, V351, P150; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	61	110	110	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					319	U42		10.1038/ncb2033	http://dx.doi.org/10.1038/ncb2033			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228811	Green Accepted			2022-12-27	WOS:000276194600005
J	Khew-Goodall, Y; Goodall, GJ				Khew-Goodall, Yeesim; Goodall, Gregory J.			Myc-modulated miR-9 makes more metastases	NATURE CELL BIOLOGY			English	Editorial Material							BREAST-CANCER METASTASIS; TUMOR INVASION; C-MYC; MICRORNAS; PROGRESSION; EXPRESSION	The microRNA miR-9 is induced by Myc in breast cancer cells where it targets the major epithelial adherens junction protein, E-cadherin. This primes the cancer cells for epithelial-mesenchymal transition (EMT) and also stimulates angiogenesis in tumours.	[Khew-Goodall, Yeesim; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology	Khew-Goodall, Y (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	greg.goodall@health.sa.gov.au		Khew-Goodall, Yeesim/0000-0002-0473-5392; Goodall, Gregory/0000-0003-1294-0692				Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; HAOXIANG T, 2009, MED ONCOL; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	14	93	98	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					209	211		10.1038/ncb0310-209	http://dx.doi.org/10.1038/ncb0310-209			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173743				2022-12-27	WOS:000275054200006
J	Finetti, F; Paccani, SR; Riparbelli, MG; Giacomello, E; Perinetti, G; Pazour, GJ; Rosenbaum, JL; Baldari, CT				Finetti, Francesca; Paccani, Silvia Rossi; Riparbelli, Maria Giovanna; Giacomello, Emiliana; Perinetti, Giuseppe; Pazour, Gregory J.; Rosenbaum, Joel L.; Baldari, Cosima T.			Intraflagellar transport is required for polarized recycling of the TCR/CD3 complex to the immune synapse	NATURE CELL BIOLOGY			English	Article							T-CELL-ACTIVATION; ANTIGEN; RECEPTOR; CILIUM; TCR; INTERNALIZATION; MECHANISMS; PROTEIN; IFT20	Most eukaryotic cells have a primary cilium which functions as a sensory organelle(1). Cilia are assembled by intraflagellar transport (IFT), a process mediated by multimeric IFT particles and molecular motors(2). Here we show that lymphoid and myeloid cells, which lack primary cilia, express IFT proteins. IFT20, an IFT component essential for ciliary assembly(3,4), was found to colocalize with both the microtubule organizing centre (MTOC) and Golgi and post-Golgi compartments in T-lymphocytes. In antigen-specific conjugates, IFT20 translocated to the immune synapse. IFT20 knockdown resulted in impaired T-cell receptor/CD3 (TCR/CD3) clustering and signalling at the immune synapse, due to defective polarized recycling. Moreover, IFT20 was required for the inducible assembly of a complex with other IFT components (IFT57 and IFT88) and the TCR. The results identify IFT20 as a new regulator of immune synapse assembly in T cells and provide the first evidence to implicate IFT in membrane trafficking in cells lacking primary cilia, thereby introducing a new perspective on IFT function beyond its role in ciliogenesis.	[Finetti, Francesca; Paccani, Silvia Rossi; Riparbelli, Maria Giovanna; Baldari, Cosima T.] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Perinetti, Giuseppe] Univ Trieste, Dept Biomed, I-34138 Trieste, Italy; [Pazour, Gregory J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rosenbaum, Joel L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of Siena; University of Trieste; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Baldari, CT (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Aldo Moro 2, I-53100 Siena, Italy.	baldari@unisi.it	Finetti, Francesca/T-3788-2019; Giacomello, Emiliana/E-3080-2018	Finetti, Francesca/0000-0002-3421-1637; Pazour, Gregory/0000-0002-6285-8796; Giacomello, Emiliana/0000-0003-3329-6269; Perinetti, Giuseppe/0000-0002-7226-5134; Baldari, Cosima/0000-0002-4414-6744	AIRC; National Institutes of Health [GM060992, GM-14,642]; FIRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM014642, R01GM060992] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors want to thank G. Callaini for invaluable help with fluorescence microscopy, S. Grassini for technical assistance, A. Alcover, S. Valitutti, P. Lupetti, A. Luini, A. Colanzi, A. De Matteis and C. Mencarelli for useful discussions and J. L Telford and A. Alcover for critical reading of the manuscript. This work was supported by grants from AIRC (to C. T. B.) and the National Institutes of Health (GM060992 to G. J. P. and GM-14,642 to J. L. R.). F. F. is the recipient of a FIRC fellowship.	Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dustin ML, 2006, CURR OPIN IMMUNOL, V18, P512, DOI 10.1016/j.coi.2006.05.017; Esquerre M, 2008, P NATL ACAD SCI USA, V105, P2550, DOI 10.1073/pnas.0708350105; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; OHAVER TC, 1979, CLIN CHEM, V25, P1548; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; Patrussi L, 2005, ONCOGENE, V24, P2218, DOI 10.1038/sj.onc.1208384; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Perinetti G, 2009, TRAFFIC, V10, P379, DOI [10.1111/j.1600-0854.2009.00875.x, 10.1111/j.1600-0854.2008.00875.x]; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Wulfing C, 2002, IMMUNOL REV, V189, P64, DOI 10.1034/j.1600-065X.2002.18907.x	28	238	240	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2009	11	11					1332	U163		10.1038/ncb1977	http://dx.doi.org/10.1038/ncb1977			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514WC	19855387	Green Accepted			2022-12-27	WOS:000271425800013
J	Carroll, CW; Silva, MCC; Godek, KM; Jansen, LET; Straight, AF				Carroll, Christopher W.; Silva, Mariana C. C.; Godek, Kristina M.; Jansen, Lars E. T.; Straight, Aaron F.			Centromere assembly requires the direct recognition of CENP-A nucleosomes by CENP-N	NATURE CELL BIOLOGY			English	Article							HUMAN-CELLS; KINETOCHORE; CHROMATIN; COMPLEX; DOMAIN; DNA; PATHWAYS	Centromeres are specialized chromosomal domains that direct kinetochore assembly during mitosis. CENP-A (centromere protein A), a histone H3-variant present exclusively in centromeric nucleosomes, is thought to function as an epigenetic mark that specifies centromere identity. Here we identify the essential centromere protein CENP-N as the first protein to selectively bind CENP-A nucleosomes but not H3 nucleosomes. CENP-N bound CENP-A nucleosomes in a DNA sequence-independent manner, but did not bind soluble CENP-A-H4 tetramers. Mutations in CENP-N that reduced its affinity for CENP-A nucleosomes caused defects in CENP-N localization and had dominant effects on the recruitment of CENP-H, CENP-I and CENP-K to centromeres. Depletion of CENP-N using siRNA (short interfering RNA) led to similar centromere assembly defects and resulted in reduced assembly of nascent CENP-A into centromeric chromatin. These data suggest that CENP-N interprets the information encoded within CENP-A nucleosomes and recruits other proteins to centromeric chromatin that are required for centromere function and propagation.	[Carroll, Christopher W.; Godek, Kristina M.; Straight, Aaron F.] Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Palo Alto, CA 94503 USA; [Silva, Mariana C. C.; Jansen, Lars E. T.] Inst Gulbenkian Ciencias, Lab Epigenet Mech, P-2780156 Oeiras, Portugal	Stanford University; Instituto Gulbenkian de Ciencia	Straight, AF (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Room 409,279 Campus Dr, Palo Alto, CA 94503 USA.	astraigh@stanford.edu		Godek, Kristina/0000-0002-2512-9295; Straight, Aaron/0000-0001-5885-7881; Coelho Correia da Silva, Mariana/0000-0003-0532-4998; Jansen, Lars/0000-0002-2158-0345	Helen Hay Whitney Foundation; National Science Foundation; NIH [T32GM007276, R01GM074728]; Damon Runyon Cancer Research Foundation; Funda ao para a Cincia e a Tecnologia [SFRH/ BD33219/2007]; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM074728] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Funda ao para a Cincia e a Tecnologia; EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank members of the Straight Lab for helpful comments and support, J. Minshull and DNA2.0 (CA, USA) for gene synthesis, S. H. Hanissian for the CENP-U(50) cDNA, J. Yang, G. Narlikar, M. Resch, K. Luger and J. Hansen for reagents and help with nucleosome reconstitution, S.- T. Liu for the CENP-H and CENP-I antibodies and D. Herschlag for advice. C. W. C. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation. K. G. was supported by a predoctoral fellowship from the National Science Foundation and by a NIH grant (T32GM007276). A. F. S. is a Gordon Family Scholar supported by the Damon Runyon Cancer Research Foundation, and this work was supported by a NIH grant (R01GM074728). M. C. C. S. is supported by the Funda ao para a Cincia e a Tecnologia (FCT; SFRH/ BD33219/2007). LETJ is supported by the FCT, Funda ao Calouste Gulbenkian and the EU Seventh Framework Programme.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; CHEESEMAN IM, 2007, MOL BIOL CELL; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Yang CH, 1996, MOL CELL BIOL, V16, P3576	24	207	213	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2009	11	7					896	U297		10.1038/ncb1899	http://dx.doi.org/10.1038/ncb1899			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	465QY	19543270	Green Accepted			2022-12-27	WOS:000267603100020
J	Garinis, GA; Uittenboogaard, LM; Stachelscheid, H; Fousteri, M; van Ijcken, W; Breit, TM; van Steeg, H; Mullenders, LHF; van der Horst, GTJ; Bruning, JC; Niessen, CM; Hoeijmakers, JHJ; Schumacher, B				Garinis, George A.; Uittenboogaard, Lieneke M.; Stachelscheid, Heike; Fousteri, Maria; van Ijcken, Wilfred; Breit, Timo M.; van Steeg, Harry; Mullenders, Leon H. F.; van der Horst, Gijsbertus T. J.; Bruening, Jens C.; Niessen, Carien M.; Hoeijmakers, Jan H. J.; Schumacher, Bjoern			Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity	NATURE CELL BIOLOGY			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; OXIDATIVE STRESS; GENE-EXPRESSION; LIFE-SPAN; DAMAGE; HORMONE; MICE	The accumulation of stochastic DNA damage throughout an organism's lifespan is thought to contribute to ageing. Conversely, ageing seems to be phenotypically reproducible and regulated through genetic pathways such as the insulin-like growth factor-1 (IGF-1) and growth hormone (GH) receptors, which are central mediators of the somatic growth axis. Here we report that persistent DNA damage in primary cells from mice elicits changes in global gene expression similar to those occurring in various organs of naturally aged animals. We show that, as in ageing animals, the expression of IGF-1 receptor and GH receptor is attenuated, resulting in cellular resistance to IGF-1. This cell-autonomous attenuation is specifically induced by persistent lesions leading to stalling of RNA polymerase II in proliferating, quiescent and terminally differentiated cells; it is exacerbated and prolonged in cells from progeroid mice and confers resistance to oxidative stress. Our findings suggest that the accumulation of DNA damage in transcribed genes in most if not all tissues contributes to the ageing-associated shift from growth to somatic maintenance that triggers stress resistance and is thought to promote longevity.	[Garinis, George A.; Uittenboogaard, Lieneke M.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.; Schumacher, Bjoern] Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; [Garinis, George A.] FORTH, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Greece; [Stachelscheid, Heike; Niessen, Carien M.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Stachelscheid, Heike; Bruening, Jens C.] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Fousteri, Maria; Mullenders, Leon H. F.] LUMC, Dept Toxicogenet, NL-2300 RC Leiden, Netherlands; [van Ijcken, Wilfred] Erasmus MC, Erasmus Ctr Biom, NL-3000 DR Rotterdam, Netherlands; [Breit, Timo M.] Univ Amsterdam, Fac Sci, Inst Informat, Integrat Bioinformat Unit, NL-1098 SM Amsterdam, Netherlands; [van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, Lab Toxicol Pathol & Genet TOX, NL-3720 BA Bilthoven, Netherlands; [Bruening, Jens C.; Niessen, Carien M.; Schumacher, Bjoern] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Niessen, Carien M.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany	Erasmus University Rotterdam; Erasmus MC; Foundation for Research & Technology - Hellas (FORTH); University of Cologne; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Cologne; University of Cologne	Schumacher, B (corresponding author), Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	bjoern.schumacher@uni-koeln.de	van der Horst, Gijsbertus TJ/E-3661-2015; van ijcken, willem/N-9805-2018; Schumacher, Björn/I-4829-2013; Garinis, George A./B-2943-2012; Fousteri, Maria/M-2312-2017; Hoeijmakers, Jan/AAX-6972-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; van ijcken, willem/0000-0002-0421-8301; Schumacher, Björn/0000-0001-6097-5238; Garinis, George A./0000-0002-3200-5004; Fousteri, Maria/0000-0003-1729-5899; Niessen, Carien M./0000-0002-4892-9391	Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative [NGI/NWO 05040202]; SenterNovem IOP-Genomics [IGE03009]; NIH [1PO1 AG17242]; National Institute of Environmental Health Sciences [1UO1 ES011044]; EC [QRTL-1999-02002]; Dutch Cancer Society [EUR 99-2004]; Cancer Genomics Centre; EMBO long-term, Marie Curie Intra-European; NWO; Deutsche Forschungsgemeinschaft [SFB829]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; SenterNovem IOP-Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EC(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); Cancer Genomics Centre; EMBO long-term, Marie Curie Intra-European(European Molecular Biology Organization (EMBO)); NWO(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Christel Kockx, Zeliha Ozgur and Anja Raams for technical assistance, Casper Hoogenraad for neuron cultures, and Anton Gartner and Francis Barr for comments on the manuscript. This research was supported by the Netherlands Organization for Scientific Research (NWO) and the Netherlands Genomics Initiative (NGI; NGI/NWO 05040202), SenterNovem IOP-Genomics (IGE03009), the NIH (1PO1 AG17242), the National Institute of Environmental Health Sciences (NIEHS; 1UO1 ES011044), the EC (QRTL-1999-02002) and the Dutch Cancer Society (EUR 99-2004). G. G. acknowledges support from the Cancer Genomics Centre and B. S. from EMBO long-term, Marie Curie Intra-European fellowships, Veni grant of the NWO and the Deutsche Forschungsgemeinschaft (CECAD and SFB829).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bonkowski MS, 2006, J GERONTOL A-BIOL, V61, P562, DOI 10.1093/gerona/61.6.562; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104; DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dibiase SJ, 2000, CANCER RES, V60, P1245; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Essers J, 2005, MOL BIOL CELL, V16, P769, DOI 10.1091/mbc.e04-10-0876; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gems D, 2000, BIOGERONTOLOGY, V1, P289, DOI 10.1023/A:1026546719091; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jaspers NGJ, 2002, DNA REPAIR, V1, P1027, DOI 10.1016/S1568-7864(02)00166-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; Kirkwood TBL, 1981, REPAIR ITS EVOLUTION, P165; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li MH, 2003, MECH AGEING DEV, V124, P771, DOI 10.1016/S0047-6374(03)00124-6; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paci A, 2006, DRUG METAB DISPOS, V34, P1918, DOI 10.1124/dmd.106.010512; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piwien-Pilipuk G, 2002, J PEDIATR ENDOCR MET, V15, P771; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200	71	104	107	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					604	U370		10.1038/ncb1866	http://dx.doi.org/10.1038/ncb1866			215	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363488	Green Accepted			2022-12-27	WOS:000265640000019
J	Huang, C; Rajfur, Z; Yousefi, N; Chen, ZZ; Jacobson, K; Ginsberg, MH				Huang, Cai; Rajfur, Zenon; Yousefi, Nima; Chen, Zaozao; Jacobson, Ken; Ginsberg, Mark H.			Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; INTEGRIN ACTIVATION; NEURONAL MIGRATION; STRUCTURAL BASIS; ADHESION; DOMAIN; MOTILITY; BINDING; CONTRACTILITY; DEGRADATION	Cell migration is a dynamic process that requires temporal and spatial regulation of integrin activation and focal adhesion assembly/disassembly(1). Talin, an actin and beta-integrin tail-binding protein, is essential for integrin activation and focal adhesion formation(2,3). Calpain-mediated cleavage of talin has a key role in focal adhesion turnover(3); however, the talin head domain, one of the two cleavage products, stimulates integrin activation, localizes to focal adhesions and maintains cell edge protrusions(2,4,5), suggesting that other steps, downstream of talin proteolysis, are required for focal adhesion disassembly. Here we show that talin head binds Smurf1, an E3 ubiquitin ligase involved in cell polarity and migration(6,7), more tightly than full-length talin does and that this interaction leads to talin head ubiquitylation and degradation. We found that talin head is a substrate for Cdk5, a cyclin-dependent protein kinase that is essential for cell migration, synaptic transmission and cancer metastasis(8-11). Cdk5 phosphorylated talin head at Ser 425, inhibiting its binding to Smurf1, thus preventing talin head ubiquitylation and degradation. Expression of the mutant tal(S425A), which resists Cdk5 phosphorylation thereby increasing its susceptibility to Smurf1-mediated ubiqitylation, resulted in extensive focal adhesion turnover and inhibited cell migration. Thus, talin head produced by calpain-induced cleavage of talin is degraded through Smurf1-mediated ubiquitylation; moreover, phosphorylation by Cdk5 regulates the binding of Smurf1 to talin head, controlling talin head turnover, adhesion stability and ultimately, cell migration.	[Huang, Cai; Rajfur, Zenon; Chen, Zaozao; Jacobson, Ken] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Jacobson, Ken] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Huang, Cai; Yousefi, Nima; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	frap@med.unc.edu; mhginsberg@ucsd.edu	Chen, Zaozao/AAS-6111-2021; Rajfur, Zenon/H-2506-2013; , UNC Flow Cytometry Core/AGU-9839-2022	Rajfur, Zenon/0000-0003-1265-6480	National Institutes of Health; Cell Migration Consortium; NIH [GM64346]; Ruth L. Kirschstein National Research Service [1F32 HL08321]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083215, P01HL031950, F32HL008321, P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Migration Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Burridge for critical reading of this manuscript, M. Schaller for critical reading of this manuscript and supporting of phosphorylation assays, A. Huttenlocher for the pEGFP-talin plasmid, L.-H. Tsai for the Cdk5 and p35 plasmids, D. Cyr for the HA-ubiquitin plasmid, E1 and Ubc5 alpha, and M. Kerber for assistance with TIRF imaging. Supported by National Institutes of Health grants to M. H. G., a Cell Migration Consortium grant (NIH GM64346) to M. H. G. and K. J. and a Ruth L. Kirschstein National Research Service Award (1F32 HL08321) to C. H.	Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen F, 2001, BLOOD, V97, P3763, DOI 10.1182/blood.V97.12.3763; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Lazaro JB, 1997, J CELL SCI, V110, P1251; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Negash S, 2002, J CELL SCI, V115, P2109; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tsai LH, 2001, FASEB J, V15, pA2; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	35	159	159	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					624	U404		10.1038/ncb1868	http://dx.doi.org/10.1038/ncb1868			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19363486	Green Submitted, Green Accepted			2022-12-27	WOS:000265640000021
J	[Anonymous]				[Anonymous]			Focus on host subversion	NATURE CELL BIOLOGY			English	Editorial Material								A collection of seven reviews surveys how microorganisms subvert host cell biology.											0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2009	11	5					509	509		10.1038/ncb0509-509b	http://dx.doi.org/10.1038/ncb0509-509b			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	439PR	19404328	Bronze			2022-12-27	WOS:000265640000002
J	Siller, KH; Doe, CQ				Siller, Karsten H.; Doe, Chris Q.			Spindle orientation during asymmetric cell division	NATURE CELL BIOLOGY			English	Review							MITOTIC SPINDLE; CAENORHABDITIS-ELEGANS; G-ALPHA; CYTOPLASMIC DYNEIN; SELF-RENEWAL; CORTICAL POLARITY; G-PROTEINS; SACCHAROMYCES-CEREVISIAE; MICROTUBULE INTERACTIONS; DROSOPHILA NEUROBLAST	Development of a multicellular organism from a fertilized egg depends on a precise balance between symmetric cell divisions to expand the pool of similar cells, and asymmetric cell divisions to create cell-type diversity. Spindle orientation can influence the generation of symmetric or asymmetric cell fates depending on how it is coupled to cell-intrinsic polarity cues, or how it is positioned relative to cell-extrinsic cues such as niche-derived signals. In this review, we describe the mechanism of spindle orientation in budding yeast, Drosophila melanogaster, Caenorhabditis elegans and mammalian neural progenitors, with the goal of highlighting conserved mechanisms and indicating open questions for the future.	[Siller, Karsten H.; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Inst Neurosci, Howard Hughes Med Inst 1254, Eugene, OR 97403 USA	University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Inst Mol Biol, Inst Neurosci, Howard Hughes Med Inst 1254, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu						Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENG NN, 1995, GENETICS, V139, P549; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cockell MM, 2004, J CELL SCI, V117, P4571, DOI 10.1242/jcs.01344; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Heil-Chapdelaine RA, 2000, MOL BIOL CELL, V11, P863, DOI 10.1091/mbc.11.3.863; Huisman SM, 2004, J CELL BIOL, V167, P231, DOI 10.1083/jcb.200407167; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; IZUMI Y, 2006, NATURE CELL BIOL; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Maekawa H, 2004, GENE DEV, V18, P1709, DOI 10.1101/gad.298704; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Miller KG, 2000, GENETICS, V156, P1649; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Park DH, 2008, DEV BIOL, V315, P42, DOI 10.1016/j.ydbio.2007.11.037; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Pruyne D, 2000, J CELL SCI, V113, P365; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Reinsch S, 1998, J CELL SCI, V111, P2283; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Roszko I, 2006, DEV BIOL, V298, P212, DOI 10.1016/j.ydbio.2006.06.031; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Segal M, 2000, MOL BIOL CELL, V11, P3689, DOI 10.1091/mbc.11.11.3689; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; SILLER KH, 2006, NATURE CELL BIOL; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	109	368	388	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2009	11	4					365	374		10.1038/ncb0409-365	http://dx.doi.org/10.1038/ncb0409-365			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	434HD	19337318				2022-12-27	WOS:000265264900004
J	Hayashi, MT; Takahashi, TS; Nakagawa, T; Nakayama, J; Masukata, H				Hayashi, Makoto T.; Takahashi, Tatsuro S.; Nakagawa, Takuro; Nakayama, Jun-ichi; Masukata, Hisao			The heterochromatin protein Swi6/HP1 activates replication origins at the pericentromeric region and silent mating-type locus	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; CHROMODOMAIN PROTEIN; EPIGENETIC CONTROL; DNA-REPLICATION; ESTABLISHMENT; CENTROMERES; POLYMERASE; GENOME; RNAI	Heterochromatin is a structurally compacted region of chromosomes in which transcription and recombination are inactivated(1,2). DNA replication is temporally regulated in heterochromatin, but the molecular mechanism for regulation has not been elucidated. Among heterochromatin loci in Schizosaccharomyces pombe, the pericentromeric region and the silent mating-type (mat) locus replicate in early S phase, whereas the sub-telomeric region does not(3-5), suggesting complex mechanisms for regulation of replication in heterochromatic regions. Here, we show that Swi6, an S. pombe counterpart of heterochromatin protein 1 (HP1), is required for early replication of the pericentromeric region and the mat locus. Origin-loading of Sld3, which depends on Dfp1/Dbf4-dependent kinase Cdc7 (DDK), is stimulated by Swi6. An HP1-binding motif within Dfp1 is required for interaction with Swi6 in vitro and for early replication of the pericentromeric region and mat locus. Tethering of Dfp1 to the pericentromeric region and mat locus in swi6-deficient cells restores early replication of these loci. Our results show that a heterochromatic protein positively regulates initiation of replication in silenced chromatin by interacting with an essential kinase.	[Hayashi, Makoto T.; Takahashi, Tatsuro S.; Nakagawa, Takuro; Masukata, Hisao] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Kobe, Hyogo 6500047, Japan	Osaka University; RIKEN	Masukata, H (corresponding author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	masukata@bio.sci.osaka-u.ac.jp	Nakagawa, Takuro/A-1367-2017; Hayashi, Makoto/K-7155-2019; Takahashi, Tatsuro/AAD-9936-2020; Takahashi, Tatsuro/F-4669-2016; Nakayama, Jun-ichi/C-6003-2011	Nakagawa, Takuro/0000-0003-3455-8224; Hayashi, Makoto/0000-0001-6360-7131; Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Nakayama, Jun-ichi/0000-0002-5597-8239	JSPS Fellows; Ministry of Education, Science, Technology, Sports and Culture, Japan	JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Hiroyuki Araki for critical reading and Yoshinori Watanabe for providing CFP- chromodomain constructs. M. T. H. is a Research Fellow of the Japan Society for the Promotion of Science. This study was supported by a Grant- in- Aid for JSPS Fellows to M. T. H., and in part by a Grant- in- Aid to H. M. and to J. N. from the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; KLAR AJS, 1991, GENETICS, V129, P1033; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; OLSSON T, 1993, NUCLEIC ACIDS RES, V21, P855; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamada Y, 2004, MOL BIOL CELL, V15, P3740, DOI 10.1091/mbc.E04-04-0292	24	115	116	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2009	11	3					357	U284		10.1038/ncb1845	http://dx.doi.org/10.1038/ncb1845			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413FI	19182789				2022-12-27	WOS:000263777900021
J	Ziel, JW; Hagedorn, EJ; Audhya, A; Sherwood, DR				Ziel, Joshua W.; Hagedorn, Elliott J.; Audhya, Anjon; Sherwood, David R.			UNC-6 (netrin) orients the invasive membrane of the anchor cell in C-elegans	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; AXON GUIDANCE; EXPRESSION; ANGIOGENESIS; MATRIX; CANCER; PROTOONCOGENE; MORPHOGENESIS; ATTRACTION; MIGRATIONS	Despite their profound importance in the development of cancer, the extracellular cues that target cell invasion through basement membrane barriers remain poorly understood(1). A central obstacle has been the difficulty of studying the interactions between invading cells and basement membranes in vivo(2,3). Using the genetically and visually tractable model of Caenorhabditis elegans anchor cell (AC) invasion, we show that UNC-6 (netrin) signalling, a pathway not previously implicated in controlling cell invasion in vivo, is a key regulator of this process. site of action studies reveal that before invasion, localized UNC-6 secretion directs its receptor, UNC-40, to the plasma membrane of the AC, in contact with the basement membrane. there, UNC-40 polarizes a specialized invasive membrane domain through the enrichment of actin regulators, F-actin and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). Cell ablation experiments indicate that UNC-6 promotes the formation of invasive protrusions from the AC that break down the basement membrane in response to a subsequent vulval cue. together, these results characterize an invasive membrane domain in vivo, and reveal a role for UNC-6 (netrin) in polarizing this domain towards its basement membrane target.	[Ziel, Joshua W.; Hagedorn, Elliott J.; Sherwood, David R.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Audhya, Anjon] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Sherwood, David R.] Duke Univ, Mol Canc Biol Program, Durham, NC 27708 USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University	Sherwood, DR (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	david.sherwood@duke.edu	Sherwood, David/ABG-4265-2020	Sherwood, David/0000-0002-4448-6917	Basil O'Connor Award; Pew Scholars Award; NIH [GM079320]; NATIONAL CANCER INSTITUTE [K01CA098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079320] Funding Source: NIH RePORTER	Basil O'Connor Award(March of Dimes); Pew Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Bargmann for the GFP::unc-34 and unc-40::GFP vectors, the hs>unc-6::HA integrated strain, and advice; W. Wadsworth for the Lam-1::GFP vector; E. Lundquist for the GFP::ced-10 vector; Y. Goshima for Venus:: unc-6 strains; D. Kiehart for the moeADB::GFP vector; the Caenorhabditis Genetics Center for providing strains; and N. Sherwood, Z. Wang, G. Lopez, G. Miley and D. Matus for comments on the manuscript. This work was supported by a Basil O'Connor Award, Pew Scholars Award, and NIH Grant GM079320 to D.R.S.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hwang BJ, 2007, DEVELOPMENT, V134, P669, DOI 10.1242/dev.02769; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kao G, 2006, DEV BIOL, V290, P211, DOI 10.1016/j.ydbio.2005.11.026; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rimann I, 2007, DEV BIOL, V308, P187, DOI 10.1016/j.ydbio.2007.05.023; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Sherwood DR, 2005, CELL, V121, P951, DOI 10.1016/j.cell.2005.03.031; Sherwood DR, 2003, DEV CELL, V5, P21, DOI 10.1016/S1534-5807(03)00168-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704	29	98	195	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2009	11	2					183	U161		10.1038/ncb1825	http://dx.doi.org/10.1038/ncb1825			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	406HL	19098902	Green Accepted			2022-12-27	WOS:000263285500016
J	Choi, CK; Vicente-Manzanares, M; Zareno, J; Whitmore, LA; Mogilner, A; Horwitz, AR				Choi, Colin K.; Vicente-Manzanares, Miguel; Zareno, Jessica; Whitmore, Leanna A.; Mogilner, Alex; Horwitz, Alan Rick			Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESIONS; MIGRATING CELLS; ARP2/3 COMPLEX; STRESS FIBERS; REGULATES ADHESION; MATRIX ADHESIONS; F-ACTIN; PROTRUSION; PAXILLIN; DYNAMICS	Using two-colour imaging and high resolution TIRF microscopy, we investigated the assembly and maturation of nascent adhesions in migrating cells. We show that nascent adhesions assemble and are stable within the lamellipodium. The assembly is independent of myosin II but its rate is proportional to the protrusion rate and requires actin polymerization. At the lamellipodium back, the nascent adhesions either disassemble or mature through growth and elongation. Maturation occurs along an alpha-actinin-actin template that elongates centripetally from nascent adhesions. alpha-Actinin mediates the formation of the template and organization of adhesions associated with actin filaments, suggesting that actin crosslinking has a major role in this process. Adhesion maturation also requires myosin II. Rescue of a myosin IIA knockdown with an actin-bound but motor-inhibited mutant of myosin IIA shows that the actin crosslinking function of myosin II mediates initial adhesion maturation. From these studies, we have developed a model for adhesion assembly that clarifies the relative contributions of myosin II and actin polymerization and organization.	[Choi, Colin K.; Vicente-Manzanares, Miguel; Zareno, Jessica; Whitmore, Leanna A.; Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Choi, Colin K.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95618 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95618 USA	University of Virginia; University of Virginia; University of California System; University of California Davis; University of California System; University of California Davis	Vicente-Manzanares, M (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA.	mvicente@virginia.edu	Vicente-Manzanares, Miguel/H-1010-2018; Bustelo, Xose R./A-9526-2010; Mogilner, Alex/A-3135-2008	Vicente-Manzanares, Miguel/0000-0001-5943-3220; Bustelo, Xose R./0000-0001-9398-6072; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023244, R37GM023244, U54GM064346] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM023244-33, R37 GM023244, GM23244, U54 GM064346-08, U54 GM064346, R01 GM023244] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Eto M, 2007, J BIOL CHEM, V282, P17806, DOI 10.1074/jbc.M700944200; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2004, MOL BIOL CELL, V15, P2568, DOI 10.1091/mbc.E03-11-0836; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; VASILIEV JM, 1984, BIOCHIM BIOPHYS ACTA, V780, P21, DOI 10.1016/0304-419X(84)90006-4; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Xu XXS, 2001, DEV BIOL, V232, P255, DOI 10.1006/dbio.2000.0132; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	49	543	546	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2008	10	9					1039	U36		10.1038/ncb1763	http://dx.doi.org/10.1038/ncb1763			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	344EW	19160484	Green Accepted			2022-12-27	WOS:000258910400009
J	Meixner, A; Zenz, R; Schonthaler, HB; Kenner, L; Scheuch, H; Penninger, JM; Wagner, EF				Meixner, Arabella; Zenz, Rainer; Schonthaler, Helia B.; Kenner, Lukas; Scheuch, Harald; Penninger, Josef M.; Wagner, Erwin F.			Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation	NATURE CELL BIOLOGY			English	Article							COLONY-STIMULATING FACTOR; MICE LACKING JUNB; SKIN-DISEASE; C-JUN; EXPRESSION; GRANULOCYTE; PHASE; DIFFERENTIATION; PROLIFERATION; KERATINOCYTES	Mice that lack JunB in epidermal cells are born with normal skin; however, keratinocytes hyperproliferate in vitro and on TPA treatment in vivo. Loss of JunB expression in the epidermis of adult mice affects the skin, the proliferation of haematopoietic cells and bone formation. G-CSF is a direct transcriptional target of JunB and mutant epidermis releases large amounts of G-CSF that reach high systemic levels and cause skin ulcerations, myeloproliferative disease and low bone mass. The absence of G-CSF significantly improves hyperkeratosis and prevents the development of myeloproliferative disease, but does not affect bone loss. This study describes a mechanism by which the absence of JunB in epithelial cells causes multi-organ disease, suggesting that the epidermis can act as an endocrine-like organ.	[Meixner, Arabella; Zenz, Rainer; Schonthaler, Helia B.; Kenner, Lukas; Scheuch, Harald; Wagner, Erwin F.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Meixner, Arabella; Penninger, Josef M.] Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Zenz, Rainer; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res LBI CR, A-1090 Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, A-1090 Vienna, Austria; [Schonthaler, Helia B.; Wagner, Erwin F.] CNIO, Canc Cell Biol Programme, E-28029 Madrid, Spain	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ludwig Boltzmann Institute; Medical University of Vienna; Centro Nacional de Investigaciones Oncologicas (CNIO)	Wagner, EF (corresponding author), Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	ewagner@cnio.es	Schönthaler, Helia/AAG-4767-2021; Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Wagner, Erwin F/0000-0001-7872-0196; Kenner, Lukas/0000-0003-2184-1338				Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Borregaard N, 2005, J LEUKOCYTE BIOL, V77, P439, DOI 10.1189/jlb.0704381; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Hess J, 2003, J CELL SCI, V116, P4587, DOI 10.1242/jcs.00772; Kawada A, 1997, ARCH DERMATOL RES, V289, P600, DOI 10.1007/s004030050246; Kawakami T, 2004, ARCH DERMATOL, V140, P570, DOI 10.1001/archderm.140.5.570; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kokai Y, 2002, BONE, V30, P880, DOI 10.1016/S8756-3282(02)00733-0; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LEE MY, 1991, BLOOD, V77, P2135; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Licht AH, 2006, J CELL BIOL, V175, P981, DOI 10.1083/jcb.200605149; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu DL, 2004, LEUKEMIA RES, V28, pS61, DOI 10.1016/S0145-2126(03)00247-1; Mueller MM, 1999, INT J CANCER, V83, P780, DOI 10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.3.CO;2-3; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	33	42	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					1003	1011		10.1038/ncb1761	http://dx.doi.org/10.1038/ncb1761			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18641637				2022-12-27	WOS:000258147100019
J	Rybak, A; Fuchs, H; Smirnova, L; Brandt, C; Pohl, EE; Nitsch, R; Wulczyn, FG				Rybak, Agnieszka; Fuchs, Heiko; Smirnova, Lena; Brandt, Christine; Pohl, Elena E.; Nitsch, Robert; Wulczyn, F. Gregory			A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment	NATURE CELL BIOLOGY			English	Article							POSTTRANSCRIPTIONAL REGULATION; HETEROCHRONIC GENE; NEURONAL DIFFERENTIATION; SMALL RNAS; MICRORNA; PROLIFERATION; EXPRESSION; REVEALS; NICHE	miRNA populations, including mammalian homologues of lin-4 (mir-125) and let-7, undergo a marked transition during stem-cell differentiation(1). Originally identified on the basis of their mutational phenotypes in stem-cell maturation, mir-125 and let-7 are strongly induced during neural differentiation of embryonic stem (ES) cells and embryocarcinoma (EC) cells. We report that embryonic neural stem (NS) cells express let-7 and mir-125, and investigate post-transcriptional mechanisms contributing to the induction of let-7. We demonstrate that the pluripotency factor Lin-28 binds the pre-let-7 RNA and inhibits processing by the Dicer ribonuclease in ES and EC cells. In NS cells, Lin-28 is downregulated by mir-125 and let-7, allowing processing of pre-let-7 to proceed. Suppression of let-7 or mir-125 activity in NS cells led to upregulation of Lin-28 and loss of pre-let-7 processing activity, suggesting that let-7, mir-125 and lin-28 participate in an autoregulatory circuit that controls miRNA processing during NS-cell commitment.	[Rybak, Agnieszka; Fuchs, Heiko; Smirnova, Lena; Brandt, Christine; Pohl, Elena E.; Nitsch, Robert; Wulczyn, F. Gregory] Charite, Ctr Anat, Inst Cell & Neurobiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wulczyn, FG (corresponding author), Charite, Ctr Anat, Inst Cell & Neurobiol, D-13353 Berlin, Germany.	gregory.wulczyn@charite.de	Pohl, Elena E./A-4025-2009; Nitsch, Robert/AAI-9129-2021	Pohl, Elena E./0000-0002-0604-5950; Fuchs, Heiko/0000-0001-9142-4084; Rybak-Wolf, Agnieszka/0000-0002-1192-5290				Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; CHENDRIMADA TP, 2005, NATURE; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanamoto T, 2006, DEV DYNAM, V235, P1142, DOI 10.1002/dvdy.20712; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	33	630	667	3	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2008	10	8					987	993		10.1038/ncb1759	http://dx.doi.org/10.1038/ncb1759			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	333IV	18604195				2022-12-27	WOS:000258147100017
J	Saharinen, P; Eklund, L; Miettinen, J; Wirkkala, R; Anisimov, A; Winderlich, M; Nottebaum, A; Vestweber, D; Deutsch, U; Koh, GY; Olsen, BR; Alitalo, K				Saharinen, Pipsa; Eklund, Lauri; Miettinen, Juho; Wirkkala, Riikka; Anisimov, Andrey; Winderlich, Mark; Nottebaum, Astrid; Vestweber, Dietmar; Deutsch, Urban; Koh, Gou Young; Olsen, Bjorn R.; Alitalo, Kari			Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; GROWTH-FACTORS; VE-CADHERIN; IN-VITRO; ANGIOGENESIS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; MIGRATION	The receptor tyrosine kinase Tie2, and its activating ligand Angiopoietin-1 (Ang1), are required for vascular remodelling and vessel integrity, whereas Ang2 may counteract these functions. However, it is not known how Tie2 transduces these different signals. Here, we show that Ang1 induces unique Tie2 complexes in mobile and confluent endothelial cells. Matrix-bound Ang1 induced cell adhesion, motility and Tie2 activation in cell-matrix contacts that became translocated to the trailing edge in migrating endothelial cells. In contrast, in contacting cells Ang1 induced Tie2 translocation to cell-cell contacts and the formation of homotypic Tie2-Tie2 trans-associated complexes that included the vascular endothelial phosphotyrosine phosphatase, leading to inhibition of paracellular permeability. Distinct signalling proteins were preferentially activated by Tie2 in the cell-matrix and cell -cell contacts, where Ang2 inhibited Ang1-induced Tie2 activation. This novel type of cellular microenvironment-dependent receptor tyrosine kinase activation may explain some of the effects of angiopoietins in angiogenesis and vessel stabilization.	[Saharinen, Pipsa; Miettinen, Juho; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FIN-00014 Helsinki, Finland; [Saharinen, Pipsa; Miettinen, Juho; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; [Eklund, Lauri; Wirkkala, Riikka] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu 90014, Finland; [Eklund, Lauri; Wirkkala, Riikka] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu 90014, Finland; [Winderlich, Mark; Nottebaum, Astrid; Vestweber, Dietmar] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Deutsch, Urban] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Eklund, Lauri; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Oulu; University of Oulu; Max Planck Society; University of Bern; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard School of Dental Medicine	Alitalo, K (corresponding author), Univ Helsinki, Lab Mol Canc Biol, Haartmaninkatu 8,POB 63, FIN-00014 Helsinki, Finland.	Kari.Alitalo@Helsinki.fi	Alitalo, Kari K/J-5013-2014; Miettinen, Juho/J-7356-2016; Koh, Gou Young/C-1615-2011; Saharinen, Pipsa I/C-9601-2016	Alitalo, Kari K/0000-0002-7331-0902; Miettinen, Juho/0000-0002-3987-1693; Saharinen, Pipsa I/0000-0003-2652-0584; Nottebaum, Astrid Fee/0000-0003-2246-7851; Vestweber, Dietmar/0000-0002-3517-732X; Deutsch, Urban/0000-0003-4265-6262	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036820, R01AR036820] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL075183-02] Funding Source: Medline; NIAMS NIH HHS [P01 AR048564, R01 AR036820, AR36820, AR48564] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jones N, 2003, MOL CELL BIOL, V23, P2658, DOI 10.1128/MCB.23.8.2658-2668.2003; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Pfaff D, 2006, J LEUKOCYTE BIOL, V80, P719, DOI 10.1189/jlb.1105652; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Salven P, 1996, BRIT J CANCER, V74, P69, DOI 10.1038/bjc.1996.317; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	42	323	336	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2008	10	5					527	537		10.1038/ncb1715	http://dx.doi.org/10.1038/ncb1715			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	295VQ	18425119				2022-12-27	WOS:000255502400009
J	Jiang, JM; Chan, YS; Loh, YH; Cai, J; Tong, GQ; Lim, CA; Robson, P; Zhong, S; Ng, HH				Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Cai, Jun; Tong, Guo-Qing; Lim, Ching-Aeng; Robson, Paul; Zhong, Sheng; Ng, Huck-Hui			A core Klf circuitry regulates self-renewal of embryonic stem cells	NATURE CELL BIOLOGY			English	Article							FINGER TRANSCRIPTION FACTOR; KRUPPEL-LIKE FACTOR; MOUSE EPIBLAST; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; EXPRESSION; NANOG; SOX2; FIBROBLASTS	Embryonic stem (ES) cells are unique in their ability to self-renew indefinitely and maintain pluripotency. These properties require transcription factors that specify the gene expression programme of ES cells. It has been possible to reverse the highly differentiated state of somatic cells back to a pluripotent state with a combination of four transcription factors: Klf4 is one of the reprogramming factors required, in conjunction with Oct4, Sox2 and c-Myc. Maintenance of self-renewal and pluripotency of ES cells requires Oct4, Sox2 and c-Myc, but Klf4 is dispensable. Here, we show that Kruppel- like factors are required for the self-renewal of ES cells. Simultaneous depletion of Klf2, Klf4 and Klf5 lead to ES cell differentiation. Chromatin immunoprecipitation coupled to microarray assay reveals that these Klf proteins share many common targets of Nanog, suggesting a close functional relationship between these factors. Expression analysis after triple RNA interference (RNAi) of the Klfs shows that they regulate key pluripotency genes, such as Nanog. Taken together, our study provides new insight into how the core Klf circuitry integrates into the Nanog transcriptional network to specify gene expression that is unique to ES cells.	[Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Lim, Ching-Aeng; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Jiang, Jianming; Chan, Yun-Shen; Loh, Yuin-Han; Lim, Ching-Aeng; Robson, Paul; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Cai, Jun; Zhong, Sheng] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Tong, Guo-Qing] Nanjing Med Univ, Dept Obstet & Gynecol, Nanjing Maternal & Child Hlth Care Hosp, Nanjing 210004, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing Medical University	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Loh, Yuin-Han/E-1096-2014; Chan, Yun-Shen/GWC-4616-2022; Ng, Huck Hui/A-1135-2009; Robson, Paul/A-3464-2009; jiang, jianming/B-3421-2012	Loh, Yuin-Han/0000-0002-4715-6454; Robson, Paul/0000-0002-0191-3958; jiang, jianming/0000-0003-3251-2716				Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2007, NAT CELL BIOL, V9, P871, DOI 10.1038/ncb0807-871; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	31	572	597	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					353	U103		10.1038/ncb1698	http://dx.doi.org/10.1038/ncb1698			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18264089				2022-12-27	WOS:000253778300018
